Content-Type: text/html

#

    Reference sequence (query): batch____
    Identities normalised by aligned length.
    Colored by: property

    HSP processing: ranked
    Search cycle: 3

                                                                                                          1 [        .         .         .         .         :         .         .         .         .         1         .         .         .         .         :         .         .         .         .         2         .         .         .         .         :         .         .         .         .         3         .         .         .         .         :         .         .         .         .         4         .         .         .       ] 438
         batch____                                              bits   E-value  N 100.0%  1:438             MGNTSIQTQSYRAVDKDAGQSRSYIIPFALLCSLFFLWAVANNLNDILLPQFQQAFTLTNFQAGLIQSAFYFGYFIIPIPAGILMKKLSYKAGIITGLFLYALGAALFWPAAEIMNYTLFLVGLFIIAAGLGCLETAANPFVTVLGPESSGHFRLNLAQTFNSFGAIIAVVFGQSLILSNVPHQSQDVLDKMSPEQLSAYKHSLVLSVQTPYMIIVAIVLLVALLIMLTKFPALQSDNHSDAKQGSFSASLSRLARIRHWRWAVLAQFCYVGAQTACWSYLIRYAVEEIPGMTAGFAANYLTGTMVCFFIGRFTGTWLISRFAPHKVLAAYALIAMALCLISAFAGGHVGLIALTLCSAFMSIQYPTIFSLGIKNLGQDTKYGSSFIVMTIIGGGIVTPVMGFVSDAAGNIPTAELIPALCFAVIFIFARFRSQTATN
       1 UniRef50_C7QKK3        Drug resistance transporter...   245     3e-63  1  12.6% 26:405  18:423     -------------------------LVFAGVMLGMLLAALDQTIVSTALPTIVSDLG-GANHISWVVTSYLLASTALTPLWGKLGDQFGRKRIFQTAIVVFLIGSALCGLS---QNMTQLIASRALQGVGGGGLMVLAMALIADVVPPRDRGKYQGVVGAVFGVASVIGPLIGGFFVDNLSWRWVFYVNLPVGAIALVVVAIGLRTHTAHRKPVIDYLGTFLIAAAagAVAAACLIAWFYAEKHAKEPVLPLHMFKNPVFAMCSTIGFVVGLCMFGSLTFLPLY-QQVVHGATPTASGLQLLPLMAGLLFASITSGQLISRTGRYKIfiVGTAVMTVGAWLLSRMTDTTsaVAMLVFGLGLGLVMQVLIIAVQNNVDYegTATSAVTFFRSIGGAFGASLFGTIF---------------------------------
       2 UniRef50_Q4R0K5        ChaT1 protein n=1 Tax=Strep...   242     1e-62  1  14.0% 15:407   6:429     --------------TAEAPVTQRPWLVLAIMCVGFFMALLDGSIVNIAIPTLIDGLDASYDQVLWIIDGYMLVFSVLLITTGRLGDIYGYRRLFLIGITLFTVASALCGLS---ESPDWLLAARVLQGLGGALLFPQVISSILTIFPPQLRGRAFGLFGAIVGFAPIVGPVVGGFLLAHLSWRWIFFINVPIGIVTALLAVRYVPVMRPGRSNSLDLTGVALATAGLTGIVFGLIEGErwQHRRKTDSLMPLALFNARNFSVGNGVGFIFQLGMIAIAFVLVLYL-QTARGYSALETAAVMLPNAILTAVGSTYAGRLSDKFGGKYVLMAGLAMLTVGLLVLVAStaWSLLPGLIIIGIASGATFAPLQQATMDGVNPQLAGAASgnTTRQVGGVLGTAVLGALLSA-------------------------------
       3 UniRef50_Q2J7M8        Drug resistance transporter...   242     2e-62  1  15.2% 22:436  32:489     ---------------------RERQWALLVLCTGALAIVIDTSIVNVALPSIGQDLGFSAAGLSWVVNAYLIPFGGLLLFAGRLGDLVGAKRMFLAGIALFTPASLVCGLA---QNPETLVAARFVQGVGGALAAAVVLGLVVSTFPNaeQAKAIGLYAFVSSAGAALGLLLGAWITEALSWHWTFFINVPLGLLVLPLGARLvdERVVLDDRSIDVPGVLllTWALVGISAALLAAFVVRQRTARNPLVPLSIFRARNVAWANMVQALMIAGMGGM-FFLGTLYLRQVLGLSAMEVGLAFLPTALMVAVISlaTPRLMEKIDPKTVLVPGLLLITAGLALLAVAPADgvLPAMVLLGAGAGLGYPSSLTMVMADATAADRgsGLVNTTQQVGPAIGLAVLATVaaLTGGYHLAFWIGSGASLVALVLTVLFLRPA--
       4 UniRef50_Q652N5        Probable anion transporter ...   241     3e-62  1  12.4%  2:429 159:580     -PAEAVLIGDTNEISPWWQQFPKRWTVVLLCFFSFLLCNMDRVNMSIAILPMSSEFGWSPATVGLIQSSFFWGYLLTQILGGIWADRFGGKVVLGFGVVWWSIATVLTPLAAKI-GLPFLLVMRAFMGIGEGVAMPAMNNILSKWVPVSERSRSLALVYSGMYLGSVTGLAFSPLLISRFGWPSVFYAFGSLGSVWFALWQRKAHSSPSEDPELSKAEKRYILGGSTLKEPVTS--------------IPWKLILSKPPVWALIVSHFCHNWGTFILLTWMPTYYNQ-VLKFNLTESGLLCVLPWLTMAIFANIGGWIADTLvrKIMQSIGFLGPALFLTLLsvRTPAMAVLCMACSQGSDAFSQSGLYSNHQDIGPRYAGVlgLSNTAGVLAGVFGTAATGYILQK-GSWDSVFQVAVVLYIVGTVVW---------
       5 UniRef50_C6QHH0        Drug resistance transporter...   239     2e-61  1  11.7%  6:408   1:429     -----MQNPTVENSDDAQSETRRRLAIFGALALVLLLASLDQTIVSTALPTIVREIG-GLSHLSWIVTAYLLATTVVVPLYGKLGDLFGRRLILQAAVIIFLVGSALCGLA---QNLPELIAFRIVQGLGGGGLIVTAIAVVGDVVPPRERGRYQGFFGGIFGLSTVLGPLIGGFIVDNMSWRWIFLINVPFGLAALLVINRTFRPHARKERVEIDYVGAGLLAITLtaLGVLAFAWFLYAETVVPDPLLPLSLFKERAFVIASSVGFIVGMALFGSITLMPVYL-QIVQGLDPTSAGLHMTPMMLGVFVSSVTSGQIISRIGRYKMfvLGTGLMTLGLVFllATSAETASVYMLCLGLGLGMVMQILVMSVQNAVAYegVATSGTTLFRSIGGAVGAALFGGIFSFT------------------------------
       6 UniRef50_B5XQW0        Transporter, major facilita...   237     7e-61  1  13.1% 14:432   1:416     -------------MNTTANTTRIRWWIAGLMWLAIAINYIDRTVLSAAAPHLIDELKLDPEMMGFIMAAFFWSYSLLQIPAGWFADRFGQKKGLGLAVAWWSIATSMMGVA---TGFKSLLALRLALGVGEAAAYPSNAGIAARWFPDKERATVSGLFDSASKFGGAVAMPLIVWMIYTFDWRLTFLIIGSVGILWVIAWYFIYAENPEEHKRISPSEVRII-----------RDGQKQHHGDKTVLPMKWYKLLRYRNIWAMCIGFFTINYTSYFFITWLPTYLVKE-KGMDFIKMGMVAALPLLCGMVIEVFAGWASDRltRKLFLTIGLLMALCIGFAPFTDSVFMTVFLLCVAKSGTTVAASQVWALPGDVAPKNSVsaGLQNTVSNMGGAVGPIITGAIVAATGSFNWALIFSAILVVIGIINYLFL------
       7 UniRef50_C6D8J1        Drug resistance transporter...   236     9e-61  1  12.1% 23:403   6:415     ----------------------RKWWVLITVSLAVFMAMLDITIVNVALPDIQRSFSSDFSNLQWVLNAYTLVYAAMLLPVSKLGDIIGRKKVFLMGLGIFVIGSLTSGLAG---SDLWLNIFRGVQGVGGAAMMSLSLTIVTASFPEKQRGLALGIWSSVVGLAISGGPLIGGALVDSFGWRSIFLVNIPFGIAAILLGMFFIQESNKNSKGKIDYLGFVFSTAMIFTMVLALIQKEVHeeRMVKQPMIELSIFKSRSFNGANIAAFVLGAGLYGGFTYL-TILMQNYMGYSAFETGVKMLLISGFTIILGPLAGMVSGKIGNRWLISGALFIGAIGIIVivPVEWSYLMPGFVLLGISNALVNPPIANAAMSSIDKKQVGMASgnVFRQVGISFGVVMLGI-----------------------------------
       8 UniRef50_B9JKN8        Tartrate transporter protei...   235     2e-60  1  13.0%  2:433  51:478     -AQAAAQGERAANPVEDRAYRKVFWRIVPFLVLCYIVAYLDRVNVGFAKLQMSSELGLSEAAYGIGAGIFFIGYFLFEVPSNVIMNKVGARVWIARIMVTWGIVSAAFMFT---TSETVFYILRFLLGIAEAGFFPGLIFYLTSWYPARHRAKIITTFMSAIPVSAIFGNPLSGFLMDSfgWQWMFLIEAVPAILLGVLVFFYLDDKISDAKWLAADEKAVLTANI-----------EAEDRAKSSSPHDVASTLRDSRVWLMCLIYFCFVLGQYGLNFWMPTI-VKASGVVGNLNIGLVSAIPYICTFIVMIALGRSADRHRERRWHLiaLIAAVGFIAATASTSTTFSIIALSLAAAGAISCAPLFWSLPtlAGTGAAAGIAWINSVGNLAGFLGPFLVGYLKDFTGSTSAGMYLLAAALVIGSIAVLTVP-----
       9 UniRef50_A5N6X3        Predicted transporter prote...   235     3e-60  1  11.3% 17:432  10:423     ----------------ESKPTGKRWFILFLVCAITFINYLDRANLSVAAPFISKEFMLDPAKMGLIFSALSWSYTVMQIPSGWFLDRLGPRLVYGVALCGWSAFT---GIVAFTFNFTSMIFCRLGLGFFEAPAFPANGRIVTTWFPSKERGSAIGAYTASEYVGLALCTPILTWLLVTFGWRVIFIVTGILGLLFAFIWFTHYNDPAHSKGINKEELELI---------KEGGGLSDTVSEQKKITKKEIKYLFTSRQLWGMYIGGFAITAILFFFMTWFPSYLVNE-KNMAILKVGIYGALPYLAAIAGVLVAGKWSDwlSRKLPVIVGLLLSSVIMVANYTTNVNVVITFMSISFFGQGMASAISWALLSEIAPKDLVggGTYNFVANMGGALSPAIVGYLISRTGSYSSALVFVSCMALIGALSYIFI------
      10 UniRef50_A0QVE8        Major facilitator superfami...   234     6e-60  1  12.6%  1:435   1:430     MDLKSDSPRQARRQRDAKKVKNLRYWILGWLLLAGILNYMDRSSVSIAAPHMIAELGLTKTDIGLMGAVFSWTYALCQLPAGYLIDKLGARRMYFAAVGIWSVATALM---SVGQTMAHFLTFRFLLGVGESPNSPNSSKITTEWFPREERGQAAGIWDSGSKWGSAIAPPVLTVLSLAFGWRAMFLIIGLAGLVLALAFWAYYRAPESSRHLSEEEYRYIVA--------------GRDDTTQPKAHLPWGKFFTYPQTWGMMLGFFSSIWIWNIFITFLPLFL-QDTLDVSIAQTGWVAAIPYLASAITGIYAGRLTLTLVRRrvLIGGSVGLGILLAVVPLVHNPVLAIVVLCAALGlaAVQSQSWALTSDIVPDTHAagGIMNFGGYFGGALAPLVTGVIVDKTGSYTPSFLVSGVIAVLGACVYGFMVRR---
      11 UniRef50_C1XTU0        Drug resistance transporter...   232     1e-59  1  13.6%  4:406   2:431     ---AEPIRSDPGAGEAPQGMPRETRMTLIGILLGLFLAALDQTIVSTALPKIIADLN-GTELYAWVTTAYLLASTVSAPIFGRLTELFSRKSILLIAILIFLGGSALCGLS---QNMPELILFRGIQGIGGGALFALALTTIAVLFPPRERGRVGGLFGAIFGVSSAVGPWLGGLLTDHLSWHWVFYINMPVGAVALWFIGRFMPRLRPDHRETFDFLGAALliLGLFAMSAVALALWVWSQSREKHPLFDLSILKIPTFTIASVAIFFYGPAFLGAVAFLPLYL-QVVKGVSASASGVTVLPLTVGVVLGATGSGVLSGRLGRYKplWLLAVFLTLHLVLSVNTPLWLAVVLFFLLGLGLGPSQSLLQVAAQNNIPPQRLGSATAAtiRQIGSTIGIALLGTVLT--------------------------------
      12 UniRef50_Q3AB00        Drug resistance transporter...   232     2e-59  1  10.9% 23:417  11:430     ----------------------NKWLTMFVVVIGTFMAILDTSIVNIAIPKMMQVFAVGTEEIQWVLTGYMLVMGVVIPVTGYLGDTYGYKRLYIAALFFFTLGSALCGFAWSNNSM---IAARVVQAIGGGMMMPASMTIIFNTFPKEERGMALGIWGISVMVAPAIGPTLSGYLVEYFNWRLIFTINIPIGLFGMVMALLFLKESVRRPHATFDLPGFITSSVGFFALLLALSKGTDWGWSSapEPLLDLSVLKNPTFAMSLVITMINTMGLFGGLFLFPIFF-ENLRGYPPMDTGLIMLPAALASGLVMPIAGRLFDRFGAKPVVLFGLTLAIISSYGLSLThlWWLQTLLIIRAMGIGFSMMPVNTAGMNALPNygRASAINNTLRQVSSSLGVAIITTITQQRVAFHTARMV---------------------
      13 UniRef50_A6CHD2        Major facilitator family tr...   231     4e-59  1  12.5% 21:405   6:416     --------------------PRKKILIMLAIMSAMLFAALNQTIVGTALPTIISDLG-GIEYYSWVFTIFMLTSSVTAILVGKLSDMYGRKPFILIGIGVFTLGSFLNGLSG---SIIELIAYRGIQGFGAGMIMSTSFTAVGDLFAPRERGRWQGLMSGIFGLASVFGPTLGGWIVDNAEWHWVFWVFLPFGLLAFIMIWKLFPSQQVQEKKKVDYLGSLMliIGLFVLTGASLIFFIVTEKKAANPVLPLHLFKNDIFTLSNIIGFILGAGMFGAIMYMP-FFIQGVIGTSATKSGFVMMPMTLSMVFASAIGGQLITKTGKYKLIalGLFIMASGLASLSmtTNTTAVINMIIVGTGLGLSFPVFTLTVQNAVQHQYLGVSTAAtfRQIGGTVGVAVMGTVM---------------------------------
      14 UniRef50_C6PT89        Major facilitator superfami...   231     4e-59  1  11.0% 16:432   9:423     ---------------EKSKATGKRWFILLLVCVITFVNYLDRANLSVASTSISKEFALNPAVMGLIFSAMSWAYTCMQIPCGWFLDTFGPRLVYGIALLGWSLVTGIMSLASGVSS---LIACRIGLGFFEAPAFPANNRIVTTWFPSHERGLAIGAYTGSEYVGLALCTPILTWLLVTFGWRSIFITTGVLGVLCFIGWIAFYHDPASAKGVNKAELDLIKNGGGL---------SDTIKEKRKISLRELKYLFSNRQLWGMYIGGFSIASILFFFMTWFPSYLVNE-KHMAILKFGIYGAIPYFAAIAGVFVAGRWSDwiSRKMPVIIGLLLSAMIIGGNYTNNISLVITFMCIGFFGQGMASTVSWALLSEIMPKNLVggATYNFITNMGGALSPLIVGYLIARTGSYSSALVFISIMGIIGAVSYIFI------
      15 UniRef50_A8G9M5        Major facilitator superfami...   231     5e-59  1  13.7%  5:435   4:436     ----TMEKQTVKQTAETQVYGKITRRLIPFLILCYFFAYLDRVNVGFAKLHMQDALNFSDTVYGLGAGIFFIGYFIFELPSNLLMQRFGPRFWIARIMATWAVLSAAMMFVTTPTSFYVL---RFLLGVAEAGFFPGIVFYLTLWFPSWRSARTLGLFILVTPLSVIIGSPLSGLILKLfnWQWLFLIEAVPSLVLAFVVLRYLDNNVAEAKWLTAAEKNLV------QADLAKDQANRDRAANGKAAHSLKEMLANRYVWLLALIFFSFNVGYYGISFWLPSIIKTSGI-SDDLQIGLLAALPYVFGALFMIWNSRHSdkQERRWHIAIPAVIGCIGLTLSAygSTFWMMTWICVAMSGTLALIPTYISLPGALLsaAAAGIALVNSVGNLAGFFGPTVLGWLKDQTGQTDSGLYILAGFLLLCAPLIFMLPAR---
      16 UniRef50_D0KBI4        Major facilitator superfami...   230     7e-59  1  14.3%  1:435   1:426     MKQTTASSTPAAVTQPSQKISRLRWNIIFILLIAAVVNYLDRANLSIANTTISKEFGFSSTQMGLLLSAFLWPYAIANLPAGWLVDKFGPKKMFSWALGLWSGFTIL---AGFVNGYAMFYGLRMLLGVSESPFFTSGIKITHRWFPSNERGLPTAIINTGSQIANAIAPPILTILLLTMGWRGMFIAIGLAGIPLLLVWMKLYRNPTPQ-----------------EEVEIHGPVEATETQKPDAPKASWGSLFKHKTTWFMILGNFSIMFTIWVYLTWLPSYLERS-LGFSLMKTGWVASIPFMAGILGVLCGGIISDRlaRKIPIVCGAALAACCVAPVPFVTDTTliALLSLGYFFSQMPSGVIWTLATDIAPKTQVagAIQNFGGFLGAASAPIVTGIILDMTGAFTNVFIFGASLLMLGAISYGVFVKK---
      17 UniRef50_C2AN99        tRNA-guanine transglycosyla...   227     7e-58  1  12.8%  1:405   1:441     MTATtqSPEQAAGVPSGPLTHKQILYILAGLMTGMFLAALDQTIVSTAIRTIADDLS-GYQLQVWVTTAYLITSTIVTPLYGKLSDIYGRKPFFMFAITVFVLGSLLC---SFSTSMYELAAFRAVQGLGAGGLMSLALTIVGDIVPPRERARYQGYFLAVFGTSSVLGPVLGGviLGITGWRWVFLVNVPIGVIALLVVYRVLQLptRREGVRIDWVGAFMLAVGIVPLLIVAEQGREWGWGSTKsaIIPLRIFRNRIFAQGVLISVVVGAAMFGGISLLPQYF-QVVRGASPTVAGFMMLPMVLGLMMGSILAGQMISRTGRYRIyiIGAVLLTVGMWALHYVTADvvMAGAALIGFGLGNLMQPLTLAMQNILPPQDMgtAAATFFRQIGGTLGVAVFLSVL---------------------------------
      18 UniRef50_A4FF64        MFS transporter, phthalate ...   225     2e-57  1  14.4%  3:432   2:430     --AVQAQNGSTNHPAVRKRRVRIRYVVLAVLFVSTAINYLDRTNLSVAAPHIQHDLGLSATELGVILSAFSWGYAFLQIPGGWLLDRIGPRLAFGWALVLWSLATVAT---ALARGFGSLFAVRASLGVLEAPAFPANGRLAASWFPSSERGRATAIYTAGEYVGLALAVPVLSMLVVAFGWQSVFVVTGVAGLVWAVVWFRQIRNTPQEDPRVDDDELA-------HIEERHLGRANVVPSSAKLNWADLRYLLTRKRLWGIYLGQFAINSAMFFFLTWFPSYLTQSR-GLELMEAGFYASIPYLAALAGVLLGGWWSdrRgaRKTPIITGLFLATVIVAANYVDDVGLIVAIMSVAFFAQGMAAISWLLPPEIAPSRMVggGVFNFVGNLGGASTPIVIGMIVDATGSFAGGLVFMSCVALMGALSYVFL------
      19 UniRef50_Q46TQ9        General substrate transport...   225     3e-57  1  12.4%  1:418   1:419     MTTISTSAARQRTAdvRSVYAKVTRRIIPFLFICYVFAYLDRVNIGFAALQMKHDLGFSDAVYGLGAGIFFIGYFLFEVPSNLLLEKIGARKTMMRIMVVWGVISASF---AFITSPTQFYVARFFLGAFEAGFFPGIVLYLTYWFPPAMRGKIITLFMSAIAVSGIIGGPLSGWIMTNlgWQWLFIIEAVPSVILGVLVLFVLADKPADASWLSAREQEVVA-------------REVGATDPHGHDHSFLKTLRDPRLYALSVVYFTIAAGLYIISFWLPE-MVRSYHVTNPLHIGILTMIPYLITTVGMVVVGKHSDKTrrRWHVALGMIVAAMGLVAVTFvsLPVALAVLSITTLGVLTAMPLFWTIPTSYLSsaAGGIAIINSIGLIGGFASPSMLGLVKTTTGSLDYGLYTF--------------------
      20 UniRef50_C8WV76        Drug resistance transporter...   224     6e-57  1  11.7%  4:406  17:444     ---ASPNAPSHAPSGEAAHGHPHRTPIMIVMIFGAFVAILNQTLLNVALPHLMSAFNVDANTVQWLSTAYMLTNGVLIPITAFLMGTFTTRQLFISAMSLFLVGSFLC---AIAPSFGVMVFGRIVQASGSAVMMPLLMTVILELFPPQQRGRAMGTMAIAMFFAPAVGPTLSGWIVTNWSWRWLFWIIIPLAFIDIVLAVAVLRNVAKPVRPKLDVPGFLLSIVGFVSLLYGLSEAGSkrELTAKEPMLDLRVFKYDVFTMTTIVGCIVNMAMFGAMILMPIYL-QDIRGYTALQSGLMMLPGAILMGIMSPISGAIFDRVGARPLAVVGLAITTVTTwlNAQTGYGHIMLLYTVRMFGMSLLAMTVQTAGLNQLPRhrHGTSAANTARTVASSVGTAVLVTIMT--------------------------------
      21 UniRef50_O82390        Sodium-dependent phosphate ...   223     8e-57  1  13.4% 22:431 100:504     ---------------------PKRWVIVLLCFSAFLLCNMDRVNMSIAILPMSAEYGWNPATVGLIQSSFFWGYLLTQIAGGIWADTVGGKRVLGFGVIWWSIATILTPVAAKL-GLPYLLVVRAFMGVGEGVAMPAMNNILSKWVPVQERSRSLALVYSGMYLGSVTGLAFSPFLIHQFGWPSVFYSFGSLGTVWLTLWLTKAESSPLEDPT--------------LLPEERKLIADNCASKEPVKSIPWRLILSKPPVWALISCHFCHNWGTFILLTWMPTYYHQ-VLKFNLMESGLLSVFPWMTMAISANAGGWIADTLvrKIMQTIGFLGPAFFLTQLKHIDSPTMAVLCMACSQGtaFSQSGLYSNHQDIAPRYSGVlgLSNTAGVLAGVLGTAATGHILQHGSWDDVFTISVGLYLVGTVIWNLF-------
      22 UniRef50_D1YA33        Transporter, major facilita...   222     1e-56  1  13.1%  9:436  10:433     --------ETTDKADASKPPAKRWVYVIPVAVIMYMLAYLDRTNTAMILPYINSdiHLTKADEGIVSGIFFFGYMFLQIPAAILAERWSAKKTVAILMFLWGFAAMA---VSFVQSNGQFYTARFVLGFFEGGVWPSVLILIANWFPLKERARANSLWMCCLPLSSVLISPITGALLDHFSWRTVLFVEGIPPLIWAIVWLLVVSDHPHNAKWASDAE---------REYIEAELTADEANKPIIDGDGGYLAAARSAHVWQLITIYLCFMGGFYGYTLWLPTVVKGLMSGSSASSVGLVTAIPYIFAVVGMLAVSSWSDHTGNRRVAIalAIGAVALTIGQVVHHPIVNIVLLVIVAIGVYSPYGPYWAVPGAYLRIeaGGLGLINALGNLGGFVGPYLVGWLTDVTGSAATGYYALAGLLVVGAVLTWVVVKPK--
      23 UniRef50_C8XGB2        Drug resistance transporter...   222     2e-56  1  11.4%  4:423   2:447     ---TQTVATGPGTRARPPMGRTQMNLVFVTVMLGMLLSALDQTIVSTALPTIVGDLG-GAGHMSWVVTSYLLAETISTVLAGRFGDMFGRKIVFQISVAVFIIGSFFCGLA---QNMEMLIASRAIQGLGGGGLAVTATALIGEVIPLRERGKYQGALGAVFGVTTVIGPLLGGLFTDHLSWRWAFYVNVPIALIVIAMAATTIPRLSERSKVPVDYLGVLFIGLGATGLTLATTWGGNevESRAVAPILPLHLFRSRVFTVSSILSFIVGFAMMGSITYLPAFL-QFVGGASATESGLRMLPMVVGLLITAIASGNFVSRTGRYRMfiAGAVVTGLGLYLFSTMGVGTSYWlmLVLGAGIGLMMQILTLIVQNTVsdLGSATSGVSFFRTLGGSFGASIFGTIYANALDDHLPQAVLAAGLL---------------
      24 UniRef50_A8KZV5        Drug resistance transporter...   222     2e-56  1  13.4%  4:435 262:738     ---AAEKTEEKTAAPAGRGRRVPAWAVLAVCCFAQFMVVLDVSIVNVALPSMQTELGLSSSGLQWVVNSYTLAFAGLLLFGGRAADLFGRRRVFITGLTLFTAASLAGGLA---NDQTMLIVARAVQGLGGAVLAPATLSMLMTSFppRERARALGMWGATAAGGGAMGALAGGVLTEIADWRWVLFVNVPIGLVLIVGARAALIESRGQARGVRDLDIPGTVTvaWLAGAVVLLAAFLIIESRTANPLVPLAIFRRRALRYANTIGVVMGSIMFGLFFFLTLYLQQ-VKGQGPLEAGLALVPMPIMIIVGSQVSSRTVGRFGPRPLIIGASVIVASSVGWLSALSAHGSYWalALLGFGMGINMVAVTTAATAGVPPQLAGLASgnTARQIGAAVGLAVLAIIADttSGYSLGFLVCAALMLGAAVLAVFMPRK---
      25 UniRef50_Q24N35        Putative uncharacterized pr...   222     2e-56  1  13.2%  7:438   1:431     ------MDKTYTSEFEKQTVSKVSRRLLPLLVACMFIAFLDRINIGFASLQMNSALGLSSAAYGFGAGLFFIGYFFFEVPSNMILEKIGARIWITRIMITWGFIAIGFAFVQGEKSF---YIMRFLLGAAEAGFFPGVIFYLTKWFRAKERAAATAIFISGSYVAGIIGAPLSGGIMTYmgWQWLFIVEGIPAVILAFIIWFYLPEKPQNAKWLEPEE----------REWVVDVISKEEAALTEKEHKSLLSALASPRTLMLSLVYVCYVGGNIGLQLWMPQIIQKVAgaTSTMNITLLTTLPYIAIIIAMIFWARHSDKTRERRWhvASLVAAVGLVISASASSLTISMLGLIITGLGMGGAQPTFWASVTQILDpaAVAIAVVNSVGNLGGFFGPNLMGVASTITGQYNAGIYIFASCFVLLLIFMQVLYKTNQK
      26 UniRef50_A9B1V7        Drug resistance transporter...   222     2e-56  1  14.0%  6:413   1:434     -----MAATAQDSEQSPKGGLAYKWKVLISVIFGIFMVILDTTVVNVAFRTVQQDLGATINEAQWILSIYVLMLGISTPISGYMADRFGLKRTYVIGLSIFVLGSFLCGVA---PTIETLVVARAIQGLGGGLSTPLGTAFIYGAFPPNERGKALGVFGIAMVLGPALGPILGGLLVDNDLWRWIFFINVPIGVLGVSLAIRWLKPTPPTGKPKLDVLGLITSTVGFGSVLYAATIAAEQGWESGsePLLDLRLFKKPTFTMANLVGWVSVLALFGAEFLLPLYL-QVLRGRTALETGFILLPLAIAAGFATPTAGRLYDKIGPRPLIVTGYAILILNTwlQADTSIGWIMFLLALRGLALGMTVQTTFVTALSDvpKVPRGSALINATRQVIQSIGVAVLATILASTTSVAT-------------------------
      27 UniRef50_B2JWD4        Major facilitator superfami...   222     2e-56  1  16.9% 14:432   1:412     -------------MEKHTRRVKTRHIILAVMCVMYFISYIDRVNIAVAGPLIRHEMGLTSAELGLVFSAFAYPYAIMQIIGGWLSDKYGPKLVLTVLSIIWGAATLATGFAG---SVAMLVALRFTLGIGEGGAFPTATRAFTYWMPVSERGFAQGITHSFARLGGAVTPPLVLAVVAAGGWRDAFVLLGVASLAWTVLYLCVFTNSPEQNKRITPEETA------------EIGYRVGDCDRAKRMPTPWRKL--IRRMWLVTFVDFCYGWLLWVYLTWLPSYLKESR-GFDLKHLALFTALPLLAGVIGDTLGGVVSdrFARCAVLVVGMGGSLAFLlmVSASNPLTAVWYLSASFFFLEITNPVLWTLPLDIAGKYAGTAGGMMNTGfvAGMVSPVVFGYLIQTTGSYNVPFSISAGLLAVGVVAACFI------
      28 UniRef50_B2HEY4        Conserved transmembrane tra...   221     3e-56  1  13.6% 18:436  35:488     -----------------RRRQPSPATVLLVAAFGAFLAFLDSTIVNVAFPDIQRYFHSGISDLSWVLNAYNIVFAAFLVAAGKLADLLGRKRLFVYGVVLFTIASGLC---AAADSVEQLVAFRVLQGIGAAVLVPASLGLVVESFPAERRAHGVNLWGAAGAIAAGLGPPIGGALVEALNWRWVFLVNLPLGIVAVLAARRALVESRACGRRRvdWGWSSLPAIGSLVAAALAMIGFVMSSRNHPTPLVEPALLRIRSFVAGSALTAIASAGFYAYLLTHVLFL-NYVWGYTLLQAGLAVCPAAIIAAVTAGLLGRVADRHGYRVIIGVGALIWAGSLLWYLTCVGTtwLPGQILQGIGVGAAFPLLGSAALAGLasYATASAVTGTIRQVGAVIGVALLVILVGTPAPGAagWTMAAICFVAVALGAVWLGRIR--
      29 UniRef50_A8KYD1        Drug resistance transporter...   221     4e-56  1  12.9% 17:403   2:414     ----------------AEPTSRRRFAVLAICCMSLLIVGLDGTIVNVALPALRRDLGASPAGLQWTIDSYTLVLASLLMLGGSTGDRLGRRRIFQTGLALFTAGSLLC---SLAPGLGWLVVFRMVQAVGGSMLNPVAMSIITNTfdPRERARAIGLWGAVIGISMALGPVLGGILVETVSWRAIFWINIPIGLAALVLTHRFVPESRAPSPRRLDPVGQLLVIAVLATLTYSIIEAPAAgeSRRTEPLLDVRFFRSAPFSGATAIAVCAFGALAGFL-FLNTIYLQDVRGYSALHAGLLTLPMALATLVIAPLSGRAVGRFGPRPSLLAAGVALTAGSAAMTGLSptTLMVAYVLFGTGFGLVNAPITNTAVSGMPLEQAGVAAAvtSRQVGQSLGVAVIGS-----------------------------------
      30 UniRef50_C8QBB2        Major facilitator superfami...   221     4e-56  1  13.0% 18:432   2:412     -----------------RNYPKIRWFMIIMCFIAMAINYIDRVNLSVAAPHIKHDLGLDDVSMGLIMGAFFWTYALMQIPVGRLLDRFGERIGLTIAVAWWSVFTVLT---AFGRGLVSMMGLRMLLGIGEAGGHPGCAKVVYSWFPKKDRATASGIFNAGPRAGSALALPLVAWIITTWDWETSFIVTGVLGIIWAVAWYIIYRTPELKAGLNAEERDNLIA-------------DRGPAKKQGTEKKAWLFLFRYRTMWGMMLSFFCLNIALSFFLTWFPSYLMAS-QGFSLKQLGTLGMIPPLVGIPASMLGGYLSDwfARKSCLVFGLLLSSVISFATYTNSIPLIITLLSISYASIAFAAAVVWSLPADVAPStgTIGGIQNFAGNLAGIISSSFTGIMLSlnGSFEVPLIATGVICLIGALSYIFI------
      31 UniRef50_D2LUR6        Drug resistance transporter...   221     4e-56  1  12.0% 20:426   1:432     -------------------MDRYQRNIIIALLIATFLAAIEVTVISTAMPVITRDLG-GLDLISWVFAIYLLTYAVMTPIFGKLADLFGRKKIFIIGATLFLIGSGLCGLS---QSMEQLIFFRAIQGIGAGALMPMSFTIVGDVFKYEQRGKVQAILGSIWGIAGICGPLVGGFFVDYFTWHWIFYINIPFGIISMYLIGKYLEEKIEKRKRKIDYGGAVTFIIGMGALLYALLSgfVWIQIKVSEPMLPFRLFKNRYLLIANVSGFLLGMILIGLTAYLPLW-VQGVLLLAATSSGLTLIPMSIGWPLGSFLSGRFLVKLGTKLISLTGVIVISLGTFGLTftPNIILIIIMFFIGLGFGLSMTVFTVIVQSSVsnRGTAASSNAFLRTLGQTLGITILGVVLNQHIGGQTNNGTDVAPALLAA------------
      32 UniRef50_C6CBG7        Major facilitator superfami...   221     4e-56  1  11.4% 19:432   2:424     ------------------KATKNRFFILSLLFIVTAINYMDRANLAVAGSNIQNDFSLTPTQLGLLFSMFTWAYAASQIPVGYVLDRIGSRILYGGAIILWSVFTFLMGFAsvTASFIMLLVCRALIGVAEAPSFPSNTKIIATWFPDHERARATAIYSSAQYIGLALLTPALSFIVAQYGWEMSFYLSGAAGILFGIYWLIYYRDPQHSKNINQAELDYIKAGGGYGSV-------NQSTVSEKISWRDIKYFLKRKTIWGLFITQFACSSTLYFFLTWFIVYL-EKGLHLSISKAGMGAMLPYIMAMFGVLCGGTLSdtLARKLPVLMGLCLTLIIATVNFFEDQPIIAIIILSIAFFANAFSNLGWVVWSDVIPRNYLGtgFLNICGNLSGIVSPIVIGVILERTHNFQYAMWYIAGVAGMGILAYVFL------
      33 UniRef50_Q5YPQ7        Putative transporter n=2 Ta...   221     4e-56  1  12.8%  7:406   1:426     ------MSMATVGAETATRRSAGAIWTLVVVALATFMLMLDLTVVNVALPDIRAAFGSSFSALQWILDAYALGLAAVLLAAGSLADRLGRKRVFDAGLVIFVLSSLACGLA---PNDLVLIVARFVQGLGGAILFAVGPALLGHEFRGKDRGMAFGVFGGVTGLAIAFGPLIGGGLTETAGWRWIFLINVPVTIAALVIGYLKVRESRSDTPPPVDWPGMITFSAGLFFLVLGFMRGEQDGwtRPGRAMFDLSLFGSRTFNGLSAVTALCALTVMPALFLLISY-VQNMLGYSAFASGLRFLPLTLLLFVAAAVAGSLVTKLPPAVLVGVSQLLIAGGLLAVVLvsAWTALiaMILIGLGMGVFNPPRAAFSIAVTTPDKSGMASGitFQQAGVAIGIAAVGAFFQ--------------------------------
      34 UniRef50_Q1IRM2        Drug resistance transporter...   220     7e-56  1  13.5% 10:409   2:430     ---------SSAAVQQQEASATSPWLIAIAVMLATFMEVLDTSIASVALPHIAGSLSATNDEATWVLTSYLVANAIILPASTWFALRFGRKRFLIICIAIFTVSSFACGAA---TSLWMILAARAIQGAGGGALQPLSQAILLESFPPQKRGLAMAVFALGVVVAPVLGPTFGGWLTDTYSWRWAFYINIPIGILAVFMILRYVVDPppGRIDAIGLGLLAVWLGALQIILDKGQEVDWWSAttAEKPLVNLRVFTHRNFTLGCIMIGLFGAVIYGMVTLLPLFY-QELMGYTALNAGIAVSPRGVGAIVAMPIIGILTSRIDNRWLIAFGFALFGICSIWflGIGPWTFIWAIILSGFASGCVFVPLSTTTMAGLRNEEIGNASgnLLRNIGGSIGISIVNMIVARHS-----------------------------
      35 UniRef50_C6IWM4        Major facilitator superfami...   220     1e-55  1  13.1%  3:414   4:440     --TTQRSDLRTTSYQDDPDIQRKRWLILIVLNLFTFMSTLDGSIVNIALPVISKELHLTVAQAEWIVSAYLMMTCAAILFFGKLGDIVGKIKVFKWGMVIFTVGSLLCGFS---HNLPLLVGSRLLQALGASLTMANSQGIVTDIFPAGERGKALGFTGTFVSLGSITGPSLGGVIVSALGWEYIFWVNVPVGLIAIVIGWKLLPADRTKLKVKIDKAGSTLfiVSALVLAVAVFLVFLWIETRSEAPMLQLTLFRNPLFSLSILSGFLVFVANFCFNIIAP-FYTQSILNLSPSHAGFLMMLFPIVMVIVAPLSGALSDKIGSELLTFVGLIVMVIAQIGLARLHDSSSivWIAMLGLGNGLFQSPNNSLIMSKVPKTQLGIAGSInvRNMGMVVGITVATTTLFSVMSSRAG------------------------
      36 UniRef50_A1HMH9        Drug resistance transporter...   220     1e-55  1  11.1% 23:417  13:432     ----------------------YKWWALGVTIIGGFMSILDTSIVNIAVPKMMAVFAVDTDQAQWILTAYMLTMGVLQPATGYFCDVYGTRAMYLFSLAVFTVGSALCGAAWSNDSM---IVFRIIQAVGGGMIIPVTMAIVYHVFPPQERNMAMGIWGISAMVAPAVGPTLSGYLVEYWDWRWIFTINIPIGILGYVLAVLVLKETPRIRGQKFDYGGFITsiVTLLYIAFASLALFVAIELNHENPILDLSLFKDWNFTLSSIVIFIGTIGLFGGIFLVPLFM-ENIRGYTAMQTGILMFPSALTAGLMMPVAAKLADKFGAKPVVVVGLFFLAAGTWPLMYLDLDtvMLVMILRGMGLGLFMMPVTVLGLNTvpKISRASALNNAIRQVSGSFGIAVLSTVLQNRQIFHYAHIA---------------------
      37 UniRef50_D1C6K4        Drug resistance transporter...   219     1e-55  1  13.1%  4:414  21:456     ---STAPSAPPSDGPPGIVPGRHKWLVLSTVSVGTFMATLDSSIVNISLPTIQQHFGVSLSTVEWVVVAYLLTLGTLLLSVGRLGDMVGYKRVYLGGFALFTLASVLCGAS---QSIWMLIGFRVLQAVGGTMLQAMGPAITTRTFGSQERGRALGLNAISVSLGLTIGPTLGGVLTEFASWRWIFYINLPVGIFAILWAWRVLEPEGRRARQMFDIPGAALsvIGLLLAAAVLGTAFIVVELHHRQPMLDVRLFRIRSFWAGNLSLLIVFSGLFTATFLMP-FFLQQGQGLSPFAAGLLLTPVPLTTLVVAPISGALSDRIGPRLPATLGAAVMTLGLYTLTQLHVGslIWRLVVLGVGQGLFFSPNSSAILGAVPRPRLGTASATvmRIFGQVLGIAVAGAVVASRLPVHLA------------------------
      38 UniRef50_C8VWC5        Drug resistance transporter...   219     1e-55  1  11.3% 16:430   4:443     ---------------SDSTPNPKRWLILFAVMTGSVMGPIDGSVVNVALPTFAKAFNAGLHTVGWISMSYLLVLGSLILTYGRLGDMYGYRKIFLTGILIFTLSSAVC---ALAPNIWTLIAFRAVQAVGAGMFMAIGPAIITSVFPPHERGRALGTNGMIVAIGLALGPTLGGFLLNRFGWPSIFAINIPIGILSYIFCLKVIPPYRDLKPQKFDIAGAILGFISLGVFLLFASYGEEWGWarVEQPMLDLSLFQNKVFSAANFAALMNFVSQSAMIFLLPFYMQQ-VLHFNSEYIGLILTVSPLTVLLLARISGTLSDRLGTRWLAFTGQSIVCAALFLMSGLTANsiVWRLFLFGLGIGIFQSPNNSAVMGSVPRHRLGIGSGvtVRNVGMVMGIAVSSAIVTIHTSGNASANIANFMVGLKTAYWV--------
      39 UniRef50_A5CZS7        Permeases of the major faci...   219     2e-55  1  12.1%  6:435  30:456     -----STTGIPAGDLEAGVQKKRFIRIIPYIFVLYIISFLDRVNVGYAALAMNNDLGFSSAVYGLGAGIFFIGYFIMEIPGNLIMARWSARLWLARILITWG---LIAGLMAFVRTPWQFYTVRFLLGLAEASFMPGIIYYLSCWFQAKEQARAVALFMLAVPVGSIIGGPVSTSLLGVhgWQWMFILEAAPAVIFGLIT----------PFYLTDKPGQAKWLTAEERNWLINRLNEEVDAKKAHKAYTLWQAFADRDVIILALIYFFWVTGFYGFNMWLPTIVKGLSTTFTNQTVGWLVAIPYIGSLFSMILVSRHSDRTGERrmLMLLTGGIGLAVSMLVVKTVGWQLVFFTVTAMGIYGAFGPFWALPGSFLtaAAGTIALINSVGNLGGFVGPYVVGFLKNATGSFTGGDVFLVVCLVVAGLMPVLLKKP---
      40 UniRef50_P54585        Uncharacterized MFS-type tr...   219     2e-55  1  11.5% 14:413   2:426     -------------ATGKEKNAKNPMSLLIVLMAGLFLAILNQTLLNVAMPHLMTEFGVSATTIQWLTTGYMLVNGVLIPLSAFLITRFGQRSLFLVAMFCFTLGTLVCGIA---PNFSTMLIGRLIQAVGGGILQPLVMTTILLIFPPESRGKGMGIFGLAMMFAPAVGPTLSGWIIEHYTWRIMFYGLVPIGAIVIIVAFFIFKNMVEPQKIKLDTLGAILSIVGFASLLYGVSEAGSDGWtrHDDPMLDFRVFKYDIFSLSSVINIIITVALYTGMFLLPIYL-QNLVGFTALQSGLLLLPGAIVMLIMSPISGILFDKFGPRPLAIIGLLVTVVTTylTIDTPYTHIMLIYSIRAFGMSLLMMPVMTAGMNQLPArsHGTAMSNTLRQISGSIGTSLITTIYTNRTTFHY-------------------------
      41 UniRef50_B5HBC1        Transmembrane efflux protei...   219     2e-55  1  13.0% 14:436   1:476     -------------MASDDRHDRRRWIALAIVMTAAFMDLVDVTIVNIAIPSIERDLGASFGAIQWITAGYALAFAAGLITGGRLGDIYGRKRLFLIGITGFTLASALCGFAA---NEEMLVASRLLQGAAAAMMVPQVLAIVHVTFPAHERGKVFGLFGAIVGLGAVSGPLLGALLTQwlEWRPIFLINLPVGIAGLILGRKYILESRAPKALKLDLVGVVLVTLGLLMLIYPLTRGRELDwrKDGSPLVELSLFKVKSFAAGIAVQ-LTFGIVMGIFFLVWTLYMQTGLGWSPLKAGVTGVPFSLasAAAGMSVQLLVPRFGRKVLQAGAATMAAGLLVYIwaVQPWQMILPLLVMGVGMGLIVAPLTDAVLSEVPREHAGSASgnTTGQMGTALGLGLVSLVfaVGGAFAQAfwVAAVLGVIFVVMFALPARPK--
      42 UniRef50_Q7N4W5        Similar to transporter n=1 ...   219     2e-55  1  12.6% 20:432   1:439     -------------------MKRNKRNVLLAANISYILVILDSSIVNVALPTIKESLSLGVTTLQWVVNAYLVLFASLLLSGGALCDRFGSKSVYITGLGLFTLSSALCGISSEA---AILLTGRVLQGISAAILVPGSLALITHTYTDkeRTRAIASWASWGGIALVAGPVIGGWLTEYLSWRSIFLVNVPLCLAGIFLTLRVQSPEHEHKSLTMDIKGQLLLfvILLCLSLIIMTAFIVVERRSKAPMLPLELFRRPNFSAISWIFFSGAFSFFGAMFIL-TFWFQDIQHLSATQTGMALLPLSISVILGNKVSGWLARRYQTSHMMIVGAMIRLVGFSGLLVtdYAYLFVPLVLIGFGGGLGSPMSTSLFMQSTPKQYTGVASGvaTGQIGSAFAVAVFGQMVNSEKLFVLNMKYAVITIIIATLSILII------
      43 UniRef50_B4EPQ0        Putative transporter protei...   218     3e-55  1  13.8% 13:432   2:418     ------------SSSRAHKPTKFRWFMVFLAFLAIVTNYMDRANLAVALPYMNTELHLSSAESGLILGAFFWTYAACQIPAGMLVDRFGAKLVFAGAVVWWSAFTMATSLARGGAS---LLGLRFLLGVGEAGAFPSATKFVERWFPPTERGLASGIYDCGARGGTLIALPICTAIITAYGWRASFIFTGAIGLVWVVVWLLVASEFPSQNRFVNAAEA-------------KHVDQDAPTEKHAPVRIKWGRLFTSRVVWAMSLGFACQGYVVYFFITWYPTYLVKER-GFSLLQLGFYGILPGLAGLVGSWVGGWISDrfARKFCIVVGMALSATIGLAGLASQAWLALLLLSIAFFGVSVATSSILALPADVSAraGTVAGFQNCISNLAGIASPAVIGLLKDATGSFTPGLISASIMAIIGCLIYIFM------
      44 UniRef50_C4LJI9        Permease of the major facil...   218     3e-55  1  11.0% 20:429   3:447     -------------------PEKDAWRALVALCIGFFMILLDQTIVAVATPDFQSALNADYSQVLWVTSVYLLTYAVPLLVTGRLGDHIGPKNVYVAGMVVFTLSSLGCGLA---PDIHWLIAARAVQGLGAALLTPQTMSVINRIFARERRGAAMGLWGATAGMAGLAGPVLGGLLTTWIGWEWIFFVNVPIGVVSVIMVLKWVPQLpqEGGNVNWAPWIWIMIAASVVVFGIFIMIEKWGAQRGVEVLVPLSLFKDKNFSVGNISITTMGFAVAGPMVPIMIYFQQ-FHHMSALKAGLMMVPMALISGLLSPFVGRLSDTVPPRRLSLTGFTFMTLSMLCYFltSVWWMFVPIALQGLGNAFVWAPNSTTTMRDLPMEKTGAGSgnTTRQVGSVIGSATVAATLDVfsSLGWTMIFPAAVLLIGLVVV---------
      45 UniRef50_Q48M53        MFS transporter n=5 Tax=Pse...   218     4e-55  1  11.2%  5:433  35:459     ----TTMTLDAVSTTRANAYRKTAWRLMPFLMLCYLCAYLDRVNVGFAKLQMMNDLSFSETVYGLGAGMFFIGYFLCEVPSNLTLHRVGARRWIARIMISWGIISALF---AFVETAWQFYALRFLLGVAEAGLAPGLLLYLTYWFPSYRRARMTVLWFIAIPLSGMIGGPLSGYIMtwAGWQWMFVLEAIPTVIVGLLVLSYLKDGVHQATWLSAEEKELV------------NKELQEDNSQKVVHASVGAFIRDKRLWLLACIYFCVVMGQYAITFWLPT-LIRNAGVSDPLHIGLMTSLPYLCAIVVMLLMGRSGDKHRERRWHLVGPMIAGAllAALFGGNLLLSVLSLCIAAAGILSASSMFWMLPTTLLgsAAAGIAGINSFANLAGFCSPYLIGWITTTTGSSAIGMYLITGVLFIGAYLVLRIP-----
      46 UniRef50_A8GEQ9        Major facilitator superfami...   218     4e-55  1  13.3% 15:434   1:415     --------------MDNKIPNTRWLRVIAPILIACIISFMDRVNISFALPgmESDLGITSQMAGLASGIFFIGYLFLQVPGGRIAVNGSGKRFIAWSLCAWAVVSVATGF---VTNHYQLLILRFVLGISEGGMLPVVLTMISNWFPEKELGRANAFVMMFAPLGGMLTAPISGAIINQLDWRWLFILEGLLSLVVLAVWWLLISDRPQEARWLPAREREYLIT-------ELTRERQARSKMQPVSKAPLRDVFRNKGLMKLVLLNFFYQTGDYGYTLWLPTILKNLTGG-NMASVGFLAILPFVATLLGIYLISVLTDKTGKRrmVSLFCFAAALLASVVLRHNVVAAYIALVVCGFFLKAATSPFWSMPGRIASAEVAGggVINGLGNLGGFCGPYLVGVMIYLYGQNVAVCALAVSLIIAGIIAWRLPRE----
      47 UniRef50_A0JRG7        Major facilitator superfami...   217     5e-55  1  13.7%  1:432   1:430     MTALGSKVASTSSPKNPRLMTRKRWVIIWLAFIGLSINYLDRSSLSVALPFMGKDFELTATQQGLIFAAFFWAYDFCQLAAGWYVDKVGPRKSFSLAALWWSVFTMVT---AAATSFWSLFAARFLLGVGESPAPSTAAKVVATWFPVRERAFATSIWDSGSRVGAVIALPIVTLIVALTSWHAVFIIIGIAGVIWAAVWWKVYRSPQEHPGANAAEVAYI----------EEGGARGEGSDDANAAKLPWRSLFKYRTILSMMFGFFCLNSAIYFFITFFPSYLVKER-GFDLLKLGFFGAIPGICAVLCGWLGGYLADRavRKTAIAGGLAGGSVIMFAALVPEAWMALALLSVAYSSLTVAATGIWSLPADVAPSSKHVGSIgnFASNLAGIFTPILIGVLVDQTGSFVAPLAVIGAISLVGAANYLFV------
      48 UniRef50_C8XHY0        Drug resistance transporter...   217     5e-55  1  11.7%  5:406  28:456     ----TKNPAPTPVAADDDKLDGTVWRIAGVVVLGAIMSILDVTVVSVALPTFQTTFDASYATVAWTMTGYTLALATVIPLTGWAADRFGTKRLYMLALTLFLLGSIACGLA---WSIESLIAFRVLQGLGGGMLMPLGMTIMTHAAGPHRIGRVMAVLGVPMLLGPIFGPILGGWLIETASWHWIFFINVPIGIVALIAAWRVLAKDEPSPSESFDFVGMLLliIPLVVGLLLMTGFVFHALRRQDHPLIDLHLFKRKQMSVSVITMSLFAIAFFGAMLLLPTYFIQVRE-ESTLTAGLLLAPQGIGAMLTMPIAGRLTDKMGPGKFVITGLFLILIGMSVfsTTPIPLLLGALFINGLGMGMTMMPIMTAALATLRHaaRGSTLMNIVQQSAASVGTAVMSVILT--------------------------------
      49 UniRef50_D1TM96        Putative permease transmemb...   217     8e-55  1  13.1%  1:435   1:429     MSTTSTQPAANHEAALESLYRRVNWRILPFLLICYLFAALDRLNIGFAKLQMQSDLGLSDAVYGLGAGIFFLGYVLFEIPSNLLLPKLGVRRTMARILVLWGLTSASMMFVRNVPTFYTL---RFLLGVFEAGFAPGIIFYLTYWYGEARMARAIAIFLTAGPLSGVVGGPLSAWAMTTlgWQWVFLIEGLPSVVLGILAWFVLADRPETARWLSSEERATL--------------QTQLRAPAEKTHRSFASVARDPWIYLMAAAYFCVVCGIYAVNFWLPSIL-RADGVTDPMRIGFYSTIPFIAAVTGMVVVGRSSDRSGERRWHSafAGGVSLAIAATSAGHLVTSLLFMTIATLMMFASYTVFWAIPSDYldAAAGGIALINTIGQLGGFLSPTIIGFATTATGSLRAGLYVMVALLVIGACLMAIRLPR---
      50 UniRef50_P39398        Inner membrane transport pr...   217     8e-55  1  10.9%  2:434  18:444     -SSADIPVPPDGLVQRSTRIKRIQTTAMLLLFFAAVINYLDRSSLSVANLTIREELGLSATEIGALLSVFSLAYGIAQLPCGPLLDRKGPRLMLGLGMFFWSLFQAM---SGMVHNFTQFVLVRIGMGIGEAPMNPCGVKVINDWFNIKERGRPMGFFNAASTIGVAVSPPILAAMMLVMGWRGMFITIGVLGIFLAIGWYMLYRNREH--------------VELTAVEQAYLNAGSVNARRDPLSFAEWRSLFRNRTMWGMMLGFSGINYTAWLYLAWLPGYL-QTAYNLDLKSTGLMAAIPFLFGAAGMLVNGYVTDWlsRKICIIAGMFCSAAFTLIVpaTTSMTAVLLIGMALFCIHFAGTSCWGLIHVAVASRMTagSIQNFASFICASFAPIITGFIVDTTHSFRLALIICGCVTAAGALAYIFLVR----
      51 UniRef50_C8WXY9        Drug resistance transporter...   216     1e-54  1  12.7%  7:424   1:444     ------MSASYEVQRTNQITGSRKWWAFATVLVTMFFSSLDQTVVSTAMPTVISDLH-GLNLYTWVFTAYMITSSITVPIYGKLSDVFGRKPFYLFGLVMFGIGSAI---SGQAHSMLELVWARAVQGVGAGAMMSMPRATIGDIFSPKERARWMGVMMAVFGLSSIVGPAIGGFITDDWSWRWVFYVNLPFVVVAIVGVVFALPTVRTKDQVKVDWQGAALLTVGLVPILLALtvAFVVWEMRAPDPLVAPWLFRNRVFTTSLVLQLLVGMAMFGSLMYLP-IFVQGVIGLNAQNSGWVMTPMMGGFMVGSMVSGQVMSKTGrrHVAWISGAVIVVGSVLlvHTSWPTIMVDMVVLGLGIGALMPLMNMAVQNAFPYRVMGtaSQQFVSSLGGVIASPVFGTVLNHAFSRKLGELLPPSLSAM--------------
      52 UniRef50_Q46984        HpaX n=38 Tax=Proteobacteri...   216     1e-54  1  11.0%  5:433  14:448     ----PANQHKALTAGQQAVIKKLFRRLIVFLFVLFIFSFLDRINIGFAGLTMGRDLGLSATMFGLATTLFYAAYVIFGIPSNIMLSIVGARRWIATIMVLWGIASTATMFATGPTS---LYVLRILVGITEAGFLPGILLYLTFWFPAYFRARANALFMVAMPVTTALGSIVSGYILSLdgWQWLFLLEGFPSVLLGVMVWFWLDDSPDKAKWLTKEDKKCLQEMMDNDRLTLVQPEGAISHHAMQQRSMWREIFT-PVVMMYTLAYFCLTNTLSAISIWTPQILQSFNQGSSNITIGLLAAVPQICTILGMVYWSRHSDRRQERRHHTayLFAAAGWLLASATDHNMIQMLGIIMASTGSFSAMAIFWTTpsISLRARAIGIAVINATGNIGSALSPFMIGWLKDLTGSFNSGLWFVAALLVIGAGIIWAIP-----
      53 UniRef50_C6CYV8        Drug resistance transporter...   216     1e-54  1  11.9% 26:404  10:415     -------------------------LVIAGLLLGLFMSALDQTIVSTAMAKIIEKLG-GMDKFVWVYSAYMIAMVVATPIFGKLSDMYGRKRFFISGLIFFLIGSILCG---TATDMNQLIIYRAIQGVGGGAIMPIVFTIIFDLFPPEKRGKMMGLFGAVFGISSVFGPIMGGAITDNISWRWIFYINVPIGILSLIFIMRGYQESKNHRKQAIDWAGAIILMAAVLLLMFGLELGGTDgeKMAKDPIIPLTLFKKQLFTSSMMISLLYGGIMIAVATYIPLFM-QGVFHLSATSTSTVLTPMMLGVVISAQVGGRIANKVRFRDVMIVSSIVLMVGTYLLGYvsRALITVFMVIIGLGIGVSFSLLNISTLNSVPPQYKGSAsiTFFRTIGSALGITVFGAM----------------------------------
      54 UniRef50_B7H8Z0        Drug resistance transporter...   216     1e-54  1  14.5% 26:404  15:418     -------------------------FVVAGLLLGILMAAMDNTIVATAMATIVGDLG-GFDKFVWVTSAYMVATMAGMPIFGKLSDMYGRKRFYIGGLILFLFGSALCGTAS---SIEQLSIYRAIQGIGGGALMPIAFTIMYDIFPPEKRGKMTGLFGAVFGTSSVFGPLLGAYITDYISWHWVFYINIPLGLISFFFITKYYSESLEFRKQKIDWAGAITLVISIVCLMFALELGGKevERKATEPIISFHLFKKPLFAASQGVAFFYGAAFIICTVYIP-IFIQGVLGGSASNAGLILTPMMVGSVIGSQTGGQLASRTSYRNIMMVSGVFFVLGIYLLSttPRLLVTLFMILAGLGVGFSFSvmSSIHKLEMRDRGSATSTNSFFRSLGMTLGVTIFGTI----------------------------------
      55 UniRef50_C7VU37        Major facilitator superfami...   216     1e-54  1  11.6% 18:438  14:434     -----------------TAQKKVRWHILPYLFLIYFVAFLDRSSITYalGGMDDALGLTATMYGFIAGIFFIGYFLFGIPGNMMLEKVGAKKWISLILVLWGAVTLLTG---YVQSATELTILRFLLGTFEAALFPGMTLIVTYWFLNKTRAAAIALFMIAPPLANAFGAPVATAIITQigWRWLFIIVGLPAILLGFFTYWYLSDDPSKAKWLTTEEKQWLT--------KELDKDRLKSSKHGEISAPFKEALLDKKIWIVTLMNIFYVMGLYGITFWLPQMIRGISKNSSTMAIGWFTAVPYLLGAVALVLNAKSSDKTGERIYHTASGAIIGGASLfaSVTNVYLSLFFICLAAMGLYAWSGPYWAITTDIDPraAVGLGIVNALGNLGGFISPYIVGWLKDMSNSTVSGMYFLSASLIIAGCLVMLLKKKETK
      56 UniRef50_A6CE81        General substrate transport...   215     2e-54  1  12.6%  6:432   1:440     -----MTDQDEPKLISEETPTRARFKVLTLLCLVAAVAYISRNAISVPAKLIQEELDISQTQMGWVMSAFFWSYALSQIPSGWVAHVWGTRRSLTAFAVLWSIATALTG---MVTGFGMLIGVRLIFGISQAGIFPCCASTISRWLPHARRGLASGLLGSFMSIGSAFGAFSIGLLLAGfsWRTIMYLCAVPGVVWAIVFYYWFRDRPEKHRGVNAAELELIRGDEALTPAEQTKGQEKEE---HVEPTPWDQILTSFSMWMICGQQFFRAAGNIFYMTWFPVYLQEAR-GISLASSGLLTSLPLLTFVVGNFLGGVVVdrWSRQGVAIVAMLGCGLCTLCAYFVqmTLAMTLISVSMFFAGLGGACGYTVTIDKGGQHVaiFGMMNMTGNLGAALLPVIVGVMFDA-GWYETVLILMAGIYVSAAVCWMLL------
      57 UniRef50_UPI0001B4F4CA Major Facilitator Superfami...   215     2e-54  1  11.8%  2:435  13:452     -PPEDETASASAPPRPRGLRHNTRWLMAFLCFLGMTVNYVDRATISISLPYMTDDLHIGPEWQGVILSMFFVTYALGQLPAGAMIDRYGEKKMFAIGGLIWSLVTVATGF---VRGIGSLLIARLALGAGEAPAYPSCAKSVSRWFPVRERALANSVWDNGARAGTAVAAPVVTALIAWQGWRMAFWVTGGVALLWVALWLKAYREPSAAGGISAEERAYVTAGGARL---EETPAEDSGKAAPEGPAVRWRDLFRYRTVWGMMIGFFCLNYVIYFFITWFPSYLVDAR-GFDLLKLGFYGALPGLVAIGGSLLGGWTSDTLLRRGwlVCGMLFSSVIAFAVLVPSAMWALTLLSVSYASLAFSAASVASLPADVAPTPRHVASLgnFASNLAGVLGSTTTGLLLGFfhSFVAPLMLSGALCVVGALTYGLVIKR---
      58 UniRef50_C4DSS7        Sugar phosphate permease n=...   215     2e-54  1  13.9%  1:432   1:431     MSTPSAPAADAGPPRRTpaVGRMRWAIIWLAFVGLTVNYLDRASISVALPFLGEDIHLTKTQEGLILAAFFWTYDFFQLAAGWYVDKVGPRRAFTIAAVWWSIFTAVT---AAVHSFWTLVAARLLLGAGESPAPATSAKVVATWFPKRERGLATGIWDSGSRVGAVIAIPLVTGIIALAGWRVTFVIIGILGLAWALGWWKAYRDPAQHPKVSAAELEYI----------NEGGARTADNDAEGAAKLPWRKLFGYRTVRGMMLGFFCLNSVIYFFITFFPSYLVDER-GFSLLKLGFFGMIPGICAVVSGWLGGWVADRAIRrtVIVVGMVGGSVIIAAVLVPQAWMALALLSLSYASLTFAGTGIWSLPADVAPSSAHVASIgnFASNFAGILTPIMVGYLVDTTGSFVIPLSVIGGIALLGALNYLFV------
      59 UniRef50_Q20Y82        Major facilitator superfami...   215     2e-54  1  12.8% 16:437   9:424     ---------------ARPIPSARWWRIIPPAILVYIFSFMDRTNIGFAMAgmNESLQMTASMSGLAAGIFFIGYVMLQAPAGHWAEHRSAKNFIGWSILVWGGLSILCGF---VQNSTQLLIIRFLIGVAEGGVWPAMLVILSHWFPNEERGRANAYFIMNIAIASIITGPLSGWIISSFGWRWVFIGEGVLSLLLILVWFPLISDSPATAKWISKEERDYLTT--------RLAAEQEEMKSKDRAPISYGAVMRDPNMWKLILLYLFYQMGIYGFAMWLPTLLKE-LTNTGMTGIGFLSMFPYIAMIFGLYGFAQLSDRSGNRRRYTALPILGFAICFLLSTlhIWVSFGFLVACGLFMQSASSIFWTIPPLLFPSEVAGggIINALGNLGGFVGPFAVGWLRTSFDSYDVGVYFLVGMLVIGFFIALSLPAKTT-
      60 UniRef50_A6CLZ7        Putative transporter n=2 Ta...   215     3e-54  1  13.2%  6:408   1:428     -----MEMNSDGGLIGQAPKRTKRPFVLAAVMLAMFMGAIEATIVSTAMPAIVGDLG-GFSLYSWVFSAYLLMNAVTVLIYGKLSDLFGRKPIITFGIILFMTGSILCGFS---QSMEQLIAFRLIQGVGAGAVLPIATTIVGDIYTREERAKIQGYLSSVWGISAISGPAIGGLLVEYVSWHYVFWVNVPLGVLSIVALWLFLHENVKKEKHNIDYLGAVLLTISISSLMFILVEGGVhqEKRASEPMMPFGIWKERSIFIANIVSLTTGVMLIGISSFLPAF-VQGVMERSPTVAGFTLTTMSIGWPIAATVAGRLLLKIGYYRTSLAGGISLIVGSTFFVtsGPVWAAIGSFFIGAGMGLTSTSFIVSIQSTVeqRGIATAANMFMRSIGSTLGAALLGGILNSS------------------------------
      61 UniRef50_A5G512        Drug resistance transporter...   215     3e-54  1  11.6% 23:411  29:445     ----------------------NKWLITITVMLPTIMEIVDTSVANVALPHMQGSLNAGTDEITWVLTSYLVSNAVVLPMTGWLARMFGRKRFLITCIILFTLSSLLCGAA---PTLATLIFFRILQGAAGGALIPTSQAIMMETFPPYQQGMAMAIFGVGAMFGPIIGPALGGWITDNMNWRWIFYINIPIGIVAVTMATYFIFDPpkRAKVAIDYWGLALLVIGLGALQVVLDKGQQdvELKHPHPIVNLRLFKNVSFSAGNFIMFIVGFCLYSSIMLIPLFL-QTLMGYNATMAGMVLAPGGVATLITMPFVGAIIQRYDGRKVVFCGLLIGAFSMYImlDAAYWDFVWPRIVLGVGLAMIFVPLTTVTLATIQKEEMgtGIFNLLRNVGGSVGIAIAATLLSRYAQF---------------------------
      62 UniRef50_B4TEN0        4-hydroxyphenylacetate perm...   215     3e-54  1  11.0%  2:437  11:452     -SPESVSSHNALSTGQQTVINKLFRRLIVFLFVLFIFSFLDRINIGFAGLTMGQDLGLSATMFGLATTLFYATYVIFGIPSNVMLSIVGARRWIATIMVLWGIASTATMFAVGPKS---LYVLRMLVGITEAGFLPGILLYLTYWFPAFFRARANALFMIAMPATTALGSIVSGYILslHGWQWLFLLEGFPSVLLGIMVWFYLDDTPAKAKWLTAEDKKCLQEMMDNDRLTLVQPEGAISHNAMQQRSLWREVFT-PIVLMYTLAYFCLTNTLSAISIWTPQILKSFNEGSSNITIGLLAAIPQICTILGMIYWSRHSDKHQERKHHTALPFLFAAAGWLLASahNLIQLLGIVMASTGSFSAMAIFWTTpsISLRARAIGIAVINATGNIGSALSPFMIGWLKDITGSFNSGLWFVASLLVVGAAIIWLIPMKAS-
      63 UniRef50_P0AA77        D-galactonate transporter n...   214     4e-54  1  14.1% 14:432   4:423     -------------PVNAAKPGRRRYLTLVMIFITVVICYVDRANLAVASAHIQEEFGITKAEMGYVFSAFAWLYTLCQIPGGWFLDRVGSRVTYFIAIFGWSVATLFQGFATGLMS---LIGLRAITGIFEAPAFPTNNRMVTSWFPEHERASAVGFYTSGQFVGLAFLTPLLIWIQEMLSWHWVFIVTGGIGIIWSLIWFKVYQPPRLTKGISKAELDYIRDGGGLV-----DGDAPVKKEARQPLTAKDWKLVFHRKLIGVYLGQFAVASTLWFFLTWFPNYLTQE-KGITALKAGFMTTVPFLAAFVGVLLSGWVADLLVrrKTPIICGLLISTCIMGANYTNDPMMIMCLMALAFFGNGFASITWSLVSSLAPMRLIggGVFNFAGGLGGITVPLVVGYLAQGYGFAPALVYISAVALIGALSYILLV------
      64 UniRef50_O30513        Benzoate transport protein ...   214     4e-54  1  12.5%  6:436   2:439     -----SREINVNQMIDDSKLTPFHWRVIILSTLIIIFDGYDLVIYGVALPLLMKEWAIDPVTAGFIGSIALFGMMFGALIFGTIADKlsRKKVIAVCIILFSLCTVLCGFS---ETTTQFSIFRFLAGVGIGGVMPNVIALVSEYAPKKFKSFFVTLMFSGYAIGGMTAAFLGSILVPLYGWKIMFMIAGIPLVLLLPLMKVLPESIDYLVRKKKDETVRFIMTKMVPSYQYQPDHVFVLNSSNQNQAQAPVKMirAFSTMMFWCSIFMTLIMVYALGNWLPKLMIEA--GYNLSKSLIFLFSLNVGGMIGSILGGYLADRYNVKFVTMGLLLLGAISLSLLSffSSVILYILIACAGAASIGAQIMLLAYMAKFYAprSTGIGWGLGMGRVGAILGPILTGWLLSLQLPHFYNFLALSIPAVLGIVTVFLINDRR--
      65 UniRef50_C6D685        Drug resistance transporter...   214     4e-54  1  11.2%  6:406   1:425     -----MEQRLTDNPQEQEFSIKSILLPLVAIILGCFMVILDTTAMNVALSKLVEDFHTQLPTLQWTVTGYMLAQAAVIPLAGWLSDRFGAKTVFLTSVILFTIGSLLC---ALPNDPQTLIMFRVIQGLGGGFVLPVAMAYVYRLSPPNKVGQVMGMLGVPILLAPAIGPILSGWLVEYHSWRWIFLINLPVGIISVLFGLWSLPKLATKKLAGLDIPGMILGPLAFASLSYGVNQGAEsvELRAKHPLLDLRVFRSIDFSFGIVVQWIVQFSLFGAIFLLPQFLQQGR-GYGAFDTGLTLFPQALASACMMPIGGYLFDRIGVRWLVVIGLSLVSGAIFQYSHLDIHtlLLPLIMAGSGMGLMMMPLNSHLINKTPResRVTSLTSAMQQVISSLAVALLVTVLT--------------------------------
      66 UniRef50_D1Y9V4        Drug resistance MFS transpo...   214     4e-54  1  13.0%  9:407  26:450     --------TSTATAAVKFRPDRRFWVVYFCLMMVMFLSSLDQTIVATALPTIVGDLS-GVEHMAWVITAYTLAITVGMPLYGRLSDLIGRKTLYLIAIGLFLLGSALCGTAG---TMITFIFYRFIQGLGGGGLMILSQAITGDLIPPRVRAAYMAPMGAMFGVSSVLGPLLGGWLTDSISWRWVFWINLPLGVVAWIACLFALKLPKHELAAKIDWLGLTFMDAGAVAIVLLATWGGSqvERRVEDPVLPLELFRNRTFVVSTIIGMLAMGAMFGVLAYLPTYM-QMTYGYSATVSGLLLIPMTIGILLASTVTGLLTSRIGRYRiiIIGPIVAAGGMVLMStsPVWRIMGDTFVLGLGMGMFFQLLVMAVQNDVRPTLLGTATsnFFRQIGVCLGASLIGVAFTT-------------------------------
      67 UniRef50_A9AT19        Major facilitator superfami...   214     4e-54  1  11.2%  4:432  12:439     ---TPPTRDDRMPDTAARKPTRVRFLMLFLVFVGTVVNYVDRANLSVAAPLLKHEFGLDPVAIGVLFSAYSWTYVLANLPGGWVVDRFGSRAMYALALLIWSSFTFLQGFAGR---FATLFGLRLGVGIAEAPTFPINNRVVSIWFAQRERGSATSVYLVGQYIGMAALTPALFWIAGTFGWRAIFFATGLVGIVWAGIWYLLYRDPEQCRWVNQAELDHI-------RRGGAVVETGKPARGEPFPWRKLAIVFSNRQIVAICAGKFASLSSLYFFLTWFPSYLISERH-MTVLKAGGVASVPFVAASIGVLAGGALSDWLLrrKTPIITGLLLVPTMTLTVLTDTNWIVIAIMSFAFFAQGVASASWSLIGDIAPRSMLGigAVNFVGNLSGIVTPIAIGFIVRETGSFGWALGLISVFAVIGALCYTFL------
      68 UniRef50_D2AUZ4        EmrB/QacA family drug resis...   214     5e-54  1  12.5% 13:405   3:430     ------------ETAAAPARRREVMVVLPGLMLAMVLAMLDNMIVGTAMPRIVGELG-GLTHLSWVVTAYVLGTTVSTPIWGKIGDLYGRKNIFLWSIVIFMIGSVLCGMAGstDGMAQLIAFRALQGLGAGGLMVNAMAIIGDLVPPRERGQYQGIMAGVMSLAMIAGPLVGGFITDHLDWRWAFYVNLPVGFVALALLAAKLKLPKYRTEHRIDWLGAILliLGLAALAIVTLALFIPVERRAVEPIMPLQLFRNRNFTLISLVGFLLGFAMFGAINFLPLF-QQTVQGASATNSGLLLLPMMGSAMVISLFVGQAITKTGKYKLyvLGGVIMAVAMWLLSltPSWQTGVFIAVLGLGMGFLMQTTMLIAQNSVEQKDLGvsTSTFFRSIGGSFGVSLFGAVF---------------------------------
      69 UniRef50_Q01SW3        Drug resistance transporter...   214     5e-54  1  11.9%  1:412   1:444     MAEVTETLPPPARAPQRWEPKANPWLIAVVVALAAFMEVLDTSIANVALPHIAGNLGASNDQSTWVLTSYLVSNAIVLPISGWLASLFGRRRFFLLCIVLFTVSSVLCG---SAPSLGLLIVFRAIQGVGGGGLQPIAQAILADTFPPQKRGLAFALYGITAVMAPTIGPTLGGWITDNYSWRWIFYINLPIGMMTLFLVHRLVEDPPYLRRLSGagIGLLALGIGALQVVLDKGQEDDWFGSrhRDPVIDVHLFKNFNFAAANLMMFMLGVVYFSSLVMMPQFL-QTLLGYTAELAGLVLSASGILLLVCMPIVGQLTTKFPAKYIIAFGWLSIAAALFYslEISFRVAMWLRVAQAAGLPFLFVPITLASYTGLPAAKsaSGLINFMRNIGASVGTSLVTTMLARRAQFH--------------------------
      70 UniRef50_C1MAF1        Major facilitator transport...   214     5e-54  1  14.5%  7:433   1:416     ------MNLQTSLPSGKPKTWKARYTVLTLIWLAWLLSFLDRMVMSVSLPYIGKDLNLDTTQQGLIISAFFIGYAAFQIPGGLLADKFGSRKIMAIGIAWWSVFTSLTGA---VMTLPLMLAVRFFFGIGEGCFPSASWKMISTYFPSKERGRATAIQSTVNTLGPALAVVVAASIIGAFGWHMVFIVLGIPGLFIAAGIYLFTRDNPKDHPAITQQDLAELA-------------ADDQGSLQNTSAIAFKDVLKMPVLWQMASIWFLFDITFWGFSTWLPSYLITVRE-FSLAKTGVMAAIPFLFGAGGTLLGGYCSDKFKPQryVVTSVIAAGFLYLTFSVSSADMAVVYQCVSALFMFFAMATFWGILMDTIPSngRASGIVNFGGQMAGVVSAPIIGWLIqsGGSYNSAFIFMIAALLCSAVVTLTVK-----
      71 UniRef50_A6X340        Major facilitator superfami...   214     5e-54  1  13.0%  1:437   1:435     MVNSTLSAVGATPDLRDSTIRKLNLRIVLFCFICFIVNYLDRVNIGYAALHMNNDIGLTPYMFGIGAGIFFIGYMLFEVPSNMMLHKLGSRVWIARIMVTWGIVSCAM---AFVQGPVSFYVLRFLLGVAEAGFAPGVLLYLTYWFPAKERGRATALFMTATVLSIVVGAPFSGWLMDahGWQAMFILEGLPAVILGVVTFFYLVDSPEKDKRWLTADERAWLMAEL---------AKENAGKQADTRHSLKEVFSDYRVWLLTLVYMFNGIAVYGVIMWLPQI-VKSLGDYTAAQTGLISAIPFVFAAIGLVVISRSSDRTGERKiaIAGLFGGVFLAASALAPSPILSLVLLSVCAFFLWSYLGVFWTLPTQFLsaAAGGLAAINGFAQLGGFTGPYLVGWVKSTTDSFSLSLLALSIFPILGFFLCMSLKAKRD-
      72 UniRef50_D0IVS3        Major facilitator superfami...   214     7e-54  1  14.4%  3:434  11:449     --ATPRQDTSHDIDADNALYAKVSWRLLPLLLICYMVAYLDRINIGYAQIQMKQTLDFGDAAYGFGAGLFFIGYFLFEVPSNLLLEKIGTRKTLMRIMLVWGVIATAM---AWVSTPMQFYVARFLLGAFEAGFFPGVILYFTYWYPSARRGRVISIFLSAVMAMAIAAGPLCGAIlgLHGWQWLFLIQGPPACILGLILYFYLQDKPSDAGWLTDAEKARLQHNIA-NDGGQVAHHGGHGHKAAHSSASLGQLLRDPKVYALSLVYFMMHGATYLFVFWMPT-VIQGLGVQDVLHVGIYSAIPFVAGFFGMIAFGASSDRFRDRRwiATGLAIAGLIVTLQMHGHLEGSLIALAFTLIGLAALPPLFFALVSDYLSpaAGGIALISSLGNLGSAASPTLAGLLTQHTGNRHYSIYLVLVMLILSALVLMVTVR----
      73 UniRef50_C6IYY7        Drug resistance transporter...   214     7e-54  1  11.9% 19:405   3:414     ------------------PMQLKRNYILTGLLLSTFLAAIEGTVIGPAGPRIVGDLG-GARLLSWVFTAYLLTMSVTTPIFGKISDLYGRKPVFVISSLLFLAGSVL---SGTAHSMGQLIGFRALQGIGAGGLLPVTFTIIGDIYSIEERSKIQGWISSVWGISSLIGPLLGGYVVDSLNWRWAFYFNVPFGLLSLYFIIVYLHEQIEKRKVKVDYLGAVTFTIGVSALLIGLATGGQqvEQRAEEPLVPLKLFRIRDIAFSNITSLLASALLIGLTSYLPLW-VQGVQGQNATTSGLVLAPMSIGWMLGSVLGGRWIITRGSRNTSLIGMVIIALGALGLAttPIWPLLIYNALYGIGFGFSFTVFTIISQSSVGYNLRGASTAlfVKSIGQTIGVTAFGTLI---------------------------------
      74 UniRef50_A0AX35        Major facilitator superfami...   214     7e-54  1  13.5%  7:437   1:432     ------MRRHVPGSTGDNMKTRYRWWIGALLFGAGMLNYLDRAALSVVAPIIKRELGIDDAQMGILFSSFFIGYCVFCFVGGWAADRFGPRRVFACAAGVWSLF---CGATALAGSFAHLLIVRVAFGIGEGPMGTTTNKAISNWFPRREAGRAVGWTNAGQPLGAAIAAPIVGLVALQFGWRVSFVVIATLGFVWLAAWWALFRDDPASHPRVSPEEVREIASDRTVGVSLDAHADERAA-------RPLLRDLLSRPVLGVALAFFSFNYVLYFFLSWLPSYLTD-YQHLNIKQMSVVGILPWLGATVGFVAGGTVSDrfARKIVIVVGLAVAAACVLLASRVSSLGAAVTLIAIASLFAFMApaCWSLLQEIVPRERVGSAGGFvlANLAGILSPSLTGWLVQYGGGYASAFVLAGASALAGAVILTFAVRARA-
      75 UniRef50_A4G6X0        Putative major facilitator ...   214     8e-54  1  12.1% 16:437  22:442     ---------------ETVAYSKVTWRLIPFLFICYIVAYLDRTSISFAQMQMQNDLGFSAAIYGLGAGIFFIGYSLFEVPSNMLMQRIGARKTLLRIMVLWGIVATGMMF---VTTPMQFYVMRFLLGVFEAGFFPGVIYFLTKWYPGSRRGAVLSMFMLGMPISGVLGGPIAGWALNSlgWQWLFFIEGLPAILLGLMVYWILCDEPSQAKWLTERERALII----------RNVKVDQANNPPEHGHSMLSALKDSRVYILSLSYFTFISGIYAIGFWLPA-MLKNAGVIDVFQIGLYSMIPFGISAIGMVLISRSSdrLERRWHLALCAFIGAASLSamFSADLTMSLIVMTVATTAIYTLLPLFWSITSAYFtaAAGSIALINSLGLIGGMASPSIIGWVKTTTGSMSNGLFAISAMLVLGGIVLLVGIKAKD-
      76 UniRef50_C1YG27        Drug resistance transporter...   213     8e-54  1  12.9% 21:414  16:435     --------------------SGRIAVIMSALMLTVLLAALDQTIVSTALPTIVSDLG-GLNHLSWVITAYLLAVTAVTPLWGKLGDQFGRKQFFLVCIAVFVAGSALCG---TAQSMLQLILFRALQGVGGGGLMVLASAIIGDVVSPRERGKYQGLFGAVFGISSVAGPLLGGLFVDHLSWRWVFYVNLPLGVLAFVTVLVVLPRRQPTGRQSIDYSGIVLlvLGLGAVAVVLGVGWWLSARRAQDPVMPLSLFRDPTIVVAMAIGFCVGFAMMGSMAFLPLFL-QVVHGLSPTASGLHLLPMVLGLFLTSITSGRLVTRTGHYKVyvLGMAVTSLGLFLLSRLGPESSmfYFFVLGLGLGLVMQVVVVVvaASYANLGVATSAATFFRSIGGSFGTAVFGAVFSGQLAANLA------------------------
      77 UniRef50_D1XNB1        Drug resistance transporter...   213     9e-54  1  12.3% 15:421  67:499     --------------PAEEISPRRVRLVFLGLMLTLLLAALDQMIVATALPKIVGELH-GLDKMSWAVTAYLLASTIGLPLYGKLGDLFGRKGVFQFAIVVFVIGSAL---AGWSRTMDELIAFRAVQGIGGGGLMIGVQAIIADIVPSRERGRYMGLIGAVFGIASVAGPLLGGFFTDHVSWRWCFYVNVPFGLVTLAVIAVVLKLPKPAVRPRLDVLGALLliLGLAAGAVGTTLLFLVVEHRAVEPVIPLRLFRDSVFNVTSLVGAVVGVALFGAASYLPTYL-QMVEGVSATESGLLMLPMMGGIVVASVVSGQLVSRTGRYRIflVGGAVSAVGMWLLSFLDTETsgLWQAILGLGIGLGMSVLVLAVQNSVPPagTATSAHNYFRQIGGSVGAAIFGTLFAGRLADALGVRLPSGA-----------------
      78 UniRef50_C8NL34        Drug transporter n=7 Tax=Co...   213     9e-54  1  11.6% 18:406  43:459     -----------------PLPEKEAWPALIALCIGFFMILLDQTIVAVSTPALQEDMGATYNEVIWVTSIYLLTFAVPLLITGRLGDKFGPKNVYAAGMIIFTVSSLACGLA---PDMMSLIIARGVQGFGAALLTPQTMATINRIFSIERRGAALGIWGTTAGLATLAGPIVGGVITENWGWQWVFYINVPIGVISVLAVLKYVPAFPPHTRPLDPLSMLlvMIIVALVLGYGFVRQQARLAQAGSDPLIPLDIFRIRNFSLGNISIVAMGFTVAGIPLPIMLYFQQ-IHGMGPMQAGFMMIPQALVAVLLSPSIGRLVDKRNPNTMAALGFGvlGLSLMMILDAPIWVALVSMFFLGVGNSLIWAPNSTSTMRDLPGRFMGAGSgnTTRQLGSVMGAAAIGAVLQ--------------------------------
      79 UniRef50_D1CIC9        Drug resistance transporter...   213     9e-54  1  14.4%  4:405   2:430     ---AQTTVAAPKATSLSELPRRQVYLTLAGLLLAMLLSALDQTVVGTAMPRVIAELR-GFNHYAWVFTAYMVTSTTMVPIFGKLSDIYGRKWFYLGGVALFLVASWLCGLS---QTMTQLILFRGLQGVGAGVMQAIAFTVVGDLFPPAERGKIQGVFSAVFGLASIVGPTLGGWITDNLNWRWVFYVNVPIGVLALGTLFLFFpdYWGVLALIFGVVPMLIAFSWAGTEYPWGSSrfIWLETRAQEPVIPLSLFRNRTFTVSVISTFITSAGMFGAIMYIPLF-VQGVIGTSATSSGTILMPMMFALIFSSIVSGQIISRTGKYKViiVGLLVMTGGLYLlaSATNALVVRNMVITGLGLGVTMPVFTMAVQNALPYkgVGTSSLQFFRAIGGTIGVAIYGSLL---------------------------------
      80 UniRef50_UPI00017458CE permeases of the major faci...   213     9e-54  1  12.0%  1:432   1:442     MSSVTSASPSPPSALDRAR-KKAFYRIIPLLFISYMIAYVDRQNVAVAKLTMTKDlgFTDAVIGFGAGIFFIGYFLLEIPGSLIVEKWGARRWISRIMVTWGIMAALT---AAVHTPVQFYTVRFLLGLAEAGFFPGVIVYLTHWFTDRDRSKALAMFLVATPFAQMVSPKISYLllGMTGWQWVYVFWGIPAVMMGLIVFFIMKDRPRQASWLTDEEKEAL----------ESELERERAVRSRGKRMKVSEALRHPKVLLMAWAYFSIVTCSYSIEFFMPSVL-NDWYHMNLNTLTWLIILPPALALVGQLVGGWSSDHFQERRLHaiVVGATALACAPMTQGNLPLTVACFMIGFAGFKTYMPAFWSLPSTFLTQAAAAGSIgnSFGNLGGALGPYIMGKVKTVTGSFVGGLYFISCSMLLSAIIIYFL------
      81 UniRef50_UPI0001B54FA8 EmrB/QacA family drug resis...   213     1e-53  1  11.4% 23:407   7:422     ----------------------NPWAALSALCIGFFMILLDTTIVSIAVPAMLQHLGAGLNSVVWVISVYLLTYAVPMLFTSRLGDRFGPKRVFVAGLVVFTASSLWCGLSG---NVEMLIAARAVQGLGAALMTPQTLAFISHLFPPAKRGAAMGAWGGVAGLATITGPLLGGVLVQHLGWEWIFYVNVPIGVIAIALTLWLVPDWQPKHSHSFDLLGILLSAAGLfaGVVLLIAFVLWQRRNRREPLVPLAVFANRNFSAGTLTATTVGFTMTGMFLPLIIY-IQTVLGLSPTMAGLLTAPMSLLSGVIAPFVGRASDKINGKYLVMGGLALLAAGVGIIAltSPWALIPALLVCGLGVGCIFSPMSNLTMASVEPRLTGTASgnTARQVGGVLGSAAIGVLLQA-------------------------------
      82 UniRef50_D2QIM0        Major facilitator superfami...   213     1e-53  1  11.8%  2:435   6:439     -SIPRQPNTLTPTPVTTSKTHNYRWIIVVLLFTATTINYLDRQIIGLLKPILEVEFSWTETQFANIVIAFTAAYAVGLLVFGWFIDKVGTKIGYAVTIVWWSVAGMLHALARSAFGFG---LARVGLGLGEAGNYPAAVKTVAEWFPQKERALATGLFNAGTSIGVVAALLIVPWILSHYGWQEVFWITGAMGFVWLIFWLIFYEVPARQQRLSAEEYDYITS--------------GQEAETEKKLPIKWFRLFTLPQTWALITGKGLIDPIYWFFLFWLPSYFSSTFK-LDLKKPSLELMLIYLATTVGSIGGGYLSSWlaRKTVLIIFAGLELSIILAQFATDVWVAVGLISLAVAVHQAWATNVFTMASDLFPKQasAVGIAGMAGAVGGIFFPMLVGRLLDTygGYNVLFTICGFTYLTAWVIIHLLTRK---
      83 UniRef50_A8PMU8        Putative transporter n=1 Ta...   213     1e-53  1  10.9% 23:415   9:425     ----------------------RKWWILLAMSTSLSLIFIDQTALVVALPAIQRELNLTSSLTQWVINAYLLTLSTFILLGGKIGDRWGHKRAFLLGVIVFLMGSVGC---ALSHSSSWLILLRGLQGIGGALMMPSTNALITNAFPDKERGRALGMYVALAAIFLALGPLLGGFLTQFFDWRAVFWINVPIALISIILAFASVPGWTRTEKLNIDWLGFFISTLFISSFVLSFMEGSHWgeTHHHHPFVELDLFKNSTFSILFSILLMIQSVGIIFVFW--SLFLQNILHYTPLKAGLFLLPAMLPLIFMAPIGGHLRDRYGPKKPMSWGALLVILSLIWIGIFsyVLLLPGFLGFGIGMPLILSGIMATAMTIVGTQQRGIAslNGARQLGTSMGLAVLAGLLSSVNKWQLSF-----------------------
      84 UniRef50_C7PW41        Drug resistance transporter...   212     1e-53  1  12.2% 11:405   2:425     ----------SSTNGASSLVDPRRWKALAFVGLAQLMVVLDGTVVNIALPSAQRDLGFSDADRQWVVTAYALPFGALLLFGGRLADRLGRKRTFQIGVIGFALASALGGASADT---AMLLGARALQGCFGAMLAPSALSLVTVMFtpAERAKAFGIWGSIAGGGAAVGLMLGGLLTQYLSWRWTMFVNVVFAVIAFSGAAITVREprRHDHGRLDFLGIFLVTGGLGCLVYGLSRAESdaEALSKAPLLPLHVVWNRNRGGAYLSLGLAIVGMFGAFLFL-TYYLQSVQGMSPIRSGAAFLPMVGGMLIGaqISARLMTRVRPRYLMPPGFVLGSAGMLALTRITvtWILPGTIALGLGMGCAFMPAMNVATGGVDPRDAGVAsvNTSQQVGGAVGTALLSTLA---------------------------------
      85 UniRef50_B1LKX9        Transporter, major facilita...   212     2e-53  1  13.6% 25:429  17:421     ------------------------RKIIPLAFILYFFNYMDRVNIGFAALRMNESLGITPEDFANISSIFFVSYLIFQIPSSIGLQKLGARKWISAIIVGWGTVTTLIFFAKDTQHI---LLARVFLGIFEAGFFPGMVYYLACWFPARERGKVNSFFMLSIAVASVLAAPMSGWIIEHmgWRWLFAIEGIPTVLLGALTFYLLPDRPEKARWLTPSQVTAL-------VDKLNSDNEKAAALNKNTNASFLSIIKNPVLLQLSFAYMFIQAAALAANYWLPGLVKGFSSDFTDTDVGLIMSIPFIFAMFSMPLWGWHSDKKNERKWHAAlmLVAGCGFLMIALVPSMTlmMGLTLYGVGILSYYGPYWALPSALLSPSGLaiAFINSCSSLGGFLINKSLGYVSTHYGATGIFIVEAILCFIAVAILL---------
      86 UniRef50_A0AHA0        Complete genome n=22 Tax=Li...   212     2e-53  1  14.0% 27:412   9:419     --------------------------VTIAVFVATFMAAIEGTIVSTAMPTIVSQLD-GIELMNWIFSVYLLTSAVTVPIYGKLSDLYGRKNIFVIATIIFIIGSSLCGFA---QNMEQLIIFRAIQGIGAGGILPSTMTIIADVYPFEKRAKVLGFMGSAWGIAGVFGPLVGGFLVDQLSWHWIFFINVPIGLLTILLILLYLREQVEHVKLPIDYLGASLFTVALLGLLFALQRAGEsvEKRAKDPIMPFVLFKNPVVLIGNLIGFLISAFLIGINVYIPMW-AQGMLGHGATIAGFMLAPLSITWIIGSFIGGKLLMTLGNRHTVGIGVLITAASGLILALFPASTNDIFfaFMGFGFGIIFTTTTVTVQDAVPRFQTGIATASnfRTVGQTIGVAVFGTIFNSVLTSQ--------------------------
      87 UniRef50_O32182        Uncharacterized MFS-type tr...   212     2e-53  1  13.6% 22:410  10:423     ---------------------SKRTLLITGLIIAMFFSALDGTIVGTAMPKIVGDLG-GLSMMTWLTTAYLLTSTTIVPIAGKLADLLGRRIVYVSGLIIFMAASALCGMA---NNMTELIIFRGLQGIGGGIMMPMAMIVIGDLFTGKQRAKFQGVFGAIYGLASVIGPQIGGWIVDSLNWKWVFYINLPVGIIAVIFIARGLQGRQQTGPINFDIAGIFTMIVGVVSLLLALsvSFIIVESKAKEPILPMYLFKNRTFTFLNLIGFFMSIGMFGAITFVP-FFMQGIVGVSASESGTIMTPMMISMIITSIIGGQLVYKIGIKPQIITGMLVMAGGftLDLDTSKLVATSFMAIIGLGMGLVMPILTLALQESFSKegVVTSSSQFFRSIGGTFGITMLGAVMNARSG----------------------------
      88 UniRef50_B2HKA0        Integral membrane transport...   212     2e-53  1  12.8% 19:433  15:454     ------------------RRPGHQGLVLAVTCLALGTVVAAMASLNVALPDIARQTHADQTQQAWIVDAYSLVFASLLLPAGAVGDRYGRRLALLVGLVVFGAGS---GVATLTTDPTALAGLRALLGVGAALIMPATLSTITSSFPAQRRAAAVSIWTAVAGASGVVGLLASGLLLQWWSWQSIFWLNVLLAAVALTGTLLFVPESAERDPAPLDVVGAVLAAAGIAVLVYAVIEafVVIEMGRRYPLLDPRLFTNRRFAAGSLSITLQFFALFGFLFVIMQYL-QSVRHYSALTAALGLLAMPIGMIPSSRLSPYLTERFGIRLPWVAGLLIVAEGLMVLAHlpYWHIASGLIPLGAGLGLAMPPATTAITGALPSRLQNVGSAVnaRELGGALGIAVLGSLLTATYRNHLPTAGAVSAFCTGLHVSLTGA-----
      89 UniRef50_C4LHP2        Permease of the major facil...   212     2e-53  1  10.2%  2:422  39:485     -SPADQTSQTTEGTSSAPKNKSNIPAVMVAIMSAMLLASLDQMLFSTAFPTIVGDLG-GVEHMSWVITSYLLCQTIMMPIYGKLGDQIGRKPIFVGAIAIFLIGSIIGGLS---QSMAQLIIGRGIQGLGGGGLMILSQAIMADVVPPRERGKYAGWMGSVFGVSSVLGPVLGGWFTDGPGWRWAFWINLPVGLLAVAIALFALKLPKRGTGLKLDYFGIIFmiIGLEIGTVVAAAIFVFIELHAKDPLIPMSLFKNRNFNLVTLGGLCVGIVMFGVMSYMPTYF-QMVHNMNPTTSGFMMISMMVGLMGTSIGLGNVVTRTGKYRIypIGMLIVVASCVLlvDTSLWYLGLCLFIMGVGLGMTMQILILVVQNSFpkVGVATGSNNFFRQIGSSLGSALVGGIFTNRISELVADRMPAAMA----------------
      90 UniRef50_Q6US34        LacCD (Fragment) n=5 Tax=Cl...   212     3e-53  1  11.8% 22:438   5:456     ---------------------KQKWIVLIIICIGVFMSTLDGSILNIANPTIAADFKINMSQIQWVVTAYMLVVTATMLFFGKLGDKVGSNRLYTLGFFIFTIGSFLC---SMSNNLSTLISSRIFQAVGASILMATGLGIVSNAFPANEKGKAIGITGAVVGIGNMSGPVIGGIILEHFGWPSIFIINIPIGIIAVFLGIKFLPKPvdEQNKSFDIPGLLLFalYLGITALIIFLLLALREVKFEQSFIDLPLFKNRNFTVGNIIGVACYFPQMAVSFLLPFYLEQ-LKNLSPMMAGYVMTVHPLIMVLIAPIAGSLSDKHGAKNILTASFSFMTISLVGMAlsPLYLLIVCLVIFGLGLGAFSSPNNSSILADVPPQKqgGSFLATIRNLSFALGTAFFSSFFAQSLTynQSYWIAASVCFIGLILTVFFMRKTDK
      91 UniRef50_C7QAG1        Drug resistance transporter...   212     3e-53  1  10.6%  2:405  11:450     -PSDPAKSVQGAPLQDWSHLDPKRWLALAVILIAAFMDLLDATIVNVAIPSMQDNLHARYSDIEWIVAAYALSFAAMLITGGRLGDIFGRKLIFMVGVLGFTASSVLCGLA---QTPGELIGARFAQGAMAGLMVPQVLSIIHVTFPPNERGKVFGMFGGIVGSASVFGPILGGLLVQwlHWRPIFLVNLPVGLLALIPAYFVIRESKSPTAPRLDLFGMVLAIAAVVLVAYPLTEgeRWRTGRAGSPLVVLSLFRQRSFDAGLSVWLIFNVALSGFFLVWTLYM-QIGLGWTPIHSGLTGIIFAFGAAPAAGASvvLTPKFGRKVLMAGALLNAAGFAVFIYMatTWEMIPPLLVAGVGFGLVVAPITDLVLSDVPTADAGSASGvtVQQVGAALGIALIGVIF---------------------------------
      92 UniRef50_B2JTI4        Major facilitator superfami...   212     3e-53  1  11.7%  6:433   2:426     -----QANQATQAIDERALVRKIAWRIIPFVFILYIISYLDRANIGYAALQMNRDLALSSEAFGFASGIFFIGYFIFEVPSNVMLNKYGARVWIARILVTWGMVSVG---SAFVQNATQLYVLRFLLGVAEAGFFPGIIVYLTYWFRSKELATTVALFTAAIPVSYIIGAPLSTWIMdwSGWRWMLVLEGAPALVGGILCFLYLTDRPADAKWLKPAE----------REWLLNELANDRKARPDAKHFGSLKAMTNPKVLYLSFIYFVYQCGSLGVGYWMPQIIKGFSKTLSHTQVGLIAMIPYIFATIVMVLWSRSSDRHSERRLHSalAVAALALLGAGLTNNPYVSITLISVSLAGLYAFKSPFWALPTLFLTRSTAAvaVINSVGNLGGFVGPFAIGYIKGSGQSATPGLLFLAALLVASFFMTFFIR-----
      93 UniRef50_A8LBP2        Drug resistance transporter...   211     3e-53  1  14.9% 12:408  36:456     -----------RPIEPTDTPYPRRWAGLAVLCLALLIIVMANTSLIVAIPDMVRDLSLTSADQQWTIDAYTVPYAALMLVLGALGDRYSRRGGLIVGLLLFGAGSIV---GALADSTAAVVIARAIMGVGAATIMPATLSLLVATFPKRERTLAITIWTTTSGLAIALGPLLAGQLLESYPWNSTFLINLPIAAITIGATMVCIPPSKANGPGRSDIVGGLLSIATIAALIYAIIEGPHFgeLRTRTPILDVRLFRIRAFSGSTLAVLLFFLGTFGAIYYISQYL-QFVLGLGPLDTGIRLLPLAGAVFVGAALTGRMTPRLGAKVTVPAGMAIGAAGILLMtgSGYTDFLAPLTMLGLAIGLSVAPCTDAIMGVFPEDELGVGGAatAVELGGSLGIAILGSILATS------------------------------
      94 UniRef50_C1XZJ3        Drug resistance transporter...   211     3e-53  1  12.5%  7:422  37:488     ------MASPNSAPKAALLTPQQRLFTLLGTLLGLLLAALDQTIVATAGPAIQRDLEIAASLYVWITTAYLVTSTVFVPIYGKLSDLYGRKPVLIAAISIFLLGSLLCGIS---QSAVQLILFRALQGLGSAGLFVTAFAIIADIFPPAVRGRYTGLFGAVFGLSSVVGPLVGGFLTDNISWHWVFFVNLPVGAVALAFIFSRMPLLRLSQRRPTIDYLGAAwiLGMFALAAAGLVGFLLTERRVREPILPLSLFANRTFAVGNAASFVLGAGFLAAIVFLPLFMVIVV-GLSATNSGLTVTPLTLGIVSGNVISGQLVSRFGrkPLMLTGLSILSVAFVIMGFtsQLELILKMILMGLGLGPAIPLYTLAVQNAVSPLMAGVAsvLFFRSMGSTIGVAILGSIFANTFSSELSTRVTAATA----------------
      95 UniRef50_C8QAG3        Major facilitator superfami...   211     4e-53  1  13.3%  9:435   5:423     --------SNGASAAVSARKGKFRFIILTVLSVGIAINYIDRAAMSVAIPFMSQELHFSPTDSGLLLSAFFWSYVLFQLPGGWLVDKLGPRITFALSSLGWGLATAACGLAS---SIAALVGFRFVLGAFEAPSYPASSSTVTRWFPRQERSFAAATFNNGSKIGGTLAIPIISFLIALVGWRMTFVISGLVAVVWALAWYLWYRDPREHKTVSAEEVAFI----------------EANQDPQNGEPMSVRQLLAQRTVQAMMAGFFCINFVSYFFFTWFPTYLVETFH-LSLMKFGLLGMLPGIAAIVGGWCGGLLSDSLVRriPLVGGMLGSATIGLAAFSPTVGLALSALCFANFAATFASAALWALPSDVAPNRatIGGIQNMAANLAGIISPILIGVIMQFTHSFVIPLEIAGVIGVVGALVYAFWLPR---
      96 UniRef50_Q1IM05        Drug resistance transporter...   211     4e-53  1  11.1%  3:408   2:435     --SATTAPPGVLATEAGGVREINPWWVTAAVMMAVFMEVLDTTIVNVSLPHIAGNLSASVDESTWVLTSYLVANAIILPMTGWLANHFGRKRILMSSIIGFTLASVACGMA---PNLSSLIFFRVVQGATGGGLQPLSQAIMLEAFPGKKRGKAMAIWALGIVVAPMLGPMLGGWITDSYSWRWIFYINLPVGLLATMMSQWFIFDPPyvDYWGIGFLIVGIGSLQVMLDKGQEDDWFGsrELMAEHPIVDLRVFRVRTYATGVFLMTILGFVLYGSTVLIPIWL-QTLMGYSSLEAGFAVLPRGLGSFLFMPLVGVLMGFVEPRKLLATGLITAGGSLYFLSlaGYWDFFWPQLIQGAAMGLLFVPLTTITNDPIAPegNATSIFNLMRNIGGSIGIAMTTTIVARS------------------------------
      97 UniRef50_C3JIB8        Efflux membrane protein n=2...   211     4e-53  1  13.1%  6:433   1:460     -----MKPSSGIEPQVIGLDARRRWGILAICCTSLFVVGLDTTIVNVALPTIGEGFRVGTRGLEWVVNAYTLVLASLLISSGAVADRFGRRRVFQIGLVVFGVASIAC---ALAPSVEVLIAARIVQGVGGSMLSPVALAIVVnmTDPKERAKAIGVWAAVFGLSMAAGPIVGGVLIESFGWRSVFWINVPVILAVLVLTAVFVPESRAQQSRRLDLPGQLLLVILVGGAVALLIEGPrrVESRKREPLMDLALFRRRPFSSAVIGAVVVFVALNA-TLLLGTFYLQHSRGMSPALAGAITLPMAVAATVCAPLSGILVGRFGPRRPLLIAGSFTTLGGLCLVSLDnpMLLAAYLFLGIGFGFSNAPITNTAVNGLPRSQAGLAGGItaRQFGAALGVALAGGivDVAQASRLGWILVAGCGIAVLLIALASR-----
      98 UniRef50_A8YWU6        Multidrug transporter n=13 ...   211     4e-53  1  13.4% 26:414   8:419     -------------------------LVTLAIFMTTFMSGVEGTIVSTAMPTIVSDLN-GLEIMNWVVSIFLLMTAVSTPLYGKLADSIGRKPVFLFGIALFVIGSSLCGLA---QNMVELIVFRAIQGLGSGAVQPVAITLIADLYTLQKRAKLLGLNSGFWGVASVIAPLLGGFIVQHLSWHWVFYINVPIGIIAFLLVIFYLKEPKHNAKSKLDLQGTTWLVILLLALMFFLQdaFFKTEKRATDPMMPLSMLKNREFLALNLITLLICGVVIGFEFYIPTWM-QGINGTNASLAGFAVTPSSLMWIVGSFILGWMFGRWGIKRTYDYMLGVLVITDLVLLLVPIYTPFWVFCIVAAFNGTAFGVITTasQVLVPKSDIGVATSFnmKYLGQTMMISIYGIAFNTSVAHGLA------------------------
      99 UniRef50_Q045L7        Permease of the major facil...   211     4e-53  1  14.1% 21:403   6:410     --------------------KSNTKIVTIAIFLTTFMTAIEGTIVSTAMPTIVSDLN-GLEIMNWVVSIFLLMTAVSTPIYGKLADSIGRKPVFLFGIAVFVVGSALCGIA---QNMVELILFRVIQGLGSGAVQPVAVTIIADLYTLEKRAKMLGLNSGFWGVASVIAPLLGGFIVQHLSWHWIFYINVPLGIIAFLLVIFFLKEKKTSSNSTLDLKGTTCLVIFLLALMIFLQELEdkTEKRAKDPIMPLDMLSSKEFTMINLITLLISGVVIGFEFYIPTWM-QGINATSASVAGFAVTPSSLMWIVGSFLIGGMLGRWGIKKTYDYMLLILIIADLALILVPIYTSFWVFCLIAAFNGTAFGAITTavLVGRDKIGVATSFNTLMKYLGQTMMVSIYGI-----------------------------------
     100 UniRef50_A7KH09        NapR6 n=6 Tax=Streptomyces ...   211     4e-53  1  12.3% 22:410   4:417     ---------------------KNRWLALIGLTISVLVIGFDTTILNVALPTLAADTGASAGELQWIIDSYAVVYAAAMLPAGFLGDRFGRRKLLIVGLVIFLGGSII---GTLVDTPGALIGARTVMGLGAALIMPLTLSLIPTLFKGEEQTKAIAIITVGLSIGLPLGPLISGWLLDHFWWGSVFVINIPLVAIGILATVLLIPETKDPAAPKVDIISTVLGILGLGALVYGVIEAPAerEKRQPRPMVDLELLRNPTFGWNTVFLILGMFVFMGLLFVLPQYL-QVIQGNDAFGTGLRLMPLMAGMIVVAKIVPPLSLRFGTRPQVIAGLLIMAGAMFMGSATDANtaVVWMILVGLGTSLVMVPALDTALGVLPKGKEGTGSGltLRQVGGAIGIALLGSVLNAVFT----------------------------
     101 UniRef50_UPI0001B4F865 major facilitator superfami...   211     4e-53  1   9.3%  8:436  11:474     -------AVPRPSAPGAGDRRKPLWVIIVACSVPMFMVALDNLVVSTALRTMAVDLDASTTELQWFVNAYVLSFACLLLTGAALGDRFGRRRIFVAGIALFTLASVGCGLA---DSSEQLILMRAVQGLGASAVMPLSLTLLAEEVPDKKRNLALGLWSAVSGLAVALGPVVGGAVVDGLDWQWIFWINIPVCLVAIPLVLVVLREsvWAIVNGEDEGWTSGIILSAFAGGAVLLALFVMWERRAPQPLLPLSFYRVRAFVFSNLVSASMYFGVFGSIFLLSQFF-QIAPVRTPLEAGVLTLAWTLMPMFVAPVAGALTDKVGGGRLMALGLFLQAIGLAWINltPYSRMVGAMVVAGIGMGLVFAPTAAVVLGSVGPQYRGKASgnTVREIGGALGTAILSSVFVHYggMKPGIWIGVAVVLVGALCALAIPRPR--
     102 UniRef50_Q212R7        Major facilitator superfami...   211     5e-53  1  11.8% 14:435   1:434     -------------MASQSQASRYRWIVLLLIFLCYMIAGADRANIGVVVPFMKKEFELSNTDIGAMASLFYLGYAFIQVPVGLLYEKFGVRRIFTLAMVATSFSTL---FIGFAHSAFQLKLGRVLLGLAEGPINIGILTIINRWFPPHEKATAVGVFMSSIKFAPAVVPPLCAFIIYAFGWREVFYIFAIPGVFIAAFWFFSVSDDPRDSRFVNAEEVAYIESTAVAGVNEGAEGAKARaaRDIQPLASNAAIFRSWNVWGCALGYGFIVGVAYAIMTWVPTYLI-SVKHYPLFQMGFVAATPWVGAIIGNLIGGVLSDKlrRKPVMILTASSTVVMMYALIYSppFLLAALFIATGVLLNLGYSTFLVYPMGLVAKDKvaAAIVNTVGSLGGAFAPFVVGMILDRY-SWDMVFVFLAASSLATLVLVLTIIEP---
     103 UniRef50_C9S1T3        Major facilitator superfami...   211     5e-53  1  14.0% 15:435  11:432     --------------IDEQPLNRFHISLLFMCMLIIIADGYDMFMFGAIVPSLMKEWGIGPVEAGALNSYALIGMMIGAMIFGPSADRFGRKNVILLCFCLFSLFTFTSGFSQSSTSFG---VQRFFAGLGLGGVMPNLIALMTEYTPSKWKSTLVSIMFSGHAFGGIIASAGAIYLIPHLGWRAVVWL-GLIPLVFLPFFYRKMPESVYfhHQTDRLLSVFRRLTQQMISDDEQIQWVENGEQKTSFPVtlFREHRGWSTAMFWVSFFMCLLVMYGLSTWLPKIMQEA--GYPLGSSLTFLVTLNSGAVIGAIIGGRLADLFGARKILILFFVIAFLTLMSLSLKPNVILliLIGIAGGTTTGTQIVANSYVSQYYPTEMrgIGWALGVGRIGGIAGPVMGGILLNHHLSLYGNFLAFALPCLVSAVAIWLVQEK---
     104 UniRef50_Q0G4T6        Putative transmembrane effl...   210     6e-53  1  14.3%  7:405  25:458     ------MLTTTAENKDSLEGDPRRWIILAVLLLAGFMNLVDVTIVNVAVPSLTADLGASSAEIEWVVAAYILSFALGLLPFGRLGDIVGRKRMFLIGISGFTVGSALCGLA---PTIGLLIASRFVQGLSSAMMMPQVLALVQVTFSREERGFAFSLFGVTAGMAAVTGPLAGGALIAalEWRPIFLVNIPIGLFALVMGWRLIPRTRRGDYEPLDLCGVALAALAVFTVVFPLVewEARRARMNKTQLLPISLLTNRHFLLGLTMTATLFAGIPGF-FFVTAIFLQVGFGFTPLESGLATTPFSVGVFIASLVSGRFGSAYAKARLVTGPLILASGMIYLLTVVSgwAFTAPLVLAGLGMGITVAPLFATILTVVDNRDAGSGSgqTFQQIGGALGVAVLGQIF---------------------------------
     105 UniRef50_A9WJU2        Drug resistance transporter...   210     6e-53  1  14.3% 36:420  42:452     -----------------------------------FLSALDQTIVSTALPRIVADLQ-GIELIGWVSTSYLLASTAMVPIYGKLSDIYGRKYVLLFGIVVFLLGSLLCGLAA---DMTQLVVFRGLQGFGAAALTSTAFAIPADLFAPAERARYMGLFGAVFGLSSVVGPFIGGLLTDNLSWHWVFFVNLPLGVIALGFIVAKLPRLHSGLMPAIDYAGAATLLLTVIPFLLALTLdfLLIERRAESPILPLHLFRIPTFTLTALIGVTVGATLFAAIFFLSLYLV-NVLGVSATAAGTTLIPLTLSLVVGAMVSSQIVQRTgyKWVIIVGMAIIVGSLWWLTTLTPDTSIWmmIALGLGLGPSMPILNLAMQNAVPRtgAATASRQFFQQIGQVVGSAVFGALLTGVLTTSLSTSLAPI------------------
     106 UniRef50_B9L0U9        Putative drug transport pro...   210     6e-53  1  15.0%  1:406   1:432     MSMETQTVRETTAMERAQTERSRLALILPGLLLGMLLAALDQTIVGTAMPRVIAELQ-GLEHYAWVFTAYMLTSTVTVPLYGKLSDLYGRRTFFLFGMIVFLIGSALSGMA---QSMTQLIFFRALQGIGGGALFPIAIAIVGDLFPPAERGKWQGLFAAVFGFSAIIGPSLGGWITDNWGWRWVFYVNMPVGALALLTTGLTMPKLASGRQHRIDYLGAALLVSGVTPLLLAFSWafVAAELRAPEPILDLRLFGNRIFTPTLLAAFLIAIGMFGTILYLPLF-VQAVLGRTATNSGAVLTPMMLGFVFSSIVGGQILSRTGRYKILAIGTvvAVIGMFLLSRMDVTTTSTtmIILGLGIGTTMSLFTIIVQNAFPAQRLgtSALTFFRSIGGTVGAAILGTVMT--------------------------------
     107 UniRef50_D2TP69        Major Facilitator Superfami...   210     7e-53  1  14.1% 24:435   6:417     -----------------------RWIIVLLLFLVYMINYLDRVALSITVPMIEKDLMLNAEQFGMIFGSFFFGYAIFNFIGGLAVDRFGATLVLGVAVGLWSLF---CGLTAFATGFYSMLILRVLFGMAEGPICSSANKMINGWFPKKQAATAVGFLSAGSPLGGAVAGPIVGYLALALGWRPAFLIIFTIGIVWMIVWFFIAANSPEKHKRVSTEELALI--------QRMKSEDAEQEVVGNETAHSLGYYLKQPIILVTAFAFFCYNYILFFFLSWFPSYLVQQ-HHLDIKSMSLTTMIPWIVGFVGLALGGYISDKisRKIVLVVCLMMAAICVGLAGTVSSVvaVILMSVSIFFLYVTGAIYWAIIQDVVHKSRIGGTSGFiiGSISGIVGPIVTGYIVQSTGKFDSAFILAGSVAALGALLVLFVIKT---
     108 UniRef50_C1EUC4        Drug resistance transporter...   210     7e-53  1  11.8% 34:433  18:455     ---------------------------------AMFMAAMDATIVNVALQTISKELQVPPSAMGTVNVGYLVSLAVFLPISGWLGDRFGTKRIFLTALFVFTTASALCGIANDITS---LNIFRIIQGAGGGLLTPVGMAMLFRTFSPEERPKISRFIVLPIAVAPAVGPIIGGFFVDQMSWRWAFYINLPFGIMALLFGLLFLKEHIEKSAGRFDSLGFILSAPGFAMIIYALSQGPSRgeLKVKQPMLDLRLLKEPVFRKMSLISLFSSAGLLGMLFVFP-LMYQNVIGVSALESGLTTFPEAIGLMISSQIVPWSYKKLGARKVISIGLICTVIIFVLLSftNPWQIRALLFGIGIFLGQSVGafSAFNNITPPSMGRATTIFNVQNRLGSAIGVAVLASILAGFGnyQAALIGSAIFLLVALLFSLRLS-----
     109 UniRef50_B4ETY4        MFS-family transporter n=3 ...   210     8e-53  1  12.5% 23:405   5:413     ----------------------KRLSLICAICLGTFMATLDISIVNVALPTIQNDINANMATLQWIVDAYALCLSACILSSGPLSDRFGRKKVWLWGVIIFTLGSLICAIAQQH---EILILGRIIQGIAAAALIPGALSLITHAFPVdeRIRIIGIWSSVSALSLIIGPILGGALVHASGWASIFLINIPIGAITVLLGWYGLSESADPEDVALDPLGQLTSILGLGLLTYGFIEAGSVgeKRIERPLLPLSLFKDRSFFQYNLSSFTLGFATYS-NVFFIAFFLQKAQGWSALETGLRMAPEFIAMALFSMLFGRFSRYISVRKLMIFGFLLIAISSCLLATLATNSSYTilFILGAGMGLATPAIGVLVMKSVAPSRSGMAsmNALRQTGMTMGIALLGTLM---------------------------------
     110 UniRef50_B9L4A7        Major facilitator superfami...   210     9e-53  1  16.7% 12:437   5:437     -----------SQRLDELPLTREHWRIVLLAGIGWMFDAMDVGLVAFVLVSLGRDWNLSRPELGLVASAGFLGMFLGALLAGRLADRYGRRTMFLANLLLYSLGTALC---ALAWNFPSLILFRFLTGIGLGGELPVAAALVSEFAPARHRGRMLVILESFWAYGWILAAVIGLLVvpSWGWRVAFLIGALPALTAAYL-RRQLPESPRYLDIAGRHTEAVAVlaASMPPAEVTTTPAPPHPSFAQQFRALWSRQLLRRTVMLWLLWFGIVFAYYGVFTWLPSLLVE--RGLTVARSFTYVFITTLAQIPGYFSAAYLVDRWGRKPTLVTYLLGSALSAWLLgaGTAPILVLWGCALSFFNLGAWGVVYTYTPELYPTTLRGFGSGAafGRIAGIIAPYLTPWLLTSGGfpAVFALFMAVFAVIAADVLLLGEETRG-
     111 UniRef50_C0ZBH9        Putative multidrug resistan...   210     1e-52  1  14.2% 21:415   5:419     --------------------KRRVGLVTCGVLMGLVLSALDQTIVSTAMPTITKELG-GLSLYSWVFAIYMLTSTTSMPIYGKMADLFGARKMYLIGLFVFLLGSLLCGMA---NSMTGLIAARGVQGLGAGALMPVAFIIVGELYPPEKRGKFQGLFGAVFAMTSIFGPSLGGMIVEHLPWGWIFFINLPIGIVAFLIIALAFRddWYGAISLSAAIILILLSLVMEGREYKIGLGGawIETKAKEPLLPLSLFRIPAIGYGNLAGFFVSAALFGAIAYVPLF-VQGVRGASPSEAGFLLVPLMLSAAISSTIGGRWMAKASFRAILIPSLLIMATGFFLLSttTNAQLVIYMIVTGLGMGAIYPALGTAAHSAVKPEDRGVAMSTsfRSIGGTIGVSVFGSIVEWRMRAGLVF-----------------------
     112 UniRef50_Q3ZW08        Major facilitator family tr...   210     1e-52  1  11.1% 21:407   3:416     --------------------KGNKLFILLGVILSMMLASLDQTIVATAMPKIATELN-GLSHLSWVFTAYMLSSTVTVPIYGKLSDIFGRRPLYLIGIGIFLLGSVLSGLA---QDMTQLILFRGLQGIGGGAMMVNSMALIGDIFSPAERGKWQGVLGGVFGLTAVAGPLLGGWITDAFSWHWIFYINIPVGIAAMVVLAMAIPPIKHKIKDrlGGALLIVGLVPLLLAFVWGGSQYAwvERRVKEPVLSMGLFKTRIFSVSAITLFLTSMGMFGALLYI-TVFAQGVIGVSATSSGLILAPMMLSMVVSSAISGQIISRTgyKKLAVGGVALATVAMFVFSftTNTQLVMCMILLGLGLGVTMPIFTIAVQNAFSHKQLgtAGTQLFRSIGGTVGGALLGGVMNA-------------------------------
     113 UniRef50_C2BRX3        Possible transporter n=4 Ta...   210     1e-52  1  10.9% 10:412  28:467     ---------PTGLASLEHTVPNRWGLILALYLAGIFMGALDMGIVNPARTVIQNSLGVDDQAGVWVFTIYTLAYAIAIPVIGKLADVLGRKPVYVLAIALFGIGSLGCGLAQDFQSFGLLLASRVVQAVGGGGMMPVATAAAGVIAPPAKRGMALGLVGMVYGVASVIGGSAGSLIMDIAgwQWIFYINVPIALAVVVLGAMFLDRERAEAGRHLDIPGTVLIVVAITALlaIAGIVFWVTEHRVHDPLINFDYFANIPV-GVTLLLGMVAGALMMTVMFIPQFAENSMR-LSTGDGGYPTIIIGLASGIAAPISGRLTDKLGPRFVLGLGMLISAISGLLLIFWTSpsTSVSIFVMGFGLGFLmaPLTYLILHLVPSRDagQATLSLTRSLATTLAPAImgLLATAMGGLS--------------------------
     114 UniRef50_C9KLG5        Major facilitator family tr...   209     1e-52  1  15.6% 13:436   4:433     ------------ERLEALPVGSFQYKLLMVTGLGWLFDSMDTGLIAFVLPVLTKDWGLSPAQAGWIGSIGLIGMALGAVLAGTVADRIGRKKVFTITVLLYSISTGLC---ALAWSYESLLVFRFLVGFGLGGELPVAATLMSEYAPSHLRGRFIVLLESFWGVGWLVAACIAYLLIPHFGWQIAFVI-GTIPALYVFLIRLHMPESVRYLISHGRIDEAKDIILDLERKLHvsPAELEQPKAAATSFATLWTKPFRTRTAMLWLAWFGIVFSYYGIFMWLPSIVF--AQGFAVIKTFEYVLIMTLAQLPGYYAAAWLVDVIGRKYTLSLFLLMSGICSFFFgaASASSLLAWGAAMSFFNLGAWGVIYTYTPEQYPtrALGSGWAAGFGRIGGMIAPMLVGLMLANAFGMSTIFLMFASVFVIISAVVLTLGKES--
     115 UniRef50_B4VDF7        Transmembrane efflux protei...   209     1e-52  1  12.2%  3:436  24:505     --APPFTNGATPNPAASSPADRRRWLALAIVMTAAFMDLVDVTIVNIAIPSMRQDLGASTSAIQWITAGYALAFAAGLITGGRLGDIYGRKRLFLIGIAGFTAASLLCGVAA---NPAMLVTSRILQGGMAALMVPQVLAIVHVTFPPHERGKVFGMFGAIVGLGAVSGPMLGALLTEwlEWRPIFLINLPVGIAGVLLGRKFITESKAPDALRLDLVGVVLATLALVMLIFPLTQGRENDwrKDGSPLVELSLFKVKSFAGGIAVQLTFGIAT-GIFFLVWTLYMQMGLGWSALRAGTTGIPFSVasAAAGMSVQKLVPRFGRKVLQAGALTMAAGLLLYIWESdsWQMALPLIVMGVGMGLIVAPLTDTVLSEVPPRHAGSASgnTTGQMGNALGLGLTSVVyqYVDAFRGALWWVVAVMLVIFAVMFALPRRA--
     116 UniRef50_B4D7J3        Major facilitator superfami...   209     1e-52  1  12.1%  5:435   4:434     ----TDSSSQEHRDARQAVYRKVTLRLIPFLFLCYILSYVDRVNVSFAKLQMQHDLGMTEEMYGIGMGIFFIGYFLWEVPSNLMLQKVGARRWIGPIMIVWGVVSSLTLFAKTSTLFYSL---RFLLGTIESGFFPGVVLYLTFWFPRTHLAKTISMFMSAIALSGAFGSPLSGWIMGKMswQWLFLLEGIPSAIVGIIAIYYLDDGPKKAKWLSAEEQEILVQA--------LAEEEALKRSQGESHHSIAGAFRSPQVWWFCLVYFGMVVANYFVGFWMPEI-IKSGITTDPWKIGLVSIIPWGVGAVTMIWFGHHSDVTGERRWHLTVALLVSAVFLIFCGLHGLPPVLGIVVLSFAVAGImsTFWALPTSMLsaAAAGLAWINSVGNLGGFVSPYVVGGIRDRSPNPIYPALLVAFCCLVSAAAVLISTRK---
     117 UniRef50_C8QGR5        Major facilitator superfami...   209     2e-52  1  15.6% 17:432   7:434     ----------------AGRTSHVRIWILMLILFLSVVAYADRSILSISGSAIKEEFGLSAIQLGLILSAFSWAYVIGQIPGGLFLDRFGTKKVYGVTLALWSLATIAMGFVGEFSslALMFALRFILGLIEAPSFPANARVVIMWFPSAERGRASSLFSSAQYFAVAIFSPLSGWLVSRYGWEWPFFVLGGIGVLAVLVWTGYMRSPKHHPQVSETELRHIVDGGALV----DIDAAQTLKARPALSKAMFKKLLSNRMLWCAYIGQYCIIALSYFFITWFPIYLVQAR-GMNILDAGFATIAPALFGFAGGISGGYISDkwARKTPYIVGMLMAATLILAAVIPSNAGIIAIMSFAFFGKGVAAGatWTVVSDTAPKEAVggSIFNGIGNIAGFLTPLLFGIIVGVTGSYSIGLVFVGAHCVVAALLFWLV------
     118 UniRef50_C7D2V9        Efflux protein n=20 Tax=Ent...   209     2e-52  1  10.9% 23:433  11:450     ----------------------RKKVILYTCCMSLFVVTMDVTVVNVALPSIQSDFHTNLSTLQWVTDGYTLMVASLLLLSGSTADRIGRKRVLQLGLACFGLASFLCGIS---QTPGQLIAFRMLQGIGGSMLNPVAMSIITQVFTEkeRAKAIGLWGSVTGISLGMGPIIGGLIVSYFSWRYVFFVNVPIIAAAIILTQKFVPESKVEKTAKNDFVGQALMILFLFSSIYSIIGLPRKGLFAPdsLINPRFFLSIPFTSASFLAIF--GFIIYNGYLFLNTLYLQEMRGFSPLEAGLSTIPLAFVSFLVAPRAGEMVGRIGTKRPIMLCGISMLAVSFLQLFVTKTTPmiIYIFLGIGFGMLNSPITITAIEGMPLSQSGTAAAIAVtqIGNSLGVALPSLLIttSSLTRTPFTNVWLLFGCCAIAIIFLS-----
     119 UniRef50_Q9RDF0        Probable transmembrane tran...   209     2e-52  1  13.1% 13:433   3:418     ------------SPAVQSAVRKIFRRVVPLFFVMFVANYMDRVNLGFAQDELRADVGLSAAAFGLGAGIFFIAYAIFEVPSNMLMERFGAKVWLTRIMISWGVVATAM---AFVDSVEMFYALRFLLGVAEAGFFPAVIYYFSRWLPDSHRGRATSIFLMGSGTATVIVGPVSGALMehAGWQWMFFIEGVFSVV-----YRFLDSGVEQATWLTDEEKSGLVAAI-----DAEQDERDARRGGKAARVSRWKLLADPQMLLFLWIYFAINVALYAVTFWLPSI-VDDIGGVSDFQVGLLTAVPWLCALAALFVSGRVSDRIGRRRplVVLLLLGGCGTLLAVFVSPWVGLGALCLAAMGFKPASPVFWTIPQSYLDARAagIALINSIGNLGGFVAPTAFGIIEDTTGSTKGGLVGLTVVGFLAALSVLLVR-----
     120 UniRef50_C7QBP0        Drug resistance transporter...   209     2e-52  1  12.2% 15:408   1:428     --------------MDRETLQRRRWAILGVLVFSLLVVVLDNTILNVALKIISqgLGASQSDLEWAINSYTLVFAGLLFTFGIVGDRFGRKKILMAGMVGFGIASVLC---AYAGSPGALIATRAVMGFFGAAIMPATLAIIANVFEPKEQPKAIGIWAGGVGLGVAIGPVLGGLLLDHFWWGSVFLINVPIIVVALIAMAILVPDSKNPKPGKLDPLGVFLsiWGSLAAGILLSAGFVFWELRTDHPALDVRLFrsRPFSASVMLVGLSFFAMMGVLFFL-SFYLQSVLNYSPLKAGLFLTPFALAQLIFSPLSARLVQRFGARAVSTFGMVVIGVTFLMYQFVnaWLLLLIFFLQGMGMANVMPPATTTIMTSLPREKAGVGssNTVRQVGGALGVAVLGTLLTTA------------------------------
     121 UniRef50_Q2NX64        MFS transporter n=24 Tax=Pr...   209     2e-52  1   9.2%  1:433  20:449     MTQATRPLPPPDGMGPT--YRKILWRLIPFLFVCNLFNYLDRVNVGFAKLQMLRDLGMSQTVYGLGAGIFFIGYLACGVPSNLILQRIGARRWVAIMMVSWGLLSTCLLF---VRTPAGFYTLRLLTGAAEAGFFPGILLYLTRWFPRDRHGRVTTVFMSAIPISGVLGGPLSGWILGYfgWQWMFLLQGLPTVLLGNGVWFLLSDGVQEASWLNPQEKQALARVL----------ADDEAGKPAGASTSLRAVLCNPAVWLLGTVYFCIQSGVYAINFWLPSI-IQDSGVTDPVRIGLMSAIPYLAAAVFMVLMGRSADRRGERrvIPLLMGAAGLCIAASVTDNLGLALFGMTLATMGAVSGLPLFWPLTNGFLtaAAGGLALINSTGQVAGFVSPYLVGWIKDTTHSTQLALYVLAGAMLLGAALVLRVP-----
     122 UniRef50_A5W310        Major facilitator superfami...   209     2e-52  1  11.9% 13:432  32:442     ------------TMQSQSLAPRRWWYIIPIVFFTYSLAYLDRANYGFAAAsmAEDLHITPVLSSLLGALFFLGYFFFQVPGAIYAEKRSVKKLIFVCLILWGG---LATLTGMVSNVYMLIGIRFLLGVVEAAVMPAMLVYLCHWFTRAERSRANTFLMLGNPVTILWMSVVSGYLIKHYDWRWMFIIEGLPAVIWAFFWWRLVDDRPAQVVWLSEQEKAALAQALAAEQQGI------------KPVKNYREAFRSPQVIILALQYFCWSIGVYGFVLWLPSILKQAA-NVDIVQAGWLASVPYLAAVLAMVGVSWASDRLQKRKRFVWPPLLIAALAfaLGSEHFWLSYALLVVAGACMYAPYGPFFAIVPEILPANVAGGAmiNSMGALGSFGGSWLVGYLNGATGGPGASYLFMCGALLTAVALTAAL------
     123 UniRef50_A0RLM3        Major facilitator family tr...   209     2e-52  1  10.4%  6:438   1:430     -----MMNVTTDVQSTTEETKEKRYKTLFGSALGYAAEGLDMLLLSFVLVYILKEFHLSPVEGGNLTLATTIGMLIGSYLFGFIADLFGRIRTMAFTILLFSLATALIYFA---TDYWQLLILRFLVGMGVGGEFGIGMAIVTETWSKEMRAKATSVVALGWQFGVLVASLLPAFIVPHFGWRAVFLFGLIPALLAVYVRKSLSEPKIWEQKQRYKKE-------LLQKESEGNLTTTEAEQLKQMKKFPLRKLFGNktTIGLIIMSFIQNFGYYGIFTWMPTILANKYNYTLAKASGWMF-ISTIGMLIGIATFGILADKIGRRKTFTIYYVGGTilIYFFLFTDSTLLLWGSALLGFFANGMMGGFGAVLAENYPAEARSTafIFGTGRGLAGFGPVIIGLLAAGGNVMGALSLIFIIYPIGLVTMLLCVPETKDK
     124 UniRef50_A7IAC7        Major facilitator superfami...   209     2e-52  1  10.3%  7:433   1:425     ------MSAPKNEGIGPRTIRKVSIRLLPFLILLYVIAYLDRVNFGFAALEMNSALGLSSEIFGFLSGIFFIGYLLFELPSNLILQKIGARIWITRILISWGIVVIVTAFATDA---VQLAVLRFVLGVMEAGFFPGILLYLTYWFREREQAKAVGLLMSALAISTIVGAPVSTWILDsaGWRWLFVLEGLPAIILGVVTYWYLTDRPEDAAWLDPEERDWLA---------GEIKKESRQRQKQGGHSGLVSVITDLRVWHLALIYCMLVVALYGLGFWMPQIIRSMHAGLSNTSIGLIMTVPYACAGVTMILWSRHSDLTGERRWHTAllIGGIALAGSGIAVSPPVAFLLLIIATMGIFCAFGPFWALPALFLatAAAGIAVINSIGNLGGFVGPTLMGYLTQVTGSTNAGLIVIGAGLVLGGAGAVFVS-----
     125 UniRef50_D1BKW4        Drug resistance transporter...   208     3e-52  1  13.1%  6:417   2:443     -----AAPTSAGASPQVDLGGRSPWSVLPPLLLGFFMIMVDTTIVNIAVPTLVETFDVGLSAVGWVTSAYLLSYAVLLLVTGRLGDRFGPKNIFVAGLVVFTLASLWCGLSG---SIGMLITARAVQGVGAALMTPQTMAIITRVFPPQKRGAAMGVWGSVAGIATITGPVLGGLFVETLGWEWIFFVNVPVGVVALFLSFRSLPALAteTFDWGQVWGPVSIPLIIGFGAVVIAAFLLWQRRLGQDALLPLSLFRFRNFSLANVSGMAVSFAMIGIFFPLTLFL-QTTLGLSPLHAALVSLPSSVVSGVVAPFAGRLSDRVPAKWVMVTGFASLAVATVWlpGISPWTIVVPMLFFGLGTGCVFSPMASLATAGLdtAGAGAGAFNTTRQVGGVIGSAAIIAMLQTRLAVTLPAAA---------------------
     126 UniRef50_B2GGX6        Drug resistance efflux prot...   208     3e-52  1  12.7%  1:418   1:447     MTPARQPTSRTRPARTSEQEHRDVLRALTGILAAFFMAMVTLTIIGTALPVIMADLGGDQTALSWTVTGTLLANAVTTPMWGKLADLFDKKKLLLMAIAIFVIGS---GAAGIAGSIGMLVVARVIQGVGMGGLMALAQTILGTIIPPRERGRYAGYMGAVMAVATSVGPLLGGLIVDAFGWRWCFLIPVPLSLVAAVIIVRTLhrSPRVDFLGMGLLALATSavLLIVLALVTAVAFVAVERRASEPTMPLHVITERTTVLAIIAAIATGAAMFASTTYLGQYF-QLGQGYTPTESGLLMLPQVVGSFLGSTIAGQLISRFGRWKRivVLAVGLFLGAGLTHTTPAWLVGIFICLVGLGVGTLNQNLVLAVQNTVgdMGAASSAVAFFRTVGGAVAVSMFGALLTRHMATQMSRFAA--------------------
     127 UniRef50_D2PP46        Drug resistance transporter...   208     3e-52  1  12.4%  1:418   1:447     MSTPEPAAPGGAVAEPDAPshKQIMVVLGGLMAGMFLAALDQSIVGTALPQIVSEFN-SLDKLSWVVTAYLLTSTASTPLWGKISDLYGRRPLFIAAILTFLAGSVL---SALAQNIEELIGFRAVQGLGAGGLLSLAFATIGDVIPPRERGKYMGYFGAVFGLSSVAGPLLGGLLTDGPGWRWIFWINLPIGAVALAVVAAVLKLPHVRRSHKIDYLGAAIVTAAVTSLLLAVSWSGPevELRVAEPIIPMDLFKGRIFAGYAGYTFLLGFAMFGALIFLPLYL-QAVKDMSPTRSGLALLPMIFGIFCASIPSGQLMSRTGRYKIYPIISAVLVGGAMVmmSTPYWQLAVYMFVMGSGLGLSMQITVTAAQNSVPRkgTATSTMTFFRSMGGAIGTAVYGAVLTSRLTEHLGDIVP--------------------
     128 UniRef50_Q02B98        Drug resistance transporter...   208     3e-52  1  12.3% 26:408  29:429     -------------------------WILAATILGSSMAFIDGTVVNVALPALQSALRATLADVQWVVESYALFLAALLLTGGSLGDRYGRRKIFVIGVVLFSIASAWCGMA---PNIRQLVLARAVQGIGGALLVPGSLALISANFYQAERGRAIGTWSGFTSITAAIGPVLGGWLTEHGSWRWVFFINLPLGIAVVALSLTKVPESRSGtgLGGIVFGLIESAPLACVAGAIALIVLLYWEGRAPSPMIPLRLFGSRDFSGANLLTLFLYAALSGVLFFFPLNLIQ-VQGYTPTQAGAALLPFILLMFLLSRWSGGLLDRYGAKLPLVVGPIIAATGFALFARPgwTTFFPAVLTLGFGMAVSVAPLTTTVMNAVDESYAGAASgnSVSRVAGLLAVAVFGALLSGV------------------------------
     129 UniRef50_Q3AEJ0        Drug resistance transporter...   207     4e-52  1  11.1% 23:417   3:422     ----------------------YRWRVMWVVALGTFMAPLDASVVNIALLSIIKDFKASLATGEWVILIYLLFISTLLLTYGRLGDLYGKKLVYVTGFVVFTVGSLLCGLS---PTLGFLIGARVIQSLGAGMMMAMAPAIVTEVFPSQERGKALGINGMMVAAALAFGPSAGGFLTHFFGWRSVFFINLPIGLIGSILAFKIIKNDFTREKHSFDFLGAFllMIGALVISILAFLLFLYTEKKVSEPMVDLGLFKNRDFSFSNLSAFLSYVALYQVVFLMPIYLQQLRH-FTPEKAGMVMSVHPLLTMIVAPLSGSLSDKIGSKVLAPLGMTVMALGLFALSrtTVGIIILSLMLIGLGSAIFQSPNNSTIMGSVPKNRLGTASGftMRNVGMVMGVAVAGAVFTGRRTYYLTYYL---------------------
     130 UniRef50_C5D2D1        Drug resistance transporter...   207     5e-52  1  12.3%  1:413  50:485     METASTAAPPRQAELANIGDSRAK--VVATIMLGAFVAILNQTLINVALPHMMNDFNVETSTIQWLVTGYMLVNGVLIPISPFLIAKFPTKKLFLSGMLFFAIGAFIC---SVSPSFAIVLIGRLIQAIGAGIIMQLMMVIMLNIFPPEKRGVAMGTVGIAMMFAPAVGPTLSGWIVEHYSWRLLFYVVLPIAIIDIVLAFLWLKDTSRTGNPPLDLRGAIYSTIGFGGVLYGFSEafAWRSLIVENPILNFRVFKYNVFTLSTIIGCVINMAMFAAMVLLPVYL-QNLRGFTPLDAGLLLLPGAIVMAIMSPISGWIFDRIGARMLAIVGLVITVVTTwlTMDTPYSHILALYIFRMFGMSMLGMPIMTEGLNALPRhsHGTAMANTLRQVAASLGTAFLVTVMSNRSKFHA-------------------------
     131 UniRef50_B2JFU2        Major facilitator superfami...   207     5e-52  1  13.6%  2:434  13:438     -SGSSAAQNIASNDRASPRVRRIQRTALALLLLSGVINYIDRATLSIANPLIRHDLGLSVAEMGLLLSAFLWAYAFAQLPAGALVDRFGARVMLSVSLATWSVAQA---FGGVVSNFSQFFAARMVLGIGEAPQFPTAAKVVRDWFGKKERGAATGIWNSSSTLGTAISAPLLTVLMLTVGWRWMFGVMGIAGLLVALGFFIMHRDPRQ---------------VELTQRERAYLSDVDGEAQSRPTWREWRRLFEFSTTWGMLLGFFGTIYVLWLYNAWLPSYL-QMELHLTIAKSGWVAAVPYLFGVVGSLSGGKICDVLARRGvmAASLFGVAVFTVLTGLTHNVTLAVVFISISMLLLYVSSSAAWATASVAAPaaSIGAMQNFGGYFGGALAPVVTGFIVQQTHSFAPALFVGAAVAAVAVIGYWLLVR----
     132 UniRef50_B8IND3        Major facilitator superfami...   207     5e-52  1  11.4% 13:432   2:415     ------------TAPTPIPLPRQRWLIVLMCFLAVAINYIDRANLGVAVPMIQKEYGIDPALMGLILSAFFWSYVLMQLPGGWLIDRFGSRATYTVATLIMSVATLATAFAGGVYS---LIACRLVLGIGEAFCYPVNAKVTALWFRRSERGLATGIWASGSRVGSAMTLPLVAFLIANFGWREAFLVTGAIGLVWMVVWFLVYRDPARHPAVSPEQRAVL---------------EADYAVTAGQRRIGYAELFRHRTIWGMMIGFFCLNFVIYFYTTWFPSYLTESR-GFSLAKLGTLGLLPGLVAIPAGWLGGYLSDRlaRKTCLVGGLLASSVVAIAPLVPGDAAALILLAVSYSGLAFAGANIWTLPGDVAPTPAHVagIQNFASNLAGIALTTFTGVMVSLtgSFVIPLAVAGCLSLVGAAAYLFI------
     133 UniRef50_P11551        L-fucose-proton symporter n...   207     6e-52  1 100.0%  1:438   1:438     MGNTSIQTQSYRAVDKDAGQSRSYIIPFALLCSLFFLWAVANNLNDILLPQFQQAFTLTNFQAGLIQSAFYFGYFIIPIPAGILMKKLSYKAGIITGLFLYALGAALFWPAAEIMNYTLFLVGLFIIAAGLGCLETAANPFVTVLGPESSGHFRLNLAQTFNSFGAIIAVVFGQSLILSNVPHQSQDVLDKMSPEQLSAYKHSLVLSVQTPYMIIVAIVLLVALLIMLTKFPALQSDNHSDAKQGSFSASLSRLARIRHWRWAVLAQFCYVGAQTACWSYLIRYAVEEIPGMTAGFAANYLTGTMVCFFIGRFTGTWLISRFAPHKVLAAYALIAMALCLISAFAGGHVGLIALTLCSAFMSIQYPTIFSLGIKNLGQDTKYGSSFIVMTIIGGGIVTPVMGFVSDAAGNIPTAELIPALCFAVIFIFARFRSQTATN
     134 UniRef50_C1AEC8        Major facilitator superfami...   207     6e-52  1  12.6%  6:435  12:469     -----MSNRPTVQYDDDAMFSRIARRLLPLLFLCYIVAYLDRVNVGFAKLQMAAELQWSDAIYGFGAGIFFLGYFLFEVPSNLLLERVGARRWIARIMISWGIISSLFAFvgVAPDVFGFYALRLLLGIAEAGFFPGIILYLTYWFPAARRARTVAWFMTAIAFANVIGGPLSGLIMDVfgWRWLFVLEGIPSVFMGVAVLRWLPDGPRQASWLSAHDCDVvlAADQEARTSQTQAAGREQMSGGHGPATVKAAMTDRRVWALAFVYFAGTVSLYGVNFWMPTLIQELGIDRTalRVGLLSMIPWGVAGLAMVWAGQNSDRTGERRWHVAGALAVTaaTLSLVGHAVIPSLIGLALVASGVLAFFATFWSLPTSFlsAAAAGIAWINSIGNLGGHFGPDLIGRVRAATGGTTGAFLALGALALLGMAVTLGVTRK---
     135 UniRef50_Q88M64        MFS transporter, phthalate ...   207     6e-52  1  13.0%  1:432   1:433     MSSTPTPRAASsaAPAQRLPTRRRWFMLSLLLVATIINYVDRVNISIAAPFMAKDLGLDKVEMGLIFSAFAWTYALALVPAGFIADRFGSRLTYGVSLISWSAVTVAQGLAS---GFASLFGLRLAVGAMEAPAFPANSRAVTVWFPARERGMASSIYVCGQYLGTALFTGALLWLATTYDWRHVFYSTGLVGILFGVVWLVLYRDPLNCKKVSKEELAYI---------ENGGGLVKSSQERTRFDWRQVAELFRYRQVWAICLGKFASTSALYFFLTWFPTYLIEERQ-LTLIKVGIFAVMPFIGATVGILLAGIVSDLLIrrKLPLVVGSMLGMSIVLVNFTDSNVLCIAVLTLAFFAQGIASSSWAAVSEVAPKELIGLTGGItaANIGGIVTPIVIGAIVHASGSFAMAFWFIGGVALMGTLSYSLL------
     136 UniRef50_C1YSU3        Drug resistance transporter...   207     6e-52  1  10.2% 14:406   1:422     -------------MVDAQTAYRRRWGGLAVLIICLLVIVADNTILNVALRVLsrGLGASQSQLAWAINSYTLVFAGLLFTFGVLGDRWGRRRMIVVGLTVFGAASAL---SAYSQTPEQLILARAVMGFGASMVTPQTLSIIANVFPPEQRARAIGIWAGAVGLAMAIGPSAGGLLLENFWWGSIFLVNVPFVALGLALVFFLIPESRDADPGRLDVLGVLLSVPGLVLLIYGIITAGERaeSRAPNPSLDVRFFRDPRFSVSVATIMVLFFSMSGIIFFL-SFYWQSVREFSPFVAGLLVLPAALGQMIMAPLSPTLVRWAGPRVVAAVGVLGVCSSFLFFTqtPLPLIVGFFFLQAGAMAVVLTPATDAIMSSVPPGRAGAASanTVRQVATAMGVAILGAVIS--------------------------------
     137 UniRef50_D0KYI8        Drug resistance transporter...   207     7e-52  1   8.6%  7:413   1:434     ------MSQSKPLFDATKLTSFERVMITFAVMTATVMQVLDTTIASVALPYMAGDLGASPDQISWVLTSYLVASAIVMPLTGYFTDKFGQREYLMFSIGLFVVASALCGLSA---NLPQIVSFRLLQGVAGAALVPLSQAIMVQVFPPDQRGKAMAIWGIGVMVGPILGPTIGGWITEAINWRWTFYVNLPVGLLSFFIVGRFVPRLPRKHGRTMDWWGFTLLGLAIGGLQYVLDRGNQDNwvPDRKPVFSLEIFKDRNFTLANGVMLLMGLGMFGAIFVQPLMLEQE-MNYPVLTTGMVLAPRGIASMIAMMIVGRIIGKVDIRAIILMGIVLSLVGSWGMTqiNTWQIVWPLLFQGAGIGMIFVPLSTAAFSTLSpaAEAAGIYSLVRTVGSSIGISLVATLVSRHAQVAW-------------------------
     138 UniRef50_Q1J327        Drug resistance transporter...   207     7e-52  1  12.0%  6:405   1:436     -----MTASPSATLPAPTFNDQEKRTTLIGLLVVFLLAALSQTIVSTAMPRIIADLQ-GFNLYSWVTTAYLLASTVMVPIYGKLSDLYGRKPILVFGIVVFLIGSALSGLSglGGGMNQLIAFRAVAGFGGAALFTTAFTILADMFAPAERAKFGGLFGAIFGLASVVGPAVGGFLTDNLSWRWVFYVNLPLGLLALFLILAKMPRLTHRAEGRIDLLGAALILSTTIPLLLALTWGGTtvEARTKDAIIPLSLFRIRMFSLGNLAAFIMGMAFLGVILFLPLYM-QMVLGVSPTKSGFSMLPLMGGLILSSIGVGQIVARTGkkPWMIGGGVILMLGIFFltHTTLADLAWRMFVVGLGLGPSQSLFTLAIQNAVpqLGIATSSSQFFRQIGSTIGAAVFGTLL---------------------------------
     139 UniRef50_C9Y3Z6        Putative tartrate transport...   207     7e-52  1  11.4% 17:436  54:470     ----------------STTLRQLNAKIIPFIILCYFVANLDKTNISIAALQMNADLGLSASMYGLGVGMFYISYIIFEIPSNVIMTKVGARIWIARIMITWGIVSAGM---SLVQTPTQLYVMRFLLGMAEAGFTPGIIYYISCWFPKSNRARAMSFFYMGSVMASIIGLPISGSIldIAGWRWLFAIEGIPAIVLGIMVLWRLPQTPDHAPW----------LSTEQKGWLKAQLARDNAGVEVGNNHSWLSALKNKTVLLLSLVWFLQAFGSIGITLFLPLIIKSMASDQSNIVVSLLSAVPFIAACVFMYLNGRHSDTTKErwHLGLPLILSGVSLAIAIWSSNLLVAYGLLVLTVGFNFALTPIFWAVTtaGVAAAASIAFINTVANFVGLGLPPVLGKIKDATDSYHYGLLIVAVALILGGIIGVLVSRPA--
     140 UniRef50_D2PM93        Drug resistance transporter...   207     8e-52  1  12.7%  7:414   1:432     ------MRVTSTAFESTSTGHPRRWWILLILCLSLMVLVVDNTVLNLAIPSLMRDLSATPADVQWIIDAYILAFAGLLLTAGSLSDRFGRKRMLVIGLVLFGAASML---ATAATDPAQLIACRALMGVGGSLLMPSTLSLLFTVFPPEEQRKAMAGWSTVAMVGVVAGPTIGGVLLDKFWWGSIFLLNVPIAVLAIIGTVVLIPESRGPARDVDPVGAVlaRVLGALVIGVLALVAFALWERRSAHPMLPLALFRDRNFSGTSLSIVLLSFTAGGLLLALTQYL-QFVLNYSPLKAGLALIPYAASAMLFNGLGATLGKKLADRTLIATGLAVIAVAFGILTqtGYGLLIVGLLVMGIGGGLAGPAAYTLLMQAVPAEHRGVGSAmtVQQTGAALSVAVLGSVLAAAYSAALP------------------------
     141 UniRef50_B9XB69        Major facilitator superfami...   207     8e-52  1  10.7% 22:422   4:398     ---------------------RRWLRIIPVALIMYTISYVDRTNISLALDpmMNDLLMDDRLKGIVAGIFFFGYVLLQIPGGYWATHWSPKKIISIFLVAWGICAVGCGLS---RTFVHFGVMRFFLGVAESGVFPATTVLLANWFPRSERARANAYWNLCQPLAVAASAPFTGWLLGAYGWQRMIVIEGALPFIWLPIWIYFITDHPRDAKWISEEERTYL----------ETTLKREIAELEPVKSVSMLERLLQPSIFVMIAIYFLHNCAAYGCMTFFTSGLKE--RGFSATQYGILFAIPYAVTAVIMVLNSWHSDKTHERraLVYAMSGISLIASVLLRNHFWVSYAFMCLAIPGPFAAMAPFWAIPSETLPRAVMgvGLVNAFGNLGGFFGPYIVGWLKGKYHDISVPFNLLGVGM----------------
     142 UniRef50_Q4KBA3        Major facilitator family tr...   207     9e-52  1  11.8%  1:433  29:454     MPHSTLATAPVAEVDD--CYRKITWRLMPLLFVCYIFAHLDRINIGFAKLQMTQDLGFSDSVYGLGAGLFFVAYALFGVPSNLALDRVGPRRWIAFLMLVWGLLSSALML---VDSAWGFYVLRFLLGVAEAGFFPGILVLLNRWFPASRRGQVTALFAIAVPMAGVIGGPLSGWILESfgWQWMFLIEGLPVVLLGLVVLKALPESIEQVGWLTPAQKTWLL-------------QALQQEEQHKSITRFSGILRDRHVWLLVCIYFAVMLAVNTIAFWMPTLIHHAGIARD-SNVGLLSALPYLAGCLFMLGVGRSSDRLrrRWHLGVPLLMSSLGLILTGLAppWLVMFGLLVAGMGASAALPMFWQLPPAFLatQAAGIALISSFGSVAAFLAPYLIGVVRDATQSASLALYALALLIACGAWLVLQVP-----
     143 UniRef50_Q15SI0        Major facilitator superfami...   207     1e-51  1  11.7%  6:432   1:430     -----MTTIQQMKSNAASRKSKSKFGVLALIFLSVVINYMDRTNISVAAQAISDDLELTKVQMGIIFSAFAWTYSIMQIPGGMLVDSVRIRILYPVILVAWSAATIVQGLLS---SFSAIVGCRMAIGFFEAPSYPANNKIVTQWFAEQERAGAIAVYTSGQFIGLAFLMPVLAIIQQWFGWRGLFFISGGIGILWAGVWYLLYRDPAPEHDDEENINSQE--AIKAHTQAQVAKAPVKSQAQASASWSNLKIAFSSRKLWGIYIGQFCLGGTLIFFLTWFPTYLAEYR-GLSELNTGFVASIPFLAAFCGVLLSGFVSDWlaRKTPIILGLLLSSSVIFANYVESTQWVTFFLSVTFFGNGLA-SINWVFVSLIAPKHMVggGCFNFIGGLSAVTVPIAIGYLAKD-GDFRPALVLVACLALIGLCSYIFL------
     144 UniRef50_D0KDX1        Drug resistance transporter...   206     1e-51  1  12.4% 16:403   7:415     ---------------QKPTPVPHRHWILIACMLAMFTAAIEVTIVATALPTIIADLG-GFSLLGWVFAGYLLTQSISIPIYGRLADLYGRKKVFFFGMIVFLLGSILCGFSTQ---MGWLIVFRTLQGLGAGAITPIAFTIVADVYSSTERPKIQGYLSSVWGVSAIIGPLLGAFIVQHFNWALVFWVNVPIGLFSIFLLARYLplDWVGAFYLVVSVASLlwVIPLLAISVVGSILLVRQEKHTPEPLFPLALWRNRIIIAGNLGGLVVGAAMMGVSAFLPTF-IQGVMGKTPLEAGSILAMMSIGWPLASTLSGRLMLWTSYRFTAMCGGIVLLIGSLTLLTvnLMWARLAAFLIGSGMGLSSTTFLVSIQNSVDYSIRgtASAMFTRMLGSALGTAILGA-----------------------------------
     145 UniRef50_D2EIM5        MFS transporter, ACS family...   206     1e-51  1  11.9% 24:434  15:426     -----------------------RYVILAFVFINIVINYMDRTNVSIAMPELSKEIGLSTVQQGLIFSAFGWIYAAMQIPGGILLDKFGSRIMYFISLFGWSLVTV---FQAFISGFGQLMGLRLGVGFFEAPVMPANNRAISYWFPEDERGTAIGIYSSAQFLGLAFSTPILYGIHNSIGWRGLFVVTGVVGIIWSIIWYIFYSDPDKSRFVGQDELKYIKAGGAITDDDLKNVDKHKVKLNSQNIKQLF-----SRRLIGIYIGQFAISGTFWFFLTWFPTYLTKA-KHVNFLQSGFLSSIPYLAAFCGVILAGFISDQLiaRKAPVITGLLLTLLILGANFVSNPALIILFMSIAFFGNGLATITWVFVTALAPKHLIGLAGgnGCGALSSIVIPVVIGILVSNGDFSSALVFIAAIALLGALSYIFVVGK----
     146 UniRef50_A8M4Z3        Drug resistance transporter...   206     1e-51  1  10.6%  8:433   7:469     -------TNRPSSPPGHRRRLPYRYWVAVVYVLGLFVEIMDTTIVNVAVPALAAEFGTTPIHTHWAVLGYLLSLALFIPASGWIGDRFGTKRVFLVALALFTVASALCGLA---QTLDQLIAFRILQGVGGGMLTPVGGAMLYRAFPQSQRAKAATAVFGVAVLAPAIGPVLGGLLVDTASWRWIFYINIPLGILTVALAATVLVEHREPHARRFDIAGFVltIVAALICAPLVAVAFVMVERTRSEPLVHVALFRDPMFRIGNIAGGFLIGGYLGLIFLLPLFL-QGPQGQSALHSGLILLPQSVGALVSSQIAgwWYRHYGPRPLMVYGALLAAASGVAFLatDPLVTAALLGLRGLAIGPVFIALQTATYATISPAATgvAIYNTQRQVSAAVGIALGAAWLTavSAFHESFVLVSILLLVGALISARIK-----
     147 UniRef50_B5WBD0        Major facilitator superfami...   206     1e-51  1  14.1% 22:432   6:406     ---------------------RHRYLVLLILFAIYLLCYMDRMIMAAAIPFIASEFHLSAMEMGGILSAFFFSYALCQIPAGLLADRFGPRLMTTIGITWWTIFTALTGLC---NSLGLMLVVRVAFGVGEALFPPAAFKALSAWFPKREVGRATGLMMTTNALGPALAPLFVAAVMAVWGWRAIFTSLFIPGIAMAVFGWIYIRNSPNQSKHVSEI-------------ELEEIGNSEKTLSTSAGTADFSGLIKTPLVWWCFVTLFVFSIASWGIMSWFPTYLLKAR-GLSTARMGIMASVPFLVGTIAYCITGFLSDKfrRELLVVLGCIVAAIFAYLTAHatAETAVFYQTIGYFFSTMAGCSLYTIPNAALPNKVVGSAIgnAAGQLAGFLSPLIVGYILTRTNnfNIVFHLFVGCFLLASVSAWFI------
     148 UniRef50_UPI0001C318BD drug resistance transporter...   206     1e-51  1  14.7% 23:424  15:442     ----------------------RRWWTLGAMCFALFMLMLDNTVVNVALPSIQSDLNADLASLEWTINAYTLSLAVLLVVGGRLGDIFGRRKIFLIGVSVFALSSAAIGLA---PSDTALIVGRAIQGIGAAMMMPATLSIVTNAFPPHERGKALGTWAGVSALALAIGPVVGGFLTEQVSWRAIFFLNLPVAAAAIAMTLFSTRESRDETVGRqaWGWGSARIVGLFALAVVSLAAFVVVELRVRTPMVDFGVFRSRQFAGASSVGFIVSFGMMAMFFFTALYM-QNILGFSALEAGVRFLPTTLVLIVMGPLAGRLTDRIGPKPLLVSGMLITGASQIWQSFLTADtlLPSFVLMGIGMGLVMSPMTTAAMNSVDRTKAGVASGvmGRMVGSSLGVAIFGAVVASVGSAKLEQSLPGLPAGA--------------
     149 UniRef50_C7MAI0        Drug resistance transporter...   206     1e-51  1  14.0% 22:414  30:448     ---------------------RQGKLVFVGLMLGMFVASLSQTIVGPALPRIVAELG-GVEYYSWVATAAMLVSAVAVPIVGKLSDLYGRRWFYLAGLAIFMLGSIL---AGMATNFWFLVGARAVQGLGMGTLMPLSQTIIGDIIPPRQRGKYQGIMGAVFGVTSVVGPLLGGTVTDNLGWRWLFYLTLPIGVVAFAFILRYLHLPRAAQRGKVDLLGIATliIGMYAVAAVLLIAFVIIETRVEEPLLPMHLITRPIIALSVGASFAIAVAMFGAIIYIPVY-AQGVMGVSATSSGAILIPLSVAMIVTSIVVGLLISRFGNYKvlLLGGAVLVAGYLLLSRisPWHLTLAMVVIGLGLGLCMQVYTLVVQNVVSQrgVATAAIQFFRNIGSTIGTAVLGTVMSAQMGSAIA------------------------
     150 UniRef50_Q43975        4-hydroxybenzoate transport...   206     1e-51  1  12.4%  3:431  13:447     --ATQRSSLDAQALINDAPLSRYQWLIAIVCFLIVFVDGIDTAAMGFIAPALAQDWGVDRSQLGPVMSAALGGMIIGALVSGPTADRFGRKIVLSMSMLVFGGFTLAC---AYSTNLDSLVIFRFLTGIGLGAAMPNATTLFSEYCPARIRSLLVTCMFCGYNLGMAIGGFISSWLIPAFGWHSLFLLGGWAPLILMLLVIFFLPESYRFLIVKGKNTKKVRQILSRIApeFHVPEEKVEAGTKKGVFGMLFSAKYVKGTVLLWVTYFMGLVMIYLLTSWLPTLMRET--GASLERAAFLGGLFQFGGVLSALFIGWAMDRFNPNRIIAGFYLAAGIFAVIVglSNPTLLALFILCAGIAVNGAQSSMPVLSARFYPtrATGVAWMSGIGRFGAVFGAWIGAVLLGNNWSFTMILSMLIIPAAAAAIAIFV-------
     151 UniRef50_C8WL65        Drug resistance transporter...   206     1e-51  1  15.9% 21:436   4:459     --------------------TRKQIVMLAVLVFGTFVTVLNQTVVAPALPSVMTEMSVDASMAQWLTTGFTLVNAIMIPITAFLTDRFTTKRLFLVSMVIFTLGSFL---AGWGPSFVVLLLGRLVQAAGAGILMPLVMTVLMWTFPVDKRGTAMGLFGIVIAFGPAIGPTVAGVIIDRYTWHDMFYIITALSAVVVLIGAFVLQKGGETKKDviGSYGLRADAIAGTLVGAVALVFFFRRQLKMEKPMLQVRVLQNRKFLIATIIGMLVQGALLAAGILVPIYL-QSLMGYSATVSGLVLLPGAIIMGAMGPIAGRLFDKHGPRVLALVGMGVLTLTTFCFAFLSTETGIITLTLLyfSLSLVNMPITTWGMNALDNELvgTSVNNTFRQVAGSLGTAIIVSASTIATNMsvAFALAGALCLVGFVMVVALVKNK--
     152 UniRef50_Q2RJ64        Drug resistance transporter...   206     1e-51  1  12.6% 18:429   8:444     -----------------PAPNPRRWLILFAVMAAGIMGPIDGSVVNVALPTIGRVFNVDLNTVGWVSMAYLLVLGSLILTYGRLGDMYGFRRVLLTGIVIFTIAS---GICALAPNIWVLIVFRAVQAIGAGMFMAMGPAIITSVFPPYERGRALGTNGMIIAVGLALGPTLGGFLVTVAGWEAIFTINIPIGIISYIMCRQVVPESRDLKPQQFDLIGAAmaTLVLSVVFLVGGWLFLRWEKRVQEPMLDLTLFHNKVFSAANFAALMNFMSQYALIFLLPFYLQQ-ILNYTAGHTGLILTASPLVVLMLAPVSGALSDRLGTRWLAFTGQAIVSLALFLmvTSRAFDIIWRLCLFGLGTGIFQSPNNSAVMGSVPRHRLGIGSGvtVRNVGMVLGIAVSSGVFTWQRSAKLVAWGPGSATAAFMAGM---------
     153 UniRef50_D2L762        Drug resistance transporter...   206     2e-51  1  12.2%  9:408   2:433     --------ASPAASGQPWQPSVNPWLIAASVMLATFMEVLDTSVANVALPYMAGNLSATLSESTWVLTSYLVSNAIVLPMTGWLSTNFGRKRFLMTCVAGFTLASAACGAA---PTMALLVVSRILQGAAGGALQPMSQAILMESFPPHKRGMAMAIFGMGVVVAPIVGPLLGGWITDNMSWRWIFFINLPIGIAALLMCQAFLEDPPYLKEAKAKRGgaAVWIRWFAGISLTSMIAFVLWELRAKYPLVDLRVLKDRDFAACTGMIGVVGVVLYSAITLLPLFL-QNLMGYSAFASGLALSPRGVGAVIAMILVGRLIGKVDTRVLIGLGFLLMAYSSYRFAEINLDIsvWPGFILGLAIAMVFVPLTTQAMSNLPNEQIgaGIFNLMRNIGGSIGISALIAVVDRG------------------------------
     154 UniRef50_Q2SYQ7        4-hydroxybenzoate transport...   206     2e-51  1  13.8% 10:438 140:573     ---------EVERVIDDTHRPAFHAMLLALCGLCLVIDGFDAQAMGYVAPSVIAEWGVKKQALGPVFSASLFGMLLGALGLSVLADRIGRRPVLIGATLFFALTMLATPFA---TSIPTLIALRFVTGLGLGCIMPNAMALVGECSPGAHRVKRMMIVSCGFTAGAALGGFVSAALIPAFGWRAVFFVGGAVPLALAAAMAARLPESPQLLVLRGRHDAARAWLAKFAPQLAVSPDTRLVVREAGPQGAPVAELFRSGrtLLLWAINFMNLIDLYFLSNWLPTVMRDA--GYASGTAVIVGTVLQTGGVIGTLSLGRFIERYGFVRVlcFACAAIAVGLIGSVAHAFYWLLAAVFVGGFCVVGGQPAVNALAGHYYPtrSTGIGWSLGVGRVGSVLGPLVGGQLIALGWSNDALFHAAAVPVLCSAVFVIGLarRRGT
     155 UniRef50_C8Q1P0        Major facilitator superfami...   205     2e-51  1  12.1% 14:435   1:421     -------------MPSHQVVGKQRWFVAFVLLIGGFINYLDRASLAVAAPSMMSDLHLTNTDIGLMGSVFSLFFAFSQFPAGWLADRFGPRKVYASAASLWGVSTMITGLCS---TLPALLCARALLGMTEAPGWPTSAKITSIWFPRKERALASSIWDASSRWGLAFAPPLLVLMSVHFGWGALFYLAGSLGVIFGLIFFCIYRHPEQHQGLGEAEKQYILA-----------GGGGSISAIPSGKRVKWRELFRYQSMWGMMLGWFCYIWLFNIFVTFLPLYLMKT-QHLSLSSMGVYASIPYLAGIVGAALGGYAVKWlaKKVVIMVAALISGATTIAVPfdSLIGALSMMTVAMFFLSTVSCTCWAIPGDVASNDIVGsgIQNFGGFFAGALSPLVTGYIADVTGSYALAFISGGVIAALTGLCYWLLVRK---
     156 UniRef50_UPI0001C316E6 drug resistance transporter...   205     2e-51  1  14.0%  7:413   1:437     ------MSAKVRQNPPAERLYAIKWRVFAVMMIAWFMSMLDMSIMNTALPELQHDFETDLPNASWVVNVYSIVFAVLLIATGRLADQFGRKKMFIGGLVVFTVGSALC---AVAWDIGWLIGFRALQAIGAGMLAPLGFAMTALVFPPRERGKGLAMIAVVALVANGLGPVIGGGLIEIASWHWIFVINLPLGVIGVVLAWRWWPedWQGMVLLGASVSLfaAILFFIQISIVLGIGFVVWQKRARNPMIPPALLANKQFLSANLAMVILGAGAVGGIFLLAQVFV-NLWGFSQLEAGLSLLPIGVCGGLVWPLVARAADNAPAYRLAVPALGSLALGLLWFSFMPStfVLPGLILIGMGIGVGFPTLNVGAMNAapNLGVASGVVNTSRQLGSALGIALLITVFTTTAGWHY-------------------------
     157 UniRef50_D1A916        Drug resistance transporter...   205     2e-51  1  10.4% 13:424   2:442     ------------QSQPRQGGHPRRWPILGVLVFSLLVVVLDNTILNVALRTIarGLGATQSELEWAINSYTLVFAGLLFTFGVIGDRLGRKRVLVAGMAVFGLASLV---SAYAQSPEQLIAARALMGLGGAAIMPQTLSIITNVFDPTERARAIGIWSAAVGLAVAIGPITGGLLLNHFWWGSVFLINVPIVTLGLTGMLLLVPESRNPDPGRLDPLGVLLSIVGLVSLSyaVIALFAWHEARTDHPAFDVRLFRDPRLSVAVGSIAFCFFATSGV-FFFGSFYLQSVRGLSPLEAGAMMLPFAAGQLIFSPYSPTLVRRYGAKAVCTAGMLLVATAMVGYLlsPLWVFGVVAFVQASGMAHVMPPATESVMSALPRERAGAGSanTARQVAVAMGVAVLGSLVASVYRGELSGLLARLPAGL--------------
     158 UniRef50_C3K8B3        Putative transport-related ...   205     2e-51  1  11.5% 11:437   8:433     ----------PQATFDQRLYRKLAWRIMPFLFLCFVLNWLDRVNISFAHLQFKTDLNISDATFGIIVGVFSIGYLLFEIPSNLLLEKIGAKKTMMRIMVLWGLVTIAT---AFAQTPAQFYVLRVLLGAAEAGFFPGVILYLTYWFPASHRARITSRFIMAIAVCGIIGGPLSTSIMAHfgWQWLFVITGIPPVLAGLFAWYWLDDKPASAKWLSDDEKHAI----------EQALARERLQRKPGGHTRFVEALKDRKVWFITLAYCLTIMCTGNVTNIWAPSIIRDSGVSNLGQLGLLSALPYVVGVCVMLWACRHSDVNQERRWHFALGGLTAALAMLVllFSPYSAIAVLTLMTSGYLVATAIFWTIPTYYLSDhaAGLALVNCCGQISSLLTPIMIGAIKTSTGSISLALYIVAALVACGTLILLLGVPRSA-
     159 UniRef50_UPI0001788C5E drug resistance transporter...   205     2e-51  1  12.5% 23:414   8:425     ----------------------KRSYILVGILLSTFMAAIEGTVVGPAGPAIISSFG-SVSLMSWIFTAYLLTMAVTTPIFGKISDLYGRKPVFLYGSLIFLVGSLLCGLS---QNMTQLIIFRAIQGIGAGAVIPVTFTIVGDIYNLEERGKIQGMISSVWGISSLIGPLLGGYFVDYLSWHWIFVFNVPFGLLSIWLIFRYFKEERNAREVSIDYGGAALFTVGMTALLFALaaAFLVVENRVKEPMLPLHLFKIRDITVSTIANILVSALIIGLTTYLPLW-IQGVRGGNATLSGLTLAPMSIGWLIGSIISGRLIVKSGSRKTALIGVVLLIIGAVGLAFMhlGVLLVFTFIYGVGFGYISTLFQIIAQSSVGYEVRGASTAlfIRTFGQTVGVAVFGLWVNAGIAGRLA------------------------
     160 UniRef50_A6LQ19        Drug resistance transporter...   205     2e-51  1  11.9% 26:412  11:422     -------------------------FTLLALAIGTFMSALDSSVVSIVIPVIQKYFNVNIAFVEWVITAYLLVVSSVLLTFGKLSDLYGHKKIYLMGFTAFTLGSFLCGISL---NIQMLIVFRIFQALGAGMMFSTSSAIITASVPSNKRGKSFGIIAIAISAACCAGPVIGGILASMMGWQSIFYINIPIGILGIYLSYRYIPEDKKKISVPFDLGGAVlmFIILIVLGIALGVLFIVYEGKTNYPLLNLNLFKNKTFSAGLIATTFNYMAQFIMAFLVPLYFQNTLQ-LSPMMTGVLFLPMPVSSILIAPISGSFSDKHDSRIMSSTGMGILAIALFMLSftSSWYIVIAMILSGVGSGLFQSPNNSAVMGSVPAQHRGVASGttMRNLGMVMGVAVSGALFSYSTNYA--------------------------
     161 UniRef50_B1J6X1        Major facilitator superfami...   205     2e-51  1  11.9%  1:436   1:432     MPSRSLPADQVaeSLDSRLFRKISWRIVPLFIVCFLFAYLDRVNISFAKLQMQSALGFSDAVYGLGASLFFVGYFLFEVPSNVLLHRIGARIWIARIMISWGLTSAAMMF---VTSETWFYVLRFLIGVMEAGFVPGVLYFFTQWYPSDRRARINAYFKSSICLCGIVGGPLAGFILGHfgWQWLFLLEGLPSVLLGLLVLWLVTDRIEDARWLDGEEKRYL-------------RERLDAEPKPSGGSSIRAILREPASLALSAIYLCLVMALTGLLFWMPQ-LIRNAGVDDALDIGLLTMIPYLLAVVGNLLIGRSSDLRGERRWHMAGCAAMATVGYALCaaQLLVLMLGMSLVMTGIIAWMPIFWTLPPKygLAAAAGIALINSIGQLGGIIAPYMVGKVRDVSGSATPALWLLTAVSLLAVVLIVWAVPRR--
     162 UniRef50_C9N837        Drug resistance transporter...   205     3e-51  1  13.0%  2:409  15:448     -STMTGSRAESAQVADSPERGHGKGIALLIIASCQLMVVLDITIVNIALPHIQSSLGFSTESLSWVINAYTLTFGGLLLLGGRLGDILGRRRVFVFGVLLFVLASLLGGLSQES---WQLLAARALQGVGGAIASPTALSLITTTFREgeRNRAFGVFAAVSAGGSAIGLLAGGVLVEWLDWRWVFFVNVPIGLLIAFATPRFIKESQRHPGHFDLLGALtvLTIGAFAGAVVFMAVFLTVERRSRQPITPLHMFRDRNRAGAYGMMLSLAAAMFGMFFFL-TLFVQNILDFSPLRAGLAFLPVSVIIAISAGLASQLLPRWGPKPFMVTGAILAAGGLAWLTQTdlGSILGPILVFGSGMGMQFVSLTLMAVSGVEPREAGAASgnATQQVGGSLGLSILVTVFGTAS-----------------------------
     163 UniRef50_B7LMF9        4-hydroxybenzoate transport...   205     3e-51  1  15.7% 10:429  45:466     ---------DVRELINRNPLSRYQKLVILLGFVVIALDGFDIAIMGFIAPVLKQEWGASNHELGFVISAALIGLALGAMFSGPLADWLGRKKIIINSVFFFGIWTVAT---AFSQNIEQMIFFRFMTGLGLGAAMPNMSTLVSEYAPERKRSFIITIIFCGFTFGAAAGGFAASWLIPQFGWHSLMALGGILPVLFAPVLIWLLPESVRFLVIKRAPPVRIRMILQRLYPGKIADNVepTQPLDKSAMRIVLSPQYRFGSLMLWLVYFMGLFLVYILGSWLPTLVKEV--GMTVSQAAVITALYQAGGTIGSLFAGWLMDKINPHRALGVIYGVGGLITMSMGYFSTSFTLLClfICGACLNGANTGMNAMSARFYPTQARATgwMHGIGRIGAILSAFAGAEMMAMELSFEAVFLLLGIPAAITVVAI---------
     164 UniRef50_C7PPZ2        Major facilitator superfami...   205     3e-51  1  15.0% 15:434   4:448     --------------MDSTKIGKYRWSICALLFFATTINYIDRQVIGLLKPILSDQFEWTEKDFGGMMSAFSAAYAVGLLVFGRLVDKIGTKMGYILSIVVWSFAAMGHALAKTTMGFG---IARVLLGLGESGNFPVAIKTVAEWFPKKERALATGIFNSGANIGAVVAPIVVPWLAGTYGWQHAFIWTGIIGFVWLVFWIFMYEIPARHKKLTQAEFDYIHSDDTAHTVADGEIPDGVksTPPEKKSVSWSKLLGVRQTWAFVFGKLLTDPIWWFFLFWLPSYFATTFNLdpNLQLFVIYTATTVGSIGGGYLSSWLINkrARKTSMLLFAICVVPIMFAKSTNNIWVVVGLISLAAAAHQAWSANIFTTASDMFPKHasVVGIGGMAGSIGGSLFPIFAGFLLDhtGYNILFLISGSMYLLAWLIMHLFAPK----
     165 UniRef50_B0U9D2        Major facilitator superfami...   205     3e-51  1  10.3% 11:436   2:424     ----------VDAELERSAMRRIGWRLVPFLILAYFVSFLDRVNVGFAAIQMNHDIGLSATVFGWGAGIFFLGYFLMEVPSNLMLERYGARLWIARIMATWGLISVAM---AFVQGPWSFLAMRFLLGVAEAGFFPGVILYLTYWFPSEYRARIVGIFMISIPISSFLGSPISGAllGLAGWQWLFILEGLPAVLLAGVVLVVLPDGPHKAAWLPPAERDWL-------ELRLRSEAGRNNASGGEAKPPMRETLRDRRLILFAAIYFGSTASSYGLSFWTPQIVKS--FGLGNFETGLLNSIPYGFASVAMILWGRHSDQTrrRWHLALSFLVLALGLAGGTVLSGLVPViaLTVAAVGVYMLKGPFWALATEQMRpaAASIAAINAVGNLGGFLGPYLIGAIKDASGSFTMSLLPLVLFALISAALSLVPERGR--
     166 UniRef50_B1JV59        Major facilitator superfami...   205     3e-51  1  11.6%  5:418   3:412     ----PPSSALPGRDPLASAVSKVKWHVLPLVLIMFIANYIDRVNVGFVDRHLEASIGIGAAAYGLGAGLFFVGYALFEVPSNLLMQRYGARIWLARIMATWGIVAAAM---AFVWNDTSFYALRFLLGAAEAGFFPGVVLYLSQWLPPQERGKAMAIFLGGSAFASVLSGPVTGALLslEGWQWMFLIEGLFSVALCGASWLLLKSHIRDATWLTAEE--------RTALQNALDEERATRDVRSNVPVRATTLLRDPQIMLFCFLYFSIQLTIYAATFWLPTI-IRKMGGLTDFQVGLYNTIPWMIAIGAMYGFAVLSSKWkpQRWLACALVLAACGLFASTSHDPVWSFASICFAALGFKAASSLFWPIPQGYLDTRVAAaaLINSVGNLGGFVAPTAFGYLKQHTGSITGGLYAL--------------------
     167 UniRef50_D1BAI6        Drug resistance transporter...   205     3e-51  1  13.8%  6:419   2:441     -----STEKTPVTEAPRAEAAPRIGWIYASLLLVMFLAALDQTIVGTALPTVVGELD-GVNHMAWVVTAYVLAMTIAMPVYGKVGDLVGRKKLFLFAIAVFLLGSALCGVA---QDMVQLIGFRALQGLGGAGLMITSQAILADLVPARERAKYMAPMGAVFGVASVAGPLLGGWLTDSVDWRWIFWVNLPLGVAAFAVAATMIHLPRRTSTARIDYLGIATmiLGLGAVGVLATAAFLVVEHRAAEPIIPLALFRNRTFVVATTLGLFVGAGMFGALAYMPTFL-QMAYGVNATESGLLLIPMTVGMLAGSLFSGAMVSKTGRYRVyvVGTVIAAAAMLLLSRVSDQTGLwiLALMGLGIGLFFQLLVLTVQNAVPPrgTATSSNNFFREIGVTLGTAILGTVFASRLTSGLADVLSG-------------------
     168 UniRef50_D2QQ49        Major facilitator superfami...   204     5e-51  1  12.5% 22:436   2:408     ---------------------KVRYRVLAGLFLLSTITYLDRVCMNVVSKYVKTDLNLDNQQFGWILGAFSLAYALFEIPTGSLGDRIGPRRVLTRVVVWWSGFTMLTG---TAFNFLYLLIVRFLFGAGEAGAYPNSSIVIARWFPAVEVGRAQSVIWAAGRLGGALTPLLVIPLVHWAGWRWAFVLLGLLGVLWALGWYLSFRDEP--------------AAQPGISLEEVREIERGRKIRDADHLIPWKTIISNPDLWALMLMCHLFFYGSYFFTNWSSVYF-QEGRGMTEDQTKNFISLSYFLGAVGCLVGGILSdkIGRRAvvGGLGLSSLFFLLAGLTTDNQLAGYFLATCVLMKDLALPVAFAVCVDIGQRNAGstGAMNFAGQLGGFFITILFGIIVENTHNFSYPLFMIAGCLLVSALLWLRIDPTK--
     169 UniRef50_B7LTG9        Aromatic acid, possibly hyd...   204     5e-51  1  14.3%  5:431  12:440     ----TNRTTDIQAFINQHPFSRYQWMILVLCFVTVAMDGFDTAIIGFIASDLVQEWGVEKSALGPVMSAALVGLAVGALTAGPMADRIGRKKVLIMSILVFGGFSLLTAFAS---TLNQLTALRFLTGLGLGAAMPNAATLMSEYAPERRRALLVNLMFVGFPIGSSMGGFISAWLIPHYGWQSVLILGGIMPLILAVVLIFLLPESARYLVVKNKSQQQIGTILRRIAPVPEQTYFVLREAGLVKEKSALGVIFSPrgTVMLCLTYFMGLLIFYLLTSWLPLLIRET--GATLSQASIITALFPLGGGIGVLLLGALMDKLNPNKVVAVGWLLTGIFVCLVGFSTSNLVlvMVFIAGTIMNGAQSSMPALAAGFYPtrATGVAWMLGLGRFGGILGAFSGAFLMQAQLSFETIFTFLAIPALVSALALMV-------
     170 UniRef50_B2I0G3        Permease of the major facil...   204     6e-51  1  15.6%  6:429   1:426     -----MKTIDANTIINREKLSPLQWVVFILGFFVFFCDGLDTGIIGFVAPALLDDWGITKPQLAPVLSAALVGMSIGAIISGPLADKFGRKGVIVFTSLLFSIFTILCGFANSTQD---LMIYRFITGVGLGAAMPNISTIVSEYMPVKRKAFLTGLAGCGFMLGISCGGVLSAYLLESYGWAKVIIIGGSIPLILVVALLLKLPESTQYLITRHQQGKAQRILENIQGHSFQEPVKLVLTQSETASDENPVKVVLGKYLwmLWLCCFTSLLVFYLLTSWMPTILKTA--GFSTQQFSLIAAIFPFGGVIGATIMGWYMDKLNPTTVIKYSYLIAFGLFIIAGLVSSNIFLLGlfLIGALLAGAQSSLLPLAAMFYParAVGVSWMHGIGRIGAILGAFFGSLIFTFNLSLSGIFFILAIPTFISFIAL---------
     171 UniRef50_C1B0S2        Putative MFS transporter n=...   204     6e-51  1   9.7%  6:436   4:432     -----SRSTVPDSEIGARTLKKVSYRILPFVMLLYIFNYMDRTNISYAQLGMQHELGITVGTFGAVASIFFLAYVVFEIPSNMALKKFGARIWLARIAITWGIVTVIMGF---VNSVTQLYVARVALGIAEAGLFPGLLLYLTFWFRSGERARAIAMMAMAQPIAMIIGSFTGGLILDHigWRWVFILQGAPTIVLGLIVLVYLPNRPREAKFLTTQESEWLEDEITAEYQEPETHAGVKEQ---------LGAIKNRKILHLAVANLFAACGLYGFTFFLPQIVKQMDPSYSATNIGFLGAVPFVVGAVGMLLISRYSDRTGERKLFVIGLMVLAAVGliVFRHSPVLALTSLSMVAVGVLGYMAPYWAMAAQVLTRaaVGLAAINTIAAMGGFFGPYVIGK-NATADNVTIGLYFPIACLLICAVMLAFLKIPK--
     172 UniRef50_A0LW52        Drug resistance transporter...   204     6e-51  1  13.6%  9:413   6:440     --------TAASAPPPTHMSHRQIVIVLSGLMVGMLLAALDQTIVATALPRITGDLG-GQQHLAWVVTAYLLTSTASTPLYGKISDLYGRRKIFQLAIVIFLIGSAL---AGASQNMAELIVTRAIQGLGAGGLITLALAIVGDIIPPRERGRYQGYFGAVFGLSSVIGPLLGGWFTDTISWRWVFYINLPLGALALVVTSAVLHIPFQRREHKVDYLGAAVLVAalFALSALLFAAFVAVEARAAEPILPLRLFRNRVFTVANSAGFILGFALFGAVIFLPVYL-QNVKGSSPTVSGLQLLPLMAGVLFTSIGSGRLITATGRYKIyiVGMVLVSIAFAMLSftSYATLAGEIALLGAGMGLVMQVLVLAIQNAVPYagVATSSNAFFRSMGSSLGVAVFGAIATNGLTAYV-------------------------
     173 UniRef50_C6WMM8        Major facilitator superfami...   204     6e-51  1  13.6% 15:433   1:443     --------------MSTSTPRGGDWLALASLCLGFFLLLVDSTIISVALPALMADLGADEGTAIWVNSSYLFAYAVPLLVAGRLGDRYGARAVYLAGLVLFILASLACGLVS---DPLALVAWRVVQGLGAALMTPQSMTIIRRLFAFPALGVAMGVWASVGGVASVSGPLLGGVLVGTWGWESIFLVNVPIGLLALAAAWVWLPrpVTGVLVSGLGVFGVVAGIHGGVLPPWVPGWAaaQRGEPDRALVPVPLFRDRGFVMASVGAAMSSFTVGAAMIPVMLHL-QGARGLDSMSAALVLIPMGVVCAATAPFAGRSVSARGPRFTALIGSivLLAAVLVAASAPIWVFAAALTVFGLANAFVWAPMSVAALNSAPDRLMGAASgnAIKQVGAVVGSAVTAALLAVTSQGAALAALGVAALVCVLASALLGR-----
     174 UniRef50_C7C586        Putative tartrate transport...   204     6e-51  1  12.2%  2:435  18:447     -TMSAINEKPTGGAQARITHKKIYRHLLPLLIVAYIISFIDRTNIGMAKASMSVDLGLSATAFGLGAGLFFLTYSVLEIPSNLFLAKIGARRWIARIMITWGLISCAM---AFVTGPWSFYAMRLLLGAAEAGLYPGIIYYLTLWFGREERAKATGLFLLGVCFANIIGAPLGGLLlgWAGWQWMFFIEGLPAVALAFVVWRVLPDKPADAKWLDKQDVEFI---------ETTLAREAREANHAPSSFSLKKALATRVFLLLVLVYFAHQFSVYGLSYFLPGI-IGSWGDLSPLQVGLLTAIPWIAAACGGVLLPRFARTEGrrRMLMVGYLVMAVGMAIGATGGPSVAMIGFSVTAFMFFAVQSIIFSWLPSIMSGsaGSFGLLNCLGLCGGFLGPFILGAFEDRTGSPTSGLWFAVGLLVIGALVATLIRSR---
     175 UniRef50_B2JT19        Major facilitator superfami...   204     7e-51  1  13.0%  5:436   2:426     ----TAIQTLRESDPVRTLYNRLNWRLLPFLLACYMFAYLDRVNVGFAKLQMQSDLGFSDAAYGVGAGIFFLGYVLFELPSNLLLPKIGARKTFSRILVLWGLTSASMLF---VHNVPMFYGMRFLLGIFEAGFAPGMIYYLSCWYGPTRMARAIAIVFLAGPLGGIVGGPLSAWLISAfgWQWMFLIEGLPCIALGVLTLFVLSNRPADARWLNADEKRLL---------------ESETGAAHAHNHSFKAVALDRRIYVLALAYFSIIFPIYAISFWLPT-LIKEQGVSDTLRLGWYAAIPYVAAGIAMYVAGRSSDRTGERRLHCAVPALTGALLLvfTQGNLFATLALLTAATAAMWMAYTVFWAMPGEYipAAAGGIALINTIGLSGGFWGPAAIGWARTATGNSHLALIVMACMPVIAGLLILASRQSR--
     176 UniRef50_C6VP74        Multidrug transport protein...   204     7e-51  1  11.6% 27:405  11:413     --------------------------VTVAIYVATFMSAIEGTIVSTALPTIVGDLH-GVSLMNWVFSIYLLTNAMMTPIYGKLTDLVGRKPVMQAGLIIFIVGSMMSGLS---NSMPVLIFWRAIQGIGAGALMPVSMTIIADIYSFERRAKVLGFNSSAWGIASVLAPLIGGLIVDKLSWHWIFFINVPVGLITLFLFQFYLREPKRHNNVKIDYLGSfvAVGTAWIISALSLWLFIRRESRTDEPVISMDLFKNHTFIIQNAVAALVSGFLMAVEVYIPTW-TQGILGVPASLAGFAVTPSSLMWIVGSFVTGRLLAKWAPRRILYLSLAFILVTSICLAWLPVNTAFPWFFLigVGFGITITATTVTSQHLVPAENVGVATSFNtrTIGQTLMISIFGIAL---------------------------------
     177 UniRef50_P96712        Multidrug resistance protei...   204     7e-51  1  12.5% 37:404  24:416     ------------------------------------MSAMDNTIVATAMGNIVADLG-SFDKFAWVTASYMVAVMAGMPIYGKLSDMYGRKRFFLFGLIFFLIGSALCGIA---QTMNQLIIFRAIQGIGGGALLPIAFTIIFDLFPPEKRGKMSGMFGAVFGLSSVLGPLLGAIITDSISWHWVFYINVPIGALSLFFIIRYYKESLEHRKQKIDWGGAITLVVSIVCLMFALELGGKtvERKAEEPIISFWMFKNRLFATAQILAFLYGGTFIILAVFIP-IFVQAVYGSSATSAGFILTPMMIGSVIGSMIGGIFQTKASFRNLMLISVIAFFIGMLLLSNMTpvWLTVFMMISGFGVGFNFSLLPAASMNDLEPRFRGTatNSFLRSFGMTLGVTIFGTV----------------------------------
     178 UniRef50_Q21A62        Major facilitator superfami...   204     8e-51  1  14.1%  6:432   1:424     -----MSDVAALPASSLVKATKIRWIVAGLMWSAIAINYIDRTVLSAAAPHLSAELSIPADQMGFILSAFFWSYALLQIPAGYFADRFGQKIGLGASVGLWSVATSATGLA---TGFYSLFAMRLGLGVGEAGAYPSNAGIASKWFPDRERATISGLFDSASKFGGAVAMPLIVWLIALVGWRMTFVVIGAIGVVWAIIWWWFYTETPETHPMANKAE-----------VDYIRDGQAMKHGEDKTIPMRWYELLRYRNIWAMCLGFFTINYISYFFITWLPMYLVKE-KGMGMIQMGFIAALPLLSGLVAEIVAGMLSDRvtRKLFLIAGLSMALCIGLAAVAESVALTVALLCIAKAGTTIAASQVWALPGDVAPKNMTSVVAgnMVSNFGGVVGPIVTGFIVAQTGSFTAALVFSAGIGMLGILNYALL------
     179 UniRef50_D0L4G9        Drug resistance transporter...   203     1e-50  1  12.1%  6:401   2:430     -----TEHTAHTEHAGAGLPHRQILTILGGLMMGMFLAALDQTIVSTAIRTIADDLQ-GYDLQAWVTTAYLVTSTIVTPLYGKLSDLYGRKPFFLVAISIFVVGSLLC---SMATSMYELAAFRALQGLGAGGLFTLALTTIGDIVPPRERAKYQGYFLAVFGTSSVLGPVLGGLFAGHagWRWVFLVNVPIGIIALGVVYRVLNYDQQKGVGGRTDYWGATALAVAVAPLLIVAEQGReeHLMGDDALIPLRVFNNRVFTQGIVISVVVGAVMFGGISMLPQYF-QVLRGSSPMVAGLQMLPMVLGLMLGSITSGQIISRTGRYKIFPIIGSILITAMTFLLhtPVAVVMLYAFGLGVGLGNMMQPIMLAMQNILPPKDMgtGTATFFRQIGGTLGVAVF-------------------------------------
     180 UniRef50_B8H5X3        Transporter n=2 Tax=Cauloba...   203     1e-50  1  12.8%  1:422   1:412     MGKEAKSMDVPKAPEPSEKIGRYRWIIVTLLFLAMVINYVDRQTIGFLKHDLSVEFGWSEHDYANLVFYFQLSYAVAYLVWGKVMDKIGARWGFGIAFLIWQVAHIAH---AGARGLTGFIFARMALGVGEAGGFPGGIKAVTEWFPKKERAFATGIFNAGTNIGAIVTPLVVPAIVLAWGWQMAFIVTGVAGLIWLPIWLLVYRTPRETKNLSAAELAHI-----------------EQDPADPVEKIAWTKLLTKRETWAYAIGKFLIDPIWWMFLFWLPDFLGK-RYGLDLKTFGPPIVAIYLLSDAGSVGGGWLSSNfaRKITMLICALLAVPVMFASFADSLWVAVLIIGVATAAHQGFSANLYTLPSDVFPRGAVgvGIGGMLGAVGGMVFSKYIGGVLESIGTYTPIFIVAGSAY----------------
     181 UniRef50_D1XR12        Drug resistance transporter...   203     1e-50  1  12.5%  1:433   7:490     LPSAAAARAVPTKPAAQQGADRRRWFALAIVMTAAFMDLVDVTIVNIAIPSITRDTGASFSSIQWITAGYALAFAAGLITGGRLGDIHGRKRLFLLGIAGFTIASALCGFAV---NPEMLVASRILQGATAALMVPQVLSIVHATFPAHERGKVFGLFGAIVGLGAVSGPLLGALLTEwlEWRPIFLINLPVGIAGLVLGRKFITESKAPKALRLDLAGVavSMAASLLVFAGLVAYERQKARKDGSPLIELSLFRVKSFAAGIAVQLTFGVGL-GIFFLVWTLYLQTGLGWSALKAGTTGIPFSIasVAAGLSVQKLVPRFGRKVLQAGALLMIAGLLLYAgaITSWQMVLPLVVMGVGMGLIVAPLTDAVLSGVPKEHSGSASgnTVQQMGTALGLGLVSVVfqFVDAFQRSLWCVAGVLAVIFFVMFALP-----
     182 UniRef50_A9AZB7        Drug resistance transporter...   203     1e-50  1  13.0%  6:419   7:450     -----QAASAAVEFEQPRYTKRETLLTMLSVLLVMLLASLDQTIVGTAMPKVITDLH-GFDRYTWVTTAYLLASTVMVPIYGKLSDMFGRKPLFIFGLIVFLIGSGLCGAA---QSMNQLIIFRGLQGLGAAALMPIALAIVGDLFTPRERARWQGITGGVFGISAILGPTAGGWLTEHVSWRWIFYVNLPLGIIALLTLVFLMplGRKAQRVKIDYIGSILLVAGTVPLLLGFTWaeAWLERNNGQPIIEPSLFKNSIFRISVLITIISNMALFGNIFFLPLF-VQGVIGTSITNSGLIMTPLMLTAIICSVVAGQIVAATGKYKIIAigMAISVLGGFLLLqsTNTNVAIDMVVLGLGMGAGMSLYTLITQNALPNKIgaTSALTFFRSIGSTIALAAMGSVMNSAYLPAFKAAIPA-------------------
     183 UniRef50_UPI000197C959 major facilitator family tr...   203     1e-50  1  13.5% 14:429  12:423     -------------AQGKKTNAKIYRNLMPLLILAYIISFIDRTNIGMAKNAMSIDLGLSATAFGIGAGLFFLTYSILEIPSNLIMEKVGARFWITRIMITWGLLSAAM---AFVTGPTSFYILRLLLGAAEAGLYPGVILYMTYWFSQEERAKATGLFLLGVCLANIIGAPLSGLLLsfHGWQWMFVIEGLPAVILAFVVWFVLPNKPEDAKWLDEDD---------RNYIKYKHDQDKNSISVSNSKFSLKAAFKNKAFMMIVAIYFTHQFSVYGLSYFLPTIIGEYGK-LTPIQIGLLTAIPWISAAIGGIFVARKANtrRSSRILISGYAVMAVGLVIGALGGPVVGLIGFCLTAFMFFVVQSIIFSLPPTYMSGsaGSLALLNCLGLFGGFLGPFILGFFEDYTGTATSGLWFGVGLLVIGTIIA---------
     184 UniRef50_B2TD29        Major facilitator superfami...   203     1e-50  1  13.9%  2:432   7:447     -SSSADAATPQGVTASTARRSKARYQILALLAVGTMINYLDRTVLGIAAPQLTKELGINAALMGLLFSVFSWSYVASQIPGGLFLDRFGSKLTYFLSMTLWSLCTLAQGL---VHGIGALFAFRLGLGVSEAPCFPTNSRVVATWFPQSERAMATGTYTVGEYIGLAFFSPFLFMLMGAFGWRSLFYVVGGVGIVFGGIWWMFYREPRDHPSANQAELDYIEAGGGLtdADSAGGADAASAKSGGFEWRTIGRLLKHRQLTGICLGQFAGNSTLVFFLTWFPTYLATERH-MAWLKIGFFAIMPFIAASIGVMFGGFFSDWLLrrKLPIIAGLLLASTIILANYVESNVAVIAILSVAFFAQGMAALGWTLVSDIAPDGLLGvgIFNFAANLAGIVTPLVVGFIVAATGSFVGALVFIGAIALIGALSYIFI------
     185 UniRef50_A3TZ27        Drug resistance transporter...   203     1e-50  1  15.1%  1:418   1:443     MPSKTEHPVTPPPDLPG-PDAATLRVLLITVATTLFLASTGNTIVTTALPRIVSDLG-GLAYISWVVTAFLLASTVGAPIAGKLGDMYGRKIVLQVAIGVFLLGGLICGVA---RSMEVLIAGRFVQGLGGGALIVVSMAVVADVLPPRERGRVQGALSSVFGFSTVVGPLIGGFLVQTVGWHWIFFVNFPIGVVAFVILTRTLKSSTEKVPHKMDFVGSalTVLFLLALAPMALVGFVSAERRAAEPVMPLDLFRIRNFQAANSVNFLVGMAMFGTIAFIPMFL-QVVKHVGPVSSGLYLVAMMGGLIGTSFAAGRVISSTGRYKVMPTVSTAVLAGAMLLLttPLAVITLYLFLVGAGIGPTMSVGIVSIQSAVPRegVGTASANMFRLIGGAIGTSVFGALFTLGLGRHVQPLMP--------------------
     186 UniRef50_C6C954        D-galactonate transporter n...   203     1e-50  1  10.8% 17:432   6:424     ----------------AVKRTRVRYVILLFLFLATVFNYADRATLSVVAPIMSKELNFDPETMGLAFSVFGISYVAMQIPGGWLLDRYGSRLVYGWALIGWSLVTLFQGTiqFASPIMALVVLRLLMGAIEAPAFPANSRLSVQWFPNKERGFVTSVYQAAQYISLGLITPLMTIILHNLSWHYVFYYIGAIGIILGAFWLMYVQDPYRHKKINQEELDYI-------RNGGGEPELGRKEQSTKLTLSDIKSVCINRMMIGVYIGQFCLTSITWFFLTWFPTYLYQA-KGMSILKVGFVASIPALAGFIGGLLGGVFSDYLLrrKLPIICGMLLSCTIVAANYTGSESIVIAAMSLAFFAKGFGNLGWCVLSDTSPKELLGIAGgnMCGNLASIVTPLVIGFILSATHSFDYAILYVGSMGLVGLVSYVFI------
     187 UniRef50_C8X9A9        Drug resistance transporter...   203     1e-50  1  11.6%  1:405   1:437     MATATGEIQAAPTASPSGLTHKQIRFILFGLMAGMLLAALDQTIVSTSIRVIADDLH-GLSAQAWVTTAYLITSTVTTPLYGKLSDIYGRRPMFLTAISIFIFGSLLC---TFSTSMYELAAFRAIQGIGAGGLFSMALAILADIAPPRERAKYQGYFLAVFGMSSVVGPLVGGfiLGIAGWRWVFLVNVPIGILALVIVSITLHIPHMRHDHRVDWWGATALMVGLVPLLIVAEQGREWGWMSGseALIPMRLFRSRVFSTGLGANVLIGLGMFGALSTLPLYL-QLVKGATPTESGLLLIPMMVGIMGGSVLSGQLTMRTGRYKIfvMGTALLTASFFLMLTVDVDTGYPLlvMIGLGLGLCMQTLLIAVQNTVPAkgVATSSATFFRQLGGTLGVAVFLSLL---------------------------------
     188 UniRef50_D1C5K1        Drug resistance transporter...   203     1e-50  1  13.0% 23:413  11:426     ----------------------RRWWTLAVLSLALAVISLDNMILNVALPTLVRDLNATSSQLQWIVDSYVLVFAGLLLTAGALGDRFGRKLALMVGLGVFGAFSAL---AAMSGTANQLITTRALMGIGGALIMPSTLSILTNVFPPAERAKAIGIWAAVNGLSIPLGPVLGGWLLEHYSWGSIFLINLPVVVVSLIAATILVPESRDAKALPLDPVGAVLSIAGLAALLYAIIEAPSAgeRRVPYPMFDTRLFKNPRFSAASLSVTMVFFGLFGATFFLTQHM-QFVLGFDTLQTGVRMIPVAVGVGIAAPLSARLTARFGSKVMVAAGLTVVALGLGLMSTAtyGLVATCMIVAGAGMGLAMTPATDAVMGAVPKDNAGVGSAvtTRQVGGALGVAVLGSLLATNYSDAM-------------------------
     189 UniRef50_UPI0001C424B6 drug resistance transporter...   202     1e-50  1  14.4% 18:407   2:421     -----------------SKRKTKRPIVLTAVILAMFMAAVEATIVATAMPQIVADLG-GFSLFSWVFSSYLLMQVVMIPVYGKLSDMYGRKIIFAIGISIFLIGSILCGFSA---TMEMLIISRFIQGLGAGAVQPIATTIVGDMYTKEERANIQGYLASVWGISAIMGPVLGAVFIEYLHWAWIFWVNIPFGIIALIGVTLFLHEDIKSarQSIDYKGALLLLLAITPFMLVLIQGNVWgeRREANPMMTLSLWENQHIRNANIASFTAGAILLAVSTFLPTY-VQGVMNQPPIIAGLALTAISIGWPISSTIAGKMMLKKGFRTTALIGGCALVTGGLFYMLLppLWAGAGSFVIGVGMGFSTTTFIVSIQSSVDWNVRgtSMNMFMRLLGGAVGVAFLGGLLNR-------------------------------
     190 UniRef50_A0JW59        Major facilitator superfami...   202     1e-50  1  16.7%  6:437   1:432     -----MTQFTPIKAMADARLNRFHIILLLCCSFIMFFDGYDLIVYGSVLPTLMTEWSLTPDQAGWLGSAALIGMMIGALTLGSLADRIGRRPVVVHGTLLFSLAAIATGLA---TTPEAFGALRFLTGIFLGGVIPNIVSLMNELAPRANRHALTTIMLSIYSVGSIVATLVALWVLPLLGWKPVFFLSGA-ALLFLPFLYRWMPESMTFLMSRGKETEARALLRRAVPTQNHEHVHWTVPAPQHRPSVSASRLFREGRLlmVWLSFGMCMLMVYGLNTWLPKIMI--AGGYDLGSSLQFLIVLNIGATVGALAGGWLGDRFGNKLVLVIFFALAVVSLILLGTHPGPELliLLFIAGATTIGTLAVVHAFGADYYPAEIRSTgwCSAMGRFGAIAGPILGGALIGLKLPLGQNFLIFAIPGVIAIAAVLLVARTKT-
     191 UniRef50_B1SYR9        Major facilitator superfami...   202     1e-50  1  12.5% 33:433  30:424     --------------------------------ICYLFACLDRLNVGFARLHMQSDIGLTDAQYGLAAGVFFIGYALFEVPSNLLLPKIGARKAISRILVLWGLTSAAMVATRDATTFYVL---RFLLGVFEAGFTPGILFYLTCWYPESRRAKAIAAVMIGGPLAGVLGGPLSMWIMTTfgWQWMYLIEGLPCVALGIMARVLLADRPE--------------TATWLSPEERQELVDMTAQPQHAERHGFAEVVKDPYVYLMSAAYFCVICGIYLINFWLPGLLA-ARGVTDPMKIGLYSSIPFVAATIGMVVAGRSSDRRNERRWHSAIPALVSAISLVATVVslDVSLICITVATTAMWMAYTVFWTIPSAYlpAAAGGIALINTIGVLGGFFSPAAIGWLRTSTGSFRACLLLMAAIMAIGAALLAATR-----
     192 UniRef50_C7QJD3        Drug resistance transporter...   202     2e-50  1  13.2%  6:428   1:448     -----MSQTEQGTAVPPGAADGRKWWALGGLALSLLVVGLDLTVLNVALPTLSTSLKASTSQLQWFANSYNLAMAIALLPGGLLGDRFGRKRMLVIALTAFGIASAFCAFSSNA---GELIAWRAVLGIGAALLIPLSMSVLTVLFTPEERPRAMGIWATANMLGIPLGPILGGWLLDHYWWGSVFLINLPVVVIALLAVVWLVPESRAERKPRIDLPGLAASAVGLAAITYGLIKAGDAGWGSAEAllIDLELFRARGFTWGTILSTIVSFALFGLMFTLPQFY-QAVEGADALGTGVRLLPMIAGLMVGVRVGQPFLKRVGPSPLIGAGFVLLAISLMIGTATGVhfVAIWLTMGGVGVGLAMPITMNVALDELSAERAGVGSgmTIRQIGGTCAVAILGTVLNSQYRSHLAPAVAHLPAPLASAA----------
     193 UniRef50_B2JWX0        Major facilitator superfami...   202     2e-50  1  14.1% 18:436   3:411     -----------------RLLPKATTMVLATLCLMYFITYVDRVNISTAAGQFKSELGLTNTQLGLIFSAFAYPYVMFQFIGGWVSDRFGARRTLIACATVWAAATALTGFAG---GFLSLIAARLLLGLGEGATFPASTSAMAAWVTKDKRGMAQGITHSCARLGNAIAPMLVLALMTAFKWRFSFYLLGALSAGWLMLWYFTYTERPADHPRITRGELAAL---------------PPPKVRLADAPGTWMRL--YRRMAPVSAVYFCYNWILWLMLDWMPLYFMHSFH-LNIKKAVVFTSGVFIAGVVGDLAGGLVSDRLLRkyLVACCMALTGLSLivVLLHDPMYSLIFLAAAMFFNEMNIGPMWAIPMDiyDRAGTASGIMSGNGFVAAIASPVVAGYVVDRLGNWNVTFMLSIGVMVCGIALSFVMKPER--
     194 UniRef50_B5XYU9        Transporter, major facilita...   202     2e-50  1  14.3% 16:435  10:442     ---------------TDARKTKYRFVVLTMIFLVYAINYADRTNIGAVLPFIIDEFHINNFEAGAIASMFFLGYAVSQIPAGFFIAKRGTRGLVSLSIFGFSAFTWLMG---TVSSVFGLKLVRLGLGLSEGPCPVGLASTINNWFPPKEKATATGVYIAATMFAPIIVPPLAVWIAVTWGWRWVFFSFAIPGIVAAIAWYLLVKSKPSESGFVSQSELAEINAGriLIADRFTWLDKIIRVKKMAPIDTAKGLFTSKNILGDCLAYFMMVSVLYGLLTWIPLYLVKER-GFDVMSMGFVASMPCIGGFIGAIGGGWISDKvrRKPTMMFTAVSTVVMMLIMLNIPASTLAVclFFVGFCLNIGWPAFTAYGMAVSDSKtiASSIINSGGNLGGFVAPMAAGFLLDKTGSFNSVFTYFGICAAIGLVVILFLDEP---
     195 UniRef50_B1HS27        Probable glucarate transpor...   202     2e-50  1  14.6% 14:432   1:397     -------------MTTNDVTKKSRNVILALLFLGWSLGNLDRYIMNYAVVSITGDLQLDASSTGIILSAFFLGYAIMQIPGGWLADKFGAKRILLMAVIMWSIFT---GLTAIAWSLTAMIVIRFLFGIGEGGFQPSSSKIIATIFPKEERGRAMSIMLTSGGIVSLIVPLLAAYLLGTIGWRMMFIIIGAIGAIIAYLYWKYI-------------------------QLPKAETADAAETGSPTVKVSFKELLKTPLMWNLIIAYFCIYAVNWGLVSWIPTYLQKNR-GLDLMSIGWAQTIPAITTIIGVYGSGYIIDKlgMEKVliSCAVIGILLYLMFTAKTVTLFIGYQTVVSIFIAFVITLLPVIVLKKLPSSITGSAMgnTGGQLAGFVTPMAIGFMVDAfgSFDAAFWMLIGFALICIVSLVTL------
     196 UniRef50_Q0SF98        Possible antibiotic efflux ...   202     2e-50  1  12.6% 12:417   5:437     -----------EARAVATGSRTRRFLALAVICLAELLVVLDNTIVNVALPSIGVELRTSVSGLQWVVDAYTLTFAGLLLAFGNLGDRYGRRRVMVIGLIGVAVMSIA---GANAESLGQVIAARAAMGVFAAAVFPATLALVINIfdVRERALAIAAWTAMAGFAIAIGPMAGGWLLEHFSWHSVFWINVPIAVVVAAATLLLVPESRASVIGRMDLVGIAASITGITVLVWAIIEAPHHgeLRTEHPILDLRLFRNRRFSLPALAIAIGYFSMFGFLFLITQYF-QGVREYTPFEFGVASLPFAVSVAVGAPVATLLAQRVGTTPVIVFGLLLTGVGLYLGGQVAVDsvLPSMVSMALGLAIVQGPATESIMASLPLDEAGAGSAvtTREIGGTLGVAVLGSIVASYYATTISPVL---------------------
     197 UniRef50_B7JD79        Benzoate MFS transporter n=...   202     2e-50  1  12.7%  6:437   1:432     -----MKSINPMNVIDESRIHSMHLWLIFWLFIVIAFDGYDVVIYGAAVPSLIKEWGISDVTAGAIGSYTVIGTAIGAIFFGLVADKIGRKNIILLTTILFSLFTFLSGFA---NDPVTFTIFRVIAGIGLGGVMPNVIAIATEFSPKRVRTAIVSFIFCGYSVGAMAAALTSRSLLMTAGWKPVFWLAG-LPLLFLPFLIKSIPESVSFLLGKGKIEEAKKVIAKVNPKLGEYATIEFTKPPTKEAGSPVVKLfrAISTIMFWISCFSAFVLIYSMNTWLPRLMMQS--GYDLKSSLSFTAVMQIGAIVGTLIFGPIVDKVGFKKVLVPLFFCGAIALSLIGFANSmvGFLLIAIIGASSVGLQNMSNAFVSQYYPSNMRSTAVgmAFGRLGGVVAPTFVGVLLSMHFLPQYNFSAIASAAVIGGIAMLFVKEEHG-
     198 UniRef50_C8WJX2        Drug resistance transporter...   202     2e-50  1  12.1%  1:414  74:514     LAAASARQGGVPASEPKPEHSRGVAAVFAGLLLAMFASTLSETVTATALPTIVGDLG-GVDHMQWVTTAYILASTVMMPIYGKLGDLFGRKYLFIIALSIFIVGSATCGLA---PSMDGLIAGRAVEGLGGGGLIILAQATIADIIPPRQRGKYMGLMGSVFAVSTVVGPLLGGWFVQVTGWRWLFAFNIPLALLAIAAVAFFLTKPVRRDDRPPIDIGGMMaiFALFALFFVAAVAFVLVERKAKEPIIPMLLFKNRNFVVCTVTGMFIMLGMMGTISYLPTYF-QIVEGLAPEQAGLMTVPMMAGVLITAVGTGFLATKTGrkWMPIASCAVTAVGFVLLSqtPLVVTGVFLFVLGFGIGLGQQILVLIVQNEFPHagTATAANNFFRQIGSTLGASLVGALFTSRLTADLA------------------------
     199 UniRef50_D2LED4        Drug resistance transporter...   202     2e-50  1  12.8%  6:434   7:473     -----TRRTDTSGTCPEPPSDAVKRLLPWLVAVAYFMESLDTTILNTAVPVIAKAMDVPPLSMKAVLASYTLSLAIFIPISGWMADRFGTRRVFAGAIGLFTLASLL---AGLSQNMYMLIACRILQGCGGAMMVPVGRLTLVRTFDRTEFIRILSLVTIPGWIGPVIGPTVGGFMVAHLHWSFIFFVNVPIGILGLILVARYLPDYREegFLLFGAGVALMstIALLAVSVALILAYGYHSLRTRWPLLELGLFRIRTFRISVSGSFFTRLGVGGVPFLLPLLY-QIPLGFTPMQSGLLIMPQAIGGILAKLALSRILDRLGYRNMLTSNTIILGALLMLFATVGPYTPVWLIvlYGAFSSLQYTTMNSMAYADMDQhsSAGSIASTAQELSISFGIAAAGLITamGFGLHEAFIVLGIMTILSTFIFAGLKR----
     200 UniRef50_C6VYJ4        Major facilitator superfami...   202     2e-50  1  13.5% 17:432   3:415     ----------------QTNIGNYRWVICALLFFATTINYIDRQILGLLKPTLETEFNWSETDYANIVMVFAACYAAGYIVFGNIIDKIGSKLGYAVSIVIWSVAAVAH---AFVKSTFGFGAVRAVLGLGEAGNFPAAVKATAEWFPKRERALATGIFNSGTSIGAVAAPILVPWLLSSYGWQGAFLITGALGFIWLIFWWVMYEIPSRHKKVTAEEYAFI-------------HSDNEAGDGEGQKPIHWTKLITLPQTWVFIVGKFLTDPVWWFFLFWLPSYFATT-FDLDLKKPSLHLAIVYTATTFGSIGGGYLSSYlaRKTTLLVVAFAVMPIILAQFATDIWTVVAIIAIATAAHQAWSANIFTIVSDIFPKRasVVGIGGMAGSLGSTFFPLLVGALLdsAGSIGAGYNILFIICGLAYIIAWLI------
     201 UniRef50_B1ZUY3        Major facilitator superfami...   202     2e-50  1  12.0%  7:432   3:419     ------SPSGAAGSPAATPPTRARYWVVVFAITLAVIQYIDRVCISQAAPSVSSALDLSKEQMGWVFSAFTLAYALFEIPTGYWGDRNGPRRVLLRVVLWWSFFTAATG---WVWNWSSLVVTRFLFGAGEAGCFPNLTKAFEAWLPTRERIRAQGIMWMSARWGGAVTPYLVFLVLSVMNWRLAFLVFGLLGVVWAILFARWFRDNPREHPSVNAAEAALL----------------PERPASSHFAVPWRKLITAPSVWCVCGQYFACSYAWYFFITWFPTYLLE-VHKFDLKSSALLAGLPLLLGGAGCFLAGALVPRFtrRLFGVVGQGGAALCLIAATFFspLLAVTAIALASFSNDLSIPCSWTTCMDVGGRYVGtsGMMNMVGNIGGFLSPIVLGYIVGRTGDWNLTFYVTAAVYLLGALCWWLI------
     202 UniRef50_A9BN10        Major facilitator superfami...   202     2e-50  1  13.7%  3:433  44:471     --AGAAPALASETPAEAAVYRKVAWRLLPFIMACYVAAYLDRVNVGFAKLHMLADLQFSEAMYGLGAGLFFIGYFFFEVPSNMLMHRIGAKATISRIMIMWSLISAAMMF---VSTPTQFYVLRFLLGAAEAGFYPGMILYMTYWFPSYRRARMVALFMCAIPVSGILGGPLSGGIMDLmgWQWLFLLEAIPSMILGLAVLWYLDNGIRAARWLTEAEKTLL-----------ERNIARENASKSDSHVTLRALFSDPRIIKMALICFCTVMGQYGLTFWLPSLIRQS-GVEGAFHIGLLTAVPFSVAVVSMNLVSRSSDRMRERRWHLifCVGAAGLMLSAIFSGNvlSLAALALAAGGSLATSPLFWSLPTAIlaGAAAGIALINSFANLAGFISPYMIGLIKDATQSTNAAMFVLAGVLLFGAFLTYTVP-----
     203 UniRef50_B5FKE9        Major facilitator superfami...   202     2e-50  1  11.9% 15:433   6:415     --------------IEKPTTRGRWLHIIPATILVYIVAYMDRTNTAiiAGGMDEDLGMTASFAGLVAGIFFIGYIFLQIPGGQIAERLSAKKLIAWTIVAWGGFALLTGF---VQTPTQLLIIRFVLGVAEGAVYPAILALIGHWFPNEERARAIAYFQMNLAVASIITGPLSGWLIETYGWREMFIIEGLLSLGLLFVWLPLVSDHPHQAKWLDPKERA----------WIEQKLLADRALSIGGEQSSIRGVLKSINLWKLVGIYFFVQVGFYGFALWMPN-LIKHLTGSGMTIVGVLTAAPYVLCIIGQYYIAKWCDKTMNRRLYTAIPLLGFAVCLALSLlnVWLAYGMMVICGFFLQAYAGPFWTLPPLLFAPNVLGggTINALGNIGGFIGPYLVG-LLTVTFSQTAGMTVLVAALLIAVGLLFSLP-----
     204 UniRef50_P70786        Putative tartrate transport...   202     3e-50  1  10.5% 11:438  18:439     ----------VTNDLEARVLRKITFRIVPFIMLLYFIAFLDRVNIGFAALTMNQDLGFSSTVFGIGAGIFFVGYFLFEVPSNLILNKVGARIWIARVMITWGIVSGLMAFVQGTTSFYIL---RFLLGVAEAGFFPGIILYLSFWFPARRRAAVTALFMAAAPLSTVLGSPISGALMEMhgWQWMFLIEAAPALILGVVVLFFLTDRPEKAKWLTEEE-----------RNWLVKTMNAEQAGRGTASHSVMAGLADIRVIALALVYFGTSAGLYTLGIWAPQIIKQ--FGLSAIEVGFINAVPGIFAVVAMVLWARHSDRTGERTWHVvcLLAAAGLAFAAGATSVFMVLIALTIVNVGISCSKPPLWSMPTMFlpAAAAGIATINSIGNLGGFVGPSMIGWIKDTTGSFTGGLYFVAGLLLISAILTLILARSSPK
     205 UniRef50_D2TRG8        Putative 3-hydroxyphenylpro...   202     3e-50  1  12.4%  6:432   2:430     -----TQRRELQALIDAAPVGKTQWRVIICCFLVVMLDGFDTAAIGFIAPDIRLQWQLTAGELAPLFGAGLLGLTAGALLCGPLSDRFGRKRVIELCVLLFGALSLL---SAFSPDLQTLVILRFLTGLGLGGAMPNTITMTSEYLPARRRGALVTLMFCGFTLGSALGGIVSAQLVAVIGWHGILVLGGVLPLILFVALLFVLPESPRWQVRRQLPQTTIARTVSAITSERYDDTHFFLNETAATATGSIRQLfqLPITLMLWVVFFMSLLIIYLLSSWLPTLL--NHRGINLQQASWVTAAFQVGGTLGALALGVLMDKHNPFRVLALSYALGAVCIVMIGLsgLWLMALAIFGTGVGISGSQVGLNALTATLYPtrATGVSWSNAVGRCGAIVGSLSGGVMMAMNFSFDTLFFIIAVPAAISAVMLTLL------
     206 UniRef50_P37489        Uncharacterized transporter...   202     3e-50  1  13.5% 19:432  15:426     ------------------RPGHTRWYISSLLSGIIILNYFDRVAISVAAPAIQDSFHLTATELGIVFSIYTYSYTLMQLPVGSLLDRFGVAWVTRVGMTIW---SFLTILLAFLQGKLLLYLFRFLIGLTSASAFPAASKATALWFPPSERGLANSLFDSAAKFSNVIGAPLVAFLVTTFDWRVAFLTIGCINVLFTIFFWQYYEQPERHKRISKSELNYI-----------QKHNAITTEQIPYKTGPLLKKLFTNRKVWGLMIGFTGYGYTFNLLLTWLPTFFKHT-YGMDLMSSGLFTAVPWLISTigIAVGGWLVDYfvYRTVIIVGMSFGFFFLGSILTNNITVAIICISIGLAGISATAPVGWSISAELApgSVSMLSSMVNLAnfGGIIAASLTGYLFDVTGSFTLSFLVAGFVLLLGLVFYVFV------
     207 UniRef50_C6CTB0        Drug resistance transporter...   201     3e-50  1  12.3% 40:406  24:416     ---------------------------------------MDETVVSTAMPTIIRELH-GLSLYGWVAGVYMLAMTIAMPILGRLADVFGRKKIYMSCMALFCLGSIVCG---SADSMAQLLIGRGIQGIGAGGLMPIALVIIGESFPLEQRAKVQSLIGPLMILPQLIGPTIGGYFVGNLNWHWLFLINIPVAVIAVAFLFKGLHESKGEEKHTIDWAGAGTLVAalLILSAVLIGLFIRIESRAKQPIIPLHLFRNRNVVVLSLLVFTLMLGLMGGIATFP-FFAQNVMGLTPTEAGYLMFAFMAGAIPSSIVNGFLITRVAYRNLFITCFILPLVGIflAVSTTPVFVIIAFFVMGLGIGALFGGDNLIVQESVEKKHSGVALGTvfQSLGATVGLSVFGSVLA--------------------------------
     208 UniRef50_A6WG02        Drug resistance transporter...   201     4e-50  1  14.0%  1:414   1:447     MSSTPAGSPPASASTDTPALSHRQILAIlgLLLGMFLGALDQTIVSTAIRTIADDLD-GFSLQAWATTAFLITSTISTPLYGKLSDMYGRRPFFIAAIVIFVIGSALCGIS---TSMYELAAFRALQGLGAGGLMSLALTIIADIVPARERARYQAYFMMVFGTSSVLGPVAGGFlvGLDGWRWIFWINVPLGALALFVVLKNLKLPKRTTKHRIDWPGALtaLVCYGLGLVGLIGFVLAERAYGEEALLPLRMFRGRTFVVGSLGSLILGMGMFGGFAVLPQYL-QVVKGSTPTEGGLQMLPVVVGIMSASMFSGKFIARTGKYKVlvVGTGLMVVALFLFSrtPIWQTMIAMLLLGWGLGGNMQPIILAVQNAAARtgVATSSVTFFRQMGGTLGTAVFLSILFSSLGTHVA------------------------
     209 UniRef50_Q2SB76        Permease of the major facil...   201     4e-50  1  10.4% 23:418  11:433     ----------------------NPWLIAPLVALAAFMEVLDISIANVSLQHIAGSLGAGPEETTWILTSYLVTNAIALPIAGWLSDYFGRTRFFIGSIIGFTLASLACGMA---PGLEMLIIFRAVQGLAGGALQPVSQAILADSFPLEKRGMAFAMYGIAVVAAPAIGPTLGGWITDEFSWRWIFLINVPVGIVLIMLVKRYLPDEPANhyFGFALIAIGLGCLQWMLDTGQREDWFESPQIvqKNPIVDLTLYRYPNFAMANVIMFMMGFVLFGSTALLP-LLMQTLMGYSAFDAGLVLSPGGFAIMFMMPIVGRLVGAVDSRILLTLGLGVSSLALwlTLAVDRDQLAMARVWQTLGLAFLFIPTTSSAYVGLPTSaqAAAMLSFMRNLGGGVGIALLMTFLDRVATVNRGHLVA--------------------
     210 UniRef50_B8G0U7        Major facilitator superfami...   201     4e-50  1  12.7%  1:432   1:433     MSNASKQDHEPqtLVGNVKRTNVRWYVFIAMLVLVTINYVDRAVLSIAMPAIQKDLNLDPAIVGVILSSFFWGYALMQIPSGFLLDRVNPSKVVLGSAVGWGIAQTLTGF---VNSAGSLMFFRVLLGVTEAPIMPAGAKLQGIWLPSKERARGATIIDSGAPLGTAVGGPIIIAFMAWfgWRGALIGAGLMTIILGVICYYILKGNPATHKGVNQAE--------REYIQTHLAQEQEEAQKETKTELKTSTYLSNKSFWGMCLGWFSFNTVFYGLLTWGPSFLAQT-QGIDIKAIGFSTLLIFGCGFVGELVGGQLVDKWRqkTCIGIAGLATSASIFLLTRASSLTMAIALLSTALFFLRWAGIFWSVPAAIAQRHHVGvgCMNFAGNIAGVITPIYIGLIVKFTGSFHAGLLIFVAAGVLLAVAGALI------
     211 UniRef50_B1EKH7        Major facilitator superfami...   201     4e-50  1  13.2% 14:437   1:420     -------------MTTGSGQWRVRNKMLLILWLIFLISYLDRVNFSVALPAISNELGLTAGEKGLVLSAFFIGYGLLQIGAGLMVDRFGGRVTMTLALFWWSLFTA---FTGMVGGFIGLLLVRPLFGAGEAMHPPASWKLISQWFPKKEQVRANSLNLCSIALGPAFAPLLVVLLMQWVGWRGVFYIFAIPGFIVTWLCWKYMRDKPEDHPDVTPQELAEI--------REGQTASDTVALSKEEKRLALAAAVREPGLWMLMCTYLLFGIAFWGFLSWLPSYLVDVRQ-FAMVKMGLVASIPFFASFVAMLIASWVCNHlgRKQIFVATCYLLGALFMWQAFapNMCVLWLTLTAAFGIFMPFGVFWAISMEVLPTKVMGFASgnTGGQIGGFIAPIAIGYLIQYygSYAAGFGLMVGCLIAAAILVLTIRPRKA-
     212 UniRef50_P39886        Tetracenomycin C resistance...   201     5e-50  1  12.0%  1:407   1:433     MSTETHDEPSGVAHTPASGLRGRPWPTLLAVAVGVMMVALDSTIVAIANPAIQQDLHASLADVQWITNGYLLALAVSLITAGKLGDRFGHRQTFLVGVAGFAVTSAAIGLSG---SVAAIVVFRVLQGLFGALMQPSALGLLRVTFPPGKLNMAIGIWSGVVGASTAAGPIIGGLLVQHVGWEAVFFINVPVGLAALVAGLVILTDARAERAPKSFDVSGIVLLSGAMFCLVWGLIKAParESRATEPLMPLAMFRSVPLSAGTVLMVLMAFSFIGGLFFV-TFYLQNVHGMSPVESGVHLLPLTGMMIVGAPVSGIVISRFGPGGPLVVGMLLTAASLWGMSTLEADSGmlWFVLLGLGLAPVMVGTTDVIVSNAPAELAGVAGGlsAMQVGGSLGTAVLGVLMAS-------------------------------
     213 UniRef50_C8WSL6        Major facilitator superfami...   201     5e-50  1  12.3% 20:435   2:424     -------------------ATRFRWVIIGLLFFITVVNYIDRSAISYAIGDIAQVLHLNDSQVGMILGAFGIGYMITTFFGGIWVDHVGARWALFFASLLWSLS---IGLTGVAASFTVIYLMRILLGVAEGPNFPAVNRAVGDWLSPRERAIALSNSLVAVPLALAIGAPIVTSLILGVGWRGMFIILGIVGLLWVPVWFFLFRDFPEHSRHVNDEELRHIRASEHVDRTRPAKEMRFRQAHHVSSGTLWKYLLVNRTLMANNWSFFVFGYYLFFFMTWLPSYLKSEYH-LNLKSVGAFSILPWALATVLLWLVGYLSDWILRRtpIWISQLLSALCVVPLTFTHDLTTAIVFITLAVGFGMSANSTFYAMNVDLMRERTGTALGltFFAAAGFLAPVITGWIVNATGSFKSAFWLMAVLSATSVLAVLIFHQP---
     214 UniRef50_B0RZ15        Glucarate transporter n=45 ...   201     5e-50  1  16.1%  8:429  65:477     -------PVNAAATGPLARLGRMRWRVCALLLAATTINYVDRQVLGVLAPFLQTQIGWNEIQYGYIVTAFQAAYALGLLCSGAVIDRFGTRAGYALAIGIWSLAAMGH---ALATTVVGFAIARFFLGLGESGNFPAAIKTVAEWFPRRERALATGIFNSGSNIGAIVAPLLVPVIATAWGWQAAFLFTGVLSATWLVVWWCSYHPPEQQPGLTAAELAHI----------------RSDAYEPVQRRLSWLQVMRHRQAWAFVLGKFITDPIWWFFLFWLPKFLHAE-YGLSLLQLGAPLIVIFVLADIGSIAGGWVAGRfaRKTAMLICALSVVPIVFAARADNLWVAVGLIGLATAAHQGWSANLFTLPSDMFPRHAVAtgIGGFAGAVGGMLIATFIGFLLQATGSYVPVFLMAGSAYLLALAIV---------
     215 UniRef50_D1TMW2        Major facilitator transport...   201     5e-50  1  12.3%  5:435   3:429     ----TPTTPSTQLERPTPLLRLVTLRIIPFLLLCWLMAFIDRVNIGFAQLQIKQDLGFGDAIYGLGAGIFFIGYVLFEVPSNIYLEKIGARKTFSRIMICWGATSSLTML---IRTPEHFYIMRFLLGACEAGFFPGLVFYLSCWFPESYRARVISWFFVTSAFSGIVGGMMSGTILHYlgWQWMFMMEGIPSIILGIVAIFYLDDSIDEARWLDAG------------QKVELKELLRPEVSRKPEKIRFRDLFGDPYVYILAIAYFSLNSGNFGLGFWLPTILKD-FGIRDPFMIGMWSAVPYAIGSIGIAIISGSSDRRQERRWHLLACTVFGGLALASLTLHvwLVILQLTVAIAFMYGGMPLFWAVPFKELNTKALaiALVSSLGQLGGFAAPYALGLIKAATGRLDTGLIALGALFAAGGVLVWITARS---
     216 UniRef50_UPI0001692C61 multidrug-efflux transporte...   200     5e-50  1  12.5% 23:407  11:423     ----------------------NKRLVLAGLIIGMFFSSLEQTVVGTAMPTIIKDLD-GFSIFAWVTTAYMITSTTIIPIVGKLSDLFGRRMMYLIGTVIFVVGSMLC---ATATSMEQLVIYRGIQGLGGGMIMPLSQTIIGDIFTAEQRARWQGVFGAIFGLSSVFGPFVGGFIVDHVSWHWIFSINAPFGLLSALLILFGMKHEITalTLVTGLVLFLLGITFAGDKFAWASTefILAELKAAEPIIDMGLFKNRVFTSVNLLGFVLGLGMFGAIMFVPLFM-QGILGVSPTAAGSTMTPMMIALILASVIGGQLLLRFTYRTILFIGMLIASLGFFLMSTLGIDTASlfMIVMGLGMGLVMPTLTIAVQNEFPRngAVTSATTFFRSIGGTIGVTVLNVVMNH-------------------------------
     217 UniRef50_A0PTR3        Conserved transmembrane tra...   200     6e-50  1  11.0%  8:406   4:432     -------SAPAERSALTSRRQPSATAVLLVASFGAFLAFLDSTIVNIAFPHIQRSfsYDISSLSWILNGYNIVFAAFLVASGRLADVLGRKRMFVFGVVLFTIASGLC---AVAGDVEQLVGFRVLQGIGAAVLVPASLALVVEGFDASHRAHAVGLWGAAAAVASGLGPPVGGMLVEASSWRLVFLVNIPLGIVAVLVAGRVLTESRASGRRRVPDLRGAMLLGVALGLmsVALVAFVASSRSHPTPLIDPAFLRVRSFVAGNLLTLVAAAGFYCYVLTHVLYL-NYVWHYSLLKAGFAIAPAALIAAVVAAVLGRIADQRGHRLVVMAGAIIWAGSLVWYLQRVGteWLPGQLLQGIGVGATLPVLGSAALAGlgSYATASAVVSTTRQLGAVIGVALLVILIG--------------------------------
     218 UniRef50_C9RSF6        Drug resistance transporter...   200     6e-50  1  11.6%  2:406  55:484     -STETDGRPAAPAGQGGLGDIGSRGKVVATVMLGAFVAILNQTLINVALPHMMQDFNVETSTIQWLVTGYMLVNGVLIPISPFLIAKFPAKRLFLSGMSFFAIGAFVC---SIAPSFAVMLAGRLTQAVGAGIIMQLMMVIMLSIFPPERRGVAMGTVGIAMMFAPAVGPTLSGWIVEHYTWRLLFYVVLPIAILDIVLASVWLKHTPRKGNPVLDVQGAVYSTIGFGGVLYGFSEafTWRSLRSEHPVLNFRVFRYPVFTLATVIGSVINMAMFAAMVLLPVYL-QNLRGFTPLDAGLLLLPGAIVMAIMSPISGWVFDRIGARMLAIVGLIITAVTTwlTMDTPYSQLIWLYIFRMFGMSMLGMPIMTEGLNALPRhsHGTAMSNTIRQVAASLGTAFLVTIMS--------------------------------
     219 UniRef50_B1FU92        Major facilitator superfami...   200     6e-50  1  14.0%  7:434  19:443     ------PTGSLTAAAVRPARLNFRWHVLIWLLIGGIINYMDRASLSIAAPGMIAELGLTRTQIGLLGSVFAWTYAVMQLPAGWVIDRFGAKRAYALAMIWWSVAT---WLTGVVGSISGLLVMRALLAVGEAPCWPTSAKITAAWFPAKERGFATGVWDSSSKWGPAIAPAVLVALMVAFGWRSLFHVTGAVGVAFALLFLMLYRNPVDSKRLSKDEREYIEA------------GGGGHERSLANSSLRWRSLFARRSVWGMILGYFCTIWLWNIFLVFLPLYLLD-RFHISFAQLGVYAGIPWAGGALGEIAIGYLAKKmaKRLLIACCAVGAAVCAIALPFSHTLNVTLALFTVGlfIAAVVGSAWALAADIAPSsaSVSAIQNFGGYFGGAFSPVVAGFIVDRTGSYALAFISGGAIAGCAALFYWFMAR----
     220 UniRef50_B2JVG3        Major facilitator superfami...   200     7e-50  1  11.2%  1:438   9:441     MIGAELSASDDVVSFEARTYAKVARRLIPFLMLCYLGAYLDRVNVGFAKLQMLNDLRFSETVYGIGAGIFFLGYFLFEVPSNVILHKVGARNWLARIMLTWALISASFVF---VKSPTVFYVLRFLLGVAEAGFAPGVILYLTYWFPAARRAKALSMFFMAIPLAGIVGGPLSGWIMHSfgWKWLFMLEAVPSLVLGFAIILYLDNGIAGAKWLTDDEKALL------------KRNVDKDRTQTTEHVSIRGFIADRRLWLMAAIYFCVVLGQYGLTFWLPTIIRRT-GVVDPLWVGILTAIPYICAIIALPLLGSSADKRRERRLHLamLVSAAGFATLPMLGSVGASIVCVSVAAAGILASSSLFWALPTAVLgsAAAGIAAVNCFANLAGFFSPAIVGWLNDLTGKSTAGLLFISSAVVLGAVMVFFVPARTVN
     221 UniRef50_B2GJL0        Drug resistance efflux prot...   200     7e-50  1  13.1%  1:405   1:430     MTATATRAVSSPPVDEKPP---HLGLLFASLMVVMLLASLGQTILSTALPTIVGDLG-GVDHMSWVITGFILASTVMMPVYGRISDLFGRKPVLIAAIVLFI---AGSALGAAAGTMSSLITARVVQGLGGGGLMILAQTSIADVVPARERGKYMGVMGAVFAVSSVAGPLLGGWIMEGPGWRWAFSFNIPLGILAIIAVAVFLKLPRRPREERERIDYLGMVLLalCATTLAGAIAFVIAETRASSPVIPLSLFKDRNFTLTTVSGLAVGVAMFGAIGYMPTY-IQMVKGVDATQAGLLMTPMMASLLITSIVSGQIVSRTGRYKLflVGMVIMGIGLWLLSTlsTVRMCVFLAVFGAGIGLSMQILVLIVQNSVPNrgTATASSNFFRQVGATVGSAVVGSLF---------------------------------
     222 UniRef50_B0KHM4        Major facilitator superfami...   200     7e-50  1  11.6%  8:438   9:438     -------AERAPAHQLDAIYRKMSLRLIPFLFVCYVLAYFARINVSFAKLDMLADLHISETAYGLGAGIFFLGYLVFAVPSNMMLERVGARRWIGFIMVAWGCLTSLMMFIEQASTFYAL---RFLIGVAEAGFFPGIIFYFTRWFPSERRGRVIALFMAAIPLSGIIGGPLSGWIMSaaSWQWLFLLYGLPTVVVGLLVKRCLPDSYQDANFLSAAEKRLV---------GDELTRDAMRRPSSAQRRSLSSFLFSPVIWYFSLVYFLIEMGEYALGFWMPTI-IRNAGFDDLQSVGLLTAIPYLVASGVMIYIGRSAdrNERKWHLAIPLFIGMVGLIIAAHfsGVLAMLGLTLATCGVMASFPIFWTVPtlLGANAAAGVALINSIGNLAGFFSPFLVGWTVDLTHSTDLSLYVVAGCAFLGAVLFVLVPNRFGS
     223 UniRef50_D0L8R8        Drug resistance transporter...   200     9e-50  1  11.2% 22:424   2:429     ---------------------SRKWLTLTAVCTGVFMLLLDITIVNVALPDIQADLGASLSGLQWVIDVYALTLAALLLTSGTIADIVGRKVVFATGIVVFTAGSLACGLA---PTIEFLVTARAVQGVGGAIMFATSLALLAQAFPPRERGVAFGVFGAVTGVSVAVGPVLGGLLTSGISWHWIFYVNIPVGIAALAVTIWGVDESKAPGVHRIDWLGCvlTVAGSLVLAAVLIVAFVIVERVVAQPMIDASLLRVPTFNGGLVAAWAISASMFSVLTYLVIYL-QSIMGYSALEAGLRFLPFSGVVFVAAGVAGRLSDIVPIRWLIAPGFVLVAVGLWLlpTGGWTQLIPGFVIAGVGTGMINPPLASTAVGVVEQARAGMASGitFRQIGIATGVALLGSLLAARYSDVVTDALAGGPLGG--------------
     224 UniRef50_Q145U5        Major facilitator superfami...   200     9e-50  1  13.2% 13:436   2:414     ------------ESIRRRSRFSATTGVLVVLCIMSFLMYVDRTNISTAALAIRRDLHLSNSQLGIVFSAFALTYALAMIPGGFIGDRLGARKMLAVCGVLWGLGTLLTGFAG---GLATLLLARFVVGLGESPIVPASARALTAWMEPERRGFSQGITHACARLGNASTPILVAGLITAFSWHIAFILLGAASLAWVVLWVWYYRDNPADHPGIT----------------PEDIARLPAKVGKTRVPMRWAPLL--RALWPATVVSFCHGWILWFFLNWMPSFFAQAYH-LNIRHSAVFSSGIFLSGVVGTTLGGWLSdrRSRQTLITIGFLAPIVFFVPMFLHPSATLAAFSLAAALFLslVTAPLWAVAMDLAPNHAATSSSIMNTGliAASVSPPLVGWLVDTMHSWEPVFALSMFFLVLGPIAAHWIRPDR--
     225 UniRef50_B4UDV1        Drug resistance transporter...   200     9e-50  1  12.9% 15:418   1:440     --------------MSAARAPTNKWLVTVSVTFGTLMGAIDASIVNVALPQIRGAVGATVQEITWITTGFAIATVIVMPLTAFLGRLFGQKRVYMASLLVFVVGSALCGLAS---SLGQVVAFRAIQGLGAGALQPTEQAILRQTFPPREQGMAMALFAMAVMVGPAVGPTLGGYIVDNFHWSWIFFINLPVGALGLFMVWRFVHEPEDIrrRNMDWLGIALLAVGLATLQYFLEEGQrwRELVAKVPAVNLRLFRDAVFTSGTVIGAVMFAILMASMFLLPLFM-QELLGFTAMQSGLALMPRVLVMMLVTPVVGRLYSRVSPRLLVAIGVVLVSLGSfiTLESTSSGIVHAILIQGVGFSFLFVPLTTAALSNVPRARLADATGLnlRQVGASMGLAIFATLLDRAGVHARAAVAS--------------------
     226 UniRef50_A8W034        Arabinose efflux permease-l...   200     1e-49  1  13.9% 23:432   4:438     ----------------------YQKKIIVALLIATFLAAVEVTVISTAMPSITSDLG-GMDKISWVFAAYLLTYAVMTPIFGKLADLFGRKRVFIGGVSVFLLGSVLCGFS---QSMEQLIFFRAIQGIGAGALTPMTFTIVGDVFQYEQRAKAQAIIGSIWGVAGIFGPLVGGFFVDFLTWHWIFFINVPFGLVAMHLVGRHLQEQIEKKKRRIDYKGALTFIIGTGALLYALLSgfVRIQIRTAEPMVPLHLLKNQHLLTANLASLMLGMILIGLTAYLPLW-VQGVLGLAAIFSGLTLIPMSLGWPIAAFMSSRLLKQFGAKPVCIGGTGLIMLSTLAmaATPNWLLVIIMFFVGAGFGLAMTMFTVIVQSSVdnRGAASSSNAFLRTLGQTLGITILGATLNQYIGGYGGEASAPADVLASGLSTVFL------
     227 UniRef50_C6CDT6        Major facilitator superfami...   200     1e-49  1  14.9% 17:433   2:415     ----------------STSIGNRRWGIVVLLIIDYFVMFVARSGMSMCGPALMQEYGWSATQFGWVSTAFFIGYAITMLPAGMLADRFGGGIVLMTGTLWWAIFTFLTPLG---TTLGTMMALRILVGIGQGLLVPANFSLLSNWVTRNESGKGTGLLQIGCPAGIAAAMVIAAWIIQTWGWQHVFYLLAAPGLVWCLLWWRMGSNRPQQDRHISPTERAYI---------DAGQKPDAHAADDEAHPITRRDILSTPSVWCCSLCYFCTNYLFFLFMTWLPTYFAMGR-GINLKQSAILSMLPYLVAILAYPLGGVVTdrlgRKLTPMVGLLLAGIFLILGTRANSLWNAAALISAsfFLCFTMGAHFSIPMVFSRRNTGMLVGLNgfGTTAGILAPVFSGLIIDLTGQYEYALYLGATLAIIGALFMWMAR-----
     228 UniRef50_C1D5T9        Major facilitator family tr...   200     1e-49  1  13.0%  6:436   1:407     -----MAMLQTVPMEDRRCGIPGWWITVFLFWLGWVFMYADRTILNPIMKDIQLEYGLSATQLGLLNSVFFLSYAFLQVPAGVLGDKIGKKKVLVPGFIFFGVFTAV---SGMMKSFTALLFARVMTGAGQATYYGPQYGLSSEQIPPERRTFGSAIINCGMAFGLALGMMVSSYLvqGYNWRVPFFVMSVPTVVIALLIWFLVKE---------------------------KKSEPVAQQAADTKKGSFMDLLKNRNLMVTYLMVFCSLFGFFLMVTWLPYYLQNER-GIDGSQIGNISSLIAWVSIPGGLLFASISDKLGRRKPLIMFMVPVAIISLISimQDVNMMIVALCVYGLFGKLAmpVLVATIADNAPKesSAFGMFNFVGMSSSILAPTIAGAITDVTGSLAAGFYLSAGLLVMGLVGIMFLKEHK--
     229 UniRef50_Q13UG3        Major facilitator superfami...   200     1e-49  1  11.6%  2:407  16:448     -STTPRSFMSSDTPVATAAAPLNRPMITISIMLATLIQTLDSTIANVALPHMQGTLSASQDEITWVLTSYIVAAAIATPLTGWLSDRLSVKRLLIVAIGGFTVSSALCGLS---ETLTQIVASRLLQGVFGASLVPLSQSILLDINPREKQGQAMAVWGMGVMVGPILGPTLGGWLTDSYNWRWVFFINVPIGAFALFGVATFLPSREPKHDVKFDAFGFATLGLAIGALQAMLDRGeaHTATVGKKSFFKYELLKDPNFATGTFFIFVIGAVMYATRALLPP-MLQNLMNYPVATTGLVTAPSGAGTMVAMLFAGRLLKRIDARILLLAGFLISAFALWQMMHYTIVLsvWPGVIQGFGLGLVFVPLSALTFSTLTPELrgTATYSLMRNIGSSIGISIVQTLMTR-------------------------------
     230 UniRef50_C7MDF8        Drug resistance transporter...   200     1e-49  1  14.0%  1:406   1:446     MPSPDHTASPAASADRDPRLDR-PWPALWSIVLGFFMILVDTTIVTVAIPRMQQDLDTDLTSLLWVTSAYLLAYAVPLLITGRLGDRYGLKAVYMVGLVVFTASSLWCALAG---DVGMLIVARVVQGLGAGVMTPQTMSMITRMFSPQQRGRAMALWGATAGVASLVGPLLGGVLVDGPGWEWIFLVNVPVGILTLLLVQRNVPRFSRRAHSFDWLGVVLSAIGLFLLVFgaLVVFVVWQARNRREPLVPLSLFRDRNFSVASLAIAMMGATVLTLAIPATLFFQQ-VLGMTPTQAALMTAPMAVVSLVLAPPVGRWMTLHDPRWMALGGFASLAGGLLWLSrtPFVLLLLPFLLVGLGNAFVWGPLSLTATRNLPPSLAGAGSgnETRQIGSVLGSAAIATLVS--------------------------------
     231 UniRef50_C1F892        MFS transporter, anion:cati...   199     1e-49  1  13.1% 16:434   4:419     ---------------DSAVSHSRRWRIAVLLGIGVLIDFFDRVNISVSHDSLVHAFHISDVTFGILASAYAWTYAIMQIPVGVMLDRIGVKLIGRVSTLLWSLSSFL---AAVAPGIGSFFAARLLLGVGEAPVFPSNAKATGYWFPENERSFATSFFDAAAKLASAIGVPILGLLLIHFGWRWMFGVSGFISLAYCAVFWVVYRNPSQDRKLSEQERRIL-----------REGNAQPEGVAKTTHGAPLLYLMRNREVIGASIGFAAYNWTFYLLLTWLPDYLSKTLHINLLHSVLYTSVPWAIATVTDLVIGGWLVDHLVRrtVLCVGMACGAGIFGAGFAHTPMQALFWISLSIGGLGAMAPVGWSIPSLIAPKESVggGIMNFLTQLAAIGAPIVTGFFAREHNFKGAFLVAALLLAIGIAAYLFLLGK----
     232 UniRef50_Q01X90        Major facilitator superfami...   199     1e-49  1  15.4%  2:435  23:450     -ATSVKTSADPDAIRPSARIVSIQRWSIVLLVGGGALNYVDRATLSVANKLIQEDLGIPVVRMGLLLSAFLWAYAIAQLPVGGLIDRYGPRRLLGLGLFGWSLAQAAGGL---VTSFGPFIAARFALGVGEAPLFPGGARVVRDWFGIRERGFATGLLQSASSLGNFIAVPLLTFLMLRLSWRWMFVIVGTAGVFLAAIWWAIHRDPAE--------------VRLTGEEVRYLTEGDENTTTRPPSFAQWRQLFAHRTTWGMIAGFFGTIYTLWMYTGWLPFYLEHERH-MSVARVGIVAAIPYFFGCVGAVLGGWLCDFlgRKLLISCALLGISACTLGTAFasNAMALTFISISLFLIYIASSAAWATVPIAAPSQYTagSIQNFGGYLGGALAPTVTGLILQRTGSFSQALLLSAGLSALSAVAYLLLVRS---
     233 UniRef50_Q2T8K3        Drug resistance transporter...   199     2e-49  1  10.4%  4:407  55:485     ---ASKPAAGDRQPVHAPPSAREVRTIYWALMVVIGLGTLDQSIVATALPRIMSDLG-DIAKSSWIVTAYVLSSTTSMPLYGKLSDQFGRKRMILIAVAVFLVGSLLCGLS---RSLTELIAARVVQGLGAGAFLPLSQAIIADLIPPAQRGHKQGGIAAVFAATSVMGPLLGGVITDALSWHWIFLLNLPVGGAALYNIVRKLRPGRPGGAQRIDYLGSLLMTAAVTaaGLVLTAALLAHLRRTAAPILPPTLFDNTVFNIACIVMSLTFMGLFGATLFLPLF-SQLVSGTGATESGLLMVPLMLGAVISSVMGGRILARIGRYKPTQVAGLSTAIVAFALLalSYWFIEPCVFMLGIGLGLVMPNMTVAVQNALpqRGVGTAMLTFFRSLGGLVGIAGSSAIIAS-------------------------------
     234 UniRef50_A1T2G7        Drug resistance transporter...   199     2e-49  1  13.3% 13:410   3:426     ------------ETVVERLSRRHKAFVLASCCLSVLIVSIDVTIANVAIPSIRADLSASPSQMQWVIDIYTLMVASLLLLSGAMADRFGRRRTLQIGLTIFASASLLC---SVAPNVETLIGARFLQAIGGSMLTPAGLSIVTQVFTGreRARVIGIWGGVVGISMALGPIMGGILLEYVDWRAVFWINVPICALAVLLTAIFVPESKSVTMRHVDLIGLVLGMAFLFGLVFVLiaTFLRYESRRLDPFVELRFFRSIPFASATAIAVCAFAAWGAFLFMMSIYLQGER-GLSAVNTGLMFLPVAVGAFIFSPLSGRLVGRFGARPSLMIAGALIVAATLMFaaTPQWQMLVAFAVFGVGTSMVNAPVTTAAVSGMPTDRAGAAAAitSRQVGVAIGVAICGPVAGAALG----------------------------
     235 UniRef50_UPI000050F7A1 drug resistance efflux prot...   199     2e-49  1  13.0%  6:406   1:429     -----MPKTPEDSSEPEQMKTSAIILLFVGLMIAMFMFSLNQTVLATALPTIVGELD-GVDQMLWVSTAFMLASTIMMPIYGKVGDLFGRKPLFMFAISCFLLGSV---FALIANDMGMLIFGRVLQGIGGGGMMILSQSIIASVVPARERGKYMGIMGSAFAVSSVAGPLIGGWLTEGPGWRWAFAINFPLGIIALFAAAIFLKVPKRAPGPRPKIDVIGMALigLIIVGALSIVGFIFVELKVSEPVIPMYLFKNRDFLLCTIAGLFIGIGMFGVLSYMPTYL-QMVHGIDATVAGLMMVPMMGTMLISSTLIGFVVSRTGkkKYPLMGILIMAASLVLLSqsAAWETMGCLALLGLGLGLSMQTLVLVVQNAFPVAMVGTATanYFRQVGATLGMAFIGSVFT--------------------------------
     236 UniRef50_C7PKR0        Drug resistance transporter...   199     2e-49  1  12.8% 14:410   1:427     -------------MATVPLSSAAGRWIMISAIMASAMAFIDGTALNVVLPSIQKSMHASGTDLFWILNAYLLMLAALMLIGGSLGDRLGRKRVFIAGILIFIAGSAACGIAGDVT---LLILFRMLQGIGGALMIPGSLSLISSSIHEKERGKAIGTWSAFTTVVTIGGPVLGGALADAGYWRYIFFINVPIGIVAVLILWRKVKESVDDtfAGAFSIAAGLAAVTFGFLRIPDTGFNNWqeRRSPHPMMPLSLFKNMTFSGANLLTFFLYAGLSAGMLFLSLNLVQ-VQGYDQLQSGLTFLPFTILMVLVARFAGTLADRYGPRLLLTIGPAIAGAGLLILSfaYFTTFFPGIVVFGLGMSFTVAPLTATVMGAVSDHYSGTASgnALSRIAGVFANAIFGAMAVLFFS----------------------------
     237 UniRef50_A8GDL0        Major facilitator superfami...   199     2e-49  1  12.6%  9:430   7:430     --------VDVKAWIDSRPISRYQWLVLILCFVIIMFDGYDAAVMGFIAPALIEDWGISRAEMGPILGAAMFGVALGALIAGPYSDRFGRKKVLLLSILCFALFSLL---STFARTPLEMALLRFLTGLGLGAVMPNCVTLVSEYMPERRRGLMITLMYSGFNIGSGAGGFIAAAMLPHYGWKAVLFLGGIMPLLMLPLLIWILPESTLYMVVRNHHKEKIAQILRRAGGVFSAGTTFILKTPVIPKKARVLQLFSnrGTLVLWLTYFMGLFVIYLLNGWLPTIV--RGAGFSLERAAIIAGLFQLGGTLGGLLVGYLMDRFVAKRVIGLFYLMGMFCLlgIWGFGPTLLAVLVFVSGMCINGAQTGLQAFSPAFYPtrATGVSWMHGIGRSGAIISSSMGGVLLGIFPGATSIFIILAIPALLAAITII--------
     238 UniRef50_Q0SBA1        Probable tartrate symporter...   199     2e-49  1  10.4%  6:419   1:414     -----MSSVLQQPEIEARVVRKVARRLIPFLGLAYFVNYLDRTNIGLAKLTMSEELGLTETMFGLASGLFFIGYLLFEVPSNLALHRFGARRWIARIMLTWGIVAAAM---AFVPNAGSLYALRMLLGIAEAGFFPGVLLYLTLWFPRAYRVRLMGLFLLALPVSSALGAPLSSAIIQYwgWRVMFLLEGIPAVALAVVTWFYLTDRPSQAKWLDEDEKV------------WLTHELESEASESGSHMSVRRALTDSRVWMLGLVYFGITYGLYSLSFFLPSIvkTFDTDFSLFTTGLIVAVPFAVGAVAMVLWSRHSDRTGERIWHVatLIGAVSIPVALYMQSPLTTMIAVTVNAVGVFCALPVFWYLPSAFLtgAAAGIAVVNSVGNMSGFGAPYVTGWLFDATGNSRAGLWVVG-------------------
     239 UniRef50_O50465        Uncharacterized MFS-type tr...   199     2e-49  1  13.0%  9:407   2:425     --------TTAIRRAAGSSYFRNPWPALWAMMVGFFMIMLDSTVVAIANPTIMAQLRIGYATVVWVTSAYLLAYAVPMLVAGRLGDRFGPKNLYLIGLGVFTVASLGCGLSSGA---GMLIAARVVQGVGAGLLTPQTLSTITRIFPAHRRGVALGAWGTVASVASLVGPLAGGALVDSMGWEWIFFVNVPVGVIGLILAAYLIPALPHHPHRFDWFGVGLSGAGMFLIVFGLQQGQSawQARNAREPLIPLEVFNDRNFSLSNLRIAIIAFAGTGMMLPV-TFYAQAVCGLSPTHTAVLFAPTAIVGGVLAPFVGMIIDRSHPLCVLGFGFSVLAIAMTWLlgTPIWRLVLPFIALGVAGAFVWSPLTVTATRNLRPHLAGASSgnAVRQLGAVLGSASMAAFMTS-------------------------------
     240 UniRef50_C1P9C5        Drug resistance transporter...   199     2e-49  1  13.3% 27:403   9:410     --------------------------VTIALFVATFLTAIEGTIVSTAMPRIVSDLK-GIGVMNWVFAIYLLTSAVTVPIFGKLADLYGRKKIFTAGTVVFLAGSTLCGLAG---SMGQLIVFRAIQGIGAGAIMPVTNTIVADIYPHEKRAKMLGFMGAAWGIAGVIGPLFGGFFVDQLTWHWIFFINLPFGLISVLMVILFLHEQVEKTENAIDVWGAATFSAGMLALLYALQKGGDTseYRHPDPLMPLSLFHVRAISVSNLVCFLGSAVLMGINVYIPMW-IQGLEGHGATLSGLMLAPSPVLWMLGSFAGGRLQLKYGDRLAFLTGMAFILGSTAWLSLFSlwSFYVFSAISGFGFGIVMTISLVSVQSAVdlRGAATASNTFFRNLGQSAGSAVFGT-----------------------------------
     241 UniRef50_A4F6M0        Anion/cation symporter, MFS...   199     2e-49  1  12.7%  6:437   1:428     -----MTFTPARPDALSSAIGKIFRRVVPLFVVMLVCNQLNRSNIGYAETYLEADVGIGATAYGFGAGLFFIAYALFELPSNVMMEKFGARVWLTRIMVSWGLVSAAM---AFVNSPEMFYVLRFLLGAAEAGFFPAVIFYFTRWLPDSHRGRATALFVAGSSIAAAISGPLSGPLLSMhgWQWLFGLEGALSVVVGVVAYFFLDSKIRDAKWLTEDEKTALI---------SRIDEEDAAKTAETRGGSRWRLLLDGKLLLFCWIYFAIQLSIYANTFWLPSI-VRRIEGTNDITVGLLSSLPWICAVVAMYVSGRAGDRAgrRPLLVAALITAAVGTWLAAVVSPWPALAFLCVAAMGFKSASPLFWSIPQRSLSPVVvaIAVINSLGNLGGFVAPFGFGFVKEQTGEVTYGLYALALASLLAAASVLLIRQRRA-
     242 UniRef50_Q3JFH0        Drug resistance transporter...   199     2e-49  1  14.2%  5:419  17:457     ----SPDSSAPPAHADAGRPAASVRLTIAALLLVLLLSALDQTIVSTALPTIVGDLG-GLEKLSWVVTAYLLSSTVVLPLYGKLGDLYGRKIVLQAAIVLFVVGSALCGLA---RDMTQLIVLRALQGLGGGGLMVVTMAAIADLIPPDERGRYQGMFGGVYGIATVIGPLLGGFLVQHLSWRWIFYINLPLGALAFAVIGAAFKPHTAHVRRRIDYAGAAFllWFTLALGLVATAGFVYEERLAAEPILPLELFRHRTFVLCCLIGFVVGLALFGSVTFLPLYL-QVVKGSTPSEAGMQVLPMMGGLLATSIGSGRLITTLGKYRLfiAGTFVACAAMLLLATLSLDtmYLYMALLGGGLGMVMPVIVLAVQNTvrHLGVATSGATLFRSIGGSLGVAAFGALFSNGLHARLAATLPP-------------------
     243 UniRef50_Q30CT1        LipEx1 n=1 Tax=Streptomyces...   199     3e-49  1  12.8% 19:400  16:425     ------------------RNHRNRWYVLAVIATAQLMVMLDGTIVQIALPSVQQSLHMSDTNRQWMVTAYALAFGGLLLIGGRLADRFGRGRTFLVGLVGFAVVSALGGAA---PNTETLITARALQGVFAAILSPATvlLTTTFTSTKERAKAFGLFSGVVGSGAAIGLIVGGVLTEYAGWRWCLYVNVPIAVAVTALGIATLPRDRGHRDISLDAIGAVllVAGLLAASVVLIAAFLLSQTRIRQPLLPLRVVAERTRAGSFLGAALLNFGMMGISLFA-TYHLQIVMHYKPLKAGFAFLPMVGAVMvaTQVVARVMGRVPTRWLVGPGLAFTAAGVWMFTTLslFGVLPAWLLLGVGMGLSYSPTTHASLAGVAERDSGAVSAftARQIGGAIGLAL--------------------------------------
     244 UniRef50_B8H028        Transporter n=6 Tax=Cauloba...   199     3e-49  1  12.0%  6:412  23:432     -----MAEAHASGGDRPLYSNGYKATVLGLLLATYTFNFIDRTIISTIGQAIKVDLKLTDTQLGLLGGLYflLYTILGIPIARLAERFNRVTIISVSLVIWSGFTALCGAAA---NFAQLALFRFGVGVGEAGCSPPSHSLISDYYEPKKRATALSIYSFGIPLGTMFGAVAGGWLAQEFSWRVAFVIVGLPGILLAVIVKLVVKEPPRGHSEIVERP-----LEAEDVVVEPAKPAFSMANEFKELWAVTKILFGKWPVLHMVLGVTIASFGAYGSGAFVPSYFVRAFDLGLAQVGLITGLIGGFSAGVGTLVGGFLSDWAGKrlTPAIGLILCTPIYILAYLQTDWQTTALILLvgIFHYVYLAPTFGVVQNSVEPRRRATATAlfLNIIALGVGPVFTGWLIDHLAQFH--------------------------
     245 UniRef50_B1G4X0        Major facilitator superfami...   198     3e-49  1   9.9%  2:437  12:449     -PSDELPAVTAVSADEHKLYLRVALRIVPLLFVCYVVAFLDRINVGFAKLQMQDALGFSDAVYGLGAGIFFLSYCLLEVPSALLLKRMGAKKTIARIMICWGI---VGMCTAFVTNVTEFYIVRLLLGVFEAGFFPGVIFYLSSWFPENRRGVIISCFMVGFPIAGLVGGPVSGWAMTGlgWQWLYIVEALPAVALGILTLFILDDNIDKAKWLSDAEKNTL-------REGFRVETERKRKNHQDGHGTLAQALADPKVYMLAFIDFAFVCGTYSVTFWLPTVMKSSGI-SNLSQLGWLSAIPYGMGALGMIVISRSSDrlERRWHATIAGVIGAIALLLvsMSSAVVTLALLTVACVGIFSINVLIWSIAADYlaAAAGSIAFVNCIGLLSGFCSPFVIGWLKTMTGTLNSGLYVMTAVLFLGIIVMFAGFKPRA-
     246 UniRef50_UPI000197687E putative transporter n=1 Ta...   198     3e-49  1  12.5% 10:408   9:434     ---------PTPMPVRRHARSGNRGLALTALCLAVLLVVMDNTIVNVAIPTMSDALNASSTDLQWVVDAYTLSFAALLLPAGKLSDRWGRRRMLLVGLAGFAVVSAAT---AFSWALWQLVTLRVVLGVCAALIYPATLSSIIVIFEgrYRSLAVGLWAATSGVGIALGPIIGGVLLEHYAWNSIFWVCSVIGVVALACIAVAVPEVRAYRSERFDFPGTVLSVAGVGLLVWAIiaVFAAVEGHMHAPLIDVGLFRRATFTSSTCAICVAFFCLFGFIFITTQWF-QALRGYTALQTAVATLPFAVVMAAVAPLATQLAKRFGYRSVVSTGLLFLSASMFVVTRVDAhvVVPTMALMAAGIALIQGPATDALMSTVPESSTGAASAvtIREIGGTLGVAVMGSAISSV------------------------------
     247 UniRef50_D2TK31        Major Facilitator Superfami...   198     3e-49  1  14.3% 20:433   4:410     -------------------MKNKSTKILALFCALSFLMYVDRVNLSASAALIKEEIGLDNTELGIVFSAFAYTYLVFQIIGGWFCDRFGAKRTIIICGSIWVVATICTGFVG---GFASLFFSRLLLGIGEGAALPSQARAISFWFKKEKRGFVQGLTHSFSRFGNAVTPSLVALLVLAHSWRFSFIALGVLTAIWLLMWIAWFRDTPHQ------------FTQLSKEELAQYPQADPDVSEKVKEPTPWGALLK--RMGPTMGVYFCYGWTGWLFFTWLPTFFM-SGRGMDIKSSALFTSGVFLSGVVGNTVGGVLSDYiaRRNVIIFSFLSALLLLIPVILSSSMTVilCLAVAFFCLELTIGPIWAVPMDITPKHVGIASGLMNAGsvAGIISPILFGVIIDRTGNWSLPFYGSVVLLMVGIILTFFMR-----
     248 UniRef50_A0LNI8        Drug resistance transporter...   198     3e-49  1  10.8% 19:406  13:429     ------------------ASRSNKWAIALTVMLPTFIEVMDTSVVNVSLPHIQGSLNAGVDESTWVLTSYLVSNAIIIPITGWLASVFGRKRYLIFSVVIFTLSSLFCGAA---PSLEVLILCRILQGLGGGGLQPLSQAILLESFSPKEHGIAMAAFGMGVVLAPILGPVLGGWITDNWSWRWVFYINLPAGILALFLVVLFIQDPprRTQFRMDTWGLFLLTVGLGCLQIVLDKGERevELNAEHPVVNLRVLRDRSFAAGTVIMFFGFFCLFGSIVLLPLYLQQ-LMGYTALWAGLVLGPGGFASFFIMPVVGVLLKkvKPRYLLSIGLVATALSTWMMSgaDFYTVAWPRFVQGFGMGLFFVPLAAAAYVNISREEMgsGIFNLLRNLGGSFGVAFSTTVLS--------------------------------
     249 UniRef50_C0ZQU7        Putative MFS transporter n=...   198     4e-49  1   8.2%  7:433   5:427     ------RTVTEQLPLPARTVRKVMLRFMPVIGLAYIVLYLDRLNIGVAALTMNKELGISASMFGFAAGIYFWSYTICEPPSNYILTKVGARRWITRIMITWGVVTIGT---AFVQGASGLVAARFLLGIAEAGFSPGMLFFVSKWFPNRDRGKAMAWIVTFICISGLGTPITTHLmlGLSGWRWVFILTGVPAVVMAFVIYKVLRDKPSEAEFLSEEE---------RGWLADTLESEAQEREAVVGKHSFLQGLVHPRVLVLIAVFICFTFSLNGFQIWMPQIYAQ--FGMSTNQIGWVAALPALIAIGPMIWWTRHSDRAGERPviAASVAALGFAIAALFFTTPVVAIFGFCIAGIGLYSSMSIFITMPSSFLTGaaAGFGVINGMGNLGGYFGPQVTGWIKDATNSFTPAIGVYSAVLATAALIVLLLK-----
     250 UniRef50_A5W1N5        Major facilitator superfami...   198     4e-49  1  12.3%  3:433  55:482     --ANATTVHSDIDHGTKALYSKITWRLIPFLCFCYLAAYLDRINVGFAKLQMLEDLQFSTAAYGLGAGLFFVGYIIFEVPSNLILQRVGAKLWIARIMITWGLLSACTLF---VTSTTQFYILRFLLGAAEAGFLPGVLYYLTMWYPTYRRGRIIALFMIGLPLSSVIGGPISGWIMGHfgWQWLFLLEAIPSVLLGILTFWALPNHFQQAKWLSADDKAQLAADLAADDAEG-----------KDSKHSFRDGFFNLKVWMLGGIDFSILLSAYAMGFWMPTF-IRDAGVSDTFHIGLLTAIPSLAALAGMLMIGASSDRHRERRWHIIVPFIIGAIAMalFSQNLVMTVVLFAIASAAIIGAVPVFFSLPATFLKGTAAATGFALavANIAGLVSNSLMGVVTDLTGTSHAALWVFAGCLILSCFLVIALP-----
     251 UniRef50_A4J1M4        Major facilitator superfami...   198     4e-49  1  11.3% 17:433   2:415     ----------------SQKSTNMRWILGFSLFLIGFVAYMDRVNLSVAGPLIMKDFGFDKVQFGLVQTLFFIGYSLMQVPGGLIAERFGARKAMALAIGWWSSFTILT---AYASNFLTFGIVRALFGVGEGPLYPGASVLVSKWFNKKERGTANSFILAGSFVGPVLAPAITVYIMTAFGWRAVFWLFGAVGFLVALGWWLLARDNPANHPFVNKAELDKII----------EGTSQASMESEKKEFAPLGKFINSVQFWAIGFQYFVADYIMYVYLAWLPIYLMEA-QHFSLKEMGIMAAFPWLALAITTLSTGVISDRLVSRGVSVagLVISSIALYFAAVstVLWLTLSLGILGFTFNASWASCNDLGQKFTG---TVSGWMNLCGNLGGVLAPTLTAIVATHWGWQSALVFTAGIGLTGVIAWFLVKP-----
     252 UniRef50_D2BYM9        Major facilitator superfami...   198     4e-49  1  12.2%  6:432  21:437     -----PSSLHNPALEEAKPKSNYRWVVCSMLVFATTVNYMDRQILGLLAPMLQKDIGWTEIEYSWLVNAFTVAYGVGTLVCGRIIDKLGTKMSYAVAMVVWSTAAMLHAVAGSVTGFA---VVRVLLGLGESANFPAAMKVIAEWHPKKERTLATGILGVAVNIGVVISPALIPLIAIHYGWQGAFLILGAVGFLWLIPWFLAFGP-----------------VKAKTSAEEQAWIAQDKEEIVNVSAIKWSSLLGYRQLWAVALGKMLTDPIWWFFLFWLPKWLHESR-GIDMKGLGLPLIVIYLFAIVGSLGAGWLPGKlaRKITMLICACLVLPIFAATQVENLWAAVALVGLAAAAHQGWSANILTSVSDLFPSAAVgvGIGSTFGMIGSVIFSTVIGAVLDASGNYWALFAISSVAYLLAWAVMYLL------
     253 UniRef50_C8WSK8        Drug resistance transporter...   198     4e-49  1  13.7% 36:414  21:424     -----------------------------------FVAAMDNTIVATATGNIVAHLG-GLEQIVWITAAYMLTEMAGMPIFGKLSDMYGRKRFFMFGIAAFLIGSILCG---TAQNMTELAIYRAIQGIGGGALMPIAFTIIFDVVPPKEQGKFSGLFGAVFGMASIFGPLLGAYITQHWSWRIVFYINVPIGVVAFLLILFAYRESARHGRQAIDWFGIFTLVPGVTALTFALeaLFFAVELRAREPVVSLHLFRKRSFAVSNVAGILSGSAYIVAVVWVPIY-VQGVRGGSPIDAGLFLLPMMVGSSVTAAMAGRFASRAPYRTVLLPFALVFGAGIALLLgtPTWRVILDMAVVGIGIGPFFSVTGMAAMGDLDAQNRGAGSStfVRELGMTVGIVIYGAIQKHAFAHQVA------------------------
     254 UniRef50_B2T664        Major facilitator superfami...   198     4e-49  1  14.7%  2:436   4:437     -PSLSAADASSDAWLEAAALRKITWRIMPFLFLVYVLSYLDRVNIGYAKLQFTGDLGLSNAAYGLGAGIFFFGYFVFEVPSNLLLKKFGARATIARITMLWGLLSCLMMF---VRTETMFYVLRFFLGVAEAGLVPGVVLYLTFWFPSDRRARMVAVFMAAIPVAGIIGAPLSGFLMSAlgWQWMFLIEGIPSILAGFWALAVLRNTPAEAAWLTDDEKRVILGRLARENTAAAAAGAEHSLAVA---------LRSGRFWLLTLIYFCLVTGNAGFSFWLPQI-VKDLGVTNLVTNGFVTAIPYLAAGIGMILIGRSSDITgrRWHYAVCCFIGAAGLLGSASVTnpLAVTGLSIAYVGILAGFGIFWSMSTTFltAAVAGIAVINSIANLAGYVSPYVLGIVKDATHSVTFGLVLIAGALIVGGLVTLMMPRVK--
     255 UniRef50_C6PT88        Major facilitator superfami...   198     4e-49  1  13.5% 13:434   2:427     ------------ETSTKKIPGARWMYILPVCFITTFFYFMDRQIISIALpgLQKGLALNSTMAGLVAGVFSIGVLFLSVPAGQLAQKGKVKKFVSLCIAGWSIFTILTGF---VQTGWQLVAVRFVIGFFEGAFSPAITTIFTFWFPDkeRNRANSTYFTAISIAAVSMGPIGGTLIQFYGWRSLFIILGLLSLVGCALWQFFIFDRPEQAKWLSKEEREYIETTIQQEREEAKKVAGNVEVKSEKLPLGI--LLRNKYVWSLCIVGFTVNIGQFGYTIWMPT-MIKAITKTNILNVGFISIVPNIFTVIGLWAWTYIATKVKNRRLTTGLPLIMFAASLLIatLTPVAEIGLLCLVSIFVQGHMPSYYSIPSLVLVKegPARGMMAVAMGLGSFVGPYAVGYFITLTGSSKAGMYFLTAMLIIGGLSTLILPK----
     256 UniRef50_B1G529        Major facilitator superfami...   198     4e-49  1  10.0%  6:437   3:432     -----SPISAAASPLAEQAYRKITRRLIPFLFLCYVFAFLDRVNVGIAQLDMKHDIGFSDFTYSIGAGIFFLGYVLMEVPSNLLLTRIGVKRTFSRIMVLWGI---LAAATAFVTLPSHFYTVRFLLGLAEAGLYPGIIFYLTRWYPVERRAKAIAIFTCATGIAGLLGGPMSGWLMThhGWQWMFIVQGLPASFLGIAAFFFLDDGPEKAKWLSDAEKAQILADLKHSSGVSGTHAE----------HTFMNALRDPRVYVMGFVWFAQIAGVFAIGFWLPTLIKSTGL-TSPLEIGIYSAIPYFVSWIALIGMNWNSDrmERRWHCGITMIIGALGLFAAGlgSLAWSLVALSIATAGILAPNPLIWAISTDYisGAAGGVAVVNCIGLLGGFVSPMIIGSIKTATNSMAGGLGAISLLMLIGALAAIVLAPKTT-
     257 UniRef50_Q1IZ90        Drug resistance transporter...   197     5e-49  1  13.8% 38:413  39:451     -------------------------------------SALDQTIVATAMPRIAADLN-GLNLYAWVTTAYLLTNTALVPIYGKLSDLYGRKPVLMVGILIFLLGSALCGLSGEagGMMQLVVFRGLQGIGAAALGSVAFAIVADLFEPAERPRYQGLFGAVFGLSSVIGPLLGGFLTDQISWRWVFYVNLPLGLIALSFIASKMPRLASGLQAKVDWLGAFLIILFAVPLLLALtvAFLFVESRHPSPILPLTLFRNPTFGWGAVARFLIGAGFLGAVLFLSLYLVQ-VKGVSATRAGTATIPLTVGLIIGSVGSGQIASRIGrkPLILIGLVVAALGFFSLSTLTADTPYSGVILRMvlGLGPALPLYTTALQLAVkiGVATSAGQFFQQMGSTIGTAIFGAMLTAGLTTNL-------------------------
     258 UniRef50_Q21AE7        Major facilitator superfami...   197     6e-49  1  10.6%  5:436   7:436     ----PGATDAPASEAAGHVYRKITLRLIPFLFACYVLNYIDRVNISFASLQFRQDLGISAAAYGFGVGIFFVGYILFEIPSNLLMQRIGARRTMMRIMVLWGLVSISTMF---VTSATQFYVVRALLGIAEAGFFPGVVFYLTLWFPSAMRGRIMAMFVLAIAVSGVIGGPVSGLIMSQmgWQWLFLIEGIPPVLVGIMAYFYLDDGPEHAKWLNAEEKRFVIGNLAI----------EAASRESSKHGTFWTAVRDPRLYAAAIAWFTVAWCGSVINYFSPTI-IRNSGVSDTLMVGLLSAIPYAVGALGMVLINRHSdkLERRWHYACSVFLAAAAIALLPSVAQNwaIALLAVLSVGYLGSVALFWSIPTAYLSKKASAGSIALiiGQCGGLTAPNIIGWTQQATGDFALGFYIIAVGMVTGTVIMLLGLPAR--
     259 UniRef50_C5C3L9        Drug resistance transporter...   197     6e-49  1  14.2%  1:424   1:462     MSTTTTAPGSPAPGGAVDLHGRSPWSVIPPLALGFFMIMVDTTIVNIAVPTLTAELDADLVSIGWVNSAYLLSYAVLLLLAGRLGDRYGPKPVFVLGLVVFTAASAWCGLAG---TVEMLIVARVVQGIGAALMTPQTMSMITRVFPPRGRGAAMGLWGAVAGVATITGPVLGGFLVETWGWEWIFFVNIPVGVIALVMAFTNLPrgRIGVVSVGPVDVPVTVVGLIVVGLLVLTGFVLWQHHLRDRALLPLSLFSHRNFSLANVGGMAVSFAMIGIFFPLTIYL-QTILDLSPLHAALLNLPGSLVSGVVAPIAGRLSDRIPGKWVVAAGFAAIAGAVVWLWatSPLAFLAPMALFGVGTGAVFSPLANLATSGLDHRTAGAGAgnTTRQVGGVIGSAAIVAMLTARLSVTLPAAARDAAAGL--------------
     260 UniRef50_A5G086        Major facilitator superfami...   197     6e-49  1  10.9% 23:433  14:415     ----------------------RWFRLIPIAMIVYIISFMDRTNIAYAFSGIGHDFHITKADEGTAGGIFFVGYVLLQIPGGWLAEHWSAKKFVAIMICFWGLMALACGLA---QNFTQLVIFRFLLGVAEGGIWPATLVLLSHWFPVQERARAYGFWIANLAISSIITQPLSGFIVAGSDWRTLFFVEGALpiIALPLWLIFIKDRPEDAHW------------CLPAERDYINRSLAQDRANEPEPGPFSDIFKSATVWRLVVVYFLVQVGFYGLNMWMPTLLK-SLTHAGFGAVGLIATLPYVVAGLMLWFNGWWADTNRRyrHVFLPMTLAAVSLILSVTVGEGMILLSIFFLCLAMGGAmgPFWAAASRTLPVagGAMGLINALGNLGGYLGPFLGGYLQDKTHNFYATAILFAISLFAAGLVMLTIR-----
     261 UniRef50_A1HSG5        Major facilitator superfami...   197     7e-49  1  12.5% 14:436   5:425     -------------QSGARKIWGYRHIVLIMLWLLYIINYFDRISVLTFLPLIRKDLNLTHQEIGFAASIFFFAYALAQVSAGYLADKIGPKRVMGIAIVVFTAVTFLTG---MVRNYIQFVLLRLGLGLGEGHHFSPANKTIADWFPKSEKGRATAFFSTTWAFAPAIIPVVITSIAAALgwRTIFYILAVPGVIGIFLLYYFVSDKPEEMLKR----------GRLSQEEYDYIKAGLVSDEAAVEKLGVSVILKDQSLWMYSAQLFCLLAVYWGSTTWISSFLFEQ-HGFSLAKMGALSALPYVVAIVSTMCGGWLMDKvrTKPVALISFLVSIPVLMYLGQVpiNLLIVMLILNGFFVNLIWGVIYAYPQVRYPKegSAIGLANGIGQLGAFLSPLLAGYLVEKTafYDKVFFMFAACSALGALVTCLLKEET--
     262 UniRef50_Q034A5        Permease of the major facil...   197     8e-49  1  11.1% 18:404   8:424     -----------------TTPKRHQWLALTAMSMGVFMGLLDVTVVNVALPTMVNDFNTNFTNLQWVLNAYTLVYAVSLLIMSKLGDMYGRKKVFLGSLILFVLASTVNGMAS---SLIVLDIGRGIQAIGGAGMNSLSMALVASNFSGNKRGVALGILGSVIGMSTASGPLIGGFLVENFGWPSIFYVNVPVGIVAVIMTLTFVNETPSYGQHERIDFAGMLfiGGWIIAGFILIALFIWTESRVQQPMMSLNFFKQCHFVGTIFVAFALGASLYSFNTFLTA-LMQNYIGYSALQTGVRQLTISGWSLVLGPISGYLGTRFSKKRMISASLLVGACGFLVMlrVGFMDLMPGMLMIGFTNGIVSPLINTVGMEGVAPQQMGMASgnIFRQLGIVIGVVGFGLM----------------------------------
     263 UniRef50_Q466K6        Efflux PumP antibiotic resi...   197     9e-49  1  10.6%  2:436   8:479     -AGSPAKVPEIYNTPDAPVVGTGKQVVLFIAILSGFITPFDGSAVNIALPAIGAEFHMDAIALSWVATAYLLSSALFLVPFGKIADIYGRKKIFLYGITLFSFSSLIMTMASSS---EMLIGIRVMQGIGSAMIFGTGVAIVTSVFPPGERGKALGTYITAVYIGLSVGPLLGGAMTQYLGWRSIFFVNVPIGITAILLILWKIKGEWaeKFDLTGSVIYGASVVAVMYGFSVLPDFKGAaeIRTPSPVLDISLlkNRIFAFSNLSALINYSATYAVTFLL-SLDLQYTKGFTPEHAGFILVAQPVIMAMVSPIAGRLSDRIEPRIVASAGMAFTALGLFLLIFLTETTPIwtLIILGIGFGLFSSPNTNAIMSSVDKRFYGVASGmtMRLLGQMLSMGIAMMIfqFVLSLHYAFTLFTAFCILGIFASLVRGKRS--
     264 UniRef50_UPI0001AEDADB membrane transport protein ...   197     9e-49  1  11.0%  6:406   3:432     -----SASETEPGHAPGPMNDKQILQAMSGLMAGMFVAILAGTVVANALPRIIADLGASQSSYTWVVTAELLAMTATVPLWGKLSDLYNQKMLLQLSLSLFIVGSLV---AGLSHDVGLLIFSRVVQGIGAGGLTALAQVVMAAIIPPRRLGKYAGIFGAVFAVGTVAGPLIGGVLVdwLGWRWCFFIGVPFALLGIILLQRTLKLPTVRREVTIDYLGAFLIVAGVCALLIWTSLAGNsvEARAKDPVIPLSIFRNRTVTLTTVASLFVGVAMFAGTVFLSQYF-QIALGKSPTVAGLMSLPMIGGLLVSSTVAGQLISRTGrkGYLVGGGITMTVGLALLSttHFGLLSLYMAILGIGVGMLMQNLVLAAQNDVPAqgTATSVLSFFRSLGGTVGVSVLGAILA--------------------------------
     265 UniRef50_B2JQ30        Major facilitator superfami...   197     1e-48  1  13.2%  1:432   1:431     MSTPGAVAAGSRdsATADIIKKVTWRLMPLVMICYLFAFFDRINISFAKFQLQTDLGFSDTAYGLGASLFVIGYVLFEVPSNMLLYKVGARKWIARIMISWGLATAAMVF---VQNEWQFYGLRFLIGAMEAGFAPGVLYYLTLWFPASYRGRVTSLLFLASAFSGLVGAPLSGLVLGQmgWHWLFMLGGLPCIVLGILVLKVLKDRIEDAGWLSASEKTYL------------SSQIAQQAQPTTHGHSLPGAIRTPGFLTLGLIYFLIQIASYGLNFWAP-HLIRAAGTQNPTIIGLLTAVPYICGAICMVVVGRLSDATgrRKFVSALLVMAAIGFFAAGYFdtVMLVVALAVLGAGVIASIPAFWALPPKLVtgAAGGIALINTLGQLGGIVSPVMVGRVRDVTGSTTPALYVIGALSLVCALIILYG------
     266 UniRef50_Q81II9        Benzoate transport protein ...   196     1e-48  1  12.5%  1:433   1:434     MNIMQPSAPPHLESTETIFPSSITKLVVFICWLAILADGYDLGIYGAVLPKLLEdwALSPAHAGTIASYALLGMFIGAILVGTITDLIGRKWTLICCLALFSIT---MGLAAIAPSPELFGLSRFIGGIGLGGVIPTASALTVEYSPKKRQSFIYALMFTGYPLGIVLGAILSMLMLEDFGWRIMFGI-GMIPLLLIPFIIRYLPESIQFLLSRNRQEEviLNRFQIEFHVKDKTHQDPSTIRKKNGFFTLFSKEYIKATLLFWITYIMGMFLIYGLNTWLPQMMRQA--GYPLGSSLSFLLMLNITAAIGALFAGAIADRIGAKIVISISYLMAAICIGLLTIKPSVTIIYLLilAGIGSVGITQILNAYVTQYFPSHIRAtgWGLGLGRVGAIAGPILVGIIMTMQYDLAWNFYLFSFAGLIAAISVFFIP-----
     267 UniRef50_B1VKV2        Putative permease of the ma...   196     1e-48  1  12.4% 10:435   9:478     ---------PSPTPDQTTEPYRWRWLILVVMIVAEIMDLLDASIVNVAGPDLERSLGAGSVGLQWVIGGYALTLGAGLVLGGRLGDRYGRRRMFLIGLASFTAASLLC---AIAPNIESLIAFRLLQGTAGAMLLPQGLGLLRENFSGPELTKVFAIFGPVLGLGGIIGPVLGGFLIegLGWRSVFLINLPIGIAALIIAATFVPKKTGDRTVRVDMTGAALVVASCALLVLPltLQQRRTAAAGREPLVTPGLLRKPAFTVGLGGISLFFGGLIGTQLVLTLFL-QIGQHFTAGDAGLGNLPLAVGTAIGGAISgfLADKIG-RKVLQIGPLVQLAGAAVLWffSIWDIVPGTTVSGIGAGMVIAALFSFILAAVDDDEIGSASGvaVQAVGGSIGVAVFGSVfdFTGGFHRALIVQACLLVVFLAITFLLPKK---
     268 UniRef50_A6W4M6        Drug resistance transporter...   196     1e-48  1  12.4%  6:425   2:447     -----STPAPLSAPRDTAEAKPRIGWIFTSLMLVMLLASLDQTIVGTALPTIVGELD-GLEHMSWTITAYTLALTIAMPVYGKLGDLVGRKNLFLVAIALFLLGSALCGLS---QDMLWLILSRGVQGLGGAGLMIMSQTIIADVVPAKDRAKYMAPIGAVFGVSSVAGPLLGGWLTDSAHWRWVFWINLPLGIVALVVAAVTIKLPQRKNTAKIDYAGMVLLALalAAGTLVAAVAFVLVERAVPEPILPMRLFRNRTFVVTTLLGLVVGAGMMGALAYLPTYL-QMSYGVDATGSGLLLIPMVVALLVTSIGSGAVVTRTGRYKFlvVGTLVAAGGMYAMSTMTLDTPLwyVAVLGAGLGLFMQIIVLAVQNAVDPrgTATSANNLFREFGVTIGIAVLGTLFSSRLTERLGGALGGDVAAGG-------------
     269 UniRef50_B1J5X9        Major facilitator superfami...   196     1e-48  1  12.6%  7:418   3:411     ------ATTHTKTQKGQSLNALMFRKLMPMLIVAYIISFLDRTNISLAKTHMAVDLSISAAAYGFGAGLFFLTYALMEVPSNLIMHRVGARLWITRIMITWGLLSAGM---AFITDETTFYIARALLGAAEAGLFPGVMLYLTYWFGREQRARASGYFLIGVCLANIISGPVGGLLLewHGWQWLFFLEGIPAVLFSVVIWRKLPDGPSTATWLSKEQA--------TEVEQVLKKEHDEEIASGNVGHSFKGVLKIPQIWLAIAVYFLHQVSVYSVIFFLPGI-IGTYGGLSSLQIGLLNSIPWIAAALGAAFLPKYapKIS-RKIMFGGLLLMSAGLTLAAYTTPLIALIGFTLTASMFFVVQPVIFLFASSRLagMAAGLALVNTFGITGGFFGPSLLGFVEQTTGSTKNGLIIV--------------------
     270 UniRef50_D2PYB1        Drug resistance transporter...   196     1e-48  1  10.9%  4:406  17:447     ---SATTPPEQAAEQVAALTPRQTVQAISGLMMGMFVAILAGTVVSTALPRIIHDLEASQSSYTWVVTLELLAMTATVPLWGKLADLYNNKLLVQLSLGFFVIGSLV---AGLAPNIEVLLGSRVLQGLGAGGLTALVQIVMAAIIPPRELGRYSGIFGAIFASATVGGPLLGGFLVDslGWRACFLVGVPFVLAAIVLLQRTLKLPTVRRDVQIDWWGAFLITAGVCTLLVWSSFAgvLVERRHPEPIIPMGLFGNRTVTLSIVASALVGVAMFGGSVFLAQYF-QIAQGYSPTKAGLMSLPMILGMMVASTIAGGLITKYGKWKilVIGSVLLPIGLALfaHTSKYLLWVFMIVLGVGIGLVMQNLVLAAQNDVPArgAATSAVSFFRSMGGTIGVSVLGAILA--------------------------------
     271 UniRef50_B1JF48        Major facilitator superfami...   196     1e-48  1  11.1% 14:437  22:447     -------------VTENSVYRRITWRLVPLLFLAYLLAFLDRINVGYAKLQMSADLGFSEAVYGLGAGIFFISYLLFEVPSNMWLERVGVRITLLRIMVLWGLVSASTML---VKTPEQFYFVRLLLGVCEAGFFPGIILYLTYWFPSTRRGKVTGQFMFAIPVAGIIGGPLSGWIMQSmgWQWMFLIEGLPTVLLGCFCYLLLANRPSEARWLSDAEKQVVADAMA------KDSDASVEKGHVGALSKLRLALGDSKVWLLAFIYFTTACANYTFTFWLPTI-IKNLGVNDVSHIGALSAIPYVFAALGVLFVSASSDRLKERRWHVGGSLILGAIGLafLNNSLVATIAVLSFVGFFQFGAGIAYWAIPSTYLNKATAAVGIGLviGVVGGFVSPALLGFIKELTGSLDNGIFTISLLMLAGGLAILLALPAKA-
     272 UniRef50_Q13MI5        Major facilitator superfami...   196     1e-48  1  12.4%  9:418  14:445     --------PDTHSPLMSRNPQSSRPLVIAAVMASMAMVAIEATIVSTAMPQIVAQLG-DLHLYSWVFSSFLLTQTAMTVVFGKLADLYGRKPVMLAGIAIFLIGSVL---AGFAWSMPAMIAFRLIQGVGAGAIQPVTLTIVADLYPAHERGKVQGYLASVWAISAVVGPMVGGFIIHNMSWAWIFWMNVPIGLASAAGFIAFLRESERHARPSIDFGGATLFMAAIAALMMALtvAFVWQERRAAEPMISFALWGRRPIAACNGATLLAGMILMGATTFLPMY-VQGVLHRSPVIAGLALTMMMVGWPAGATFAAKSFHRFGLRRILIGGSAFIPIGAVLLLFlsPLVAAFGSLIMGFGMGTSSVSSLVLIQEIvdERGSATASNLFSRNLGSTLGATLFGAVLNFGLSHSKGVAVV--------------------
     273 UniRef50_C6PVV4        Major facilitator superfami...   196     1e-48  1  11.8% 14:436   2:420     -------------TIEGSLTKRKYLNVILPLFIASMLAYIDRLNISYAALTMNKDLGFSAQVFGMGAGILFFGYVVFEVPGTVFAEKRSPSKWVVRIMITWGIVTALMGF---VQTELQFYIVRFLVGAAEASFYPVCyaIVPRWFNAKERPKALSILLTSMLVSSIIGSPLAGMILGItgWQMLFILEGTMAFVFGIILIFWLKDWPKDVNWLTAEE----------KKSLQEEYEKEIAAKNSIKKYTLWEALKDKTVLKLCFIYFMWVTGFWGFGFWLPTVLK-SISGLSNSSVSWLIIIPMSAALIGFIINGNSTSKTGekWHIALPLFIGAVGMALGTLVSNPVlfIFTCVTAVGVYVGMGVWWTVPISFlpAAAGATGLINSVGNLGGWVGPYLVGFIKTSTGSYSAAYVYLAVSLIIAGITMLTLKEKA--
     274 UniRef50_A4X8R4        Drug resistance transporter...   196     1e-48  1  11.7%  3:421  15:465     --TVQAPAPAPPDEFVPPITGRKRTLALVVVLTGFVLDLLDITIVNVALPSIRDGIDATAATMQWLVAGYALAFASMLIISGRLGDIVGVRRMFLIGVAGFTLTSLL---AGLAQTPEQLIVLRFVQGAMGAIMVPQVYTLIQLLYAPKERGRAFAAMSAALAFGTVGGPLVGALLTTalGWRAIFLVNVPIGIAAFIAARVLLPESEANRRERLDLVGAVLITLAVLLLVYPLVQGREQDWprTDSPLVPMSLFRHRSFNAGLVVVFLFQGAVMSF-FLVITIYLQIGVGYSILRAGLSGLPWDIAVPLLGWLSAriTPRIGRTGLQLGLVLLIASMFWFMWvvSIWQLLVPMFIGGAGMGMTFPPLMGYSLADVPGNQAGSASgnANYQIGVTLGIAACGTLFFSLLAAQTPHATATVV-----------------
     275 UniRef50_B9JKD4        Tartrate transporter protei...   196     2e-48  1  13.0%  4:434  76:500     ---PALPQGGNDVVDEKQLISKITWRLMPFLGILYLIAYIDRQNVSYAKLEMVGALGMSEYAYGLGASLFFIGYFLFEVPSNLLLDRFGASKWFARILVSWGIVTVAL---AYTQNPTMFYILRFLLGACEAGFFPGVLYLLTLWYPSAYRGTMVGLFMIFSALANAIGAPIGGLLLdhAGWQWVFIVTGIPAIIAGFVTFFYLSDLPEKAGFLSTDE-----------KKWLKDRLAAENAGMEQHASDGFKALINPRVLLMAICYVGFPLAAYGLSYWLPTIVK--GFGVSNTTNGFLNIIPWLLVAVALYVVPSMADKAASKTpiVVSALTGAVCLVLSAVIPNHTlfAFLCVAAAGIFAGQPVFWSLPSRFLqgAAAGLAAINSIGNLGGFVAQNVVPWIKDTTGSTIAPMFFLAGCLTIAAVLVLFVGR----
     276 UniRef50_A3P6S1        : Permeases of the major fa...   196     2e-48  1  13.8% 25:437  20:446     ------------------------WVTVFLLFVVYGINYLDRVALSIVAPMVQRDLGIDAAQMGIVFSTFFVGYALFNFIGGLASDRLGPKRVYVIAVGLWSIF---CGMTAITIGFVSLLIVRLLFGMAEGPLCSAANKMVNNWLPRESAATAMGLLSAGSPLGGALAGPIVGVLAAQLGWRPAFWIVCAIGLAWVLVWIATTSDRPApaGGSGAAAAAARAAAAPRACASGGRTVDAAHASETADVPPLRDYLKQPRILATGVAFFGYNYVLFFFLSWFPSYLVQA-HHLNIREMSVATVVPWLVGTIGLACGGVISdmLSRRIVLVGCLLGAGVCVAIAGSvsTQSAIALMSVSLFFLYATGAIYWAIVQDIVAPGRVGAVSghCMGSLSGVIGPAVTGFIVERSGSFVSAFVLAGAIALAGAVLSALFLRNRA-
     277 UniRef50_C5VFP5        Methylenomycin A resistance...   195     2e-48  1  10.2% 25:435  82:520     ------------------------RLATITVLLGFFVIMLDTTIVNVSLAHIGKDLHGTTASLQWVVDAYTLSFAALLLSAGTACDRLGAQRIYLFGLILFALFSIAC---ALSPSMEILISARALQGVGAAMVVPSSLALISEMYSdkERAKIIGLWGAAGGIAAALGPIIGGVLVSTTGWRAAFWVNIPIIGVLAILTISFIPRRVPQASNSFDVLGQTTSIISLSLLTYLVITWGERGWNTtpTPMLPLTLFKTQAFSISSIVGFCLNFSFFGQLFVLSLYF-QKYLGWSPWIAGLAMVPQATSAIVASPLGGRFSAKFNPYSAMFVGLSVGALGFSSLVvtPYVLVALLTFCAGFGMAFAMPAATSAAINAVPYEFAGIAGgnAARQTGSVFGVAILGIMIafLAGFHHAVLMAGGVFALAAVLVMLASRH---
     278 UniRef50_A8LBD4        Drug resistance transporter...   195     2e-48  1   9.9%  4:407   7:436     ---ADDQRTRSAPAEGTGGRRGNPWWTLTSVALGVIMVGLDGTVVSIANPRIAEDLGASLTDLQWITNSYLLALAALLVFGGKLGDRYGRKLIFLIGVVGFGLTSLAIGLVG---NIVGIIALRALQGVFGAMLMPNTLAILRGAFPPKELNRAIGIWSGASSISIAGGPIIGGLLVEHVSWESVFYINVPMGAIALAVGLAVLRESreSTGQRHDIPGIITLSGGLVGLVFGLIKASTWgeTRVAAPLLPMRLFGNRSISVGSAVLVINFFALFGVLFFVTLFL-QNVQDTSPIETGVRILPLTLAMMIMSPIAGSATERFGPRPPMVIGLVLSGTALLLLTgsSFNALWPSLLMLGIGMGLVITASAEAIVGNAPVDDAGVAGGltALQLGGVVGTAVLGSVLSS-------------------------------
     279 UniRef50_B0SY69        Drug resistance transporter...   195     2e-48  1   9.2% 21:401  11:417     --------------------AANRVPITVAVMLATIMNSLDTTIANVALPHIQGSVSASAEQITWVLTSYIVAATIMTPLTGFFADRVGRKMVFLVSIAGFTVASMLCGVA---TSLVEIVLFRLLQGLFGAALIPLSQAVLLDINPPEKHGSAMAIWGAGAVLGPILGPALGGWLTDNLDWRWVFFINLPIGILAFCGVFFFlpEKKRFDVLGFASLALAIGGFQMMLDRGPSQDWFASSeaTAAKPFVDRALLADVNFITSCVFGFFIGILLYSVLALLPP-MMQNLMGYPVAFTGLVSMPRGIGSFIAMFAVGQLIGRMSIKLILLIGLAVSAVSLWMMTQFTLglIIVSGFLSGVGTGLIFVPLSTIAFATVRPQHRAEGAGLfiRNIGSAAGISIM-------------------------------------
     280 UniRef50_C6D276        Major facilitator superfami...   195     2e-48  1  12.6% 30:434  13:454     -----------------------------ALYVATFLAAIEGTIVSTAMPSITGELH-GIQQYSWIISIYLLATVITTPIYGKLSDLFGRKKMFIAGAGIFLLGSMLSGLAS---TMPQLIAFRAVQGLGAGALTTIPYTIIGDLYPFEQRAKVQGWMSSIWGIAGITGPLAGGLLVDYVSWRAIFYMNLPFGIVALVLLMVSMKEVSVKQKRHIDYPGIAAFAAGMFAFLYALTILREPdeKRSREPIIPLKIFKIRTISAVNAISFLICIINVVAIFYLPLW-IQGVLGESATYSGMAMIPLSIGWPLGAILAGNFIARYGMRRIAITGSLFLIAGSAGFMLMNAHTSIVLfcLSGLSFGLSLTSFTVAVTSAVSWELRGAAVgnFIRTLGQTVGIAMFGLLLNTghSLHRIFMILGIMSVMVLLSMFMLPK----
     281 UniRef50_B0UEX3        Major facilitator superfami...   195     2e-48  1  11.2% 14:433  19:435     -------------PIRQRVLGKLRTRIVLYCFVLFIINYLDRVNVGFAALHMNRDLGFSSTVYGLGAGIFFLGYIAFEIPSNMIMHRVGPRRWIARIMVSWGLVSCGMAAIQGETSFYLM---RFLLGLAEAGFVPGVLLYLTYWFPARDRAKATAGFMTATVLSSVIGAPLSGWILSaaAWQWLFILEGAPAILLGIVTYLYLVDRPQDGRWLDAEERAWLIA----------TLARENRDVARTGSHEFAAIFRDPRVWVLTLIYLFNAVAVYGVVLWLPQI-VRSIGGLSDFQTGLVTALPFAVAAVGLVVVARSSDRTGERRLHTALAALCGGVFLGllAPSPLAGLLLLCVAAFGVWAVLGVFWTLPTQFLtaAAGGLAMINGFAQVGGFAGPYLVGWIRDATQSFTPALLTLAAGPVIAALLCFALR-----
     282 UniRef50_D2TUF3        Major Facilitator Superfami...   195     3e-48  1  12.0% 10:433   3:433     ---------TLDSTASKKKPTHYRYMILLMVFLSIALNHGDRATFSIAGTDMVKAAGLDIVALGYLISTFTWAYVLGQYPGGWLLDRFGSKKVLVTGVFSWSFFVFLVGFSTSFDNVwmIFGFIFMMGLIEAPTLPANSRFLAAWFPAKERGKASGFTTAAQYFALVVFLPLMGWFSYTYGWESVFWFMGGLGIFVSLIMNKVLADTPKVHPLVNNEE------LEYIQAGGGLTNMKVTKKGESKGTGYTRKLLTNRLALGVYMGQFFFTVLSYFFLTWFPVYLVHDR-GMTILKAGFVASLPALCGCVGALSGGVLSDYmaARKTPIVIGMLLAVSMVICNYVDSAWIVIAIMSLAFFGKGFGAMGWCVVSDFSPKEAVGLSGgnMIGNISGIFTPIIIAYIIKDTGSFNGALIFVGVCAFLNLCCYLFVA-----
     283 UniRef50_A9FRQ7        Permease of the major facil...   195     3e-48  1  16.3%  6:435   1:429     -----MTAASPVAPATAGVMSRTRWTICALLFFATTINYLDRQLFSLLIPFFENELRLGPTDLALINVSFLLAYGFGMVFVGRWIDRVGPRKGLSATFLLWNIASAGH---AIVGSFAGFAGIRFLLGVGEAGNFPAAVRTVAEWFPKKERALATGLFNCGSNVGAILAPLLAVRIAEAYGWRTCFLILGGAGVVWIFFWTRLYRRPEEHPKVSPEELAHI-----------------RSDAKEATESLGVGEVFGMRPVYAVAAAKFFTDAPWWFYLTWLPKFLVSE-FNLKPTFMAYAIPVVFLVADGGAIGGGWLSSRlaRKLAMLACALSAVPVMSVGLLVDVpvAVAILSLAAAAHQGWSSNLYTLVSDALPrmATVVGVMTAFGVVGGALFQIFVGWALTATGSYALPFLLAGTLYLVGLLALHLILPR---
     284 UniRef50_Q022M8        Major facilitator superfami...   195     3e-48  1  12.1% 10:432   2:406     ---------NTSPALAAAMRSRTRFRILALISVGTMINYLDRTVLGIAAPSMSSELHISPAVMGILFSAFSWSYAAAQIPGGWLLDRIGTRLTYFLAVTFWSLFTLLQGFAG---GIASLLAFRLGLGVSEAPCFPTNGRVVATWFREHERAQATAVYTVGEYLGLACFGPLLFWISRRFGWRSLFWAVGTAGIVFAGIWWRLYRDP------------------------ESCGPMEKPAGAAPVNWKQVRQLLRYRQVWGASIGQFGGNSTLVFFLTWFPTYLAKERH-MDWMRAGFYAILPFLAAACGVLLGGWGSdrNLARKLPLIAGLFGASTIILANYVNGDALVIAIFSTAFFFQGMTGLGWTVISDVAPTEMLGvgIFSFAANLAGVATPIVVGAIIGATGSFYYALAYVGAAALLGALSYVFL------
     285 UniRef50_Q846X9        Putative monensin resistanc...   195     3e-48  1  11.0% 17:408   2:418     ----------------SADLGARRWWAVGALVLASMVVGFDVTILSLALPAMADDLGANNVELQWFVTSYTLVFAAGMIPAGMLGDRFGRKKVLLTALVIFGIASLAC---AYATSSGTFIGARAVLGLGAALIMPTTLSLLPVMFSDEERPKAIGAVAGAAMLAYPLGPILGGYLLNHFWWGSVFLINVPVVILAFLAVSAWLPESKAKEAKPFDIGGLVFSSVGLAALTYGVIQGGEKgeKRVADPLVDLSLFRSARFTSGTMLGTVINFTMFGVLFTMPQYY-QAVLGTDAMGSGFRLLPMVGGLLVGVTVANKVAKALGPKTAVGIGFALLAAALFYGATtgTGLAAAWTAAYGLGLGIALPTAMDAALGALSEDSAGVGSGVniRTLGGSFGAAILGSILNSG------------------------------
     286 UniRef50_UPI0001B54ABC major facilitator transport...   195     3e-48  1  13.7% 15:436   1:442     --------------MTATISARRQRLALIALCLPFFIVQLDATVVNVAVEAIRRDLGGGLGGEQWVIASYTIALAAGMLTAGSLGDRYGSRRVCVLGTVVFGVGSALC---SLAPTLPVLIVARTLQGVGAAALLPCSLALIIRQFppRARAHALGLWGGIAAIGLATGPVAGGVLIALADWRAIFWINIPFAALAIVLTCRYVVESPQRRDRRLDPYGLVLGTVALCALAGGLIqaFVLVERRRRDPMLPLAIFSSRPFSAASTAGLLFNFCLYGALLCLSLFL-QGPLHQSAYATGMLTLPLTIAIGIGATASGRLTARFGARVPMLAGFSLAGLGAVLLAAAGSLPLLVAGGIVLCCCSIAMPAMTSVAMSTPPEEHTGLASgnTARQTGGALGTAVLGTLLTAGssLSLPMTVVALGYAAAVGCTLLATRRR--
     287 UniRef50_A0B158        Major facilitator superfami...   195     3e-48  1  11.2% 20:437   1:413     -------------------MTNIRWRIVLLLFIAGFINYLDRAALSVAAPAVMRELHMSPSSLGLLFSTFFIGYAAFNFIGGWAADRWGGKRVFSGAVLTW---SLLCGATGLAGGFGSLLAVRTLFGMAEGPLATTINKIVNNWFPHKESATAFGFANCGLPLGGAVAGPVVGLLTAAYGWRVAFAGIACFGLLWLVFWMFMATDKPHQHARVSDDERRLI-------------ESDRSVPESPSDLRPLGFYLKQPAILAAMISYFGYSYILFFFLTWFPTFLTMDRH-LSLKSMSLATVLPWLLGFIGYGLSGVLSDLiaRKRVLIACLGTAGVCVTLAGAVTTTlaLLLMAVAVFALYLSGSAYWALIQDTipKLGSVGGCVHAIANCAGIVGPAATGFLVQESHTFFSAFFLAGGIALASVLAVAILLRPRA-
     288 UniRef50_Q4ZSW8        Major facilitator superfami...   195     3e-48  1  11.4%  6:433   9:432     -----TVPGTTDVTVLARAAAKVKRHVLPLFVVMFIVNYIDRVNIGFVRSHLETDLGIGAAAYGLGAGLFFVGYALFEVPSNMLLQRYGARAWLTRIMFTWGAAAMAMAFVQGETSFYVL---RFILGAAEAGFFPGIIYYFTQWLPSSDRGKAMALFLSGSAIASVISGPVSGALLglHGWQWMFLIEGFASIVLCGFVWFWLQSHPHEARWLSDEEKTALSTAIA--------EEQRLREASQTVRPSVFRLLADRQILLFCFIYFSVALTIYGATFWLPS-MIRKMGSFSDFEVGLFNSIPWIISIVAMYGFAALAARFKhqAWVAVTLVIAAAGMFMSTVGGPVFAFVAICFAAIGFKAASALFWPIPQGYLDARIAAaaLINSIGNLGGFVAPTTFGFLEQTTGSIQGGLYGLAATSLLAAVVIFFAR-----
     289 UniRef50_Q1DG35        Drug resistance transporter...   195     3e-48  1  12.1% 41:413  41:446     ----------------------------------------DQTIVATAGPAIQADLRIPASLYPWLTTSYFVASTTMVPVWGKLSDLLGRRAVLAAGILIFLAGSFLCGVA---RSTVALILFRAVQGLGSAALFTAALAVVADLFEPRERGKYQGLFGAMFGLSSVVGPLAGGFITDHLGWHWVFFINLPVGAVALALVLSRMPRLKPQRVSRGGLDLVGAfiLGLFALSAVGLVAFLWAERRAPEPLLDLTLFRLRAFSAGNAAVFIVGGAFLSGIVFLPLFMVNVV-GLSATRSGLTVMPLTLGVVAGNVLSGQLVSRVGRYKALLLGSLVLLMAGFAVMAFTLTpvTAKMVLVGLGLGPSIPLYTMAIQNAVPPdgVGTAAATFFRQLGMTLGVALLGTVFASTLSSEL-------------------------
     290 UniRef50_A0Z910        Major facilitator superfami...   195     3e-48  1  13.9% 17:433   3:416     ----------------NPTHWPKRVHVVGLSFLAVFICYIDRVNISVAIIPMAADLGWGMQQQGLVLSSFFIGYVLLQVVGGRLADRYGGKAVLGMGVILWSLFTMLTPPAA-ALGFTVLILTRIAMGMGEAVTFPAIYSTFSKWIPSVERSRAIGLINSAIPLGTIFALVTTPIIVQIWGWQWAFYSFGAVGIVWFFFWQRLVTSTPQQHADITDHELALIAL------------DNDVPVDDEQTSPPWHHFLRSMPVWAIVVAHFCNNWSLFVLLSWMPTY-INKGLGVDYASVGLLAIIPSIASVFFLNIAGNLADRlvRKLMQTIGFGGLTAALVTVGHLDTVWMAIATMTVGSALGAFVTGGFAvhMDVAPRHAGtmGITNTAGAIPGIIGVFVTGLILELTGSWIIVFSLAGGVTLFGLVFYLMFA-----
     291 UniRef50_B4ECA8        Major Facilitator Superfami...   195     4e-48  1  13.2%  9:432  12:436     --------SAVEPTLEEHVYRKVSWRLLPFLCALWVLAWLDRVNIGFAKLQMLDTLKFSEAVYGLGAGIFFLGYFFFEVPSNALLQKIGAKKTIMRITIGWGI---ICILQSFIKTPTQFYILRFLLGAFEAGFYPGIILYLTYWYPSSRRAKAFGTFMSASAIAGVFGGPLAGSIMTSlgWQWLFVIEGIPSVLAGVVAYFYMTDRPEQATWLSVAEQQVV-----------RNALDADKRELGERGHDWRTLFRNPKVWLLIAIFFCLLCANSALTFWIPTIIRDSGFGATV-VIGWIAALAYVFGAAGMILNGARSDRNQEVRWHFAVPAGCgaVLLGMPGVAPAFTIAAMIIALAGTMSAIPVFWQLPNLYLaaAAIGVALINSVSNLAGFGAPYVLGLVKSATGSLAPGLYLVAAIELMAAVLVVTA------
     292 UniRef50_B1JA25        Major facilitator superfami...   194     4e-48  1   8.7%  9:433   8:435     --------PVRDQAFEDRTYRKVIVRILPVLLLCYMAAYLDRVNIGFAKLSMLEDLQFSNTVYALGASVFFWGYFLFEVPSNLLLHRYGARFWIARIMLSWAIISMAVAFTQPLASftMFYVLRFLLGICEAGFFPGVILYLNYWFPTHRQSRVMSGFLMAMPVSLTLGGIMSGWLMTsaGWQWMLLVEGVPSVIMAAIVFCCLCDNIDKAAWLTPHEKELLKANL--------------KQDEHGKVSRLKDVFFSPRVWLLVFILLTFNTGFYGLAFWMPSI-IKSAGVTSSLEIGLLTAIPYGVALIAMFLNARHSNRTGERRLHaaFIGGCGLILSAAFAHDVVLSIVFLTVAASGVLSLMPIFWTLPGTVLsaAAAGIGMINAFGNLSGFTGSMITAVAENLTGDINNGTYVLGLCLFISGALIMAIP-----
     293 UniRef50_D2TL15        Major Facilitator Superfami...   194     5e-48  1  16.7%  4:427   2:427     ---SQTQRLDVRELINANPLSRYQKLVIFLGFCVIALDGFDIAIMGFIAPTLRQEWGVSNHELGFVISTALIGLALGALFSGPLADWLGRKKIIINSVFFFG---FWTIATAFSQNIEQMIFFRFMTGLGLGAAMPNMSTLVSEYAPERQRSFIITVIFCGFTFGAAVGGFAASWLIPQFGWHSLMALGGIMPLLFAPILIWKLPESARFLVIKRAPAARIHAILQRCYPGQLSENVCFTLPPQPVNSSAIGTVLSRQYllMLWLVYFMGLFLVYILGSWLPTLVKEI--GLTVSQAAIMTAIYQAGGTIGSLFTGWLMDRIEPHRALGVIFTIGGLFTMAIGYAGVNFLLLClfVSGACLNGANTGMNALSARFYPTQARATgwMHGVGRIGAIISAFAGAEMLALELDFKSVFLILGIPAALTVV-----------
     294 UniRef50_C4RMY0        Tetracenomycin C efflux pro...   194     5e-48  1  10.1%  1:407  10:445     MSQATLTRPGGPNNDVRRPGrgHPWLTLLAVALGVMVVGLDATVVAIANPAIARDLGADFAQLQWVTNGYLLALAVSLIVAGRLADRFGRKTVFLVGVAGFAVASIAVGLSG---SIEMVIFWRVVQGFAGALLQPASLAILRNTFPAEKLNMAIGIWAGTSGLAIASGPIVAGLLVENASWEWVFFLNGPVATVAILLGLWVVRQSrpEAAGSFDLPGVGLLSAALFSlaAVLGAAFVVRERTASHPLMPLGLFRNRSFSAGSVLAMLGFFALFGSFFFLTLYLQQ-VHGMSPVDAGVRLLPMTATFIVASPVAGALTARYGPRPPLVVGMLLTAVALFAlvQADYLSLWPWFIVIGMGFGMVLVSSTEAIVGNAPVHLAGLAGGitAAQLGGVLGTTLFGTILAT-------------------------------
     295 UniRef50_C8Q2N4        Major facilitator superfami...   194     5e-48  1  12.3% 19:431  15:427     ------------------PQGRQRWGVLGLLCLLAIINNIDRLTLSIAAPVMQTEMHITATDIGLLGSAFALAYAFGQLPSGWFVDRFSPRILLGTSVIIWSAATVAMGLSY---TLTGFILARIWLGLAEAPSLPATNKIVTRWFPKKEQGIANASWDAALKVGPAFFTFLLIWIVSEIGWREMYFIAGGAGIIAAVIFFAFYRDIEKHKSL---------------TKEEREYIQHDATPIITKNNLPWRELFKHQTMWGMMAGFFCNMWVYQIFLVFIPLYIINQ-FGIKFSSLGLVASIPWIGAIIGDLVSGVISGKLSErvTIIGALVLQAIVLALLPfaGLTVAVILMAFALGFNGGVVAHAWSIPAEVTAPGTVaaAVQNFGGFLGATVSPLVAGAIVDATHSFTLVFLISAVVSVIGAGIYFW-------
     296 UniRef50_A5WDF2        Major facilitator superfami...   194     5e-48  1  12.5% 15:438  10:435     --------------IDSRALGNRQKSIIALCMALMILDGYDIQAMAYAAPLIISDWQIDKTMLGVVFSSSLVGLFFGSLLISNLSDRFGRRIILLISTLLFSIFMLVT---PMAHNLEQLAILRFVTGIFLGGIMPNAMAYCAEIVPSKYRVFTMIMISSGFTIGAMLGGFVATWL-KAYGWQAIFYFGGIVPLILFVIMFLALPESLQFLASKPNNESKIKSILQRFYPSATISNDtpKNETVKASPIELFKENRSFFTITIWIASMMNLMSLYFLSSWLPTLGMEA--GLTTTQALMIGSTLQFGGTVGSLLMGTRINKLGFYKVLIPIFIVAavAMIGFSAGSIVVLFIVVFIAGFTVVGGQPTLNALSAERYPtrTTGVGWSLGIGRIGSMIGPVIGGLLSKSLTLSTLFLFAAVPSIVVVIMMIMQARHPGSK
     297 UniRef50_D0SXB1        Benzoate transporter n=4 Ta...   194     5e-48  1  13.7%  1:432   8:440     MRTMTTEKIDVNSVVDNAKFTPFHFNVVAWCLLIILFDGYDLAINGVVLPLLMQDWGLSAVQAGMLASTALAGMMFGAMIFGSLADKIGRKKVIMICIVLFSGLTFAGGFAS---NPTEFGILRFLAGLGIGGVMPNLVALTSEYAPQKMRSTLVTTMFSGYAVGGVMAALLGSWFTPSFGWQIMFFIAGIPLFLLPVIWKFLPESLAFIVKQNKQPEARRIVRRLAPNLTVTENTTFTLPQENVPEAANVVSLFRRGrtLLFWVAFFTCLLTMYALSSWLPKLMMAA--GYSMDNSLMFMMVMNVGAVVGIVGGGILADRFHLKPVLMFLGMMGAIVMSSMGFASNQLLliLVFLAGAASIGSQMLLYSYVAQFYpvRSTGIGWSSAIGRMGAIVGPILIGGLLGMNLPAYFNFMAVGLPVLITAIAVALI------
     298 UniRef50_C6QAT4        Drug resistance transporter...   194     6e-48  1  12.3% 14:420   4:434     -------------SDTASESTASKVLTASAVLLAVLMVILDMTVVNVALPHMMGALGATPDQITWVLTSYIVAEAIVIPTSGFLAARFGRKRVIFVSVAGFVVASMLCG---QAQTLAQMVIFRLLQGAFGASVVPLSQAIMVDTFEARNRGKAMAIWGIGILLGPIMGPTVGGFITDHLGWRWVYYINVPIGLVNLAMILVFLKQTPKSRAVADWIGALLLAVGVGSLQMLLDRgaFAVRSYKRSDAILKLSLLRDHNLSTATFMIMAFGVGMLSTIALQPLFL-EHLLGYPASTAGLVMAPRGIAVAMGMVFVATTINRFEPRWLVLIGLTLAAAGTYATTWYNLDvwIAPGIVQGLGMGMIFVPLSTLAYQTLPQDAtaAGIFNLARTIGGSIGIAIAATVLTRASHSNWQTLGAGI------------------
     299 UniRef50_B7L180        Major facilitator superfami...   194     6e-48  1  14.9% 26:415  12:391     -------------------------RVLLIICLMYLVTYIDRVNIGTAAPAMQKELGLSNFELGLAFSAFAYPYAFFQIAGGWLGDRLGPRMTLLICGTIWSAATVAIGFVEGAVS---LVIARFVLGVGEGSAFPTATRALANWMAADRRGFAQGITHAFARLGNALTPPLIAVLIVALSWRDSFVIVGLISFAWVALWFWYFRDDPRDHKHVTPEEIAVL---------------PTVKIAGERKAVPWRRLLK--RMLPVTITDFCYGWTLWLFLNWIPSYFLHQYQ-LDIKKSAIFASGVFFAGVVGDTVGGVVSDRiaRVSVIVVGFLGAFVFMLPVLFAtlVTITLCLSGAFFFAELIVAPIWAVPMDIAPQHSGTASGFMNFGflAGMISPVVFGAVIDATGRWDLPF-----------------------
     300 UniRef50_UPI0001901B8D drug transporter n=9 Tax=My...   194     6e-48  1  14.4% 27:436   1:445     --------------------------MLLVAAFGAFLAFLDSTIVNVAFPDIQRHFHSDISDLSWMLNAYNIVFAAFLVAAGRLADLMGRKRVFILGVALFTVASGLC---AIAESVGELVAFRVLQGIGAAVLVPASLGLVVEAFPAERRAHGVNLWGAAGAIAAGLGPPIGGALIEADGWRWVFLVNLPLGVFAVLAARRALVENRAAGRRRVPDVRGAVLLAFALGLlaVAMVGFVMSSRHHPAPMVEPTLLRIQSFVAGTGLTAVASAGFYAYLLTHVLFL-NYVWGYTLLEAGMAVAPAALVAAVVAAVLGRVADRHGYRFIVGIGALIWAASLLWYLKVVGSqwLPGQILQGIGVGATFPLLGSAALARlgSYATASAVTGTIRQVGAVIGVAVLVILVGTPAPGAagWALAAICFVAVGIGALSLGRIR--
     301 UniRef50_B2T4B0        Major facilitator superfami...   194     6e-48  1  12.2% 16:433   4:425     ---------------EARTMKRVTVRLVPFLILCYFIAYLDRVNVGFAALQMNKALGLSASAFGFGAGIFFIAYFFFEVPSNLLLEKFGARRWIARIMFTWGILAGAMAYIPDIARFtvFYGLRILLGVAEAGFFPGIIFLLTLWFPAAYRGRVVGYFMAAIPLSTVIGGPISGALLslAGWQWVYLIEAAPALVLAFVVLSYL----------TDKPADATWLAADERGWLVARQAQERAHREAVHTFSVKEALFNPRVLAVALIYFGANATNYGLSFFLPQIVKS--FGLTNLQTGFVTSLPYIVGVISMVFWGRHSDrlERKRHVAIALLVAAGGIAAAAGLDNPVqmIALSIAGFGIFGCLPVIWTLPASFLsaAAGGIAAVNSLGNLAGFFGPYAMGWIKDSTGGFGAGLLCLAGAGLVGVAAVLLLH-----
     302 UniRef50_UPI0001C347BE ExuT n=1 Tax=Providencia re...   194     7e-48  1  14.1% 40:435   1:394     ---------------------------------------MDRSAFAIAAPVFSKDLNLTPSEMGILFSSFSIGYALFNFIGGYASDKYGPKKVFAVSMALWSIF---CGMIGVTVGFISMLIIRTLFGAAEGPFAATLNKMVNNWFPKKEVATAIGIATAGNPIGGAIAGPIMGILIITTGWRVAFFILAAIGFIWLIGWLKIAKDKPEQHKKISKEE-----------LEYILSDDNNVESNTTNTISKPLSfiKSPTILATTLAFFSLNYILFFFLSWFPSYL-SNVQNLSIKDMSIVSIIPWLLGAIGMALGGILCDffSRKIVLVSCLGVSAILVFLVGNVTRVESAVALMAFgfFLYLSATTYWAILQDTVAKNNIGAVGGfaMANVAGILGPIITGYIIEWSGMYSIAFFVAGGIGIVGAISVALYVKP---
     303 UniRef50_D1ADS9        Drug resistance transporter...   194     7e-48  1  14.1%  2:406   4:434     -SAPSEVAAPAGGPPGSDRLDRSVWVTAGVVVLGAIMSILDATVVNIAIPVLTEEFATTLAKIQWVITGYTLALATVIPVTGWACARYGTKRLYMTSLTLFVLGSAL---AGLAWSAESLIAFRVLQGLGGGMIMPAGMTILTQKAGPQRVGKVMSVVGIPMLLGPISGPILGGWLVDLDAWRWIFFINVPIGAIALLLSWRVLERDVPKPAERLDVPGLlaTVIVTTAVGALLVIAFVVRALMAANPLIDLWLFKRRSMAAAALTMLLFSIAFFGAMLLLPLYF-QIVRGETALNTGLLLIPQGIGSMLTMPIGGMLTDRIGPGRVVTVGLPIILAGAFGLTQVTADTSyvIFFVLGLGMGLTMMPTMSAAMQTLVHDerASTAMNIIQQVAGSIGTAAISVILT--------------------------------
     304 UniRef50_Q9L210        Putative integral membrane ...   194     7e-48  1  13.3% 17:407   3:416     ----------------SSAGHPRRWQILNILCLSLVLIGLDTLILNLALPSIQKDLDATSSQLQWMVDSYALAFGGLLLMAGGLSDRFGRKRLLSVGLGAFALTSLG---AAFASNAEMLITFRALMGISAALMMPATLAIIKDVFPREEQGKAIGIWSGAAAVGVPLGPLVSGLLLEHFWWGSMFLINVPLAAIALIGGAKLIPESKAEGHPGLDLVGALLSVAGLVAIVYGLVEAPHNgeRKTAHPMLDVGLFLNARYGGGALAIACTSFGLYSGLYLLTQYL-QSVLELDPLGAGLRMLAI-GTMMVGAPLSAKLVERTGLKATVVVGLLLCAAGLGVLAGLSvtQALIGLAVFGLGMGIALPAAVDAILVVSAARQAGAGSAVagMQVGGALGIAISGSVIAT-------------------------------
     305 UniRef50_Q5HLB8        Major facilitator superfami...   194     7e-48  1  11.6% 19:433   4:411     ------------------KRSNVRWYFAIGFFFIGVIAYMDRSNISYIAVPMMKDLGLTKTQFGLLASFFSLGYALMQVPSGMLAEKFGPRKMITVALVWWSAFTILTGMIKHH---GLLYFIRFLFGVGEAPMYPSNAVFNSFWFAKNEKGRASSALLAGSYFGPVLAPIITIAIVNAFNWQAVFYIFGVVGILMAVLWAIIAKDLPEQHKMVNDAEKRFI-------------TQNRDIVATEKSLPPWKRFLSHFSFYAIALQYFVVQFVIALFLIWLPTYLTEQYHVNFKEMT--ISALPWLFMFFLILFAGAISDKiaRGVIAIAGFVVFSISIFLAVHTDnyVTIFWLSLCLGGVGISMGMSWAAATDLGRnsGTVSGWMNLWGNVGALISPLLAGIVVDHLGWSMTLQLLIVPAIIAAILWFFVKP-----
     306 UniRef50_B2J6X1        Drug resistance transporter...   194     7e-48  1  12.3% 21:418  18:444     --------------------GPLKWAIALTASLGAILEVIDTSIVNVALTDMQASLGATVSEVGWVVTGYAIANVVLIPLSAWLGDYFGRKTYFIFSLIGFTIASVLCGLA---FNLPMLVLSRILQGLCGGGLLAKAQAILFETFPPAEQGLAQAVFGVGVIAGPAIGPTLGGFLVDGLGWRWIFFVNIPFGIVAVAMSFMFLpeTQSQSVDWFGIGFLIIAIGCLQTLLEEGEKEDwwRELKTNHPAVDLRVLRHRSLAAGSVLSAVVGMGLYGTLFAVP-IFAQSVLHFTATQTGLLLAPGALASAIVMVLLGKLSSKIDARFLIAMGAVGSSGVMFQLAAITPQtlFWPLVWRGAFTVLMFLPLSLAVLGPLPKQDVSAGSgnLTRQLGGSIGIALLTTLLDRRQTFHRAILLA--------------------
     307 UniRef50_A4XFE0        Drug resistance transporter...   194     7e-48  1  11.8%  5:401   2:423     ----SASNPGSAGADTPPLVSRNRTLMLIGTMAAMIMYTLDTTIANVALPHMTASLGATQDTITWVLTSYVLASAVALPLAGWLVDRVGIRNMMLASVLLFTAASMLCGAA---QSLEQMVLFRVLQGLGGAFLSPLAQTVTLDSSTAAERPRMMGIYTQGVMLGPITGPIIGGFLTDNYNWRWVFYVNVPVGVLCFLLLLLYLPKTPTRERKVDLTGWLLVAlvTYAVVAGACAWLGLFHLSGSRNPLFPTALFHDRNFTVGLAFMFLIGLVMMSVMALLPGLLQQ-IYGYTPLQSGMLLAPRGVGMLASITLFGRFMAKVDARILLAFGLSLMGASMWMMTGWSttPIIMAGLLQGLGLSFTFMPMNLISFATLPPQYraSSLGNLMRNLGSSIGIAAA-------------------------------------
     308 UniRef50_B2VE80        Putative uncharacterized pr...   194     8e-48  1  12.3%  4:433   2:429     ---SSSSAVHPTGKREEKAWRRTVWRILPILTISYIFAYLDRINVSIAKLHMSGDLAFSETVYGLGAGIFFIGFFFFQIPGNILLQRIGARRMLAALLISWA---AIAPLTALVTTPGQFYTVRFLLGLTESAFYPGVILYLSMWFPSYRRGKIFALFAAAVPLSGLLGGPISGWIMTsaGWQWLFILQGTPSLLIGLLLFWLLPERIEHAGWLDPEEKSLLNA----------RLQEDAVQDTATAQATLNSVLCNGRLWLLTFIYFCLIAGFYTVSFWLPT-LVQNAGTQDVFTVGLLTAIPYTAAIITMLVAARSADRHrrRWHLAIIATVGAVGMvaLYSDNLWVAMFGLTLGAAGSLSTLPLFWSLPTAFLGgaAVGIALINSFGNLAGFVAPYLMGVLTDLTHSTLSGMLIISCTLLVGAGAIFFIP-----
     309 UniRef50_B6ZK58        Putative resistance protein...   194     8e-48  1  11.1% 18:413   6:431     -----------------SVSDARRWWAVGALALSALVVGLDTTVLNVALPTLATDLEASTSELQWFANAYNLVFAAVLLPAGLSGDRYGRKKLLVVALVLFGAASVGC---AYSGSTDALIWWRALLGLGAGFIFPLSLSVLPVMFSDEERPKAIGMVVTASALGLPLGPIVGGWLLDNFWWGSVFLINVPMVALAIVAVLLLLPDSRSPEPPGLDLVGVLLSSAGLAGITYGAIKAGEkaARPDGKPLVDLSLFRSPAFTWGAVMATVVSFALFGLLFTVPQYY-QAVLGADALGTGLRLLPIIGGIIVGARVGGKVTAKAGPKRLVSVGFLLMAVGLFMGAVTDTDtaATWIAVVGLGTGLALPLAVDSALGALSTERSGVGSAvtVRQVGGTIGVALLGTILTSSYHSHL-------------------------
     310 UniRef50_C8WXP9        Major facilitator superfami...   194     8e-48  1  13.5% 25:403  27:429     ------------------------WFIVGTVCFGAFMAALDASIISIALPKLEQAFHTMMNRIEWVSLIYLLALAGCIVAFGRLSDLIGRRPMYTMGFGVFIIGSALCGAS---WNLSSLLAFRVVQGIGASLLQANSVSIITAAADAERRGQAIGFQALAQGLGLSLGPLVGGVLTHIASWRLIFYINVPVGILGTISALLFLPRDRrgPRPRFDLVGALVLAFLLIVTMYVLKEGFRPeeRRAESPLVPISYIREPVIWLGNLTSILSFSVMYAITLVVPYWFV-HVEGLSSAKAGLLLTALPVGMALCTPFAGRLADRWSKVKVSAAGMVLAAMGSASLFAFatPAFLAGLFLVGCGIGTFTPANNARVMNATPAAHLGVAGgnMSRSLGMGVGVTAGGV-----------------------------------
     311 UniRef50_C6WMK4        Drug resistance transporter...   193     9e-48  1  14.1%  2:435  33:514     -SRQPDSRQPDPQRPGGQEPDPQRWRALAVCLLAGFMTLLDVTIVNVALPSIQRDIGATTAELSWVVTGYALAFGLVLVSAGRLGDDLGRRRMFLIALALFTLTSAL---AGLAPDGTWLVVARLLQGVAAGLLNPQVAGFIQQLFPGRERGKAFGLFGAVVGLSTAVGPLLGGLLLQWGgwRWVFYVNLPLGALALVLGLRLLPRDRPAARGGARKPLDAVGAVLLGGAVVSlvPWERAAKRRHGHPLVDFALLRTRGYSTGVALGLVYFAGFTSIFFVLTLFLQQ-GHGYTPLQAGLALTTYSVGGATAAAIGGRLVGRHGRVVVVVGLALEAAGLVVVDLVLRGaaIALPMLVAGIGNGLVIAPNQTLALHDVPPRQSGTAAGvtGQRIGSAIGISAAGAVfaITTSLLVTIGLILLALVVGLVDLVQGRRR---
     312 UniRef50_A9HGA4        Major facilitator superfami...   193     9e-48  1  12.3% 21:434   3:416     --------------------ARQRWLICSLLFAATTINYVDRQVLSLLKPLLEKTFDWTEKDYSYLVIAFQACYMLGFLSFGKLVDRIGTRLGYAVCMVVWSVASIGHALVGGTVSFA---AVRGLLGFGESGNFPSALKAISEWFPARERTLAVGIVTAGTSIGAIMAPATVPWLAVTWGWKATFIITGLSGFVWLAVWLCLYRIPEEKASLSPEELRYI--------------RQDTKPDAMPVFAGRWIDLLRMKVTWAFAIGKFMTDPIWFFILFWLPSYF-SDRYHLNLQHLGLPLMAVYLSTSVGSVGGGWLSSFlaRRAVMLLTALLVVPLAFSAQVGAMWLMIGLLSLAAAAHQGWSANIYSLPADHFPKEIIAsgIGGMAGSIGGMLFPLGVGVLLDHyeGYDILFVVCGGAYLTAWCIIQVLTR----
     313 UniRef50_Q13P00        Major facilitator superfami...   193     9e-48  1  14.1%  9:413  23:453     --------QDSPQGGTQAGDHPPIRLLFPALLLVMLLAALDQTIVSTALPTIVGELG-GLNNLSWVVTAYLLSSTIVVPLYGKFGDLFGRKIVLQTAIIVFLVGSALCGVA---QDMTQLIVLRALQGLGGGGLLVVTMAAIADVIPPAERGRYQGVFGGVFGLATVVGPLLGGFLVEHLTWRWIFYINLPLGIVSLVVIGAVFKPHVRHVKHTIDYMGAAFllWFTLGMGLVAIWGFIHEERSAVEPIMPLELFRQRTFLLSSLIGFIIGVSLFGSVTFLPLYL-QVVKGSTPSQAGMQMLPMMGGLFVMSMVTGRVISKIGKYRMfiAGTLLVAVAMLMLasTPIHVMYIDMGILGCGLGMVMQVLILAVQNTvrHMGVATSGATLFRSIGGSIGVAGFGAVFSNGLAARL-------------------------
     314 UniRef50_A8LFX3        Major facilitator superfami...   193     9e-48  1  12.8%  3:433  60:528     --ATGAPPSSTVAAVDEAGVDPRRWRALPVILIASFMSLFDVFVVNVAAPSIESDLHASNAGLELVVGGYSFTYAAALVTGGRLGDRFGRRRIYLLGMAVFTAASALCGLA---PNEAVLIGGRLLQGAGAAAMVPQVLALISVTFPPAERPRAFAFFGVTIGLGGVCGQVLGGVLLDllDWRPIFLVNVPIGLAALVGARRLVRESRAARAERLDPVGLglALAAGIVVLGGFGAWEARLARSGGHPIIPPAVVRSRAVVGGMVMSAGYFF-FFGSFLLALTIFLQVGQHRSPLNAGLMFAPLGVVFAFSSLAARRLVTVYGPRVLTAGALTTALSLVGVAVAVsaYELTPLLMLAGIGNGLVIPALAASVMAAAPPDISGtgVLTTTQQFASALGVSGVGALftARSGADAGLFAAVICGLISVGAAFLGS-----
     315 UniRef50_B5WS08        Major facilitator superfami...   193     9e-48  1  12.9% 17:434   5:417     ----------------SQRLKRIQVVAVVFLTVAGIVNYLDRSTLSIANHLVSEELHLSASQMGLLLSAFSLSYAFAQLPVGALLDRFGSRVMLGLGMLVWSIAQVAGGF---IQTLNHFLSARVVLGIAEAPLFPAGAKVVSEWFALRERGAPIGTFISSSTIAPMIAPPLLTVLMLSFGWRTMFVIMGVVGIVVALAWHVVYRNRSE-------------IALSAEESAHLNEGATSEENPPRLSWSEWGALFKLRNTWGMIFGFMGVIYMVWLYLTWLPGYLERERH-LSIAHTGWVVAIPYVFGTIGMASSGLIADYlsRKWPLCIGLVGAAAFTVPAAYTPSTtaVVYVSLAMLFVNLSSGSAWALVSVAAPRHLVagSMQNFGGYLGGSFAPVITGIVVDQTHSFVNALLISAAVAFAAALVYLFVVK----
     316 UniRef50_C7QA77        Drug resistance transporter...   193     9e-48  1  12.7%  6:438   1:470     -----MSPVASAEAGSVRLGTPIGRGVLATTILGSAMAFLDGTVVNIALPRIGSQFGATLAGLQWTVTGYTLTLAAFVLVGGSLGDRFGRRRVFLIGVVWFALASLACGLA---PSLGFLIAFRAIQGIGSALLTPGALALIQSVFHPDDRAKAVGAWSGLASIAGAAGPLVGGYLIEYASWRWIFLVNLPLAAAVVAIALRYVPESKELVAGHFDLPGAVLGAVGlaVLGVAALVAFVLVERRSPAPMMPLSLFSSREFSAANALTLTAYGALGALFFFFATYL-QVVGGYSPLEAGLASLPTTVVLMTLSSRVGGLTTKVGARRLITAGGALTAIGTLILATSglTHILPGLLVFSLGMVMIAVPVTVTVLNSTTTDRAGIASGVnaGALAVAAFPLLVGLKGDGYAnfTKAMVLSAALFAVSGAIAWFGIRDAAT
     317 UniRef50_B8FQK7        Major facilitator superfami...   193     1e-47  1  15.6%  6:434   1:429     -----MRKINVNKVIDEAKFNRYFLIIFVLLLLALIFDGYDMGIYGVTLPSVMKELNLNATQTGLLASAGMFGMMFGALLFGMLSDVIGRKKTIIIGIFVYSVF---NGIVAFIHSASIFAVVRFIAGMGMGALTPVVISLLSEYTPRSRRTLLLTMVMVGIPLGQLVASLAGVAFLESIGWR-VLYLATLIALIMIAFVVWNVPESMKFYVPRGETKTIKKVLAKANPDFEQTEEDVYELSIVNQQKASLGSLFKskNTIYIWIAFFCNLYLFFGISTWLPKLM--TMLGYPLKSSVMFLAIFLLGGVLTTPFVGMLGDKYGYKKVMPVLYAMSAVLVSLLSfmSTFIFYTLLFLAGCAVTLVQSMTLAAAPDFYPirGTAMGWGSAVSRLGSAVAPTVVGVLLTANLPVRGVFLTFIIPAVIACIAILLTKK----
     318 UniRef50_D2ELL4        Major facilitator superfami...   193     1e-47  1  13.1% 21:431   7:441     --------------------RTNSAWILTLTSLGFFMSMMDSMIVTTASTAIRNDFGISVDTLQWALNAYNITIAAVLLVGVALGERLGRRKIYNWGLFVFTVGSILCALSG---NITVLVIARIIEGVGASVMTPMSMAILSNALPASERGKALGIWSGIGGLVLIVGPSLGGLIVAKLTWQWIFWINVPIGIIAIYLSNRLLPESKGAAEKVNIIDAILIILSSAGVIWalLGIWFVIRQKAESKPMIPMTFFKSVTFTGGNVATFLLYASMYGVVFFLPQFL-QVAGHADALQAGLEILPWTGTLVVVAPFAGSAVDRFGEKSIATLGLFLQGLGYLLIMmtAYWKLIIPLIIAGAGLSMAGPALQKAVLGAVEPQSVGKASgnVFRLLGGAVGTTVSVIVFYAWGGIVGSLAFTAGFKAVMLSSGVI-------
     319 UniRef50_Q13H89        Major facilitator superfami...   193     1e-47  1  11.2% 13:415   2:408     ------------RTVAQQTVRLVTRRLGVFMLVVYLLSSMDRVNVSFAALTMNDDLHFDPGIYGFGVGLFFVSYMLFQLPGAALIRRFGAARPLAIMMVAWGFCASLMSCINGRFDFYVL---RFLLGLAEAGVVPAATFYLANWVPRQNLGRIMTWAALSLPMAVIIGAPLSGWLLTQhgWRWMFFVEGLPTVILGVVAYFRLTESPAEVRWLTHEQRE-----WLMRELEKDRPKQSLSTYSSGQTAGLWTVLSDRNILTIALAYFCIAMGTYGLLYWLPQVIKAASTGLSPMAVTLVSTMPWIAAAAGMLLNGWHSDRNQErrHVATGALIGALGLIlcAFSSPWLALLGLVATGFGQGAAQGLYMAIPIDLlpAAPTAFALINMIGNCAGLVGANLIGWLRNATGSFSMPI-----------------------
     320 UniRef50_Q0W8L4        Predicted permease (Major f...   193     1e-47  1  15.7% 15:403   3:413     --------------QTSEKPGLSPVYVLAVLAIGVFIAQLDATIFVPALNTVVSEFNTSYEWVVWSVTIYMLAFTVTMPLAGKIADLYGRKRLYILGVALFCIGSLACGLAWDIPS---LLVFRVIQAIGGGMILPAALSEIGAVVPEKSRGMAMGIMMAINAVAAIIGPNLGGFLVEHFGWRYVFYINPPIGILAILLALRF-TETYGHEKHSIDFPGAAMLGGFLLTLMLGVIRLSSLpeRKAKEPILSIPLLARPEVLAVNFAALAFGFCFFSIVLYVPSY-SQMVLGLGIQDSGSILTPLTVSVLVMAILGGRLADKIGIRFVLLAGAIvgALFAMAYALSGTLVLAIILLIMGIGVGFSMGSFQSLTLALVPPNMKGSASgnTFMNMGGIIGPTIGSY-----------------------------------
     321 UniRef50_B2JUA3        Major facilitator superfami...   193     1e-47  1  14.4% 10:432   2:421     ---------ANTSEDSGKRIPNRRWVIGLLLGIGVLINYFDRINLSVAAPQMKEAFNLSPADMGLLFSAFFWPYALLQVPAGLFLDRYGVTRVGRWGAFLWGLASAITVFAS---GFGGVFAARAVLGIAEAPGFPVSSKATGYWFPRKERALATAIFDAAAKFSNVIGVPLVAVVVVNAGWRWGFGVTALLSFAYFVAFLLIYRDPSKDGKLSPVELDYI-----------QKGGATPEGTSSASVFGMLGYLLTKTKVWGLTIGFAAYGYSFYLFLTWLPGYLVQTMHMSILKSAGFAAIPWAVATVTDLVVGGWLIDHlvRKAVLVTGMLFGLAVFGATQTVNPGWAIFWISIALGGLAAAAPVGWSLPSLIAPKGGVGtgIMNFANNLMGVAAPIVTGFIVGATNSFTNAFLVAGVILAVGIVSFVFV------
     322 UniRef50_B0K4M3        Drug resistance transporter...   193     1e-47  1  13.5% 23:406   7:413     ----------------------NKWLILSAVVIGSIMGPIDGSIVNIAMPEFTKIFHTNITTVSWVSMTYLLVLSSLMMTFGRLGDMLGYKKLYQYGLLTFS---ISSAILSLSVNIYMLIIMRAFQAIGAGMLMSMTSAIITSVFPPNERGKALGINAMSISIGLAIGPTLGGFLLSNLGWQSIFYINVPIGIIGYIWAHIVVPdgVPEKFDIYGSISFFGFLASLLLFISEGGTWGWTseNKVDFPMFDFSLLKIRSFTFGNISTLLNFMSQNTMTFLTPFLLQ--HLGFTTEKAGIVMTSFPLVMFVVAPLSGILADRYGAQILSTIGALISATALFLMVtsTMFSIMTHLALFGVGNAIFQTPNNSAVMGSAPKNRLGVASAftMRNVGMVMGIAVGSAIFT--------------------------------
     323 UniRef50_A4FIK0        MFS transporter, phthalate ...   193     1e-47  1  12.9%  3:435   2:427     --ATLSRSEPTGTPAPRRGIGKLRYAMLGVLFAGIAINYVDRATISVAMPFMSEEMGISDALGGVILSAFFWTYAAGQMPGGFLADKLGARKMLLLASLCWGLSTMAMGLA---WGVVSLVVLRLVLGIGESPAFPASAQVVSRWFPRSERSFAAATFNNGNPVGATLSVPLVALAIATLGWRWAFVLAGALGVVWALVWWKVYREPREHPKITAAELAHI---------------EEGQEESEADASVRWAQLFRFRAVWAMMIGFFCVNFVAYFFITWFPTYLVKT-YGLSLLKFGFYGMIPGIASMVGGWCGGLFSDYLVRRGtlVGGLLGTSVIALAVFSPSVEMALTALSASYFCSTFAAASVWALPADFAPTPGHvaGIQNTAANIAGIISPILIGVLTGLTSSFVLPLLIAGGVALTGAAVYAFVLPP---
     324 UniRef50_B9JXZ3        MFS permease n=2 Tax=Rhizob...   193     1e-47  1  13.2%  7:437  16:452     ------PQAEISARLERLPVTREVFWARNIVGAATFFDGYTVIAIAYAMPVLVREWNLTPGQTGMILSMGYLGQLIGAVCFGWMAEKIGRLKVLLFTILLFVSMDIACLFAVGA---GMMMAFRFVQGIGTGGEVPVASAYINELIGSKGRGRFFLLYEVMFLLGLVGAGLIGYFMVPLYGWKAMFVVGLVPAILMIPLRWFLHESPRWLVadADRIVSKLENSARAAGNELPEPKIVAAPMRRKSDWRELFQGIYLKRTLSIWAMWFCAYMVANGTITWLPTLYRQT-FNLPLETSILYGFITSVGGVIAAIICAFLIDKVGRKRWYTGALLIAPIPLVILAWLGATSAVQVLVLAGLAYAIVQTVTFSlsSEIYPTRLRAIGTGTGSarLGSSAGPIAVGWVMSSMGIQYVFGAFAVILLVGALVTALFAVETKD-
     325 UniRef50_D2AS24        Sugar phosphate permease-li...   193     1e-47  1  10.6%  3:407   2:431     --ADTKTVASAPPPGTGEAKQRHPWLTLIAVSLGVIMVMLDGTVVGIANPAIAQDLKASLSDLQWVTSGYLLALAVFLITAGKLGDLFGHRLIFLIGVAGFAITSLAIGLSS---SIGMLIGLRVLQGLFGALLQPAALALLRAAFPGERLKMAMGAWGAIIGLSSAAGPIVGGLLVEHVSWQSVFFINVPVGIVALAMGLWVLTESKARTLSKIDWLGVVLLSGVMFSLVWAIIKAPEWgqARASEPLLPLSLFGNASVSIGTGLMMLVAFSMFGAMFFL-TFFFQGVHGLTPLESGLRMLPMSAGMIVASPLAAVLLSKFGTKFTIAGGMLVTATAMFLMSRLSLDASfiPFVLLAFGLSPVFVGATEIIVGNAPEDLSGVAGGvsAMQVGGALGTAILGAIVSA-------------------------------
     326 UniRef50_Q2RGP4        Major facilitator superfami...   193     1e-47  1  11.3% 13:435   4:437     ------------SLSPSTGWWRYRYLVAAIVFFGYSIQYLDRVKTTVLVPLISQSLHLTHSDVGNAMFLLMIFYGPTQILSGFLCDRFGPKKVLVFSLITWSIFTIYM---AYMQNATEWYIRNALFGIFVGTEFVPSARLIARWFPKRERAQAQGVLSWSWIITPAWAPLLTTFLASYfdWRPVFIWLGIFGLVPLVIVLLFIYDRPEQVRWLSDREVKESYalESGILKEAAISRENLAKQAKKAEIPLRDVLLNKSFIAVVLSYLACQMTFWGIVTWSPSYLSEVFK-FNLMKMGVWASIYFAAGVIGAFLSSRISDKfrRRPMIILSFLGTIPFILLLAMssHMGLMLILAGAGFFANMIWGPILAWPADVFSPegRALGFVTGIAYFGAAFAPLIMSRLipAGVSYTYAWTFIAFCAVAGLIASAIVRDR---
     327 UniRef50_D2S4K5        Drug resistance transporter...   193     1e-47  1  11.2%  5:422   2:445     ----TATERSLPEAAEEPPGHARRWWVLATMTVCLLVVIMGNTTLNVAIPTLQRQLGASQGQLQWAIDAYILVFAGLLFSWGVMGDRIGRRRVLLIGLSVFTAGSLL---GAFSSSPGELIAWRAVMGIGGAAVQPTTLAVITNVFPEGERGRAIGVWAGAAGIAVAGGPLASGAVLEHFWWGAIFLITVPVALLGIVATVLVVPESRDPSPGRLDIPGVLLSVLALAGLVYGIIHgfVWLQRRSAHPALDVTLFRNPAFSAAAAALGLNFFALMGATFYVV-YYLQGVLAHGPLASGAALIPMALGMAVMAPGSSRLAERFGAKAVVGAGFGLLTAAvlLDTTSPLWLLLVILTVQGLGMGTVMAPTTESIMSVVPRHKAGAGAanSVRQVGGALGVAVLGSLLANAYAARLGSAVDALPA----------------
     328 UniRef50_D2U3A9        Multidrug efflux protein (M...   193     1e-47  1  14.8% 23:414   8:424     ----------------------RRWIALLLISSALFLIVIDMTVLYTALPTLTHELHANASEKLWIINAYPLVVAGLLPAAGMLSDRIGHKKMLITGLPLFALASLC---AAFSPNPESLIAARVFLAVGAAMMMPATLSIVRHIFtpHERSLAIGIWSAVAAGGAAVGPLVGGLLLEYFWWGSVFLINVPVVMLVLPFSVSVIPSCGGTNKRVIDFLGSVLILIGLVGLIYALKElfVLRQRKQSQPMLDFSLFSNRLFSAGVIIAVITMSVIVGIELVLSQRL-QLVLGFTPLQAALCILPIPIGSVLASPLAGLLLPRFGERLTAVVGflVGVIGMVLFYQSHLILLLINLFMIGIGMGMVFTTASTTIMLNAPDEKSGMAASivAYELGSVLGVTILGGMMTAIYSSKLF------------------------
     329 UniRef50_B1G6I6        Major facilitator superfami...   193     1e-47  1  10.6% 20:434   1:412     -------------------MKQRWFRLLPVMMIAFIIGFMDRTNVGFAIPTMGGELGLTSSILGFASGVLFVGYGIAQPICGWIADRGYGKPMIALMMVLWGIAEISQSA---VHTAPQLVAVRFAIGLFEGGIFPTFLLFVKNWFAPSERARANGVWQLCYPLAALLSGPIAGYILQFGSWRTLFIIEGIFPILWVAVWLWGVADSPRNAKWLDAGER------ERILERIAQETRARALQSGPQVAASFGSQIRRPSILIFMASILLWNVGFLGFVIWLPSVIHQQ-PGLSSATTGWLSAIPYGFAMLVMPVLTYWSDRTLERRllAIAGIALAVGGITYASNAFAVNMALLVVAGAMLYGSQPVLWSIATELLPQEVAgtGTINGVGVIGAFAGPYIVGYVRSLTNSFSSGLLAMGVSLVATSALLLLITE----
     330 UniRef50_D1VJD3        Drug resistance transporter...   192     2e-47  1   9.9% 11:414   2:433     ----------STAPSQISVSPRQLRLIFVGLMLSVLLASLDQTVVTTALPTIVGDVG-GLNHLSWIVTAYLLASTVSAPLYGKLGDLYGRKTLFHAAIGIFIVGSLLCGAA---QNMPELILFRALQGLGAGGLAVGPQAIVADIIPPAERGRYSGLMGSVYALASVLGPLVGGLFTDRLSWRWVFYINLPVGVFTVIVIALVLPASTPRRRQRVDWAGTAlvVAGLMAATVVLAAAFVAVETRVPEPVLPLRLFRSSVFDISILGTAAITMAMLGLITFIPLFL-QTVQRISPTLSGFETAPIVTTMLVCTIWAGRRVARTGRYrpIVGAVLLIAGSGAVALfaPYWHTAIGMVLFGAGVGLATVVYVLTVQNSVPHggAATASMAFFRSMGGAVGVAIFGGIFAHRLGATLG------------------------
     331 UniRef50_D2S5D9        Major facilitator superfami...   192     2e-47  1  10.6% 11:414  13:441     ----------TTVTRASVGLRSERGPVLGAVMLSTALIALDSTIIATAVPAVVDDLG-GFSQFPWLFSVYLLTQAVTVPVYGKLADVYGRKPVLLFGIAVFVAASLFCGLA---WSMPALIVGRALQGIGAGAVQAIGMTVIGDIYTVEERAKVQGYLASVWGVSSVLGPTLGGVFSDYLSWRWIFLVNLPLGAVALVVLYRRFSERVERREHRLDVAGAVLlsVAVLVTAVALLAAFTVVERRAAEPVLPLWVLRRRILLTGNVAALALGALLIGLSSYLPTW-AQGVLGASALEAGFALAALTLGWPIAASQAGRLYLRIGFRNTALIGVVLAVLgaLLGLHAQLWQVAASMFVTGIGLGLSSSPLIVAVQSVVgrRGVVTATNMFARSIGSAVGAAVFGAIANTTLAGRFA------------------------
     332 UniRef50_C5D9I7        Major facilitator superfami...   192     2e-47  1  14.2% 23:431   3:427     ----------------------NRISVMVSIVLAMLVASMDTTIMNTTMPIIAKELG-GFSLYAWSFASYMITTTVLSPIAGRLSDIFGRKKVFSFGIILFLIGSLLCG---MSQNMVQLVVFRALQGIGAGFMMPFPAIIAGDLFPIEKRGKIQAFFTAMWGISAVLAPLLGSFFVEYASWRWIFYVNIPICLLSLLTLLPYKEVYEPKRAVIDYIGAVLFATAISLFLLTTVAESNHWmeKKQTSPLVPLTLVQHKTLKWMNMNGFVSCVALFGTSSYIPLFL-QNIAHQSVFASGVALLGMSIGWMIVAVPAGKWILRYGYRMLLIIGNVLLVLSGLLLALLNESHGFLYVFFAMFIQGLSFGLTSTVglADAHEKGIATSFFMFCRNIGTAIGVTIMGAFLTKAADFMTGIHHLFLFGFIGSIVALF-------
     333 UniRef50_A7GPK2        Drug resistance transporter...   192     2e-47  1  10.5% 26:433   6:452     -------------------------VVTVVYIIAMFMASMDATIVNVALQTISQELQVPPSAMGTVNVGYLISLAIFLPISGWLGDRFGTKRIFLIALSVFTVASALCGIA---NSITTLNIFRMIQGVGGGLLTPVGMAMLFRTFSPAERPKISRFIVLPIAVAPAVGPIISGFFVEHLSWRWAFYINVPFGMIAFIFGMLFLVEHIETDAGRLDLLGFILSAPGFTMLVYSLSQGPSKgeLRVKHSMLDLRLLKEHLFRNMSIISFLSAAGLLGMLFIFP-LMYQNIGHASALETGLTTFPEAIGLMISSQIVPWSYRKIGSRRLISIGLLCAAILFVLLSFVTNETNPWLIRLLLFGIGFFLGHSVGAVQFSAFQHIQSSSIGRAtnRLGSAIGVAILASMLAliTAYQIALCTAAGFLFIALLFALRIR-----
     334 UniRef50_B1G6M5        Drug resistance transporter...   192     2e-47  1  12.1% 10:407  19:442     ---------SARRAGLRHWLSTRNARVLLCTSGVSFMIMLDSNIVAVSLSTIAKDLNASFTDIEWVVSAYILPFAAFLMPAGALADRFGRRRLLLTGMLLFTAASLVCGLA---PNSTILDASRGLQGVGSAIQLSAALAVLGHTFRGAERARAFAFWGTLVGVAVAIGPLIGGFITSTVGWRWAFLVNVPAGAALIAVGFSSVDESRDPHSRKLDLAGITFLGGGLFYLVWGLINafVVAELVQKRPMVDFSLFRRRTFLGSSIAMLGFASAAQVMMTYLPLYL-QNSFGFNPALAGVTMMPFALPLFLLPRVGASLARSMSGRAILTIGLCIVACGNLSTALvsLKLLWMGMLITGCGAGLLNGETTKVSMTVIPPERSGMASGitLRFVGLLLGITFLGAILAS-------------------------------
     335 UniRef50_Q7NNZ0        Glr0268 protein n=1 Tax=Glo...   192     2e-47  1  11.3% 16:414  33:457     ---------------TTALDERTKRLVMGAVLIALFLTSLDQTVVVAALPKIVADLG-DLDLLAWTSASYLLVSTTSLPILGKLSDLYGRKNILLIGIAIFLLGSFLCGLA---PSMLMLVVFRGIQGLGAGAITSVALTIPADLYVPAERAQLQGIIAAVFALSSIVGPLLGGVLTDTLGWHWIFFINLPFGLLALAFIVAFMPRLNSGLTRSIDYWGAVLLMLTVVPLLVALSLEKEkaELRAKEPILPLSLFRIPIFSLICAMSVMVGATFIVAILFLPVFLV-NVMGASATEAGVALIPETLGLLVSSFISGLVVQRTGrkAAMLVGLVLMSIGIFLLTQLSLTTTIasIAIFGLGAGATFPQANLALQNAVPFEYVGVATalFFAQLGQTVSAALYGALLVAYLNTALV------------------------
     336 UniRef50_A9ACF8        Permease of the major facil...   192     2e-47  1  10.6% 11:415  16:415     ----------VPRPQIDAVYAKVARRLVPFLFVCYLFSFIDRSNVGFAQLQMKSSLGFSDAAYGIGATMFFVGYALFEVPSNLLLQRIGARATLFRIMVLWGAASAATMF---VRTPAQFYLLRFLLGVFEAGFFPGIVLYLTYWFPSNRRARVIALILMASVAAGFVTGPVSGVILKSlgWQWMFVLEGLPTMLAAGFVFVLLPDRPEQAAWLDDAEKALI-------------RDALAEGGEPREPRSLLRVLSDPRAYLLAFGIFVNGCAGYFLAFWVPT-LIRELGVADPRAIGLYTVIPNAFGIVAMLVYGRHSDRRNEQRLHWALAFVVAALGFVAlqHSLPWTIAALAFGGSALVSSTPIFWAMATRYFprAAAGIAFVNSLASLSGA-SPALVGLVKAHTGSLVPAI-----------------------
     337 UniRef50_B4EQ46        Major Facilitator Superfami...   192     2e-47  1  11.4%  5:418  13:421     ----AAPASAHDLAQEDRIFRRLAVQILPILMFAYVTSYIDRVNVSFAKLQMSQHLGFSDAVFGFGAGIFFLGYVIFEVPSNMLLVRVGPRRWITRIVVSWGIVS---GLTAFVSTPMQFYVMRFLLGVAEAGFIPAIVLYMARSFPGRRRARILSMFYAALALAGLIGSPLTGFILQYfgWKWIFILEALPAFLAALYVWKDLDDDVTRSARFSHAERAVLARVL-------------AEDRATTESVVHRGLFSSWLVWAFCVIYFLDVFAIYGYTFWAPTMIKQMGIG-SDFVIGLLAALPNAVAVVVMVLFGRSADRRGGRRLHVATLLLMGagLSVVWHDQLWLGMFALCIANAGLISFPPLFWSMPTAALGAASvgIAVISSFGNLGGFFGPYAVGYLKQLSGNLAVPLFLM--------------------
     338 UniRef50_A8M3B7        Drug resistance transporter...   192     2e-47  1  13.7% 13:407   2:431     ------------TQATQAAVRPKIRIVLFGLMIAMMLAMLDNMIVSTALPRIVGEFG-GLDHFTWVVTAYVLGTTVSTPIWGKLGDLFGRKSIFLTSVVIFLVGSALCGMAGSndGMAELIAFRAVQGLGAGGLLVGVLAIIGDLVPPRERGRYQGMIAGIMAIALVAGPLVGGFITDHLSWRWAFYVNLPLGGVALVLLVATLRLPRYRTEHRIDWLGAALliVGLVGLAVAALAVFAVVELRAVEPILPLKLFANRNFALISAIGFLLGFAMFGAMSFLPLY-QQTVQGASATESGLLLLPLMFGMLVVSLAVGRTITRTGRYRVfiVGGVVMSAGMALLTYLDAQtsSLYLFVLGVGMGFLMQTTMLIAQNSVDQrgAASGAATFFRSIGGSFGISLFGAVFAS-------------------------------
     339 UniRef50_Q0SEY0        Anion cation symporter, MFS...   192     2e-47  1  16.2%  3:429   5:431     --TSGPVSPDSAEAAAHPKVGRARWTIAGVLGVGMFVNYIDRVNLSIAAPEIMRDFEISASQMGMVSSAFLWTYAMLQMPIGSFIDKIGVRWVNRAAAFLWA---VASFASAAAGGLGMLLVARLVLGVGEAPTVPAGWKAIGQWFPRQERGTATAIFDGCAKISNVIGIPIMAFLVTTFSWHAAFIFTGILSVGYLAVWWLLYLTPKQALAKGR--------LSQAEFDFIRAGGAEDEDAETAGSLNGLGYLLRRRKTWGLALGYASYTYAYYVLLTWLPAYLEKQ-FGVNLLKGGIYTMIPWLVAVIAQFlaGILMDRwvRRTVLVVSLLASLAVTGAAYAGSIAVALIFLSIGAAGLAVSVPAGSSIVALIAPQGYTggGIVNFVANLLGIAAPIVTGMVVDSTGSFAGAFLATGAVLIGGIFCY---------
     340 UniRef50_C7LZ16        Drug resistance transporter...   192     2e-47  1  11.4%  6:417   1:438     -----MTDTTLSPSSTVRAHGARLGLILTGLLLGMLVAALDQTIVATALPTIANDLH-GFSHLSWVVTAYLIASTASTPLWGKLGDLYGRKRFFQLAILIFLVGSALSGLS---QNMLELILFRGLQGLGGGGLIVGAQAIIGDVVSPRDRGKYQGLFGAIFGVASVVGPLLGGFFVDSLSWRWVFYINLPIGIIAIAVISSALPQLSTRVQHRVDYLGTLLVALalTIASTVALVAFVLVEQRASEPILRMGLFRNRTFSMTSAIGFVVGFAMFGAITFLPTFL-QIVRGASPTVSGIQLLPLMAGLLVMSIGAGLLISRFGRYKVfiVGTALMTVGLWLLSRLSVHTSYGvmIVLGVGIGGVMQVLVIAVQNAVGYegVATSGATFFRSIGASFGVAIFGSIFTNALDSKLAAVA---------------------
     341 UniRef50_A9KG82        Multidrug resistance protei...   192     2e-47  1  10.7% 23:406  25:434     ----------------------RKWWIFVAMSGALSVVFLDQTAISVILPPIQKDLGLSNVLLQWVINAYLLSLAALVIFGGKLGDVLGHKRTFLAGIIIFVLASISC---AAAQTSYWLVTSRIIQGVGGAFMIPVTSVMMAHAFSESERGKVMGLYVAVAPVFLSLGPLLSGLLAHYFNWRWVFWINVPISLLSIFLTIIAVpeNQRDTSKPLDWLGFLTfiIFLFVVAAFSAIAFIFVERKAADPIVSLHLFTRKTFLSASLCLLFFTCAFSSSVFWA--ILLQKVMGYSPAATGLFYLPVTIPVMFMAPLGGMLRDKYGPRLPVMMGSAAVAAGSFWIALshYSAMLPGFLLFGLGPALVYSAVMATTISSVPLSQMGMASgnGIRQLGRVLGVAMIGSVIS--------------------------------
     342 UniRef50_D1AEL3        Major facilitator superfami...   192     2e-47  1  13.6%  6:430   1:458     -----MSATQAPATEGRELESGPSRWLMVAVLGGMFLSMLDQTIVGPALPDITADIG-GENLYSWFVSAYLLTTTVSVPLYGRLSDVYGRKPLLLTGLGIFIAGSALC---ALAQTSWQLIAARALQGLGAGALIPLSLALLFDLFPGRAMGKVQGWIGAVMGVSYVTGPMLGGLLNDHAGWPWIFLVNVPIGVVLAAVVVIRLPHRprPDYLGIAVFSAAVSLLMVGLTQKGLTGADGriELRVSEPLIPLGLFRNPVYTATNVASFATAFAMYSAIIFLPRYLRDAR-DYSAVASGVLIYPLLIGIVVGSFAAGAIIGATRRYKLLLAsgIGAVCFLWLEADTPLPVLSVWMATLGLGIGPMLSGLTITVQNSVPIEHIGTATgtFFRQIGGAVALTFAGSIYMETMTDHAPAVGPQQAAAEAAAQVL--------
     343 UniRef50_Q21C25        Drug resistance transporter...   192     2e-47  1   8.2% 10:401   2:419     ---------TTAGAAPVAVPGLRRNMVTICAMTATIMQALDTTIANVALPYMQGSLSASQDQINWVLTSYIVAAAIMTAPVGWVANRFGRKRIFIICSAGFTIASVMCGLA---QDITQMVAFRLLQGVFGAALVPLSQSVMLDIYALHERAKAMSIWGMGVMLGPIMGPSLGAWLTETYSWHWVFFVNLPFGIVTVAGLLVFMDETKLNHALRFDWFGFAALAIGIGAMQLALDRGEqaHSFTTPKPFIQFAIFTDKNFIGGCVFMAVMGLVLFSTMA-LSSPFMQNVIGFPILTAGLLLATRGTGTFVAMMMVGRIMRHIEARTLIAGGLTLTCATLYFMTQWTDQTSVYSIIVvgFGFGLVFVPLSTVAFLTLPGHLrgTAMLTLVRNVASSIGISVV-------------------------------------
     344 UniRef50_A8ICY0        Permeases n=22 Tax=Bacteria...   192     2e-47  1  13.7%  7:437  56:492     ------RQADISARLERLPITRRVFWTRNIIGAATFFDGYTVIAIAYAMPVLVREWGLKPEQTGMILSMGYLGQLIGAVFFGWLAERIGRLSVLLFTILLFVSMDVACLFAWGAGSM---MLFRFIQGIGTGGEVPVASAYINEYIGSKGRGRFFLLYEVMFLFGLVGAGLIARALVPVYGWEAMFLVGLVPAAILIPLRFFMKESPRWLAAKgdRIVSDLERSAEAAGHKLAMPQPVPMKQSEQGGLRELFSGIYRRRTLTIWSMWFCSYLVANGMIAWLPTLYRQT-FNLPLETALLYGLLTSVAGVVASIACALLIDKVGRKRWYTAAFLCAPLPLLALAYMGATSPMEVLLLAGLAYAIVQTITFSlsAELYPTRLRALGTGLGSarLGSSAGPIVVGTIMGAAGIQYVFAAFAGVLVIGALVTMLFAIETKG-
     345 UniRef50_B0T3E3        Drug resistance transporter...   192     2e-47  1  13.2% 14:407   1:439     -------------MTTQTFTDTERRLTLGALMIVFLLSALDQTVVSTAMPRIIAELN-GLTLYAWVTTAYLLTSTVMVPIWGKLGDIYGRKPVLLAGIGIFLAGSWLAGLSggMSGMVQLIVFRALQGIGGGALFTTAFAIIADLYPPRERGKFAGIFGSVFGLASVLGPLIGGYFTDHggWRWVFYVNLPLSLLSLFMILVKMPPLEHRRSGAVDYVGAILLVAAFVPLLLALSLGGHdaQTKASNPLVPLRLFGNRVFATANLAGFLISMAFLGVVTFLPLYM-QLGLGVDATTSGLAILPLMGGLIVASTAAGQMVSKTGrkPLMIVGAVLLMTGVWLLSRVTVHTTlwRMAIVGLGLGPGQSLFNIATQNAVEVrgVATSSNQFFRQIGSTIGVAVFGALLTH-------------------------------
     346 UniRef50_D0MIG8        Major facilitator superfami...   192     3e-47  1  15.0% 20:406   5:436     -------------------ASPERRYTLAGVLLALFLGALDQTIVATALPRIVADLQ-GLDRYAWIVTIYLLTFTVATPIYGKLADLYSRKAIELAAIGIFLGGSFLCGLAglGDGMNQLIVFRALQGLGGGGLFSLAFIIIADLFPPAERGRYQGFVGAVFALASVLGPFIGGVLTDHggWRWVFYVNLPFGLLALGFIWSKMPTLQPPATHRaaHPWDAPETIGLFVLAALLLVLFVRQARRSPSPILDLELFRGRVFTTSVLALLFMGAAFLNIVLFAPLFLI-NVAGVSATVAGLSMVPFSLGVATGSTVSGQLVSRFGHYRRFMLGgvAVGLLTTLTPETPPGLVALYLALCGLGLGPTMPLFPLAIQNAVDVrgQATSAAMLARQIGGVVGTAVMGTVLA--------------------------------
     347 UniRef50_B2IIT2        Major facilitator superfami...   192     3e-47  1  11.0%  6:433  12:431     -----ASLAVDDDALKKAAFRKVIWRMLPILTLGYVFNFLDRTNIGFAALQMNRDIGLSASQFGWGAGILFIGYCGFEVPSNILLYRFGARLWISRILISWGLLSCAMSLVSGPTSFYLM---RFALGVAEAGFFPGVAYFLSAWFPAQYRARILSWFLVAIPVSSVilLLELDGHLGLAGWQWLFIIEGIPAVIIGLVLLKQLADRPQDAAWLTPDEKRVIV-------------ASVESEKRDRVVNRLGLALRDIRVWMCTIVYLGFTVGSYGVQIWLPQILKQQ--NLSNLQIGWISALPYLAASVGMIIWAGFADRSGRKilSTCCFLAVVGFVLAIATRRFDLSLLGLTAALVGVTGARAIFWSIPTRFLtaAAGGIAFINTIGTTGGFFGPTIVGWLKDTTGTFEAGLLAMAGFLAVSTVFALLLK-----
     348 UniRef50_A9IEK2        Putative 4-hydroxybenzoate ...   192     3e-47  1  12.8% 10:438  15:445     ---------NIASVIDSARLSPFQIRTIVFCGCAAVLDGFDTQMIGFLAPSIAENFGLEVGSFAPVFAAGLFGLMVGALLLGPIADKIGRRWLVIAATFTFGLFTFLT---ASASSINEFVILRFLTGLGLGGAMPNLTALATEYSPRRYQGMIVAWLFAGIPIGAIVGGLLSSWLLPFAGWQAAFHVGGVLPMLLALVLVFTLPESLRFLILKQDNPRRVLAIANRIVPSGFPPEQQFSSPQKPVTGIPVRHLFTNGrtLLLWIPYFMNLLIIYFIISWLPAMLRQS--GMPITAGIEAATAFSFGGAIGCLGTGKLLQMFGARKVALIEFVATILFILLLSTYsyWSVMLIAGFLGFTVQGAQAALNALVAGFYPtrSTGIGWALGIGRVGSIIGPLIGGLMLSMHWQTSTIFLATIVPAFLAATAIACMMARRGS
     349 UniRef50_Q829Q8        Putative transmembrane effl...   192     3e-47  1  13.5%  1:414   1:440     MSTPSTPPASTTGPPRADPHPARLGAVLFVIVTAYLMVGVDSTVVNVALPDIQRDLRFSPTGLSWVLNAYTLAFGGLLLLGGRIGDIAGRRRTLTCGVLLFALSSLLGGLAGES---GWLLAARALQGIGAALTAPSTLALITTNFpgPRRHHALGVYTSMASIGASIGLILGGMLTSWASWRWALLINVPIGIGVALALPRFVAETPRHAGRFDAAGALttRALLGFTTAAALLAGFARVESRAGQPIMPLRLFRDRNRAGGYAGVLLLPAGMFGAFYFL-TLFTQQVLGYGPLRAGFAFLPMTLALFATVRFVPRLLQRHGAKPLLLIGTTLLVAAAGWLWRLEptGLLGPLILMGMGVGMSFMPLNATILAGIEPRDAGAASGltLQWLGGTLGLSVLVTVYGTATRHATG------------------------
     350 UniRef50_Q5WI75        Major facilitator (MFS) sup...   192     3e-47  1  11.6% 22:435  10:461     ---------------------RTIIGPLIAVVVGMVMVILDSTIVNVAFPKFQQEFGSTLAVVQWTFTGYTLALSAVIPLAGWMTDKFGAKRIFLTTVALFTLGSVLCGMA---QTIEQLIIFRIVQGIGGGMVTPIGMAVIYRLTPSHKIGEVMGVLGIPILIAPALGPVLSGWLLDYVSWQWIFLINLPIGIIAIALGMKWLPAFPQGEVPKLDTLGMILAPLAFSMLAFGVGEGAVdtELRHRQPLLELRVFKSSDFTRGILLLWLVQIALFGVMVLFPVYL-QTVRGYSPLDTGLIMLAQAVGSILFTPVGGRMYDKVGARPLALIGLTAVSAALFWLSHVSptMLLLPLFMIGSGMGLIMMALNTHVLNSAPRDLVgtSLTTAAQHVITSFAValTGFLasIAAAYSDTFLLTAILAAIGIVLSLTLRKP---
     351 UniRef50_Q1ATX5        Drug resistance transporter...   192     3e-47  1  14.3% 20:410   4:414     -------------------SRRRKILVTLATLIGTFLAALDSTVVGTAMPTVIGDLG-GLGLYPWVFASYLLAATVTGPLFGRLSDAYGRKPVYLAGVSLFLLGSVLCGTAG---SMGALIVYRTIQGLGAGAVQPVAVTIVGDIFELETRARIQGLFGAVWGVSAVVGPAAGGLITDYLSWRWVFYVNVPFGLAAGALLALALRESFERRPGRADYPGVFLLtlALLAGGASALALFVLAEARAPDPIVPLELFRERLFAVASAGNAALGGVLLGVSVYVPLY-VQGALGGTALTAGTVVAPLSIGWPVGSFVGGRMLLRAGYRTTLLVGsaGSAMCLALDAATPLAYVILSVFVIGLGMGFSSTSYLVSVQNAVprRGIATSSVVFFRTIGGSLGVAVMGALLDLSLG----------------------------
     352 UniRef50_A4AB75        Glucarate transporter n=1 T...   192     3e-47  1  12.1%  6:433   1:424     -----MTQSELARGFGRVSRWPKRHVLVGFCFLATFICYIDRVNISVAIIPMAEEFGWSATTKGYVLSSFFVGYLLAMIPTGWLANKYGGKLLLGVALIGWSLFTFLTPIAAGV-SLGALLLTRVLMGMGEAASFPGVYNLLGRWIPKQEKSRAAAVNLTGIPLGTIFALSTTGLLVSAYGWQSVFFVFGASGLLFAVVWLRVVHAKPSVHPTISAEERALLAEL-------------ENSEADDKEPIPWGLFLRHPSIWALFINHFCANWTLYLFLAWLPSYF-RDVQGLSIAGSGLFAIGPWVCQFLAGNLSAVVADrfVRKFMQCGGLIGGAAMLLLAAQASTPGMALFTLCAAFGvsMAWAGFACNHLDVAPKHavLFSITNIGGTLPGIVGVALTGVLVDLTGGYTATFVVAAGINVFGAIVWLLFA-----
     353 UniRef50_A4JKW7        Major facilitator superfami...   192     3e-47  1  15.1% 19:434  63:481     ------------------PASRKRMVILALLFVTVVINYLDRSNLSIAAPALFKELNIDPVRAGLVFSAFGWTYALMQIPGGWLVDKVSPRVLYALALALWSAATLLLGFAG---SFVGLIVLRLAVGALEAPAYPINNRVVTTWFPTRERAGAIGGYTSGQFVGLAFLTPVLAWLQLHLGWHMVFVATGLAGIAWAAIWYALYREPRAFRGINAAELALIRDGGGLVDLEDRIAA---RPERVPSTWRDLGVVLGRRKLWGIYLGQFALNSTLWFFLTWFPTYLVKYR-GMDFIKSGFLASLPFLAAFVGVLCSGVLSDWLMrrKLPIISGLLISTCIIGANYVTSTGWVIAFMTIAFFGNGFASITWSLVSGLAPARLLggGVFNLIGNLSAIATPIVIGLLVDGADFSRAITYIAAMALAGSLSYGLLVGK----
     354 UniRef50_A5W2D7        Major facilitator superfami...   192     3e-47  1  15.0%  3:434   6:440     --AQPGLAREAEAVASSNPFRKYQVITVSLLLVIGIINYVDRSALSIANTSIQRDMGITPSQMGILLSAFSLAYAFSQLPLGVIIDRLGSKISLGAALLGWSVA---QTASGLINSFSAFIGLRVVLGIGEAPMFPSAAKALAEWFEAEKRGTPTGIVLSSTSIGPCLAPPLLTLLMVTWVWRGMFIVTGVFGILVAACWFAFYKSKARYLAELPAE-----AREQLLAAQAHKQAVPSARPSVQAQLVAWAELFRHKSTWGAVLGFMGVIYMLWLHLTWLPGYFERE-HGLSLYQTAWVVSLAYVFGALGTIVAGRICDRlsRKRVVVTALFAAAAFTVPLSFGSGFLlvALLCCALFSVNMASSTAWMIANTVVDSQRVagSIQNFGGYLAGSVAPIVTGFSIQQTGSFASAFLISAAVAAVAAMAYVLLLK----
     355 UniRef50_O05147        Putative 3-(3-hydroxyphenyl...   192     3e-47  1  13.7% 10:432   2:425     ---------DVREAIRTQPMRRYQISTIAICLILSMIDGFEILVMAFVAPHLGKSWDISSVEIGYLLSAGIIGTALGAIFISPLADKIGRRRLAIWCLVGITVGMAL---SACAVNVPQLIAFRAFAGLGIGGLVANLNVLVSEFSSDKRRGTALGIYGVGYPLGGAVGGAISGVLISVFDWRSAFIFGTIITAIMLVVVIKTLPESIEFLIEKRPVGALERYNEIADRLGYEQSSELPVPIRKTERVvgLFKGIMLRRTVFLWLGYSCLIASFYFANTWTPKLLSDATGDSNMGVTAGVLV--NVGGVIGSIIFAGLSIVLRPRVVTVLLMFGGVFAFiaSGFHIVALALTLAVLVGIFANGGITGFYAISPPIYPAAARGtgWMIGCGRTVSIIAPILTGYLLDGGWTPKSVYMMFGGVLVIAGIATLLL------
     356 UniRef50_P71879        Multidrug resistance protei...   191     3e-47  1  13.5% 20:413   1:419     -------------------MNRTQLLTLIATGLGLFMIFLDALIVNVALPDIQRSFAVGEDGLQWVVASYSLGMAVFIMSAATLADLDGRRRWYLIGVSLFTLGSIACGLA---PSIAVLTTARGAQGLGAAAVSVTSLALVSAAFpaKEKARAIGIWTAIASIGTTTGPTLGGLLVDQWGWRSIFYVNLPMGALVLFLTLCYVEESCNERARRFDLSGQLLFIVAVGALVYAVIEgfVWLERRSSNPMMDLTLFRDTSYALAIATICTVFFAVYGMLLLTTQFL-QNVRGYTPSVTGLMILPFSAAVAIVSPLVGHLVGRIGARVPILAGLCMLMLGLLMLIFssSALVLVGLGLCGSGVALCLTPITTVAMTAVPAERAGMASGIMSAqiGSTIGFAVLGSVLAAWLSATL-------------------------
     357 UniRef50_D1YY72        MFS transporter n=1 Tax=Met...   191     3e-47  1  11.8%  7:422   1:442     ------MAEKQAAAVQELPEYKNRYIILAIVLSGVFMGVLDTNVVNVALPTITQAFGVELSQSQWVVTAYLVVNTALLLIFGRLSEYTGKVRLFFAGIGIFTISSLACGLS---TDLNQLILFRIVQGLGASIVFSINTAILVQAFPRKERGRTLGMIGTIVAIGSIAGPILGGFITGTVGWQYIFFINVPVGIVLLAAASKYLKLTEkmLGDLADSVEPDTAMLIYAGIFLVSLAWFVSTELGHRNPIIDLRLFKVRKFTFASLSTLINFTAFSMFILCIP-FLLQYVWGYSPQQVGTMLLAVPLLTGIVAPLSGYTYDKLQSTYHSSFGMLVMALALFLLglSSPVLLLICLGLFGLGTGLFTSPNNTEIMSALPPQKSSTAslATVRNFGNSIGVSLASILLYILLEAAGFTGVVSASL----------------
     358 UniRef50_Q13LS8        Major facilitator superfami...   191     3e-47  1  11.4% 21:431  14:418     --------------------RGRWTIVLPIVFAVYMLSYFDRVNIAMALPHMTKALGLTSVQGGWIGGAFAWGYAFTQLLGGYMSLKFGPRRLVAICLLLFGGAAMLTGVA---TTFWQIVAVRILLGCAEGPIYAATSMLLAQWFTRPERGRAFGIWNLGAPLGGFLAGPISGALIAHFDWRVMLIAEGLPAWIFCLVWFKAIPQSLDLAGWLSAADRDVL----------RRDLATEQAGYTKPEHDPWWTIFNEPAVWLLTIGFGLNTILLYGTTLWLPSVMKSYGQ-LSETTIGFLSGAPFVMSMFGIYYISRRSDRHgrRWHAAIPTMLTGALMVLAAFVPAPLfiALFIALGFTLKMLMPLVFARLTEILPMRKAMPAVAFVSglIGQFLGPLMVGYVRAASSDYKLSLIALGASALLGGVAIAM-------
     359 UniRef50_Q2JDZ4        Major facilitator superfami...   191     4e-47  1  11.1%  5:409   7:447     ----TTWPSEPVLQVAQPAPDPRRWWALAVLLVATFMDLLDNNIVTVAIPNIQQHLGASPTSIQWMNAGYTLAFAVMLITGGRLGDIFGRKRMFLTGVAGFMAAS---GMCAIAQSPEFLVGARVVQGGAAAVMVPQVLAIIHVSFAREEVGKVVSLYAGIVGLAIVAGPLVGGLLLQwlEWRSIFAVNLPVGAVALVAVSAWMRESRSPNARRPDGIGmiVAMVIAVPVFALFLRYEREKVRRDDSPLLALNLFKTGSFSVGVGTQLLFSCVPAGFFITWTVYL-QGGLGWSALHTGLTTIPFSVAvvAGGLAVRYIFPKYGRRCLMVGVAVMTSGVLSYVWTAhaWHAAPSLLLIGSGMGLLVAPLTGMILIDVPPHEAGAASgnATGQLGAAVGVALIGGLFFSQG-----------------------------
     360 UniRef50_B9BJM9        4-hydroxybenzoate transport...   191     4e-47  1  14.2% 16:438  33:459     ---------------DAQPVGRFQWLVLLLCMLIVMLDGLDTVMIGFIAPSISSAWAIPRDALGPVMSGGLLGLAFGALTAGPMSDRFGRKTVMVGAVLFFGIWSVA---SAFATGVASLTVLRFLTGIGLGASMPNAATLMAEYAPPRRRALMVTAVFCGFTFGAAGGGFVSAWLIETWGWHSVLLLGGVLPVAYVPVLARWLPESARYLALKESRRVRLVGVLNRVQPGIADERTRFVSHEPARDARSPVRAILSrgTVMLWICYFAGLLTVYLLGNWLPTLI--RGLGFSLGEAAVVGALFQAGGTVGSVLIGWQMDRFNPHRALGATVLAGGALAWYMGASAHSFAVICVLALGIgmNGSNTGFCALAAGSYPtrATGTSWMLGVGRFGGIAGAMLGAAMLHANWSFGQVFAALAVPAAVGGAAVLlgARHRGT
     361 UniRef50_Q0AXW9        Drug resistance transporter...   191     4e-47  1  12.9% 25:436   7:453     ------------------------WRVLIIICIGIFMSTVDGSILNIANPTIARELSVSMREIQWVVTAYMLVITTSLLFFGKLGDMLGSSKIYSYGFLIFTIGSLLCSLSPSL---AYLVAARVIQAIGASMMMATGIGIVSNTFPPGERGKALGITGSIVGVGNMTGPSLGGILIGNFSWPVIFLINVPIGILAFYLGMRYLPQQAKSLAQKKHDLGGLLLFALSTILLLLSFSGSHGieKRISEAVLDLELFKIKNFTHGNLMAFAAYSAQTSVFFLMP-FFLENLLHYPPAFSGLIMTIPPVTMAITAPLAGALSDRIGNRRITPLSFLFMTSAYLLLStsGLLKIAGSLLLMGVGMGSFGSPNSSSILGSIPREKAggGFMATVRNFSFSLGVAASVSTFAYFLSLyaVYRIAAIISILAFLLSLLEREPA--
     362 UniRef50_A0Y8A9        Probable transport transmem...   191     4e-47  1  11.9%  7:435   1:424     ------MPGSTNQVDTGNSAIPERFKVIGLTILAVFICYIDRVVISLTIIPMGAELGWSQTEKGIILGSFYAAYMLTQIYGGALSDRIGGKTVLGIGLIVWSIFTIVTPYAAAA-GFFILILARLGMGLGEGVTFPAWHSLYARWVPIGERSRAVAATNSAIPIGTVFGLLVTPVIIINLGWQWAFYLYGGIGFVWYYFWKKYVTSSPKDSENISKEELDFIVA--------------NAPASESGETLPVKKWIRNKPLWAIIVAHFCNNYSLFVFLSWLPTF-INEKLGIQLAAIGFIAMIPQLVSFAAGNFGGYFADRFarRLFNSIGFGGLAFCLCLVPEFNSTFAVIGLLCVGNVFGGFIAGGFIINHADIGPKYTgmGITNTFAAIPGLVGGILTGVILDVTNSWDMVFYVTAGVTFFGGLFYLLFAST---
     363 UniRef50_Q13G64        Major facilitator superfami...   191     4e-47  1  12.0% 10:435  14:437     ---------ATTDGIRERTYRKVTRRLIPFLFLCYVLSMLDRINIGFAQLQMKHDLALGDATYGLAAGAFFIGYLLFEIPSNVILQKIGARKTISRIMLCWGFASAAMMF---VRTPVEFVCLRFLLGAFEAGFMPGVFLYLTYWYPPRRQGRVIGAYMTAAVVAGLIAGPLsaSVLGLHGWQWLFVCEGIPSVAVGILAFFYLTDRPADASWLTDEEKALVEGDIALISSTWDRPVEAG----------WYDVFRQPKVLILGFCSFAAQAGSYVIFFWMPQIMKSTSH-AGVSLIGLYSMLPYAAAIVTMTFWAAHSDRKMERRWHFALAVLTSTAGFLMVIANPGSLilALTVAAAAVMAAFPVFWAVVAVALPPtaAGLALISSLGSLGGAFSPALIGFVRESTGRIDAGLYIVMALMVIGSLAMLAVIPR---
     364 UniRef50_B7UQL4        Predicted hexuronate transp...   191     4e-47  1  11.0% 19:437   3:415     ------------------KIKNYRWHMIALVCFITVINYLDRTALGIAAPTIMETTGITKEQYSWIVSAFQLAYTLGQPIMGFFIDTVGLKLSFAICAAIWGLATMGHALTG---TWSGLAFMRALMGFSEASAIPAGVKTASTWFPAKERGVATGVFNMGTSLGAMLAPPLIAWCIMFHSWQFAFIVSGSLALLAALFWFFCYKDPKDAKRLSDEE------------RHYIESGQEQHLKTDKKEKTSIKHILSQRNFWGIGIARFLADPAWGTINFWVPIFFVET-LHFSLKEIAMFVWLPFLLGDLGCLASGFVAKFfsRRITFTIAAVIMMTIGLVSIVENPYIAVLLISIGAFSHQCLSTVAATLGGDLFKKDEVATAVGmaCAWSGQLIFNLFIGAFVHIIG-FAPFFIALAFFDIIGAIALWMLIKVKD-
     365 UniRef50_D2QSD2        Major facilitator superfami...   191     5e-47  1  13.8% 20:431   5:411     -------------------PTSYRWQMTALLFVATTINYLDRQVISLLKPTLEKVFVWTETDYSHVVMAFQGAYALSFIGFGWAIDRIGAKIGYTLSVFVWSIGAMLHAVASSTFGFG---VFRALLGLGEGGNFPASIKTVTEWFPQKDRAFATGIFNSGTNIGAVVAPLMVPWILGQYGWQAAFLATGAIGFIWLIFWWMYYEKPSLHKK---------------ISPEELDYVSEAVPTNVAEPALKWLDLLNRRQTWAFILGKLLTDPVWWFFLFWLPSFLASTFQ-INLTKPSLPLILIYSSATIGSVGGGYISGYfaRKASMLVFALCIVPIMAIQFASELWQVIALLGLAVAAHQAWSANLFTLVSDLFPRKasVVGIGGMAGSIGGLLFPLLVGSLLdaAGSIATGYNILFVLCGSAYLIALL-------
     366 UniRef50_C8NPR9        EmrB/QacA family drug resis...   191     5e-47  1  13.6% 21:358  17:374     --------------------ARGRRILLYTCCLSVFIVSMDGYAVSVALPDIGESLGADVSQLQWVISAYALSTAGFLILAGSVADRVGRRRVFQFGLSLFTLGSLL---SSLAPTVEILITARVLQGLGGSMLNPVALSIISNTfdAGARARALGIWSSVIGISMALGPPIGGLLVDLVSWRAVFWLNIPIAVAAIILAARFIPESRAATHRRLDPPGQVLMILFlfLVAATAIMSFIWWENRATEPLLAPAFFRSRTFSVAVISAVLAFISTTGILFSITLFLQNTR-GLTPMQAGLMLLPLAVMVAVSSPVSGRLVAAYGPAPSLMIAGSVMATGGLLLTFLGQDTPLWYLGLAS--------------------------------------------------------------------------------
     367 UniRef50_B5GUC1        Integral membrane efflux pr...   191     5e-47  1  12.9% 20:414   5:424     -------------------RHPRRWLILVVLCLSTLVLVIDNMVLTVAIPSIAEDLGATSQDIQWIIDSYILVFAGLLLTAGSLSDKYGRRKVMVVGLVVFGAASVV---ATCATSPEQLILGRVLMGVGGALVMPSTLSILITVFDEEERPKAIAAWSTVAMVGLVGGPVLGGALLDRFDWGAVFLINVPIALLAIVAALVLMPEspVGMVLSMAGMTALVWTIilAITLLGLIGFGVWETRGTDSPMVPLSLFRNRTFTGASLSLVLLTFANGGLMLVLTQYL-QFVLGYTPTETGLAFTPMALAVIVFNAVGASLLARTGNRALAVIGLLVIAGGFALLASLSagLLATAMVLLGAGSGLAMPAAISALMGAVPTEHAGVGSAltIQQAGAALGVAILGAVLSSTYTDGMA------------------------
     368 UniRef50_D1S758        Drug resistance transporter...   191     5e-47  1  13.3% 11:431   2:449     ----------AVAADEPRSPVRRRWWALTLLCFVQFMLVVDDTVVNVALPSIREDLGYSATGLAWVVNGYLLAFGGLILLGGRAGDLVGHRRVFLAGVAVFAVASLACGVA---QEPWQLVAARFLQGVGGALASPTALALITLIfeGAERAKAIGLWGGIAALGGIVGYVLSGLLTDLVSWRLVFLINLPVAVVVLALVPALVPPAATAARQRVDIPGAVTATVGLAALVFALLEAPGaqERRVAYPLVPLRFFANRTRSAANGTMMLFTTGLFAMFFLL-TLHVQERLGWSPLQTGLAYVPMAVCLLIGISLSQRLVGRLGPRPVLLVGPLLTAAGLLYLSWIDgpDILPGMVLVALGAGLAVPVLATAAMSATTAEDAGLGSGmvAQQIGGAVGLALLVSLAGLRSRQMVSDGAGEDAAAIGGTVLAF-------
     369 UniRef50_B1EIR9        4-hydroxybenzoate transport...   191     5e-47  1  12.0% 10:434   8:435     ---------DISTILDTYPISHRQWLIVFLGFLVLGIDGFDVTAIGFIAPAIVDDWQISRHMLGPVMMSGLLGLAGGSLISGPLADRYGRRKIIIASVIFFGICSLL---SAWSWDLYSLTFFRFITGLGLGTAMPNITTLVAEYAPGKYRSRLSTVIHCGFNTGAALGGLLSQQLLETSSWRSVLIIGGILPLLLALILLRYLPESMLFLVQSPQNKNKLMRLLNKFIPGIANEhsFFTTEPEKNHANTAKSLLSSPYTLglWLTLFGGLFCVYLLSGWLPLMIKDA--GLTLSQAVIIGSVFQVGGMMGNFCIGIEMDRWGQHCAIILTLLGGACCALILGLYTPSMPLLCVMVLLLgiNGISPDCYALAAHFYPtrATGVSWATGVGRLGAITSEGVGSAMLAAGWTFNEVFMFLPLPLLIGTLALYCKKR----
     370 UniRef50_Q01VP2        Major facilitator superfami...   191     5e-47  1  13.8% 17:435   2:396     ----------------ETAAHRMRWSIAILVSAAIAVSYFDRQTLPVAIAAIQRDIPVSNTQFSYLQGAFLLAYAGMYAGGGKLIDVLGTRRGFLWIMIWWSLACASHGLAA---SFGMLAASRFLLGMGEGGGFPAATKAVSEWFPAHERSTAMGIINAGSAVGAVMAPPGIAFVIATWNWRWVFLLSGAVGMLWTLWWSRTYFVPPR------------------------------AAQTEASSDISWSRLFTYRQVWGLVTAKFLSDAAWYFYIFWLPKYLYDVR-GFDTKQVGYFAWIPYAASGVGSLCGGWFSSHLLrrKIALGASAGLMPLIFFVTQAPVQVAILLFSIAFFGQQSWSTLVMILPADLFPHEVVgaGLVGFGGAMGGFVFGLVVGYLLDHGFGYGTVFPMVSTMHVIAFGVILLTVRK---
     371 UniRef50_A4JDS9        Major facilitator superfami...   190     6e-47  1  13.6%  7:381   1:368     ------MNENHAVPAAPPGIRRGQRIALALLMVSGIVNYLDRGTLAVASSAIRADLGLSLSQMGLLLSAFSWSYALCQFPVGGLVDRIGPRRLLGVGLIVWSIAQAA---GGMVSTFGWFIVARIVLGIGEAPQFPSAARVVSNWFPLRARGTPTGIFNAASPLGTALAPLLLSVLVASFDWRLAFVATGALGLVVAVVWFALYRDPAR-------------AQLSVAERGYLDADAQTAAAAPKLTFADWRSLFSHGTTWGMLIGFFGSVYLNWVYLTWLPGYLTMERH-MSLIRTGFAASVPFLCGFVGSLVAGWLSDFVTRraVVVAMLGMVAFTIPAALVQSNTVALACISVVIFLANAASACSWALATAAEPRRIA---------------------------------------------------------
     372 UniRef50_C7QG01        Drug resistance transporter...   190     6e-47  1  12.9%  2:403   3:430     -TTSSGSASPSEPEPDTAPALHRPGVTLLATCLALFLGQVDTTAVNLALPAIRHDLSGGISGLQWVVDAYNVTFAALLLTGGTLGDRFGRRRLFRTGVAVFVLGSTVC---ALAPGLPVLLAGRVTQGVGSGMMLPQSLAILATAFprRERNKAMAAWSIVAGSGLAVGPTLGGLAVQTLGWQSIFWVNVPIGIAALVLTLRHVPESRNPRARTLDPLGQVLAIASLGLLTFVapAAFVAVERRRSDPMLPLDLLRRGQLPVAVIVAACMTFGMYGL-FLLTSLMFQQERGASALGAGVAMLPLAVAATVLSPLTGRLVTRYGPRLPMTAGMTAMGTGVLIFAVAGADANliAFTVIGIGLALNTGPVVGVAVSAVASELAGLASgnLARMFGATLGVAVQGS-----------------------------------
     373 UniRef50_C6Q2H1        Major facilitator superfami...   190     6e-47  1  12.9% 13:438  41:467     ------------ARMESVPFSRWHIKSRVIVGTASFFDGYGALSLAYALPVLISLWHLNTAQSGMLIAAGYLGQAVGAIIFGVIAERFGRVFGIKASMFMMSVMGIACMFAG---NYTALFILRFLQGIGLGGEVPVAATYINELSAAHGRGKFFMIFEIIFPVSLMLTAQLGAVIVPSLGWKWLFLLGGVVGLILLPL-FFMLRESPRWlkGKFDEAERIIEELEASTDKRLPVNMDAKKPTVKANWKEIFSPFYRFRTLIVWVLWFSAYFISNGLNNWLPSLYK-TVYKLPLKESLYAASVTNVLQVVMVLACAFLIDKVGRKRWATFAFIVAGCLLLVLFLTGAKSamYLGSSAYGVIGSITVLLYLYTPEIYPTRMRAIGTAFATtrLASAIGPMIIGIVLDAKG-ISYVFVGFAVICVIGSVVATRMIETSGK
     374 UniRef50_B8FQN6        Major facilitator superfami...   190     6e-47  1  13.3% 10:438   5:437     ---------SISEVMDSFGVNKFTWSIFFFLGLAMVFDGYDYMIVSYTMPQISAEWGLSAVEKGSLSSWSLFGLIIGGAISGIVSDKIGRKRTLVYSIAIY---SLLNIPIFFAPSFGFYALFRVLAGLGLGACIPVVTTIFSESTPTNRRALFITFGMAWMIVGWVLAGLVATYLVPRVGWRWCYLVGG-FPFIYSIFLHFKMKESVYWLANKGRNEDAVKRlaTGKVTNWDPNALVVPPKSKVVGPKALFSKTYRMTTAGVWITYFCGCFTVYGINAWLPSLMLE--KGLQLSSAYGLSIAQNAAAVIANCSTGFVAEVIGRRKNLIGSYGLGIVAILIMAFvsFWAILAANIFLGFAINYSITAVQPLMAEGYPTDIrgVSWCQAFGRLGGALAPIVAGMIIGLNLGYSSAFLFYVVPLLFGLLAAFLLIRNETK
     375 UniRef50_B7KHY2        Drug resistance transporter...   190     6e-47  1  11.7%  6:407   2:429     -----TNPSNFSDSISPNPSPNDKWWAMLGIGVGVFMLTIDTSIVNIALPTLVKVFKTNFATVQLVVVSYLLVLTALVLGAARLGDMLGKKKLYLIGIIIFTISSLLCGLA---PSIWLLIIFRIIQGFGAVFMSGLGPAIITEVFPRSERGRALGIIGAVVSIGIAIGPSIGGLLIGVSGWRTIFLVNVPIGIIATFIVIKFVPFSprQRFDWLGTVVITLTllTLFLMTVISLIAFVVIENKLRQPMLDLSILKNGRLSLSLIAAVIVFIVVGGFVFILP-FFLELVLNYTPQQTGLLLAVSPILGGIVAPFSGSLSDRFGQRIISLIGLLLMIVGCLLVSRFNAQLtiLYIAPFGIGFGMFQSPNNSAILGSVSRERLGITSGllSRTLGQTTGVPLLGSIFDS-------------------------------
     376 UniRef50_D0L5Z8        Drug resistance transporter...   190     7e-47  1  13.2% 23:422   8:434     ----------------------NRWWALAALCFAELLVMVDNTIVNVALPTMARDLDAGISGLQWIVDAYTLVFAGLLLTGGYLGDRFGHRRMLITGIVGFTAVSVL---AAGSQGLGQLIAARGALGMFAALVFPATLAIVTTVFtpRERAAAVGVWAATSGVAVAVGPVLGGWLLEHFSWTSVFWVNVPLGVIALAAILLVVPGTRPETVSRFDLPGLALSVAGLGLlaVAILGVFARRQLSIDHPILDVRLFANRRFATAAGMISVAFFALFGFIFLITQFF-QGVKGYGPLEAGLRTLPFAIVMAVLSPVAMALSHRFGPRLVAVFGAFVMSAGFGLVEIAswELIIWSMSLMAVGLAFISGPCTQMIMDSSRPEQAGAGSAvtTREVGGTLGVAVLGSVLTSAYLAGVGDRLSGLGL----------------
     377 UniRef50_D2QF74        Drug resistance transporter...   190     7e-47  1  14.2% 32:404   1:399     -------------------------------MFGTFMSTLDSSIVNIALPTIRRELNAGDS-VEWIVLCYLLTTTSTLLIMGKLSDWIGRRQMYITGFFVFVLGSLLCGLA---WSLWSLVGFRVVQGLGAAMIYSIGPAIISDAFSSKERGQAMGLMGSVVAAGSSAGPVIGGLLLGKFGWSSIFFVNVPIGLLAIWRAWTILPESPKVTGQRFDLVGAGLFLVGVTTLLTAIEFGPEPreMRVKEPMLRLSLFRIRPFTMAILAAFCGFLASGGNLFVIP-FFLQQLLKLNPERAGLVLLAGPLTLSVVAPLGGYLSSRVSTRWLSSFGLLITATGYFAFSFLDTSwvVWRSSLVSLGFGLFQSPNSSSALNAAPLDQRGIAsiAFMRNLGFVVGIALAAAV----------------------------------
     378 UniRef50_A9VKL9        Drug resistance transporter...   190     7e-47  1  12.6% 24:405   2:410     -----------------------RKKVMMSLMLMTFLSAVEGTIVSTAIPRITSDLS-GVELVSWVYAIYMLATAVSTPIYGKLADLFGRKKVLLIGATIFLIGSALCG---VVTSMEQLIFFRALQGIGAGAVMPITMTIIGDLYsaKDRAKAQGWMSAVWGVSGVIGPLVGGFLVDSLSWRYIFFLNVPFGIIACLMFATSYKESVkaAKQHIDYLGATVFSLSTIALLYALLTGSSKqeKKSPEPLIPLALFSNRTLSTINILTLIAGAMIISITVYLPIW-SQGVLGKNATEAGLILMPIPVMWTFGAIFSGNLVGKLQTKQIILLGASILSVATFLLFtsPSFLIYVAVGLFGLGMGLVTPIYMVTIQAAVPANTRGTAVGlfINTFSQTLGAAIFGTIF---------------------------------
     379 UniRef50_C7Q679        Drug resistance transporter...   190     8e-47  1  13.0%  1:414  16:460     MSTTtpAGTGAGAETGTPALNPRRWAALVLIAVAQLMIVLDGTIVNIALPTMQRNLHISDVNKQWVITAYALAFGSMLLLGGRVADYTGRKRAFVIGLLG---FAAASALGGAATNEAMLFGARAVQGVFGALMAPAALSLLTVTFTEeeRARAFGVYGAIAGGGTAIGLIMGGVLTEYASWRWTLLVNVPIAVVAAFFASRVLTESKAAGNTKYDIPGALTSTAGLAALVYGFNKANTDgeLRTSHPLLPMRVILDRNRGGSFLSSLLMGVGMFGVFIFL-TYYLQQILGYSALKSGFAFLPFTFGVIAGAGVATRFLPRIGPRVLMAVGFGLATLGMVLFTGIGVDtvVPAELVMSFGIGLFFVPLSSTSLIGVADHDAGVAsvNTTQQIGGALGTAMLVTFATTATTNYLG------------------------
     380 UniRef50_C7NFY0        Drug resistance transporter...   190     8e-47  1  16.1% 18:397   2:411     -----------------TPPPVRPWPALWALCLGFFMVLVDSTIVSIATPALMREFDASVSHVVWVTSAYLLAYAVPLLVTGRLGDRLGPKRLYLAGLGVFTAASAWCGLA---DSIEALIAARVLQGLGAAMLSPQTMAVITRLFPGNQRGRAMAAWGATAGAATLVGPLMGGVLLDSAGWEWIFFVNVPVGILAMVLAARLVPALGTRAHSMDWWGVALSAVGMFLLVFgvLTVFVVWQACNTREPLVPLRLFTHRNFSLANVAITTVGFATIATAFPFILYL-QSVRGMTPTEAALVMAPSSVMTLLLARWAGGLVDRVHPRTLASIGMVGLALTYLFVAltPLPVLLVPWFMLGITSSFVWSPLSVSATRTLPPHAIGAGSgnTTRQVGSVLG-----------------------------------------
     381 UniRef50_A4TM16        Sugar transporter n=57 Tax=...   190     8e-47  1  12.1% 15:434   1:415     --------------MDSKIPNARWFRVIVPIMIACIISFMDRVNISFALPgmESDLAITSQMAGLAGGIFFIGYLFLQVPGGRIAVHGSGRKFIAYSLAVWAIVSILTGFVTHH---YQLLFLRFVLGVSEGGMLPVVLTMVSNWFPEREIGRANAFVMMFAPIGGMFTAPLSGFIINTLDWRWLFFLEGGLSALVLVMWWFVISDRPEEAKWLSARERDYLVT-------ELSRERAERMFNKPVTNAPLKAVFLNKGLMKLVALNFFYQTGDYGYTLWLPTILKNLTGG-NMASVGILAVLPFVATTAGIYVISALADKTGKRRLLilFCFAAALVASVIFRHNVLVSYLALVVCGFFLKAATSPFWSIPGRIAVPEVAGGagINGLGNLGGFCGPYLVGVMIFFYGQSAAVCMLAGSLIIAGLITLTLPKE----
     382 UniRef50_O34456        Hexuronate transporter n=4 ...   190     8e-47  1  14.2% 27:435   9:406     --------------------------VILFLFLAGVINYLDRSALSIAAPFIQDDLTLSATQMGLIFSSFSIGYAIFNFLGGVASDRYGAKLTLFVAMVVWSLFS---GAVALAFGFVSLLIIRILFGMGEGPLSATINKMVNNWFPPTQRASVIGVTNSGTPLGGAISGPIVGMIAVAFSWKVSFVLIMIIGLIWAVLWFKFVKEKPQET---------------------IKEAPAIKAETSPGEKIPLTFYLKQKTVLFTAFAFFAYNYILFFFLTWFPSYLVDER-GLSVESMSVITVIPWILGFIGLAAGGFVSDyfSRKVVLVTCLFSSAVLifAGLVATTAGAVTLVALSVFFLYLTGAIYWAVIQDVVDQngSVGGFMHFLANTAGIIGPALTGFIVDQTGTFSGAFLLAGGLAVFASLAVIRFVRP---
     383 UniRef50_C7PZI4        Drug resistance transporter...   190     9e-47  1  11.9% 12:405   8:432     -----------AAPPDDGPADPNRWRALTVCLVAGFMTLLDVSIVNVGLPQMEAGLRASPADVSWVRAGYTLTFGLVLVPSGKLGDALGRKRVFLLGLFLFTGVSLMCALSPTAQ---WLVVARLLQGVAGGLLNPQIIAMIQQLFRGSERGKAFGLYGGTVAVATAIGPLAGGLLIEAGGWRWMFLINLPIGVVGLVLGVLLVPkpPRRRGRGMDLVGVALLGGGITSIMLPLIewERWWKGRGLDPLVNLSLLRTPSFGASSLVGLAYFAGYPGVLFILSLYLQQGRA-YSALAAGATSMPFAVGSAISAAVSGRAVYRIGRVLVVAGLVAVLAGLIPAAVIIQHDtlFLPLLVAGLGSGLVIGPNQTLALQFVPPASSGTAAAmtGQRIGMSVGTAMAATMF---------------------------------
     384 UniRef50_A9AR81        Major facilitator superfami...   190     9e-47  1  14.4% 17:433  18:443     ----------------SRTIGRVRYAVLALIFAVTVVNYADRATMSIAGTGVARDLGLTPVQLGIVFSAFAWAYAIGQIPGGWLLDRYGARRVYGLSLLLWSVFTMLQGTVGWLgaTLALFAMRFMLGLVESPAFPANSRIVACWFPTAERGTASALFNSAQYMAVVLFTPAMAWLTHALGWTHVFLWMGMLGIALAALWFAWYREPHSHPRVSDAERDYLRAHGALVDL-----EANRVRHRARVSWRAASQLFRHRNLWAIYIGQYCITALTYFFITWFPIYLIKGR-GMTIMEAGWVAALPAICGFTGGVLGGVLSDWLIRRGvfVAGMAMATLLVLANGASSNTVVIALMTIAFFGKGLA-AVGWAVLADTAPAGMVGLSGgnGLGNIAGIVTPLVIGYFVAHTGSFAGALWFVAAHGLIGIAAYAWLA-----
     385 UniRef50_B9BG87        4-hydroxybenzoate transport...   190     9e-47  1  12.8%  3:431   2:431     --STPSASLQVHEVIDNRPLSRLQFYAISLCMLTAVLDGFDTQVIGMLAPVISHGLAVPVKQFGPIFSAGLVGMLVGALTLGPLADRYGRRTMIVLSSAIFGALSFAT---AYVQTYDQLLVLRFITGIGLGGALPNAISLASEYAPRRHSRTVVSTLMCGMPLGAVLGGIISATLIPIHGWQSVFLVGGALPLVVAFLSVLLMPESPRFLVLRGGKQRQLGEIVRRIApdPETVRYTPTEEAIRVPLRDLFARGHAAQTFLLWVPYFMNLVVLYFIVSWMPAVLADAQH--SVSAAIRAVALFSLGGVAGCLLQGPAMNRFGMRKVLITELVVYMVLAAALaaSSVDIVVVVSILMGVATQGVQAGLNALAAEIYPIHMRATGVgvGIGRIGSISGPLLGGLLLQMHWNVSEVFLAGIVPAVIATAAIAL-------
     386 UniRef50_Q0RXT7        Permease n=1 Tax=Rhodococcu...   190     1e-46  1   9.2%  2:436  29:465     -TMTAPPRTGSPEATAHSAYRKIFRRIVPVIMLMYLLAWLDRVNIGFAALTMNKDIGLSDTAFGLGAALFFVGYFIFEVPSNVIMEKVGARMWLARIMITWGLVSAATAFVVGEVSF---YAVRILLGITEAGFFPGVLLYLTFWVPRALRGRITALFLMAAPLATAIGAPIASLILAHlgWQVLFLAFGLPTALVGVAVFWLLPSKPADAKWLTADEKAFL----------HHQLALEQADTDKDAGHSTFSALKSPKVLALAFVFFGIASGSYLLNFFLPQVVatYGISLSVTQIGLISAIPFLCAALVMYFAARRSDRTQKRVVYVSGGTVIGAVALAlfVGNPVLAIVLLSVTASCVYIALPLFWQLPPRFLtsAAAGIALINSVGNLSGFVWPYATGALKATTGTFTVAFVLVAATMFIAAVAVIALDRSR--
     387 UniRef50_Q6FBB3        Putative benzoate transport...   190     1e-46  1  15.0%  5:438   2:436     ----STMSLNINDLLNQAKFSKFHLSVVFWCTLINICDGYDLVIYGVVLPRLMEQWSLTSVQAGMLASTAMCGMLVGALSCGILADKFGRKRVLLLCVFFLSTFTLLGSFAS---TPTEFAILRFLAGLGIGGAMPNVVALTSEYSPKKSRVTMVSIMSCGYAVGAIISALVGSILVERFGWQIMF-ILAGIPLLFIPIIWKYLPESLVFNVKKNNTEKAHALIatVLVSQHTKLVLNESLEKAYGSRRVLFQEGRAAGTLKFWIAFFMCLLVVYALSSWLPKLMYNA--GYPLGKSILFLLAMNVGGIIGGTTSGMLADKFKIKPVVISLFCIAALSLIALGftSAIILYTLVAVAGASIQGASILLYSYVAQFYpaNSTGIGWASAIGRTGAIMGPILAGMLLVLNLPHLMNFVLISVPALIAAISIGFLTTSKKK
     388 UniRef50_P37514        Putative metabolite transpo...   190     1e-46  1  11.8%  5:438  10:449     ----THPFSNAANRLDRLPISRVHFQVLTALGIVYFFDLADLFTLSNVAPALIEHWGIPLSTIANVTAASFLGMFLGASLGGRLSDRIGRKKALNLFVFVFSIASLCN---AAAWDIPSLMTFRFLTGFGVAAAMVITNSYLAEFFPSSVRGKYISFCAMIGLIGVPITNIVSAFVIPLGSWGwlVFVWGAVGLIYFFFIHRLEESPRWHENRGEYAKADAILTRIEEQVEKEKGPLPAASQPKVSEtaGYAGLLKGRntIVLSAVWIFETFGFYGFASWVPSLLKSN--GVTMENTLWYNVLHSVGAPLGALLGSMISERFQRKWILAASAFLTAIAGLLYGMTFIPIMIIVffIVNITERVFTSNLYAYTSEPYPTEYRSSGSGLalGRFSNIFGSLLVGFIAVQLGYISVFLFIGGCWLACSLLLIFFGPNTNAK
     389 UniRef50_B2TEE6        Major facilitator superfami...   190     1e-46  1  10.7%  3:432   7:434     --SDATTSGGNTSVGVERTYRKIFFRLIPLLFLCYVISYIDRVNISFAKLQFMHDLGFSESTYGLGAGLFFIGYVLFEVPSNLWMQRIGARRTLLRIMFAWGLVSSLMMF---VRTPMQFYAMRFLLGVTEAGFFPGIIFYLSCWFPGARRARVTAFLMMATAVAGIVGGPMSGFIMTRlgWQWLFLLEGVPAVTLGIVAFLLLGDKPDDVSWLDEHEKALVS----------RELAADEKAKQTGHLDGLRGALANPRVYLAALVYFAVMMPFNAIGFWAPTI-IRDLGVANVLDVGLLSALVFIAAALGTYVVGASSDRTMERRWHVAVSACVTALAFALLPanVTLGVGLLALAAAASYGSFVVFWTIPQTFLPraAGGIAMITSLGGTGGFVSPAFVGWVKTQTGSAQYGLIGLAVVLLAGVVLMLVV------
     390 UniRef50_C1E3Q4        Major facilitator superfami...   190     1e-46  1  13.0%  8:438 164:597     -------PSSLDDLGERWRSMPSRYRILLGTCCAFVLCNMDKVNISVAIIPMAKDMGWSVGTAGLLQSAFFYGFALSQLPGGYLATKFGGARMLPIGVFIWSAATMAVPFVAGDTT--ALFISRVLVGLGEGISPAAATDVIARSVPLRERSRAVAFVFNGFNIGSVLGLSAAPLIIEAFGWRTVFEVFGALGVLWVMSVGFGI-----YARGGATPGTPAGASGDLAPVEGLTGQRKLEPGAEERDGVPWGQIFGATPLRALAYVHFCNNWGFYVLLAWLPSYFTQE-LGVNLTNASLFTLLPPLGSGLVASAVGPLAdrVRKTAQAIAFLGPASAMTAAAAIDDPTLTVGLLTVGLSLASFSYAGLYCNHQDMSPRYSSilGITNTVGALPGVIGVPLTGYLLEMTDNWELSMFVPAVFFYVTGVGVFTKWGRAEK
     391 UniRef50_Q0B5E9        Major facilitator superfami...   189     1e-46  1  13.8% 18:437   2:412     -----------------PTDHRQRRHTLWLLCALSFILYVDRVNLATAAGAIKAELGLSNTELGIAFSAFAYSYAICQIGGGWIADRFGARITLIGCGLIWVASTFMTGL---VHSLALLFAARLLLGIGEGATLPAQARAITHWFSRERRGVVQGFTHSFSRLGNAVTPPIVAALMTWLSWRAAFFVIGAVTMVWLVWWVVGFREYPRGESDGNGVGRTHTAATARRAAP--------------SGPTPWGPLF--RRMAPTIFVYFCYGWTAWLFFTWLPTFFL-NGQGLNLKSTALFASGVFFAGVVGDTLGGWLCDRisRQSVIVTSFTGALVCLLPLAFVHSTaiALCLSGSFLCLELTIGPIWAVPSDIAPQHAGIASGMMNAGsiAGILSPILFGYLVDRTGSWTVPFVGSVAMLLIGIVAALRIRPDRA-
     392 UniRef50_Q1BU78        Drug resistance transporter...   189     1e-46  1  15.3%  1:411  63:498     LSRATAPAVMFQRPPAAAPGEKNLTVMLWLVATGFFMQTLDATIVNTALPSMAASLGESPLRMQSVVIAYSLTMAVMIPVSGWLADTFGTRRVFFSAILVFSLGSLLC---ANAHTLTQLVAFRVVQGVGGAMLLPVGRLAVLRTFPAERYLPALSFVAIPGLIGPLIGPTLGGWLVKIASWHWIFLINVPVGVAGCIATFYSMPDSRNPAAGRFDLKGYLlaVLVLLILSLACFVAYGLYAVRAPQPIFSLELFKIHTFSVGLLGNLFARIGS-GAMPYLIPLLLQVSLGYSAFEAGLMMLPVAAAGMFSKRIITRLITQHGYRKVLLANTIMVGVMMASFAlvPVWVKVVHLALFGGFNSMQFTAMNTLTLKDLGtaSSGNSLFSLVQMLSMSLGVTVAGALLATFTGM---------------------------
     393 UniRef50_C3JMK8        Major facilitator superfami...   189     1e-46  1   9.9% 13:437   2:464     ------------TAPITPKNTAVRRATLLAVCVSTAMLMLDIAVVNTALPSIASDLDTGVSALQWVIDAYTLALATVVLSAGSWADRRGRRHVFVIGILWFTTASL---FCALAPNIWVLDLARAAQGIGGAVLFACSLALLADVFEKgqRATALAAYGATIGGAFAVGPLVGGLLTELLDWRAIFLINVPIGLITLAMTVRWVPESRDPRPRRADVPGQILVSTGLAALVFGLLrgFSLHELRTTEPMLPPHLLANRAFAGAQIAAFSISASLFAVFVYTTIYL-QNVLHLSPVDAGLVYLPATIAMFVVAGATAKLDGRIPVSVSLTCSLLLVSVGLVMMTVvsPYAILPGFVVACVGAGVFNPVMSGLVLGESTSNHSGLAAGiaFRQTGIAVGVAVLGAFLPavGGLRLALFVAAFIAALGALVCAATLRTTS-
     394 UniRef50_A8L0G2        Drug resistance transporter...   189     1e-46  1  11.8% 11:408  40:464     ----------AATEINATEVDPALRRLALTVTLGAIMAILDTTIVAVAINTLGRDFDASLSTISWVSTGYLLALAVVIPLTGWSVERFGATRMWNISLVLFLAGSALCGAA---WSAGSLIVFRVLQGLGGGMIMPICMTLLASAAGPQRIGRVMNIVGVPALVAPILGPVIGGLLVDNLDWRWIFFVNLPIGAVALVASWRVLpdDRGQSHHRLDVPGLLLISPGLAALVYGLSeaFVVHALRREGALLDLRLFGDRTFTVAGVTTFMVGAGLFGGMFLLPLYF-QVARGQSALAAGLSLVPQGVGAMIGMPIAGRIADRRGAGYVVPVGMAVCLLGTVAfaHTNTVALGALLFVRGLGFGASMMPAMSAAYVTLRPAarATTTLNILQRVGGSIATALLAVELQHG------------------------------
     395 UniRef50_Q9Z9P3        YhcA n=3 Tax=Bacillus RepID...   189     1e-46  1  11.2% 22:406   6:416     ---------------------PKKWMVVCAVLFGSFTMILNNSMLNPAIPQLMNVFEADAVATGWVITIFMVAMGMTMPLTGYLGDKIGKKEAYILGLGIFVLGSLL---GALSWNLPSLIVFRGLQGIGGGVMMPLSMTLIFDAFPRNERGLATGVWGVASMMAPTIGPTLGGFIVETSNWKYLFLVNIPFGLLGIIAAVIYLplDRWGFLFVTAGVGSILLAFGRMSDLTHLTEwfVQVEKRAEQPLLDLSLFRIPAYSLSIWVAGISSIGLFAGIFLVPLLLQQ-VYDYGPIMTGLVFLPSALFTGLTMSIGGRMLDKRGPSGIMTAGMMIAAVGTFALGytGLWYIFAWMAIRGVGMGLTTMPATTTGMNAIPEgsRGSAMNNVLRQMSSAFGIVFISVFFE--------------------------------
     396 UniRef50_A5KS25        Major facilitator superfami...   189     2e-46  1  11.1% 20:433   1:439     -------------------MNRRLFFVLLTTIIGSGIVLLDGSVVNLALPALSKELGADFADLQWIADGYLLSLSALILLGGSLGDIFGRKKMYLIGLVGFGITSVLXGF---VQTTESLIAMRVLQGIFGALLVPGGLAIINTNFRAEERGIAIGQWAAWSGIATAIGPFLGGYLIDNFSWRAIFFINIPLVIICFLLGLPHIKESKDENPRKVDYWGaaLGTTLALVLGFICLGLFITTEYRERDPMMNLRLFTSRNFTGANITTFAMYGALSGFFFALIIYLQTTV-GYSSMAAGLSILPVTLLLLLFSGRMGKLTSTYGPRIFMTLGPILGGIGMLTLLGLGHNavLPGITLFGVGLVFTVAPLTVTVMTSVSDNQSGIASgnAISRAAGLIVIALLGLFGASQSYQFTVMLCSALAIIAGIASWLLIK-----
     397 UniRef50_UPI0001B514C8 major facilitator superfami...   189     2e-46  1  11.5% 19:437   2:450     ------------------PSERHSWAPLLAVCAGYFMVILDVTVINVAVPVIGRELSASLTGIQWITDGYTLVFAGFLLTGGALGDRLGNRRVFCAGVVVFTVSSAACALAPDAP---FLVVARLVEGLGAALIVPGSLALIQQAYPEraRSRAFGLWGSMAGIAASAGPLLGGLLVSTVGWRWVFLINLPVGAACLALTLRHVAPSPRRADRALDWPAQVaaVLAGLGLAVLSAAAFGLRERLARSPALPLSLLRSRAMSGGAVIGLLFNFGFYGM-VFTASLEFQHQRGYSALGTGLALFPAVAMTMFASVLSGRLTRRTGDRPLVVSGMLLAALGLAGWAAaaYGLLVLPMMAAGFGTSFALTGSTATVMGAAPQAYSGAASanTTRQVGSATGVALGGSLLASAATYGTgmLIGAVAYLAAAGLAWRCVPPKT-
     398 UniRef50_A8M3X0        Major facilitator superfami...   189     2e-46  1  14.5%  1:433   1:472     MVERPAPGPGTAPLDADRGGQQRRGPALGIGLVAVFMTLLDVSIVNVAIPSMERALDVAPSDVQWVLSGYALTFGLMLVPAGRFGDGHGRRTAFVVGIVLFTITSAG---AGLAPTATWLVAARLLQGAAAGIVNPQVTGLIQELFRGPERARPFGLLGATVAISTAVGPLLGGLLieEHGWRWVFFVNVPIGVLTAVLGWRLLPRRAHRARDRHQFDPVGVLLLGAGVLLVLLPLVQQHWqaRRREPLFDLRLLGIRSYRLGVVVALLYFGGFTAIFFVLTVYL-QNGLGHSALAAGLASTPFTVGFAIASVVGGRVVNRFGRPLVAVGLATVVVSLvvPTGATVSWWTATPLFVAGLGSGLVITPNQalAQVPVPRAGGGAGLLQTGQRIGSAAGIATVGSVigATGDWSVAFHHAMLLTSGVVAIALCVA-----
     399 UniRef50_Q13I23        Major facilitator superfami...   189     2e-46  1  13.4%  4:421   2:423     ---TSLRRLSVRDLIDGRPFGRFQTLLVFLGFMTIVLDGFDAVVMGYIAPQLKLDWGLSHESLGAVLSAGLIGQAIGAMAGGPLADRYGRKPVVVSNVLFFGIWTLATAMSSDVRGM---VIFRFLTGLGLGAAIPNTSTLISEYAPQRMRSFLITVTLCGYTAGGAGGGFISAWMIPAFGWRSVVLAAGVLPVILGVILMALMPESLGFLVARKKGAAAVKAIVARIAPEIARTPYELVQDAQSPHRSSSIRIVLAPqtAMLWCGYFCVLFLIYLLSSWLPT-LVKEGGGYSVSESAIAMAMFQVGGPIGSLAIGWAMDRWSKHWILAGVFLIGAASVAAIGETSQYYLALcaLVVGFCMSGGSVGMTALATGYYPTEARATgwMLGIGRIGAILSAMLGAEMLSLGWSMSDIFTALVIP-----------------
     400 UniRef50_A0QS22        Major facilitator superfami...   189     2e-46  1  14.3% 20:432   1:412     -------------------MSNTRWRMFALLLLLVTVNYVDRGSLSVALPAIKEDFHISAEVTGLLLSAFFWAYAAMQIPAGWLIDRFGPRKLITAACTGWGTATAL---SGMAPNIGTMAVARGLIGVTEAPIMPAGGKLNAVFLTEKERGRGATILDAGAPLGSAVGGIAFAALIGATgwRWAFIIAGAVTVLLGIWAWRAIRDTPEEHPKVDEAE---------REYLVSAHREESARHQSTGERAGLVYYMKYRSFWAMCAGWLGFNGVFYGLLTWGPLFLSES-KGFELEAIGWSTFAIFGSGFVGEIIGGQLADRLKerSLLGFAGMCVVAGLVGVVLMPSPLAAVLLLSTVLFFLRWVGLFWSVPSILGGREDAGvgAMNLAGNISGFVTPMAVGFIVGATGAYTWALLYFVGAGVIMTAAVLIL------
     401 UniRef50_C6CS78        Drug resistance transporter...   189     2e-46  1  13.5% 20:435   3:456     -------------------STASRVRLLVVTCIALFMAMLDNLVIGVALPSIQEEFHASMSDLQWFLNAYTLAFAVLLIPFSAIGDRFGRKKIFLLGIVLFTLGSLASALSTSS---IELSLSRALQGIGSAAIIPLSLTLVNAAFPPEKRAAAIGLWSGISGLGLSIGPLVGGIIINGAPWEMVFWINVPVGIIAVILGALWLTESKGERKPLDLPGIVLLGVSLFGIVFGLMRGNSEgwERSRKQPFIQFEYFKSRTYSAYLSAGFWMNAGIFGAIFLLTLFLQQA-QGYSALGAGVREMVWTVCTMICAPLAGLLVGKYGSKKILLFGLFLQTAAMIYFALmpFGYIAPAMVAAGAGMGFSFTPLSHGILTSVPEHAAGEASgnASRELGGVFGVAISGLIFESGGAITsaLFVLAAMLAIGFLSVTFLVRR---
     402 UniRef50_C2CZ37        Major facilitator family tr...   189     2e-46  1  15.7% 10:416  14:405     ---------DAKSKAAVNVSRRYWWKVVALCFVGWILIYADRTILNPVQEQIGAQFHIGNTQLGLVNSIFFLTYAICQIPFGILGDRVGRRLVIMGGFIVLGIMTFFSGFAFSF---GIFLLFRALAGAGQGTYYGPQYALSTEAIPTKDLTLGTAIINSGMAFGTSGGYLLSSSMVLQHgwQTPFYVMALPTIIVGVLFYVVLKEKVIRP------------------EDQGNTEKTAEVKKSEESKVQLKDLFKNRNLVFAFILCFCSIYANFVILTWLPQFL-QVERGFQGSSVGFISSLVPWASIPGAIVFARIYDKLKKTKLMIAFLviSLVAVFGIAFVTNKLLLIVLLIVYGLTgaIDPILVAFVTKNSPRgsTALSAYNFIGMSGSILAPYLTGWISDQFGSMQIGFY----------------------
     403 UniRef50_Q20XM9        Major facilitator superfami...   189     2e-46  1  12.3%  5:436   2:422     ----TEQATALRPTHWSKSIFSAPNVVLGLLCILYFSAYVDRVNISTTASMMRKEFDISNVEMGVVFSAFAYPYVLFMVFGGWLADRFGARRVLMVCV---TVAAVATFCTSLVSGVVGLFMCRLLLGFGESVMFPSATRGMQAWIPSDRYGFVQGITHSFSRLGNAVTPPIVAALVILWGWRGSFAVMGVLTLAWVGFWVYYYRDDPRDHPKI----------------RPEDLIGLPERAPAKARKIPWLRLG--WRMAPVTFTYFCYGWSAWVYLNWLPSFFLE-GQGFDLKKSAAFASGVFFAGVVGDTVGGLMSDAIKRRtvLWIGMLGSAVCLTAMMYLHDIMWITLALAAGFFFllVIAPAWAVPMDIAPQYAGTASAMMNIGflAGILSSVTFGWILDLTGNWYLPFLCSIALMLAGTLTSLLMHPER--
     404 UniRef50_C7HY03        Major facilitator superfami...   189     2e-46  1  12.3%  5:418   3:436     ----AASPLDSDAMTNAHAAPTDRRVILLILCLAVLIAQVDTSVVNLAVHAIGVGLHAPLPALQWVVDGYNLSYAALLMTGGTLADLLGRRRVLMAGAAVFVLGSLL---AGLAPNITALIAGRVLAGIGAAMLLPASLALIRvwADPHERAHAIGVWAGTNGAALAIGPTLGGWLIQTVGWRSVFLLIVPIGLAVLLWAPRAIPESRDAQGRRVDLPGqrLLLPAVAVSLLAALLFVRAERRAGAGAMIPLPLLRNTRLAAVNGVAAAMTFGMYGVLFLLPLNWLR-GGVLDATGAGLALLPMSLAFVALSHRSGPWSKRYGTHRLIAGGMALIGAGIAVLACSHawLAEAGLLLTGVGMALNTGPVLASAVAAVEPARAGTAsiNTARMIGATLGVGVLGSVFAAGATMTTGFTVA--------------------
     405 UniRef50_B1J8P3        Major facilitator superfami...   189     2e-46  1  15.7% 21:435   9:420     --------------------KKKRVWIYAFLFTLTLINYVDRVSLSVASKVLKEEFDISPVAMGYLFSSFVWLYFLALIPMGYLVGRFGPKKVNGYGIGVWSVATACT---ALSTGFISLLSCRLIMGMGEATTYPAGARVIREWMPLKERGLATAVFHSGSLVGPAIGAIGFGWLISAFGWRIAFVVAGALGFIWLAAWLKWYSHPSKAP-----------WLDDVERAEIAEGGTSSADGPEKSVSLGLKGLARSSSMWAIALSHGCAVYATYFFLTWLPSYL-QAEKGLTVMSSGLYTAIPYLGAAILAIVIGRLSDktGQRRLVVASVLLASSVIFLVPAIDSTWAILFVITLSLAtaSAISLNLSLVNDLVRSegTAAGFITAVGNLFGLLAPIVTGYVVAGSGSFALAFVVVGALLVVGAVLSMFCTRR---
     406 UniRef50_A6WDT7        Drug resistance transporter...   189     2e-46  1  11.6% 10:407  11:436     ---------QPAPGVAPKMSHKEILEALSGLLLGMFVAILSSTVVSNALPRIVNDLHGTESGYTWVVTAALLATTISTPIWGKLADLFSKKLLVQIALVIFVVASAI---AGLSTSMGMLITLRVFQGLGGGGLLALAQVILASMVSPRERGRYSGYLGATFALATVGGPLIGGVLTEHLSWHWCFYVGVPFAVIAFFVLQFKLKLPEQPRrvSIDYLGAILLALGISALLIWVSLAGTeaEHRAKEPIVPLKFFRNPTIALSAAASLFVGVAMFGATIFLSQYF-QLARHESPTMAGVMTIPMIAGLFLASTVAGQAITRTGkkAWLVVGGVLLTAGLALMGttNYWVVAPYMALIGLGVGMMMQNLVLAVQNVADArgSASSFVAFARSLGGAIGVSALGAVLGH-------------------------------
     407 UniRef50_Q2RG28        Drug resistance transporter...   189     2e-46  1  11.8%  6:413  11:443     -----QSGAGAGLPAADGEVQGSWIIPVLVALIGAFMSILDSSIVNVAIPTIMHVFNTDTSTVEWVVTIYMLALGVIVPLSGWLGDKLGFKKLYVIALVIFTFGSLLC---TLSWNVDSLIAARVVQALGGGLIMPTTMAMIYRMVPRERIGSAMGVLGIALFVAPAIGPTLGGYLVEYVDWRWIFTINLPIGVLGVLLSLVLLPDFPAAEAGRLDIGGAVTAAVGLFTLLLALSKGADWGWTSEAtpLLELRVFRYPAFTLANLMVVVTTIGLFGGIFYVPLFL-QTVRGLGAMETGLLSMPGALASALMMPVTGRLYDRIGPRLMAVTGLVVLAITTYLfiVTPDRVIITWLILRSVSMSFASMPAQTAALAGLPPegRASAMTNIINRVSGSFGIAILTSILNHRTALHA-------------------------
     408 UniRef50_Q0RWE8        Probable terephthalate tran...   189     2e-46  1  15.7%  3:434   2:438     --SLAPSRVTLPDFIDSRPVSRYQYIVIALCGVVMFIDGFDTQSISYMAPHIAEEWGLSKQVLGPIFSAALAGLMVGYLALSPLSERFGHRRMILTSTVIFALGTLA---AAWSQNVTELMALRFITGMGLGAAAPSAIALTGEFSPKRLRATFVLVIYCGFSLGFVAAGLVSGWLIPILGWRSVLVVGAVAPLLLLPALLRYLPDSLTSMINRGAEPNRIQAIfaLAVGPDITYEAEKRTDGQRTALRSLFTRDRVLGTLLLWLVFVINLGEFYALQSWLPSIM--TSLDYDMGTVVTATTLTTVGGIAAAFVTGPCMDRLGAYVTLGTVYVVGFAFVAlaFTAPLWVLLTANFFAGVCISGGQKSLIALSAVFYPtrSTGVGWALGVGRLGGIVGPIAVGAALGMGWSASAVFYAMSVPMLVAGAAVFLLGR----
     409 UniRef50_Q0KB60        MFS transporter, AAHS famil...   189     2e-46  1  14.4%  6:437   1:433     -----MQQIDIHKLADTARFNRFHALVLFWCALIIIFDGYDLAVVGIALPSIMKDLGVAPTQAGLMVSSALFGMVFGAIFLGTMADRIGRRWTIAICVALFSVFTAA---AGLVKDPLLFSMARFLAGLGIGGVMPNVVAQMTEYAPKKIRATLVTVMFSGYAVGGVLAALLGKSLIEAYGWQSVFLAAGLPVLLIPVILGSLPESMPFLLARGDHEALRRIVSRLAPEQRWSATDRFAVPAQDKAASAPIRHLFHEGrtIMFWIAFFMCLFMVYALSSWLTRLM--AGAGYSLGSALTFVLVLNLGAMIGAVGGGWLADRYHIKYVLAAMYALAAVSITLLGfmPTELLFVVVGLAGASTIGTQIVANAYTGQFYPtrSTGLGWALGIGRSGAILAPIVIGVLVAMELPLQQNFIAIAIPAVIGMGAVLLIDHRRS-
     410 UniRef50_UPI0001B5708B EmrB/QacA family drug resis...   189     2e-46  1  13.1% 35:430   1:412     ----------------------------------MFLVQLDVTVVNVALPTLGSELHADVPQLQWTVVGYSVVLAALLLTGGALGDVLGHRGVVLTGLAVFGAASAACGLA---QSAGWLVAARAVQGVGAALLLPGTMAVITGTFPGreRARALGIWAGFSALALPAGPLLGGILVQTAGWRPVFWLNVPIVAAAAVATRRMVPPDVRKPGRVdgVYAVIAKTPWAGLLAVAFAVAFVVVEQRSSAPMLPLSLLRSRQTAGANLVSAAMNFVGLGSVLVFTLYL-QDVLHADPIAAAVALLPMFVPLVLVGPVSGRLTAKFGPRPQIVTGLLLGVAAMliGTGTGYWTLLPTLFVLSVGMGLLTAAVVTASVAEAPGERAGIAGgnAARQAGGALGVAVFGAVAGEPAARVSFVDGLHVLGLVSAGLWF--------
     411 UniRef50_B2JVW5        Major facilitator superfami...   189     2e-46  1  10.4%  9:432  25:443     --------ASDDYAASERTLAKAFRRILPFIFICYVISYLDRTNVGFAALTMNKDLGLTSEQFGFGAGLFFVGYFLFEIPSNLIMQKVGARVWIARIMITWGVFSMATAFVVGPKSFA---AARFLLGLAEAGFTPGIYLYFTHWFPGKWRAKVTAAFLVGIPVANMVGSPISGALLELgsWQWLLLIEGVPAVILGVACLFLLADRPEKAKWLSDEEKSSLA----------RRLALEQDDIGAKHGSKLRDAMTNWRVFVLAFINFCGIVGSLGVGLWMPQIIKQ--FGVEHSVVGWLTAIPYAIGAVVMLWWARVANRSQNRIPYVAGALVVaaLCASTFVDTPVLKLIALCFTVSGILAFQATYWAIPSGFLTGRAAAGGLALivGNLGGFVGPSMIGALKQISGGFTLPLLAVSGVLLLGALTIAWL------
     412 UniRef50_C8SZC4        Phthalate permease family m...   189     3e-46  1  13.2% 16:432  21:413     ---------------TAVKTGRRRYLTLIMIFITVVICYVDRANLAVASAHIQEEFGISKAEMGYVFSAFAWLYTLCQIPGGWFLDRVGSRLTYFIAIFGWSVATLLQGFATGLMS---LIGLRAITGIFEAPAFPTNNRMVTSWFPEQERASAVGFYTSGQFVGLAF-------------------------LTPLLIWFKVYQPPRLTKSISKAELDYIRDGGGLV-----DGDAPVKKEARQPLSKADWKLVFHRKLVGVYLGQFAVTSTLWFFLTWFPNYLTQE-KGITALKAGFMTTVPFLAAFFGVLLSGWLADKlaRKAPIICGLLISTCIMGANYTNDPIWIMALMALAFFGNGFA-SITWSLVSSLAPMRLIggGVFNFVGGLGGITIPLVIGYLAQDYGFGPALVYISVVALIGALSYILLV------
     413 UniRef50_B7DQN8        Drug resistance transporter...   189     3e-46  1  14.8% 16:400  19:429     ---------------PSRLEYRKMWWIFTSVVLGTLMVNIDSSVVNVLIPTLERAFHRPPSLLQWAVSAYLLVVTTLLPLLGALSDRGSRKKYYLMGVALFTISSALC---AMATNLIELIIFRMIQGLGGALIMANVMSIITFTFPPERRGKPLGYVNSIVALGTIIGPGLGSVLLSLFGWRSVFWINIPIGMISLALSIVHLPPLreQPLDLVGAIWITAAVAAMFFEFSEAGSWGwvHERHTPAPLIQLTYFCIPSFGIHVISSFLSYVLMMMPQFLLPIFL-RDVQGESATRVGLVLMTQSLSMFVFSPVAGWLSDRYGPRAWPVIGMVMVGISVAVFSSLSAHTPLAYTTifGLGLSLFTAPNNALVLAAVPPQHSggSLLALVRNLGRLVGIAV--------------------------------------
     414 UniRef50_C1B433        Putative MFS transporter n=...   189     3e-46  1  16.9%  7:438   8:415     ------RRAPERGTPDRTSLDRAARITVILLFAAWVVDYIDRLAINLALPSIGAEFDLGHTEQGMVISAFFLSYALCQIPGGLLADRFGSRRVVCWSLLIWSLFTALTG---TAWAFVVLLAIRFVFGVGQGVFPAAAMKAVAERTVPHQRMTATGWAQSSNAFGAVLAPLIAAPIIALWGWRMSFFAVAGLGVLVWAAIQLWLP------------------------AALPQSADTSPRPDGSDAQGGLRTVLASWVMWRFTLMFFGYGIIVWGLNSWIPSYL-QTVRGISLTGSGLLSAIPALVGGGAIIAGGKLIDRLGGRHRLIVFPAMTVCAVCILFltSLAEFVALLSLATASATLCYMPIFAIPLRTLPGALVGTGSgnLGGQAAGFITPMVMGALVDRY-SYTAAFAFLVVGAVVAGAFALGTPQRSGT
     415 UniRef50_C7Q2J6        Drug resistance transporter...   188     3e-46  1  11.9%  2:412   3:438     -TDTIGRPGGGAADGLRAATIGHPVRTFVITAAAMFMAQLDNLVVSIALPSIRESLHAGLSGLQWTVSAYTLTFAVFLLTGSALGDRFGRRNLFVAGLAVFTAASVA---SALAPNIAVLIAARTVQGLGGAVIVPLSLTLLSASVRPEKRGAAVGAWGAIGGLAVALGPVIGGAVVEAASWQWIFWVNVPLGIVLLPLAWWGLTESRGPVRRLddAGWTTPLVLTGFVAGAVLLAAFVVWELRTDAPMVPMHLFRGRSFPLVNLSALLMSFGMFGAVFFLSQVF-QTVFGDSPLASGIRVLPWTGMPMLVAPIAGILSDRIGGKWIVTAGLGLQAVALGWiaSVSYTALLPAFVIGGTGMAMFFAPIANLVLGSVSREQEGIASgnALREFGGVLGIAVMGAVFSANGGYG--------------------------
     416 UniRef50_A9M570        Drug resistance transporter...   188     3e-46  1  12.2% 12:406   2:422     -----------AEATAIAASGSKRLAVTICVMMATLMQALDSTIANVALPYMQGSLATTSSQVNWVLTSYIVAAAILTPATGWLEERFGRRPLFIICVAGFVIASMLCG---TATSIEQMVIYRMLQGAFGAPVVPLAQAVLLDSYSARMRGQAMAVFGLGVMLGPILGPTLGGWLTQYYDWRWVFYVNVPLGVMTLLLAFGFLesLARLDWLGFATLGLAIAALQLFLDRGEQLNWFDSTevTARKPFLDKRLFADRNFVMGQVLIFVIGAVLLATLSLLAPYL-ERLMGYSVLMAGLVLAPRGVGTMVAMVLVGRLTSVVDIKYLLLTGLALTAVAlmFTPDVSQSTIIWSGIIQGFGLGFVFVPLSTITFVTLPahTQGTGFFSLMRNVGSSVGISVTTFLLS--------------------------------
     417 UniRef50_D1UNR9        Major facilitator superfami...   188     3e-46  1  14.7%  1:429   1:449     MNNAEGVAAAAKAGPLAQKRTGHRWIVMGLIFCIWAIACADRANFGIALPYLKKEYGITNTQAGLIVSLFSFAYGFVQIPVGLLYKRLSEKTTGFLFSVFMILTSVFTGLMGTTSSVFLLQAYRVGLGLSEGPLGIGCTNVINRWFPAKEKGTATGLWIAASKLGPLIVPSVCIVVIQLWGWREIFYVFAVPGIVLAVLWMFLVTNSPGQNRFCSEAEQRYIADDTPRQGHGQAAPGRpnRTKRVAQLETIREVFGSWNILGVAIGYGCMIGISNIFMSWMPTYLV-TVKGFASVKMGFLASAPFMGAVAGNLLGGVISDRlrRKPMMMLGALGTMLTMLLLIDAPNSVAYLglMFAGLMLGIGFAGYSAYPMGLATKSttAFGIVNCVGQIGGACAPLAVGILLDRFSWTSVFLYMVGTAFLCLLLLF---------
     418 UniRef50_Q01QD8        Major facilitator superfami...   188     3e-46  1  13.6% 17:429   8:410     ----------------SGRIAGLRWWIAGLIFLATLINFINRLTISVLAPVITQDLHLSNQQFAGITNAFLIAYTFSQAFSGKLYDRVGNRRGFSLSIVVWSIASMLHATAAGLFS---LNCFRFLLGLGEAGNWPGAAKVIAEWFPPRQRALGMAIFNSGTSIGSVVATPLIIGLQIHFGWQATFLAVGGLGFVWLALWLRFYHPPHEHPRITPAELALI-----------------SEGRPPAVARLPWKVLLRYRQTWAILLSRFFCDPVWWLYITWLPLYLYK-VHGFSLKEIGYFAWVPFVAADAGSLFGGWMSSHlaRKSVILFGMLCMCAGLGAAAAHTATVALGCIAVVLFGFQTWINNVQTMPSDYFPESAvvAGLGGMGAGIGAILFTQATGFVVDHFSYTPMLIIAGLLPLVGTAVLF---------
     419 UniRef50_B8FIL7        Drug resistance transporter...   188     3e-46  1  12.2% 25:408  16:425     ------------------------WFVFGIVGVGIFMSTLDGSIVNIALPSILKSYGVSLSTIRWVPLVYLLTISCLLLSFGRFSDMIGRRRVYTRGLFVFSLGSLLCGLAGSA---GVLITARSLQGMGAAMIMSCTPALIADNFPPEERGMAMGMIGAVVASGLTVGPALGGLILEHFSWHWIFFINLPVGLGAIIAANRVLKEspRESFDWIGALLLALviVGLIAAFAVGAVFFIFVEVKAPHPLVDLELFRIRLFACALCAAVTLFISLFCLIFLMPFYLK-YPGGFSDAGAGGMLVVPFLFMLVGAPLFGAMSDRLGSRLLCTLGMLMLSASFFSFMFMEPTtiFWRLALAGFGTSLFTSPNNAAAITAVPVNRRGIASAltARNMGMVMGIAMASTVFTAV------------------------------
     420 UniRef50_C3PFC8        Permease of the major facil...   188     3e-46  1  11.2%  6:425   3:449     -----ATAKPSVANTDNGKPENNLVLVFSALVLTMLMSSLGQMIFASALPTIVGELG-GVDHMSWVISAFLVTMTIAMPISGKLGDMMGRKWLYIGGIATFVIGSTVGGFA---NSMNLLIIGRAIQGFGAGFMMISSQSIIAEVTTARERGKFMGIMGGVIGLSSVLGPVLGGWFTDGPGWRWGLWMNIPLGLLAMTVCVLVLHLRVGDTDLRKFDALGATFIAITTASLILMTTWGGTqeKRAKEPLIPVLLFKNRNMVLTTAAGMVLGLAMFGVLGYMPTYL-QMVHTLTPTKAGLMMIPMMLGMIGTSTTVGFVIARTGhkRYPIIGLAITAGALFWMSKLTVDTSlaEFLVFGIGLGFVMQVLVLIVQNSFPVagTATAANNFFRQIGSAMGASLVGSLFIHNMKDELAANMPAAIASMG-------------
     421 UniRef50_B7RQJ1        Multidrug resistance protei...   188     3e-46  1  13.0%  6:420   1:441     -----MTAAPDISVPRRSTGEAVRWTIVLAVVLTAVLEVLDSTIVNVALPQIQAAFGITNDQTVWILTSYIVASVVVMPLTGFFVRMVGRRRLITTAIIGFATFSALCGLS---WSVEVMVACRLGQGIFGAFLIPLSQSILFESFPKEKRGQAMALFGLGVVVAPVLGPTLGALLTEYFSWRAVFYVNLPLAAFAL-MMMTGELEREDTKRLTVDWVGLALMIAaaALTLIACGAVFVWRGRGKADNIIDFSLLRDRSFAGANVAIMGFGVAMFGSIAILPLF-VQGLLGYPVLDAGFLFIPRGIAAGASMILTGalVNRFDPRKLLMLGLILTGTGNILLAFLNlwQLALPGMVSGLGMGLFFVPMSTLAFQNIGPERqaSGIYGVTRSLGSSLGIALVGWQLASRMQYHYATLAAGI------------------
     422 UniRef50_O53186        Uncharacterized MFS-type tr...   188     4e-46  1  10.6% 20:414   1:421     -------------------MTPRQRLTVLATGLGIFMVFVDVNIVNVALPSIQKVFHTGEQGLQWAVAGYSLGMAAVLMSCALLGDRYGRRRSFVFGVTLFVVSSIVCVL---PVSLAVFTVARVIQGLGAAFISVLSLALLSHSFppRMKARAISNWMAIGMVGAASAPALGGLMVDGLGWRSVFLVNVPLGAIVWLLTLVGVDESQDPEPTQLDWVGQLTLIPAVALIAYTIIEafVRHEHRAAFPLVDLKLFAEPLYRSVLIVYFVVMSCFFGTLMVITQHF-QNVRDLSPLHAGLMMLPVPAGFGVASLLAGRAVNKWGPQLPVLTCLAAMFIGLAIFAIsaHPVALVGLTIFGAGAGGCATPLLHLGMTKvgRAGMAAGMLNLQRSLGGIFGVAFLGTIVAAWLGAALP------------------------
     423 UniRef50_Q65DR1        Putative transporter n=1 Ta...   188     4e-46  1  13.0%  7:438   4:437     ------RSVHPAEVMAASKFNKVHLTVFLWCFFAIAFDGYDIAMYGVSLPWLMEEWSLTAIQAGAIGSYTLIGMMLGALIFSPIADQYGRKKVLGFCIFLFSLFTAA---AGLIDSPLLFTIMRFLAALGMGGLMPNAISLMTEYSPKKNRAVIVAAMYCGYSAGGVLASLVGMFAVPVTSWRVLYLIGAVP---LFVLPFFFSRFPESLSFYVLKKKTKALAEIFNQVHPAGRYREDdaKEKKGFPVKKLFGQKRAASTFAFWLSVFSCLLMVYGLNTWLPKMMQASGYGL--SSSLSFNLALCCGQAAGAVFGGYLADKAGHKNVLAAMYVIGAFCFAAFGMtnPVLLYLLIALGGACTVGAQNIANPYISEYYPkrATGIGWALGVGRLGAIIAPSLFALILASGMEPKQAFMVFAIPSVFAALGIMLVQEKHAS
     424 UniRef50_D2QJY7        Major facilitator superfami...   188     4e-46  1  13.9% 17:418   2:414     ----------------PTPSGRFRWRIVALLFLATTINYIDRQVLSFTmlDIAPDTVLTKEayGDVDAAFKFAYAIGFLLAGWLVDRIGTKRGFSLGILVWSVAGVLT---ASVNTIAGLSWMRALLGLGESANFPSAIKTIAEWFPRRERSFANGLFNAGTNVGIILTALAVPYLILQFGWRSSFLVTGVLGFGLLIFWWLLYSKPERHPKLSAEELAYI----------------RADAEKTPPLKVSWSRLLSYKQTWAFAVGKLMSDPIWWFYMSWLPDFFNSNDAllDLKSFGLPFLIIYVVSDAGSIFFGWLStrWgrKTTLLICALCVVPIFFAAQTNSLTIAIALIALATAAHQGWSANMYTFASDLFPRnaSVTGIGGMFGTVGGILLALLAGRIITAFGYLPMFIVAS--------------------
     425 UniRef50_Q82I69        Putative integral membrane ...   188     4e-46  1  12.9% 11:413   3:430     ----------TVTQQHDPRHDARRWWALGALVASMLVLGFDMTILNVALPTMARDLGASTGEQQWMADAYVVVFAALMLPAGLLGDRFGRRRMLITGLGVFLAGSLA---GALVDDVTPVIVARALMGVGGALVMPLAMAVLPSLFGPEERTRAVGAVSAASALGLPLGPILGGWLLDHFWWGSVFLVNVPMAAIGIAACVFLLPETRDPASPKVDAVSTALTAAGLSILIYAIIEAPGrrERRSARPMLDLSLLAQRGFLLNTLAATLVMFVLSGLMFVLPPYL-QAVLGNDTFATGVRMLPMMGGLLIASRGAQPLLAKFGARAVISAGLVTLAFAAILGSRTSVdfTALWLSIAGLGFGFAVVPAMSAALGALPRDRAGSGSgmTVRQVGGAIGIALLGSLLAGAYGDRL-------------------------
     426 UniRef50_Q01XR3        Major facilitator superfami...   188     4e-46  1  12.6% 32:436   1:399     -------------------------------MLLAAVTYLDRVCISVLAPDISRDLGLDKLQMSFVFSAFAIAYAGFEIVTAWWGERVGARRILTRIVAWWSCFTIATGLS---WNYPSLLAIRFLFGAGEAGAWPNAALAFSRWIPTGERGRAQGFFFAAAHFSGGITPLLVAAMLPAMSWRAIFAACGTVGFVWAAGWYRWFRDEPREHKAVNAAEAELI------------ETGRRIAVHMHSGGAVWRALAASPNVWFLCLAYFSNSYGSYFVMTWLPTYLSEQRH-FQKESLSLFSGLPLLLSVFGDLSGGALTdrVGRSAVCVAGYSVAAAAMFASVYSATPVLAACLIAVAVAASMvlSATWAACMDIGGEHTAvsAAMNTTGQLGSIISPVATGWVVSRFSNWQAPLVIMGVLYLISAVLWTMVDARK--
     427 UniRef50_B9TAI6        Phthalate transporter, puta...   188     4e-46  1  13.6%  1:433   1:446     MSQGARILHLRGAAGMDAIYRKISWRLLPLLMLCYGVAYLDRVNVSYAKLQMGADLDFSNQVYAWGAGIFFIGYCLCEIPSNLLLEKIGARKTLLRIMLCWGLTAAA---GAFVREPLEFYVMRFLLGVFEAGFFPGVILYLTYWYPAARRARVIALFASAALMAGVAAGPLCGATLQYmgWQWMLLMQGLPAALLGIGAWFYLDDKPEDARWLSSFEQQMVEQDlaLNAAEGDAAPHDEDAAPPSALAVLWSLLRQPSIALLAVANLLLMGASYALVFWSPTLMQRWGAG-SHMQLGLLAMIPNLAGVVGMILIAYDSDRRRERRGHFIACMVLAAGGLGFAIahLAWALGGLALASAGIAAGSPLLVSILTAMLNRRRAAAGIALvfGLLGGAFGPPLSERMLAWGDSAAMLAGLIVLYLAAGAFLLWALK-----
     428 UniRef50_B1MI45        Hypothetical major facilita...   188     4e-46  1  14.6%  1:438 214:625     MTSTAENTTGTHPPQSRPVTFRQAFFVALTAGLGYGFDSYAVNIYGLVLPEIKDTLHITEAQAGYIGSIFLLGYTIGTVGFGLAADRWGRKTTLGASILLYGITTAL---AGLTTNVAAFTGLRFLTGVGGAGELAVGAPYTAEVWPAKTRAIGvgVIFSLFSLGYVLAAGVALVLVPRFGWQAAFIVAIIPAVV-LFLARQGIKESHRY------------------------TQTKARVQGRATRPKLWHVPGVRRRLVVGWLVYTANAVGYWGMTLFLTTYIVKKFHATSI-DAIRYALAFFLLQAVFVFIGTALADRIGRRPSAVLGALIEIASTALGATSDTLPEYLVFGAISIalGWLWGVGDTYVAELFPTVLRGTGFGIAvgRVVSIAAPALVGWAITHYG-IQTPYLALSGLWILTIIGYLLGPETKGK
     429 UniRef50_A7I9I4        Drug resistance transporter...   188     4e-46  1  11.8% 15:388  10:411     --------------SQGSAPRSGFFLLVFSISLATFMAGLDGTIVNIALPTISEAFHVSSTTVSWVATAYLLVMAGCVLIFGKISDIIGFKKIFLTGFVIFTLGSLACglPDLFHSLPVLVGSRMVQAIGGAMITAIAPAMVTAYIPLDQRGKAMGIVMTLAGLGTALGPTIGGFLTQYLSWHWIFFINVPVGIGAVILGTREIPAsrSGAVLIFTGLAALlaILGIAALAIVTLAWFIRHECRLSDPLLDFSLFKNKNFLAVNLLLSLVFLSFSGINYLLPFYLK-YIGAYDTSTAGLIMTALSFAMMVAGILAGMLFNRTGPKLLCIAAGILLTAGYFLIMQLHPDtiVLCLALIGFGLGLIITPASNLVMNSVAKAKQGMVSSLT--------------------------------------------------
     430 UniRef50_B0KTN8        Major facilitator superfami...   188     4e-46  1  11.7% 20:437   1:414     -------------------MKGIRWWMVSLVTAGLVVNYLARNTLSVAAPTLMTDLSISTEQYAKIVAAWQVCYALMQPVAGWFIDFIGTKLGFAVFAMAWSVA---CAGAALATGWQSMAFMRGLLGMTEAAGLPAGVKATTEWFPAKERSVAIGWFNIGSSLGALLAPPLVVWAILHSGWQLAFVIVGASGIVWTLLWMLLYKHPRDQKRLSDEERDYILA------------GQEAHFKQDTREKGAWKRIFKTRNFYAIASARILSEPAWQTFNAWIPLYLMTERH-MNIKEVAMFAWLPFLAADIGCVLGGYLSPLfsRKMVLVFGASCMIGPACIGLVESPYTAILLLCIGGFAHQTLSGALYSITSDSFSKdaTATGMGGMCGYLGAAVFTLVFGVLVTQIGYSPLFVVLAAFDIVAAVLVWKVAREVSG-
     431 UniRef50_A0JT68        Major facilitator superfami...   188     4e-46  1  12.2%  1:436   1:433     MTSLSMRPAGLGELGERT-LRKVRRRVMPLIVLLYFVAYLDRNNVGFAKLTMSEDIGLSAAAYGLGAGIFFLGYALLEVPSNAGMYRFGARKWLARILITWGIFATAMCLVNGESTY---YIIRFLLGAAEAGFFPAILFYLTLWFPAAQRVTVLGIFILAQPVSNALGAPVSGLLLQMdgWQWLYIIEGIPAILLGLLTPILMTDRPRDAKWLNTDE----------REWLATTMEAELAAKSKGGQHNFLAGLKDKRTLVYSALYFGLVCGIYGLGLWMPTIVAALGKFSTAEVGFIVFIPYAVAAVFVYFWSKR-ADRTGKRAWHTAVSMVLAGMGLLAAgvNPVLALIALTVSAMGIYGAIAPFLSMpaLTGAAAASGLALVNSLGNLGGFVAPYAVGMLKDATGNNQSGLLFLSFCLCVTAVATYLYARKR--
     432 UniRef50_Q46PV8        General substrate transport...   187     5e-46  1  14.2% 11:434  21:445     ----------VREFIDAARLSPLQLRIMLLCFAIVALDGFDIAIIGFLAPHIRSEWSLSMVALGPLFSAGLLGLMTGAFLCGPLADRIGRRRVLMLSVAWFG---AACAASAVAPGIGWLIALRFLTGLGLGGAMPNAITLTAEFSPSRRRGTLLTVMFCGFSLGSAIGGVVTAYLIDQVGWRGVLALGGALPLALVPVLALALPESVRYLATREGMQARIAAILARIDARRITADMHYVADEPEGPGSPVSQLFAPrgTLWLWLAFFCSLLLLYLMINWLPILVQRS--GLSLKEASMLAGLLQGGGVLGAIVLGMLLDRFNPYAVVAGAYTLGAISVACLASVSAPLAmaAIFVTGFCVSGSQVCANVLASAFYPtrATGVAWALGIGRVGAIAGSLGGALLLSAGWSNAALYLLLAIPAVAAGISIFRVGR----
     433 UniRef50_D1CFG2        Drug resistance transporter...   187     5e-46  1  12.2% 14:405   1:417     -------------MVSEGLARNSRKLIVVGLMLATFLSAMDSSVVSTAMPTITGILG-GFSLYSWVFSIYLLTSTVTVPIYGKLADLYGRKRVLLFGILVFLLGSGLCGLA---QSMLQLVIFRGIQGIGAGAILPITMTIFGDIFSIEERARVQGLTGSVWGISAIVGPALGGLIVDNTSWRWVFLINLPAGLLSLLVLIFFFHEKTQVHQHSVDYVGAIALMAGSAALLLALTSGGRdvEVRVSEPILPLSIFADRMIAVSGIASLLAGGVMIGATTYVPLF-AQGSLGTSATVAGAVLATMSIGWPIASSLSGRLILRVGYRITAVVGGVFLVLGSGLLflSSPLLIAVASFVIGAGMGFSTTAFIVGIQNAVdrRGVATSSNLFLRSMGASIWVALLGAIA---------------------------------
     434 UniRef50_A7JTE1        MFS family major facilitato...   187     5e-46  1  15.2% 10:436   2:429     ---------DIRQKIAHNKMTSFQWLVVGLTVLLNMLDGFDLMALAFTAKSIREELQLDGAAIGSLMSAGLFGMAIGSLFLSPLADKFGRRPLLLIGTGLATLGMLLTYFATSAFEIG---VWRVLTGLGVAAILTGTNVLVSEYSSQKWRGLAIAIYASGFGIGAMLGGMSAVLLQGEYGWRAVFLVGSILTGAVFVLLFFVLPESVEFLISKHPVNAKARLNQIAVKLGLGNGWELPEIEAKSKSKVAITRLfyRRNTLLIWLAFIAISASFYFISSWTPALLEEA--GMPKTQSQTVGMAISVGGTIGSLIFGFLVSRWAAKHILQAFSILAASAVVAFVFAGNLGLAITLalVGGLINGCITGLYTINPTLYAprSTGVGTAIGVGRLGSIVSPTLAGILLDAGWKKNELYLGAAVVLLIAAFTVHFLKQRK--
     435 UniRef50_D2SGU4        Major facilitator superfami...   187     6e-46  1  12.0%  5:405  10:441     ----TARTAGDPGGEEEYRPDPRRWRALSVTLVAGFMSLLDVSIVSVALPTLQRDLGASAAAVQWVVSGYALTFALVLVPAGRLGDALGRRRMFLAGLAGFVLCS---TAAGAAPSVGLLIAARLAQGLAAGVLAPQNSGLIQQLFRGGERGRAFGLFGAVVGVSTAVGPIVGGLLLQVADWRWIFYVNVPIGVVAFVLAWRLLPRGGAGGRGHIDVGGVlwLFPVGVLLVGGFVAWERRVVRRGGEPVFDPRLVttRGYGLGAALGTVYFVGFSGIWLVFALFF-QTGLGLTPLQSGLAVTPFALGSATAAVVAGRLVERFGrvGVLTGLGATVAVLLLVPADAVPWAVAPALLVGGLGGGFVISPNITMTLRDVPVRMAGAAGgqTAQRFGAVIGTAALPGLF---------------------------------
     436 UniRef50_Q1AYE3        Drug resistance transporter...   187     6e-46  1  10.8% 26:406   9:415     -------------------------IIFIGVALGMLSAAAAQTIVSPAMPRIVAELG-GMNHYSWVATAALLASAVTVPVVGKLSDMYGRRGFFIWGLVVFMAGSALSGAA---QGFWWLVAARAVQGLGMGTIMPLAQTIIGDIISPRERGRYVGYLGAVFGVASITGPLVGGWITDNFSWRWLFYVNLPLGVAALAFVVAYLHLPHTPRRHAVDYAGFATLAVGLSAVlaAVLAVFLVNEHRAEEPVLPLRLWKSGVFTFSNIANLAISMGMFGAIYYIPVF-AQGVLGVSVTNSGAITLPLMLAALPVSVLVGRMITRTGRYKLFLLAGVAVMWLGYLILssTQAELTLAMVVVGLGLGAVMQTFTLVVQNAVTRegVATAATQFTRSTGATVGIAVFGTIMT--------------------------------
     437 UniRef50_D2QLS4        Major facilitator superfami...   187     6e-46  1  13.7% 21:437   3:401     --------------------RNLRWLIVSLLFVATGLSFLDRQVLSIAIIKIQQEFHITDVQYGLINTSFLISYAIMFTLGGWLIDRVGGKLGLAISVGLWSVANSLH---AVMTTFSQLLAFRFLLGMGEGGCFPGAAWTVYRWFDKEERALANGIAIGGSAIGAVIAPPLTIWLSTNYGWRGGFLIPGLIGIVWVIVWL-------------------------LTPWRKENLAAEQPLASSVGKTVPFLDLLKLRPTWVFILIRFLLDPVFYFMMFWIPKYLSTER-NVSFEAIGKLFWIPFLALGIANILGGWFSGQlaRKTVMGIAAVLTLVTPAISWVSSVEVAVGLMSVFMFAHGFWITNYITSISDMFGQKATSTVVGltAGAVSSLLLNPLMGVVIQRYSYTPLWVASGLLYPLAFILLIVLIPKIKA-
     438 UniRef50_C1YPU6        Arabinose efflux permease f...   187     6e-46  1  12.1%  2:405  48:479     -PAADVPAVSAADEAPGLPSRRVVRRIMVGLVLAMLTSMLTNSIVGTALPTIMGELG-GQDRLAWVATAALLTMTASTPVWGKLSDVWGRKLLFQLALGIFIVASVA---AGLAQDINWLIAARALQGLGVGGLATLPNIILGDVVPPRERGRYSGLIGMVFGVSTVLGPLVGGFLVDslGWRWCFLITVPLALFAFVVIQFMfpVDWLGAGLIFSAASTVIVLLSLgaGALLLTAAAVVVERRAREPIIPARLFGDRTFVLSSLGSACVGMMMFGLIIYMPQYL-QMVHGMTPTVSGLMTLPLVASFLLTSIGSGYAVGGSGRWKamALCLFGFAALSLAYLDTGLTTVVAGQVMVGLGLGLCMQILLLATQSALpdMATGTASVVFFRNLGGATGVAAFGAVM---------------------------------
     439 UniRef50_C8NS95        Major facilitator superfami...   187     6e-46  1  13.2%  7:409   1:407     ------MNLTRNDRLDRLPVTSKHRKLLGGSGIGWALDAMDVGLISFIMAALVTHWDLSPTEASLLGSIGFVGMALGATFGGLLADKVGRRQVFALSLLVYGLAT---GASALSVSLVMLMALRFVVGLGLGAELPVASTLISEFSPRRIRGRMVVILEAFWALGWIMAAIIGTFVVTIggWRWA-LALGCVPAAYAIYVRLGLPESVRFlkGRHEEAEAIVVSFEEQAVREGKPLTDSLPESRDVEVEGSESIWarRRTAALWVVWFCINLSYYGAFIWIPSLLVAD--GFTLVRSFQFTLIITLAQLPGYAAAAWLIEKWGRRATLSTFLAGSAVSAAMYGMADawQILVAGCLLSFFNLGAWGALYAIGPELYPtrGTGTGAAAGFGRIASIIAPLIVPPVISLGG-----------------------------
     440 UniRef50_A8GE47        Drug resistance transporter...   187     6e-46  1  12.9% 16:403   5:413     ---------------DASAPIAHRPLILIACMLAMFMSAIEATIVATAMPTIIGDLG-GFSLLGWVFAVYLLAQAITIPIYGRLADLLGRKRVFFFGASLFLLGSVLCGFS---PNMYWLIGFRLLQGLGAGAIMPTATTIIGDIYSPTERPKVMGYISSVWGVSAIIGPLLGAFIVQHLPWALVFWVNLPIGLLAMFFLARYLPSRQQVREHALDLAGTAWLTLFVTALLLSLLQAeiRQERRAPEPLFPLALWQSRVIVAGNIGGLVIGAAMMGISAFLPTF-IQGVMGGTPLEAGTTLALMSIGWPLASTFSGRLMLMTSYRTTALLGALLLLAGGLILLLLQPTGGlvAAFMVGAGMGLCNTTFLVSVQNAAHHSIRGIATavFTRMMGSAIGTAILGA-----------------------------------
     441 UniRef50_C7JF94        Transporter n=8 Tax=Acetoba...   187     7e-46  1   9.7%  2:435   3:432     -SVAVSGQTSRSEPSGNRLFSTMAWRILPLLFLGFLASYLDRVNVGYAKLRMLSDLGMSEAAYGLGTGLFFLGYILCEVPSNLMLVKFGARNWIARILVTWGLCSGLMMF---VHTPTQFYVLRILLGVAEAGFMPGVLYYLALWFPPQYRSKVTAAFMAGIPLASVIGGPVSGLLMEGlgWRWLFFWEALPPVLIGIAVFLFLPTSPDKATWLTASES------------EWLRRENPLSFNKVSLSVSIAAAFRSPWVWLLGIVDGTLLLGLYTIAFWTPSLLHDDGI-RSTFQIGCLSAIPQIGAVASMILIGRSSDERGERRWHIVLPIviAMACIPLCMGNPFIAIACITAANMGILGALPPFWVLPSLMLKGNSAAVGLALaiANIAGFFATALVGYARSVTGDMSGVIWLFAGLVLLGGLSVLMIPKS---
     442 UniRef50_A9B396        Drug resistance transporter...   187     7e-46  1  12.8% 23:414   8:424     ----------------------QKIAVCVVFVAALFMSIMDGTIINVALATIQQDFGASSSAINAIVVIYLICIAVVIPASGWLGDRWNTKWVFLTSLGLFTLASLACGLA---QNIEQLMLTRAAQGIAAGALMPVGTTMLFRTFPPHQRIQVSRVLIIPTVIAPAVGPVLGGFLVDHLSWHWVFFVNGPIGLAALIFGVIWLQAPAQEEVGAFDWLGFILAGAGFAALLYTLtaALVVVELAKAKPMLDLRLFSIRLFRVSNLVAIFGSAAFTGILFLMPQFL-QNVVGASALESGLTTSPEAIGVVLSSQIVARLYPKVGPRRLTFGGVLGVAVMMGLMSttNLWLVRALMFGTGVGMAYLFLPIEAAVFAQIPHASTGQASAIFSmqLGSALGVAILGSVLALNHSGTTV------------------------
     443 UniRef50_UPI0001B4B8B8 integral membrane transport...   187     7e-46  1  13.6% 13:408  15:436     ------------AVTPGAAGHPLRWPILAVLCLSLLIVGLDVTVLNVALPTLVSELGATTSELQWLVDIYSLMAAGLMLVAGSVADRFGRKPVFLIGLVLFSGASAV---AAFSDSTTSLMAARAVMGVGEALIMPATLSIIGSVfdPAERMKAIGLWSAMIGVGLAMGPLVGGWLLGEFWWGSVFLINVPIGIVALAVALRVVPNSRAAIARRLDLPGAALSVLGVGTLlaVLLAAFLGRERTAKEPMLPLGIFANRHLAVGNVLVFLGLLSLLGALFVLVQYL-QFVLGYDAGETGMRIAPTALVILVAAPLASFLGQHVGTRWLAAAGLTFATVSLLLLATTGNGdvLAAMLFLGFGAGFIIGPTSDAIVGSLPEDDLGVGSATNSaqLGSALGVAVLGSLLAGT------------------------------
     444 UniRef50_B1K9L9        Major facilitator superfami...   187     7e-46  1  12.0%  6:431   4:431     -----TPVVDVQTFINEQPFGGFQWLVFLMCFVIVLLDGFDTAAIGFIAPSLLGEWNLTKPDLAPVLSAALFGLACGALVSGPLSDRLGRRSLLLGSVFLFGVA---CLMSAFSNTIGHLTILRFITGVGLGAAMPNAVTMMGEFCPDKRRATVINLMFCGFPLGAAFGGFLAAWMIPHFGWRSVLMLGGVTPLLLGVLLLLKMPESVRFMVASGQSIDKIRATLARISRDALNAGSFALTEAAPQTGGKGLGVVLSRSyvMLWLAYFMGLVIFYASINWMPILLKDA--GLTPKSATLISALFPLGG-VGAVLCGVLMDRFNANRVIAVCYALTAVSVYAiaAGNVGLLVLVVFVAGVLMNTAQSSMPALAAAFYPTEGRGtaWMLGVGRFGGIAGSFLVAELTRRHFSFAGVFATIAVAGVLACVALLI-------
     445 UniRef50_D0KH31        D-galactonate transporter n...   187     7e-46  1  12.7% 18:433   2:413     -----------------RKIKGLRWYMIGLVTIGTVLGYLTRNAISVAAPTLQDQLHITTQQYSYIVAAYSACYTIMQPIAGYVLDLLGTKVGYAMFAIIWAI---CCMGTALANSWGGLAIARGAVGMAEAAMIPAGLKASSEWFPAKERSIAVGYFNVGSSIGAMIAPPLVVWAIVAHSWEMAFIITGALSMVWAICWLIFYKHPKDQKKLSDEERDYIL------------NGQEAQHQTNNAKKMSAWQILRNRQFWGIALPRFLAEPAWGTFNAWIPLFMFKA-YGFNLKEIAMFAWMPMLFADIGCILGGYLPMLfsRKLVVTMGAVLMIGPGMIGLFSSPYVAIALLCIGGFAHQSLSGALITLSSDVFGRNEVATANGLtaAWMASTMFALVVGALADTMGFSPLFAALAVFDLLGAVVIWTVLK-----
     446 UniRef50_C1DKH4        Tartrate transporter n=10 T...   187     7e-46  1  11.6%  9:432  32:457     --------SPSKDSVEYQTMRKLGFRLIPFLVLCYFIAYVDRVNIGFAALTMNEDLGLSASVFGFGSSLFFVAYVLFEMPSNIAMERFGARRWIARIMITWGLVGFL---SAFVVGPISFSVSRFLLGAAEAGFFPGVILYLTQWFPKAYLARIIAFFMVAIPLSSFFGSPLSALLlqFQGWQWLLMLEAIPAIVLGLLALVCLPSKPSEAKWLAAEQKE---WLEAQLKKEVIERQEHAQDGKHDHGGKIKAVLTNKYVWLLALVYMGSSATSNTLSLWMPQILKS--FELTNTQAGLLNMIPFGIAAAFMIFWGIRTDKSGKRVlaLPLALTSISFAATLLTGSLVVTLILLTLVLMGNYAIKGPFWSLTSETLSpsAAGIAAINTLAHLGTGGMSALIGYLKHETGSFPVALLPLCALTAVGCMLVLLI------
     447 UniRef50_P94131        Cis,cis-muconate transport ...   187     7e-46  1  14.3% 37:435  28:406     ------------------------------------VDGADLMLLSYSLNSIKAEFNLSTVEAGMLGSFTLAGMAIGGIFGGWACDRFGRVRIVVISILTFSILTCGLGLT---QSFIQFGVLRFFASLGLGSLYIACNTLMAEYVPTKYRTTVLGTLQAGWTVGYIVATLLAGWLIPDHGWRVLFYV-AIIPVLMAVLMHFFVPEPAAWQQSRLA-------------------PSKQTETVKTSAFKLIFQDKRNRnfILWALTAGFLQFGYYGVNNWMPSYL-ESELGMKFKEMTAYMVGTYTAMILGKILAGFMADKLGRRFTYAFGAIGTAIFllIVFYNSPDNILYLLVIFGFLYGIPYGVNATYMTESFPTAIRGTAIGGavGRLGAAIAPATIGFLASGGSIGLGFVVMGAAYFICGVIPALFIKEK---
     448 UniRef50_D1P1K9        Major facilitator family tr...   187     9e-46  1  11.4% 23:407   2:413     ----------------------KRIFLIVAVCLGTFMATLDISIVNVALPVIGQELNANLSMLQWIIDSYALCLSALILSVGPISDRYGRKKVWLTGIVIFTVGSLICAFSLSAQ---MLLFGRVIQGIAAAALIPGALSIITQAFSNdeRIKVIGIWSAVSALSLIIGPILGGFLVDTFEWSFIFMINLPIGLLTLLLGGLGIKESADPDKAALDPLGQLLSVVALAGLTYGLIEAGDMGWAspRPLLPIFLFKQNPYFLQYNLASFALGFATYSNVFFIALFL-QKGQGWGAFEAGLRMAPEFIAMALFSFSFGRLSRTLSVRNIMVIGFLLIATASMLLTRVNSDtiAAILFILGAGMGMATPAIGALVMASVEKAYSGIAsmNALRQTGMTLGIALLGTLMTH-------------------------------
     449 UniRef50_A9WTP1        Multidrug resistance protei...   187     9e-46  1  13.1% 13:417  15:453     ------------PEPGQAYSHRQIMTILVGLLLGMFLAALDQTIVSISIYTISNDLN-GLSLQAWATTAYLITSTVSKPLYGKLSDIFGRRPLYVIAISIFLAGSI---YAGFVHSIGELAVARGIQGLGAGGLMSLGLAIIGDIVPLKDRGKYQGYFMSVFGISSVLGPVVGGFFAGSsgWRWVFLINVPIALAALVVVWMFlkEGARQKVDYWGAASITLALVPLLIVAEQGREWGwaERMAGDSALIPLRFFKIPAFGVSALLNFIIGIGMFGAIAMLPMYL-QLVAGLTPTEAGLLMITFTVGILVGSITSGQVISRTGTYRvlILGASALAMGLLLGVDTSLLVPGGIAIAFGLGLGFCMQPLTLSMQFAVPPkgVATSTATFFRSMGGTVGTAVFISMLFATAQDKIATLL---------------------
     450 UniRef50_C9KL50        Major facilitator family pr...   187     9e-46  1  11.3% 24:411  24:434     -----------------------RTKILLTMMMSSFVTPFTSSALTLSLPDIGRDYGASANELGWVLEIFLLASIVFLLPMGKLADRFGKRRVFLWGTVLFTLSSALCIVT---PDMGFLLAARALQGVAAAMLYATNMSIVALSFPPEQRGRALGWMVSMVYVGLACGPVLGGLLNYYAGWQSIFVFITAACLACVVMTKLYLHQEWReaMFGLSELAELDWGWLALVLGLVLLIAFVRHEMKAKDPILSIYIleNREFSLSNLTAMINYSATFAISFLMSIYL-QSVLGLSSREAGLVMLIQPIVMAVLSPTAGKLSDSHSPTRIVTVGMAITALGILGLVAvsLWLVVPVVVIIGIGFALFAAPNNNAIMGAVPKrsLATSMIGTVRLVGQVISVAIVTMVLSLDWNW---------------------------
     451 UniRef50_B8IGK8        Major facilitator superfami...   187     9e-46  1  11.6%  7:437   8:433     ------TAANFPPTSVPDPYRRVSLRLVPFLMLCYVAAFLDRVNVGFAKLTMLHDLGIGEAAYGFGAGLFFVGYFLFETPSNVLMHRIGARATLSRIMILWA---FISGAFAFVQAEWQFYTLRFLLGAAEAGFYPGVILYLTYWFPSARRARVIALFICAIPLSGLLGGPLSGWilSLHGWQWLFLVEALPSLALGLLVLAYLDDTPNKSSWLSVEEKAAI--------QRDLDEDQSLTPRRAGWAGVLSGI-----VVLLSIVVFCQAMGQYGLSFWLPTLIAQAGA-KDPLTVGLLSAVPFSVAIVCMLLSAWNSDRTnrRWHLAIAFLVGGVGLSASTFLTgpASMVALCIAAAGCYTVSALVWSLPPLFLtgAAAGIAVINSFGSLAGFLSPFAIGWIRETTQSTNIGMLAISVFMMVGAVLMFIVPKPTT-
     452 UniRef50_B8IEH9        Major facilitator superfami...   187     1e-45  1  12.2% 11:436   4:427     ----------ANDELEARTIRKVAWRLLPLIVIIYLVAYIDRTNVSFAATgmSNALGLSAKDFGFGAGIFFLGYFLFEVPSNLLLEKAGARRWIARIMISWGLVAAAMAFATGPTSF---VIMRFLLGVAEAGFFPGVILYFTYWFPKSYRSRVLASLYVAVPVSNAVTAagLDGLFGLAGWQWLFIIEAAPAVLLAFVVLRYLTDTPAKAEWLQPDEKAWLC--------STIEKERQDLLRQESGHMTLRRAFTDVRVLSLALMYFTIVTATYGITYFLPQIVK--GIGGSNLQIGLISAAPYIVGTVGLLAWSWSSDRMRERKwvVACLLGAGGLAAAGFYGSTMMAVVAIAVATVGLYGCKPAFWTMPSEFltAAAGGIAMINSIGNLGGFVGPFVVGWIKDATGGFGAALGFLTACAILSALLTVVTVPSR--
     453 UniRef50_Q7N7U6        Similar to 4-hydroxybenzoat...   187     1e-45  1  12.5% 10:432  12:436     ---------SVQDTIRFAKISSLHIKILFLCLSILILDGFDTALIGYIAPAIVDSWGISKTDLGIAMSSALVGLSVGAVTSGPISDKLGRKPVIVISVFMFGICSIATIFS---TTVYQLSFWRLLTGIGIGAAMSNALTLISEYAPENRKSLMVNSVFCGFPFGAAMGGILGSFMIPKFGWESMLVIGGIIPILLVVPLIFILPESVLFLINKNKSEDKIKRICKKIVGENYNKIDFSreKQKIKPINEILSHGHLSSTLLLWNAYFMGLLIFYVVTNWMPILIKDS--GFELSYATILTALFPLGGGIGTIISGIIMDKLSPHKIVSFNYLITGILLFSIGYVDniSLGILILLAGTTMNSAQASMGTIATLHYPtrATGVSWMLGIGRAGGILGAMFGAWLVQLGLGYRGVLMTLFIPSAIASISLLSL------
     454 UniRef50_B5FLH6        Probable glucarate transpor...   187     1e-45  1  11.1% 19:432   6:422     ------------------KRTKVRHTILIFLFLATVFNYADRATLSVVAPIMNKELGFDPEAMGLAFSSFGIAYVIMQLPGGWLLDRYGSRLVYGCALIGWSLVTMFQGTIYLYGSpiVLVILRLLMGAIEAPAFPANSRLSVQWFPNNERGFVTSVYQAAQYISLGIITPLMTIILHNLSWHFVFYYIGAIGVMLGIFWLMKVKDPMHHPKVNQAEIDYI-------RSGGGEPSLGCKKEPQKITFAQIKTVCVNRMMIGVYIGQFCVTSITWFFLTWFPTYLYQA-KGMSILKVGFVASIPAIAGFIGGLLGGVFSDWlaRKLPVICGMLLSCVIVIANYTSSEFVVIAAMSLAFFAKGFGN-LGWCVLSDTSPKEVLGIAGgnMCGNMASIVTPLVIGVILANTQSFDFAILYVGSMGLIGLISYLFI------
     455 UniRef50_B4RF98        Major facilitator superfami...   187     1e-45  1  12.6% 10:428   2:415     ---------SVDAVPAPKVSASYRYMVVWLLAVVYTLNFLDRQIVSILAEPIRKDLQLDDTQLGMLSGifAIFYTGFGIPVGWLADRARRVWIISGACALWSLFTALCG---TATNFVQLALYRMGVGIGEAGGSPPSYSLISDYFKPEERGTALAIYSLGVPAGSMFGSALGGWIAAEHGWRTAFYVMGVPGIILALVVLLFVKEPKRGGLDKIA-------------------DGKDAHDAAPPLWTAIGGFFSNRTLVLTAFAAGLSAFVGYAALTWNPPFLMRVKGMSLTEVAAYYSLVLGITGMIGTFAAGWIADKLGAkwIPALAFFITIPFWFGIVYAPTwiALICIAVPALLNNCYLAPALAVVQNAVPPNRRTISglFVLNLIGLGAGPVYVGRISDManSLSIAFLALVPVIVITILA----------
     456 UniRef50_B2T8V6        Major facilitator superfami...   186     1e-45  1  13.6%  1:435   1:429     MGTSPCRTSNRK--METSVESKFRWKVMGLMFLIAAVSYLDRANLAVAAPVIRAQMHFSSSEMGFILSAFTFAYAIAQVPAGFIANRLGPRKCFFYFMWLW---CALLVATTTATSFTSWLGFRIPFGAAEAVSWPALAFLMSRWFPRIEYSQVSSIQNLGLVIGSAVAPPLVSAIILVAHWQAAFIITGLMAGLLGTFIWFYLKDDPSTDSRVSQAE------------LSWILHDKGQETTRPIPPGFWKLIASRPSVWACALACFGLNLINFLFLSWYPTYLTDTYQ-MSMSKMGLLAAQPYVFALVSVFGAGWLVRRMVerRVIFCGLFLGTLCLfaVSVDNVYVSVTAMSFGYAFVMSILGPMWAMAPEVGGPRGASvsIMNCVGLFGGIVSPITMGYSFQLFKSYTPAIVVSASITLLCALVFAKTFRS---
     457 UniRef50_B0U9X5        Major facilitator superfami...   186     1e-45  1  11.1%  3:434   4:431     --APPSTSTTTADETLRVATAKVMRHLLPMMVFIYFLSFIDRTNVALAKSAFQTDLGITPAMYGFGAGIFFWGYALLEVPSNLLAHRVGPRRWIARIAVTWGALSAAMMF---VQGEWSFYAFRLLLGVAEAGLFPALMYVTTLWFAQRDRAVAVGWIYTAPAMGLTIGNPLGGALMqlHGWQWMFLLEGVPTVIFGIVLWFIFPDRPRDARWLTPAEAAAL----------ESNASGETVHQSHAPSKEWISAIKRPSTIVIALIYLFNQIGFVGLYFFVPS-MVQQMQANTPLMIGLLSSTVGIGFLLGVLILPRVKRFFTGDMLflITAGLLASSILFLLTTLPAIQLVLFTTTAFFAGGILPIFWSVAMKRLhqAAAGLAFINTIGLIGGFIGPYIFGLVEKETGRSASGFAVIALTSVLGLVLIPILAK----
     458 UniRef50_B8I5X8        Drug resistance transporter...   186     1e-45  1  12.2% 17:408   2:416     ----------------HQLTQKRKTTVMIALMATMFFAAINQTIISAALPKVIAQLG-GMDYYSWVITGYMLTSTISTVIFGKLSDIYGRKIFLLSGIIIFLIGSFLTGLSA---NIFQMIAFRGIQGIGGGILMSISLTAVGDLYPPQERAKWTGVMMSIFGISSILGPVLGGVMVDYVAWKWLFWIFLPLGVIALIMIWSLFPKLSGNSSESIDYLGSIFLALSITSLLLGFSWAGTkiERNAKSPVMPLSMFKNKGVTISFVASFVMSGGMMGAMSYIP-FFIQGVKGHSATTSGLLNIPMSLMMIIFSTLVGRWMSKYGNYRLFAvgLGIMSASMIIMANMNnvWAAISLIIFGVGLGFGMTVFTTTAQNSAPTSQLgtASCTLFRNLGGTIFIAIFGSIMNTS------------------------------
     459 UniRef50_UPI0001C314E7 drug resistance transporter...   186     1e-45  1  11.2% 23:414  18:435     ----------------------NPWLTLVAVALGVMMVGLDGTVVGVANPTIAADLDASLAGLQWVTNGYLLALAVLLIVGGKLGDRFGRKKVFVIGIAGFALTSLLC---ALSTSTGMLVGARVLQGVAGALLMPNTLALLRAAFPPAELNRAVGIWGGASALAVASGPIVGGLLVEHVSWESIFLLNLPLGLLAAVVTLRWVREsvPGVALLSGGLFLLIwvIGFGIAALVTLAGFVVREARTREPLLPLELFRNRSLSAGVVLVVTGFFALFGILFFIGLYL-QNVHGYSPIQTGVRLLPLTATFTISAPLGGLLTEKFGPRVPLCLGMLILAGCFFGLTGLEVDTGypFYLLIGLAMGFVIVASTEAIVGNAPVERGGLAGGltANQLGGVLGTAVLGSVIVSGVGSALA------------------------
     460 UniRef50_B8DCW5        Major facilitator family tr...   186     1e-45  1  13.7% 22:414   6:434     ---------------------KRKTLALISIMLGAFISLLDTTIVNVALPDITTALHATSETIEWVISGYALAFGLVLILAGRLGDKFGRKNIYIIGITLFLIMSV---TAGFADSENSLIISRVIQGLAAGLFFPQINATIMDMYSGKSLGKIFGILGSVIGVGTAIGPLTGGLLIELfgWRAVFFVNVPFVLVTLVLAMLYLprTVSAKKISFDLPGVglLMALSIPLFIILYKWSVYQEKKGNQPLIAPNLLKNNQFVSGMLLSLVYFAAFTSIFFVL-SLTWQTGFNRSAILSGLAISPFALGSVLAASNSYRLIPILGRKLLMLGVALVIIGLGTVsgAFSAWLLFLPLFIAGIGSGLTIAPLNSFTLSTVtdRGGASGMFNTAQRIGSSFGIAVVGSVFFRTLGNTAA------------------------
     461 UniRef50_Q4K783        Drug resistance transporter...   186     1e-45  1  11.7% 15:398   5:414     --------------QQPVSPKPAIRSVLIALMLAIFLGALDQTIVAVSMPAISAQFK-DVGLLAWVISGYMVAMTVAVPIYGKLGDLYGRRRLMLFGMGLFTLASLFCGLA---QNMEQLVLARIFQGIGAGGMISVSQAIIGDIVPPRERGRYQGYFSSMYAVASVAGPVLGGYMTEFLSWRWVFLINLPLGLGAWWVAHRTLilPVPQRKPIIDYLGTVLMIIGLTALLLGItaLFVWHERRAREPLLPMHLFTNRNALLCWCTIFFTSFQAISLIVLMPLRF-QSITGAGADSAALHLLPLAMGLPMGAYCAGRLTSVTGRYKPMILSGalSILGMALVPPQSELLSGLFMLLCGSAGGMQFPTSLVGTQNSVEQrgVATSTTNLFRALGGAVGV----------------------------------------
     462 UniRef50_A0Z3J4        General substrate transport...   186     1e-45  1  12.5% 24:431  13:414     -----------------------RHSLVLASFFALFIAYLDRVNISVAAIAMQETLGWSETEKGFVLSSFFIGYMAAQILGGVLADKYGGKRVLIWSMVAWSIFTILTPIAASA-SFFALILIRIGLGLGEAPLSPAVLSLFGRWIPENERSRAVAIYSSAAIAGTIAALLVTGFTVARFGWQSVFYVFGGAGLIYALWLNRTIHESPDLHPNVSSSERALLAGSVI---------------SEDRAPIPWKTIWSLPAIWALLVTFFCTSWSLYVFMSWMPSYFT-SVHGLDIGSAGIYTMAPWAAMFVMMNVAGWIADGLISRrmQTIGLLGSAAFLLVtfVTTPEMALLSLCGALGLLAFAYSGSAPNVLDIAPRFGGVvgVMNTLGTLPGIIGVATAGWLVDTTGSYDSVLLLAASVSVFGAVVYIV-------
     463 UniRef50_A8G9X3        Major facilitator superfami...   186     1e-45  1  13.3%  4:386   2:386     ---AHSTELNIQQAIDDSKFSLFHWTLIILGFLILAIDGFDTAAMGYIAPSVAKDWGIVKQDLGPVLSAALLGLSLGALVAGPISDRIGRKRVLVFSCLFFGLSSLAT---AYAGSLNSLTLWRFLTGLGLGAAMPNAITLISEYAPQRCRSLAINTMYCGFPLGAAGGGAISSWLIPAYGWHSVLLLGAIAPLVLTVLLILFLPESVKYMVNRGKDAIKIKRIAQRFVslDNVTRFYLYEEKLAQSKTSVGLLFTRpgTLMLWLTYFMGLVIYYVLLSWMPILMQ--GLGYQLEQSAILTSLFTFGGTLGILVAGWLMDRWNAHKVVSSGFVITALLIVAMATEDSHIVLLgiFLMGITMNGAQSGLQTLAATFYPTHSRATGIA----------------------------------------------------
     464 UniRef50_D2B7D6        EmrB/QacA family drug resis...   186     1e-45  1  10.0%  2:430   5:459     -TSEHRAMSAHSPPGPSLGRRSNPWLTLIAVAIGLFMVNLDASVVSIANPEIGRDLNASTADLQWVTNAYLIAMAAALILGGKLGDRFGRRTYYMIGTIGFTIASVAIGLAG---SIEGVIAFRAAQGFFAALLIPNTLGLLRAVFPPKKFGMAVGLWAMVASCSTALGPIVGGLLVERVNWESVFYINAPIGIIALAVSALVLPQSkhHRFDIPGVIMLALGLVAllVAGVAILVAFGWYETRVRHPLLPMRLFRSPSLTIGTIVTAINFFVLLGVIFFLMLYL-QNVRGFTPVEAGVRTLPLSLATVVASPLGAALTGRFGARLSMPIGMMLQAAASFWmaHSSYAAVWPPFLALGLGVGMVMSASSDAIVGSAPAKDGGVAGGvtALQIGGALGTSVLISLVSSRVGSTLTGELIDAGVPASAAGAF--------
     465 UniRef50_Q39MF3        Major facilitator superfami...   186     1e-45  1  13.2% 15:415   1:421     --------------MSNSSSKVRKYVGLTGICIASFLGCIDLTVVNTILPAIGRDFSIPIQTTQWITSIFMVALSAFMVPVATLADNLGRKKLLIIGLVIFGAASL---FAGLAHQFWLLVAFRFLQGIGCAILYTVSGAIVSYTFDESEQGKALGILFGANGVGLALGPIIGGLFAGALDWHDAFLINIPFIVISLALCAWAIPEFKAQARKRIDVTGCLlfTLGLLPVSLVALALFVWHELRTRDPIVEFHFFREPRFLSALLATFFLAFFYCIVLLTLPIFFSTQLHKSDITIGLFLLPATITFSIASSWIGGR-SERLGPSRVIVTGLALFVVASILLSVadASWFIVPLLLFGIGWGAILGPSTLVALGALPREKAAVAMGttVHNVGGASGIAFAIFLMRHVDDFRQGY-----------------------
     466 UniRef50_Q8XQ69        Probable transmembrane effl...   186     2e-45  1  12.0% 22:413   8:424     ---------------------RTQKWVLILTSIATLMAMLDAMVVATATSAIRADLGASLSALQWTMNAYNLSLAALLMTGAALGDRFGRRRVFVTGLCVFVAASIAC---ALARSAEWLIAARVVQGAGGALVTPLSMALLSAAFPPERRGKALGLFGGITGLALILGPVLGGVIAGNLPWQWIFWLNVPIGLPLIVLAVRRIPDSKGPAAALDIPGALLVMGASIGLVWGLMRGsfVLWERRAKHPMIPMRLFASRAFSSGIAACFLFYAGMYGVVFFLPQFF-QSAQGHDPFAAGLRLLPWTVTLFFIAPLAGSMVDRIGERSVMVTGLLLQAIGFAWIAWAASPglVAPLVISGAGISMAGPAAQKAVLGAVTVqgKASGVFNMFRILGGATGIAIAVVAFSIWGNLGS-------------------------
     467 UniRef50_C4FBR9        Putative uncharacterized pr...   186     2e-45  1  11.0% 16:398   8:414     ---------------AASAGSSNKWAILLTVLIMTFMATLDSSIVNVALPVMQKALGAGLDQIQWISSVYLLTMCAFLLVFGRLGDLYGKVRYFEIGVVIFSIGSLMCG---MSTSLPALVASRAVQGIGGASAMANNMGIITEAFPARERGRALGLLASFVALGMMCGPVLGGFIVSMFPWEGIFLINVPVGILSLVIGHFTLPRspECAGQSMDVKGAVLLVPGMLLTFLSVtvFFGLHERRVEHPLVNLAIFSDRHF-AVNVVCLFISFVAIGVYELMTPFYLQDARGFDPGASGLIFCIIPLVNAVAGPISGAVSDRIGCNLLTVLGLGAFSVGLYLtmTATLPQILFYLGLASFGTSIFQSPNNSLIMGSVSTEMLGFAGSVsaRYLGMAVGI----------------------------------------
     468 UniRef50_A8ACG7        Putative uncharacterized pr...   185     2e-45  1  13.6%  6:432   1:425     -----MSIVNVNTEEEKLKATTVRWRIFIIMLLLGAINYIDRTSLSIAMPYITDEFGITDtvVGVIHSAFFWAYALMQIPSGVIADKFKARNIIALATILWGAFQAV---AALCHSIFTLSLSRLGLGVTESPIMPAGAKLMGTWLTPTERGRGSMLLDGGAPLGTALGAviAGLIAFFDSWRMAFVVAGVGTMLVGLLAWWYIRTYPSEHPRINQAE-----------LDHITAANGPATNSKKYRLADIKPYLKQRNVLALIGGWVCYSFVFYGLMTWLPLYF-QATYGFDIKSMGGAMALIFLLCFIGQLTGGYIMDKWRSktMLAISATTAGVGIFLCAQSSTPAIAITLLTIALFPLRWASVYWSIPGLLGAQSVAGtgTMNFTSNLFAAILPIFIGFLVQSTGNYYAAMMFFALAAVGYLICSLLI------
     469 UniRef50_B8IWA9        Major facilitator superfami...   185     2e-45  1  15.5%  7:432   4:449     ------ATANADPILSPKAATRFRWVVMNLIFVVYTLAAADRANIGIVLPFVKKEFAMSNTEAGAVVSLFFIGYSVMQIPAGFLVRKLGTRTVFPIFMLLTSLFTGLLGTAGSA---LAMKLNRLALGFAEAPLPVSMLSTMNRWFPAREKGTAVGLFLAAAKFGPVIVPPLGALIIATLGWQYVFFVCAMPGLIFAVLWYFLVVDDPARSRFVSAAEVapVTIAAEPSKGRFSRLDRVIRGRRVRLIATAKETFRSGNIWGLALGYLMMTGIINVILAWLPTYLT-NVKHFSLMNVGFVASAPFVGGVLGNIIGGWFSDRirRKPTILISAISTVFMMVALIQAppVTLATLLFLTGFLLNVGYSSFTVYPAGLTTKDalAVSVVNTGGQAGGALFPFLTGLLLDAYSWDAVFLFLGASSLVALAVMLLVV------
     470 UniRef50_B2I132        Permease of the major facil...   185     2e-45  1  11.0% 13:429   3:444     ------------ATPTHQALQPEYRLLVLLVSIGFFMQALDTTIVNTAIPAMAHHLNEDPLRMHSVVVAYVLSVAACIPLSGWLADRFGVRNTFLSAIIIFTLASLGCGLS---QSLNQLLFFRVIQGVGGALLLPVGRLSLLKIIPRTQFLAAMSLMSLAGLLGPLAGPTLGGWLVEVATWHWIFLINIPMGVLGILMTLKVMPNVKEPTVKTFDLIGFVLLVVAMIGWSLGIEHLASphSHTHQNALFRSRLFRNKIYAIGILGNFFARFGGNALPFVLP-LMLQVAFGFEPFIAGLMMIPLVLGSLFSKPIVRPIIQKMGYRRFLLINTTLVGLCIASFAIMTVDTPTWffFLFGTLNSLQFVGMNTLTLKDLPqaSSGNSFLSMIMMLSMSIGVALAGTLINVFTDYYGTAHVTTAFHVTLICLG---------
     471 UniRef50_C8XHI6        Drug resistance transporter...   185     2e-45  1  11.1% 22:410  36:458     ---------------------PKRWKALSVLVVGLLVVILDNTILNVALKTIQIDLDATQNELVWAINAYSLAFAALLFTWGVLGDRFGRKRILLIGLVLFGFASALCAFAS---TPGQLIAFRALMGVGGASVMPISLSIITVIFPPQERGRAIGVWSAAVGAAVAIGPVLGGLLLEhnDWGSVFFINVPVVIVGIIGIVILVPETKNEHPGRLDPVGLVLSVAGLFTVVYGIQNASEVgeHRSTHPSIDLSLFRIRSFSVPLTGVTLAFAAMQGTLLFL-TFYYQIVRGWSPLQAGLLVLPFAVGQLLGAPRSAGMVKRFGARVVIPVGLAFAAAGMVFFSVVTpwMLVVLGVVFGFGLGNTIAPSTTRMTLATPPARSGSGSanTVRQVGAVFGVAILSSIVTTVYS----------------------------
     472 UniRef50_C6IZA1        Drug resistance transporter...   185     2e-45  1  13.4% 41:406  26:414     ----------------------------------------NQTIVSTAMPRIISILD-GMDYYTWTINIYLLTSTIATVLVGKLSDMYGRKPFLLIGILLFMMGAFMTGTSS---DVFQFIAYRGIQGIGAGIIQSTAFTAVGDLFPPRERGKWMGLMTAIFGFSSVLGPTLGGYLVDHMDWHWLFWIFLPLGIVAFIMILSLFPKMERGSSQSIDYVGSLFMTTTIVPLLLAFSWAGTtvESKAKNPILPLHLFKNDVVTISNIIGFIMNFGMMGALIYL-SFFVQGVLGISPTYAGYVTMPMSIVMVVASAITGQLIAKKGKYKQFALFGiiMIAGMVIMIFmsVPVAILSMIVFGLGLGVGMPVFSLATQNAVPHkgVVTASTQLFRNLGGTIGIAVMGTVMS--------------------------------
     473 UniRef50_C7Q642        Drug resistance transporter...   185     2e-45  1  12.2% 20:414   1:427     -------------------MTAAQRWVLTLTSLAAFMIALDGTIVTTALTTIRKSLNTSVEALEWTVSAYILTFAVLMLTGSALGDRFGRRKVFVGGLTLFTAASAACGLSS---TVAELIAARAVQGVGAAVIMPLAIAQLGAAFPPQERGRAMGVSAGIIGLATAGGPFVGGVVAQGLAWQWLFWVNVPVGVLVIAGVLLKMSEtpQGPRARLDLVGVLLTTGGVLGLVWALVRGNDAgeLRVPAPMVPMHFFTHRAFSAGNVASFTMTGAMYAQLYFLAQYY-QTVLHYGPFGAGVRMMPFSATLLVFGPLSGRLADRLGERRLVSTGLAVQSLGLVAIAlaAYLAMVPALVLSGAGVSTGIPPTQKAVVSAVQPHQIGQASGVflRQFGALFGTAVSVAVFAASGSYASV------------------------
     474 UniRef50_B1VTL7        Putative permease of the ma...   185     2e-45  1  12.9% 22:423  14:451     ---------------------RRRWFALAIVMTAAFMDLVDVTIVNIAIPSIQRETGASVSAIQWITAGYALAFAAGLITGGRLGDIYGRKRLFLIGIGGFTLASALCGFAG---SPEMLVAARILQGATAALMVPQVLSIVHATFPAHERGKVFGLFGAIVGLGAVSGPLLGALLTEwlGWRPIFLINLPVGIAGLLLGAKFITESKAPRAVRLDLPGVALITLAMLMLIYPLTRgqRRRATGDGSPLIELSLFRVKSFAAGIAVQLTFGVGL-GIFFLVWTMYMQMGLGWSVLRAGTTGIPFSVasVAAGISVQKLVPRFGRKVLQAGALLMIAGLLIYLwgITSWQMAVPLVVMGVGMGLIVAPLTDAVLSEVPKEHAGSASgnTVQQMGTALGLGLVSVVFFGAIGDRLAPAEVGPAFV---------------
     475 UniRef50_B4RA76        Major facilitator superfami...   185     2e-45  1  12.2% 12:437   2:422     -----------QALDEARVLRKVALRLLPFIGLLYFVAYLDRVNVGYAALTMNADIGLSAAAYGAGAGIFFLGYFLFEVPSNLILEKVGARRWIARIMVSWGLLSAGM---ALIDGPVAFYVVRFLLGVAEAGFFPGMILYLTYWFPWSERGRIVAAFMLAIPISAVVGAPLSTALLdlAGWRTMFLLEGLPAVVLGVVVFFWMTDRPAAAAWLSDPEKATL----------QQALDRDHVAAEDSHLHSLRHALTSPKVWKYAFVYFGAVMGSYGLGLWMPQI-VKGFGGLTNQQTGLVTAVPYLLAAIAMLLWGRHADRTGERLWHFILPALLAAGGFLLAATstAVQFAGLALGAIGVNGACSAFWALPTRFlsAAAGGIALINSVGNLAGYLGPYVMGFLRERTGAYGAGLLALSAALVASALLAPAWSRRRS-
     476 UniRef50_UPI0001B544DB EmrB/QacA family drug resis...   185     2e-45  1  12.7% 12:413   2:435     -----------AGESREGGFARSPKLILAVVSFGSFMSSLDMSIINIVTPVMAREFGSSLAAMTWVINAYLIANAALVILCGRLGDMFGHRRMFLAGATVFTVASVGC---AVAPNLEALLISRAVQGVGSAMLYPQAMAIIVAVYPAAKRGAAIGIWSAVSSLASVLGPLIGGTLTSLASWRANFVLNLPIGIALVVVGAFVLPAAGARQRQRLDWLGATLVTAALVGVSFGLIEGevERRKQGHSPLISFQFFRDRNYTLMVPATTTVSLVIVGTMLPMAMF-GQYALDFSPAQVGALMFPIFVTVAICAPLAGKLADRIGGKRVFLAGPVFFGVGILWFVGVADIDTWwgLLLVGMGLSCTFTPLNSLAMHNVPKQLAGSASGitARQFGSVIGGSVMAVLMQAFLASAV-------------------------
     477 UniRef50_B2TAU5        Major facilitator superfami...   185     2e-45  1  13.7% 12:433   2:420     -----------TAINEAVTMRKVYGRLMPLLFAMMFFNYLDRINIGFAALDMNKQLGFSPAVFGFAGSIFFVGYMLLEVPSNLLLHRVGARRWIARILMTWGAVAAATAFVFNDSSFYVL---RFLLGVMEAGFLPGVAVYLTKWFPVRYRARAVGGYIIAGSFSAVLGGPISTALMTYagWQWMFILEGVPAMLLGLLTLRIMTERPADADWLSDDE----------KRWLESTLSAERQAVGGNAHVPLLRVAGDIRVWSLACLFGCALVGIYGLFLWLPQI-VKSLGHLSNLEVGFLSAAPPLLGVLGTFLISRSSDRTgrKKHLAFVYGMSALAIAGSAYAPNPvaYVLLCVTGLFIYAGNPLFWSLASSfgAAGAATIALINTIAQFGGLVGPWSIGLVRNATGNFKLALLTIAAFLIVATIIALVMR-----
     478 UniRef50_C4GKQ5        Putative uncharacterized pr...   185     2e-45  1  14.5%  4:430   2:439     ---PQPQEINIRQLLDRSPISFYQKLIIALCFFIVVADGFDVAIMGFVAPYIKADWQLTNNALAPVLSAALAGLAVGAMITGPLADKFGRRKVLLGNVLCFGCATLL---VAHAGDIWQLVVFRFIAGCAMGGIMPNAATLVTEFSPARKRAFLITIVFAGFTVGAAGGGFLAAWLIPHYGWHSVFYVGGITPLVLSVIMFFRLPESIGFLIHKRGDQAQIRALvvFVLPHHTLPSEAEAAASNESPVQTVLNAHYRAGSLLLWLAYFSHLFLVYLLGSWMPTMIKES--GMSAEQASIVSAMFQLGGPLGSVAVGWLMDRFNAGKTVALWYASGALVLVGlvLGSYALMCLLAFLLGVSLNGGGTGMNALSSMFFpaRATGNGWMHGIGRIGAFASAFAGAWFLNWGWDFKTVATVLTIPALLVGIALW--------
     479 UniRef50_A0QQC4        Putative permease of the ma...   185     2e-45  1  14.7%  1:430   3:425     LNDETHIPTTASTSRPTGRPTRIRWYVGALVFVICFVAYLDRIVFSVSATSIMEDLHLTPVQFGLITTLFNVGYFVFQIPAGIFIERAGTRRAMTVALLLWSVFT---GMTGIANGLLMLALSRLAFGAGEAPLFPTANSIFARWFPPRERGKATSLMNSGAFLGTAIGAVLLVPIIGHLSWRGAFFTCAVVGGVLTVASHVFLRDHPAQHAKTNDAEVRLI--------------EDGTDLPATSGGAPWRLFLRQRSFWALAVGFFGTLWTIQFFVYWLP-YYLQHALAVPFSAVGRYTSIAFACITVSVLVAGLVSDRLLrlVAVAGLAVAAVCLVVSLTSGSVLVSVIWLSVALGGAGFAQTLAWTIATDIGRAHTAAVgwMNAWGFVAAAIVPTLAPVLARDLGWTPVILVNAAVAVVGIGGFLL--------
     480 UniRef50_B2JSF8        Major facilitator superfami...   185     3e-45  1  12.3%  7:422  77:483     ------RNEEANVVRKTWSVGRLRWAMLALVFAATALNYIDRAALGILQPILSVSLGWTTMDYANINFWFQAGYAVGYFLQGSLIDRLGVRRVFFWAVLLWSLAT---GAHAFTTSVAGFMLCRLILGLTEGANYPSGVKISRLWFPPAERAIATGIFNGGTHIGAILTPIILPALLFAFGWQAVFIGVAILGLAWALVWARCYYDPKDHPWISASEREYV-----------------KSDDEKPAIKVPLHRILVMRGTWAFALAFSLTAPVFWFYLYWLPPYlqQYSLGISVNQIGLPLIIIYVAADVGSIGGGLISSFLITrrLITMFLAAVLVTSVVAANSNNLWTAVLAIALGLAAgaWITNIYNICMDYTPKELVSTVFGFGGMCAagMFMTQVVGYVLTTTHNNYKILFMGIPGL----------------
     481 UniRef50_UPI0001B547B6 drug resistance efflux prot...   185     3e-45  1  10.2% 17:438   3:463     ----------------ATNKGPAPVWALIATSLPMFMVSLDNLVVTNALPKIAEQFSVKQSELQWVMNGYVLAFAGLLLAGAALGDRFGRRRVFLWGVGLFTASSIGC---AVANSVATLVIARVLQGAGAAAILPVSLTLAVAAVSREQRNMAVGVWGGVNGLGIAVGPLAGGLVTEQIDWSWIFWINVPVGVIALPLAFWAVKEsvWGIVHAADHGWTQSTTLIGLGAAAVLAVAFIMNERRSASPLIPLHMYRVPAFVLSNVVSITMYFGVFGSIFFLSQFL-QGPMGYSPFEAGLRTLPWTVAPMIVVPAAMGFVDRIGGGVLQAVGCALQALGLGWIAlvGYGSMVPALALAGIGMGLVFAGNPATVISAvsEHNKASGANNTSREFGGALGVAALTAVFSrtDSLQSALWIGTAVVLLGAVSALFIRRRTTQ
     482 UniRef50_A8LYI3        Drug resistance transporter...   185     3e-45  1  10.6% 13:436   2:474     ------------TPPSLRLRTPAGVGTLLAAVLASGMVFLDATVVNVALPRLGDDLDATVSDLQWTVNGYLLMLAAFVLLGGALGDRFGRRRVFLLGVVWFTVASVLCGLA---QDTGQLIAARLLQGAGAALLTPGSLSVLQASFHPDDRGRAIGAWAGFSGVSTALGPFVGGWLIDELSWRWIFFLNVPLAVLVVLAALRWVPESrrRRFDVLGALLGAVALAGVTFALIDAPARGVaeRRRGETAMLPTGLFSSRLFSVLNIFTVVIYAALGGFTFFVAVYL-QNVAGWSALGTGLALLPVTVLLLVGSPLAGDLATRIGPRLPLVVGPVVSAAGLILLRQVGADASYwgVVLFGVGLTLVVAPLTASVLAAVADRFAGVASgnAASRAGGLLAVAALPLLVGLSGtrGALAWCAGLLLVGAVLAAVFVHRPR--
     483 UniRef50_Q7ND04        Gll2822 protein n=1 Tax=Glo...   185     3e-45  1  12.8% 23:406  19:428     ----------------------NKWAILLAVSIGTFLVPLDITVVALALPDIESSLRTSFADLQWIINGYNLSFTAFLLAAGTLADRFGRRRLFLVGLALFTLTSLTCGLATTPLTLTL---ARSIQGLGGALLLISSLAILSQTFREgeRANAFGVWGLVMGVGASLGPMIGGLLVDLLSWRWIFLLNVPIGVGLVAFTLSKVDESRDPGAARVDWLGLTTFTSALFSLCFALIQGNELgeRRQSQPMFDLSLLGNPAFVGTSLLAASNGASFWAMIVYLPLFF-QNVLGYSPLQAGLMLLPLTVPLLVCPPLGGRLAQVLPARLLLSGGMLMVGLGFVWmaGSPWTAFLPGFLLAGIGAGLINAEIANVAIAVLPPQRSGMGSGitFRHGAHALGIALLGSLLT--------------------------------
     484 UniRef50_Q2FLU6        Major facilitator superfami...   185     3e-45  1  12.0% 26:401   9:405     -------------------------VLLLISSLASFLVPYTVSSLNVALPAIGSSFGLDAVTLGWVTTAYLLIAAVFMLPFGKLADIYGRKRVFIIGTILFAIGSLL---AAISWSGSVIIIARMIQGLGGAMVFSTSMAIVTVVFPPGERGRAIGIITATVYAGLSLGPVLGGFLTQMYGWPSIFIVNVPLALIVVVLTILFLHDEWKDLKSGFDSGGAVLYGCMLMGIMYGLTVLPSPaeQKQERPLIRLSTFRTNRTFLCSNVAAMINYAVVFAVGFLVSLSLQYTRGFDPATTGMILLAQPLVQTVVSPLAGKASDSVEPAIIATLGMAATTIGLGVLLIvsVLWILAGLVILGLGYGLFSSPNTNAIMSSVEVTDLGMASGmtMRTVGQLISLAIA-------------------------------------
     485 UniRef50_C1F5U4        Fucose: H+ symporter permea...   185     3e-45  1  39.1%  4:435   9:436     ---PEPSAHHSGGPHNAPIITRKTLLPFVLITALFFLWAIPNNLNDVLIRQFMKSFAMTRLQAGLVQFAFYLGYFFLALPAGFIMRRFGYKSGFLIGLSFFTLGAFLFWPAAVANSYTFFLAALFIIASGCSFLETASNPFIVQLGDPRSAARRLNLAQAFNPLGSITGVLIGTIFIFSGIHLSATQIAAQKAAHTYLAYLHSETLRVADPYLVLSAFTLALLILIAITRFPHDLTTTHDEPEEHG---SIASLLQKPHFVLAVLAQFAYVGAQVGTWSYFIPYVVSYTPEHN-KAAGYLLTMSLVGFGVGRFFSAWVMRYVRPSLLMGIYCIANTLLAAMGAFLPGWIGVWSLLLSSFFMSLMYPTIFAQGIRGLGKNAKIGGSILVMSIVGGALIPLLMGYIADASGSQALAYLVPLAAYLLIGAYSFGDWRT---
     486 UniRef50_A5FZR0        Drug resistance transporter...   185     3e-45  1  10.9%  7:401   1:422     ------MAGPASHEEEMQLSGLPRAIVTVGCMIGTLMQALDATIANVSLPYMQGSLSASYDEITWVLTSYVIAAAIMTAPVGWLAAQYGRKNIFLISLVGFTVSSMMCGVA---TSLGEMVMDRLLQGVFGAALVPLSQSTMLDIYPVEKRGSAMAIWGVGVMIGPILGPTLGGYLTYFYNWRYVFFVNVPFGIAAVLALGAFMPKRARRPASgfDWIGFAVLSLFLGSLQIMLDRGQEKDwmTAKNPFIPRGVFADRNLNAGLITMFAVGSVLLSSATLMPPFL-EKLGNYPVETAGLVMAPRGIGTMGAMMLAGRLSNRIDPRALMAAGFALLVVSFWMMMqsPQSYMIETLIVQGMGLGFVFTPLQVVAFYTLPqrTQGTSLLSLMRNIGMAVGISVT-------------------------------------
     487 UniRef50_C0VJ33        MFS family transporter n=2 ...   185     3e-45  1  10.7% 13:434   2:458     ------------TTTTHQAVQPEFRLLVLLVSIGFFMQALDTTIVNTAIPVMAIQLNENPLQMHGVIVAYVLSVAAFIPLSGWLADRFGIRNTYLAAMVIFSLASLGCGLS---QTLDQLLICRVIQGMGGALLMPVGRLALLKIIPRSQFLSAMSLMSLAGLIGPLMGPTLGGWLVEVATWHWIFLINLPMGVLGVIMALKVMPNQKEPTVKSFDLGGFILLMIAMVGLSLGIENIAAphAHNHQNALFHGRLFRHKIFSIGILGNFFARLGSNAIPFILP-LMLQVAFGFEPFITGLMMIPLVLGSLFSKPIIRPIIQRVGYRRFLLTNTVLVGLCIASFSLMTADTPLWlfFIFGTLNSLQFVGMNTLTLKDLPQHDASSgfLSMIMMLSMSIGVALAGTLINLFgaFHAALIALGCINIITAMVFWQIPK----
     488 UniRef50_C4RFW2        Transmembrane efflux protei...   185     4e-45  1  14.0%  2:408  51:484     -PVPSSTHQSSAAEDSVSSSTGHRGVILTLILAVQLMIGIDITVMNMALPQIQEELNFSPTGLSWVLNAYTLAYGGLLLLGGRMGDILGYRRALIIGIGLFTIASLLGGLA---PNAWLLLVARVAQGVGGALAAPATLALVVSTFQkeERNRALGIFVMASGLGSAGGLLLGGLLTDAVSWRWVLLINVPFGLVVCLLAPKFLPITPVQSGRFDAGGAFTATliGAFVVGVLLLAAFVAIEAAHTQPILKLRLFADRNRSGGFLVFVCSGAAMFGSFFLLTQY-VQEVLGLSPFRAGVAFLPMALLMLAVPpiTPWLVNRLGAKPTMLIGLTLILLGMVWLTQVTADTAYlpMMLFGAGVGLLNPPLTGTILASVAPEDSGAASgqAVGMIGGSVGTAILVTIFGTA------------------------------
     489 UniRef50_C8WT95        Drug resistance transporter...   185     4e-45  1   9.5% 23:413   5:420     ----------------------NRRMVSLAMMLAVFLVAIDVTVVSTAMPHIVRQLH-GLNLYSWVFAIYTLTTCVTTPIYGKLADVFGRKTIFCIGVVLFVVGSALSGLS---QNMAELVWFRAFQGLGAGAVMPVTFTIIGDIFQGEERARMQGLFSSVWGVAGLLGPLVGGLFVDHVSWRWIFYINVPVGALSLVLVLLFLHERFERRQHRVDVWGALVfiLGLFAASAVFLAVFVWIEAKVAEPMLPLKLLSNPVIAVSDVLAFLAAFVLIGGNVYLPMW-IQTILGHSATNSGLTLMPMSLAWPLASTLSGRYMYRIGAKRTTVIGTLLVAVAAAWLLatPYWFFVGVMIVMGLGMGYLNTPTTVMIQSVVSWQMRGAATgqFARALGQTIGVTVFGSLFNSITSSYV-------------------------
     490 UniRef50_A0M0I8        Major facilitator superfami...   185     4e-45  1   9.4% 19:435   2:416     ------------------KIRGLRWWIIALIALATIINYIDRTAFGVMWPEMGKDLGMDESDYAVMLNVFMITYALGKFLSGKLYDQIGTRLGFIFSITLWSAAAILH---AFARGLVSLSMVRAMLGFGEAGNWPGAVKSNGEWFPVKERAIAQGIFNAGASLGSVVAPALIAFLYAQFGWRTTFIILGLLGFVWIIPWFIINKTTPKHHPWLGEKERNLILSGRI----------EPDEVGDKEKGLPVSKILSYKESWGVLVCRFFIEPIWWLFVGWMPLYLNSE-FGFSIEDIGSTIWISYLGGMAGSLAGGWFSGkfSRKLSILIGGALIFLGLLGIIFlnPMTFIYITSIVLFGFQFAIGNIQTLSSDLLKGPSVGTLAGLAGTV--AAVSVIIMNWLIPQItsYTPAFIVIAILAPLAVLSIYILIRR---
     491 UniRef50_C4RIC5        Transmembrane efflux protei...   185     4e-45  1  17.0%  9:414  69:499     --------AGTVTRARPEGSHRLFTAPFLLSAVAAFMVAVDNLVVVTALPSIRHTFGTGIEGLQWVVSAYTLTYAVFQLSGAALGDRFGRRRVFLAGLTLFVLASAG---AALAPTVWALVAARAVQGLGASMVSPLALTIVAHATPRARRAAVLGAWSGISGIGSAIGPVLGGLVVTYAPWQWIFLVNLPIAAVLLPLARLRIDES-HGPRDRLDLRGVVLsvWGMLVAAAALLPVFVVSQQRAADPMLPPALLRRGAFATAVTLYLLMTFGLFGAMFLATQYF-QDRLGYSPLQAGLAIAPAAALPVFIAPLTGKLSRRIGGARVLAAGLALQAAGLLALAltAYPRMLPGLLLMGVAASLFFGQISRVILGSVAErgIASGAGTTFRQIGTTLGVAVLGAVFAAAGGYHSP------------------------
     492 UniRef50_A5WEK3        Drug resistance transporter...   185     4e-45  1  13.0%  3:433  11:474     --TNTTATSLASDLQPKFTLSAVQAKFLpvLAVALFMQILDATILNTALPEMALALGESPLKMQWAVISYALTLAIFIPISGFMADKYGTRKVFLTAIVLFSIGSI---FCAMSPNLDILVASRILQGVGGAMMTPVARLILVKSYPRNQLLTVMNFAVIPALIAPLVGPLVGGYLVQYASWHWIFLINIPMGILGFLLGFKLVPddWFGFGLFALAAGLLTLAVELLSKPGEAIPGfvRHARKAGNPIFPLSLFDVRTFRIGITGNLFTRLGISAVPYLLPLLL-QVAFKYTPSQAGWLLTPIAVGAMGIKPWVSKIIQRFSYRKVLVTNTTILGILIILLAQlpWYYIAPLLVIMGACNSMQFSAMNTITIGDLEGSQTSSglMAVNQQLAISFGIAFGATILSVfsAFHATYYVLGIITIISGLSFLRLK-----
     493 UniRef50_Q72JZ3        Multidrug resistance protei...   184     4e-45  1  12.9% 18:428   4:441     -----------------TPDAKEVRYTMVGILLGLFLAALDQTIVSTAMPRIVGELK-GAEYYAWVTTSYLLASTVSAPVFGRLTELFSRKAVLVAAVLLFLLGSALSGLS---QNMVELVLFRGVQGLGGGALFALALTTLAALFPPRERGRLAGVFGAMFGLSSAVGPWLGGLLTDHFSWRWVFYVNMPVGAVALWFILRHMPRLSPGKREPFDFLGAFLLAAWAVPLMLAFSWGGStvELRVPHPLFDLAVFRIPTFTYAALASFFYGPAFLGAVAFLPLYL-QVVKGVSASQSGVTVLPLTFGVILGSVGGGQLAARHGRYKGLVLGSALFLLGIFLLFhtPLWLAVFLFFLAGLGLGPAQSLLNIAAQNDVprIGSATSAVQFMRQIGATMGVAFLGTVLASALSDHLKAAFPQGAAGAPVLA----------
     494 UniRef50_D0Z8I3        Hexuronate transporter n=4 ...   184     4e-45  1  10.8% 19:435   3:414     ------------------KIKNFRWYMILLVCFITIINYLDRTALGIAAPTIMESTGITKEQYSWVVSAFQLAYTIGQPIMGFFIDTIGLKLGFFICAIVWGLATMGHALTGTWQG---LAFMRGLMGFSEASAIPSGVKTASTWFPAKERGIATGVFNMGTSFGAMLAPPLIAWCILFHSWQFAFIVSGSLAIVAAFVWYFCYKDPKEAKRLSDEERRYIEA------------GQESFLQSATQEKTSVRHIITQRNFWGIGIARFLADPAWGTINFWVPIFFVET-LHFSLKEIAMFVWLPFLMADLGCLASGFVAKFfsRRITFTLGALLMTTIGLVSIVENPYIAVLLISIGGFAHQLLSTVAATLGADLFKKNEVATAVGmaCAWSGQLIFNLFIGAFVGIIGFGPFFIALAVFDLIGALALWLLIVDR---
     495 UniRef50_B8DHC5        Lincomycin resistance prote...   184     4e-45  1  12.3% 17:406   3:417     ----------------AASTSVKRNGILIVMLMGAFVTILNQTLMNVALPSIMKDFGITASQGQWLSTGFMLVNGVMIPMTAFLIERFTTRQLYLFAMITFAIGTAIGGFA---TDYTMLIAGRMVQAIGAGIVMPLLTVVVLNLFPMERRGRAMGLIGLAMNFAPAIGPTLSGWIVQQYDWRNLFFIIIPFAILDIVVAIFLLKNVGKRTFPKLDILGVIMSTVGFGSLLLGFSNAGDHdqTSNKAPLLNFRVFKYPTFALTTAISFFVVMGLFGGMLLLPIFL-QTVRGFSPLESGLVLLPGALVTAILSPVTGVMFDRFGAKYLSLVGLIIMAGSTFMFTNLDESTTLTFIIIvsAGMAMVMMPLQTAALNSLPLKLagSAMFNTMRQVAGSIGTAALITVMS--------------------------------
     496 UniRef50_Q13NA1        Major facilitator superfami...   184     4e-45  1  11.0% 17:436  24:439     ----------------AALYAKLTRRIVPFLFLAFVVAYIDRVNVSFAKLQMLSDLSLSETVYGAGAGIFFVGYFFFEVPSNLILNRVGARRWIARIMVTWAIVSGLTMFVSGPTSF---YIMRFLLGVAEAGFFPGILLYLSNWFPSTRRSQIIALFMTAIPVSGAIGGPLSGWLMAHfgWRWLFLVEGIGSLAVGIAAFFVLHDRIDNVRWLNADEKSRLA-------------ADLARDAITRTETSARGAFASKRVWLLGLLYFCIAMGNYGLAFWVPTI-IKASGVASVGNIGWLSAVPSLISAVAMVLIARHADRHDERRVHVAVCCAIGALGLllFASNVAVSIAALIVAAIGINSIAPVFWGIPtlGGAGAAAGIAVINCTGNLAGFVSPFIVGRLSDLSGglLPGMFAIAVALLIGAAIVLRMPLRR--
     497 UniRef50_D0IYC6        Major facilitator superfami...   184     4e-45  1  14.5%  2:435  12:444     -PVSAARSDVSTVQERDITFGRIIWRLIPFLTLIWFLAWVDRVNVGFAKLTMMSDLQWSDAVYGAGAGIFFIGYFFFEVPSNLLLHKFGAKKTIMRITIGWGVTGILM---AWVQTPLQFYVLRFLMGAFEAGLQPGVILYLTYWLPAHRRGKALAFFVSASALSLMLGSPIAAYLMETfgWQWLFIIEGIPSVLAGIAAYFLLSDTPAKAPWLSAREKQHVA-----------EELKAEEASLGQREHSFWASMRNPRVLMLILIFFCIVAGNSTLVFYGPSI-VKSVGITDLKTLGWVMSLIYACGWIGMVGNGWLSDRKKerWHTAIAAAMGAVGLVLTAlgNVTGVVASLALSSLGTMGSIPVYWQIPNRFLSATavGLAVINSAANLAGYFSPQLLGLLKSSSGSYAPGLLIIAAVEFCAAILVLLFVKR---
     498 UniRef50_C7HY06        Major facilitator superfami...   184     4e-45  1  11.4% 19:431  13:461     ------------------SSSSSPRGTLIAAALGFVVVLLDVSAVNVALGALHRDFATAVAGLQWVVNAYTLVFAALLLTSGSLGDRLGSRRVFLCGFTLFTLASAAC---SVAINLPMLVVARLVEGLGASLLVPNSLAILKRAFPDkqRSRAVGWWGAIGGISLAAGPVLGGLLVTHWGWRSIFLINLPIGLVGGYLTLQYVAAdpRHHDDGLDWPGQLVAILSLAAFTAALTEAGqwIESRSRSPMLPLGLFRVSAFTIATISGVIVNFSYYGLIFIFSLFFQIEQQ-LSPQQTGMAFLPMTIVLMGVNVLAGRLISRMGAKRLMVLGLLIAASGYLLLLPvaYGWLVVPMLIASSGIALMVPTMTNVTLSSVDDSRAGIASgnSARQVGGLLGVAVFGYLVRNTggMHWSLGMAVILLLAGSAMCWL-------
     499 UniRef50_C2ETA1        Major facilitator transport...   184     5e-45  1  14.1% 21:438  13:401     --------------------RPKSYRTLVLVFLGFIVCFIDRSAMNIALAYVGKSFTLTPAQLGVVGSAFFFSYSLMQVPGGWLVDRFGTKWMTVLSLLAWSVFTVMTGFA---WSFTSLIIIRVLFGIGEGSYPSAAMKQVRLAFPENKRGQASAVAISSNYIGNALAPFIVAPLIALLSWRGAFHVVGVLGLVYLAFYYFFERPLNREIPDYDTGDQKVKGKF-------------------------------DWRVLSFSVVVFGFSVITKGLDTWMPTYLLQARH-INLKGIAWLVPLPSITAGIGSFIAGFIMVKfhEKWLISLSALVTMVFMYGMFHSLSLTGVITfvLAYFTKSIGFAASYAFVAQLVAkyGASIGVVNFGGQLAGFLAPILIGLVIQGTHSYTAAFLVLTFFALLAFVASLTIHGKKAN
     500 UniRef50_Q13R21        Major facilitator superfami...   184     5e-45  1  13.1%  5:433   3:433     ----ADRTFNIATLIEEQKTGRFAVGLLFWCFLIMLMDGYDQTAVSFAAPAIIKDWHVARGGFGPVFGAGLFGTLVGSFIFGYLGDRLGRKKAIVIGSLFFGV---LTWASVWATSLQELMLLRFLAGIGMGGVVPNSVALVAEYAPKRLRATWVTLMFSGFSIGAGSGGLVSSALIHRFGWPVMFAVGGGGSLLVAVLLIFTLPESARLLVVRQRGEETVRALVARLRPDlpADAQFVPGEVREKQRFVFRLIFSDgiTLLLWIVFIANSMALYFLQNWLPILI--EGMGVDPRGAGLITTMFSAGGVIGGLILCRFVDRHGVLAIISLPAIGFPVVALLGHGSSQTWLMVAVFAAGFCVVGAQYGLYAVAGMIYPtrSAGVGSAISVGKIGSVSGPVVGGLLLSMHLPITQLFYSASLLFVVAAVFSTVLA-----
     501 UniRef50_D1VDZ0        Major facilitator superfami...   184     5e-45  1  13.3%  2:438  93:576     -PAQATTSPAPAASAPGDEPDPRRWLALAVIAVAQLMVVLDGSIVTIALPHAQKALHISTANRQWVMTAYSLAFGSLLLLGGRIADFAGRKRAFVWGLIGFAAASALGGFA---PNSGLLFAARALQGLCAAVLAPAALSLITVTFTEeeRARAFGVYGGISGGGAAIGLIAGGLLTEYASWRWCLFVNVPIAVLTAVAAVSVVRESRAEGKPSYDIPGALTVTGGLLALVYGFTRAADSgeMRTAAPLLPLRVVLDR-TRGGAFGSSLFFGAALLAMFLFMTFYFQNTLGYSALRSGFAFLPFSAGIVFGAGLASQFMPRVGAKIPMIVGSAMAVVGLLLLTQVDLHtvLPAELLISIGMGLAFVPMSSVSLIGVAPHDAGVAsvNTTQQVGGSLGIALLNTIYATvsGYTTSFVWSAIFMAIALVIVVALVRARKS
     502 UniRef50_D1BE38        Drug resistance transporter...   184     5e-45  1  13.5%  2:407   9:442     -SAPVTTGDEHVPGEPQQMSHRQVLEALSGILLGMFVSILATSVVSSSLPVILADLQGTQTAFTWVVTATLLTTTISTPIWGKLADLVNRKTLIQIALVITVISAAL---AGASQSSGTLILFRAFQGIGAGGLTALATVLIADIISPRERGKYMGLMGAIMAVGMVGGPLLGGALTDSVGWRWNFFVGIPFAIAAIITLQRTLKLpwGAFLLSVGISGLLLWVTFAGDQFAWGSWQSVavESRVEAPIIPLSLFRNRTVVLAVIGSAAVGIALFGTSVFLSQYM-QVARGKSATVSGLLTIPMIAGQFIASTGIGTLITRTGrkRFMLVGAVSLTVGLALMGTIDYHTNMAllFVVGVGMGMLMQNLVLAAQNTLSPqgTGTATIAFFRTLGGAMGVAVLGAILGS-------------------------------
     503 UniRef50_A4JNG0        Major facilitator superfami...   184     5e-45  1   9.7% 11:411  32:429     ----------APAAGDALLFRKIAWRIVPFLFLCYVVSFLDRINIGFAQLQMKHDLGFSDAMYGLGAAVFYVGYVFCEVPSNLLLARFGARRTFMRIMLLWGLASTGMMFVSQPTHFYVL---RFLLGVFEAGFFPGIVLYLTYWFPSNRRAAAISVFFAGVAVAGVLGGLLSGWilGLHGWQWMFAIEGAPAIVLACFAFTYLVDRPQDAAWLTPDEKARVAAVC-----------GDARAHGAHDRRSVAAALANPRVYLFAFVYFSLTCASLTLNFWMP-LMIRDFGVTDVVAVSLYTVVPNAVGAVGLILIARRSDRTGERRRHFACcgALALAALTLHLHSFAAMLACLSIAATLIFAALPIFWAVPTRYLSgaAAGIALISSIGITSGIVSPWVIGIIRTRTGSM---------------------------
     504 UniRef50_C5SHD3        Drug resistance transporter...   184     5e-45  1  13.5% 15:407   3:440     --------------TPQTFTPAERRVTVIALMIVFLLSALDQTIVSTAMPRIVAHLS-GLDLYAWVTTAYLLASTVMVPIYGKLSDIYGRKPILVIGVIIFIIGSGLCGMAglGGGMVQLIVFRAIQGLGGAALMTSAFAVIADLYPPRERAKLGGLFGATFGVASVVGPLIGGFFTDMggWRWVFYINLPLAGLALFMILVKTPKLLHRTGGKIDFAGAILLLATFLPFLLGLSLGGTDgeARVENPILSLSLFRNRTFASANLASVLIFMAFMGLVSFLP-LLMQLALGLSATTSGLALMPLTVGLIASATLSGLLVHKFGKYRLIMLGGAALTALGALCLAtgVWDVVWRVALVGIGLGPAQSLFNLAVQNAVERrgVATSAGQFFRQIGSTIGVAVFGAVLTH-------------------------------
     505 UniRef50_A4F9F3        Drug resistance transporter...   184     5e-45  1  10.5% 23:403   6:411     ----------------------YKWLVGITFVLGLVMQILDITILNVALATLGREFGVDASTLQWVLTGYMLSLAVFIPSSGWIADRFGSKRTFLLAVVIFTTASVLCGFAG---SIWMLIASRVLQGVGGGMLVPVGQAMLFRAFPAHERAKASAVLAIPITVAPALGPMLGGALAEYASWRWIFFINVPVGALTLVFTVLFLKEERRGRPGRFDLPGFVLAGGGLATLLYGLDQGAqwRELSVDEPMLDLRLLRNRLFGTGNALLVCQVASLFGVLFLVPLYL-QDVLHVSPFTAGLVLMPQAVAMLLATQVVSRMYGRIGPRRLLLTGFClyLCLQLLGTGTPLVVVVVLLALLGTSVGILMTPMQTaaQVSVAEMGHASSMYNVSRQVATALGTAVFAT-----------------------------------
     506 UniRef50_A6E925        Major facilitator superfami...   184     6e-45  1  11.1% 21:436  13:455     --------------------APAYGWTILVTSLAFVVAQLDVSIVNIALPQIADSYHANISILQWIIDAYTLAFAVLMLSAGSLSDLFGAKRLFQIGMLIFGISSVACGLA---MSSSFLIAARACQGVGAATMIPSSLAILNHTFADrkRAKAIGLWTAAGSAAIAAGPIVGGVLIKLSDWRFIFFINAPICLAGILLTFRLKEQPKPTVVKKFDLAGQITWMLSVTLLVAAVIEGAQLgeSKVKTPMLPLSLFNSISFNVLLLLGAVLNGFYYGTVFILSLYL-QDILKYPPLTAGLAFIPLTAGFVISNLASGNIINRYGIRTPILIGLTLFALGFSGLLVAGMHTSfaPFLLISLGMGLAVPAMTTGILSSVDKMLSGTGslNTVRQVAGAVGVAIFGTLAANGGEAVLQTIKISVIAAILCTILIILLSRK--
     507 UniRef50_UPI00018271B0 multidrug efflux system pro...   184     6e-45  1  11.1% 21:434   5:452     --------------------PRQVRWQLWIVAFGFFMQSLDTTIVNTALPSMAKSLGESPLHMHMVIVSYVLTVAVMLPASGWLADKVGVRNIFFTAIVLFTVGSL---FCAQANTLDQLIMARVLQGVGGAMMVPVGRLTVMKIVPREQYMAAMTFVTLPGQVGPLLGPALGGILVEYASWHWIFLINLPVGIVGAIATLMLMPNYTMQTRRFDVFGFILLalGILVALGITAILWYLWHARGNDKALFSLHLFKNPTYRLGLFGSFAGRIGS-GMLPFMTPVFLQIGLGFSPFHAGLMMIPMVLGSMGMKRIVVQVVNRFGYRRVLVAATLGLALVSLLFMAVALMGWYYALPLVLFCQGIifSSMNTLTLKDLPDELASSglLSMIMQLSMSVGVTMAGILLGMygAHQVFLYTYLSMAVIIALPAFIFAR----
     508 UniRef50_Q0YRG9        Major facilitator superfami...   184     6e-45  1  11.9% 13:414  10:411     ------------TAFEKATYDKVALHLIPFLFICYILAYLDRVNVGFAKLQMCSDLGFSDTAYGTGAGIFFIGYLLFEVPSNIILSKVGARIWIARIMITWGVIASMQLF---VSSEPIFYLLRFFLGVAEAGFFPGIILYLTTWFPSEYRARMVAWFMTAVAIAGVAGGPVSGVILETmgWQWLFILEGVPSALMGLCVLFYLDNTPDDAVWLSAPERELLT--------KRLADDELRTASEGRPAYTVRDAFGMPEVWMLSALYFSIVMGLYGISFWLPQIIRESIT-ADESLIGWISIIPWLSAAVVMVINGVHSDLTGERRWHIAFSClaAFALSAMPFAGGWYGIAALSVATAGIMSALSCFWSLPPSILAGSAAAAGIanSFGNIAGYVSPEMAGIIRDATGGRMSP------------------------
     509 UniRef50_B5HGM0        Export protein n=4 Tax=Stre...   184     6e-45  1   9.9%  4:406   9:437     ---SPLPTSPGPDTARPGRLRSNPWLTLLAVACGLFMVQLDGSVVAIANPEIGRDLNASTADLQWVTNSYLLALAAALILGGKLGDRFGRRTFYMIGLAGFTAASLAIGLAG---SIEGVVVFRAFQGLFGAMLVPNTLGLLRAVFPGNKFAMAVGIWAMVASVATALGPIVGGLLVEHVSWESVFYINLPIGLVTLAFSATVLPQSrfGVVKGETWGWTSAGTLGTVLAGVAVLVLFGRYESRTEHPLLPMRLFRSPALAVGTVVTALNFFVMLGVIFFVMLYL-QNVRGFTPVEAGVRTLPLSIASLLAAPLGAALTGRFGPRVVMPLGMLLQAGATFGMLtsSYTALWPPFIALGLGVGMVLSASSDAIVGNAPVKDGGVAGGltALQVGGALGTSVLVSLIT--------------------------------
     510 UniRef50_Q2VYP4        Permease of the major facil...   184     7e-45  1  13.8%  6:434   1:429     -----MALVNAHKLIDEAKFGKFHWNVLFWTALIIIFDGYDLVIYGVVLPVLMKEWHLDPIQAGTLGSYALFGMMFGALTFGSLSDRFGRKPVIAVCVVLFSLFTVLNGF---VRDTTEFAICRFVAGLGIGGVMPNAVALMTEYAPKRLRSTLVAVMFSGYSVGGMLSAGLGMTLIPVYGWSAVFFVAAVPLLLLPVILFLLPESIGFLIKAGRTAEAalARLEPSYKPQPGDEISFPTGATGQASLPALFAGGRGVSTVMFWIAFFMCLLMVYALGSWLPKLMNNAGYGL--GSSLSFLLVLNFGAIFGAVGGGHIADRMNLKRVLVAFFVIAAISISLLGvsPTLVLYVLVAVAGATTIGTQILLYAYVAQFYPmrSTGIGWASGVGRSGAILGPVLGGTLLAWKLPLMQNFMAFAVPGVIAAIAMSLVVR----
     511 UniRef50_A5EIZ9        Putative 4-hydroxybenzoate ...   184     7e-45  1  14.5% 16:430  30:447     ---------------DERPLSAFQIRVVCLCALVVGLDGFDAQALGFVAPALSKDLHLAPGALGPVFGASLFGVMIGSLVFGALADYLGRKWLVIAGVLVFALGSLAT---TQATSVSDLVMIRFVTGIGLGGVLPNTIALTGEYSPQRRRTLLIMLMFMTVSLGSAIGGAVAARLITAYGWQVIFLIGGALPLILCPILIIWLPESLSLLALDTSKSDRVRTLLMRIDPSAMLPADArtIVEESGKGFLLPQLFTKRrtLLLWIMFFMNMMDIYFLNSWLPTL--THGVGLDVQAAIAVGIAFQLGGMLGTIGLGLLIERFGFDRVLFATYVAGFLSIvgIAGASLPILVPAVFIAGVAVIGGQIGCNAYAARIYPtrGTGIGWALGIGRFGSILGVTLGGLMLAAHWDVAALFQASAVPQLCSALVIL--------
     512 UniRef50_A0Z2H4        Putative transporter n=1 Ta...   184     7e-45  1  13.4%  9:388  15:381     --------SGDGEAPYKAFSTRYRNYVLGLLTLGYVFNFVDRQVMTILLEPIKAEFNASDTQMGLLSgaFALFYAVLGIPVARLADRWSRRNVLAISMATWSAVTALC---ATAGSFAHLALLRVGVGIGEAGGTPPSQALITDYFPPERRALAQGILAAAPNLGILVGLFGGALLAEALGWRMVFLVFGIPGVLLALLLFFTVQEPKRQPRSEEGDESLLIAI---------------------------KGIIRLPGFLWIAAGVGFAGIAGYGLGIWSPSFLVRVHAMSLVDAGLWLGLIGVFGGTLGAVTGGLLVDRLARkrVPVIGLVIALPTQLAFVLWplPFALVFMGLSAVFASFWIAPSYAAVQNLVPPHWRTQASALM--------------------------------------------------
     513 UniRef50_Q39BL9        Drug resistance transporter...   184     7e-45  1  13.9% 20:423   2:431     -------------------PRYRRAALVLAACLGTFLATLDISIVNVALPTLQTALDTDIGGLQWVVNAYALALSAFMLSAGPLGDRYGHKRVWLASVILFTAGSVVCACAG---SIEPLLIGRAIQGLAGALLIPGAMPILTHAFpaRERARAIGGWSAFSALALILGPLVGGLLVEHGGWQNIFLVNVPIGIVTVLLGAWGIPERRHPQHAAFDPLGQVLSVIWLGLLTYGLIGIGEAgeTRVERPLLPVWLFRDRRLVRANLASFVLGFSGYSSLFFLSLFLQQA-QGRTPAEAGWQLMPQFVMTAITSMLFGRIAARIPLHALMVAGYGLIGAMLAVMAGFGAGTPyiVLAVLGVGMGLAVPATGMTVMELAPAERAGMAsmNALRQTGMSMGIAVLGSMMSVGALHRMTGAMQAAGSA---------------
     514 UniRef50_C2C1G8        MFS family major facilitato...   184     8e-45  1  10.2% 20:411   8:424     -------------------SPKQRNGILIVMLMGAFVTILNQTLMNVALPSIMNEFKITASQGQWLSTGFMLVNGVMIPMTAFLIERFTTRQLYLFAMIAFAIGTTIGGFA---TSYPILIVGRMVQAVGAGVVMPLLTVVILNLFPPNRRGKAMGLIGLAMNFAPAIGPTLSGWIVEQFDWRNLFFIIIPFALLDVIVAAFLLKNVGKRTFPKLDVLGVIMSTIGFGSLLLGFSNAGDHDWLtaRTPLLNFKVFKSSTFTFTSIISFFVIMGLFGGMLLLPIFL-QSVRGFSPLDSGLVLLPGAVMMAALSPITGIMFDRYGAKYLTIIGLTIMTVATFMFTNLSESTTLTYITIvsLGMAMVLMPLQTAALNALPLQLagSAMYNTLRQVAGSIGTAFLITVMSKSASH---------------------------
     515 UniRef50_Q0B782        Major facilitator superfami...   184     8e-45  1  10.1%  1:435  13:441     MQTGSDPHADATAPGIDALYTRVSRRIIPLILVCYFFGYLDRVNVGFAKLQMVTDLHLTDAAYGVGAGLFFVGYLLLQVPAGWLVRRIGVKRCLAGSMLTWGIVSVATLATRDTASFYVL---RFLLGVTEASFFPAVIAYFSVWFPSHRLAKVMAFLFLAMPLGVIVGGPLSGWIMDAtgWQWMFLIEGLPAIVLGMYLLVRVTERIDDAAWLTDAEKRMI--------------RAEMAQEATGKRTRLGAALREPTLWLLFATSFLYNVGNYGLVFWMPT-MIKALGSLSNLGIGLVSAIPYLVASVAMVANAQHSVRTGERRWHTALPVAIGGVALLASltHPVLAVMCLTAGVAGIMSTLAMFWSLPSRIleAAAGGAGLVNIGAAVAGFVGPTLMGYATGLTGSTELGVALLAFTLFAAAALILSIPRR---
     516 UniRef50_B2JRA7        Major facilitator superfami...   184     8e-45  1  13.0% 14:404  12:443     -------------TSPAPHFTPALARIVATVSIGFVVTQLDVTIVNIALAKIGADLGANVTGLQWIVDAYTLAFAVLMLSAGVLGDRFGARRMFACGIALFAAASLACGLA---PDAATLVGARAVQGMGAAAMLPNSLALLNAahDPKLRARAVGLWTAAGAIAIAAGPVIGGLLIAAFGWRAIFLVNLPICALGLAATFAWVPLApdPAARGIDPAGQLLAIVALTAFTGAVIEWRpvAERRVRTPMLPLTFFSNRTFSAAVLFGICVNLTYYGVVFVLSLYL-QHARGETALQAGLAFLPLTGGFLVSNVASGWVVGRCGARVPMIAGAMTAALGYGLlaASPLWALLVPFLLIPSGMGLAVPAMTTAVLASADRQRAGTAslNTARQAGGAVGVATFGAL----------------------------------
     517 UniRef50_Q2T063        Drug resistance transporter...   184     8e-45  1  14.0% 21:435  68:510     --------------------ASSRTTLLWIVATAFFMQSVDTTIVNTALPSIARALDQDALSMHGVVTAYTLTMATLTPASGWLADRFGTRRVFFAAIVVFALGSLCCAAAASAT---QLIFARVLQGVGGSMLLPIGRLAVLRGVPGDEYVAALAFVSTFGQIGPILGPTLGGWLTQSMSWYWVFLVNLPICAVGLATVHRYMPRDKPTDPPPFDYTGYTLLSIAMIAGSLAIDALSDGgaHWRPNPIFRLKLFREPNFAVGLAGNLVSRIGIGATPFLLP-LMMQLEFGYSPLRSGLMLVPAAIAGVIAKPWIAPLVRRYGYRTFLFVNTLIVGAVIALFAAIGPDTPLvlIAIFGAINSIQIAAMNSVTLKSLPHRDAASgvQMLSMGLGASVGSGLTSLFGAQTGSSLLGFKLSFVCVGAVTLASAAIFRR---
     518 UniRef50_UPI0001789C72 drug resistance transporter...   184     8e-45  1  14.0% 25:438  10:474     ------------------------WSVLFVVTLVSFITNLDATIVVNGIPPLMEDLHLSLEMGMWTLTSFYITSTVFLLPSGRWSDMFGTKRIFLWGFAIFTIATAFCGMAS---SGTALILARLLQGAGAAMAMAASTPILMKTFPPHELGRALGINNIAWVTGSLLGPVVGGALIGGFGWRSMFYAVVPLGILGLIAGVLILKESAELEKAKTDWPGLLTYGTGLTAFLIVLSEAQAWgeKKARHPLFDLGLLGYRDYTIGLGITASYCIGYFAVSILLTLYL-QGAQNLSPLEAGLMLIPLSVPQLFTAPIGGKLADRFGTTKMILLGSFLIGLAILLLGqlSNAAVIIPLLIISAATGLSWPSLAKAVLSAAPKNQAGPASgnMCRAISQALVLVIIQWVaaLIHASNVGFYLFAAFLAFAIVLGLFLLRQHGK
     519 UniRef50_D0WRG2        Putative drug resistance tr...   184     8e-45  1  12.4%  7:408  24:451     ------ARPKAGSAPTQSLSTARRWMATVVLSASVLVITMDMTILNIALPDLAKDLKPSATQQLWIVDVYSLVLAGLLISWAAVGDRWGRKRMLMLGYAIFGVASLLVFFA---DSPGIVIAVRAFLGVGGAMIMPTTLSLIRVIFtsKERATALSIWAAVSGLGSAIGPLLGGYLLEHFSWHSAFLVNVPLMAAAVIAGMLLLPESRVEKPGKLDPLAVVLSlwIAFAIAAVALGAFARRCLRSDEPLLDLALFRNRQFSAGILAALGTTFSLLAAILLISQWL-QLVQGDTPVQAGIHLIPAAVAGAVASIAAPPLSRVFGARAVLAGGLAVAGLGMVYVGLRGAGLSMAAVMAALVLVggTLAIASAMVMGGSPEDRAGNAGAltSYELGGVMGVAVLGSVSALV------------------------------
     520 UniRef50_B1SXT4        Major facilitator superfami...   184     8e-45  1   8.0%  2:436   6:438     -TRSVPISPIVSDMATEAVYTKINRRIVPILILAYVIAFLDRTNIGYAQLQMKQTLPWSEAVYGVGAGIFFVGYLLFEIPSNLMLEKIGVRRTLLRIMVMWGLTASAMMF---VTTPTEFYIARFMLGVFEAGFFPGTILYFTYWYPSHRRGKVFAYFMASTVISGIVAGPLCGAILKYfgWQWLYLMQGMPAAVIGILVFMVLADKPDDATWLTDAEKRIVRESLARDDKYIGNERHA----------TFWMMVGDFRVWMLTLVYALILAGSYTLLFWMPT-LVHSWNVKDVLLVGILAAIPNAVGAAGMVMISSSSDQRRERRWHYVGAIAIACLGLLTTAasVTSSVISLSVSLFGIASLSPLVMAISSEYLSARSAAVGIAfgFGNIGPAVSPSINAVIIERTHDPAYSLFFIVSVYLLSALVLMIAVRRS--
     521 UniRef50_B5H7J4        Transporter n=4 Tax=Strepto...   184     8e-45  1  13.3%  1:437  14:459     MTTVAGKPasIAARLERLPHSRWHVKVRFLIGAVTFFEAFDQLLAASALPVLMKEWNLTTGQATFAVTAASIGMLLGAIAAGWMGDRIGRVRTVALGVGVTGLASLAVAFSG---SIETFSLFRFVQGLGIGGVVPVAATYINEIARSDKRGRFVLLYEMIFPAGLAAATLVAVWVVPNLGWRAMFVIGALPVLIAAALPRHVEESPRWLLARGRTEEAEAAvvARATAEPLPLPAAEVKEDTGRGRLGDIFKGRYLRRTAVLSGLWFVAYYVNHGISTWLPSLYTK-HFGLDLTTALVYTLLSNVTGLLGTFVVAMVIDRMGRRAALMAALGGGALslALAGATSGGQVAVFASCTTFFLYAINAGLYLYSPELYPtrAKGAAFGGLWNRLGVIIGPVTVGAIIGAGGSLSLVFAQLAVVAAVGALIAWFAVETKG-
     522 UniRef50_B9BKU0        Transporter, anion:cation s...   184     8e-45  1  12.4%  8:436   4:431     -------SSSPSAATCDAACAKAFWRIVPVLFVSYVLCSMDRYNVAFAQMQLRTERHITDAIYGLGATLYFATYVACAVPANMLLHRWGAKRMFFLIMLGWGACSASMF---MLRTPYEFYAGRLLLGAFEAGFYPGVIYYLGTWFPQTHRSHAFAVFTSGVTVAGVVVGPLSGWIMTRfgWQWLFLLEGLPSCLMAVVCFVILTQGPSEATWLS---------LQERQALDEALAQDRLTAPRQIMPAGRFGMLRSRQVYLFALVYFCSISGVYALGFWVPA-MIRSFGATTPLEIGLYSVIPWGLAAIGTVMISRRSDRMNERRWHAAAALLVGAVALGLSTLPHLGFSIALSLlaVGVIGAIPVFWAIPTSMMPpaASAVGLINCLGVSSGMIAPLLIGLLKERTGSLAPGLWCLVAMLVSGAALLLFVTRPA--
     523 UniRef50_A6X4B8        Major facilitator superfami...   184     9e-45  1  12.7% 17:434   7:422     ----------------DSAVGKATKRLLPFLAIMLILAFLDRANIGFAKSEFQADTGLSDAAYAFGAGIFFIGYALFEVPSNIIMHKVGARLWLSRIMISWGIVSAAMMFA---HTEGVFYTLRFLLGVCEAGFYPGVLLYLTYWFPAKQRARATGIFYLGVPLALVLGSPLSGWLLTHHgwQWMFVVEGLGASLVGIIALFYLTDRPEKARWLSVEERDALTRVI----------AAEEAAKQTQAQHSAMSVLKDRRVWAFIGIYFFLQIGTAPLTFYFPSRFAQAanGQMNLLIGSLLALPWLCSVIATRYFTVLADQTNQHRLVCMGMVIavALAVIGLTGNPWLMLLAACIAVPGLTASQPVFWSLPTRYLggAASGIAFIVSIGNLGAFFAPQIKNWADVAVGNHDAGFYTLAALCGIAVLLLAGARK----
     524 UniRef50_A3TIV6        Putative transmembrane effl...   183     1e-44  1  11.3% 18:432   9:465     -----------------ARDSTRGRLTLTAVTLGSGIAILDGSVVNVALRTIGTELDASLEQLQWVINGYMLALASLVLVGGALGDRFGRRRIYLGGMGWFLIASALC---AVAQTPGQLIAMRVLQGVGAALLTPGGLAIIQSVFRREDRAAAIGTWAGLSGIAAAIGPFVGGWLVDNGGWRWIFGINVPLCIAVIALTLWATPESreGASRGFDIPGGALTVLSLGALTYALTSSAtiVEQRSRTPLVHLSLFGDRVFSAANAMTFVVYGAL-GVVFFILVLQLQVSAGWSALSAGLTGLPATVALMFLSSRASQLSERIGPRIPMAVGPIICAVGVLLLLpaTWWTVLPGLVIFALGLALLVSPLTSTVLAAAPDRYAGVASgnAVARAGSLIAVAALPALvaMTSGFRAAMVICAALLTAGGVVSWFG------
     525 UniRef50_C6WMQ2        Major facilitator superfami...   183     1e-44  1  11.0%  1:435   1:438     MDTSTATGATPVTAVEKSAIRKVAMRLVPFVALMFFINYLDRTAIGFAApgMNSDLALTAAQFGFASGIFFLGYIVLEVPSNIALHKFGARRWLARIMVTWGIVAVLF---TWVQNYTQLATLRFLLGVAEAGFFPGAVLFLSLWVPVRYRTRILALFYLAQPLTTVVGAPLAGWLIQQhgWRFMFLGVGAPAIIVGVIAWFYLADSPKDAKWLTKEE----------QDWLTTALSKEDAGKGPQKHHGLKAAFGSGRVWMLSLIYFGFIYGLYTLAFFLPTIieSAGVTFGLIERGLITAIPYVPAAIVLYLWSRDATKRGVkwHISIPAVVGAVSilALYAGSPAATIAVITVTACAIFAALPNFWSVPTQFLsaAAAGVALINTVGNIAGFAAPYITGAIHDATGAYTVPMFVVGGFMLLSAILMVVLDRR---
     526 UniRef50_UPI0001B50770 drug resistance efflux prot...   183     1e-44  1  14.1%  2:419  26:469     -PSGDRTSAPRRQARDSSGGPARSTLILAIICVSYFMVILDNSIVFTGLPQIRSDMGFSETGLSWITNAYVLVFGGLLLLGARAGDLFGHRKVFLYSLVVFSLASLLVGAA---QSAWWLIAARALQGVGAAVLAPSALSLLTRSfeGKARNRAMAAYSAVAGLGAAFGLVVGGLVADLISWRAGFFLNVPIGIVMMVLAVRFLPETERRGGRFDVAGALLATVGSTALVLGIVDAafVSVERRAAQPIVPLRLFASRERSGAYVTRMLYMGAMIGFFFFTAQF-VQSVYGWTPLQAGLAFLPMTLVNFVFAIRVPRLLERFGRPRILAAGVVLTAVGMAWLSRLDLHtvALPMVIIGAGQGLALAPMTSSGVDGVAAEDAGAGSgnTVHQIGSALALSVLTAVAATVSTGHAAADIAA-------------------
     527 UniRef50_A9H2B7        Major facilitator superfami...   183     1e-44  1  12.4%  1:437   1:439     MTDHATGASDAISVTEQAVFRAAAWRIIPLLVVCYMFSYLDRINLSFARVPMENSLHFSDATFGLGAGLFFIGYIAFQVPSSLLLARFGVRRTIAAIMIGWSLISFLF---TIVGTDWQFCLLRVSLGVAEAGFYPAVLYYLAIWFSRQMIARVTAAFLIAIPASGAIGGPVSVAILAHfgWKWMFLLEAVPPLLLGLVVWRRLDDGPEDARWLGAAERRIVLARVHAGWGAAGAASAPVGRAR------PFAALSRPIVRLLILICFCQAVCNYGIVFWIPTFVAQVLAASSAT-IGLYMIIPFATAMVAMTLNARSSDRHQERRWHMAAPFLIVSVTLVLAFlsGMLALLLLTAALAAALCVTGMIFTIPTLVLGQeaTGLAWINSLGALGGLVGPYGIGWLRVHTGQPLAGLFLVAFCALVGAIATLCLPRRAT-
     528 UniRef50_B8FQY5        Major facilitator superfami...   183     1e-44  1  11.7%  6:424   1:422     -----MNRTYISEVIDQLGVSKYTYTMYILVGIALLFDGFDYMIVAYTMPQMAAEWGLSKVQTGSLTSWSLIGLIIGGLTAGIISDRIGRKKTLSIFVAMY---SLLTLPIYFVHSFEVFAMLRILSGIGLGACIPIAVTMMTESAPTHKRGFFTSSIMAFYISGWVVAGIVAITIVPVFGWRVCYLLGGIPALYSLVLWFKMKESPYWLLSKGREKEAIDVVKTIEIAARGKAGEWPLGRLITPPApsMIFSKNYRKATLANWTIYFMGSVLIYGISGWLPTLLVESGFGV--VKGYSFAVLQNIFAIIGAMSIGFFADIIGRRLNVSLSWFFTAVFAILLGFATtwQVILFIIIVGFLMNGALSSTQPLLTESYPtrSTGVAWAQAFGRLGGFSGPIAAGFIQQMGAGFTGLFIFFAIPSFI--------------
     529 UniRef50_Q47HB0        Major facilitator superfami...   183     1e-44  1  13.3%  7:433  51:514     ------RPATSFDTLSQRYGERYKWMVLFILALGTVAGVLCTSSFNVAVPALSRHFRLGQDQVQWAMTGFLAAMTVGMLPTSWLLDRLGFRIIFLLSLAVLTLASVGGYFA---PSFTLVVAARILQGLAAGVLQPMGALALMRLFPPEIQGRASGILIFSIALTPAIAPSLGGALLDRFGWESIFLLGTPFAVIAALCAIYLLPAPREIKRKPFDWLGLGWLTLGAIALIESVSSLQhrHARLRSDPLINLDLFRQRTFAMGTLVSFAYGFGLYASTYLIPVFL-QNALSFKAGAAGMALLPSGIALVVMLPLAGRMADHYSPKWITLIGLVAFGASFLIFSIRGGAiiIAATIIGRIGLGMILPALNLATLRHMEPHQLGQSSVVtaRQLGGVMGVAVLAVFVEwySAYSQGFLLLTAVFSLAVLAACFMR-----
     530 UniRef50_C6D7L0        Drug resistance transporter...   183     1e-44  1  10.5% 27:408   8:414     --------------------------IIGGLLLAILMASMDNTVVSTAIGTIVGEMG-GLDKFVWVTTAYMVAEMACMPIFGKLSDMYGRKRFFIFGIIVFMIGSALCGMA---HSIIELSIYRAVQGVGAGAMVSIAFTILFDVVSPKDRGKMMGAFGAVFGLSSVVGPLLGGYITDHLNWSWIFYINLPLGFIALLMIALFYKESAAHSRQRIDWAGSILliIGLFAGFAVLAFLLVLVERKAAEPIISFGLFRSRLYTTSNLVAMLSGAAYMTAAIFIPIY-VQGVIGGSASNSGLTLLPMMVGSVVTATLGGFLMTKLQYRTIMIGTLSILFIGLALLSQITvlFITGIMILIGLGIGASFSVLSSSVLHSFPAAQRGAAslNFNRSLGMSLGITIFGIIQSHS------------------------------
     531 UniRef50_C4RKY9        Drug resistance transporter...   183     1e-44  1  11.6% 10:422   2:440     ---------TTEEAGRLVLTPRQLRLLMFGLMTGMLLAALDQTIVGTALPTIVGELG-GIDHYSWVVTAYLLASTASTPLYGKMADLYGRRPVFLFSIGTFL---LGSLLAGLSQDMTQLIVTRGVQGLGAGGLMTLAFTIISDVVSPRERGRYQGLFGAVFGIASVAGPLVGGYFAET-SWRWIFYLNVPLAILAIVVCYHVMRldWLGAALLVAGVSCLLLALSwfAAGAVLGGLFLLQEVRVAEPILPLRLFRSRTFALANSAGFVLGLVMFGSIIFIPLYL-QIVKGASPTRSGLLMLPMMAGIIVTSILTGRAMSRIGRYKWfvAGSAVLLVGMLLFTrtSLWVAFGYLVVLGVGLGLSMQSLILAVQNAVDSrgAGTSSATFFRSLGGAFGVAILGAVLSSRLADQLASRMPAAIA----------------
     532 UniRef50_UPI0001C311F1 drug resistance transporter...   183     1e-44  1  12.4% 17:418   2:428     ----------------TRTAASRARWTLGITGAALFMTALDSLVVGVALHSIRMDLGGSLEALEWTVNAYTLAFAVLLVTGAALGDRFGRKRMFIVGVGLFTVASAG---AALAPSVGALIAARALQGLGAAILTPLTLTLVSEAFPAEKRAAALGIWGGISGLGVAIGPFVGGAVVEGISWHWIFWANVPIGLALIPLASAKLTESHGPDRELDLRGLALVSSGLLALTLGLVRGefVAWERRAPSPMLPLRLFRSRAFSAANGLSFAMFFGAFGAIFLMSQYF-QMAQGVGPFEAGARTLPWTAMPMLVAPLAGVLATRFGTRPVMAVGLALQAVGMAWMAttPYAELIGPFAITGVGMALVFPTAPEAVLASVRpeGKASGATNAIRELGAVLGVAVLASVFAANGGYASAQAFV--------------------
     533 UniRef50_Q67MP2        Efflux transporter n=1 Tax=...   183     1e-44  1  14.6% 23:405   4:414     ----------------------RRMLTVFALMLASFLTAVDVTIVDTAMPRIVGSLG-GFSMLTWLVSAYMLTSTATMPVYGKLADIIGRKRTFTIGAVIFVIGSALCGAA---PSMEALILFRALQGLGAGAMQPTVQTILGDIFTPAERAKVQGWFSAVWGFSALAGPLVGGLMVDYLSWRYLFYINLPLGALALYMVWRHFDERVQRRKARVDYLGAVTliLGMAGGAAVLLLLFLWTQGRALDPILPLRLFRIPVIGWGNLSSLMVGGVMYGTSVYLPIW-AQGVQGYSATRSGASLLWLSIGWPLAAVLGSRLIVRMGVRPSALLGLGLNVAGSAALVAlpEVLLALVTFVIGAGMGFSTLAFILGIQSSvaQRGVATASFQFIRTLGGMIWVSAMGGVM---------------------------------
     534 UniRef50_A4YDT2        Major facilitator superfami...   183     1e-44  1  10.8% 11:436   2:427     ----------SNQPLRSISSSKRIVRLLPILFYLYLVNFLDRVNISYAISamFKDLGVPKSSADLIASifFVAYAIPQVFSNLGISRIGVRKVFALAFTAWGIITILTGF---VQNVPEVYLLRFLLGLAEAPFYAGVIFYLSVWFLRDERGFANSLFNAAIPVSGIIGGLIAGSFFSVfgWRYLFVAEGVLALVSVAVIWLLLTDFPKDAKWLSEGE---------KEELLSKIKVEKEEKQKLVSHASWRRALGDRDVLLLVLIYFLGVTSLYGYTIWLPSIIKS--FGVSASTASYLTVIPYLVASISLIFISRYSDRAGVRKSLALAIFLVAGIGlaFTLKTPVISFLFFVISAIGIYSFIPVFWTIPTEFLSEESAAASIgnALGNLGGIAGPIIVGFLESLTGVFTAGVYSLALFDILAGLVVLLVRKSR--
     535 UniRef50_A9AGH0        Major facilitator superfami...   183     1e-44  1  14.0%  3:438  71:511     --DATAPAVDIGATLDDGPFTMMQKCVVLLAALSIVLDGFDGQLIGFAIPVLIKEWGITRGAFAPAVAAGLIGMGIGSACAGLVADRFGRRGAVLGSVFLFGAATCAIGLA---HNVETIAALRFVAGLGIGGALPTATTMTAEYTPARRRTMMVTATIVCVPLGGMLAGLFAHEVLPRYGWRTLFFAGGALPLVLGFVLAAALPESPRYLARRPARWAELGALLARMKRPVAPGTVfaQAHGGSGGFRSLFAGGQARDTIALWCAFFMCLLAVYAAFSWLPTMLAAS--GLSVSVAGAGLTAYNLGGVIGALLCAWTIARVGSRWPLVLCSVGGAASALWLMSVDAgwLIVGLGAHGLFVNAVQSTMYALCAYIYPtrATGTASALAFGRLGAILS-AFAGAFVITTGGATAYLTMLAAAMGIVCVALLVVRRHIPK
     536 UniRef50_B0SZR6        Major facilitator superfami...   183     1e-44  1  15.9%  7:434  13:435     ------MAPTVETPRRQTAAPSGARITLAMLCFVYVLNFLDRQLISILAKPIQDGLKISDGQLGLLTGFYflFYCFIAIPIGWLADRTSRVRVLAIACALWSGATAACGLVG---NYGQLVVARMMVGVGEAGGVPPSYAIISDSFPRERRTTAMAIFNLGPPIGSALGITFGASLASAFSWRIPFYVIGVIGVVAAVAVHLIVREPKRG-------------------QMDSPERSMRKDAAGAGLIATITQFFSNPLLLMASLASGAGNFITYGLLNFTTLFLMREKGMQLADVAIWYALVVGIGMSAGIYASGRIVDRFAAriVPAASLLLALPFFLGFAWAPTwlSLLFLLVPMFLNSFFLSATVTFVQSEVPAERrgALLLLVMNFIGLGLGPTYVGMASDYfhALRAAYYALAPMYLIGAALFLVLAR----
     537 UniRef50_C8UTR4        Transporter protein n=43 Ta...   183     1e-44  1  11.1%  8:414  10:441     -------AENVKNYIEDQKVQKNRWWIITAIGMFTIMSTLDGSIVNIALPVMSRDLNIPMNQAEWVVSIYLMMICGLLLFFGKLGDSIGKIKVFRIGMVLFLIGSL---FAGFNNSLALLLAARIVQATGASMTMANNNGIVTEIFPMNERGKALGLIGSFVSIGAIAGPGIGGLILGQLPWGYIFWINIPIGIVALILGTVVLPKDLPSKRVPIDWSGFISFllGLFVIAVIALAAFVQIERHKNDPLVSFKLFSNSAFTL-SLLSAFFIFVTNFFFNVISPFYLQNARGLSPEKAGYLLMIFPIVQVIVAPVAGSIADRIGPYRITMVGLLFIVGSQIGYALFNLQTSFVFVALmgFGNGLFQAPNNTVVMSSVAPRDLGIAGGMnaRNLGMVVGISSATTVLFSSMSHTAG------------------------
     538 UniRef50_B1YLV6        Major facilitator superfami...   183     1e-44  1  10.1% 40:405  18:408     ---------------------------------------IEGTIVATATPVMASELN-GAKLVSWIFAGFLLFMAVSTPIYGKMADLYGRKRVLLFGIGVFTVASLACGLA---QSMEMLILFRAAQGIGAGAVLPIAMTIIGDLYTYEERGKIQGVLSAVWGISGVAGPLVGGFLVETLSWRYIFLLNVPFALISFIMIVLFYKENVTETSRKIDYRGAILFATGMSALLYGLLSGSerVEKKASDPLLPPAVIRHPVILVINLAVFFSAWVLVSMSAYIP-IFAQGVLGKSPTEAGFMLMPLSLFWTLTAIVGGRTIGIASPRYRTMTGMGLLVIGMAILIgsSDVFIYLAVSLIGIGFGLAQPVFMVVLQTSVdlRGSATAVNSFLSTTGQTLGVAIFGTLF---------------------------------
     539 UniRef50_C6YWV7        Predicted protein n=2 Tax=F...   183     1e-44  1  10.3% 21:438   9:419     --------------------RKISWRILPFLIVCFTLAYIDRVNVSFAKIQMMSELGFSETVYGLGAGIFFIGYFIFEVPSNYLLVKVGASRWLGFLMVVWGALSSLTMFIDSAQ---QFYLLRFLLGLAEAGFVPGVIYYLSEWYPSYRRAKVTAIFLSSIALSGIVGGPISGFIMNIfgWRMLFLIEGIPTIILGFMAPSLL--------------SSIDKAKWINQAEREYLHKQLENDCANQESPKKLAVFMDIRVWWLSAIYFCGITGLYTVCFYLPA-LINNVGIKNIFAIGVISAIPYISAIVAMIAISASSDYFKERKYHFIVVNIIAVIGFLGIAvnIYFALIFMSLATAGILTLVSLFWSLPATLMSGmaIAIAIINSVGNLSGFVTPYLIGYIIDTTKSISPALYIISVVVLFGSVLLYRFSKKVDN
     540 UniRef50_C7Q7A2        Major facilitator superfami...   183     1e-44  1  11.3% 22:429  41:486     ---------------------RRKNQALAVCLLVGFMTLLDVSIVNVALPSMQKGLSATPADLSWVVSGYALTFGLILVPAGVFGDMVGRRTAFLVGLAAFTVASGLCGIAPGA---GFLVVARLVQGFASGILGPQISGLIQEMFSGAARARAFGYFGATVGLATAVGPLVGGLLIAahGWRWVFFVNLPIGVIAFALALRLIpiDWLGVVLLGASVTAImlVVLGVLLIIAFAQWERRVARSGHTPLVPPALVSIRSYTLGSVLGLLYFAG-FTTIFFIFTLYVQNGLNYSALEAGLATTPFAIGSAVSATLGGRLVGKHGRPLVILGIILVGLGTAAAVLVVhgIATAGPLLIAGVGSGLVIAPNLALSLSEVPVMRAGTAGGvtGQRLGSALGIACVGAVFFSRVSHGKGFANAFQAGAVVAICF---------
     541 UniRef50_D1XLI5        Major facilitator superfami...   183     1e-44  1  14.0%  7:436   5:439     ------RTTNAANRLDRLPISRFHKTTLLAVAFAYFFEFADINTFAITAPVVREQWGTDVNHIAYVTSTSFVGMFIGAVVAGGLADRLGRKRTLTGTTLWFTLWSFACVFA---WDIWSLGVFRVLSSAGLSAMTVVAVVYISELFPSAKRGKFQAYAIVVGICGTPVTNLIASAVVPLSDWSWRLVYLWGALGVFFLLLVRKLEESPQWLESRGraEATLARIEASATAEHGPLPEARAPEPQGPVVRPGLRMLKDRKflLLSVLWVTQTIGFFGYSSWAPTLLAAE--GVSVEDSIFYVALTTVGAPLGSFLAAMVTDRFERKWTLAVFGLVIAASGLMYGLttPVLIVVFGFLVNLFERGYTALAYAYAPELYNTSGrgTSIAYGLGRLSNAAGPLMIAGIYNGVGYEAVFMFIAGTWTVGALVLAVFGPATR--
     542 UniRef50_P0A0J8        Antiseptic resistance prote...   183     1e-44  1  14.2% 20:407  13:427     -------------------TSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFA---ESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFepKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPEsvWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWL-QVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVGAGMASlsALIMLETPTSKAGNAAAvsMYDLGNVFGVAVLGSLSSM-------------------------------
     543 UniRef50_B1ZZC0        Drug resistance transporter...   183     1e-44  1  10.2% 10:410   2:427     ---------PTDAPSCDTVTAETRKYLPWLVAVALFMENLDATIVNTAVPTMALNLEVAPLSLKAVLTSYTLSLAVFIPISGWLADRFGTCRIFRLAVVLFLLGSLACGLA---PNVPALVGARILQGLGGAMMTPVGRLALVRAFPRSEMLRTMNYVVIPALLGPLLGPFVGGLIVHWMSWRVIFFLNIPLALGGLWMIKRYMPDFRDEQVAPLDRTGFVLFGVGVALLSYVLeaAYGWHATRDEAPVLDLALFKVRTFRLSVAGGFATRLGVGGMPFLLPLLY-QIGLGYAPWQAGLLVMPQALAAMGMKLISRPILGRFGHRTILLTNTVLLGLTIMIFTqtPWWAIIALSFLQGFFSSLQFTSMNSLVYADvrKASRASSIASTAQQLSLSFGVAFGSLLAAWFLG----------------------------
     544 UniRef50_C0XQQ4        MFS family major facilitato...   182     2e-44  1  12.8% 31:437   1:437     ------------------------------MMIGFFMILVDSTIVSVAIPAITDAFGAGYNQVIWVNSAYLLAYAVPLLITGRLGDRFGPRRLYIGGLALFTISSFACALAG---SIEALIVARAFQGLGGAIATPQTMSVMIRTFSPRERGGAMGVWGATAGVATITGPLVGGLLVDAAGWPWIFFVNVPVGVVGLALAWRFVPVLENTARSLDWTGVIISAVGMfaVGLALLVGFAAWQKRTKSDPLVPPVLFNDRNYAISILAIFAVGATVATYAIPWMIHVQQGV-GYSPTQAALLVLPAGVISGALSPYVGKLTNTLPPKPFAISGMALIGISVVLMALLTTtwMLAISVVTGLGNAMMWGPLSMIATRNLDPQLAGAGsyNTMRQVGAVIGSAAVAALMGasAAMGTSLLLPAAVILLGAVIGTAFARTES-
     545 UniRef50_A0Y8Q1        Major facilitator superfami...   182     2e-44  1  15.2%  1:407   1:397     MSQPSTPPTDLPEQTAAHKakSYRYYALAVLTLIYVFNFVDRQIIVILSEYIIEDLDLTLTQYGMLSGIAFAayCVFGIPIARIADKGKRRNVIAVSVTVWSLFTALCG---SAQNFWQLFAARFGVGIGEAGGSPPAHSMVSDIFPVSERATALSIYSLGVYGGILVGYVGGAYLVQWFDWRVAFVVVGLPGVLLAILLRLTVLEPPRGF------------------------SEARSDTEETSFKEVLALLWSRKAFRHLSFACALHAFVTYGVGNFMVIFLSRVHDMPTIDIGKYYGLVAGIGGLAGTLAGGWLSDTMANkpFISTLAAIPFALITFLVMDNGMSATLSWLIPVFFGGFYLAPCIAMTHGMVGLRMRALSSafVLNLIGLGLGPILTGWAADM-------------------------------
     546 UniRef50_B2JPC9        Major facilitator superfami...   182     2e-44  1  14.5%  6:438   5:441     -----TRTVDVQRFIDGERFSPFQWTILVLCFLVVAADGFDTAAVGFIAPSLVQEWGVARSALGPVMSAALVGLGIGALGAGPFADRIGRKAVLVLSVFFFGVWSLA---AAHATSIESLTVLRFMTGLGLGAAMPNAVTLMSEYAPSRIRAVAVNAMFCGFSCGLAIGGVASAWLIPHFGWQSVLVAGGIGPVALTIVLVVLLPESAQFMVTRQRGDARIARVLSRIAKGTHLEaaEGVAEHRGSALRVVLSTRFRFGTLMLWLAYFMGLLIYYLLTNWLPTLFKDT--GFSGQNAALMTSLFPLGGILGNLSVGWLMDRFKANRVIACTYVVAALLVMLvgIGHQIWLGTLIFLTGTVITSAVTSMSALAASFYPtrATGVAWMLGVGRIGGVAGALVGAALMGLGWQFGSVFSMLAVPALVAAFGVFAVARHPGT
     547 UniRef50_A4FCN0        MFS sugar transporter n=1 T...   182     2e-44  1  14.6%  2:438  10:453     -PSGRISTGEVAARLERLPWTSYQRSLFLIIATAWLFDSIDLGALTHLLAPISAEFGLTKLQAGLVGSATFAGMFIGAVGAGVLADRFGRLKVFKYSIIIWGSASVLL---ALSWDFASLASFRLLLGIGMGAEFPVAAALLSEFMPSSRRGRYVALMEGTWPTGFILAGIGSFVLLstLGWRGFFLAQALLAVVALIVRRNLPESPRWQVSRGRHADAIATlaAFGRPLLAPGPIDDRDTTGQQAGLRALFTDGYRKRTLASWTMWFCLLGGYYGLTTWIGKLLSDA--GYDMVESVGYIVLMALWGIPGFLAAAWLIERIGRKFCLVGFSLSSAAAAFVYGNASGVtlIISGSVLQFIFFGMFSSIFAYTPELFPTRARAIGMgtAAGRLGSIFGPVVVPLVIAAQGPSVVFAASAVLFVTGSVVAILFLPETRQT
     548 UniRef50_Q13G90        Major facilitator superfami...   182     2e-44  1  13.8%  6:432   4:432     -----AASQSVDEFIDSQPVSGYQRSIIFFCFLVVALDGFDSACIGFVGPAIRAHWQLTVAALSPVFGAGLFGTMAGGILLGPVADRYGRKTVLVASVALFGLASVV---SAFSPDIHFLAFMRFVTGIGLGGAMPNSITLTSEYCPGAKRSGYVTLMFCGFTIGASAGGLLTAEIVGTVGWQGILVAGGVLPLLLVPFLMGFLPESIRYLLLIDRAKSYVRVASIASRVAAPGVTVPRLRADEKVRRSPVKALFEKGvtLLIWTIFFSSLLIIYLLTSWMPVLLSSA--GIPLESAALISMMHQVGAALGCIWLGRQMDRFNPHRVLAWSYFVAIPIIVLCAFSGsaLLVLSVFALGFLISGGNIGAYALVSGYYPtrSTGVSWANAVGRVGAALGSMAGGLMMAAGLRLQEIILVLAIPAAVATGCLCLL------
     549 UniRef50_A8ID36        Permeases of the major faci...   182     2e-44  1  11.0%  6:415   1:405     -----MDAGAGLTAEEKLTFAKVARRLIPFMMLLYLVSFLDRVNVGFAALTMNADLGFSPQVYGWGAGIFFIGYFLFEVPSNLVLEKVGARLWICRIMVTWGLISAAT---AFVTGPTSFFLLRFLLGAAEAGFLPGMILYLGTWFPLAMRARYVALFMAAVPIASAVGSPLSALIMQShgWQWLFIIEGLPAVLLGLVVLVLLPDGPADARWLTAREQQVIA----------DRLAKDNAAGDATTRHALWPALRDGRVLLLGLVYFGLVVGLYGIGLWLPQIIRD--MGYSVEQVGLLLVLPYALSAAAMLAWGRHSDRSGERILHVAGAAFLGAAGLLAsvPTPLLAIGAVTCASVGIYAALGPFWSVPPLFLraAAAGIALINAVGNLGGFAGPYAVGFIKQHTDRFTAAF-----------------------
     550 UniRef50_Q0S9L6        Transporter, MFS superfamil...   182     2e-44  1  13.0%  2:438   6:451     -PAMAATAEMISARLERLPMSRWHIKARVIVGAVTFFDGFDQLMIAYSLPVLIPKWGLTPGDIAWVIAIGGIGMLVGALAGGWFADRVGRLNVIIFSLALYAVMSLGM---AFTDSLMLFLVFRFVQGIGLGAEVPVAASYIGEITKAHKRGRFVLLYEVIFPIGLVMSAIVSAWVVPNYGYKILFALGALPVVLLPLLwwLASRGRYEDAHDAMTRIENEITGKYGKTLPAPQPLPAVTVDPRRGTFAEAFRGIYLRRTLMLAAIWGCAYFVNYGIASWLPTLY-RSAFDVSVDTALHYSIVTSVAGLIGCILVAFLIDNLGRRICITASMVLCSSLLFLLAASGADTalFWSAGSALFVFAVNMALYVYTAELYPTRMRAiaIGGASGRLGIIVGPLAVGAILDGGGTLTVVfmFAAVAMIGALVVGFFAVETREK
     551 UniRef50_A8L266        Drug resistance transporter...   182     2e-44  1  12.4% 14:408   1:421     -------------MDVPLNRRPSQRAVVATLFVamFITIMDTTIVNVALPSIAADLGVSSGSIDEVVIAYLVSLAVSIPASGWLADRFGSRPVFLAALGVFTAASALCGLAG---SLTALVVFRVLQGVGGGLLTPVGMAMLYRVYPPAERARAARILIVPTVVAPAVGPILGGVLTDQASWHWVFLVNVPIGIAAFGFGLAFLAGSRVPGAGRFDALGFVLSASGFALVLYALsgATVWWELRRTQPLLALRLLGNDLFRTVSLTLSIAFMAFMGVLFLVPLFM-QTVRGVSATTSGLVVFPEALGVLTATQIAGRLYPRIGPRRLMAGGLVFAAASMLALGFLDSAGSLwlLFGVGFGIGFVMMPAQTAAFATISTQQTAQASALFnrQLASAIGVALVSTALSLA------------------------------
     552 UniRef50_B4B3L9        Drug resistance transporter...   182     2e-44  1  11.3% 18:407  14:429     -----------------PPSHNNKWWAMLGVGVGVFMLTIDTSIVNIALPTLVKVFQTNFATVQLVVVSYLLVLTALVLGAARLGDMLGKKQLYLIGLILFTISSLLCGFS---PSILFLIGFRVLQGFGAVFMSGLGPAIITEVFPSSERGRALGIIGAIVAIGIALGPTVGGLLIGLSGWRTIFLVNVPIGIVASFVVWRFVPLSpsSTKQRFDWLGTIFITVSLTCFIIGMTEGQNRgeSRIRQPMLDLEILKNPHLSLSLVAAVFVFIVVGGIIFILP-FFLELVLKYSPQQSGLLLAVSPILGGIVAPISGTLSDRFGQRIISLIGLLLMVIGCGLVStlTDLVYILCIAPYGIGFGMFQSPNNSAILGSVPRERLGITSGllSRTLGQTTGVPLLGSIFDS-------------------------------
     553 UniRef50_Q39LQ1        Major facilitator superfami...   182     2e-44  1  14.3% 15:434  14:436     --------------IDDRPVTRYQWLLVVLCCLVVIADGMDVAIMGFVAPSIIHDWAISRPEFGLVMSAAPIGLVIGALVAGPSADRFGRKRVLIASVFLFGVFTIVT---AQAHTPFEMAMLRLLTGIGLGAAMPNTTTLLSEYAPKRMRALMITVMFTGFNLGSALIGFVAGWLIPLHGWRAVLLFGGTLPLLLIPLQLWLLPESARLLAVRGAPSQRIAALLNRvgGQFAGNETFVSNEPPLPTRRPIGVLFSQgvTVSLWITYFMGLLVIYLLTGWLPTLIKDA--GLSVSTAANVTAMFQIGGTIGAIGVGWLMDKVRPAPVIGAAYLGGGLCVAVLAWAGAlsLALLVFAAGFFMSGAQTGLNAYAPGRYPtrATGVSWMLGMGRFGSIFGSAIGGALLGLGWKFDAILSMLAVPATLAAIAIMTSQR----
     554 UniRef50_UPI000185C2FB drug resistance transporter...   182     2e-44  1  12.2% 12:436   2:460     -----------ATDLNTQFDPKKAWPALWTVLLGFFMILVDATIVTVGINTIQHELGGELNQVMWVTSGYLLAYAVPLLITGRLGDLWGVKHTYVAGLVIFVLASLACGLA---PSLSMLIIARVVQGLGAALLTPQTMALITQMFPPAHRGAAMGLWGAAAGIASLTGPLAGGILIQLLSWRWIFLINVPIGLVGLVFAFRYLPAFETHRNKIDYLGVVLSAIGMFLLVFGIQEGESawESKTMAEPLMPLLLFKDRNFTISSLAIAVMGALVVAVGFPIILF-AQNARDLSTIQASLLLVPQALISGVMAPWTGRMLDRLKFREFALIGFGSSLVGMLGFHylSVLWLLLPGAAFGVANAFIWGTLSTAATRNIDPTLAGAASgnTIRQIGSVLGSALIATVMAatTAMSDAMWLPVALSALGVVAALGLKNPK--
     555 UniRef50_D0RZF1        Major facilitator transport...   182     2e-44  1  13.3% 20:433  11:407     -------------------PRRYAWLVFALTFGLLISDYMSRQVLNAVFPLLKTEWLLSDSQLGLLSGIVALMVGLLTLPLSLLADRFGRVKSLAIMAALWSLATLGC---ALAENYEQMFIARFMVGVGEAAYGSVGIAVVVAVFPREMRATLASAFMAGGVFGSFLGMALGGVLAQHFGWRWAFGAIALFGLILAFLYPVLVKEKR-----------------------IASSHQNKNRSKTLHIQSPLKTLYSSRSVIATYIGSGLQLFVGGTVIVWMPSYLNR-YYGMSTDTAGVMAAVIVLCSAVGTILCGMLCDYLGrrKviTYCLVSCVLLLIAFAVPTGRSQLLLICLGMFIALGTNGPSSAMVANLTHNSVHGSAFalANNFLGLALGPLVVGKISDVIGLHSAFQLMPLVSIAAAAVFFYAKR-----
     556 UniRef50_B8DRU1        Major facilitator superfami...   182     2e-44  1  11.8%  7:437  10:478     ------TPGHVASAPGQSPAPVSRGAVLFVVSTSMVLMPLMMSAVGVSLPAIGRDLAATAMQVGLVETTYVMALSVFLLIMGRLGDIFGRRRLFLAGLVLFTTITAVL---SLSQSIRMVIGLRFLQGMGAAMIVANSFAIMLEVFPREERGRAIGIVSAAAYAGISCGPLIGGFLTTHFGWRWVFLMVLPFGISALLLVFTRLRGEWRSArlGSSHLDEGAWAWGALAAGLACGGLFLWLESRTPFPLLEVTLlrNRLFTLSCLSALINYASTFGVLFFLGLYL-QYVRGLTPSDAGLLMIIQPVIQMVLSPVGGRLADRFPAERVATVGMVLCAVGLGVAAFIGQDTSTalVLLGVGYGLFASPNASAIVGSVEPRHLGVASGMTSTMRTLGMMASMIVVTIvgFLSSMRTALWTFCALCAVGVLLSVGRVRSKG-
     557 UniRef50_B5WNE0        Major facilitator superfami...   182     2e-44  1  10.8%  1:435   1:441     MTAVPSAIAAPAGRVDerTYRKVVRRLLPVLLLCYVVAYLDRVNVGFAKLQMLDDLGLSDTMYAIGASVFFWGYFIFEVPSNVFLHRYGARFWIARIMFTWGLVSMALAfvAHVETATMFYILRFLLGLCEAGFFPGVILYLNFWFPAQRQSRVMSGFLIAMPVSLMLGGVVSGWLMDHtgWQWMLLIEGVPSLLTAFVVYFSLDDGIERARWLTPQEKSLLAANL--------------QRESAHKTARFGSAVRDPRVWLLVAILLTFNTGFYGLAFWLPSI-IKATGVQDPLHIGLLTAIPYGVAIIATLANAAHSKKTGERRLHAAIPALIGGIGLIMSAahVVWAITFLTIATAGILALMPIYWTFPGQLLSgaAAGIAMINAIGNLSGFTGSMITAVAKDLTGDINNGTYALGACLLVSCVLILLVPRT---
     558 UniRef50_B2TB13        Major facilitator superfami...   182     2e-44  1  12.9% 10:435   5:421     ---------EAGSVADQTAVGRYRWTICALIFFATTINYMDRQMLGLLAPLLQKDIGWTQVQYAQTVMVFTVAYAVGLATFGRIADRISTKVVYGGAMAMWSLAAMLHAIAATVPGFA---AVRGLLGFGEAANFPVAIRTTALWFPKKERALATGLWNMGATVGGIVAPAFVPIAAVMWGWRATFIAGGAAGFVWLAVWLLVYRPPAEHASVSKRELDYI----------------NSDRDESVEQRVSWLSVLKYRETWAFIFGKLLTDPVWWFYLFWLPKWLNESRH-IDIANLGLPLIVIYTMASVGSVAGGWLSSRlaRKIAMGVCALCVLPIATLSLFQSLWYAVFAVGLAAAAHQGWSANLVTTVGDVFPRRmtVVGIGGVAGMIGSFFYSGVIGETLQRTGQYWVLFAVGASAYLVALGIIHLLMPR---
     559 UniRef50_A8LDP4        Drug resistance transporter...   182     2e-44  1  13.2%  1:425   1:451     MSADSATAAPVRPGTSAAPPTSHHllALFVIAAAQLVVVLDATITNIALPSIQTDLDVSDANLAWIVNSYALAFGGLLLLGGRTGDLFGRRRMFQTGIAIFTLASLLGGLA---PNEALLISARVLQGIGAALAAPNALALITTTFPPGkrNTAMGVYAAMGGVGATVGLLLGGTLTDVLSWRWVFFINVPIGLVVLVGTRSLvrVDVPGAVTGTGGLIALvaTLTAFAVAAVLLVAFLLIQARTAHPMMPLRLFQDRNRSGSYATMLLIGAGMFATFYFLTLYM-QLILGYSPVRTGFAYLPFSFGIAIAAGVSSKLVTHVAPRVIAGPGLLAAAAGMLWFAALDPDslMPAMFLTGLGLGLSFVPMTLGAVSDVAHEDSGIAslNTAQQIGGALGLAVLSTIATSTADNKLPEAAGALYQGLA-------------
     560 UniRef50_Q1GRD0        Drug resistance transporter...   182     2e-44  1   9.9% 22:406  28:437     ---------------------RYRGLLTVAVMGASIMQILDTTIANVAIPHMQSALGATSETVTWVLTSYILASAIAMPITGWLADRIGRRELFLAAIAGFIVASMACGAA---QSLEQMVAFRFLQGIFAAFIGPLSQSVMLDINPPERHARAMSIWGMGIMIGPILGPVLGGWLTESANWRWVFYVNLPVGLVTLALMWALLPAMRRTSRKFDLFGFSMLaiWIELGVATACLWMFFVHLFTARAPLFSRAMLADRNLVTAMGFMIVIGIVMFASMALLPP-MLQNLFGWPVIDTGLVLAVRGVGILASMWVAGQLLGKVDARWLVGTGLAIAAYSLWQMSHWSLAmvIVSGLVQGLGMGLIFIPLNTMAFATIAPQHrgSSLLNLLRSLGASVGISVVTTLLG--------------------------------
     561 UniRef50_A5D1D3        Sugar phosphate permease n=...   182     2e-44  1  15.3%  1:431   1:436     MSQAATETSTNKVQVSSQLAkrYRWVCYGILLFTYVFVYFDRVCPAVVAPELMKEFGLTATALGILSSMYFYPYAAMQIPSGILSDYLGPRFSVGTFFLIAAIGTIIFGLS---KTFGIAIFGRFLMGVGVAVVWIPCMRILANWFRPKEFATLTGLMLTLGNVGAIIASAPLAVIVGAMGWRAAFYWVGAGLVIVAILNYVLLRNKPQD-----------MGLPTVSEIDGVEYYKTNDASDNATFLQNCGKLFRMKNYWLIAIYAFCIYGTVMGFQGLWFVPYAQDIYGLSKQTAANMLMLWPIGMACGCFFIGLASDRvsRRKASLYGMIIYIITWLPVVfiSVWFFYPLLFLMGFFCGSYVPN-YAHVSEGQPHsaTANGMVNIWYFVGGAFFQTIMGRVLDAYgaYQKAFILCIIALVVGAIAMYF-------
     562 UniRef50_B5XPT6        Putative methylenomycin A r...   182     2e-44  1  11.1% 15:429   4:443     --------------PATVSHEHHQFVVLVTLCVGMFMAILDVNVINIATISIRSEFHAPVSAITWAVDAYILSLCGLMLSGGTLADRYGSRRIWLSGLVLFACASLGCGMSVA---MWQLILFRILQGAGAALFIPASFSLLSAGWPDRhrQRAIGMFGGLVSVAAATGPVLGGVLVDDFGWRSIFFISLPAGLYGICSGYRPLPTVLPSRLRALDFTGQVLAMASLGCLSWVlaGGFVMVEHKSASPILPLVFFRSPAFNLANLSGFFINVCYFGSLYALSIILQQYWH-YTPFQSGMALLPLAFFLFVGNLSAGRLMRRWGIKKQMVTGLLAGSVGYAGMISLHglLAFLSMALLAGGVAFAVPPMTAAVLAGRTQDTAGTASAitFRQTGSLVGIALAGLIFSCTQHPITVLMGLSALVHLLLALM---------
     563 UniRef50_Q392B3        Major facilitator superfami...   182     2e-44  1  10.9%  6:437  30:457     -----TPMTAAAPPLHAATMRRLNLRLIPFLMLLYLVAYIDRSNISVAALQMNADLGLSAEMYGLGAGLFYVTYILFEVPSNLFLARVGARRWIARIMITWGIVAAAM---STVHTPGQLYAMRLLLGAAEAGFTPGIIYYLSAWYPPSDRARAMSFFYIGATLASVIGLPLSGALLNLngWRWLFLLEGVPALLLGFVVLRRLPDTPAHARWLPADERA----------WLEATLRDSAPREHLSHGAALRRAFGDGKVWALAAFWLLQAFGTIGLTLFLP-LLVKSLSGQSSFAVGSLSALPFLFACVAMYVNGRHSDLGGERALHLgmLLAGALLIAAIYTPTLPVAYALLVLAVGFNWAATPVFWAVTTEYVstAAASIALINAVANIAGLALPPVMGRIKDVTHAYDLALLLVAVALLAGGVLALRIASRRT-
     564 UniRef50_D1XTP8        Major facilitator superfami...   182     2e-44  1  11.7%  7:435   1:473     ------MRDPSPATDGTDTPYRWRWLILVVMLVAEIMDLLDASIVNVAGPALEESLGAGPVGLQWVIGGYALTLGAGLVLGGRLGDRYGRRRMFLLGLSAFTASSLLC---ALAPDIGSLIAFRLVQGTAGAMLLPQGLGLLRENFSGPELTKVFGIFGPVLGLGGIIGPVLGGGLIqgLGWRSVFLVNLPIGIAALAVAARFVPKKSGDRTVRVDMTGAALVaaASALGFAGFALQQRRTAAAGREPLVTPALLRKPAFTVGLGGIALFFAGLVGTQLVLTLYL-QIGRQFTAGEAGLGNLPLALGTAIGGAVSGalADRIGRKVLQIGPLVQLAGAVLLWFELDGLaiAPGVTVAGIGAGMVIAALFSFVLAAVDDDEIGSASGvaVQSVGGSIGVAVFGSVfdFTGGFHRALVVQACLLVAFLAITLLLPKR---
     565 UniRef50_B8FUU9        Major facilitator superfami...   182     3e-44  1  14.2% 23:408   4:413     ----------------------RKTPLILSLMLAMFLAAVEGTIVTMATPTIARDLQ-GFEFISLVFSVYLLTSALSTPAYGKLADLYGRKNILSIGIIIFLAGSFLCGLA---QSMVMLIVFRAIQGLGAGAIFTVSFTIIGDVFSLAERAKIQGALSTVWGIASLVGPFFGGFLIDVLSWHWIFFINIPFGLLSVILLQSSLKETFAKKKPSIDYAGTllWVAGLLLLTFFLLYTFYKIEKKAAEPIIPFAIFT-RTTILVNLISFLIYAVLMGVNVYLPIYL-QNILGYRPTAAGLAMLPMSVSWLIVSFILGRLLVRYGGKNVILASNAVLLLSTLLLFttPLPIILAYGFIMGIGFGGASAALTIIVQDsySQRGAAVGTNSLLRTLGQTIGISVFGTIFNLY------------------------------
     566 UniRef50_UPI0001B5453D putative permease n=2 Tax=A...   182     3e-44  1  10.4% 14:435  16:437     -------------VDRKATYRTIARRVMPLLVLCYVVSYIDRTNIGIAQQGLKRDLGFGPAVYGLGVTLFFVGFILFEVPSNALLARIGARKTLARIMATWGVMTVVTLF---VQNEIMFYAARFLLGVAEAGFFPGALYLLSLWFPSSRRTRMTAVFFIGIPVSGALGSVMSGWIMHSLgwQWLFLIEGIPPILLAGLVLLFVTDGPEQAKWLTADQKAAV--------RADLDADLRDKGPAKQKHSGLLLALRDPKVWILGLCACGAYTLANAVSYWTPRIIANAGVG-NVLNLGFFSAIPPLLGIVVMLLVGRHSDRTLERRWHAAISWIAAVCAMLAigGNVVVVILLLAVMAAAHYSGLTVFYSIPSIYLTDRAAATGIAVvmGSFAAAASPSLLGFIESSTGSLSLGLQISAGIILLAVVVLLVGVRP---
     567 UniRef50_Q84HB4        Transmembrane transporter n...   182     3e-44  1  12.9%  9:435   6:477     --------AADGAEDPQAKADPRRWWVLALLSGLQFMILLDMTVVNVALPLVQEGLGFSEAGLTWVVNGYVLAAGGLLILGGRLADVFGRRRLLLIGVGIFAASSAVCGAAVV---PGMMVVGRFAQGTAEAIAAPASLGLIALLfdPKERNKALGIWGGLVALGGTLGYIVSGVLTDLTSWRWIFYINLPVALAVLLVIPRMVTESrrERDQGLDIAGAVTSTAGLVAIVYGLLQAAEHpeRRVENPLIPLDFFANRTRSVINLTSLFFMAAFISYTFIL-TLFEQHVLKYSPLETGLAYLPLGFGIGIGIGVGTALTPRIGVRAVVAMGFIGAGIGLLLTSTVDVDtiLPGMVVFGVFAGATMPAATSAALHQVTDQNSSLASgnTMQQIGGALGLAVLVPLaaVTSGYVLAFRVGAALMIIGGVLIMALFER---
     568 UniRef50_B3PJ80        Hexuronate transporter n=7 ...   182     3e-44  1  15.1% 17:434   3:443     ----------------QQNIGNYRWTICALLFFATTVNYLDRQVLSLLSPELSKEFGWTNSDYANITAVFQFVYAISMIFAGRIVDKLGTKWGYQLAIFVWSIGaaLAGIAAVPVSIVGFMLSRAVLAIGEAGNFPAAIKATAEYFPKKERSFATGIFNSGANVGAILAPLTVPWIAAHWGWQTAFIIIGAIGFVWMIFWHIFYEKPTEQKRLSESERAYI---------ESDSEKEQLQLDDAGEQKVSWFKLLTYRQTWAFTFGKFMTDGVWWFFLFWLPIFLAKQYGIKGTDLMLPLTVLYSLTM-IGSIGGGAFPMYfgRMRAMLLIAIFPLVVLLalGHISFWVPIILIGIGASAHQAWSANIFTTVSDMFPKKSVASVVGIGGLAGGIGGVVvvAGWLFDYFDSVgtGYAILFGFCAVAYLIAWFVMK----
     569 UniRef50_Q477L0        Drug resistance transporter...   182     3e-44  1  11.1%  5:427  15:464     ----PASQANASIPLSPAHDHQAIMRVIGGIVLCILLAALDQTVVIPAVPAIANDLN-GFGHLSWIVTAYLITSTVATPLYGKLSDSFGRRRLLMVAITLFILASVAC---AMAQSLGQLILFRALQGIGGGGLMSLAQAAIADVVAPRQRGRYQGYLATVWAVASIAGPLVGGWVSDNLSWRWLFWINLPLGGLAMLLCYRGLalPVRGGRARVDWVGALLllGLLALVTVAAVAALAWQERRAADPMLPPRLFANRAYVMGVAASALAALNIFLCIFALPLHF-QLVRGADASMSGLLVMPFLLATVAGNFIVAWVAPRVGrrGILTAGFIAGAIGLAVLAlvPLAVVLLAMSIGGTGLGMVMVGTLMSVQNVLERrgAGTGALLVLRSLGSALGGALAGTLLTLEFRHATAAAGVSQALDLGAL-----------
     570 UniRef50_B2GKF0        Drug resistance efflux prot...   181     3e-44  1  12.8% 10:407   2:429     ---------SHTTAETRDGTDPRAWHALWAMVLGFFMILVDATIVSTAIPAITAGLHTDISGVLWVTSGYLLAYAVPLLITGRLGDRLGPRTVYLWGLAVFTGASLWCGFA---QDITALVVARVVQGLGAALMSPQTMTVITRMFPVATRGTALGIWGATAGIATLVGPLLGGILVDLAGWRWIFWVNVPVGIFALWRAAVHLPRLPVRSHSLDLVGVVLSGLGLFLVVFGIQEGQsaWQAVTPAEPLVPLPLLRQRNFTLANAAMAAVSLTVNSMIIPAMLYL-QVVRGLNPTVAALSYAPMSLLSAVLAPLVGRALGKVAPRSIALPGMLIMAAGLAAYAltSVWLLAALTLVIGLGSAMIWSPVSLTATSDLAPDVVGAGSgnATRQVSAAVGSAMMAVLMQA-------------------------------
     571 UniRef50_UPI0001C31104 major facilitator superfami...   181     3e-44  1  11.7%  6:407   1:429     -----MQPTPSTTPSAREPADPRRWWLLTLVAIAELMIILDIYIVNIALPSAQSALEIPDASRHWVVTAYAITFGGLLLLGGRVGDYWGRKRTFTLSLVGFGVASALGGAA---WSPELLFAARALQGVFAALMAPAILSLLFVTfdPRERAKAFGVWGAVAGTGSAIGLLLGGVFTEYASWRWTLLVNVPVAVALAVAAWWIVRESRTDGETRYDIPGALTSTLGVTALVYGFTraFVAIERRSANPLLPLRVLTDRNRAGSFAANALFAGAIFSYGVFLV-YYLQGSRGYSAIESGLAILPLTLAAIAFVSIGARLLPRVGPRPLTVGGFAIGAVGLGWLALIgmAVVFPGLVLLGIAAGLVWPVLSNTALVGVQPRDAGAASGmvAQQLGGALTVAFLNTLAAS-------------------------------
     572 UniRef50_Q01ZH0        Major facilitator superfami...   181     3e-44  1  13.8% 23:436  28:424     ----------------------RRWTVIGLLSLGMIIAYASRSNLSVALVtfIRSFQLSDTDRGLLNSAFFWAYAALQIPAGWVVDRYGVKWPYAISFLFWCLASAGTALAG---TVGQLIALRILLGMGESVVAPASYRWIRLNFAERQRGLAVGLYMTGTKIGPAIGTPLAAWLILNHDWRAMFIMVGLGGLIWLIPWMILVKDTQAAPKLAAAAAPPRT--------------------------VSFARVLASPVTWGTVIATFSYMYFVYFCMTWMPAYFMERRH-LSLSQMGLYTFFSFGGMAIVAAGAGWAADLlvRKWFTIAGFAVACTELIGSQSSSVQVALVFSVVSLSGLGLATANYWALTQTLIPAWAIgsGVQNCAASIAGIVAPILTGWLKQKTGNYEAPMFACAVFLVLGVLSYIFMVKER--
     573 UniRef50_Q6D8N5        Putative transport protein ...   181     4e-44  1  12.8% 17:437  18:435     ----------------ASAIAKFFKRIIPMLAIMLIINQIDRSNIGFIKAELQTDAGISAAAFGLGAGLFFIGYALFEIPSNLMMKKYGARVWLTRIMITWGAVVVATGF---VTSPTQFYVLRFLLGVAEAGFFPGVLYYFRLWVPNAWRGRATALILSASAGAFLfgPITGGILMMhvGWKWVMFLEGIGSILVGILAAFVLVSSPDKARWLSVEEKLALEQQLQQEEMERDAQQTHTGK---------LNLLTDRRTLFYCAIFFTMTMTGYTLVFWLPQI-IQRIQGFSSFGIGLLTAIPWLCAIIAINLVGKFSDKHRQhkALGVAMLIAACGTFMATIGSPWFGFFAMIVACIGSKVSATFFWPMPQGNLPASIvgIALINSIGNLGGFVAPTVFGYLELKTGSTTGGLYSLTCVSVVTGLFLLLRSTHAT-
     574 UniRef50_B2JW35        Major facilitator superfami...   181     4e-44  1  14.2% 10:431  23:447     ---------DVQQFLDDQPIGRFQLLVLLMCMLIVMLDGLDTVMIGFIAPSLSTAWAIPRDALGPVMSGGLLGLAFGALGAGPMSDRFGRKAVMTTAVLFFGVWSLA---SAFATDVASLTVLRFLTGIGLGASMPNAATLMAEYAPPHRRSLMVTIVFCGFTFGAAGGGFVSAWLISAYGWHSVLLLGGVLPILYVPVLIKWLPESARYLALKQSRRMRLVDVLNRLKPASADATTRFISHEPERAERSPVRAILSrgTVMLWICYFAGLLTVYLLGNWLPTLI--RGIGFTLAEAAVVGALFQAGGTIGSVLIGWQMDRFNPHRALGLTVFAGGVLAWYMGSSAHTFSTICVLAFGMgmNGSNTGFCALAAGSYPtrATGTSWMLGVGRFGGIAGAMLGASMLHANWGFGEVFMALAVPAAVGALGVLL-------
     575 UniRef50_C1F2M4        MFS transporter, anion:cati...   181     4e-44  1  13.1% 19:429  20:421     ------------------KTSHQRWVICTLLFFATVIAYVDRGVLAYLEKFLQSIigLNSVKYGYILSGFTVAYAIGMVVAGGLTDKLGTRKAFAIAIGLWSIAAMLPGAA---FSVITLGIAMFLLGIGEAANFPACIKTVAEWFPKRERALATGIFNSGANIGNIVVPLIVPTLVALVTWRGAFVVTGGLGIVWLIIWLIYYRRPEHHRSVSEAELQLILSDPVEKL-----------------ERVPWKQVLPCKETWAFSIGKFLTDPIWWFYLFWLPRYL-QTTFGLSLSSNRLPLVIVYSISIVGSVGGGWISSLlsRKTAMLICALCVVPVFAAPFIHNLWAVVALIGLATAAHQGWSANLFTLPSDVFPKSAVgiGIGGMSGAIGGALFQLATGYIVYFTHSYIPLFGIACAAYVLALVII---------
     576 UniRef50_B7I819        Transporter, anion:cation s...   181     4e-44  1  11.3%  6:437   1:439     -----MEDIKNVTALEEQTIKRISSRIIPFLIILFIMAFLDRTNIGFAALHMNDAIGITQTIFGLGAGVFFLGYFIAEVPSNVLLHRFGARIWIARIMITWGIIAGLMGF---IHSGTQFIILRFLLGIAEAGFFPGVIFYLTLWFPAKYRARVFATFYLGLPIAQIIGAPISVGLMQWggWRLMYILEGIPSIILGLVCLKYLTNNPKEAQWLTAEQRQ----WLMNTLEREEREKQQSADAALTKGELIKQVFKNPLVWIMAIVYFGITSGSNAMFFFLPSVLESFRNTfsLIQNGLLTAIPYAFAAVGMVLWSRRSDRKQErhGACAALMAAFAIAIALIVNQPWAIIVGFILLAIGVFSAINIFWTIPGQTLtgAAAGIGLINSVGNLSGFTGPYLTGYLYTTTGTYTVAFLAIAGFVAMGGLGLLLLAKLKS-
     577 UniRef50_B0T5Q9        Major facilitator superfami...   181     4e-44  1  12.8%  7:436   1:435     ------MPKTLTDKLANAKDSRYRWLVLAVLTAVHSTHHIDRNVLSVVVEPIRQEFHLSDSQMGMLGsgYALAFAIAAIPMGYLVDRVNRRNMLVGILALWSVMTAVC---ASANSYVHLLLARMGVGIAESGGAPTAMSMVSDYFPPKQRSTAIGIWYLSSAIGTGIIFLVGGFLAQSFGWRTVFLVAGVPGLVMGLILFLVVREPPRGGSE----------VVALDTPETTPAATVDTPEKAATPREAFAYVIRRPAILSMMAGIVLAAAMSSAFALWSVSFLVRVHHMPLALAGVSIAAAFSVFGIIIPLISGVMGDRLSNAksATTMTGVVLCGVAAALSGSAPVAVAMMCLWCGLMLAHNGPANALVLSLLRPRMRGVVVatVATVVGTALGPFLVGVLSDVYgsLRWAIMTGMSLNVVAVLCFLNAARTA--
     578 UniRef50_Q13JS8        Major facilitator superfami...   181     4e-44  1  13.4%  6:437   1:436     -----MNDELIAARIDRLPVSRFHRRLLLLVSLPFFFDISDIFTFSYAAPALVKEWGLTMSSIAMLTSAGFFGMFLGATLGGMLSDKIGRKRALICYVIAYSVFSLAN---ALAPDIPMLMITRVLTGVGISSATAVVMAYIAELFPAKTRGTWQSWAMVIALMGIPITSWVARLVVPSggWRWIF-VWGALGIVFLVFTKHFPESPRWLARQGRMEEalIEAEVVRTTGPLPEAVAINRPAEVRAPWTSMFKGQYIGRTMTLWAIWIFQTLGFYGFQAWVPTLLVQ--HGITIVHSLTYITLINIGAVPGALIAVFLADRFERKFSIAGAAALIAVFGLLYGLSFQPVLIVSffLVGMLIQTFAALCYAYTPEQYPTDIrgAGFAYGMGRLANVGNSFIVAGIFMNFGYVWVFVYIAGAWLATAAVTLLFGARTTG-
     579 UniRef50_Q46NA8        General substrate transport...   181     5e-44  1  14.9% 10:418   8:420     ---------NVVSFIDERPVGRYQIFIIILVFLVVAFDGMDVAIMGFAAPEIIRTWGITKSQMGSILGAVFFGVAVGALIAGPIGDRYGRKLILTASVFWFGV---LTLISSQATDVNTLITLRILTGLGLGAALPNAVTLISEYVPVRKRSLIVTIVYSGFTGGAAVAGLIAAWLLQAFGWRVMIAIGGLLPIVLALILAIWLPESVAFLTLKGKRLAAIPKILRKIDRGSSVLSDatPVDQSKGSVAILFTKAYAMGTFLLCVAYFMGVCATYVMVNWLPVIAKDA--GFTLGQGVVITTLITLGGPIGSICIGAIMDRVRPHWVLVPTFLIAGAFLASLSVApfGALCVLMFALGCFFHGSMTGLQALSAMSFPTAArgISWMHGFGRLGAIASGFIGATMMGWGWGLGQIFLAL--------------------
     580 UniRef50_A0QVD6        Transporter protein n=1 Tax...   181     5e-44  1  13.3%  8:436  10:441     -------TPKSDDSARRSALRKVNLRLMPFIFLLYLVNYVDRTALGIAApgMSDELQMTATLFGLASGIFFVGYILLEVPSAMAAQRTGARVWIARIAITWG---AVASLTAFVPNYQWLIVARFLLGVAEAGFAPTVLLYLTIWFSNRERPKAFSVYLLGIPISSVVAGPVASWLINAggWRFMTLMTGVPAIILGVAALFWLTDRPSQAAWLTDAEKEALIA----------DHDEHTPAEARGHAGGMLSSLRSGRVWIMGFAYLGVVYSLYTIGFFLPsfAERFGTDFTVIENGFIIAVPYVFAAAALMLWPRHATRSgiGWHVLISTVVGALGIVIAAFAgpWIVMLGVTLCAVGVISAMPLVYSLPARILSSVAVGaaLVNTIGNVGGFAGPFVTGWLRDLFGNDQGAFAVVALLLLTSGVISVAVQSRT--
     581 UniRef50_UPI0001C31FA4 drug resistance transporter...   181     5e-44  1  13.4%  6:437   1:482     -----MSSLSPAAPAQGSGTETNRWVVLVLVCLAQFMVVLDATIVNVALPSIQTDLDITAGNLAWIINSYTLLFGGFLLLGGRAADLFGRKRVFLAGVVLFSVASLLCGLA---TSQETLIAFRGLQGLGAALVSPAALSIIMTTfdGAERTKALAVWGAIAAGGSAFGLLLGGVLTEALSWPWIFIVNVPVGIAAFVLSLRLIPEsaPDAGRGFDALGAVLVTGGLISLVYAIVRAESaaERVQSQPLVRLGIFSTRSLSTANGVMLVVAGGMFAMFFFA-TIYVQVVLGYSPIEAGLAFLPFTVGIIAGSVAAQQLIPRIGVRAQILFGLTLAAIGLLLMMRITatQLLPAVLVMSIGMGNTFVPLTLLGTTNVEERDAGLASgnTSQQIGGALGLSILSTLAAsvDGYHVAFLIGAVFIAAGALAIVLLIRRSD-
     582 UniRef50_D2TK02        Putative MSF transporter pr...   181     5e-44  1  14.6%  2:438  14:458     -SGTASTPDALLARLERLPITRRLKAIRVIVGLSTFFDAYTIIAIAFALPQLTQEWGLTPTFVGLIIAASYVGQLCGALFFGSLAEKIGRIGVLRITIIMFVLMDAACLFA---WNGWSILIIRFLQGVGIGAEVPVASAYINEFVGAKKRGRFFLLYEVIFPIGMMFAGLVGYFLVPIYGWKVMFLIGLVPSALTVPLRWLMPESPRWLTAkvVSTLESEVIRRGMTLPEPEIKAPTVHKAAPEGAKALFSGIYKSRTF-MLWGLWLTVYSVNNGMITWFPTLYK-TWFNLSLDTSLAYGWITSSCGVVASVICALMIDRVGRKRWYTWAFLLAIVPLIALSVLGAKSAVEILILGSLTYAILQTIAFSlaAELYPTRLRAIGTAYSSarAGSSIGPLMVGFIVSGFGIRFVFITFTVIALIGGLITWLFAIETKGK
     583 UniRef50_C7Q7X7        Major facilitator superfami...   181     5e-44  1  12.6%  1:435   1:472     MSTTSRSPAQYATSPAETAPKRGLMLVMVPLMLVLFISNLDATVVATAIPTIGRDLG-DVSGSSWIATAYLLTSAVTTLIFGKLGDMYGRKKIFQFSIVVFLVGSALSGAAG---SMALLVLFRALQGIGGGGLNSLVMAITGDLIPARQRSKYQALVGIVATLALIAGPLLGGLFSDQLSWRWIFYLNIPIGVLALVAVATLLHLPRRTSSGRVDVAGGVLATVFTAAIMLFTTWGGTEreRRAAEPITPLHLFRTGVFSISSAQFLIATMVLFVAMLYTPAFL-QSVQHKTAFVAGLYVIPLLVGLVVATAVAGPVIARTGRYKIyiIGAVLTGVSMFALthTATWALLVPLTFAGAGIGLFVQVALLAGQNAVDYkgVATGALNFFKSIGGAFGAALFGAIlaSAHAFQTVFAWTVPFMVLSLVLGLVMKEK---
     584 UniRef50_B8KKX4        Major facilitator superfami...   181     5e-44  1  14.0%  3:408  30:422     --TPEAVSPIVSNNTDFSASEGYKRYVIWLLFAVYVFNFLDRQIFTTLLQPIKQEFQFSDTQMGLLGgaFALFYSTLGIPIARLADQRNRVNIIAFSIAIWSAATAATGFA---KSFSHLLIARICVGIGEAGCSPPAYSLISDYFEPQKRARAMSIYSMGIGGGIFLGYLVSGVVAEQYGWRAAFFVVGIPGVLLALLLKLTLREPPRGFSDNISV-----------------------AAKPPPVAEALTALWRRRSFRHLSLAAALHAFAGYGVGSFVPAFLIRSHGMTVSEVGFALSMISAVGIMGGIYFGGYLSDRVACQrvPGIATLLAVPIALCIYLLPNKLLILALILPSQLLGYMygPTFTMTQSLAGIRERALAGAviINLIGLGLGPTLAGWLSDMF------------------------------
     585 UniRef50_B1M8G1        Major facilitator superfami...   181     5e-44  1  11.5%  4:437   8:439     ---ATDGPVIAATARLDDTYRRITWRLLPFLMVLWILSWIDRVNIGFAKLQMLAELRFSETVYGIGAGIFFIGYFLCEVPSNLLLEHIGARKTIARITLLWGICCVAMMF---VTTPAFFYILRFLLGVFEAGFYPGVILYLTYWYPSERRAKVFGLFMSASALAGVIGGPLAGAIMswSGWQWVFLLEGIPSILAGIVTLFYLTDRPAKAGWLTPEQKALVEADLARDAAALGHREHR-----------ILASLKDARVWQCIAIFFCIVTANSALTFFGPS-VVRDAGFTDPLAVGWIMSAAYLCGGAGMILNGRHSDRTGEARLhaLVGALAIALTGVFIANAPILALLMLGVAVVGTMSAIPVFWQIPGRfgSAAAAGIALINSVANLAGFGAPAVMGYLREQTGSVATGLWLVAAVEAAALVLILAFVPPAT-
     586 UniRef50_B1L7A1        Major facilitator superfami...   181     5e-44  1  11.9% 12:438   6:427     -----------TELLDRVEVGRFHYKILLTSSLIYGLTGMNVMLIASLVRPIAREWGLDTITVGYLLSVGYLGMFLGALLFGRLADVIGRRKVLIFVIIMESIFTAACGLA---PDLSTLYTLRFLAGIGLGGALPQPAVYVSEYIPKGRRGLFLGLVETSWVYGAILSLLIPYFLLPSLGWRLTFSVALLPLIALPLTLAYL----PESLRFLMARGMVEDVNSLLRKIGITELKEVKLDSAKKYSLKDLFSQKYMKRTLLLFILWGGLIYTYHGIFLWLPTIYAKQFGLEDVTSIGWSLLV-TLFQIPGYYSASFLLDRIGRRKVLAIYLTAAGLASALLSliDLSWVFIFSSMISFFNLGAWAGLYAYTPELYPTEIRGTGSGAafGRLMGILAPSITGYLFATTGLSGPFIVFSFVHIFAGLSVILLGIETMGK
     587 UniRef50_D1V7V1        Drug resistance transporter...   181     6e-44  1  12.2%  2:426  10:461     -AAEPAAEGSAPSDDPASSGGRRVGLILIALGIGLLLAALDQTIVATALPTIVGDLG-DAQHLSWIVTAYLLASTVSTPLWGKLGDLYGRKIFFQAAIIIFLVASAV---AGLSQSMGELIAFRALQGLGGGGLIIGAQTIIGDVLSPRERGRYQGVFSGLFGFASVVGPLLGGLFVDHLNWRWVFYVNLPLGAIALVIVASALPSTRNRVKRTIDYLGTALLAGATTCLVlvLLVAFAFVERRVPEPVLPPRLFANRVFNISNLMGFVSGFAMFGAITFLPLFL-QVVKGVEPTMSGLRLVPVMGGMLVSSTLTGRLVSRTGRYRviVGSVLVTASLLMLAWRLTPEimVIYLALLGFGLGGVMPVLVVSVQNAVEFrgAATSGSAFFRSIGGSFGTAILGAIFASHLTEKLPQALGGMSLPAGF------------
     588 UniRef50_D0FQF8        Conserved uncharacterized p...   180     6e-44  1  11.1%  2:433   4:433     -PTEALPLTCPTSDMEENAWRRATWRILPILTVSYIFAYLDRINVGIAKLQMSSDLAFSETVYGLGAGIFFIGFFFFQIPSNMVLQRVGARRLLAALLVSWA---AIAPLTALVATPWQFYTVRFLLGLTESGFYPGVILYLSLWFPSYRRGKIFALFAAAVPLSGLLGGPLSGGIMSYfgWQWLFIIQGTPSLFIGALVFWLLPDRIEHAHWLDQKEKSLLNA----------RLKEDTVQDSATEQATLNSVLRNGKLWLLALIYFCLIAGFYTVSFWLPT-LVHNAGVEDVFNVGLLTAIPYAAAIVTMIVAARSADKHRERRWHLAIIAIIGAAGMVISAlnLWLAMCGLTLGAAGSLSTLPLFWSLPTAFLGGSMagIALINSIGNLAGFVAPYLMGLLTDLTHSTLSGMVIISCTMLVGTAAIFLIP-----
     589 UniRef50_Q11E89        Major facilitator superfami...   180     6e-44  1  13.5%  6:434   4:437     -----AARIDAAAVINDNNISRFQYRIFILATLIMMCDGFDTQAVAYVAPSIVAEWNMAPGSFGPVFAALLLGSMVGAFAFGYLADKIGRKYTLAGCVALFGI---LNFASAYATSIETFTVLRFLCGIGLGGTVPNVTSLVSEYAPARKRATLVAITWAGFGLGAVVGGLISVPLISHFGWPAVFIAGGILPLLLLPFIFFSVPESIKFLILAGGKGAAVASILKLICPSGSFKDNDvvLEESRPGRGQISALFKDGLAIglCLAFFMSLLLVYLFINWIPLLLRQA--GLPLQHAVMGTIIFNLAGIIGSVFCTQLIDRKVARPVSILIAaaAAVFSIGYAGTAFWPIMITIFLSGFFIIGVQLSLNAFITNYYPtrGTGVGWSQVIGRLGSLLGPLIGGALVSQGMAPSQLFQVSAVAPLLACVSLLIFAR----
     590 UniRef50_C8X734        Drug resistance transporter...   180     6e-44  1  11.9%  1:405   1:451     MSTTEPTQPATSTGPTVPTTDRRRWIGLVGISLAVALIIADSTIVNVAVPYIVRDLSLTSTEVQWVQESYTLVFAATLLIWGALADRYGRRRILLIGVVVFMA---ASMVAAVAATGPLLIGARVLQGVGGAMILPTSLSLINSTFTGRDRGIAFAVWGSTIGGMAAVGPLLGGWLTTAFSWRWAFGINLPVGLLIIALVLLFVPESRSPQTTGVDWVSALLTTVGFGLLAFGLIEGRqrRTRAGRSSLIDPGLFGITSFRNGNIAALIVSLGEFGIILSLPIWL-QNVLGCTALQTGFVLLGLAVGSFAASGLSVGLPAKIGAVGVVRIGIviAGVGLVVSPTTGWAPLVGLLFVYGFGVGLATAQLTGVVLADVPVARSGEGSGitSRQIGSALGIAVLGTVL---------------------------------
     591 UniRef50_C7JI57        Multidrug resistance transp...   180     6e-44  1  13.1% 21:417  15:438     --------------------PTTRILVFIGLIMTMIMGALDQSIVSTALPTIVSDLG-GLARMSWVVTAFMLTSTIATPMYGKLSDMFGRRPLLAFSIGAFLFASLLCGIA---QNMWQLILFRGLQGVGAGGLMTLSQTVIGDMVTPQQRGRYQGLFTGAFAVSSVTGPFLGGVLTSALSWRWVFLVNLPIGLLAFALIMFSLPAGRSEAKPQIDYLGAGLLSIalFGLSLAVFYLFIRQERQAPEPLINLGLLRIANFSVCVAATGIMSFAMMGSLVFLPLYY-QLVLGQTPATSGLMMLPQVGTMLVSSILGGIVSSKTQRYELLLAIGVGIEFSALSLIaaPPLFFLISLGCLGVGMGIGMPNATVIIQNSVPSNALgtAMMSFIRSLGGSLGVALSGGVMALTLQHRLQAIA---------------------
     592 UniRef50_C4DV37        Drug resistance transporter...   180     6e-44  1  15.0% 26:431   2:433     -------------------------WVLAALCAAQFMAIVNISVVNVALPAIQKDLDTSLAGLQWVLNAFTICISALTLAGGSLGDRFGRKRVFVTGLAAFIVGTVVC---AVSVNLGMLITGRLIQGIAAALLLPGSLSILAQTfdPAERVRRIGIWAAVSAVGLVIGPVVGGVLIQAFGWPSLFWLCVPLGVTALIATLVFVPESANPEHAAIDPLGQILAMLSLGSLSFGLIRLGDKgeLRTRTPMLPVRLFADRSFAAMNFASASLGFGPYTMYAFLALYLQQER-DFSALSAGLAFVPMSIATAIVAPLAGRWVGASGPVPAMLAGYGSSAVGLAGVALFDAHTSWFLmvLIGVGMGLSMTPTTNGAVDAVPRERSGIAsiNTTRQTGLAIGIALLGAMVSAQDNFLTGLRLVAAVTALVSLIAVV-------
     593 UniRef50_B1LST8        Major facilitator superfami...   180     6e-44  1  14.7% 20:435   3:415     -------------------AKRYRFLIAFLLFIAGIINYMDRAALGVAAPFVKEDLNLSPSELGVIFSTFFFGYALFAFVGGQLADRYGPRSVYSWAAAAW---SVLCMLTGAVTGFAQMFVVRALFGFAEGPMNSTTNRTITTWFPREETARTIGFTFSGQTVGSAIAAPVVGLLAIQYGWRVAFVAIGAVGLLWVVAWRMLMTDRPQDNPRVDPEEIALV-----------ERSRAVTHLAPSDHARSLKEYLFLPSTLSLGLGMFAVNYTLYIFLSWLPSYLTDA-LHMPVKEMALVASIPWACGFVGyfVYTRMGDKLAARKITTilAVAGVALLAVNAATSTAMAVSLIALAVLMLTSSVQSCWATIHELVPEARVGGVSGFilSNISGIIGPTATGLAVQYLGGYASAFVIAALIAAAGVVAMAIFVRR---
     594 UniRef50_A6WB21        Drug resistance transporter...   180     6e-44  1  11.8% 10:407   5:429     ---------TTPQPTPLLLTRRRIWIIFSALIAGMFLSSLDQTIVGTAMPTIVGNLG-GVEHQAWITSAYLLATTIVMPIYGKFGDVLGRRRLFLIAIAVFTLASIGC---AFATDFWTFVLFRAAQGLGGGGMMILSQAIIADIVPAAERGKYLGPLGAVFGLSAIGGPLLGGFFVDHLSWRWAFYINIPIGIAAFVIALLALTLPNKKATKPIDVAGVIAltWLLGAGLVLSAAAFVLIESRAADPIIPLTLFRNPTFMNATAIGLTLGIGMFAAIGFVPTFL-QMSSGTSAAVSGLLLLPMMVGLIGTSIVSGREITRTGRYKLFPILGTLLAAMAMLaaGTALWLICGYLLVFGAGLGLIMQVIVLVAQNAVTPdgTATSTNNYFREVGAALGTAVFGTIFTT-------------------------------
     595 UniRef50_B9M939        Major facilitator superfami...   180     6e-44  1  12.5%  2:433   4:438     -NAQTKPSVSFTQWCDSLSFNRFHAMVMALAALILVFDGYDAQIIAYVMPQLVKEWHLTPVEAGSMASYGFIGLMIGAAGFGTFADRLGRKKGVMIALVVFSVFS---GAAYWAPNFKVFCLLRFLAGIGMGGAMPLTITLVTEFAPAKARAKAVSAMFAGFTLGWGVAALVAMVGIPALGWRMV-LLFGFLPVLILPLLQKALPESVRFLASKGRHEEAILEIQRMEKAAGLPPAAWTKeqTGPVEPGSSLTQLFSPGFslIWATYFLNLLVVYGLATWLPSLLVKA--GFSLVKSYSFGMVQAIGASLGGFLLGWMMDRFGRKSALIFAYMAGGVVVALFGTVSSNTALYIiaATGVFVIGAQIAQHVVTGELYPtrSTGVGYALTAGRLGSIAGPLLGGALQMAGVTFSQYFLIFAVPSFLCAGLVYLYR-----
     596 UniRef50_A8LGX5        Drug resistance transporter...   180     6e-44  1  13.5%  4:432  18:475     ---PTQSMSDPTLAAVTGGADRRRWIALVVVCLAMLMNALDSSIVNVALPSIQGDLHFSQSNLTWVVDAYLIAFGSFLLLAGRLGDLVGRKRVFLTGVALFTAASALC---AVSPNQGTLIVARFAQGLGGAVSSSVIIAIIVTEFpaTERARAMSAYMLVAVGGGSLGLVAGGVLTQAVSWHWIFLINVPIGVATFVLGVVLIEENVGLGVGRGVDVTGSLLVTAALLlgVVLLAAFFLVEARRSNPIMPLRILRVRSLVGSSVVRGCLFIAMYAVFFFGALYLEQVRDYSPLRTGLAFLPMSLVVAALSMGIVSRLLIRFGAMNVLVPGLVAVIVGLFLLTRVDEHTSYAalLILGLGMGAAMVPLLSIAMADVPPADAGLASgnVSIWLSSSVGLAVLSSLAASRTKTLTAHGHSAVAALVSGYHLAFL------
     597 UniRef50_C6Q1V9        Major facilitator superfami...   180     6e-44  1  14.4%  9:424   2:418     --------VTISQRIERLPVTPMLWKVLFLTGIGWLFDAMDQGMVAGVMAAIGREWKLTPADLGMLGSASAVGMAIGAAVAGMAADRWGRRTVVTFTLVLYGLASAVSGFAA---NFGILLLLRFLTGLGLGGELPAASTLVSEFSPAKSRGRMVVLLESFWAWGWIAASLIAYLLIPVYGWRIGFFLGGVPALYAAYLRKGIPESPRYLEQKGYFEEANEIVSKMEQQAGITSNRSTVSNKVKKRKNITLSELWsiRRTFVLWTLWLGINFGYYGFVLWTPTLLM--GKGFSLVKGFQFTLIMSIAQLPGYYSAAYLIESIGRKAVLVAYLSGTAVAAYLFSQAASVtvIVYGCLLYFFSLGAWGAVYAYTPEVYPtrGRGVGSAAAVGRIGAIAAPYIVGLVYQSKGKQAGFVYVFTMITIV--------------
     598 UniRef50_Q0K1D4        MFS transporter, ACS family...   180     7e-44  1  10.3%  3:429  19:443     --ALASGEQVVADGDIELTYRGITLRLMPLLFICCVLNHIDRINIGYAQLQMRSELGFSAAVYGIGASMFYVGYLLFEIPSNLVMQRIGARKTLLRIMLLWGLASTATLL---VRTPMEFYIVRFLLGVFEAGFFPGVVLYLTFWYPPERRARIIAMLMAAGVAAGMIAGPLSGWIIQNlgWQWMFVLQGLPASLLGIIAYFYLTDQPEQATWLSERQRQLVA----------SHTALVPHQTPASGGGGIRGIWRLPSFFALGYLYFAISCGAYTLSFWLPEMIHGWGFSNVQEVGFYSLIPYSIGMLAMFWVARRSDARRSHRQSFVIATCVAALGLAATatGSLWMSMTLVSAATAGVVSAFPVFWAIATSVLPkaAVGIAAITTLSGLAGVLCPASMGLLKTATGSTSIGLYVLAALLVSAGVVM---------
     599 UniRef50_D1JA86        Putative drug resistance tr...   180     7e-44  1  14.1% 12:414   2:428     -----------SEASARQKMSPKDLMIVLVISLGSFMAGLDVTIVNIALPSIGKAFDVSTVTVSWVLNAYLIVLISLLLVSSRLGDMKGYRKIFLVGFILFTIGSALCGIA---PGIDVLILSRMLQAVGGAIIAALGAVMITSYLPSALRGQALGIVAMFTMLGAALGPVIGGFLTSTFSWRLIFYINIPVGIVALLLGMHILPrdPIAPKAKLDAPGVILIFAALGTLIYGLIFLPGAaeRRTTEPLVNTQLFANRAFTLQNLDVMLIQMALAGVMILMPFYL-EIVKHLPTDNSGTVLLALPIGMILTSPIAGRISDVIGTKKPIILGFVICVLALFLLSTIGLNtaVIYLFLLGAGTGIAYAPLNSAVMGESPIKERGTTSGlmMTNLGSSLGVALVILAATVALGPELA------------------------
     600 UniRef50_Q7A3I9        SA2300 protein n=55 Tax=Bac...   180     7e-44  1  11.8% 19:433   4:411     ------------------KRTNVRWMFALAFFFIGVIAYMDRANISYIAKQMMDDLGMTKPQFGLLASFFSLGYALMQVPSGMLAEKFGPRKMITIALVWWSAFTILTG---MIKNHGLIYLVRFLFGVGEAPMYPSNAVFNSFWFSKNEKGRASSALLAGSYFGPVLAPIVTIAIVNAFNWQAVFYIFGAVGILMAVLWAIIAKDLPEQHRMVNEAEKRFIM-------------ENRDIVATEKSSPPWNNFFKRFSFYAIAIQYFVVQFIITLFLIWLPTYLTEVFHVNFKEMS--ISSLPWLLMFFLILSAGAISDrvARGVIAIAGFIVFAVSIIFAVRTGnyVSIFWLSLGLGGIGISMGMSWAAATDLGRnsGTVSGWMNLWGNIGALISPLLAGLFVEHLGWTMTFQLLIVPAVIAVIMWFYVKP-----
     601 UniRef50_A4A2F6        General substrate transport...   180     7e-44  1  13.4%  5:437  23:454     ----TTREIADQCAPDGKPPTAIRYRVVAWLTAAAALAYLCRNSLGIAESQIRDDLGLTLSQSGHVMGAFFWSYAFFQVPTGAFSHRFGTRLALTIFAIAWSVTTL---FTAISPGLWLLITAQLLMGIAQAGIFPASTNTVNYWMPMSTRSLACGVLSAGMQVGAITASIVTGLLLSVMSWRWSFALISLPGVLWALAFYFRFRDRPGLSPEANAAERTLI--------QAGRPRAQIVAADDDIGPTDWKAVLLHPGLWLIHGQQICRAAGYMFFVSWFPTFLQETR-GVSIEHSGYMQGVVLAGALVGSLLGGMLTdwLSRSGVGATALGVCSVLILCSWFVEDLNFAIGLLAFglFAQLASPAMFAAVIDISGSRAavLGAVNMTGNLAVAVCPILVGILFEQTANWNLVLILFAAIYLIGAIFWAFVDTRKG-
     602 UniRef50_UPI0001B4E538 major facilitator superfami...   180     7e-44  1  11.8%  1:414   1:450     MTTSDTTERGAGPDADGPPVRLTHRQITTvlVLGMFLGALDGTVVSSALRTIADDLH-GLTAQAWVTTAYLITATIATPLYGKLSDIHGRRPVYLAAIVLFTLGSLLCGIA---TSMYELAAFRAVQGLGGGGLMSLAMTIVADITSPRERGRYQGYFMAVFGGSSIVGPLIGGalLGIDGWRWIFLINVPLAILAITVILRVLHLVPHRPVRHRLDYGGAAALAVGLVPLLTVAEQGrvERRMGDAALLPPRMFRITSFRLGTTLHFIVGIGMFGAMTTLPLYL-QLVKGMSPIGAGLATLPTVAANLTVTLVVGRLIAKTGRFKVYLVTGVGSFAAAMVVYAtpMWHVSLGMVFMGAGLGAAMQTLTTLAQSEVPRkgAATAGVNFFRSNGGTVGAAAFVSILFSFAGTRIG------------------------
     603 UniRef50_C8QF69        Major facilitator superfami...   180     7e-44  1  13.2% 11:435   3:464     ----------SSTSINTPSRYSHPMTILTIVLMSYVMIVIDNSIVITGLPKIQNEFHFSATGLSWVSSAYALTFGGFLLLSAKAGDMYGRRKMLTLGLGLFSISSLAIGLSPGA---EFLVTARAIQGVGASILAPSTLAILQVTfpPHKRAKAISYYAAAGGLSASIGLVLGGLVADLLSWRVGFLINVPIGIVLIWAANRFIPETELHIGRLDIPGTVLSSAGMAAIIYGTISSAQVgiESRISDPLIPLRLFRSWERSGAYAARLLYIGAAMGFFFY-STLFMQGVLDYSPIQAGFAFLPSMLVNFVTALYVPALSSRVKSRNILLVSLISALAGILMLCTLSEtgLLTPMIFIGFGMGGAMGPLTSSGIGGVEPGDAGAASgnAVHQVGGALGISVMVAAAETRGQFLtaFIAAAVLIATSLIIVLFIMSR---
     604 UniRef50_A9AKX3        Major facilitator superfami...   180     7e-44  1  11.4% 14:433  22:436     -------------VDERQLMGLLTRRLVPFLALIYVVAYVDRTVVGFAKLHMNAAVGLSDAAYGLGAGLFFIGYFLCEVPSNLALGRFGARVWFARILATWGVITMAM---ALVRGPTSFYVLRFLLGAAEAGLYPGILYFLTQWFPMRDRARVIGLLVLAQPVAGIVTGPLAGWLLSTHgwQTLFVASGLPAVLLVWPTLRVLPESPERARWLDDA----------QRRWIARELAADRDTYRPDAHRNPLAALRDRRVLLLAALFLPFPLCIYGLSLWLPTIIK--AFGTGDAATGLLSAVPYLFAVVGLLVVPRHSDRTRErhIVVVSAAAALTMAASASVRQPALQFLFICLTAFSLYSIQAVVWALPGEFltSAAVGIAAINSLANLGGYVGPYGIGLIKQATGSLAAGLYFLAATLLFAVLITFAVR-----
     605 UniRef50_Q38ZV3        Major facilitator superfami...   180     8e-44  1   9.2% 19:433   9:419     ------------------TMRKVTLKIVPLLFVLWLVNFLDRVNVSFAALDMTKTFHFTPELYGFGAGIFFIGYILFEIPSNLALQRFGARLWLARIIVTWGIVSALQAFVFNATSF---VAIRFLLGVAEAGFLPGVLYYLTRWFPAEQRARAIGQVMSANMIAVVVGAPLSAAILSMggWQWIFILEAVPAVALGVFAYFFLSDEPEHAKWLSAPE----------REWLVDTMQRDREAAASLGTEKLGVAMREPIVWLLGMLYLLVGTGFFGITLWLPQIVKQMAA-MSTIQVGMLSALPFLLGAIAMVLNGRHSDRTrrRWHLAIPLAVGSLGLLASALVHSAAllAFVCVAMVGIGASLSVFWSIPSSFlrAAAGGLALVNTISGLSGFIGPYAIGWIRGHSPDFSNALFFMAGSIAAAAVLATILP-----
     606 UniRef50_Q7UTN9        Probable glucarate transpor...   180     9e-44  1   9.4% 22:437   6:421     ---------------------PTRFFLILGAFLLSVLMWVDRACISAAKEDMATDLGFSDQQMGWVMSSFALGYALFQVPSGKLADRFGPRRVMAVVCLIWSAFTVLTG---VVRGLSAMIGLRFLFGMGEAGGYPTLARAFTSWLPMNERGITNSISFSGGRLGAALAMPGVVWLIGAlgWQQTFWFFGAMGILFAVVWFLLFRDLPEDHFAVSEAEAAHIIQSRSPKRAGTTSDVAEA-------PIKFVQMLQSTNMLMLMVQYVAHNFTFFFTVSWFFPYLKEQ-YSLTSQQTGLYAAAPLLFGVVGNWLAGFTVDrlSRRLPAAIGFALGAIGMSLCvmTTPTSAVICMCIAIFGSDMILSPSWSTCMDIGGKSAGAvgAMNMVGNLGAFATSLSFPYLVAYFDAHEPFFYSAAALNIVAIFMWFRISPDRS-
     607 UniRef50_A8GIU6        Major facilitator superfami...   180     9e-44  1  13.5%  5:434   2:433     ----SQNTARISEIIDNAKVSPYQILILSLCFLIVLLDGFDTAIIGYIAPALREEWDLLPAQLSPAFGAGLFGLLLGSLIFGPVADAIGRKRVLLVSILIFGGGTLA---SAYTHSIESLTLLRLITGIGLGGAMPTCITLSSEYSPARRRMIMVTLSWSGFTAGLALGGLLAGQIIPVFGWRGVLMLGGIAPLMLLPLLAWQMPESVRFMASSPKHAAGLRQVVERITGKSWAGVTILDDERPTQARSPMTHLfrAVRTLLLWAAFFCSLFVFYQLTSWLPSILKDA--GYDIVHASRIGAMLPLGGTLGAILMALLMDRVGPYPVLALSYLGAavGATGYLMGDVYTLAATVFLVGFGVAGAQNGLNLVSATIYPTAArgVSWAMASGRFGSIVGSMLGAWMIAAAGSPETFFIWLALPVLVGSAAIFLLYR----
     608 UniRef50_A6T958        Fucose permease n=3 Tax=Kle...   180     9e-44  1  39.4% 15:435  20:442     --------------DTSAYLPHTPWLQFLLVCCLFALWGMAGNLNDILIAQFKKGFDLTDTQTALVQSIFFLGYFFVALPAAALIKRFSYKAAIIIGLCLYALGCFLFVPAAQIMTYGAFLACLGVIACGLSFLETSANTYSSLLGPIQSSTQRINFSQIFNSLGVISGVLIGQLMVFGENDPS-HEQLLAMPAAAADVARHQMVGQVVGPYLIIGSVLVVLALVFVFIKFPSCKGAPAQQQQLPTESmtLKRLFAIPRFRLGILSQFLYVGAQVGVWSFTIRFVQLVQQGTSEHSATYWLLASLVIYAVGKTVATWLMNRLNPAMLLGTFALAATALLLIAVFSGSMLAVYALILVSFCMAPCWPTNFGLVIKGMGKDTQTAGSIVVMSIIGGAVIPLVMGIISDmgGNMQIAFIAPLLCFVYVAFYGFWCVRK---
     609 UniRef50_UPI0001C41C4F MFS transporter n=1 Tax=Met...   180     1e-43  1  13.9% 14:393   1:406     -------------MQGKTLDTRTRNLILILFLIGVFMGSLDTGIIGPVLPSIEQSFHLTSRESSWIFTLFVITFMIGSPVMAKFSDFYGRKKIFILDVLLFGIGSCLI---AASISIELIFLGRLIQGFGCGGIFPVAGAFVGDGFPLEERGKALGILGSVFGISAIGGPLVGAALIP-YGWNWCFTINIPIAIFLIIFAWYILPDSDNDRKLKIDYLGILILSLLAIFLSYGliPIFLKVEKKAEESIVPIHMLKNKEISIACIETLCY-GIIYSSAIFIPSLVI-LSMGLDDQLASLMLIPILGANAVAAPILGKILDKTGSKKLMAMGTMILAIGLIAIAIYPSNLIFFIIAGCLIGVGLVtpLRYIVLTEAKpeRGAGQAIVNMLSSAG---------------------------------------------
     610 UniRef50_Q0H2V8        Putative transmembrane effl...   180     1e-43  1  12.1%  6:436   1:473     -----MPLKESAGSDPSVEPARRRWLGLWVMMLAMVMDLIDVAIVSLALPSIQADLEASPAALEWIVAGYPLTFGVMLVTGGRMGDALGRRRMFLWGVAGFIVASALCGLA---PNAEVLIVSRLAQGVFAGLMTPQILSMIQVAFTADERPKAFAIFGAASGIAQVSGPLVGGLLIEayGWRVIFLINLPIGILTLIASAILLRESKSEEAQRFDFPgaFLMLAAAIPAFALFAWYQERRDRRMATPLVPPRLFKQRAFTGGLLTGITFFIGVTGFLVVLAITL-QTGLGFSALHAGLSLLPYALGIAAAAGASFGLVPKLGRLLIVIGALTKAVGMAVLMVMVTawHLVPGLLIAGVGMGLVSPTIADIVLVGVRQEDAGAASgiTAGQLGAAIGVALIGVVYFGTLSAGsaLLFQIAVFVLSALLAFLVPKPA--
     611 UniRef50_Q13FE7        Major facilitator superfami...   180     1e-43  1  11.5% 19:435   4:452     ------------------PMSRDQRGTLAAAGLGFVVVLLDVSVVNVALDALRARFATDVTGLQWVVNAYTLAFASLLLTTGALGDRFGAKRIFTAGFAVFTLASIGCGIA---DSLPLLVAARVVQGIGAALLVPNSLAMLRQAFPdqQRSRAVGWWGAAGGIALAAGPVLGGLLVTHVGWRSIFLINLPIGVAGVALTLRHAAAAVSTHNRSIDLPGQLAAIVAllLLSVVATLAFLWLESRSTEPMLPLSLFRTATFSVASVAGVIVNFAYYGLIFVFSLFF-QIEQNLSAQWTGLAFLPMTAVLMGVNILAGRLLNRIGAKKLMIAGMVIAASGYLLLLPVStwMLVLPMLVAASGIALMVPTMTNVTLSSVDASRSGVASgnSARQVGGMLGVAVFGFFVRDTsgMHLSIMTAAVLLLCGSVICLYGIRT---
     612 UniRef50_B3E5I9        Major facilitator superfami...   180     1e-43  1  12.3%  6:435   2:439     -----SRSVNVNEVFDNIPFSPYQTAVCLLCFCIVFLDGFDLTVIGVALPKIAEHLNAKPSELGLALSAGQLGPMIGAVLLGMLADRVGRKKTMFCSAIVFGFFT---YMTTHITSVEELAAYRFLAGLGMGGAIPNALAFGSEYAPARIRTSLSLYMWAGMPCGAMIAGFAASWLLPHYGWQSVFIVGGIAPVAIALLILLLLPDSLHHLVRTGTAKSIaiLARIDRSSPLSADIELTVTSQTKEKGGSLKSLFTDHRLLTTILLWILFYMSFyiLFSWVPTLLKKS--GASVQQYSIGFAFIHLGSVVAILCIGRCMDKYNKLNVVKYVFLAAFFAMLAFGYfpFAVVIVVSVLAGLFVNGGNSALMGLASAVYParATGIGWAYGIGKIGSFLAPAVGGFYLARNWSVFDICAVNGSSALIIAVVVVILQRH---
     613 UniRef50_B8GHH6        Drug resistance transporter...   180     1e-43  1  11.8% 15:421   5:436     --------------SDNTSDEKYKRVALAIAALGTLVGVLNGSTLIIALPTIMVQLHTTLFGVMWALIVYMLITTILAPAWGRLADIYGRKRLYVWGLVTFTIGSILCGFSA---DIGQLIGFRVIQAIGGSLLVANGTSIVADAYPRGELGRAMGVLSMIMAAAFVAGPILGGVLT-VIDWRLNFFFNVPFGIAAIIWAQWKLKDIVALDRhgFIVGLLSPAMLATLVVGLISTWAFIRQEQKSQSPLIDLSLFKIKIFTYGQVSALLNSIARGAVMILLILFF-QGVKGEDPFTASIMIAPLAIALTISGPIGGRLADRYGSRLIATVGLILSLVGLFGLAltPYWYLAVCLFINGFGSGLFQPPNTSAIMSSVPPDRRGVTSSifFGNMGMMVSMSFATPILLGTISMDEMMQMFVVG-----------------
     614 UniRef50_Q987Z4        Mlr6842 protein n=2 Tax=Mes...   180     1e-43  1  11.5%  6:424  25:468     -----STLPDAPPAESGAKPDITTLVVYSGALIAMFMATIDMQIVVTALPTIAGELG-NLHLFGWVGAAYLLSTAAVAPFYGKLGDMYGRKNVVLTAIALFLLGSLVCGMA---WSMESLIAARVLQGIGGGGLMVSAFAMIGELFGPRDRAKYQGYSSAVFALSSVLGPLAGGYITSLFGWRWVFLVNLPIGIVVLAILAFAMRSrvYWGYHLLDPAGPDLLTFALPVVALAAIASFILVERRAEEPIVPLRLFGSSTVRIVSGVSVVAGSVTLGMFFYFALYM-QTLTGLSPAEVGFLFLPASLTSMVISIVAGRVIAATGRYKwmGIGGLLMIGFVFINSHTPIWVLAVMMGLFGISMGLQFQVLIVAIQAAApdIGAVTSLITQARTIGASLGLALNGAVMTWALNRQTSELPADAAALL--------------
     615 UniRef50_P46105        Probable actinorhodin trans...   180     1e-43  1   8.9%  9:413  25:465     --------PGPDGTAAGPPPYARRWAALGVILGAEIMDLLDGTVMNVAAPAVRADLGGSLSVIQWITVGYTLAFAVLLVVGGRLGDIYGRKRMFVVGAVGFTAASVLCSVAA---GPEMLTAARFLQGGLGALMIPQGLGLIKQMFPPKETAAAFGAFGPAIGLGAVLGPIVAGFLVDAdgWRSVFLINLPIGVAVIVGAVLLLPEGKAPVRPKFDVVGMAllMLAGAAVLVGFVAHELRQERRGGATLIELSLLRRSRYAAGLAVALVFFTGVSGMSLLLALHL-QIGLGFSPTRAALTMTPWSVFLVVGAILTGalGSKFGRKALHGGLVVLALGVLIMLLtlTSWELVPGIAVAGLGMGIMIGLLFDIALADVDKQEAGTASGvaVQQLGFTVGVAVLGTLFFGLLGSQA-------------------------
     616 UniRef50_A4BBC6        Putative transmembrane effl...   180     1e-43  1  12.7% 14:438   1:472     -------------MTAVLSDTPRYWRAFAFLMLANIMNLLDVTIVNVSLPMIQQQLGATNAQLQWISIVYVTAFACGLLPFGKLGDVLGRKPVFLIGVLGFVLASALCGFA---NSIEMLIAARLLQGLAAAVMTPQVMAIANAIFPSSEKSRMFGVIGMLSSLASVLGPFVGGLLLEwlDWRSVFLINLPIGLVALIGAWLYVpdFKSAAVRHIDLIGSLLFAVFMAALLYPLTEGAVLgaQRSHAALLPLSLQQNRSFWLGVGLIMSLASVAPGYFLILTLYLQQGYQ-LSPLMSALTTMAFPVGVMSASYLMGRLSPQWQSWRVVIGLSALIIGFALMLMSHHywLFWGPLLIAGFGMGSAIIALFQSVMASVPVADSGAASGAmiQQMGMALGMAVMGQLFFHSLslTAGLLYGLCVYLVALLVAIRFLKGKSS
     617 UniRef50_C7QB55        Major facilitator superfami...   179     1e-43  1  13.3%  2:416   4:453     -TTEEVLTPLPTTPSPDSSPDPRRWRMLPVILSAMFMAMFDYFVVNVAAPSFQHDLHTTDAGLELVVGGYGFAYAAGLITGGRLGDLLGYKRMFVGGMAAFTLASLACGVA---TSSTILIVARLVQGATAAAMVPQLLALINVIYPVHERPRAMAWFGATIGTGSVAGQVLGGVLLehWTWRPIFLVNVPIGLIAVLLALRWLPDTRGTHRPKFDPVGAIAIALSIGLALAPLirWEARLARVGGAPMVDLSLFKERTFSVGLALSGLMLAMFGGFMLAMTLFL-QGGMHMSPVKAGLLFGPLGVAFAVTSLLARQVSGRYGARVIAIGAGLSTAGLVLLGIvlASWQLLPSMILVGAGNGLVLPSLVGSVLAGIKTKNAGAASGmtAQQFGGASGVTILGTVFFSVLGSHPGGF----------------------
     618 UniRef50_P0AA79        Hexuronate transporter n=12...   179     1e-43  1  13.0% 18:432  42:452     -----------------RKIKGLRWYMIALVTLGTVLGYLTRNTVAAAAPTLMEELNISTQQYSYIIAAYSAAYTVMQPVAGYVLDVLGTKIGYAMFAVLWAVF---CGATALAGSWGGLAVARGAVGAAEAAMIPAGLKASSEWFPAKERSIAVGYFNVGSSIGAMIAPPLVVWAIVMHSWQMAFIISGALSFIWAMAWLIFYKHPRDQKHLTDEERDYII------------NGQEAQHQVSTAKKMSVGQILRNRQFWGIALPRFLAEPAWGTFNAWIPLFMFK-VYGFNLKEIAMFAWMPMLFADLGCILGGYLPPLfsRKMVVTLGAVLMIGPGMIGLFTNPYVAIMLLCIGGFAHQALSGALITLSSDVFGRNEVATANGLTGMslASTLFALVVGALADTIGFSPLFAVLAVFDLLGALVIWTVL------
     619 UniRef50_C7QEL5        Drug resistance transporter...   179     1e-43  1  12.6% 21:408   9:423     --------------------SPRRWPALAALTLSVLIVGLDGTVINVALPTIAGDLHTDSAQLQWISGGYLLALSVAMLPVGLLGDRYGHRRLLLSGIAVFGAASLV---GSLADSPTAVIAARAVLGLGAAAILPLSMAILPRVFSKDEQPRAIAVWTAATALGMPVGPVVGGWLLNHFWWGSVFLFNVPVAVVALAAGLWLLPRdvYGTILISEDGWTAPSVLASLSAAAALLAGFVVRERRFPHPLVDFALFGDRRFRWGTLIAVFVNFAVMGILFVVPQYL-QSVLGNDAFGTGIRVLPLIGGLMLSAALSEFLLPRLGVRLVVTTGLLVLAAGVLFGATTGAafAAGWLGLTGLGFGLAVVPATSLVLGTLPDHGTGSGTSltIQQLGSALGVAGLGSLLSYG------------------------------
     620 UniRef50_Q56175        ORF4; putative n=2 Tax=Stre...   179     1e-43  1  12.7%  1:395   1:427     MTDTANRRSATPDSGADAVDKRRIRLImgLLLLGLFMAALDQTIISAALRTIADDLN-GLSEQAWANTSYMITSVIMTALYGKLSDIYGRRPVYCTAVGVFVLGSVLCGLA---QSMTTLAVFR-GQGIGAGGLMSLAFAILTDLVPLAERSRYQAWFGAVFGVSAVVGPVAGGFflGASGWRWAFFINVPIGVAGALIIAALVRVQPGRAQHKFDIAGLLALIACLLPLLFAVEQGPAWGwrAADAALLPTPMFRNPLFSVYNGVNVLVGAAVFGALSVLPLYL-QMVKGLSPTQAGLMMLPQTLGIVVAGRIARPYVTRTGrkAVLLSGLVLMVVATFWFGVLTADTSLwaAGVMGFGIGLCWQVMLIAIQTGVAPqgAGMGSFTFFRQIGGT-------------------------------------------
     621 UniRef50_Q5I3M7        Aec36 n=63 Tax=Gammaproteob...   179     1e-43  1  12.6% 17:438  34:450     ----------------RRIIRQLRWWMLILFLMGVTVNYITRNSLGILAPELKDSLGITTEQYSWIVGGFQLAYTLFQPLCGWLIDVIGLKIGFMICASLWGIACLLH---AGAGSWIQLALLRFFMGGAEASATPANAKIIGEWFPKSERPVAAGWAGVGFSIGAMLAPPIIYFAHASFGWQGAFMFTGALAILWVFLWWACYNTPEEHPNLSKNELNFI-------------RQDNEAPPVKMPFLTALKTVSKNKRFYGIAIPAFMAEPAWAVMSFWVPLYLAKA-YGMDLKQIALFAWLPFLCADLGSIASGYLTKLYTRLFGlvSGAFLMVSLAVIAFIDNPYIAIVLISIGGFGHQIISCMLSALVVESFDKGQMATVNGmsAAWIASFLFSLIIGVTADKIGFNPLFIAMGFFDLIGAFFLVTFIAERRKK
     622 UniRef50_Q1GNM3        Major facilitator superfami...   179     1e-43  1  12.2%  5:430   2:419     ----AQAIADRGAAVPVPRSGRYRWLIVAVLFAATTVNYIDRTMLGLLAPTLGQELGWSENDYGNIVTAFQAAYALGFLFMGWLIDRFGPKIGYAIAIGIWTVGHVAHGFASSVVSF---MLARVILGVGEAGHFPSVVRASSEWFPQKERSYAIGWVNSATTIGVILTAPTVALFMRVLgwRETFIYTGIFGVVLLLLWLWLYSNPRESGKVSEAELAWI-----------------EHDPPEQVERIGWSRIVTKREAWAFAMAKFLTDPVWFLMLFWLPKYFSST-YDVDLKIVLLPMIIMYLLSDVGSILGGWVSSkfARKVTMIGAGLCVLPLLFVTGLENMWLAVVLIGIALAGHQAFSSTILSIPPDMFPKRAVGSVIGLGGFMGGVGGMIMatGLVLDATGGNYTLIFAACTTVYFLAVLAV--------
     623 UniRef50_C8WN24        Major facilitator superfami...   179     2e-43  1  13.5% 18:409  14:441     -----------------RGRGKGFALVAAVYLLGLFIGALDTGIVTPARTVIQSDLGIGEQMGVWIITIYTLAYAAAIPVMGKLADRSGRKYVYLASILLFGVGSLLCGLAQDVGSFWMLLAARAVQAVGGGGIVPVATAEFGTTFPPEKRGLALGLVGGVYGIANIFGASAGSLILSVFgwQFIFYVNVPICAFIVVAGLFVLPNTRAEQVKPIDGWGIAVLVAMVLSLLYglLPVFVLIERRAADPVLNLSYFRDRDIVITLVLSVITGVILMGIIF--IPQFAENVLKLPSGSGGYVVIVLAAFAGVGAPVSGKLIDRFGVKAVLAFGLAASAAGAMFLafANMATLIISLVAIGIGMGFTIGTPLNYMMLAKTKErsALATLSLVRSVGTAVAPAVLVAFIAHAG-----------------------------
     624 UniRef50_Q2AAU2        Multidrug efflux pump SmfY ...   179     2e-43  1  13.4% 21:415   3:422     --------------------AKNRWLILTMVASALFLIVIDMTVLYTALPRLTQALDASASQKLWIVNAYPLVVAGLLPGAGMLSDRIGHKRLFLAGLPVFAVASLC---AAFSPTAEWLIAARVFLAVGAAMMMPATLSIVRHVfdERERALAIGIWASVASGGAAIGPVVGGLLLEYFWWGSVFLINVPVVLLVWPLAWKLIPRCGGDNPRPADIVGSisALLAAALIGILFLALFVRRQQRSAHPMIDFSLFRNRLFAGGIGVALLSMVALIGVELVLSQRL-QLVLGLSPLQAALFILPIPLASALAGPMAGLLLPRYGERSIILGGFALTAFGIAALALLSQSGilVSLALVGFGLGGVITAASTAIMLNAPEEKSGMAASivSYELGGVLGVTLLGGLMTAVYSHSLAL-----------------------
     625 UniRef50_UPI0001C31FA1 drug resistance transporter...   179     2e-43  1  11.7%  3:422   2:448     --TRTSAPPPPLRAAGRAGVPSHVWPIAIVVILGMVMSVLDTTIVNVALQDLSVELHTSLDDIQWVVTGYMLALAAVIPVTGWAASRYSARRLYIVSLVLFTLGSLLCGLA---WSSGSLIAARVLQGIGGGMLAPIGQMILVKAAGPRNLPRIMSAIGVPIVLAPVFGPTLGGLLIEHAGWEWIFFINLPVGVVAVAAAVKLLpdSGDRAAGRLDTLGLALVASGLVGVTYGLaaAFVLRSLRIPRPLLDVRLFANKAFAAASLTTFCLGAALFGAMILMPLYF-QTVRGEDAVQTGLLLIPQGVGAAIAMGFSGRVTERLGGGLTALIGGVITVVATIPFVLLGAETSFALIAAagFGIGMSMMPSMTAAFAVLRPDQvaTPQLNVVQRVGGSIGTAILSVALESRIRDAGASATPAALA----------------
     626 UniRef50_C5VFB9        Permease, major facilitator...   179     2e-43  1  13.1% 19:429  25:461     ------------------ANKRTIFMVFAGLIVSMLLSALDQTVFSTALPTIVGELD-GVNHMLWVTTGYLVAVTIMMPIYGKLGDMMGRKTLFLGALTVFLIGSVIGGFA---TNMTWLIIARVVQGLGGGGLMILSQAIIADIVPVRDRGKYMGVMGAVFGLSSVVGPVLGGWFAESIGWRWVFWMNLPIGIIAIIIAATVLKLPKHDTKFTFDVWGTLTMAValIITAIVFSALFVWAEATATDPLIPLKVFQSRNFVLATITGLFIGIAMFGVLAYMPTYL-QMVTGVNATGSGLMMFPMVVGLMGMAMTTGALASKTGKYKWMPIASMVVLAISLWLLstPLWVLLSYMFLLGAGIGLGMQILVLVVQNSFSDhgMATASNNFFREIGASLGGAFVGAQFTTRLTDLLGERMSALGPAVASAMG---------
     627 UniRef50_C1BAR4        Putative aromatic acid tran...   179     2e-43  1  15.9% 14:435   6:430     -------------AGSATNGRSSTLAVVATCLAITTLDGLDLIMFGTVLPTlkEEWGITAASAGLVGSLSLVGMLIGAMFAGYFTDIVGRRPVILACVVNFSLFTALC---AFAPNLELFGLFRFAAGIGFGGALPTVIALTMEYVPFERRQFFNGVIQTGFTIGGCVAAISAIYVIPAYGWHMMFLVGGALGVVVLAITLKTLPESVAFLIQKGRHDEAQAIMVRYSIDMRTESGRAVTEdgRGRALARLFAPGYRGATVLFPLISFCGLLVAYAMNTWIPQMLRST--GYDLGSALVFLLAFNLGSAMGMVVLSGLADRFGPRPVISTGFVVGAIAVSVLTLEPAQALVFALILLIGFCSASQTAVSGFVGIYYSPRARGTALGLAigRLGGVCGPIVAGLIVGSSLGTQWAFYVFAAVGLVAAALVVAVPKR---
     628 UniRef50_A7IE08        Major facilitator superfami...   179     2e-43  1  13.3%  1:407   1:432     MSAPAPLPAASEDAAIALPPDKFHRVLAGLLLVLALSSL-DANIVGPALPLISSEFGA-LDSLTWVLTIFLLTSTAATPLYGKLSDMYGRRPLLTIAVLLFLAGSA---FSGLAQSMNQLILGRAIQGVGAGGLMTLTQITMSDLVSPRRRGSYQGLFGAVFTIASLAGPPLGGVIAEFWSWRWIFYVNLPLGAAALTLLWMGLPPGVRTTSHRIDVLGFVVIMAATSCVLMALNQGSHGseARAKEPLIPLAMVGNSVWLIATGVATLVTIAVFGALAFMPLYL-QLAGGLSPTASGIAMVPSAAGLMLSLLYGGRAITRTGRYKVFAVTGVGVATLALFALAlsPYLLGALLFPLGAGLGLLMPGLTVAYQNAVAHegTATSTAGFFRSLGGAFGIAVAGAILAM-------------------------------
     629 UniRef50_B2GJA6        Drug resistance efflux prot...   179     2e-43  1  12.5%  5:405  31:476     ----SPRPDPQTHRGYAHGTDPRRWRILAVLLVAIFMSLVAVSIINVGLPSIQEGLGASESQLQWILSGYALTFGVVLVAGGRAGDVFGRGFLWMLGVAIFTLSSIA---AGLAPDPTMLIVARFVQGVGSGLLNPQGVAMIQQYFKGAERGKAFGMLGSAVGVSVAIGPVLGGLLIQTggWRWLFVVNVPVGVVALVLAFLWFPRpiRHALREMDPTGAVLLGIALLATLLPFIEAGSPgkASGHQPMVDLNIFRVSSFLNGTLLISLYFLGITSVWV-LVTLYMQKGLGHTALAAGCVGLLNALASAVASNLAGSRVNRMGRKIVVLGMLSVVVGLLLSmwHISEWWLVLTLGFVGFGQGAVVSPNQTLTLAEVPLEYAGSAGGvtGQRVGTAVGIAMITAVA---------------------------------
     630 UniRef50_B9JNH8        Tartrate transporter protei...   179     2e-43  1  12.0%  2:434  11:439     -TTGPTRGQKTDPAVLARAVSRAKWRILPFLILMYMLAYLDRVNIGFAKQSYQATTGVTEAAFAFGAGVFFLTYALFELPSNLMLHRVGARKWLARIMVTWGLISALMMFAYDDTTFS---LIRVVLGAAEAGLFPGAIMYLTLWFPREARGKILAIFYFGSPLALIFGGPISGMFLdlHGWQLMFLIEGGITVLVGIWAYFYLTDSPQEAKWMPADERQALAA----------TLAAEQAEKARTGEVKFGKAIRNPRLFYFAAIYFLIQITGLGVAFYLPTQVAALLGVKVGLLVGFVSAIPWICALIAGFFYPDWAVRTGRRHICFLFSLAagLGLIASAHASPALAIVALCFVTMGIMTAQPIFWTFPTQYLGGAAAAgaVINSLGALGGFVAPNVRAMAVSWSGFEQYGIYAIALAAFLAFILVLFITK----
     631 UniRef50_B3WA74        Permease of the major facil...   179     2e-43  1  10.5% 21:438   5:398     --------------------KSYQKKVLISSMLGLGLEGMDILLLSFALSSIIREFHISSAAGGVLPSITNIGMMVGGVIFGYWADRKGRIKIFTYTIFIFAIATLLM---AFARSIAEIYVLRFIVGLGAGGEYGIGMALVAEAFPKERRGQMSAWITVGGQMGTLVAALLAAIVIPLAGWRAAFIFGVIPVILAYFVRRHLPETKSWQNAHAIDDEKHVRPRMTLLMNTPKTAL----------------------ITLGLTIMSAVQVAGYYGLMNWLPSLLEQK-QGLSVSGSSLWMISTIIGMSLGMLSFGKLFDKFGSRTTYSVFLIMSGLSVTLYTFVHSAFLMLLiaIVGFFANGMNAGYGALISSFYPTEIRSFaaIFNTGRAVGGLSPILVGYIIDRSG-FSAALLCLGALYLISLVIVNLIPNPVTK
     632 UniRef50_Q4KI32        4-hydroxybenzoate transport...   179     2e-43  1  12.0% 12:435   9:435     -----------RAALDARPVSRYQWLLLLLLALLLVTDGYDAQVLGYVVPALAQDWGLEKAAFGPVFSANLLGLTLGSLAVTPLADRFGVRRILLVCVLIYASLTVLMVFA---NSLESLMAARFICGIGMGGAMPSAMALMSEYSPPRLRTLMVTLAACGFSFGGAAGGFVAAGFIDRFGWEAVFLAGGITPLLLFPFLLWRLPESLPRLLRDAPPYARLRKVTAQMLPDWQPPAAVLNSGEQVDSKLTVLELFRhrPTLLIWATFFVSLILLYFMISWLPTLLLES--GLALKQANLVTSMFLFAGTLGAICMAWFADRLKRKvaAVLSAAALCTVLLGLNHDNPRYLVVFVFAAGFCIIGGQLTLNAFASNFYParATGTGWALGVGRFGSILGPLFGSMLLAMHIPVQQIFFFCAIPALLSALLIIQVRSP---
     633 UniRef50_Q2J5E0        Drug resistance transporter...   179     2e-43  1  14.0%  3:431   6:461     --AHSGSADGPNPSNDLEQAGPSLVPLATTLIVGAFAALLDTTVVAVAIDTLGRDLQADITVIQWVTTSYLLAMAAVIPVVGWLVDRFGARAIWSGALGLFLAGSVLSGLA---WSAGALIAFRVLQGLGGGMILPLTQLVLARAAGPQHFGRVMGVVGLVGQLAPISGPVLGGLLIDTWGWRWIFFVNVPIVVVSLLMTTRWFPREDPRTERSLDVVGLVLllVAALVGVALLAAFVLRPTTPGRPSLIDLRLFGDRSFRGGSVMLFVFGVTSWGPMFVLPLYYQQLR-GLSALDAGFALAPQSVGLGLAYLATGRYADRLAPRPLVAGGLVVASAGTLPFVFATatLLGISLFVRGIGFGAASLPASAAVYRTLRTAdgATSASNVIQRVGAATGTAVMALILQADGFTPALTWMFVLTSGALAGTVFL-------
     634 UniRef50_B5HXH6        Transmembrane efflux protei...   179     2e-43  1  14.5%  7:421   5:446     ------TTSPVPDALDTPRLSTRDKLVLFVLCAAQFMVALDFSVLNVALPVLGADLGMSPAALQWAVTAFALPSGGFLLLFGRMGDLYGRRKLFLSGLALFGAASLL---ATLAWDPASFLAGRALQGLGAAAIVPTGMSLLTTTFPEgaRDRALGISGTLLSLGFTVGMVAGGTLTDTLGWRSTMGLLTLFALIVLPLAPALLPESRTPDRPRLDVPGAITVTGGLLALIYALSTAADHgeSRSAQPLVSLPMLRRRTVAWGNIGGLVTFSMMSTVVFVLTLYL-QEILHLSAFETGLVFGVQGVLSAVAGTYAPRVIGRFGPRRTLVGSLVGQGALIAALLGlsVWLATAAVSLASMCHLGAIISYGVTVTSGVPDEEQGLATGLvtQQIGITVGIPLLGVLATTSDDLMSGVHTVLAL-----------------
     635 UniRef50_Q03R58        Permease of the major facil...   179     2e-43  1  13.8% 19:417   3:426     ------------------RQGTQTKWILILTSLGFFMSMMDSMIVTTASTAIRLDFRITVGTLQWALNAYNITIAAVLLVGVALGERYGRRRVYSYGLVVFTLGSILC---ALATNITWLIIARVVEGMGASVMTPLSMAILTHALPVSERGRALGIWSGVGGLALVVGPSLGGLIVARLSWQWIFWINVPVGVVALGLTGRLLPESYGRRERLSGLDASLIMVASAGLIWalLGAWFIWRQKQAAQPLMPLNFFHSAVFRGGNWATFLLYASIYGVVFFLPQFF-QIVGQANALTAGLELLPWTGTLVMVAPFTGWAVDRFGERRMAMLGLlyGALAGLAAPTRGYGWYVGPLILAGCGLSMAGPALQKAVLSTVAPVALGKASgnVFRLLGGAIGTTLAVAVFGYFGRVQTAVTF---------------------
     636 UniRef50_Q0AT36        Major facilitator superfami...   179     2e-43  1  12.4% 21:432   4:426     --------------------PRLRWWIVTLVALATVINYIDRQSLNVLWPEISAELYPDRTeyALISVIFVFAYAFGQAIFGKIFDWIGTRMGFALSIAVWSLATAAH---AFARGLGTFALFRAILGAAEAGNWPGATKANAEWFPTKERALAQGIFNSGAAIGGIVSIPLIAFLSVFFDWHIIFIIIGLTGLLWLIPWMVLVKAPPGSHPWVTEDERQYILTGQTRTESEGDSAQTPAESDSYAPGTV--ELLSRRQSWGVIIASAAIDPIWWLFVFWIPIYLSE-VYGFNVREIGIYGWVPYVGAMFGAWFGGLLanRiaRKLTITLGCLIMLPCLLAMsaANPVVAVLIMAAILFGFQTAIGNVQTLASDFLSGKSVGTLAGFaaAKLGAAGLTYLVPWL-TMGGNYTPAFIIGAGLALLALASVWIV------
     637 UniRef50_A3YAN6        Putative transport protein ...   179     2e-43  1  12.7% 21:413  14:428     --------------------AKARWLALLSVCLAIFVTSISMSAASIAIPSIARDLDASAQAVSWIPTSFLWGNIVLLLPAGRLADIFGRKRLYLTGVTLFSLFSLCVF---WVENINALLTMRVFQGFAVALITATSMGIVGAVFANSNRGEALGLTSSSVYLGLSCGPIVGGWLTQTFSWHAVFWMPAPVMLVSLSLIFMFVKGEWRapLDKLGSLLFAAFVSAFFVGMSDIENSLnqQNAETFPLIRISALRANKTVSRSILASFLMYSANFPIVFLMSLYL-QFIHALTPLEAGQFVLIQTFIMMLLSPVAGRLSDKYEPRYLATAGCLSFATGLAILFwtPLTYVFIGLVFLGMGFGLFSSPNNNAILSSASQERLSIASALVgrNMGNMFSTAIVMMLMSITLGSQS-------------------------
     638 UniRef50_Q46MM1        Major facilitator superfami...   179     2e-43  1  12.9%  6:438  11:438     -----SAAGVAPFLDADKTFKRITRRLIPLLFIIYLMANIDRVNVSIAQLQMKSELGFTDAVYGLGASVFFVSYALFELPNSYVMKRLGALKTIMLLTVGWGCVSSLTMF---VRTPISFYTLRFLLGVCEAGFTPIVVYYLSRWYPLERRSKPLALFSSGIVISGILAYPLSGAIlgLSGWQWMFPLEGLPCVVLGLLVPVLLDESPQTANWLSANEKTMIAAML-------------EAGAPASEGQTFAQTLRNPRLYALMAVYFFFAAAIAVLHFWLPTI-IRSLGVTDIARIGLYSAIPSVVSLFAMIMIGGHADRTRRLrvALALVGGAALCLLPLVPNSLVFALVLLSVAGAALFTFIPLFWASVPACLPGPGvaIAAVATIGLLGGVFSPASIGWLKTHTGSMSTGIYIFGALFAAGGLLYAKTTRNVAN
     639 UniRef50_B4VGK3        Drug resistance transporter...   179     2e-43  1  10.8%  6:423   4:447     -----ATSSDAQASAETGLSKKQINRAVAGVMTGLLLSALDQTVVSTALPSIVSDVG-GLENLAWVITAYLLTSMASTPVWGKVSDQFGRRIVFIVATSVFILGSVLCGVA---QEIGQLIAARAVQGLGAGALYALALSVIADVVPLRERGRYQGMVAGVFGIATLAGPLVGGGLVDAIGWRWIFLINVPLGLLSLFVTVSALRVAGERRPHTVDYLGATLVIAATTPLLLYLSWAGGAreRRAAEPVVPMTLFRLRLFSLGSVYSLVAGLALFTGVVFLPVYF-QAVKGMSPFVAGTAVVPTMIGVGFASVYAGNRMSATGrrIFPVLGAVLLVATLLPLGftPSWLMILLGMVLGVGAGFTLQPIITAVQGVVAQegAATAAVSFFQRLGSAVGVALLGAILNSRFASLLAERGGAALGV---------------
     640 UniRef50_C6BLC6        Major facilitator superfami...   179     2e-43  1  14.5%  1:433   1:457     MPESPahTSDLPSRLDRLPWSRFHTRVVVALGITWLLDGLEVTLAGAVAGALKQslQLTNAQIGMASSAYLVGAVLGALVFGWLTDRLGRRKLFFITLGVYICATLAT---AFSWNFASLVLFRVLTGAGIGGEYAAINSTIQELTPARVRGWTDLAINGTFWIGAALGAGASLWLLDPagWRLCFLIGAALGLIILVMRFWIPESPRwaRAIVRDIEEEITACGHRFDTAPLATLRLRHRGHPGLADVARVLFVQHRRRALVGLALMAAQAFFYNAIFFTYALVLTDFYDVPATRVGTYLLPFALGNFLGPLLLGRLFDRLGRRTMIAATYAISGVLLLaaGVLDGTTQTLAWTVVFFFASAAASSAYLTVSETFPLEVRALAIALfgTGLGGVAGPALFGWLIDTHSRGALFGGYAFGAVLMLLAAAVQAR-----
     641 UniRef50_A6VR05        Major facilitator superfami...   179     3e-43  1  14.8% 12:409   4:403     -----------REKIDSSPMSAYQWMIVIMAAIMNLLDGFDVLALAFTATNIRNEFGLSGEQLGYLLSAGLFGMTAGSLFLAPVADKIGRRPLLLIAVALSAVGMLG---SAFIQSHHTLAFWRVVTGLGVGGILVGTNVLTSEYSSRKWRSFAISVYAAGFGVGAVLGGMFAMTLQAEYGWRSVYLAGFALTAVCLSVLVVWLPESIDFLMSKQPHNAQCRLNKIAKKIGLAGEWRLPEKSTSPTHRLPINQLfyRRSTGLIWVAFFAIMFSFYFVSSWTPALLKEA--GMTTEQSVSVGMMISLGGTCGSLFYGLLASRWSARKVLILFTLLSAVFAVIFILSalWLAMVFGVLVGALMNGCISGLYTLNPSIYDarSTGVGWAIGVGRIGAILAPIIAGTLLDAGW-----------------------------
     642 UniRef50_B2II90        Major facilitator superfami...   179     3e-43  1  15.7% 10:436   2:421     ---------TNAGPQLTTSTRRRQWVLVTLLIVAGCVNYIDRSTLAIANHDIAQELHLSVGEMGMLLSAFAWTYAIFQLPAGVLTDHAGPHRMLTIGMIVWSLAQLL---SGMIQNFGQLLIARAGLGFGESPMFTAGTRACVNWFPIKTRGVPLGLFNAASSLGPAIAPPLLTGLMLAYGWRFMFMLMGVAGFVVAALWGLYYRDPEP---------------AGVSKEERAIINAGVTEPTKTAAPRLWTKLFLIPSTWALMGGLFGIVYVSWLYGAWLPYYLESERH-IGIAHAGLLVAIPQFAGFFGGSLGGFLSDWLIrrKLLAIGGILIAGLFTAlfIADTALTLAAISAALFFVYLSSSCSWALGASLTPSHFVAtsIQNIGGSVGGALAPLVTGFVVEYAHTFTPAFALAAGATIFSAGSYALVRKNA--
     643 UniRef50_Q0KAW9        MFS transporter, AAHS famil...   179     3e-43  1  14.4%  3:427   6:432     --SSSPGTIDVQAFIDNQRFSPYQWMLLIVCFLVVAADGFDTAAIGYVAPSLTTEWGVSKLVLGNVLSASLVGLALGALVAGPCADRFGRKPVLIVSVAAFGLFSLAT---ASAISAAELSCWRFLTGMGLGAAIPNATTLLAEYAPARRRAFLVNSMFCGFTLGAAGGGFLAAVIIPAFGWRSVFIVGGIVPLVLAIIALALPESIRFMVLRDWPAQKIKTVLRLLAGSAEVHASRFTLPDDQADKLRSPLGLILSpgTFMLWTTYFMGVLVFYLVTSWMPTLVREA--GATLAEASLIAALFPLGGTLGAMACGWLMDRINPHCVIGFAYFFTAVFTLAMGHATSGAYLVLLtiAGLFMGAGLVSMPALAASFYPTQGrgVGWMLGMGRFGGVLGAVSGGTLLQFGLGMSSILSILAVPSLLAAI-----------
     644 UniRef50_D1SW91        Major facilitator superfami...   178     3e-43  1  14.2%  3:432  32:462     --TTDVRPIDLHHLADTARFNRFHALVLFWCALIIVFDGYDLAVVGIALPSIMAKMGVDATHAGFMVSSALFGMMFGAILLGTVADRIGRRWSIVICLALFSVFTAGAGLAEGPVSFSVM---RFLAGLGIGGVMPSVVAHMTEYAPKKMRATLVTLMFSGYALGGMLAALLGKGLLESHGWQSVFFAAGLPLLLVPFILKSLPESMPFLLARGRTDELRRIAARLDPAYTPQDGDRFTIPAHEKAAAAPIRQLFSDGrtVMFWIAFFMCLFMVFALSSWLTKLM--AGAGYSLGSALNFVLVMNIGAVAGAVGGGWLADRFHIKYVLAGMYALAAVSLTLLGqaSTPVLFVLLGLAGASTIGTQIVANAYAGQFYpvRATGLGWALGIGRSGAILAPILIGMLVGMRLPLQQNFVAIAIPAVIGMVAVLLI------
     645 UniRef50_C7QE67        Drug resistance transporter...   178     3e-43  1  11.8%  2:432  14:483     -PESSPPDSGGAADKATSKLGRAVILALFAIIGADIMDLLDTTIMNIASPVLRTDLGASTSALQWIVAGYTLAFAVMLTTGGRLGDVFGRKRMFQVGISGFLLGSVLC---SVAQTSGELIGARILQGAFAAVMIPQGLGMLRAMVPAEKMNSVFGIFGPMMGLAATLGPILGGWLVGalSWRAIFLVNVPVGIAALAFGSKVLPKdaDGAKPKLDIVGMLLATAGVMLLVYPLVQGrrRRNAAGRDPFVVPTVFRKRSFVSGIAVLFAFSAAMSGV-FFVYTLFMQIGLHFSALHAGLTMLPWSIGTIASMGASQALMPKVGPRRTLQAGMLVMAIGTVIAAltTTWTLVAPLLVSGMGMGLIFGPIFGTVLGDLDDAEVGSASgnAMQQLAGAFGIAALGTVFFDKAGTLMTSVPAAATLVFAISAAILV------
     646 UniRef50_A8KQU7        Elloramycin permease n=2 Ta...   178     3e-43  1  13.9%  7:408  10:437     ------AAQAGDTASHPTKLDGPLLKVAAAVIAGSIMAILDTTVVTIALQSLIVEFHTSFDTVQWVTTAYMLALAAVIPVTGWAADRFGTKRLYALALTLFLVGSVL---AGFAWNIGSMIAFRVLQGLGGGILTPAGMTVLAKAAGPARVGRVMSLLGVPMLLGPLAGPIVGGWLVDSGGWRWIFYLNVPIGLLALALTLRYLPKDTETTGGALDTVGTLLlvWLPVALGLLMIAGFVVRAQRIEHPLLDLSLFRNRRFSLAVVTMALFAVAFFGVSILLPTEFLMVRQ-LSALETGMQLLPLGIGAVVTMPLSGRLADRVGPGKVVVPGLLLIAAGITVFTQAGptVLAPGLFVIGLGVGATMMPIISAALQVlpAVARGSTMANIIQQGFGAIGSAVMSIVLAAG------------------------------
     647 UniRef50_Q1LG74        Major facilitator superfami...   178     3e-43  1  13.1%  3:406   2:428     --ASPSRSPPRSMQPHQGLPYPQRVWAILTVFCGLIMAVLDGSIANIALPSISRELNAEAASTIWVVNAYQLTVTICLLPLSSLGDILGYKRVYRTGLAIFLIGSLI---AACAVNLPMLVAARVIQGIGGAGIMSVNTALVRFIYPPTKLGRGIGLNALVVGVTIAVGPSLGALILGISSWQWLFAVNVPVAIVALWISRWALPDTPAQPRAFDYPSAVLSAVVFGMFILGVDSMGHarRQRGRPAPLVPVDLFASRAFTLAVGTSFCSFMTQMLAFVALPFYL-EYQLGRSLQETGLLITPWPLMVALMAALSGRLSDRYPASILAGAGLIMLTTGLIGLAWLSPTAsaWRTALCGIGFGFFQSPNNRAMIGATPRERSGGASgaTTRLLGQTTGTAVVALLFS--------------------------------
     648 UniRef50_A8JFB8        Carbohydrate transporter n=...   178     3e-43  1  12.4% 20:438   3:430     -------------------TRPHRWNVVVMIAVAFVLCNMDKVNMSVAVIPMAAELGWSATERGLVSSSFFWGYSATQLPAGYISTKIGGAKVLAAGVALWSFGTLIAPPAAQ-TSLLALCATRVLVGLGEGFAPSAATAVLAKLVPSTERSRAVAAVWGGLDVGSAVGLLLCGPLIRMFGWPSVFYLFAVLGLVWVAAWPLVQPD----KMDPDANEVAASALESVDETPVSATYAKLEKSLPPDGKVPWGEFFRSPPVWAVTVAHFCFNWGYYTLLAWLPSYF-ELALGLNVERSSFLTLIPYIAMTAMMPLVGPVADGwvRKICQGIAFVGPAAATTGVSAAGPVLTAVLVGLMSVAFALGaaGLYCNHQDLSPKYASalGITNTAGAIPGVLGVTMAGYLLDTTASWANALFIPTAilFGAAVYTWLASSERQS
     649 UniRef50_C0X6B1        Major facilitator family tr...   178     3e-43  1  15.7% 18:438  11:413     -----------------QVSNSYWIKVVAIFFVGWILMYATRTIFNPVMGVIGEQFGLSNTQLGLANSIFFLTYAVAQIPFGMIGDKIGRKLVIAVGFIVLAIST---YFSGLATTFVMFLVIRAIAGIGQGAYYGPQYALSTEAIPASKRTIGNAIINSGMAFGTSGGYLLSSKLVLENGEHWsfFIMAIPTFIVGILFYTILKEKVIRPGEEAARAAAEEG---------------------PQEKISLKEIFSNRNLLAAFILCFTSIYANFVIITWLPQFLIAER-GFTGASVGFISSLVPWASIPGALIFARLNDKTGATKKLVFTLvlAILSVFAIAFVTNRTLLISVLILYGLTgaLDPIMVTFVTKHAPKAALGtsAYNFIGMSGSILAPYVTGYLADTAGSMQVGFYLSCVLLVIGLLAFAFLAKDESK
     650 UniRef50_UPI0001B4CE2E EmrB/QacA family drug resis...   178     3e-43  1  11.8%  9:408   2:424     --------TTSTAPAPRTGLGRDVWKAATVVIVGATMSFLDSTIVNVALSALGTDFRAPLNTVQWVVTAYLLAVAAVIPVSGWAARRFGARRTYVAAVVLFTLGSALCAAAQDA---GQLIAFRAVQGLGGGLIMPVGQMILARTAGPANMSRVMATVGVPIVLAPVFGPFIGGLLLHYADWRWIFLVNLPVGAAAVLCAVCLLPADRPEAAPPLDVPGLAAISTGMAVLTYGLGSTDTGSLTVpaHPLFDVRLYRDRVFRAASLTTFLLSMGMYAGMVLMPLYF-QDVRHEDPVATGMLLVPSSIGAAAATWLSGRAAERLGTGRTALAGAGLSLAAAVPFVFVGTDTSYaaMTVSGFGAGLSVMPAMTTAFRSLDPQKISDAslSILQRLGGSLATAVLVTVLQRG------------------------------
     651 UniRef50_C9YU28        Putative transmembrane effl...   178     4e-43  1  12.9% 27:421   2:422     --------------------------ALFVIASCQLMVVLDITIVNIALPDIQRSLDFSTTSLAWVVNAYTLTFGGLLLLGGRAGDILGRRRVFVFGVLLFVLASLLGGLA---QNETQLLAARALQGVGGAIASPTSLALISTTFREgeRNRAFGVFAAVSAGGGAIGLLAGGILVEWLNWRWVLFVNVPIGLLIVLATPRWIRESERTPGHFDVTGALTSTLGMVCLVYGFIRAAQelVEKRSRQPITPLHMFADRNRAGTYGIMLCLAAAIFGMFFFL-TLFTQNVLDFSPLATGLAFLPVSAVIAVGAGLASRFLPVYGPKPFMVGGAILAAAGLGWLTLTDVHSTYAgmLVFSLGMGMEFVSLTLMALSDVPTPETGAASgnATQQVGGSLGLSILVTMYGTASTNEAAEQVPAFL-----------------
     652 UniRef50_B9B8X6        4-hydroxybenzoate transport...   178     4e-43  1  13.9%  2:434   4:442     -ATTDSRTVNVQDLIDSQRFSGFHWTILVLCFLVVALDGFDTGAMGFIAPSLVQDWKISRDTLGPVLSAALVGLGVGALMAGPIADRIGRKAVLIGSVFFFGVWSVA---AARATSMEALTVFRLLTGLGLGAAVPNAVTLMSEYAPRRIRGFVVNAMFMGFAAGLAMGGVVAALLIPRFGWPSVLLAGGIAPLLLTVALILLLPESVKLLIVRHRSSVKVEQLLRRLAPGTPLDgsEEPAGAGADKRGPVSQLLSQrgTFMLWLSYFMCLAVFYLLTNWLPTLFKAS--GFTLRASVVTTSLFHVGGCLGILVAGWMMDRFKAVSVVALFYVLTAALVIVVglGHPEWLGVLIFVAGVAMSGAAASMAPIAAEFYPtrATGVAWLLAVGRLGAVGGAFGGAVLMGLGWHFGAIFGLLAVPLVIAALALIVMAR----
     653 UniRef50_Q2NSS5        Major facilitator family tr...   178     4e-43  1  10.2%  4:436   2:430     ---TETMTMENVNKLETTTLRKVALRLMPLLTLGYFMASLDRVNVGFAALQMNDDVGLSDAAFGLGAGLFFVAYCFFAVPCNVMMVKVGARRWLSLVMVAWGVVSSGM---ALVQGPWSFYILRFLLGIAEAGFFPGVIYFFTLWFPKTVRGRMVAVLMMALPLSSVLGSPLSAALLLTdgWHWLFIIEGLPAVALGLLALLILPRDVQSARW--------LTAAQRDWLTRELTEPDAAAVADVPQVPLWRQLF-NKHVLLLTLVYMGGTAVTNGLSLWQPQMIKS--FHMSTMKIGLLNAIPFAIASVAMYWWGAHSDKHRERTWHTCllLGAAGLAGTMWVTTLGPTIAVLCVAIIAASMIKGPFWAMATEQLPAHSAAVAIgnALNNLGVFAGTWLIGTIRTATGSFTYALAPLVALSLAASLAAWHLGRQR--
     654 UniRef50_Q0SI85        Multidrug resistance transp...   178     4e-43  1  13.6%  2:414   5:445     -SITDSSRAGRSTPARPFLSTARGILTLTLLCAVAFLDFVDASIVNIALPDMRSDLDISVQELQWVPSAYLLTYGGFMLLGGRLADLLGRRRVLVTGTVVIGLSSLIGGFAGNA---EVLIGARLAQGVGAALMLPAALSILTTTFEEgeRHTALGVWAGVGGLASAVGVFLGGVLTEGPGWRWVLFVNPVACALVLPAVFALIpdRRRARFANFDVAGSVLGTGGMLLLVYALVEAPDQgeQHSRHPLLPLSIFRVKGLAAANVTGLIAFAGLIAMFFFLTLYM-QNVLGYSPIQTGAAYLPLCLGVGVAAGVCSQLLTRTGTRPVVVVGALVASAGLYLLSRIPVDglLPGLMIVSFGLGAVFVGVTTAANAGVPAGEAGLAAALLnqQVGSALGLAIFAAIATSHSQHLLA------------------------
     655 UniRef50_A9AMR4        Major facilitator superfami...   178     4e-43  1  10.0%  2:432  33:458     -APPTGRLAAEDYASSERTLAKAFRRILPFIFVCYVISYLDRTNVGFAALTMNKDLGLTAEAFGFGAGLFFIGYFLFEIPSNLIMQKVGARVWIARIMITWGLFSMATAFVVGPKSFA---AARFLLGLAEAGFTPGIYLYFTHWFPGKWRAKATAAFLVGIPVANMIGSPISGALLGLgsWQWLLLIEGVPAVMLGIACLFVLADRPEKAAWLSDEERASLA----------KRLAFEQRDIGAKHGSKLRDAMTNWRVFVLAFINFCGIVGSLGVGLWMPQIIKQ--FGVEHAVVGWLTAIPYAIGAVVMLWWARVANRAASRIPYVAGALAVAAVALCASAfaPVFKLIALCVTVSGILAFQATYWAIPSGFLTGRAAAGGLALivGNLGGFVGPSMIGALKQFSGGFTVPLFAVSGVLLLGALTIAWL------
     656 UniRef50_Q0BZJ3        Drug resistance transporter...   178     4e-43  1  14.5%  7:413   1:435     ------MAGPSVRAQFERFGGIYRWILLFTMLTGSMATMLAATTINVALPAIIGAFGLGQDQAQWMSTAFLASSTIAMLANAWAMTTFGPRATYTFGMVVFVFGSLL---GAVSNTLELLIVSRGLQGISAGLLQPMSMFLIFQTFPDSRRGTAMGVFSIGVVLAPAFGPALGGIAVDLASWRLVFVATLPLALVALGIAPFLMpsTPRPPLDWVGLSLLAVAVIGLLAAFAGGNRDGWDseLRHPFPALNPKVFTYRQFWSAGLIISATGIAIYA-STYLIPLFVQLVQGYSPTAAGVMMIPAGIAMMIGFPIAGRLTDRVDPRWLLGFGITTFAASAWLlaMTPYWVLVGWILLSRIGISFCMPPSNTTAVRAVPPhaSATGGVSFLMQVGGAFGVNILAIILQRRTIFHG-------------------------
     657 UniRef50_A1UVS8        Major facilitator family tr...   178     4e-43  1  13.7% 16:437  21:453     ---------------ERLPFSGYHKLIFVIIAIAFFFDSVDLGTMTFVLGSIKREFGLSTATAGLVASASFFGMVLGAAVAGLLADRFGRRPVFQWSMVLWGAASYLC---STAQSVDALIVYRVLLGIGMGMEFPVAQTLLSEFVPAAKRGRLIALMDGFWPLGFITAGVVSYFVLPLFGWRTVFALLALPAVFVLVVRRLVPESPRwaGRVLAHVEAKVMKSARVASLPAPSRLAEPACAQGRGAFGEIWSAAYRRRTTMVWLLWFFALLGFYGLTSWLGALLQQA--GFAVTQSVFYTVLISLGGIPGFLCAAWLVERWGRKPTCIASLVGGGAMAyaLFGGSVTLLVGTGLAMQFFLFGMWAVLYTYTPELYGTGARATGSGfaIGRVGSLIGPYAVGIVLPVFGQGGVFTLGALSFVVAALAVGVLGIETQG-
     658 UniRef50_B1ZP58        Major facilitator superfami...   178     4e-43  1  12.4% 21:432  12:452     --------------------GRYRWTICALVFFATTINYLDRNVLGLLKTTLSEdfGADKAtySTVVICFQVAYAIGMLAAGRFIDWIGTKKGYAYSLIGWSLAAIGHAFGHHTWSFG---FWRAALGFTEAGNFPAANKTIAEWFPKKERAYATGLYNSGANIGSIVAPLCVPYIADAWGWEWAFILTGAIGLIWIAFWYLTYASPAEKLKSGH------LKQAEYDYIHSDRDEQEAQKADTTGARVSGAKLLTFRQTWAFVLGKFLTDPIWWFYLFWLPAFllAANPGFTGDHsgVISWPFAVAVvvGSIFGGWlmDANKARKLAMFLFALMPLTVLllGAINTWLAVATIAIACAAHQAWSANIFTTVSDMFPKKAVatGLGGMAGAVGGILIARVAGLVLAHFTTLGKVELGYGILFIICGSAYLVA------
     659 UniRef50_B9JAZ9        Efflux transporter n=2 Tax=...   178     4e-43  1  12.2% 24:433   2:445     -----------------------RYIIPAVVAVAFLMEQLDSTILITAVPDIARSLGTTPVRMNLAVTTYILTLAMFIPVSGWFADRFGARRIFALSLFIFTIGSILCGLA---TSLPMLIATRALQGLGGAMMTPVGRLILIRSFPRSQLVTAMTYMTLPAIIGPVIGPLLGGFLTTYLSWRWIFWVNLPFGIIGMAMALKYIEDTVRDTSLKFDFPGFImaIVAVLTAAGLLLVGFVRYARTAESPAVDLTLFKLRTFRVGTLAGGICRVGLNGVPFLLP-LMLQVGFGLSPIVSGTLTFVSALSSLAVRPVSSKMLRLFGFDRVLTASAIFGAAIVAGFAltPHWVIIVYVFIFGLARASQFMTSNTLSYSDTPAAqrATSLGGVLQQLSVSFGVSIAAMLLGLVTlfHMAFLLMAVIPLLGLPGFLKLR-----
     660 UniRef50_B3R8E4        2-phosphonopropionate trans...   178     5e-43  1  11.8%  1:434   1:434     METADRIQVGAFVAPAEQSFRRAQWRMLLAAMFCYFFFYTGRQTFGFAIPGIQEEFGLSKAALGWASTCLLWCYAIGQAINGNLGDKFGGRRVMTAGAIL---SCAANWVVSFAVGFKSLAIPWGINGYFQALGWAPGSRLLSNWWGAQERGKVYGFYVFAAGCASVLSFVTSIVviLHLDWRWIFRLPVLLMLLGGITFYLVVRERPEDLGYKSPDTGVA-------KGEDAGPHAPAETDADESSWSRYKAVLRNPRLIIAGLSIGFQNAARYGLIVWVPVHFldWKHTDTLIDPAWISVALPVGMALGALSNGWISDRlrSKAIMLYMVLGAVASMVMYKLPTGMGAIVALFLAGFFVYGPASSFWALCPDLVgrAGTATGILNFFSYLLAGLGEPLIGRMLDHSGNTSMVFPIVATSCVISAVIAAFIRR----
     661 UniRef50_A0K2B8        Major facilitator superfami...   178     5e-43  1  11.8%  2:432  13:444     -PAAVQSPESQTGKDGVQRRTNVRWKLFLLLLVLVAVNYIDRGSISVALPIIQKEFNLAPELVGLLLSAFFWTYALMQIPVGLLIDKFGPRKVMTASCVGWGAATAASGMAG---GFLSMFIARLGIGVTEAGVMPAGGKLNAIWMHKSERGRGATIlaGAPLGAGLGGILIAGLIAATGSWRSSFVIAGAATVLMGLAVWWYVRDNPRQHRGVNAAEA-------EYIEASHAAEDAEAELDGSKGKRALLPYLKFRSFWAMCFGWLGFNGVFYGLLTWGPLYLAQA-KGFDLKTIGWSTFVIFGAGFVGEILGGTIADKWRarTLLGTSSVVVVGGLVGVTVVADPTTAVVLLSVVMFFLRWVGLFWSIPSILGGRTNAGvgAMNFSGNISGFVTPIAVGLIVGATGSYTWALLYFVGSAIIMGVSVLVL------
     662 UniRef50_Q88HG7        Tartrate MFS transporter, p...   178     5e-43  1  13.0% 21:434  24:434     --------------------RRVAWRIMPLAIICFLFSYFDRINISFAKTQMQQELGLSDAAYGLAASMFFVGYVLFEVPSSLGLKRYGAPAWICRIMVSWGLATAALVFAY---TQYTLYFLRFLIGVMEAGFGPAILFYLACWFPRKHLAKMNGLWFLAVPLAGAVGGPAAGFLLGtaGWHWLFLMSGLPCVLLGLLVLWKLDRDIEAAKWLSREEKDLLA-----------ENLAQDKRTAKPILGSIWRVLLTREVAIMAFIYYVVKTASYGLNFWMP-HLIKSSGVQDMLWVGVLSALPYAVACIGMVLLTRHSDRTGERKRYLVYCLLAAalLACLFSDSPFAMMTALVLATAGTFIAIPIFWTIPQSTFsaIATGTAAINSVGQLSGIVAPVMVGKINDLTDSTYMGMLSIAPLILVACLVVMRYVR----
     663 UniRef50_C1A5R1        Multidrug resistance protei...   178     5e-43  1   8.9%  3:407  10:441     --SPSARGTSGAARAVADDPYKNKYLIAIAVTLAAVLELVDTSIVNVAIPHMMGTLGATLDEIAWVSTSYIIANVIVIPMSSWLSGFFGRQRYLTGSIFIFVIASFFCGAA---TSLWGLVFWRVLQGLGGGALLSTAQTTLFEAFPPHERGIGQAIFGVGVMVGPTIGPTLGGFIVDAYAWPWIFYINVPLGLIAALMVWTYVKDAAHQVRTRTIDGTGILLLTLAVGSLQWMLERGewRELTIEEPVIDFRVLKSRQLAPGVVFASFMGVALFGSVFVLPVFL-QSLHGYSAQQTGLVILPGAIASAFTMAIMGRFGGKIDARILVTIGAFLFLASMTKMSQLTLDamFWPLILRGVGLGCLFVPLTGASMAGIprLGQATGMFNLMRQLGGSLGIAIMATMLSR-------------------------------
     664 UniRef50_A8H4F5        Major facilitator superfami...   177     5e-43  1  12.5% 18:434   6:425     -----------------PSVTWRTHSTLVLLALVYVFSFIDRNVIAIVLEPIKQEFGASDTLMGFLSgaFAILYAGLSLPLSRLADRGgrRNIIAVCCGLWSIATMACGMA---QHFWQLMIARMTVAVGEAGGIAPSISMVSDLYPPHRRSLAISVLMIGPHLGLLAAMVAGGWIAQEYGWRSVFLFFGAPGILLALLLFCFTKDPGHGVYDKNTTL-------------------NNEKNKQESFFKQLKGIMKVKGFIWIAMGCALAGMAGYGYGIWVPTFMVRNYDMSLAHAGISFGLAGGIFAAIGTIFSGVFCDKLSKrpMGVAFMLWPADAFWMVGEIKIPHAIVFAALFSFFNCWWPSLSYAAISHLMTSSQRATGAalFLTLFGAGLGPLLTGTLSDVFGEIFAGeyALVATMMLLLVSAWFYYK----
     665 UniRef50_B4EKW6        Major Facilitator Superfami...   177     5e-43  1  14.4%  2:417   5:415     -PTLSTHPAVDDDGATQALYRRISRRLLPFLILCYTLSFIDRINIGFAHAQMAAELHFSDAVYGLGAGIFFIGYMAFEIPSNAWLARIGARRTIARIMVLWGLGSAATMF---VTTPAQFYACRFLLGVFEAGFFPGILFYLGAWYPPRQRAKAFALFMTALYLAGLIAGPVSGAILSYfgWQWLFVVEGLPSSALGLVALRFLDDRPDDARWLSDADKA------------TLRAAHAQAEADTPAANAARSLLAHRDFWLLCAANFAIAAAGYALVFWMPVILHRGGLH-GAMQIGLISALPYLCGIVGMLAMgtERRREWRKHGAVAMLACAAALAGLASSAGTSHLMIALCIAVATHAAALPAFWVLPGLALPKraVAIAAITMTGAIGGFASPFLMGVLNTATGSMRGGLYF---------------------
     666 UniRef50_A4XPI4        Major facilitator superfami...   177     5e-43  1  12.5%  2:409   5:437     -PQPPLTAGRLMQSTVSQLDPRTARLLPWIVAIAFFMQTLDGTILNTALPSMAADLAEDPLRMQSVVIAYMLTVALLIPASGWIADRFGTRRIFFGAIALFSLGSLLC---ALSISLPMLVGARIVQGLGGALMMPVGRLVVLRAYPRSELVRIMSFITLPGLLGPLIGPSLGGWLVVVASWHWIFLINLPVGLLGCWAALRHMPDLRGPSRSRFDTPGFLLFGAAMLLITVALEGLgwLRAARIEQPLFAPRLFHTRSFAVGIIGNLFARLGS-GALPFLTPLLLQLALGYSPAQAGMSLIPLALAAMAVKPLAKPLIDRLGYRRILTSNTLLLGALIASLALVDGQtlIVQLSLIGACNSLQFTAMNTVTLIDLDNRDASSGNGlvVVQLAMGLGVASAAALLGGFS-----------------------------
     667 UniRef50_B7KWM9        Major facilitator superfami...   177     6e-43  1  12.1% 15:411   1:392     --------------MADALTSKVARRLLPFLMLCYFFAYLDRVNVGFAALTMNRDLGLSATAYGFGAGLFFLGYVAFEVPSNLILERVGARLWIARIMVTWSLVSASTALVVGEWSF---YLVRIGLGLAEAGFFPGIILYLTYWFPARQRAGIVGTFMMAVPLSAAIGAPLSGLVMslAGWQWLYLLEAAPSLLLGIATLFVLTDRPERASWLTAEERASLVARMAEDRRLSPNRTAH-----------LGAALLDPRVLGLGLVYFGLSTGLYAVGLWLPQIV--SGFGFTTTATGFVTAVPYIVSAAGMLLWTRHSDRTGERTRHVAIPTVAAGLALFAaaGTPLLTIAALSAVALGVFAALPTFWTLPTRLlsAAAGGIALINALGSLGGFAGPALMGWIRDATGRF---------------------------
     668 UniRef50_D1UM89        Major facilitator superfami...   177     6e-43  1  11.7%  6:433   1:420     -----METPAHRAELARSTFRKMAWRVMPLLMLAYLACYVDRANISIAALSMNAAIGITQSTYGVAAGIFFLGYLLFEVPSSLACHRYGPRMWMARIMFTWGLLSALT---AFVWDGTTFVALRFMLGVAQAGFVPAAVLYVARAFPEAFRGRVTGLFLMMVPLSSVISAPASAWLVGRhgWQLMFIVEAVPSVLLAVVVMVMMSDKPTEAKW-------------LNVEEREYLRSVMSAESKAKHEHNLREALFDKQVLALGMVNFGVLITHQTVGLWLPQIMSE--FGWPKSEIGWSMAVIYALSAGAMAFWGRHSDKKRERkhLLGALAVASVGLFLSTLMPSPLafMALTVSLVCSFASMSVILAIPTQFlrAAAGGVAMVMAIGSLSGFLGSSLVGALREWTGSFTAPIVLIAAFGAIACATLARIK-----
     669 UniRef50_A1UVN7        Major facilitator family tr...   177     6e-43  1  13.8%  9:437  47:468     --------VDETSIRERAVMAKIARRLMPLLVIMFLIAFIDRQNVGFAKLQMVHALGMTETSYGLGASLFFIGYLLFEVPSTLALHRFGARLWLARIMMTWGVITVLLGFT---HSTGVFYVFRFLLGVAEAGFYPGVIYYLTLWFPQSHRTRVLGLFTLGSALANmgLLLSLDGRLGLAGWQWVFVATGLPAIAVALVAWRYLPESVERATFLSDDEKRVALAAL------------KREASPEAVSESPWRALVDPRVLMFALAYMLMSTSLYGVTYWLPTLLKSNGVPSSLNGLLNMIPWAIAALLLLWLPARLKRERIVLKAMAAVAGVGVAGFALSLALPGLPLRFAALVLGGACIPLLYPCFWSLPPRFfaRAAASIAAINSIGNLGGFFAQNLMPYVGKAAGSAGAPMLVPVVCLAALGVGMLAAASMAG-
     670 UniRef50_A4X374        Drug resistance transporter...   177     7e-43  1  12.6% 21:418   5:449     --------------------GRGRWWGLLAISLGVATIIVDVTIVNVAVPAIIADLGVSSAGAQWVQEAYTLVFASLLLVVGRFADRAGRRRMFVVGVLVFVVASLL---AASAGSGAELIGARVLQGLGGAMMLPTSLSLLNANFVGRERAIAFAVWGSTIGGAAALGPLLGGWLTTELSWRWAFGINLPIGVLVVVATLALVPESRDDRvrGIDLVGALLSVLGMTGVVFALIEGrvRRNRLGRTALIDLSLFRIGSFRVGVTAAAIVSLGEFGLLFALPLWY-QNVLGYSAFHTGLALLPLAVGSFLSSALGALLVKRWGTTRVVQLgaGIAGLGLVVAPDTRWWAPLGLLFVYGVGVGLATAQLTGVSLREVPVRRSGQGSGvtARQVGSALGIAVLGTVLFAGLSGLLGARLA--------------------
     671 UniRef50_Q0RT10        Putative antibiotic antipor...   177     7e-43  1  10.8%  2:437  14:496     -PAVAEWAEETAGRDDAFVWTNRHTVALLVLCLAQLLEALDMTVVNVALPAVRDDLGFSAGNLAWVVNAYTVLFGGFLLLGGRAGDLLGRRRVFLTGMLAFTVASLGAGLSQGETS---LISARAVQGLAAGFVSPMTLAMIASIFpgPPRNRALGVWGTTSALSASLGLILGGVLVDGPGWRWIFFINLPVAAVLLVSALRVLPPDRPTHRhrFDAVGAVASTIGASLLAYTVIQTDAHGWGSArePLVPFSLFRIRSLSAANTVQALTSAAMFALFFFTSLYM-QNVLHYSSLKTGLAYLPLTATLVIFAGIVPPLIPKLGVRWVLVAGATVSAVGLALFSRITpsGIILPSLVVSFGFSLMWIPMTIAAVSGVPGhgIAAAMLNVSRTLGGALGLAFISTFATRHtgYRLGFLISAALMVATAVTALTLFRNEG-
     672 UniRef50_UPI0001B540EC transporter n=1 Tax=Strepto...   177     7e-43  1  12.7% 30:416   5:408     -----------------------------AVFLGSFMALLDASVVSIALPTIQRDLHAEFADLQWIVDGYTVGLAALMLTGGTLGDRYGRRRIYLGGLAVFTLASLGCGLA---PTLGLLIAARVLQGIAAAAVIPGGLALLAHAYppRERARMLGAWGGVAGCALVIGPLIGGPITDALGWPTIFLINLPIGIFAVLAGRRGLEESSDPAHGALDLPGQLLGALwaAALGALGLTAFIVVELRAPHPMLPIRLFGKFRFAASIFTSFVLGFACYPLPMLLAVYLQQA-WGSTASATGVQMLPYVVANAVLAFFSGRLAGRFTAERVLPVGLAITAAGSLAFLLvpYWLLSVPLTLSGVGLGLSITPTNVVGLAGLPVRRTGTAAgnAARQVGMALGVAALGALLDQGSTLTSGLW----------------------
     673 UniRef50_C5CMZ9        Drug resistance transporter...   177     7e-43  1  14.7% 26:414  32:447     -------------------------WVLAAAIVGSSMAFIDGTVVNVALPAIQADLRATAFQAQWVVESYALLLAALLLVGGALGDHFGRRRIFAIGVGIFALASVACGLSGSVQ---QLIAARAVQGIGAALLVPGSLALISAAFPEKERGKAIGVWSGFSGITAAAGPVLGGFLVDHFSWAWAFLINVPMALLVLWIAWRHVPESRGSSASGGLDLVGAlaVLTALGIGIAASAGFIAVERRARTPMLPLALLRIGNFSGANLLTLLLYAALGGGLYFFPLNLIQ-VQGYSATVAGAALLPFILIMFALSGWAGQLVDRFGPRLPLVIGPAIAAAGFALFAVPGVEASYwaVVVLGFGMTVTVAPLTTTVMNAVGPEQAGVASgnAVSRAAAVLAIAVFGVVMAWAFDGALV------------------------
     674 UniRef50_Q0RKN9        Putative transmembrane effl...   177     7e-43  1  13.9%  1:403  14:445     MSIPESVRGTVVRSSPPTGSGRRPGLILAFLSIAGFMTFLDVSIVNVALPTIEDKLDISATRLPYVVTTYGMVLGGFLLLCGRLADTYGRRLMLQTGLTLFALSSLLGGFAQEA---VQLIVARGLQGLGAAFLATSALSLLTSSFPEgaRTRALGVWGSLSGVASVAGVTLGGLLTDGPGWRWIFFINVPIGLLGALLAPGVVNESRADRRSSSFDLAGAvlIAAGFTVSALLLGAFLLIERRARDPLITLGILRRPSLRAANLAAVLLFGNVVTLFFFASLFMQQ-VLDYSPLRTGLAYVPLAVIVAVGAGIAAQLVTRVPVGLVLMIGLLLTVGGMLLLFRAPVDalLPAFLGTGLGLGLSFVPIQVVAFTGVREHESgaGLINTSQEVGGAIGLAVAAT-----------------------------------
     675 UniRef50_P71836        Multidrug resistance protei...   177     7e-43  1  11.4%  2:406  19:452     -PITPAGRPRSGQRSYPDRLDVGLLRTAGVCVLASVMAHVDVTVVSVAQRTFVADFGSTQAVVAWTMTGYMLALATVIPTAGWAADRFGTRRLFMGSVLAFTLGSLLC---AVAPNILLLIIFRVVQGFGGGMLTPVSFAILAREAGPKRLGRVMAVVGIPMLLGPVGGPILGGWLIGAYGWRWIFLVNLPVGLSALVLAAIVFPRDRPAASENFDYMGLLLllIPAITGLALIAAFVAHSWYRTEHPLIDMRLFQNRAVAQANMTMTVLSLGLFGSFLLLPSYLQQ-VLHQSPMQSGVHIIPQGLGAMLAMPIAGAMMDRRGPAKIVLVGIMLIAAGLGTFAFGVapILPTGLAIMGMGMGCSMMPLSGAAVQTLAPhaRGSTLISVNQQVGGSIGTALMSVLLT--------------------------------
     676 UniRef50_C9ZCD4        Putative integral membrane ...   177     8e-43  1  12.6% 11:408   2:422     ----------TGTEPGTETADPRRWWILGVLSLALFAIVLNNGLLNVAIPQMMRSLDADTGQIQFIVDGYALALAGALLTAGTLSDRYGHKRATLFGTVVFGIGSVVGATAAGT---GQLTGARVLMGLGAACIMPGTLAVLVHVFPPAERARAIGIWSGCSALGVAAGPVVGGALVSHFWWGSIFLVNLLPVAVVVVAGALLLPESADPSPRRPDPLGALLGTGVMVGLVFGTIQASKHgeRRHPHPMVDFALLRRAPFIGASVSILLLMFGLAGTLFVLTQRL-QFALGYGALQAGLAVMPVAFAVLLGTLVCPAVVRRVGPGGSVAVGLAVGAAGVLVLGRvgYPPVLAGLVLAGIGFGLAMGPTTDVVMSLVPPERSGasLDMTMQEFGNALGVAVVGSVLAHS------------------------------
     677 UniRef50_C8X951        Drug resistance transporter...   177     8e-43  1  13.3%  1:406   1:440     MSAPTPPSVTVTGVPIHGRRPVRPTLVIAVFCLGLFLTLLDITIVNIAIPDLVTDLNATLETVLWVGSAYSLTYTVLLITAGRLGDIHGPRRLFLIGLAVFTLASLASGLS---QTPGQLIAFRAMQGVGAALLAPQGLPIITSILPPAKRGPAFAATGIMSGLGVLAGPTLGGLLVTHVGWRWIFFLNIPIGVAAFALAFAVMPDVRPGRRHRLDLVGVALLTAGLLGVVFGLIEGerQAVTQDREPLLPFAVFADRSFTVMTLVLLAMGFAMVGMFLPLTIYY-QSVVGLTAIAAGLVIGIQSMAMMITSGIVGGlsGRIPMKWVLFAGLLLFAGGMVEIAAVAtwVFVPGLVAAGIGLGCVWTPVFGLATRDMLPARAGVGAGvtVQEFGAVLATAILGAVLA--------------------------------
     678 UniRef50_C4XGX8        Putative drug resistance tr...   177     9e-43  1  10.1% 10:406   2:423     ---------QDHTAPAGHVPTPRPALAMIGVNLMVFMATLDMSIVNVALPTLTESLATDFATIQWVILSYVLVIASLLLLVSRLGDMYDKKRIFGSGLVLFLLASLCCGLA---PSVSWLIGFRAMQGIGAAMSQALGMAIVTQLAPPSSRGRALGFIGATVAMGLMLGPPLGGVLIGLLGWRALFLLNIPLGLLALFAVVRFMPapPQRRGERFDLPGAAIACLTLaaASALGLAVFIKVERQSPAPMLDLSLFANPLISLPLAMATLVFVT--GASGFIMPFFLQAGQGYSVTQVGLLLMILPASMAVTAPVSGSLADRYGARGMSLLGMVVLTGGCLALGTLTEHTPWWGYLlvGLGIGIFQAPNNTTIMGQMPPHRLGVGSGLaaRVFGQSTGLPLVATIFS--------------------------------
     679 UniRef50_C6XZY5        Major facilitator superfami...   177     9e-43  1  12.9% 20:436   2:403     -------------------PNKRRWFIIFIIFLAIVFNYFDRQIVSILKPVIKKEFALNDGGYALILNIFTVCYAIMYPVSGWLVDRFGAKKVMFAGIIGWSVA---CIGGGISRTFGQFTFFRGLLGMSEPTNFPAQLKVVTVWFPGKLRATANSLCVAGSSIGAIIAPPLVAWLAITYNWHTVFIVAGVVGLIIALLWLLVYRDPPAEIALEAAGTAKI----------------------EESPSFTWKQLWGRKSLWGILLIRFVSDPVWYFCLFWLPGYLQEQS-GFSLAQMGMFGWIPFLVADLGAIGTAAWSDRMVrrKVMLTSVAVLAPLCVLTPYIPNpvTLFIFSIVAVACLSWLFTISVVIAEAFPVkaSVLGIAGGFGALGAVGFNYFVGQFMGTLGAEKIFIAMAFLHPVAVLILWTMVRPEK--
     680 UniRef50_Q394W7        Major facilitator superfami...   177     9e-43  1  15.4%  4:432   2:432     ---ADTLSIDVSEWIDRHRVAPFQAAIVALCFLIVAIDGFDTASIGFIAPVIRAEWGLSPAQLAPVFGAGLAGLMAGALVFGPFGDRFGRKRLLLACVACFGIASAASASAG---GLTELIAWRFVTGLGLGGAMPNAITLTSEYCPARRRSLLVTTMFCGFTIGSALGGLAAASLIEHHGWRSVLVVGGAAPLLLLPVLAWRLPESVRYLVNTGAARERIAAMLGRIAPDPHLANASFIAPAGKPAGSPLGRLFslRGTLLLWLTFFMSLLVIYLLSSWLPTLLRTT--GATLQTAARVTAMFQVGGTLGAIVLGGLMDRFDPHRVLACSYAAAGVFVAAIgaGSPWGAALAVFAAGFCVSGSQVGANALSAAFYPtrTTGVSWANGIGRGGSVVGSMAGGAMLAMGVPLSTAFAVVAAPCVIAGIAVLAL------
     681 UniRef50_C5C8B2        Drug resistance transporter...   177     1e-42  1  14.6%  4:406  12:442     ---APAGAPSLERAAADAARHRSVLQALTGLLLGMFVSMIANTVVSTSMPVIIHDIGGDQTAYTWVITSALLATAIATPIWGKLADLVNRKVLFQLALVLFVAASAA---AGFTHDPTFLIVCRTVQGLGGGGLAALSQVIMADIISPRERGRYMGLFGAVMAVATVGGPLVGGVITDLWGWRWNFFVAVPFAVVALVMVQRTLHLPHRErfLTVATALLLIWVTSAGRDFDWASTTTAwtELRVAEPLIPLTLFRDRTFTLATIASIATGLAMFGSSVYLAQYM-QLARGATPTQAGLMTIPMILGLLVSSTVIGGLITRTGvkRWLVIGAVLLIAGTALLGTLHYDTSFWlmFLLGAGVGMTMQNLVLVVQNTTDPRQMGVAsvTFFRTLGGSIGVAVMGAVVS--------------------------------
     682 UniRef50_B2H6N7        Transporter, major facilita...   177     1e-42  1  13.1% 13:433   5:403     ------------SSGAPGAGEKRKYLVLGSLFVAWIMSYTDRVAFTVAIIPISREFGLTTPQAGYLLSAFYAGYAVMQLGGGSLSDRFGGRVVLIGCVLAWSLFTSLTG---GAWSLSSLLVLRFMFGMGEGGFSPASSVTIADNFKREERGRAKAFLLSTDYLGSAIGSGVIALFIVTYGWHTSYQYLGVVGALVAALLFWCLP-------------------------PQTKRDASVAHDARAPARPTLLSLMKLPAVLKIFSIWFFTRMLWIGVVSWMPSYLIKSR-GISLGELGFATILPYCLAFIFANIVGYGLDKLLakVLMTTGTLLAALSLFLCINssLAMTVVYWAGCMLAFNLVYVSLFSIPIKYFQEAVAgtGIMNFGGQLSGTIAPTLIgwIAADKNSYVPAFLFLSVCGVVAAAIAMTWK-----
     683 UniRef50_B6YVX2        Putative uncharacterized pr...   177     1e-42  1  16.2% 13:438  60:482     ------------EVIENSKLESFHYRLLAVLGAIWAFIAVNTIAASLIIPLLKEefQGSLAKLGSLGSAALFGMLFGAWLFGILADRIGRKKALTLAVVTFSLGSIVSSFAG---SLDELIALRFIVGLGLGGSLPVASSYFAEFMPKSVRGAMISILESFWAIGTIIIGVVA--LLVRADWRNILLFGG--AILLILPLLLTLPESPRFLLVKGRISEAEEILRRIFGVDVKLQKPGEEQKRTS---IADLWRKYSRRTLMLTVAWFSIAFAYYGFFIWLPKFLSAT-LGITVFKSFQYFIITAIAQLPGYWSAAYLIERIGRKKTLSSYLFLSGIAGVAFYLAAsaMILSSAILFSFFNLGAWGAIYAYTPELYPtrGTGTGWAGAMARIGGGIAPILAGRIMEVSGAALAVLVIAVVSIIGALDVLILGEETMGK
     684 UniRef50_UPI0001B4ED77 major facilitator superfami...   177     1e-42  1  12.6%  2:415   6:441     -SSTLPEGSAVSSDGERPPRLRTRWAVLAADFMVLCLNYADRAAIGVAAPYIIKEFGFSETAFGWILSIFAVSYAPFGLIGGWAADRFGPRKAMGWAALAWSAFTAATAAGAGFISF---LIIRILFGAAEGPQATVTAKLMNTWFPRQELGTAIGIANAATPLGGAVGTPIVVAVIEagNWRAPFIIFGVIGVLFAVGWFAVVRDTPEQHPWMKPAELREIHGAQSGTAARAADeaGAEEGEKSSALPGMWHYVARPVIWATALAYFGYAWILNVFLTWFPTYLVDER-GIDLGHLAVAGSIPWIGGCIGMIAGgwLIRRIgrRWTIVICLILTAALFGCIALVGSAvaVALMAVIIFLLYFTGAQYWTVVAEEvpRYGSVAGVVQFIAGCAGFLAPLITGAVVEHAHSWATAF-----------------------
     685 UniRef50_A0R6Y1        4-hydroxybenzoate transport...   177     1e-42  1  13.9%  6:436   2:435     -----PPTLELQSVIDRHPVGRLQRRVLMLCFGVLVLDGIDVAVVSFIAPSLIADWGISKAQLGPVVTSGLLGLAVGSLVAGPLADRFGRRKIIIGSLVFFGV---MCTATALASGVVAFSILRVLTGFGLGAAMPNATTLVSEYAPARRRSAMMAITYCGMTLGSAIAGYLTSVIVEIASWHWVLIVGGVLPVVYAVVVAVALPESPKYLARVPQRRAELSTLMSRIVPDHIPPDAQFTLDEPPAGNRAPFVALLVPRFRLgwVGFIAAFFIVYLMNSWLPILMTDV--GFALSTAATIGLLLQVGGTIGNIGIGWLMDRFGLHRIVAIGMGCAGVLLALIAVAPQEVVvvLIFVLGMFTNSVATGFPILSAAFYPtrATGTSWATGVARFGAIAGAAAGTVLVAFGMHYQQVFLTLLIPVAVCIAAVVTKGRKA--
     686 UniRef50_C7Q3U9        Drug resistance transporter...   177     1e-42  1  11.8% 14:421   1:432     -------------MSETTMGGRRRWLILIVLCLATLVLVVDNMVLTVAVPALTESLHASAQNIQWVLDSYILVFAGLLLTTGSLSDRFGRRRVLIIGLAVFGVASAV---ATMAHNPGELIAARVAMGIGGALLMPSTLSILITVfdEAERRKAMAAWTVVAMVGLVGGPVLGGVMISHFWWGSVFLLNIPIAVLAIISAVVLMPESKGPWRKPDPLGTVLSIvlTALAVAVVALISFGVWETRIAEPMVPLQLFKQRNFSGGSFSLTLVQIGNGGLLLVMTQYL-QFVLGFSALKASLCFIPLAIAALIFNTLGAGLGMKFGNRPLMVVGLLICAVAFGILADlgLTKLFVGLFLLGAGSGLAMPAAITAIMGAVPPEHAGVSSAltVQQTGAALGVAIMGTVVASRFTAAMPAKVTGAA-----------------
     687 UniRef50_B4SYF5        Inner membrane transport pr...   177     1e-42  1  11.7% 29:438  14:456     ----------------------------WIAAMAFFMQALDATILNTALPAIAHSLNRSPLAMQSAIISYTLTVAMLIPVSGWLADRFGTRRVFMVAVSLFTLGSLACALSS---SLSELVIFRVVQGVGGAMMMPVARLALLRAYPRSELLPVLNFVTMPGLVGPILGPVLGGVLVTWASWHWIFLINIPIGVAGILYARKYMPntPRRKFDMIGFFLFGLSLVLFSSGMevLLLAYIRHARRHPTPLISLSLFKTRTFSVGIAGNLATRLGTGCVPFLIP-LMLQVGFGYPALIAGCMMAPTALGSIIAKSTVTQVLRRLGYRKTLVSITVFIGLMIAQFSFQSpwMLVLPLFILGMAMSTQFTAMNTITLADldNASSGNSVLAVTQQLSISLGVAISAAVlsTVEQFHYTFITMGAITIVSALMFMLLRAKDGN
     688 UniRef50_B0TDL7        Major facilitator superfami...   177     1e-42  1  13.8% 23:412   4:430     ----------------------QQIRILVTYLSGVFLGALDQGIIGPALTTIVRDFNISPKWCVWAVTVYTLVYAVSMPITAKLADRYGRRRIFMTGMAFFAVGSL---FCALSDSLYLLLVGRAVQALGGGGILPVAVAEIGLAFPQERRGRALGLYGATWGIASIVAPILGGVVIQYLSWPWLFLINVPAAALLIVLAFGLPEEVEPQVKAMDWQGALLVGMVIFCFMLGLTHIQGqwVERNAEDPIVNPAYFQNPRLLTIFLLAALSGMVMLTVL-FMPAY-VEYVLHFPPGKASYMVVPLALASVVTSPLGGLIVDRFGASRTLSLGFGATAVGAVVLAVLvmIVTFGFILLGGGLGLIVGSPLNVLVMGEVDRrsSGLAVMTVIRSLGNTLGPVVMGGLLATATSLG--------------------------
     689 UniRef50_Q1AUV3        Major facilitator superfami...   177     1e-42  1  16.8%  8:436   7:440     -------TMTVQEAIDRIGFGRFQKRLLAVCGVTWVADSAEILMLGFALPSIIAEFAISPAQAGLIATATFAGMLVGAWFWGTVSDYIGRRTGFQLTVLTFAVFGLL---SAFAPSWEWLAVLRFITGFGLGGALPLDFSVYAEFLPSENRGRNLVILESFWAVGTILAAGLAWLLVPSFGWRPLLAASALAALLVLWI-RKSIPESPRFLAISGRADEAKEILTGIAAENGRPAPEQTLVAGERQGGVTVTRLWvrRSTLMLWIAWFCVALAYYGIFTWLPSTFAEQ--GFSPLRTYQSTFILALAQLPGYFSAAYLIERIGRRNTLGLYLLASGVFTFLFATASGfwILTASILMSFFSLGAWGALYAWTPELYPtrATGMGWASGMSRIAGVFAPILGGILFGLATTAGGSLLYvaSFIVGGIVVFLLGVETK--
     690 UniRef50_B0CN15        Transmembrane efflux protei...   177     1e-42  1  13.7% 14:437   3:465     -------------AEQGAPSAKAGKTLLTLLCLAQFMLILDVAVVAVAVPSMQSQLNISAANIQWVSTAYGLAFGGFLVASGRAADLFGPKRILLIGLSLFTLASGLCGIA---PNELTLFVARAVQGFGAALVSPAALSLVTTSfeGEERNKALGLWGAVSSGGAIAGQLLGGVLADLAGWRSIFLINVPLGLIVIVAVARMVRKDRSNDTGRIDMAGAGLLTAGVVLLVTAVSQAAErhEGRVQNPVLRLSMFRNPNVRYGNMICMLTAGGA-TVSVFLGTLYMQQVIGMSPMMAGLGFAPVTLLILGVSMRMGPLVQKFGVKNLLLASAALFAVGSLLLSFVTVDGSYwgLAIGGVGAALSFAPSMILCTTGVPDEEQGLASGltSQQIGAALFLAILSGVTAAVagFQAGFLWSLAIPALIVLCLLALPRKKD-
     691 UniRef50_A2WE51        Major facilitator superfami...   176     1e-42  1  13.9% 17:419   9:437     ----------------SAAARARRWWLLAGVCIASFLGCIDFTIVNTAIPDIQADLHASVTQSQWIVTAFLIALCASMVAAGRMADLYGRRPVLYIGLTVFGLSSLG---AGLATAIAGVIACRFVQGIACAVLYTATTAIASAAFGEDERGKALGILFGANGIGLAIGPVVGGVLVGALGWRSVFLVNVPFVLASVALCLYGASELPDVKERGrrWGWTSFRTSASFAVAVALFAALVRVERTVRSPLIRLELFSNRDFVRASIATSSLAFFYCAAFFLMPLYLK-IVAGFSDVMIGVMLLPTTALIALLSPFVGRATDRIGPVRFLAAGFLFFAVSAAMQVqvSIGYVIAAFAVMGIGWACVLGPSTVLALASVPEDVGGVAVGttMHNLGGATGLSVATTVYQVFAGHGLSAALAA-------------------
     692 UniRef50_D1NT02        Major facilitator superfami...   176     1e-42  1  12.8%  2:437   4:458     -AGAPQGNMTRNQRLDNLTINKAHRRLLTASGIGWAFDAMDVGLVSFVVTAIAAdfNLNATQKSWVLSIGFIGMAIGAALGGYLADRFGRKTIFTATLIVFGIA---NGAMAFSWTLAALLVARFVIGLGLGAELPVASTLVSEFSPTKQRGRMTVLLESFWAVGWIVAALIGYLVIPawGWRWALLI-GALPLLYAIVVRRSLPESVRFlrYFEQAGAVAAGTKRTGFGLRAKSGAAAVKTVKTKSAMRTRDLFSRriTLAIWATWFFVNFSYYGAFTWMPSLLADQFG--SLTKSFGYTLVIAVAQLPGYFLAAWLVERWGRRRTLAVFLAVSAVAAFLFSqvTVWQVITFGMLLSASNLGAWGVMYAVTPEIYPtrGAAAGAAAACGRVAAIIAPLLVPWFLTLSGGnsVAFIVFAAAFVLACVAALFLPEKMG-
     693 UniRef50_C7PVC0        Drug resistance transporter...   176     1e-42  1  12.7% 14:422   2:439     -------------STNSPPSGRRQRLILTVLIFAQLLIWIDGTVLSTAYETLarGLGATPGQLQWATGSYTLVLATVTFTGGALGDRFGHRNTLLAGMALFGLASV---FAAYSQNTGQLIAARAVMGLGAALLIPATLAVISFTYPPEQRPQAFGVLSSFAGVGIAAGPVLAGLMLANFWWGSVFLINVPVVVLGLVAIARTVPNFQPPAKRGLDFPGLLLsvWITVAGGLVVTAAFVVVELRRRHPSFDPRLFRLRQFAAGNVSLTLLFLALSASGFYFAFYL-QGARGYSALRASLVGIPGALGVVIGGPVAAKLARRTSVRRVSGTALTVSTITLLVFSRVGLGLPIPAYIAVSiaIGMTIAPLTGAILGSLPLAQAGAGSAvtMRQTGSVLGIALGGTILSIGYRHAIGGSVAALPA----------------
     694 UniRef50_O07753        Uncharacterized MFS-type tr...   176     1e-42  1  11.3% 13:427  15:455     ------------RAGGPLLSPVRRNIIFTALVFGVLVAATGQTIVVPALPTIVAELG-STVDQSWAVTSYLLGGTVVVVVAGKLGDLLGRNRVLLGSVVVFVVGSVLCGLS---QTMTMLAISRALQGVGAGAISVTAYALAAEVVPLRDRGRYQGVLGAVFGVNTVTGPLLGGWLTDYLSWRWAFWINVPVSIAVLTVAATAVPALARPPKPVIDYLGILVIAValLIGAAVALGFFVWLEGRAAAAILPPRLFGSPVFAVCCVLSFVVGFAMLGALTFVPIYL-GYVDGASATASGLRTLPMVIGLLIASTGTGVLVGRTGRYKIfvAGMALMAVAFLLMswTPPLLQSLYLVVLGAGIGLSMQVLVLIVQnsFEDLGVATSGVTFFRVVGASFGTATFGALFVNFLDRRLGSALTSGAVPVPAV-----------
     695 UniRef50_A7IEE3        Major facilitator superfami...   176     1e-42  1  13.6%  2:434   5:438     -AQAGPRPVNIQQLIDESPVSRFQLLIIVLCFLIVAVDGFDTAAAAFIAPAIRAEWQLTPAVLGPMFGAGLFGLMVGALVIGPFADRFGRKPLLIFSVVFFGLASLG---AAFSHSITELTWWRFVTGLGLGAAMPSAITLTSEYCPERRRSFLVTIMFCGFTLGSAMGGLLAAQLVAEHGWRSVLVVGGAVPLVVAVLLWALLPESIRFLVLKDPRSAAAARNLARIAPKADLAGAVFVGPKKAKGLPVQQLFSRngGTLLLWLAFFMSLLVYYLLTNWLPTFI--NAGGASIQQAALVTMMLQLGGTLGGVVLGLFMDKVNPHALLASAYVGGGLCVTAIGNSTGVPGlvAVFGAGFCIAGSQIGINALAAAYYPtrATGVSWANGIGRSGSVVGSMVGGLLLSFHWGFETIFAIAAAPALVAGLAIFLKGR----
     696 UniRef50_A9WHK7        Drug resistance transporter...   176     1e-42  1  14.2% 20:414   2:417     -------------------SRQHTILITMGVMMSLFMASMESTVIATAMPGIVRDLG-DIESFSWVFAIYMLTSTTAGPIFGRLSDLFGRRPVYMVAIAIFSLGSLLCGLA---TTMPMLIAARALQGLGAGGLLPLAFIIVGDIFTLDQRAKVQGLFSGVWGISSVIGPLIGGFLVDQISWHWVFWINLPPAAIAAALVWIAWRDPVRANAKRPPIDIAGALLllMLSAAVATLALLVMVELRAPAPILPFHLLRDRTFAIACLHGILAGGVLFGSMNYVPLF-AQGVLGTSATEAGTTLTPLMLGWVFTSIIGGRLLLRMSYRTLTIGGMVMFVAGAILMARLRPDmlAIALGLMGIGMGASIPSFLIAVQSTVARngAATASLQFSRTIGGTIGVAVLGTLLTNRLSAELA------------------------
     697 UniRef50_Q1IQL5        Major facilitator superfami...   176     1e-42  1  15.4% 10:438   2:407     ---------SSSITARSIVSPAAARVTLLILTLLNFFNYIDRSILFAVQPQVQAEFHCSDRQIGLLTSAFFFTYMCFAPFVGPLADRFTRKYIMAIGAIVWSVATLLT---AVTHSYDVLLFRHAIVGIGEATFVTITPSFVSDLFPEEKRARIMAIFYMAIPVGTAIGYLVGGYLGHRHGWRMPFYVCAIPGMIMG-LLLLLVPEPVRGSHDTIVA---------------------------THERSSFLGLFRNGAFWTCSLGMAMMTFAVGGLQVWMPTFLNRMREIPLDAANFRFGLLTVVGGLAAAFAGGWLGDRMLKrlVSGIGMAVCLPFMIVAITAKGPIMYVAILLAEFFILLNTAPLNAALVNSVSANIRSTAvlFTIHLLGDAFSPTIIGWISDKT-NLQVGFIPTVVAVILSAVILFIGIRTAPK
     698 UniRef50_B4UY57        Major facilitator MFS1 prot...   176     1e-42  1  14.8%  6:437   2:480     -----TNAEAEAVAAGPQAAPAVPWPAVSVVMVGMFMAILDSFIVVVAGPAIQADLGASVGQLQWILAGYQLSYAVFMITGGRLADLYGRKRVFITGTAVFTLASLAC---ALAQNPGALVGARIVQGLGAALMVPQVFAVITLVVPENARHQVFGTLGIVIGLATMGGQLVGGLLIGAdgWRSVFWVNVPIGVVTIVCAARCVPESRATGTRKLDVPGVLALSAALLLLTFPLIQGREAGwrRGGDPLMRLSLFSQRSFSLGIVLVLAVYALLTSYYLAL-SISMQEGLGMSALGAGLVYTPAAVTFFAFSKAAGRLVPKYGRrvVLAAGYLATAVVLLSGPRLTPLLVIPTLMFQSVGGGLLITPLLNTVLSRIAPETVGMASGvtAQQIGGALGVAVIGAVfaAGHAFAMSSLTTCSIAVLAAVLVFLLPARKT-
     699 UniRef50_Q0BZK8        Transporter, major facilita...   176     1e-42  1  12.3%  7:389  26:398     ------MSPTLLPPGTAADPQQRVRVTLWLLLIVNAFNFVDRQIVNILAEPIKNDLGLNDTQIGLMTgaFAVVYTSLGIPIARWAdkSNRVGIIAGSLAIWSGMTAICGVA---QNFWQMLLARIGVGIGEAGCTPASHSLIGDTVPPEKRGSAIAFFGLGIPIGSLFGMVIGGVLADAVGWRIAFMAVGVPGVILALLLWFLVKEPRKD----------------GTLAEAAARLKQSQAAPRASIRETIAEVLSSKVFIYATLGASFVAFLGYGKGVWNGIFLIRTHGLSLTEVGLLYGVSAGLGGVAGTWLGGWTSDKFGIRKPvaVAMLLTVPILLIGYAGPVWVAIPMLCLSAALSGVYYAPTFGCVQLLISPASRAVAVSLML-------------------------------------------------
     700 UniRef50_Q12KZ1        Glucose/galactose transport...   176     1e-42  1  32.9%  4:432   2:423     ---ATSELQSELTQVNSTHQQGNFRFALVALTSLFFMWGFLTCLNDILIPYLKNMFELSYAQAMLVQFCFFGAYFIVSIPAGVLVGKIGYQKGIITGLAIACVGCLLFYPSASYGSYNMFLFAFFVLASGITILQVSANPYVSVLGPAETASSRLTLTQAFNSLGTTVAPFFGGWLILSTVEHDEKITEV--GKVIGQLSVEQQASAVQMPYLILAGALFALALIFMLLKLPLLGKKSLDSRS-----GIAGSAWHYPHLILGAVGIFVYVGAEVGIGSFLISFLTQeiGGISESQAANYIAYYFGGAMVGRFIGAAVMQKIKAGKVLAFNAVCACVLVTAAMLNVGTLAMWALLLVGLCNSIMFPTIFSLALQDLQQHTSQGSGILCLAIVGGAVLPLLQGILADSFG-IQLAFIVPLLCYVFIVYYGLIG------
     701 UniRef50_C4TYD0        Major facilitator superfami...   176     1e-42  1  12.2%  8:433   4:455     -------TISNQTVQNSTEPSPRRIRMLIGISIASFLGCIDFTVVNTAIPAIAQDMNASIPRVQWVVSLFLMALCAFMVTAGRLADLYGRRRVLYVGMMVFGVSSLG---AGLTESIGVLNGWRFIQGAACAVLYTVTVTIVADAFPDHQRGRAVGTLLGVNGLGLALGPVLGGIVVSTLGWRWVFLLNIPLILLSFAFCLGNIRESRLSEGRPLLDITGAIltLSIITLAIVLFTAFFHIESRVAAPLVKLSLFRIPAFSIACLASALLAFFYCAAFFLMPLYLEGTRH-YSGLILGLLLLPTTAVMALISPLIGRWMDAAGARPPLIMGFIALALSAGLQATFTpwIIIAAFTLMGIGWGAILSPAAVSALNAVSAEQGGSAMGvtLHNLGGAMGLAVSSLIYTTFSQGYQSAMLLLVAISVVGLLAVSWR-----
     702 UniRef50_Q1IMI9        Major facilitator superfami...   176     2e-42  1  14.7%  6:434   1:428     -----MSVVAQRSINRPRPIPSLRWWIGGLLFVSTAINYLDRQTLSLLAPYLKLEYHWTNTDYANIVIAFRIAYTIGQTACGRFVDKVGTRRGLSITVAWYSLVSLLTSFA---RGFASFAGFRFLLGAGEAANWPAATKAVSEWFPEKERALATALFDSGSSIGSAIAPFVVLSIYFRWGWRPAFMIPGALGFVWLIAWRYLYHPPQQHPRVSAAELQYITAPAGESAASTDLRSPR------------WRELLKFPQTWAIIVAKSFTDPVWFFVTDWFPIYLV--AKGITLKSSLVAIWIPFLAADLGNFFGGGVSGYlaRKALVVFGGIGVLALIPTVLTQSLFAISGLFAIATFSYSVFSTMAIVLPSDVFHSDSVATVSGfsGAGIGTIIAFELVGHFSDavHSFDPILIVAGMVPFVGMLLVLALLR----
     703 UniRef50_B4SJL7        Major facilitator superfami...   176     2e-42  1  13.9%  8:431   4:422     -------PAVVANLRKVPVRSAVRWLIVGLIAVATVINYIDRNALAVMWPEIAREVGATKDDYALLVTVFMLFYAAGQFLFGRLFDMIGTRLGFALSISVWSISIALH---AVTHSILSFSLVRAMLGISEAGAWPGAVKANAEWFPARERALAQGVFNAGASVGAIISAPAIAGLYLWLGWRGTFVLVGAIGFLWLLPWLFVYRAGPDKHPWVSDAERRLI------------QEDQAGQQTEAAPKASVRELLAHRQSWGMLACRFLLDPIWWLFVSWLPIYLAET-FGFDIKQIGLFAWVPFVGAMLGSLSGGWLSGRmaRKLAITLGCVIMAPALLGAVLAnpLLAVLAIAAVLFGFQVAIGNIQTLPGDLFDGRSVGTLAGlgLAAVAGTLITTWLVPVLTRHSYAPIFILVAALVPLSLAALWWW-------
     704 UniRef50_D1TD93        Major facilitator superfami...   176     2e-42  1  16.6%  9:437   2:447     --------SAVAARLERLPISSFHRRLLLIGGLGYMFDGLDSSSLAFLLPVVSKLWQLTSAQTGLVASSTYIGYFFGAFLSGVLADVIGRRRIMMSALAIYCVASLA---SATAQDWHTFFALRVVAGFGSGAETVVIAPFLAEFVPRRYRGMFCGALVGFMSFGYLTSSILGFAVVRNfgWRYLAVITSLP-VVMLLWWRRTLPESPRwaAFVERGIALAPATASNALHAMPTPASAPGRANAWRNVVALWSKRLARTTAVSWLMWFSVAFAYYSFFSWIPSLLVKE--GLTMTKSFGYSIAIYGAQIPGYFSAAWLNEKIGRKAVVASYMLLGGIAAITLAFSHTGiiMTAGIALSFFMNGAFAGVYAYTPEVFPtrTTGTGSSSSFGRIGSVSAPILVGLVYPLFGFLGVFAMTTTVLVIGACVVFFLGIETRN-
     705 UniRef50_C7QKL5        Major facilitator superfami...   176     2e-42  1  13.1%  1:405   1:440     MTTTQTRPATPTAERGDTTTARAQNLTLLVLLAGIFMTTLDIFIVNVAIPATQRDLHASPAAIQWIVAGYGLTVAAGVITAGRLGDMFGRRRMYALGMALFTAASAACGMA---PTANVLIASRIVQGIGAALLSPQTLAIIGTAFEGAKRVRAFTAYALAMGLAAVFGQLIGGVLIDmlGWRSCFLINVPVGAVALTLVPRAVPESRAEVRTRLDVPGVALVSAALVATVLPLIQGQSQgaAAKKAPLIDPALFRTKGFARGIVAQIVFWMGQGSFFLVFALY-VQLGRGLDALHAGLIFTPIGVGYLLTSMVAQKVTERLGRQTAAVGTLLMAVSLllTGTHGSLLWTIPALVGDGAGMGLAIGPLAAGAMGRVAPHHTGAASGvtVMQVGGAVGVAVIGIVF---------------------------------
     706 UniRef50_B2TBX8        Drug resistance transporter...   176     2e-42  1  12.5% 22:413  41:473     ---------------------RRKKLALAATILGSSMAFIDGSVVNVALPSIQSELGASVAAIQWVVDAYLLFLGALVLVGGSLGDKLGRRTVFIAGIGLFTLASIGCGLAPGAAALIAARA---VQGVGAALLVPSSLSIIGAVFDDKERGQAIGTWAGVGAITSALGPVAGGWLVDAFSWPAIFFLNVPIACATVALAVMAVPDSRqgLTLASARGFGNRWVLASILGGLLVLIAFVALEARTRNPMMPLDVFRSRDFVGANLVTLLLYFGLGGALFFLPFTLIRA-YGYSATQAGAALLPVPVTIGLLSRFTGGLTSRYGARALLTAGPVVAAAGFAMLALPwwRGFLPALTVLGLGMTVTVAPLTTTVMTSVSAARTGVASgnAVARVASLLAIAVLGIVFVWSHDAAL-------------------------
     707 UniRef50_C4DMC4        Arabinose efflux permease f...   176     2e-42  1  14.5% 37:436  29:461     ------------------------------------IFSLDLNIVFVALPEIGAELGFPGQTQQWVVSAYTVFAGGFLLLGGRLADLLGRRRTFVTALSLYA---AASLAGGLATDPGLIIVSRAVQGIGGALLLPSTLAIINNLFAEGrrTRALAVWGGFGASGLTVGALLGGVLTQAFGWPAVFFVNVPLAAAVVLGALLVIPADGPRASGNFDLPGALTavLAAAVLGVALLAAFVATEARTADPLLPLRLLRNRNLSGAAAITFVFMGTFGALPYFLTTVLFATKYDYSALATGLAFLLPSAAIFAGTQLGASLTVRFGARAALLTGFGIGVVGTVALAvaGFLAAAPGLVVSGLGQGIVWTAMFAAASTGVDPARAGVANGLATtnVGNALGIGALVAVAGAvgGFVAVLVAAAAMVIGLGLAAALPRRSR--
     708 UniRef50_C8X8X0        Major facilitator superfami...   176     2e-42  1  12.8%  1:421   1:442     MTSADMTTPGTPPRRATTAD----WVGLSVLALACLMYVMDLTVLHLAIPQISEQLAPSSAQLLWIIDVYGFLVAGALVTMGTLGDRIGRRKLLLIGAAAFGLTSIL---AAFSTTPEMLIVSRALLGLAGATLAPSTLSLIFHMfdPRQRSVAIGIWIGAFSAGSAVGPVLGGLVLEHFWWGAVFLLALPVMVALLILGPIVLPEYKDPGAGRLDLLSVLMSVAAVLAMIFGLKEIAqrRQRRLTDPMIDVSLFRIGSFRTALSVNFLAVFISVGYFLFLAQYL-QLIVGLSPLQSGLWSLPSAAGFIVGSQLGPRIVRRVQPATIIATGLGLSAVGLGLLTQvgLWIIVTSSVIISVGLGPVFGLTTELIVGTAPPEKAGAASGitAAELGGALGIAILGSVGVAIYRGQLATTLPAGL-----------------
     709 UniRef50_Q470J5        General substrate transport...   175     2e-42  1  13.7% 14:436   1:427     -------------MHQSTLPARSSLFVVILCFLTIVADGYDLIVYGATLPKLLEewGLTPATAGMIGSWTLAGLMVGMGAAGPLSDRVGRRNLIMAGVLWFSVGSILCALAA---SPFSLGAARFFTGIGLGGVVPSAVALTVEYAPANRRQLYNALTLTGYSVGGVICALLAMTLLQEHGWRTLYALGALYALILPVMYRWLPESVSFLVERGRMEEARVLAARHSLDLEQMAREQRAQAVHAAATGTRGYRLLarTSALLFGMVSFCVQLIVYGLNAWLPQLMRKA--GYPLGSSLQFLLVMQFGAVAGMIGGAWLADRLGSKRVIIPFFAIGGLSLLALSqlAFGWLMLAVFGAGIGSIGTTTLIYGYIATYFParGSALGASQAFGRFGSILGPLIGGWIVGSNLALHWNFYAFVVPAVVAILLVPLIPKPA--
     710 UniRef50_A3K375        Major facilitator family tr...   175     2e-42  1  12.6%  6:435   1:438     -----MAHSTPLPTRSDAPISHYRWVVVALLFAIVVINYIDRSAISYAIDPISKELSLTASQKGLILGAFGVGYMFTTFIGGVLTDRFGPRIILTVAVILWAVSSALT---AVASSFFLLLALRALLGLAEGPMFPGLTGAVAHWLSPKERAKALGYSLAAVPLALAIGGPIVSGILSLTDWRSLYWILAVGSLVWFPLWFWMFRNRPEDSAHVnaELAQIRHKDIEVIDTGRGTGEVVPARSDNATATTWKRLFTNPTLLANYWAFFVFGYFLFFFMTWLPGFLEQK-FSVSVANVGWFSFVPWAVAGVVLLLLGNLSdrISRSWFIIVTQLIAAVVIVPVAFTSTLWVALALITVALASSMGANAVYYAINVDIAPDRSATALGLmfFAVSGFAAPAITGWVVGSSGSFTRAFFILAALAGSSVVLTFLFHRP---
     711 UniRef50_C3PFV4        Permease of the major facil...   175     2e-42  1  12.2% 15:431  11:452     --------------AATPISEKQAWLAMAALSLGFFMSLLDQSMIAVALSDVRREFNADVNQVLWVSAIYLLAVVVPLLFTGRLGDIYGQKRMFQLGNGLFGLGALLC---ALSPSVEFLIAARALQGLGASIQMPQTMAVINRIFPRERRGRALGAWGVVGSLATLAGPLLGGLVVAAFGWQAVFWIHIPFVIAAIALSGLWVPALPTTPGRVDFVSVWASFIALTCFVFAVQQGPerLQSVRGMAALVPLVLFKDRNYSVGSVAIVSMGFMAASMMIPIMMWL-QVEQGMSARDAGLIVTPMALVSLCVSPLAGILADKLHPRRLAVVGFGILISTFILLWfvSAWWLSLPCAALGAGQSFIWGSNAATTMRDIDAHLMGAASgnTSRQVGSVIGVAGVSAVMQVAGAANSLVLIVAILAVGCVSSLFF-------
     712 UniRef50_Q2RJS5        Drug resistance transporter...   175     2e-42  1  11.3% 23:421   9:431     ----------------------YKWYALSCTTLGALLSVLNSNTLLIALPVIARALHASLETIIWTLMIYMLAVTVMVPAIGRVADIIGRKKLYVSGFALFTVASLLCGL---VQSGGQLVAARFIQSVGGSLMLANSTAIVTDAFPKGQLGRALGINSMVIGAGAVIGPILGGLLTSWH-WRWIFFFNVPLGIIGTLWAAIQLRedWLGTSLFTIGFTFILLALTFGDMVGWHTPWIVAseNHVDQPMLDLSLFRQRLLAAAYASNLLNGIAR-GAVTFLLIFFFQGIWGIDPLWAGILLTPFALAMMFVAPVSGILSDRYGSRELSSLGLAVSAIGLYGLTrtPMTVVILWMVIMGLGSGFFFSPNTNAIMGAVAAERRGIAAGttMMNNAGMVISIALGLAMTASSMTPEAMQGLFAG-----------------
     713 UniRef50_C5CYT2        Major facilitator superfami...   175     2e-42  1  11.6%  1:432   1:430     MQSTTTVSAPAATANPAHQPTKVRWKIFLMMLFLISINYIDRASLSVAMPLIAKEFDIGPAVQGLLLSSFFWTYALMQIPGGMLADRFGPRVVIAGATLGWGFFQAI---AAACTGWVPLLLTRLGLGAAEAPIYPAGGKLNGIWMTQTERGRGATLLDGGAPLGAALGalISGLIAVLGSWRMAFAIAGGGTVLAGYFAWRYIRNHPRQHPGVNEAEARFI----------EASHAADAAKESADASGRVLDFFRFRSVWGMFFGWMCFNALFYGLLTWMPNYLSK-VHGFDIKQMGGAVFIMFFSGFVGEMFGGWLADKWQarTLFGISSIIATIAIFMVTQIKDPIAVVVLLSVTLFFLRWCGLFWCVPSILGTRARVggGTMNLGGNVAGIGVPIVVGLIVQATGSYFMALMLFTAAGAGLFVCSTML------
     714 UniRef50_Q9HID6        Multidrug resistance (EmrA)...   175     2e-42  1  13.7% 22:423   6:416     ---------------------SRKYFVLSITTLGSLMAAIDSTIVFLALPAMGHYFSSSVSYLTWIVVAYIISATIFMIPSADIMRKIGKKQLYLIGFVIFALSSLVIALSS---NVIMAIIFRFIEGIGAGFLSAVGIPILLDAFPPQERGRAVGINSISWAIGTLVGPVLGGYLV-LYDWRYVFLINVPIGIIAAILGLARIPHYPKENAQKYDPIPLIGLIAFLLplVASAIIFPFFIMAQRRNPIIPSVLLKNRNYVRVSISSTLQALSFFGVLYALSLYLQISR-GMSSLSASLYLFTYPLASMIANPVSGFLFDRTGKGAHLLVIGLVMQAFGIFMVAYTMTLIPIYLFIAGFGGSLFWAPSTTMVVDAAGPKFRGIasLFTLRNMSLILGISVFPIFVSAFSHVKSSSIIITAFGA---------------
     715 UniRef50_A7IJG9        Major facilitator superfami...   175     2e-42  1  10.9%  7:437   1:433     ------MTEPEVSAVERSAISKVSWRLTPFIGLMFFINFLDRTAVSFAGpgMSRDLGLTASQFGFAAGIFFLGYILLEVPSNLALHKFGARRWLARIMVTWGIVALLF---TWVSSVEGLYILRFLLGVAEAGFFPGAILYLSLWVPARHRNKVLALFYVAQPLTIVIGAPFASLLLGaaGWRIMFFGVAIPAILVGIVAWFYL----------VDRPADAKWLTTAEREWLTGELAKEEKAKAGKHNILASGALLNGRVWLLSFIYFGLIYGLYALAFFLPTIiaQFGTKFDVMQKGLITAIPYLPAAAALLLWSRHAAKTGVKPWHVGLPALIGALsaALFMNSPAATVAVITITACAIFSALPNFWAIPARFLsgAAAGIALINTVGNVAGFAAPFITGAVKDATGSFQVAMLVVGGFMMLSAVLTLVVSRQRD-
     716 UniRef50_B8GK17        Drug resistance transporter...   175     3e-42  1  10.8%  9:433   2:454     --------TTQPPSSSGTPAYTNRYIILIIVLTGILMAVIDGIVVSIALPTMTSYFGVDVAQSQWTITAYLITMTSLLLVFGKVSEYTGKVVLFIGGMAVFTVSSLACGLS---TSLMMLIGFRVVQAIGAAMVFSISGAILFTAFPVTERGRAMGYLGATVAVGSIAGPVVGGFLAGTLGWEYIFFINVPIGVVLLLAAARYLRVDEQrlTLGDLADGASLTTLPLALVFLLATGFFIRHERQAKNPLVELEIFQNPLFSLPMISMVLYFIANFMLGVIGPFYF-EGVMGMEPTQVGLVYLVMPTIMVFLSPLTGWLYDRHHSPHYATIGMAVVAGALFVAGYAslTLILLAFAGVGIGSAFFQSPNNTDLMSALPPQKMGLASSVTarNLGMALGVSIATILIsvFGNEDAVMGAPVSVLAAAVGIVAVIS-----
     717 UniRef50_O26207        Multidrug transporter homol...   175     3e-42  1  15.3% 23:433   6:442     ----------------------KRNRILLLLFVGVFMGALDIGIIGPALPAIEGYFKVDPRLASWTFISYILFFMVGTPLMAKLSDRYGRRDIYILDIILFALGSVIT---AISPSYPLLILGRSIQGFGAGGIFPVASAFIGDTFPPESRGKALGIIGSVFGFSSIAGPILAGFILP-YGWQWLFLINIPIAATIVVGGFLILPVTGKTDDGEFDARGTLLLAIIvlILAAALTPILWRVERAAPDPVVQVDLLASREVRIATAISAGNGLSQ-AAIVFIPSYAL-LALSLSESMASFSLLPFVTTMALSAPIVGVLLDRVGSRVVMISGSLILMVGCTIMALLSSTTPLfvLMALGLITVIGAPLRYIMLSETPphRASGQALINILSSAGQLVGGALIGGIVASMGSGVMGYRFSFLFLVAVAFTLFLLS-----
     718 UniRef50_Q2JDM0        Drug resistance transporter...   175     3e-42  1  11.7% 19:429  22:459     ------------------RLDPALIRLAGIVLVGAVVVQLDATITSVAINTLARSFNVGISTIQWVSTGYLLALAMVIPVTGWSAERFGAKRMWLLSLVLFLVGSALCGAA---WSAGSLIAFRIVQGLGGGLLLPLMQTIIAQAAGPERLGRLMAAVGVPALVTPVLGPVIGGLIVDDLDWRWIFFINVPVCLIGLVLAWLGMPDVRTPGRHRFDALGFALLSPGLAAIVYGFSVAGrhALRTAVEPIIDLRLFRSRAFAGSSGMMFLFGISLFGAMFLLPLY-EQQARGRSAAAAGLLLAPQGLGMMIALIVLGRVADRRSPRLFVLVGLLLSALGSVaaADTSEVLLGVSLTVRGIGLAMALIPVMSSAYHGLRREerATSAGRIFQQIGGSLGTAILAVVLSHQITGRPAGTGPADPVALAGAFG---------
     719 UniRef50_B4CWN5        Major facilitator superfami...   175     3e-42  1  12.3% 16:431   4:419     ---------------TPSGATHVRYALLGVATANAFLLYLDRICMTTVvpSFLRELHLSEADVGNVLSSFFFAYALGQLPAGWLADRFGPRRMLVAYIVLWSACTALTGLA---TSIAAIVIVRLACGLSEAGAYPASARVISRWFPFGHRARANSFVAFGGRLGLALAPWLTvvIARLNGWRPVLWIYGGIGLTLAAATFFTFRDEPALHPWTNEA-------------ERELIRSSGPPPSKPDYRFPWLELLCHRGLWLLSLGAIGLNFGWALLVTWLPKYL-QSVRGLDEEDANFSVTIVLACGVAGVLFGGWWCdrWGRRLPIIIGGLIGTAAYLVCPSLHSagVIIACGLVAFATDSANPAIWTLSQDIGRGHVAAtaWSNMWGNLGASaiPLALASTMHRADWSEVFWMCAASFLIFAGCALFI-------
     720 UniRef50_Q39AY6        Major facilitator superfami...   175     3e-42  1  13.4%  5:429   3:431     ----PTPAFDVQRWIDALPFSRFQLAIAVQCFAVVALDGLDTALIGFVVPALRSDWHAGTTGITLLLASGLVGLAVGAFFAGPLGDRLGRKRLLVGSVLSFGLFSTLCAVAPEIHSLTAL---RFLTGVGLGAAMPNAIAMTSEYSPRARRALIVTTMFCGFTFGSAAAGFIAAHVIPRYGWHAMFVIGGVLPIALGLVMLAALPESIRFLIHRRAPAAQVAAVLRRMSPDAPDsaDEPASVAARSPVSQLFARPLRFGTLALWCAFWMNLLIVYLVTNWLPSLFREA--GFDLAQAAIVTAMFQLGGTVGAILLGRAMDRFNAYVVLVAAYLAGALCVFLVAwdDLPSLCIGIFGIGFGVAGSQTGANALAADFYPtrVTGVSWALGVGRLGAIAGSFVGALVMASAMGLSGVFMLLIAPIVCAAVAI---------
     721 UniRef50_Q2T382        Drug resistance transporter...   175     3e-42  1  14.0% 21:427  73:505     --------------------RSAARHALATASAVCSLIVLDTNVVAVSLPSIARTFHASFADIEWVVSAYMTAFAACLLPAGGLADRAGRKRVLLAGLAVFFVASLGCGLA---PSAASLNVARAVKGVGAAMLLTSALAVIANRFpgRDRARAWAVWGMCMGIATTIAPLAGGAIAQWIGWRWIFLLNLPVCIALAAAVCATIDDSRDPHAKRIDAPGSVLFGSALALGIWALIDAPPHGWAAPGtpMIDLALFREPRFVGALLAMFGYAACAQVMMTFLPLYL-QIGFGMSAIAAGLGMLPFALAMIVGPSLGAALSARAPAATVLGCGLALIGIgaALAGASHDGLVALGMLVTGCGAGILNGDTQKAIMACVPPERTGMASGitTRFSAIVTSVGVLGAVLAARTHAALAERVAHAPELLGAL-----------
     722 UniRef50_A9WBL4        Drug resistance transporter...   175     3e-42  1  11.8% 23:404   5:412     ----------------------RKWWALAAVGTGVLVSTIDGSIVNIALNTLVQAFASNLNVVEWVVLGYLLTLVCTLLIMGRLGDMYGKRRMYLIGFALFTIASLLC---ATAPSIAALIGFRVLQGIGAAMIQAVGPALLVTAFPARERGMALGAIGSFVAAGILIGPALGGVLLQYVGWEAIFFVNLPIGVLGWWLTIRSipDHTTRPGQRFDLIGAVLMAVTLFCLLLGLTEGPLWGWgrHPQPMLQLRMFRRLAFSLNLLAALILFLGI-SFNLLLTPLFFQLVYQFDLQRTGLMLMALPIALSLTSPISGRLSDRFGPRVLTIVGLLVTGCALLGLSTTTPVtmLSFLILLGFGVGLFQSPNNSTVLGNAPPEALGVASGlvVRTVGQTGGIALAGAI----------------------------------
     723 UniRef50_C5BX54        Drug resistance transporter...   175     3e-42  1  10.3% 16:414  15:445     ---------------DSDAEHKQILRVLVGLLLALFVAMLSGTIVANALPVIIAELDGTQQQYTWVVTATLLASTAVTPLFGKLADLYDKKKLLLIGIGIFAVGSLLSGLS---TSAGMLIGFRVIQGVGLGALQALVQITIATIISPRQRGRYAGYMGAVMAFATVSGPLLGGLIVdwLGWRWCYWSAIPLALIAMVVLARRLHVPPprTEVKVDWLGATLISAAVTLLLLWVSFAGpwVESRVAEPIVPLWILRERTTTLAIVASIAVGVGMFGASVFLGQYF-QIARGYSPTEAGLLTIPMMLGLLVSSTVSGRFVTQIGrkPFVVWGLVTFTAGMGLLGstSLWLIGVFMLVAGIGLGASMQNLVLAVQNTVpdMGAATSSITFFRSLGGAMGVQVLGAVFASHVSSLTA------------------------
     724 UniRef50_C2LEN0        MFS family major facilitato...   175     3e-42  1  13.5% 23:407   6:414     ----------------------KRWIVLLLVSSMLFLIVVDVTVLYTALPRLTHDLNASASEKLWIMNAYPLIVAGLLPAAGMLTDRIGHKTLFISGLPLFAIASLC---AAYSPSATSLIISRGFLAIGAAMSMPATLSIVRQVFtpQERAVAIGIWSAVASGGAALGPLIGGLLLNHFWWGSVFLINVPIVLLVLPFSIWLIPHFSGQRQHKIDYLSSILILIGLVSAIYTLKelFARRQRRQTHPMIDFSLFKKRYFSVGVAMSTLSMVIIVGIEFLLSQRL-QLVAGFTPLNAALVILPIPIGSVLASPLAGFWLARLGAVRLIIIGFALTLMGNLWLIAISNSPIMLmlFLIGFGLGIIFTTASTSIMLSVDDKQAGMAASiiAYELGSVIGVTFMGSLMST-------------------------------
     725 UniRef50_D0XJ52        Drug resistance transporter...   175     3e-42  1  12.2% 13:413   2:428     ------------AAEPSSLSAGRKRWILAATVLGSALTFIDGSALGVALPAIQRDLGAGPAAAQWISNAYLLTLGALVLIGGAAGDRFGRKRVFLIGVVVFALASIACGLA---PTASLLIAGRALQGIGAALLTPGALALIGANFPERERGAAFGTWAGAGALFGMVGPLVGGWLADHADWRFIFWINVPLAALTVVVALKAVPESRDEQATGLDWPGAVLGISGLGALIWGLTaaFLWAEAKEAHPMMPLTLFRSRVFSGINALTLLLYFALSGAMFFLPFELIR-VHGWSATGAGSAMLPFAVVMGLFSGVAGRLADRFGAKLSLSVGPMLAGVGLALLALMSPDAGYvgMTVLAIGMTLAVGPLTAAVMGAVEPGHTGVASgnAVARIAGLLAIALLGVLLSAVFVAGV-------------------------
     726 UniRef50_Q13VP2        Major facilitator superfami...   175     4e-42  1  16.5%  6:430   1:427     -----MRTINLASLTADAKFNRFHLSILLWCALIIVMDGYDLAVAGIALPSIMQAMSIEPAHAGLMVSSALFGMLFGNLLFGTLGERIGRPKAIAICVFLFSAFTAA---AGLTNDPKTFALARFVAGLGIGGVMPNVIAQMTEYSPKRMRAMLVALMFSGYCVGGVLAAVLGKSLIEVHGWQSVFLLAAAP-IVLIPFILRSMPESVPFLIRRKDARALQQLAAKIDPTYTPHQDdgAEQAGATAPVRQLFQDGRTPSTVLFWLSCVMCLFMVYALSSWLTKLMASA--GYSIGSALTFVIVMNLGGILGAIAGGWLADRLHIKYVLASMYLIAAGSLAMLGqvSTSLRYVLIGLAGGTTIGTQIVGCAYVGQFYPnrATGLGWFLGVGRVGAIVAPIVIGALVGAELPLGLNFVAIGIPGLLAAILIF--------
     727 UniRef50_Q89HX4        Bll5865 protein n=1 Tax=Bra...   174     4e-42  1  12.1% 10:432  12:460     ---------DDGAGAPRASSRPATSLTLAAMSLGYGVVQLDVTIVNTALDAMGRTLGGGVAELQWVVSAYTIAFAAFILTAGALGDRIGAKRVFMAGFAIFTAASLAC---ASSPNAIVLIAARLVQGLAAAILVPNSLALLNHAydDRARGRAVAIWAAGASLALTAGPFVGGALITLVGWRAIFLVNLPIGLMGLWLSWRYATETTRAPSREIDLPGQLTAIGALGALAGAIIEgfVWRESRAAQPMLPLSLFGHRLFTLTALVGLLVNIAIYGLIFVLSLYF-QRINGLSAWWTGLAFVPMMAAVLPVNLLAPRLAERIGPCPTIVVGAFISALGCLGLIwtSYWMICAQMIAISGGLGLLVPPLTSTLLGSVEKARSGIAAgnATRQTGSVLGVALFGSLVASEGAFMTGLHASLVVSATVLLLAAAV------
     728 UniRef50_Q5IK41        Putative transmembrane tran...   174     4e-42  1  10.9% 14:407   1:424     -------------MSVARPLAGRRRPTFALLAMAQFVVVLDITIVNVALPSIQTSLRFSGESLTWVVDAYMLTFGGFLLLGGRAADLFGRRRMFLIGLTVFGLASMACGLAANS---GELVAARAVQGLGGALLSPASLSLVALTFqdAERNRAMGIWNAVAGAGGATGVVLGGALTDSLGWQWVFWVNVPLTLAGALIGLRLITEPSGRLAPRLREFDVFGSVAVTAGLSALILGLVQFGEhrVPTPLVHFEMFRSRSLSTANGMILVFTAGVVATNFFV-TLYAQQVLGYGSFEAGLSLLPLALGQILFSQLASRCLPRLGTLGVLLVGMGAAALGFGWFSLVSADGSFvpAVLVSVGGGFGFVALIVLAVSGVEPRRAGLAGgnMSQQVGGALGLAVLASLAAW-------------------------------
     729 UniRef50_Q2Y532        Conserved hypothetical memb...   174     4e-42  1  15.3% 23:435  37:492     ----------------------QQRIFISVLLLANFMGPLDGTIVIIALPSIAHDFNASTSMVAWVLIAFALIAASFKVMFGKLGDLKGLKTVFITGLVICTLGSFLC---SISWSLVTLIIFRIIQAIGAAMFTAITPGMVPTYLPGEIRGKVLGYASAARGLGLALGAPIGGFIAGYLSWHWIFLINVPIGIVAIYMGTKVVpePKKFPFDVAGAALIFFALLSLVFAINTGPQLGwvQEKRSPDPLMDLNLLHNRVFTLGTGAYFMMYLAFSGALFALPFYLK-LVKGVATHISGIYLMVPAVMIVIFGTFAGSLSDRVGSRGICSVSALGGCVAFFLLSmsSTSFILIAMALMGIAVGTFAGPMSSLIMGHSPAGKLGMASAIMTTGigSTLGVALFEAIFTQTggFHSAFLVGVVCCIIALVLSLVARDR---
     730 UniRef50_D1VLQ4        Drug resistance transporter...   174     5e-42  1  12.6%  6:433  21:483     -----SNRVPTTRAAEPAAQSPRRAWTLVLASLGVFMTALDTLVVANALPALRASLHADLGDLEWTVNAYNLAFAVALLTGAALGDRYGRKRTYWIGLLGFTVASAAAALSPSV---GVLIAARGVQGVAAAAVMPMTLTLISEAFPADRRGAAIGLWGGITGLAVALGPVVGGAIVGGISWHWIFWLNVPVGLALVPLSIARLRESFGPRSQLDIVGLLLAAAGFFGITWGLIrgAFLVWERRTATPMLSVQLFRSRAFNAANGVSFFMYASLFGVLFLMMQFL-QTGLGYSPLAAGLRTLPWTGAPMVVAPLAGALADRFGNRPFLIAGLALQAVGLGWIAAIAEpwLAVALAVAGVGISLCFPTVANAVVGSVPPAEMGVASGtaVREIGGVFGVAILASVFAGSghFATALWIGAAFSAVGILAAAAVP-----
     731 UniRef50_B5WPR0        Major facilitator superfami...   174     5e-42  1  14.5%  3:435   2:442     --TRSERSVDVQAFIDAQRFSPFQWTILVLCFLVVAADGFDTAAIGFIAPSLVQQWGIARSALGPVMSAALVGLGIGALAAGPCADRVGRKTVLVLSVFFFGLWSLA---AARATSIESLTLLRFFTGLGLGAAMPNAVTLMSEYAPARIRAVAVNAMFCGFSGGLAIGGVASAWLIPNFGWPSVLVAGGAGPLVLTVLLMLLLPESAQFLAVRKRADQRIARILQRIAPaaLDVRRNTGDSRAQWALAIILSARYRFGTLMLWLAYFMGLLIYYLLTNWLPTLFKDT--GFSGEKAALMTSLFPLGGILGNLCVGWVMDRFAGHRVIAFTYVLVGALVLLvgVSHQVWLGTLIFLTGTVATSAVTSMSALAASFYPTRArgVAWMLGIGRVGGVAGAFVGAALMGLGWQFAAVFSLLAVPAVIAAAGVLLMMRR---
     732 UniRef50_A9W2D5        Major facilitator superfami...   174     5e-42  1  11.8%  9:405 119:542     --------APYRADTAPRLSPAEIRSIIIGLVAAMLLAALDQTIVATAMPTIGLELG-DAANLPWIVTAYLLASTAVTPLYGKLSDIHGRRIMLLIAITTFSVGSLLC---ALAPTMIALALARGLQGIGGGGLIALSQIILADILSAKERARYQVYIAGVFALSSVAGPLLGGFFAQHLHWSAIFWINLPIGLAAFILtlRLLPRNERRHSVDYPGAALLVvvLGLAAFGLLSGGAFAARLATAGEPLIPLSVLRDRVVTSATLAACFAMGTLIGLSIYVPIFL-EGVIGLDPSRSGLAMVPLMVGTVVGATLSGRSMAYLRhkRLPLALLTLSVGACGLLAYMGPELPLwlFVLLSMGIGTVLPLSTIVVQNAVAPqgIATASMNFFRSLGGALIVAIFGTLV---------------------------------
     733 UniRef50_C7QFL2        Major facilitator superfami...   174     5e-42  1  12.7%  1:433   1:472     MSTASISTTPSTGKVVPKREPK-PGLILATIVTCQLMLVLDATIVNIALPKIQTSLKFSDANLSWVLNAYTLAFGGLLLLGGRAGDILGRRRMFVSGVILFTVASFIGGLAVDST---MLLASRALQGVGAAMAGPSMLALIITTFPEGarVKAMSLFTAVSSAGGSVGLLLGGMLTTWGSWRLVMYINVPIGAVAAIAAARLLNESPR-VQGKFDIPGAITSVTGMGSLVYGFINASEHgeSRVDFPVFPLRLLRDSTRARSYGSYVLLVGAMFSMFFFLPQFM-QEVLAYSPMKAGLAFLPLTATLFAVSRFIPKLLPRFGPRPLIVTGTALIAGALFWLSQVSIHtlLAPFLMFGLGGGIAFSPIALNIMNGLAPRDSGAGSGlaCQQIGGALGIAVLVTIFTstHGLGTGLTVGAGIAVAVCLISLTLK-----
     734 UniRef50_C0ZVM1        Putative drug resistance ef...   174     5e-42  1   9.6%  9:434   2:453     --------SDETKNAAPVSDSSVQALALTAVCLGFFMILLDGSALNIALPAIERDIGGSIAALQWLVNIYTIPLASLLLTAGVLADRVGSRSVFLWSLGGFTAASLLC---AISPNLLSLAAFRCLQGIAAAGLLPTTLAIIARTYppIARAKAITIWGATGGIALVAGPIGGGVLTEFIGWRSIFFVNVPIGVIALWLCWRHVRETATRDAESYDVPGQVLGIAGLALLVAGLIEGGSRgeGRTRHPVLPLSIFRKPAFSASIANGFAFQFGAYGMQLMLA-IFIQSYWGSSALRTGLFFLPFAVLWTFGTLVLNRVWAGRGMCWLLTVGASTAAIGALLCTAitWPVVMAGTALVGLGCGVFGPSCNGAAMAVIDKSFAGLASgnTSRQTGMAIGVAALGIALSASNSVGGARIGMIFVAACFVAIVALSRR----
     735 UniRef50_D1NUM5        Squalene-hopene cyclase n=1...   174     5e-42  1  11.8% 26:407   9:417     -------------------------LVFIALALAVFVGSLSETIAATALPTIVGDLG-GVEIMQWVSTMYILTSTIVMPFYGRMGDRIGRKHLIMVAMALYAIGKVIC---AIAPNMALLLTGRAVSGLGGGGVIILSQAILADIVSARARGKYMGAIGAVFAVSTVLGPVIGGWVVQDFGWRMVFWCTIPLDIIAITMTGLFLRKDAHKASGNSIDMWGIImiLGLFFISLLCAIAFVWIERRAQEPVIPVRLFKNRNFVLVTVTGMLVYGAVAGATNYLPTFL-QIVEDKSPTIAGLMMTPMMAGSLITSTVTGFLASITGKYKWMPIAMGAVMTFGFVMLstPAILLMTYFFLIGFGQGLGSQILVLIVQNEFPHTIVGTATanFFRQIGTTLGTAIVGSVFTS-------------------------------
     736 UniRef50_D2AW82        EmrB/QacA family drug resis...   174     6e-42  1  14.5% 21:406   9:421     --------------------RRLPYLAVFGLLLGMFLAMLDGLIVGTALPTIVGDLG-GLDRLPWVVTAYMLAGAATTPIWGKLGDLYGRKATFITAIALFQVGSLL---AGVSQDMSQLIAFRAVQGLGAGGLMVGALAIIGVLVPPRHSGRLQSMIGVIMPIAYIGGPLVGGLLTDHLSWRWTFYVNLPLGAVALLIIATRIHLPPAERVRARIDYGGAALLTTAIVTLTLLAGwfVAVERRTAEPIIPPRLFHDRNFTLAQILSFLVGAVMLSVTNYLPQYM-QFVQGASPAASGMLLLPLMFGMLGAQLLTGHLISGNGRYRVYPILGGALMIAGALALltAPVTASALSLVIGAGMGLVMQSTTLITMNSADPRDMGAASGTVtrTIGGSLGIALLGSLYA--------------------------------
     737 UniRef50_B2TDI1        Major facilitator superfami...   174     6e-42  1  16.3%  9:437   2:442     --------SAVAARLERLPLSGFHRKLLLIGGLGYLFDGLDSSSLAFLLPVVSKLWHLSSAETGLVASSTYIGYFFGAFLSGVFADLIGRRRIMMTALAIYCVASLASAAATDWHTF---FALRIVAGFGSGAETVVIAPFLAEFVPRRYRGMFCGALVGFMSFGYLSSSILGFVVVRNygWRYLAVVTSLP-VVMLLWWRRTLPESPRWlrIVSTIESWFAGRGIHLPPVGSVGVLPASARASGSALQNVLTLWsaRTTAVSWLMWFSVAFAYYSFFSWIPSLLLKE--GLTMTKSFGYSIAIYGAQIPGYFSAAWLNERIGRKAVVASYMLLGGIAAIALAFSHTGiiMIAGICLSFFMNGAFAGVYAYTPEVFPtrTTGTGSSSSFGRIGSVSAPILVGLIYPVLGFLGVFAMTTTVLLIGACVVFFLGIETRN-
     738 UniRef50_A4QIB3        Putative uncharacterized pr...   174     6e-42  1  12.8%  8:438  12:448     -------PEQILAEVRSNKMSKFQIVTVTIALLMVVLDGFEVGIMAFAAPQIQEQLGISPDILGYVLSGSLFGMAIGSIFLTPLADRFGRRPLTLAMLTLIVVGMALTL---TAPTALWLIVWRIVTGLGIGGMMANLNALVAEYSSDKRRTTAIAIYAAGYPIGATVAGFIARPLIPQYGWHSMFIAGTILAVVALIGAFALLPESLDYLLGRRPNRalGKMNVAPLDALPERTNTEEDRVSTKNTIREVLSPPTLRLTMALWLGYALLVAAYYFANTWIPTILTNVSG--DPQLGTTMGIGANLGGVLGCFVFAALAIRFSGRHLLFITLFAAAAAYIIFGMVFSIIPVAImfVLGVLTTGAIAGFYAVAPTIYsaRATGIGWMIGIGRLVSVAAPIIVGYILAAGAEPEKVFLYFSIPLIIAGVAALTLLLGRTK
     739 UniRef50_D0XMY5        Major facilitator superfami...   174     6e-42  1  13.9%  4:435   2:430     ---TDATAKTDGPIQIQPPAGKYRWVVVWLLFAAMVINYVDRQALGVLKPTLMDEFGWTETNYADIVFWFQASYAISYLLWGRLVDKIGARWGFGLAFIIWQIA---FIAHAGIRSLNTAIFARIALGIGEGGGFPAGIKAVTEWFPKKERAFAVGIFNAGTNIGAIITPLIIPFIASIwnWQMALIIVGVAGFIWVPIWFAVYKRPGEHSR-----------------VTPAELNWIAQDAPDPVHKIGWLKLLMVRETWAYALGKFLIDPIWWFFLFWLPGFLQKT-YDLNILTFGPPLIAIYLLSDVGSVGGGWLSSQfaRKLTMLICAIAVLPVAFAGMAANLWVAVLIIGIATAAHQGFSANLYAMPGDVFPRSAVGSVVGIGGMIGGFGGMAMaaGYVLDQIGSYTPIFVVAASAYLVALLVIHILSPK---
     740 UniRef50_A9A927        Major facilitator superfami...   174     6e-42  1  11.7% 26:408   7:410     -------------------------IVAVVAAISSFLTPFMGTALNLALPSIGTEFSADAILLGWLVTSFLLASSALLLPVGRIADIIGRKRILLNGLLIFGVSSLIGIFSG---SINHLILLRIIQGIASSMIFGTAIAILTSVYPLNERGKALGINIATVYIGLSLGPFLGGILTHYFGWRSIFLFSGIIGILTYIIAKKFVLNEWCDafLVYGFITFSSGGSMFILVSLLFGSIFIHREYRTKNPILNIKLLtnLAFSMSNLAALLNYGATYAV-AFLISFYLQSLRGFSAQDAGLILLAQPLVQAIFSPITGKLSDKIEPRILASLGMGITCVGLILFTftSIYQIVLNLMLLGFGFAVFSSPNTNAIMSSVERKFAGVASAmtVRILGQMTSMAIITVLIAFY------------------------------
     741 UniRef50_C7TLV6        Transporter, major facilita...   174     7e-42  1  11.1% 22:435   6:395     ---------------------SYRKKILVSSMLGLGLEGMDILLLSFALSSIINEFHISSAAGGVLPSVTNIGMLVGGVIFGYWADKKGRIKIFTYTIFIFAIATLLM---AFARSIGEIYILRFVVGLGAGGEYGIGMALVAEAFPKERRGQMSSWITVGGQMGTLIAALIAATVIPLAGWRAAFIFGVIPVFLAYFVRRHLPETKSWQLAHKSGAEKSDHPRISLLFNQPKIAL----------------------ITVGLTIMSAIQVAGYYGLMNWLPSLLEKQ-QGLSVSGSSLWMISTIIGMSLGMLSFGKLFDKFGSRLTYSVFLIMSGMSVTLYAFVHSalMLIIGAIVGFFANGMNAGYGALISSFYPTEIRSLaaIFNTGRAIGGLSPILIGYIIDEKG-FSVALLVLGSFYLISLVIVNLIPNP---
     742 UniRef50_D0J374        Major facilitator superfami...   174     7e-42  1  15.0% 14:433   5:430     -------------QTPPPAVSWRTHLSLALLALVYIFSFIDRQVLSILLEPVKQEFGASDTEMGLLTgaFGLIYAMLGVPVGRLADTRNRRNIVALCCGIWSLATAACGVATQ---YWHMLLARMSVAVGEAGGMAPSVSIVSDLYPPKMRSFAISLFMMGPNLGTLLGLVIGGMVAQHYGWRSVFLAFGIPGVILALLVYFFVKEPARGAY-------------------ESIKPTAQDSAPRESMFRQLRRLLGMASLRYICIACGVAGIAGYGYGVWAPSFFMRIHGMSISHAGLVFGLASGLGAVFGAMFCGWLSDRLTQrrLAAMGTFCAVPAGVAVFFWpvPYAMAFALLFGFFASWFATLSYSAVSQMVTAAERSVASalFMTLLGVGLGPLVTGILSDYfgLRWALMGVTSLLVITSLFFALAIR-----
     743 UniRef50_Q0SCE4        Aromatic acid transporter, ...   174     7e-42  1  16.0%  9:438  28:452     --------SDQSATGQREGAGTSARVVLLLCLLAVVFEGYDMVAYGTTLPSMLAdwNLTPARAGVIGSYALVGMLVGSILVGGIADRLGRRTLMITATGWF---SAWMGVCAIAPDATLFGVARFFVGVGVGALIPLAAAMAVEFSPKGKNHTYSAIVWAGFPGGGVLASLLGLVVVDAFGVRAMYWIGLVPLLVFVPIMLKLLPESPSFLLARGRVDEANRIADRAGIDRPEPPRPGEKVGPRALFTRELR-----RATLLFGLLSACGLLLTYALNTWLPKLMQSSGFGSS--SALTFLLVLNAGAIIVPLFASRLSDRIGPQAVTAASLASAAVAILVLStvSSWLLFALAFVAGAGTIGAQVLIYGFAASYFParAAGTAWVASVGRLGGVTGPTLTGLVIANGSNVAPAFYLFALIAVIGAIAALLVPRQRNN
     744 UniRef50_A9FCA0        Permease of the major facil...   174     7e-42  1  12.3% 43:407  28:411     ------------------------------------------TVVATAMPTVIGDLG-GIHQYAWVTTAYLLTSSVLVPICGKLSDIYGRKPIMLFGIAVFLLGSIASGAA---QTMPQLIAFRALQGAGAGAMQPMAMTISGDIFDLEERARIQGVFGAAWGLFGIIGPMVGGLIVHYFSWRWVFYVNVPFGVASVALVASSFHERIDRRPHELDFLGAALLSAGVVALLLATGraFFAVERRASEPMIPLPLFRRPVMLISNVAGAILGGAMVGTITFVPLFVQGVLRG-TPTDAGSAIAPMLIGWPVASAIGGRLIPRVGFRPLIWIGLGVTAAAGLALALgtPLMLRATTLFFGVGMGLSNVALLIAVQSSvdQRGIATASTMFSRLLGGVVAVGIMGGVLTA-------------------------------
     745 UniRef50_A3P675        Major facilitator family tr...   174     7e-42  1  12.9%  4:437   9:442     ---ASSARQETTVFTWFAAVSPRERRTFWACFGGWALDALDMQMFSLVIPAIVAEWSLSRTQAGFVGGATLVASALGGWVAGMLSDRFGRVRTLQWTIACFSVGTFAC---AFATSYPQFVTLKTLQGIGFGGEWAAGAVLMAETIRAEHRGKAMGAVQSAWALGWGSAVLLYALAFSLLPAELAWRAMFAIGLLPALLIVYVRRGIAEPSARALNPSGPCDPPEPPNSPDGAPPSGASPAVRASAPLVGIFSRGTRRMTLIGALLGVGAHGGYYALMTWLPTYLKTERH-LSVLGTGGYLAVIIVAFFCGCLASAQLLDRIGRRGTILAFAACCVGTVILYLFApnAAMLALGFALGFFAAGIPASMGALFNEMYPRGTRGTGVGFcfGRVASAGFPVLVGHMSAGMPLGTAIGIGAAVAYSIVVVAVLMLPETRG-
     746 UniRef50_Q13LS7        Major facilitator superfami...   174     8e-42  1  10.4% 11:435   2:414     ----------DTAYDTQRIGKSRWLRVGLIVFVSYLVAFADRTNIGVAAPQMAHDLQLGTTITGALLGAFFWGYLVTQIPGGWISTRIGPRRVIAVSMFITGLMACLTG---MVHTLPALIAVRVVMGLAEGVIWPSFSVIFVRWFPARERARGIAFAQYALPLSSVLMAPLAGWMIDVFHWKTMFVLQGLPAIFMAVLVWMFVSDDPATDRWLSSAERDFI---------------TQQRLAGTGADGSFGSVLKRSTVWLLAVVALSWIMVIFSFGLWMPSLIKQYFPH-GFAAVGWLTALPSLFGALSMFVNSWLSDkiSRGWFVAVPLVVGGAALLayLEGGVVFTMVMFCIAGAGLFSPAGTWWAWVISKVPRNQAavAMINMFASFGGVVGPLIVGFYARGGNLSNSFYILGYFLFGAAAVIALLIHRT---
     747 UniRef50_Q98GA1        Transmembrane efflux protei...   174     9e-42  1  12.7% 20:413  23:446     -------------------PQSQRRFVLIAAILASALGFIDGSILAIAMPAIRVNLGASLAEAQWISNAYALTLSALILAGGAAGDRFGLRRAFVAGIALFIVASLAC---ALAPNAVVLIGFRALQGIGAAIMVPGSLAIIAKAYPKKERGRAIGIWAAASALTTALGPVLGGLVLSVFgwRAIFAVNLPLGLISIYLLLVKIPADAATEKRSLDLGGGALATLAFGALAYGLTSMSSSseQRQREPMIDLSLFRIGAFAGANVATFFLYFALSANLFYLPMLLI-AGWGLSTAEVGFIFLPLSTSIALLSGPAGQLSDRIGPRFPIACGSLIVAFAFAGLALLswTGILPLMALMGLGMALVVSPLSTAIMTAVEDKDTGAASgnAVSRIGGLIAVAAMGSLATWVYATML-------------------------
     748 UniRef50_B5WAA9        Major facilitator superfami...   174     9e-42  1  15.2% 20:433   3:405     -------------------SAAQRRYILFLLFTVSVFNYVDRTILSILQIPIKKELGLTDAQLGMLTgaFAIFYAVLGVPIGRLADYWQRRRLVAGALTVWTGFTALTGIA---TSFGALLGFRIGVAVGEAGSIPASHSIISDLYPPNKRATAIAIFGLSLPVGILLGYSSAGWLVTNVGWREAFSVIGLCGLIVVPFMWF-----------------------ANEPKRGTFDPVEVARAPAPSTGEALKILWSKRAYRWLVLAGGFHAWAWYSVNSWNAMFYVRVHQVPLSTVSYYLALVNGIGSAIGIYAGARLADYFgpRVVAISQFIMVPIAIVQYLVPSHAVSMVLGAITMTMMLVYYGPIVAVAHQMMPANIRGFTSglVVSLIGLGLGPLVTGILSdaYGVQGLGYAICVTVCASLVSALMFWR-----
     749 UniRef50_Q83MR8        MFS family transporter (D-g...   174     9e-42  1  11.0% 23:432   8:421     ----------------------YRYWVLIVLSLVTFTNYLDRATVSVAVDEIKAEFNMNDIQMGFLLSQFVWGIVIVIPLIAYLLQRFGARSVGGYGVLGFSLMTL---FTPFSTGFYSFAFFRLGLGAFEAPTFPVNSFFARKWFPRRDRAKAVSAYMAASFAGLAFAVPVLTWILGVftWRAVFVFGGIVGIVVSIIWFLSIRSDDPSKSRFVSKEEL-------EYIQSDSPDAKDNKVKARASFRDWVAVLTHRRLVGLYIGAFSTSTIVFFFISWFPNYLKSNLGFDLKSGALYLSSAPYIAGIFGMLFAGWLSDRlaRKVTVTVGLTGSIPLLFIPIMGGApwVLFSLVIVVFFFAGMANTAWLLASEIATPRLLgtGVYGFWVNLFGASSPLVVGFILQFTgnYGAVFTYLGIAALIGVIAYVFV------
     750 UniRef50_B5ZHM1        Drug resistance transporter...   174     9e-42  1  12.6% 10:431   2:449     ---------TDLSPHPALRSDLRPGLVLATCCLSLLLVMMDVTIVNVALPSIRAALGGRFSTLQWVVDAYTLVVATLLVLAGSTADRIGRRRVFVTGIAIFCLGSALCGLAPSAR---ALVMARAFQGLGGAMLNPVALSIIANVftPVARARAIGMWGGMSGLALALGPLAGGVLTTLAGWRAVFWVNLPIGLVAMVLSLRFIPESRAARVRPIDVPAQVlaIQATLALAAMGMVALVVVERRRAQPLLDLRFFRALPFTGAILIAIC-AFAIFSSFLFLNTLYLQDVRGLSALRAGLYTLPFAMGVMACAPLSGRIVGAHGARLPLLLSALGLGGGAILlaTTPPAVLLAAYGLCGCGFGLCNAPITNAAVSGMPRDQAGLAAAltSRQIGALLGIAASGAMTASVMSAPVQPAPLSSAGAVVAYMALL-------
     751 UniRef50_B1ZCR3        Major facilitator superfami...   173     9e-42  1  13.7%  1:432   1:434     MSAIPSSPAETgpRDEDTRWTRLQAFAVGTCFVLNMLDGMDILMMSYLAPAITSDWNIGVAALGVVFSAALAGMMVGALVLAPLADQFGRRPVILWSVALMGVSMIGCGFALGITT---LIILRFIVGLGIGAILASMAAITSEYAPARHRVVSVALLQAGYPIGAMLAGLAVNALLPDLGWRVLMSAAGVATLILLPFAVMLLPESLEFLEKRQPRQALARiaIRRKMGRPPLPTLSEAGERKPVSLNLLFDDGQWKQTILLWSAFFCCYMTLYFAIAWIPRLAIEA--GLDRSQAIVAGTVYNLGAFSGGLALCWLLFKFDVRRLVLLMMLGGSASLMAFAamSVTLTLVVAFCIGFTVQGGFNGLYPLVAGAYPAQVRSTGIgiGIGRSGAVIGPLIAGWLLAAQQPLSIVFLVFTVPLISVGLLVMAV------
     752 UniRef50_A8G7T8        Major facilitator superfami...   173     1e-41  1  11.6% 14:436   1:428     -------------MTTALTDSRYRYRIFAMVFFIALINYVDRGALSFAANDISREFNFNKAQLGAVLGYFGFGYLFGSLCGGFLADRVGTKKVWLIAGALWSLLEIATAWAggGSAIMGFAALRIMFGFAEGPAYALMNKTIANWAPRKERGFSLGIGLLSTQVGSLlaPLAVGLLLLTDDWRSMFMLLGLFSLIAILLFARFFTDTPEEHPEVNAVELAAISA--------------DQDADSQQPRLPWWAFFTNRTLVFNALGYFSFLYVTFVLVTWGPKYL-QDTFNYDLHSLWYVAMIPWSGACFTVLLGGRIAdrLARNLFAAITLLLTATCFLLIPFMSTPTEIILLMTLgaLNALVNNVYWSVVIDVTPKASVGagMTLAIANIASITAPMLSGWLAQHHGYGAMFFATAVVSFCSMLCMTLLQPERK--
     753 UniRef50_A5EJG8        Putative hydroxybenzoate tr...   173     1e-41  1  12.1%  4:432   2:438     ---SSTAVIDVSDVIEHQRRNALVLKVVTLSTIMMCLDGYDLHAMAFAAPSLIRSWGIDKATLGIVFSAGVFGILVGGLIFGYLGDRIGRRLSIVAATVTFGGFSLLT---AWAGDLNMLIALRFLAGIGIGGLAPLCFSLNLEYVPSRYRGTVVAIIMLGYVAGGSAGGLIAAWLVPHLGWPIVFWIGGVLPLLAAIVSFFSLPESIKFLVAQGRQPDEVARIVNRIAPGLNAQprEDEPTPAGSGPFARLTALFDGRLalLWVAYIASSMTMFFLNSWTPIL--AEASGYSPAQAAFGLSMFSLGGSVGALLAGWALDRFGVLAIAAVPMIAclVASLGFAGFSDAGFLTAMMCVGFFVVGGHQGLNSAVGQFYPsrATAVGWALSVAKIGSIGGPLIAGLLIARHLPASSLFVLAALPPLVMACCVVSL------
     754 UniRef50_A7HWL2        Major facilitator superfami...   173     1e-41  1  13.6%  9:435  17:455     --------PAKEEAEKPYPKAIYGWYVVGILVLAYTFSFIDRQILSLLVGPIKRDLAISDTQMSLLQgaFAAFYCVAGLPIGRLVDRYHRVNIIALGVFVWSLMTALCG---TARSFLMLFVFRAGVGVGEAALSPAAYSIIADYFPPKRLGFALGVYGMGVYIGAGLALIIGAAVIALVswQITFLVVGLPGILVA-LWVWTLREPVRRGHVRQETGADGISRRVEVPVKEVFEYMGKN----------------WRTIVPLNLCYALSAMMAYGVAAWIPTLFVRTHGWTYPEAGFWYGLVIVIFGTTGVIAGGWTGdrNGRMMVCAFTGLAAFPFSIAYPLvdPWIALLLLCPSTFFATFTTGAGPSALQELMPNQMRGFAsiFVVTIIGLGLGPTSIALVTDYVYGDEAMlvVPAIVLTLAIVAGFLGLKP---
     755 UniRef50_P42670        Puromycin resistance protei...   173     1e-41  1  10.3%  1:437   1:486     MARKPDISAVPVESAACQGPDPRRWWGLVVILAAQLLVVLDGTVVNIALPSVQRDLGMSDTSRQWVITAYTLAFGGLLLLGGRVADAFGRRRIFAVGILGFGLASLLGGAA---PDPGTLFLARALQGVFAAALAPAALALINTLFtpGERGKAFGVYGAVSGGGAAVGLLAGGLLTEYLDWRWCLYVNAPVALLALLGCRLLPRDRRTGRAVRLDLPGTLLGCGGLVAIVYAFAEAESgvERRVQDPLLPPGVVAHRVRGGSFLVVGLPQIGLFGLFLFL-TYYLQGILDYSPVLTGVAFLPLGLGIAVgsLIAARLLPRTRPRTLIVGALLAAAAGMALLTRLEPDtlLPAQILIGLGIGCMMMPAMHTATARVAPhgAAAAVVNSAQQVGGALGVALlaYLADHghGYTVAIAFAVGVLLLTAVLAWVLIDSRT-
     756 UniRef50_B1Z5T7        Major facilitator superfami...   173     1e-41  1  12.9% 23:418   2:423     ----------------------KKWIVLFSIGICLLLANLDMTIVNLALPEFSTEFGASMQQIQLIIVSYLTAAAAFFCLFGKLADSVGRKRVFIFGALLFTVASLYIG--AFSGTVTEIIVARFIQGTGFAATLGLALVLIANAFPADQKGFATGVAVTITGVGMALGPPTGGFILQYLGWRWIFLMNVPLGLLSIALTWMFVTDDAADERRPLAltVATVTLAAIAAAGLAAAAIFIRRSLRKPAPLINVALLTNRGYLTVILIRMIFNYTMASFLFVLPLFM-QNILDYSKLKSGMWLLCMTIAVAFIAPLAGKVIDRVGFRIPTLVSMSLLFVSCAAFCLLGPDTSSAIFVVGLFCFGVSNGMLTTATINGVTtaGTAIGLFFTLVMVGSMLGVSVAGLVLDRVSHAEVAARIA--------------------
     757 UniRef50_A5G198        Major facilitator superfami...   173     1e-41  1  11.1% 20:405   4:416     -------------------THRQRLQVISGIILCILLAAIDQTVVIPAVPAMAAGLH-GFSHLSWVVTAYLLTSTATTPLYGRLSDQFGRRQTLIPSIALFVLASCVC---ATAETLPWLIAGRALQGVGGGGLMAIAQAAIADVVSPRERGKYQAYMAGTWGVASTAGPVVGGWVTDHLSWQWIFWFNVPLGLAALVLSQIGLRQLRTVARGGRIdpWLSAPVIGIFAAGFALIAALWRWEARAAVPLLPMRLFGSASFVRLVGIGFLTALAMFSAIFLLPLFF-QLVYRANAAQSGWDIMPFMIASTIGAYAAGQVARRTGrrKLLIGGLVVGTAGFVLLGLLPRATPLGLvfVMGLGIGFVLPSNLVAVQNAATRhgAATATLLLLRAMGGAFGATIAGAVL---------------------------------
     758 UniRef50_Q01ZA5        Major facilitator superfami...   173     1e-41  1  16.1% 17:432   9:404     ----------------RTSLSGKEWRVLILLVISAFINYIDRTTLSVAATDIQRELGLTNTQLGSLQSAFFATYALSQlaAGWVVGRFHVGWVLAGGFFLWSGATGLTGLAG---TFTVIFTLRLLLGIGESVSYPSYSRILASEYPEHHRGFANALIDAGTKLGPALGILIGGLLVSQVGWRIFFFVLGGGSLLWLVPWSMWMP-----------------------------QGKAVASREDGSDVPTIAAILLQRSAWFTAFGLFCSNYYWYFLITWLPAYLEKERH-FPKAKMAIFGWFPFVAISVSCVISGWLSDRlvRKTFAGLGLTGATFLIPVVLVKDANISMALLTLACLFFGIYTSNLFAISQTLAGPAAAgtSFQNGFGNLAGVLAPTLTGLVVDRTGEFYWAFVVAAGFALAGACMFVFG------
     759 UniRef50_D1X1Q6        Major facilitator superfami...   173     1e-41  1  12.5%  8:416   4:439     -------TTTAGVRLRKAADGANRWVVLVVLCLSLLVVALDATVLHVAVPAVTEDLRPSGTALLWIVDAYPLVCASLLILFGTLGDRIGRRRVLLLGYALFGVASAL---AATADTPAVLIAARALLGVGGAMIMPATLSILRQVFprRERALAIGVWTAVAAVGAATGPVVGGFLVEHFWWGSVFLINIPLMAVILPLGRRLLPESRGGDDGPWDVLGALTAAAGVLGVVLGVKRLGGGaqRRRRHPLIDVSMFARPAFSTAVGCIVLAMLALVGLQLIAVQYL-QLVLGLSPLETGLRLLPLTFAAMAAGATGSYTLRLVGPRRMVGWGFVLTAASVLLLTSMgpALLTCAFVLLGFGLQTTLFGAYESMLSDAPPERAGGAAAitSYQLGAGLGIALLGSVMNAAYAPGLVGL----------------------
     760 UniRef50_C6BBI6        Major facilitator superfami...   173     1e-41  1   9.1%  9:438  19:479     --------TAAPAHLQPDLSRWRRNATLGILTSGVFMAVLDTTVVNVALIAMRDSLHGSVAELAWIVDAYTLAFAAFILTGGLLSDRIGARTVFMAGMAVFIVASAGCGVA---PSVATLIAARILQGVGAAMFLPSSLSLIRSTfdPRERAWAIGLWGAIVATAAAVGPAVGGVLVDTYGWRSAFLINVPLGVVGMLGTWMIVRNDQPARAKPFDWAGQVTSAVMLAALCFAAIEWPVraERRARAPLVPLAWLGHRTLGAVNGVGFLLNFGYYGALFVLSLHL-QNVEHLSARQTGLVMLPMAISLSAGNIFAGKLMAHFSMPTMMLSGLVIGASGLllTGQVHPWVVSAAMVAYGGGTALAIAPMTSTILSAAPGELAGTASgnAARQTGSLLGVAAAGAVveLAHASPMVFGLMTLSYAGAMAMAWISRRPAAT
     761 UniRef50_B1ZP72        Major facilitator superfami...   172     2e-41  1  14.8% 10:415   2:424     ---------NPSPASTVASPGRFRWAICALLFFSVALNYIDRNIIGILKGPLSKELGWSETDYAHIASAFQFAYAFGYLFGGRLMDWIGVKRGLPFAVLLWSLAAGAHGLCSLLptVFGFMAARIALGLAEGGNFPGAIKTVAEWFPVKERALATGLFNAGTNIGAILCPFAVPRLYAAWGWPATFYVTGALGLVWLVAWLWIYENPEKHPRLSAAEREYI--------------RSGQPATAEKKVSVPWLSLLGYRAVWAYIAASILAGPVWNIYMFFLPDFLQKNFQ-LDLVAVGDWTAVFYFIASFGGVAGGWLSGrlARKLTLLCCALAVVPIFLAPSMPNVLLTVLIVGLAGSAHQGWSANLFSFVSDTMPKAasVVGLGGFVAYFTGGVMTEVIGLILQKTGSYASIF-----------------------
     762 UniRef50_A6WYS1        Major facilitator superfami...   172     2e-41  1  15.0%  3:435  11:455     --ATSPAIKQMENALGNIGVTTAHKQILALILIGCLFDSFEQNTIGLVGPILREQWGLSGADIGFLNTITFASAAIGRLLSGILGDRYGRRVMLTINLLLFTVGSALC---ALAPSFGWLCLARAIVGFGVGGEISTAVTMLAEFCSPKFRGTAAGLVNVggGFGNFLAPAFGLLVFTLfnWRWLFAVLAIPAFLV-VFFRRYVPETPRFLagKIDEANKVLSILASGSLRPKNLKVTeeDSDTKPVKGNWRELFQAprTVPVAIAILMSYGAQLSVLTLMPMIFVS--MGYTLSGSLLYSMIIQSGSVLGAIAASAFGYYFPRKKVLSLGAVCACAAALSIIYLGTNIYLVLFflFQFFVLLLNTSIWIYAPELYPTRIrgVALILASGSAAGSFVPTIAGALFDTYG-MLGVFGLAASMYAIFAFCIQLGPET---
     763 UniRef50_C7TM01        Transporter, major facilita...   172     2e-41  1  12.6%  9:438  22:475     --------ETDAAITQSQRMSATQIIILGLALIGAFLGVLDTSIVYTGTVKMAAQLHLNAGALSWVQVAYALTYAGLMLVGGKLGDIYGRKPLFIASLAIFGVGSLAVGAA---TNALVMISFRAVQGVGAAILAPNCLALLTDTFQGKARQRAIGYYASVIGAGAAVGLVIGGFFATFASWRVGFYMNGPIALIMVGIAARYLPSAKRQTGKIDWIGTILSVLAmtLLISAVLWVAFIASQGRVAHPTMPLEIFTDRERMASYVSSLLFSAAAIGFWFYTPQFM-QGVLGLTPFMTALGMVPMAILLFIVAVKARTFVDRWRNSKVMIFGFVTVLLSLAELafANYWFLLLGTLGFAVGFALAFATLATSGLARIRPEISGAASgnTARQFGGALGLAIFAaiADVFGQAMLIGVGMTIVGLILVVTLIIPAEKAAK
     764 UniRef50_C6D0V6        Major facilitator superfami...   172     2e-41  1  12.5% 20:436   1:453     -------------------MNTRNRWLMIAVGLGILLNPLNSSMISVAMARLQTEYKLDFTGVSWIIFSFYIASAVAQPVMGRASDLFGRRNIFLYGLVIAFLASLL---APLSPSFGWLIVFRIIQSIGTSMMVAVGMAIVRIYITDKQAA-ALSVLSIFLSGAAAIGPFVGGVLIHWWDWPAIFFVNIPFAIASYLLAWRTIPKdiRKWLDLIDASGILLfvVIGLIGLLSLGAFVRHELKAKSPFIPLRTIAQYPAMTWVNVQFILVNILFYSLFFGLPSYL-QIVRHVSEFHTGMLMLSLGLCSLAASPLAGKWIDKSGPRPALFVSAILMVFGSVWIVtsPVISVCIALAAFGISNGLNSVGMQTALFDSSPKEIIGVASgnTSRYLGTIISSLLTGIVMGGEFSFTGFRILGIILTVIALTLVLMSWRRA--
     765 UniRef50_B4VDL0        Drug resistance transporter...   172     2e-41  1  13.0%  8:414   6:439     -------SVSTLTAQEQDRLDPALVRLGAVLVLGAVLAQLDTTIVGVGMGAMADGLGTTVTTVQWVSTGYLLTVAFAAPLSGWLHKRYGGKRVWLGSVALFIAASALCGLA---WSGPSLIAFRLLQGIGGGLMQPVGQALVARHAGPRRIGRLIGVIAVPVSVAPILGPVVGGLIVQGAGWRWLFLVNVPVGVFALLLAARIVPAdvRPDVLGLTLLPTGLAALVYGLAQPGTGGWDPVRarTTRTPLLDLRLFAGRGFTLAGINTFLLGAALYSSMMLLPLYFTQVR-GMDPLHAGLLLAPQALGSAVITPLAGRLTDRHGPRNVVLAGIGLTVLGTVPFVLtpEALLIAALFLRGVGLGAVVPPNVAATYTSVDRSqaATSARTVLNRVGGSVGTAVLAVILQNALAGGAG------------------------
     766 UniRef50_C5BXV1        Major facilitator superfami...   172     2e-41  1  12.6%  3:438   8:421     --AVPATETSQTPPAAARRSDWRWLRYAFLFFLGWVMMYADRSILSPVQDTVREQFGVSNATIGLLSSVFFVVYVATQIPSGILGDRVGRIRLIFVGFVIFGIATALTGVAGILHVFGMLVLMRAFAGFGEGLYYGPQYAKSGEETPLRFRALGAAIINSGQGIGTAVGILAATFITYtlEWGWTFVLFGGITLVVGLLIRTLIPDSRP----------------------------SRPPGPLRGELGRFGTLLRNRVLLGTFVMLFCGVYAFFVMVTWLPTFLAHE-WGMEPEAAGQLSSVAFWVAVPAGLLVGHLSDRIRARRPFVVVLvlTILAILTMAFTGQHAVLVAAIAMYGAVgaLDPVLISVVADNITNEMRSTAYgnCIGMAAAIVAPYVTGALVDVTGSFQAAFLLSSVLLAIGASVFLLTFRERAT
     767 UniRef50_B8KG86        Major facilitator superfami...   172     2e-41  1  13.3%  7:435   1:430     ------MSISYQESLNKSKITSAHLLLLLTCFCLNMVDGYDVLSIAFAAPPLATEWDLQAKTLGLLMSAGVFGMTLGAIFLAPLTDTLGRRKMVLAAVSVMGCSMIL---SSRANGLTELIALRVLTGLGTGAMLASLTALISEFFPTRHRDLAIGVTLAGYPIGATLGGFLAAKIISIYSWQGVFMAGGIATLLLVPVILAYLPESVHFLMRRRPHEFLATavLGRLGLPATTFTADTGEAIARASVRSLLSPSRRNMTLWLWSGFFLTFGTLYFLLSWIPKLLVDS--GVELSIAIYASSFFNLAGALGNVGMGAASSRLGLGKSILGFAVLSAFFMLVFAMSSLETSAilAALIGFFQQGALVGFYILSAQVYPprATGIGWGIGLGRFGAVIAPYMGGVLVTRGLELSSLFIVYALPLAAAGIIGLGICRR---
     768 UniRef50_A1TY99        Drug resistance transporter...   172     2e-41  1  11.1%  4:407   2:431     ---TSAPRPDSIEGLFARFGPSYRWLVTATVMMGTIATILTATIVNVALPDIMGAFGMGQDKAQLLSTGFLAAMTGTMLLNAWMVDTLGQRATFMLAITIFIAASIMGGLA---PAEGVLILARVLQGGAAGILQPLAMQTIFQVFPPEKRGSAMGIYGIGVVLAPALGPTLGGIMVDSFSWRYVFFMAVPFCFIGLFMAAILMprATSGPPRKFDWIGFGLMTVFLVTLLNGLSNGQRDgeLRTSAPMLNLKLFTNRVYAGASVVAFIFGAGIFG-STFLIPLFVQTIQGYTPTRSGLLLMPAGLILALVFPIAGRLTDRTPAYATVMFGLVIFALSSFLMsnTSFWLFAWWIMLGRIGLGFIMPSLNAGALKALPMtsQGSGAINFVRQLGGAFGVNLLSIALER-------------------------------
     769 UniRef50_A4JQI5        Major facilitator superfami...   172     2e-41  1  10.4%  7:418  36:446     ------REPSMSESSSAFLYRRVALRVLPFLFVCYVVNFIDRVNIGFAKLQFLQDLGLSEAAFGAATAIFFISYAAFEVPSNLVLARIGASRTLMRIMVLWGLCTIAQMFATGSVS---LYVVRFLLGAAEAGFFPGLILYLSYWFPDAVRARVNSVLLLAVPVAGMIGGPLSGWIMAHlgWQWLFLIEGLPAIALGLIAPLMLSDRPEQAAWLSAADRHALS---------RDLQAERAAAVVGHDGAGVLDVLRNGRVLGLAAIYFCVYVGMGAVTFWSPSVLKAS-GVATVSGVGWLSGLISVFTMIGNVAIAWSSDRHGERRWHTVACMLVTACSLlfAAGHVWMTVTLLAVAQLCAFTVPIVFWTIPAAQLTGraAGIAAISMLGSLGGAFSSWLVGVLFTRTGAPYAGLAVV--------------------
     770 UniRef50_Q13GK0        Major facilitator superfami...   172     2e-41  1  10.6% 15:437   1:426     --------------MERIPPGRWFRKLRLTMGMATFFDAFDSLAIAAALPALSAIWHLKPTDMGVLISVGYAGQLLGALVLGRLAEARGRTNAALISVAIFTLFSALC---ALAPSYTWLCACRFLQGVGLGGEVPIAAAYINEFSRAKGRGRSFVLYEASFTLGLVFSSLVGAWIVPQMGWRVLLALGAVPAVIILWARRSLPESPRWLAEHGRLAEADEVVSRIERSVEEEGKTLPPPAKAVPRPAMARTRILTRTSLVRswAMWFACYFLSYGVGTWAPTIL-RTALHLPLQQALLFSFVLQTLYLCGTLGTAVLVDRLGRKIYFRVAFAGVSIALFCamAGNEIALMALIAGAFVFNAAISVTLYLYTPEIYPtrAKGSAFATSFARLASITSPLAIGAIMQHAEFSQIFLMLGLVALVIGGSGALFVTETRN-
     771 UniRef50_C2AIU9        Drug resistance transporter...   172     2e-41  1  11.7% 13:414   2:430     ------------SASSGALSAPKRWISLATVCIAVLMTGMDNSIVTIALPTLSNEFGGGMSALQWIVDSYTLVFAGLLLATGYFGDRIGRRKVLVAGLVCFIVISVL---ATRSTSLAQLITARAALGAAAALIFPATLAIISVLFPEkeRTKAIAVWSAAAGASIAIGPVVGGYLVEHFAWSSVFWINVPISVIAIIGCLTLVPESFGSERPSFDLFGVLLSISGITLLVWALIEafVVYERRQANPVLDVTLFRSRGFAMGSFAICAGFFCLLGFVFITIMYF-QAVLGYGPLETAVRVIPFALVAVAVTPLAALANTERRMRFAISTGLAIMAAGFVFTSRLtlTQILPSMSVIAVGLGLLQGPATTSVMTSVPSGEAGAGSAvtTREVGGALGVAILGSVVAHLYSARVA------------------------
     772 UniRef50_A8M7T9        Major facilitator superfami...   172     2e-41  1  13.8% 11:431   2:461     ----------SRSRAPTGTGPTQRWHILNVALVVSFISLFDLSVITVMLPSIDRALGVGNGAVQWVVSGYSLMFALALVPAGRLGDAKGRRYVLLLGLALFVGAS---TMAGLADSGTTLVVARLLHGAAAGVLVPQITALVEELFRPGERGRPFGVLGATTSVATAVGPVLGGLIIAVggWRLVFLINVPVGMVTAVLIWRLFPTKPVDSQADHRPDLIGTLLLGAGILLVILPALQRERWtrRHPPVFDFRLLTHRTYRLGLLLGFLYYAGFTSLPVIF-SFHLQYGLHRSPLHTGLTIAPFAIGSAIGALLGGRNVDRYGRPLLAIGLAIVMASLTMMMALTGLHGtaFPLLLAGIGSGLVITPNNTLTLQQVPRADAGSAAGmtMRQVGSAIGLAMITATLLAagRWPTALRYALAVEVGIVAAALL-------
     773 UniRef50_C7T9R7        Putative transporter protei...   172     2e-41  1  15.1% 15:432   4:398     --------------TQSAVKTHRGTITFIMVYIGYIICFIDRSAISIALSYIGQDLHLSTATLGVVASAFFFSYAFMQIPGGWLTDKFGTYRTIIVAITMWSLFTILTGFA---WSLASLIIIRILFGIGEGTYPSASLKQISETMPYNKRASATSATISSNYVGAAIAPVVIAPVIAYAGWRTAFHLMGLLGIVFIVVYAIILR--------------------------PRKQARLKASGHATQKRVPWKTVLTNGVLWQFFLIVFGLSSVTKGLDSWMPTYLLAARH-INLAGISWLVPLPSLAAGAGSLISGYIMARfkEKLFIGVASLLATGLMFGMYKSTALPAVIIfiLTYFCKSIAFAGTFALFAELVSKKasSVGIVNFGGQLSGFLAPIIIGILVqsGGSYATAFLFLVFTAGVAFIAALTL------
     774 UniRef50_A4FJ82        Transport protein, MFS supe...   172     2e-41  1  10.9%  6:436   2:427     -----SSPAEPDARLVASGAAKFFRRILPMLVLMLVINQMDRTNVGFIKEHVQVDIGVGAAAFGLGAGLFFVGYALFEVPSNMLLERVGARMWLTRIMISWGLVTVA---SAFVQNEVQFALARFLLGVCEAGFFPGVIYYFTKWLPDAYRGRANAVFLGGSATAYIVTGPISGALLEMhgWRWMFFFEGVVSVVVGALAIFVLRSRVEDAPWLTPEEKSALSAAVR----------RDAEARRSAGTVSRWRLLLDVRIVLLTIVFFAIGLTTAAITFWLPSLVGQ-IEGTSDFAVGLLSAIPWLFAVAAMYVLAKRTDGAprRPYLAGALVLSAVGAFLATVGGPWFGLVALVAAAIGVKCASTMFWPLVPQTLDVraGGIALINSLGNLAGFFAPSLLGYIEESTGSTDLALYVFAAASLVVLCALPGLRRVR--
     775 UniRef50_Q1IX11        Major facilitator superfami...   172     2e-41  1  14.6% 11:407   2:427     ----------TAAPSSAGLAPRDKILAFVGILTVLFLSSLNMTVVGSAMPRVISDLG-GFHLYAWAFTAYSLATTITVPIVGTVSDRYGRRPLILLGIVVFTLGSVLLGF---VQNMNQLIVLRALQGVGGGMLMAMSFTAIADLFTPIERGRYQGYTGAVWGISSVVGPLVGGFLTDHLGWRSVFFVNVPFALLALYFVGRFFRMPAPSASRMQRPFDALGaiLGLLAATLVLGGGYVWHSRQQAQPILNLRLLRDPAISLASLAGFLTSAGMYAAILYLPLYM-QGVRGSSASGSGLALTPLMFGLIVTSTLSGQIVSRTGRYKGLIMGgaALLLSTTLSTTTPLWIAVGLMVLLGLGLGPVNSQLTLAVQNAAPRegSATSGNQFFRQIGGTLAVSLFGALVNA-------------------------------
     776 UniRef50_C4U256        Major facilitator superfami...   172     2e-41  1  13.4% 16:434   9:422     ---------------EDAIIKKVTMKVVPLMIMLYVIAYIDRQNIGFAKLQMIDSLGLSETAFGLGASLFFIGYLIFEVPSNIFLHKIGPRIWFARIMGTWGIITLLLSFT---TNTTVFYILRFLIGAAEAGLYPGLLYYMTQWFPLKSRPKVVGYLIMASLMANLIGAPLNGALLSLngWQWIFIGTGIPAILFIIPVLLFLPEKPETAKFLSEKEKSWLLNVL----------QQERDSHQDHNVSGVLKALTDVRVLLLALVLGFISFGAYGLSYWMPTIVK--GFGVTNMNNGLINMIPWLMAILWLWWLTRKAERtsPVWNIALPMFIAAIFLTASAwaNPYVSFFAITIVVMAIFSIQPCFWNLtfLGSSAAAAGLAAINSLANLGGFFSQNAVPAVRDLTGSTGAPMYFLGGCMAIGGVVTLLVIR----
     777 UniRef50_C8SVC7        Drug resistance transporter...   172     2e-41  1  11.8%  2:407   5:440     -SKAAAVPLTSPVTNGTFCPQSQRRYVLIAAILASALGFIDGSILAIAMPAIRVDLGASLAEAQWISNAYALTLSALILAGGAAGDRFGLRRAFVAGIALFVATSLAC---ALAPNAVVLIAFRALQGIGAAIMVPGSLAIIAKAYPKKERGRAIGIWAAASALTTALGPVLGGLVLSAFgwRAIFAVNLPLGLISIYLLLVKIPADAPTEKRSLDLGGGALATLAFGALAYGLTSMSSSgeQRQREPMIDLSLFRIGAFAGANVATFFLYFALSANLFYLPMLLI-AGWRLSTAEVGFIFLPLSASIALLSGPVGQLSDRIGPRFPIACGSLIVAVAFAGLALLawAGIFPLMALMGLGMALVVSPLSTAIMTAVEDKDTGAASgnAVSRIGGLIAVAAMGSLAAW-------------------------------
     778 UniRef50_B2T6S7        Major facilitator superfami...   172     3e-41  1  13.0% 20:433   6:394     -------------------SRAQKTAVIAGLFLAWAVGYADRILMSVALVPISKEFMLTAQEGGMLLSAFYFSYAIMQLAGGWLSDKFGSRIVVVACVVMWSIFT---GVTSLGWSFASLLVIRFMFGLGEGSFSPASSVTVAEVFPKKQRARAKSFLVSTTFLGSAVGSAIIAASVTKLGWRGAFDILSVVGFAVAVILWFSLRGDKR----------------------------ARQKTDVERPRVAWKPVLQSPLAWKLTAVWFFTSALHVGVNSWMPTYLMTSYH-ISLKHAGLALVVPNLIAFAGANTVGFFLDKLDKrgCLVAGSALSTVFLVLMITTTqwLLLTYWTLFSLSFNLVYATVFATPLRRVPEQLIgsGLMNFGGQLANSIFPAIMGALITAagAFFSAFYLLIGVGVLSVVAALVFK-----
     779 UniRef50_D1VAQ8        Major facilitator superfami...   172     3e-41  1  11.5%  3:420  11:451     --ATVAGGNAGADQPVAGCWSRRDWSVLLITCVGLFVTQLDLTVVNVAVGAIGRRLHASTGAVTWVVDGYFVTFAAFMIGFGDVGDLFGRRRVFLAGLAG---FAAASTGCAAAPGVGWLILFRTLQGVAGAAILVSSLAILADAFDGTDRTRAIGVWSAVAGIALVVGPLVGGLVVDGLGWRWIFWINVPISLVSIAAGRRVLRESRRGGHDRQLDRGGQILAVLMLGALAwlAAGFVAVERRCATPLVPLSVFRSRTFRGANLASLLVNFATLGLLYLLSLDF-EHVDGRSATATGIRIAPLFAAYAAVSMLAGRIADRFGQRVPGTLGGLAAGTGVALVAvaSGAAAGAGLVLAGVGIGLALPAVVSSAVTAVPGARAGLGSgnTARQIGGTLGIALLGGVVAGAGSERAGIGRALI------------------
     780 UniRef50_Q15RP6        Major facilitator superfami...   172     3e-41  1  12.4%  1:435   1:428     MTVNTSESPVVQQEDFNQVSKPYRTYVLTILTLVYAFNFIDRQIIGILSPFIKADLGLNDAQLGWLKGLYFAvyTVVGIPIAWLADRYSRVNIVAISLTLWSGFTALSGMA---TTYTQLAIARIGVGIGEAGGSPPSHSILSDLYPKEKRAGALAIYSLGIPFGIMLAFFASAFILKGGdwRLVMLSVGIPGVLLAILLKLTIKEPPRGGNLHSA-------------------------AAKTPSWQSIKVLLTIPSWWGMCIAISLASFGSYAISTWMMDFYLRAYPNLDLTSLLivGIINGTAYAFGVWFGGAITDKWGkgWVPALGLLVGVPAYIYSvvTDLNTSLILLTVLLFTSGFYLGPSFALAQTLAPVKVRAMSTALFfnIIALGGGPTFIGILSKSLtaLRLSLSAVSVPYVLAIVAFIWTARK---
     781 UniRef50_B5FN05        Putative permease n=30 Tax=...   172     3e-41  1  11.0% 13:432   2:415     ------------SMALTAPPTRKRFLIVACLFIGIFIAYLDRVNVSVLAapFLAYMGIepLQIGMMMTVFLAAYGIANVVLSPLGDYLGPRKAMMLCILIWTIA---LMIGGVATSFALIIICRILLGIGEGFYYPLQSVFIKNWFPKQERGRANAAWIVGQSVAPAIAMPFFTWWIGTHGWRSNFFLCAALGLIPLWLLWRYVADKPEQHKSISEQELAYI----------KAGQETESAGSSESFMLRVKPVITNYSYWLLVLWYLCLQCLYWGMITWLPTYLKSAR-GFSWAEMGWLASLPFVLSIFAKAAAGVFVDKIGRSalMVLMFFAGVSIYFGTITEHKYMSAVLLSFAVAFCTMGTPVAWTLLQGMIPGksAASGVMNGVANGLSSLSPVFIGLFISITGTYTGGLLCLVFISAIAVVSALIL------
     782 UniRef50_C6XP65        Major facilitator superfami...   172     3e-41  1  13.6% 10:436   6:434     ---------DPRIEIANRPMSRLQIFVIFLCIALNAMDGFDVLAISFAAPGIADEWGINKTVLGIVLSMELIGMAIGSIVLGNIADKLGRRPVILVCLLMMAIGMFL---SAAANSVLFLSIVRLVTGFGIGGMLSSTSAMVAEYSNEKRRSLATILNIAGYAMGAIIGGVIAtlLAISGDWRSVFIFGGAVTAVLLPVVALFLPESIHSQ-LARRPPNTLAKINKTLVRMKWKPVEDLVEPDPRIDRPSILALFSKRYIVvlTVAYFAQIMAFYFIQKWTPKIVVD--LGFDPASAGQVLVFANVGSLTGAIVLGLISSKVNLKFAVIVSMISAFVCFGLFGMGHSSLMGLSIFAAacFTNAGVVGMYPILAQSFParASGTGFVIGLGRGGAALGPIIAGSLFQAGNSLQVVSLVMGSGALLAALMIFTLFRRK--
     783 UniRef50_B2TE19        Major facilitator superfami...   172     3e-41  1  12.4% 10:435  50:518     ---------AAPSADNARPRFERQGLALAVLFVGAFLAPLDYFIVNLALPSIHTGLNATDAQLQLVVSAYASAYAVLLITGGRLGDLFGRRRMFMTGMAAFVVASALCGFA---TSGHMLVISRIVQGIAAAVMAPQVLATIRAVVPLHQQTKVMSLYGFVFGLSSIVGQLGGGALITylDWRIIFLINIPIGIAAFVGTWKFVPENQPATRTGIDVKGVavMFALAVPAFALFVTTEQRVERGGGHPLVDLQLFRNRAFALGLVLAFLFYCNSAFFLTYG--IFLQTGLHWTPLASGMAIMPFAIGFVVGPLTSPAVVKRIGGHVLTLGFSMMTVGFTVTGwaTPDLLFYCGLVCAGVGHGLLLPSIMRIVLLEVVPEKAGLASGVVSsqIGSAFGTAAISGAfdYAHAFQISLAINAALMFVCIGLSVLLVRH---
     784 UniRef50_C7PWN9        Drug resistance transporter...   172     3e-41  1  14.4%  6:408   1:428     -----MEISDVGGEPAAGAGRNGQSGVLFAMCLSLVLVVASVSALNLALPNLAVELGATNSALTWIADGYTVALAALVLPLGALGDRIGRRKVLIAGNLVFGTAAV---FAAYSPTTSDLIVSRVVMGIGAAMIMPGTLSTITAVFPPEKKDRGVAIWSGFAAAGAIIGMLVAGGLLERFSWTSIFWASSATAVVCAVAAWALAPETRSSERQRFDYGGSVTTAVAIGALVYGIVEGNESGWTRprHPLLDPRLFKLRGFRAGTLAILTQFMAVFGFFFVGLQFL-QLILSYSPLKSAIALVPVAAVVLPTSVLTPRLAERLGVRTVMPAGLLCLAGGMFWLTMLhyLVFLGALVLAGVGIGLTSSTGTSAIVESLGPDSQGVASAmtTREVGSAVGIALMGSVFSSH------------------------------
     785 UniRef50_B0LJ21        Lct38 n=3 Tax=Streptomyces ...   172     3e-41  1  13.0% 23:406   2:410     ----------------------RKWLPLVAVCLGSFMLIVDTTVVTVALPEIGTGLDASLSSLQWVMNIYTLVLAALTLSAGSVGDLLGRRRVYLLSLAVFAGASLLC---ALSPNPEMLIAARGLQGIGGAAMFVTSMALLGTTYEGKDRGAAMGVWSAVIGVAAAVGPIFGGLLTQSMSWRAIFYVNIPISLVTMLLTKVCFTESRQPGGARIDFPGIITFALASGALTYGLIRafVVVEQRHPSPMLDISLMRNPSFLAIMLSTIASAWGFSSLVF--TSLWLQSVVGLTPIKAGLALLPLAAATFAASTLTGKRLHDVSPRVTITAALVLIGAGCAVNGFvsWVAALPGLLVIGVGVGVGMPATGSAVFASVPPQRAGMGSgaTFRQLGQALGVAVLGLVFA--------------------------------
     786 UniRef50_C7LZ38        Drug resistance transporter...   172     3e-41  1  12.3%  7:420   1:438     ------MATRTDDASYHSSVTDHPQLALAVIMAGVLIAAVDTTIVVLALPEIQRALHVALSSVIWVVIGYLLTITLLATQVGKLGDLFGRVRMYEAGFVVFVVGSALC---ALSWNEAAIIGFRVLQGVGGALVSANSGAVIADIFPPHRRGRAYGFNAVGWSLGAVLGIVLGGVIVTYVSWRWIFWINVPIGIVAVALATRVLHNEATSRHHRFDIGGMLTLGAGIFGLLWAVTQLATRpeLRHPEPMVNLRIFRIPTMTPSLLAATFQALGNYAVLFLVIMYLQGPRGLSALDASLLLVPGYLLGGVVG-PFAGRLADRVGPVIPATVGLAVQVIALFVYAQLSNDVTLALVVVagIGGSSFFPANNSAVMKAAPPEVFGIASGmtFSNIGMVFSFSVAILSAARSIPRGLAFAIFVG------------------
     787 UniRef50_B8HGP9        Major facilitator superfami...   172     3e-41  1  11.3%  6:438   1:442     -----MMHSNAANRLDRLPISRLHKITLIAVSFAYFFEFADINSFATTVPKLVKLWGVTINQIAYVTSLSFVGMFFGSLIASWLADRWGRKKALAITTVWFSVFSFA---AVFSWDIISLGVFRVLTSAGLAAMTVVAVIYVNEIFPAAVRGKYQAYAIVIGICGTPATNLLASWVVPLSDWSWRLVYLWGAMGIVFLLFSRHLKESPRwaLLTQMEAQVTAEKGALPEPAPAPAAAAATKSKPKASYKLLLQKKYLGPTILLTVLWVTQTIGFFGYSSWAPTLLAQE--GFSVSDSIFYVALTTVGAPLGSYLASLVTDRFERKwlVVFGTTIAVCGLFYGLTFNPVLIVVFGFLVNLFERGYTALAYAYSPEVFDTAGrgTGVSYGLGRLSNAAGPLIIAGLYTGSGYQSVFYFIAGTWLFGAVVLAIFGPKTRPK
     788 UniRef50_Q1ASB8        Drug resistance transporter...   172     3e-41  1  12.9% 14:438  12:481     -------------TSPRTGGAGRGWVVLSAVSVGTFMATLNTSIVNISLPVIAGDFGVGVSEVEWVVISYLLATGTLLLTFGRLGEVAGYRRVYLAGLAVFAAAGALCGLSGGLGSMVLL---RALQGVGAAAVQAVGPAIVTAAFPPSRLGRALGVNAMSVSFGLALGPTLGGLVAEWLSWRWIFFLNLPLGLVGLPWSWRVLPRCGRGEGQRFDPAGALLAGGMLLCLLLALAEGGGWGwlRSPQPLFDLRLFAIRAFSAGNASLLVTFVALLSATFLMP-FFLQRGQGLSALQAGLLMTPLSLTTLVVSPFSGALSDRIGSRLLASSGLACAALGLLLlaGSGGLDVVWRLVVIGFGMGLFNSPNQSSILGSVPRLRLGTASGMimRITGQMLGVAASSAILAslSIHDAFYFAAAVCVLGVAASLVRGRRPGAK
     789 UniRef50_A6C0I7        Drug resistance transporter...   172     3e-41  1  12.3% 17:406   5:417     ----------------PPPIPAHTWKIAAVTGAGAFMAMLDSTVANLAIESIRSDLESTLTLVQWVATGYLCALAVSLPTVGWLGKRFGYGRTWAGSLFAFVITSALC---ALAPGPLSLIVARVLQGLAGGIMVPTGQAIIGATAGKKELGRIMGLLGLVVALGPAIGPAVGGVLLEAASWRWLFWINVPLGIITLLAARGLVPAGEIDRNQFLdaSGVTVYTLGAMLLGVILAIAFTLHALRRKNPLIDLRLLRNRTFSLATLTTGLTGANMYGALLLLPLYF-QVALEQSISQTGFWLLIMGLASALALPFGGTLTDRYGAGRISLAGALLLLLSSLPFLYssTSVLFLALAMRGAGIALAQMPAMTAAYTAVTAEQMgaTLVNITQRIGGAVGAICIVILLQ--------------------------------
     790 UniRef50_P94422        Uncharacterized MFS-type tr...   171     4e-41  1  14.1% 23:406  11:419     ----------------------NRSVIVGILLAGAFVAILNQTLLITALPHIMRDFNVDANQAQWLTTSFMLTNGILIPITAFLIEKFTSRALLITAMSIFTAGTVV---GAFAPNFPVLLTARIIQAAGAGIMMPLMQTVFLTIFPIEKRGQAMGMVGLVISFAPAIGPTLSGWAVEAFSWRSLFYIILPFAVIDLILASILMKNVTTLRKTQIDILSVILSTFGFGGLLYGFSSVGSYGWSSSTVLISLlrVFTFGVFSLTTLLGTLVFALLIGTETILPLY-TQNVRDVTAFDTGLMLLPGAVVMGFMSPIIGRIFDRVGGRGLAIAGFCIIFLTSLPFMQLTDHTSLAWIVVLylGTAMIMMPVTTAGINALPRHlhGTAMNNTIRQVGGSIGTALLVSVMS--------------------------------
     791 UniRef50_B2TEG7        Drug resistance transporter...   171     4e-41  1  11.1% 14:408   3:424     -------------PTATALPFRNALFAMLGIGLVNMLVALDQTVVSTALPSIVAELH-GFEYYAWIASAYLLASVVTVPVFGRLGDYFGRKRFVIAAVITFTVASVLCGVA---NDMLFLVIARGLQGVGGGMMVGTAFASIPDLFppRARVRWQVVMAAAYGIGTAAGPSLGGWMSEHWGWRSTFLINLPVGAAALYFIWAHLPAFRRPHEGDVKIDWLGAALVAAVLGGLQAFIEAVPkeKRATHPIIPLDLFRDPQLVTLFTLGMLSGFVMFSLIFFAPLLL-QGGFGLSPQQAGLLATPIAACIALGSLLNTRIVIHmkPTQILSIGFALLLFAAIALAftPHVWIELPMAAVGIGLGFILNNLNVFGQEIAGRERFgtALLQSTRMVGGMLGTSIVATVVQHH------------------------------
     792 UniRef50_A3ZVB6        D-galactonate transporter n...   171     4e-41  1  15.2% 27:434  11:398     --------------------------LLTLMVIAIGVNYIDRGSLSIVKTDVAAEFELSSVQMGWLFSAFFWSYALSQVATGWLVDRFDVKWLYAGGFLVWSLATVSM---AMSGSFAIFLLLRLVLGVGESIAYPATSRMIVMNFPERRRGIANALIDAATKLGPMLALLFGGLLVANSGWRSLFVVVGLGGLLWLPAWLWLVPS----------------------------QQKPTIDAPKARTNVPFSELFKRQEVWGTSLGFFCLGYTWAFLLSWLPAYLEESRH-FSKESMALFGSLPFAAMAVTSLCGGWLADRwaRKVFLIGGLVLCSVFMFASVLTPDPRaiLLLCLACASLGFYTSNVWAVTQTLAGPNAAgtGLQNAIGNIGGAISPALTGWLVQETGSYYSAFAAASVMLVVGVFAYVGLVR----
     793 UniRef50_A4JJ60        Major facilitator superfami...   171     4e-41  1  16.0% 14:433   1:396     -------------MIDPNKSRRASFAVFALLYLGYCISYIDRSAIALSLVAIGKEFHVGSAALGVVMSTFYISYAAMQIPGGWIADRWGSKKVIVVSVAFWSLFTLMTGLA---WSLASLIAIRFIFGLGEGGYPGAAVKGVTESVARADRPKMSALLMSSNYVGSFIAPLAIAPLILLLGWRHAFFVAGCAGLVFALFYLFAVKD--------------------------THQKRDSNGRAARIDGDATRALLKMPLMWKILLTWFGMGIVNKGLDAWMPAYLLTERH-LDLKAVGMLTPLPFVAASISTALGGWILTRwrEKWLMAACCAISGFFLYQMYTAQTVTGVIAysIVYFFKSFVFAGVFALPAKFLPTngTGAGMVNFGGQVAGFVAPAIIGLLVSATGNYDAVFGFLIVATAFALVTSLSIR-----
     794 UniRef50_Q033T6        Permease of the major facil...   171     4e-41  1  13.2% 15:414   1:424     --------------MQRSETAPKRWWLLVALGFFAFMTNLDGSIVNIAVPIMAKDLKVPASQMEWTVSLYLIVLSALLLPFGKLGDRIGKQRIFKWGTGTFVLGSLM---AGINLGFNFLMLARMIQALGGAMTLANTYGIVTSTFALAERGRTMGVVSTFVALGGVAGPSLGGLILAHFSWPMIFLINVPIGLIALGVSLWSMNNGIPQRGTYDGWGMILQATAIalALAVVALIAFIVFEQRQQAPLLPLRIFRVRIFTLGVVTVFFIFMVQFFSTVLMPFYLEDAR-GLTPGTAGTLLSLYPLMMVFFAPFGGWLADKWNVPAVALLGSIFIAVGSLIGAtaPLTIYIISTLLVGIGSGLFQSPIGDVVMSVVPKNQLGIAGSFnaRNLGMVSGTAVATTVLFGTMSQLAG------------------------
     795 UniRef50_B5IWQ4        Transporter, major facilita...   171     4e-41  1  14.1% 13:438   2:424     ------------EVIENSRFGKFHYRLLAVLGTIWAFIAINTLSVAFIIPLLKKefQGSLTKLGAMGSAALWGMLLGAWFFGILADYIGRKKSLSLAVATFGIASVV---SSFVQSLDQLIVLRFIVGLGLGGSLPVASSYFAEFMPKKIRGAMISILESFWAIGTIIIGIVA--LIVKADWRGILLFGG--AIILALPFLATLPESPRFLLLNGKIREAEEIIRRIFGVSVKLEMPKKEHRKITIAELWRKHA---KTTFMLTVAWFSIAFAYYGFFIWLPKFLAST-LNITVFKSFQYFIITALAQLPGYWSAAYFIEKVGRKKTLSGYLFVSGLAGLLfsSGNAPMILLSAVLFSFFNLGAWGAIYAYTPELYPtrGTGTGWAGAMARIGGGLAPIVAGRVMEISTVGMAVLIIAIISIIGALDIAVLGKETKGK
     796 UniRef50_A1TIH3        Major facilitator superfami...   171     4e-41  1  14.4%  5:413   2:415     ----TPSMAAGIPAADRAAFGPLQLRVTLLCAIVAMLDGFDTQSIAYVAPRIAEDWGLKASEFGPIFAAGLFGLMAGAFLLSPAADRWGRKKVILLSTCIFGLFALLT---AWATSMNELLAYRFITGVGLGAAMPNIIALTSEYAPQRLRATLVTVMFCGFPLGSTLGGLISSWLIAHFDWHSVFVLGGVLPLLLLPVLALLLPESLRYLAASGAAPAriARSAYPGEDPATVMAGLRGEAAGVQGGFSVFELFRHGrtVLLWLAFFLNLLVMYFLVNWLPTLLKSA--GLPLEKAILSTAMLNLGGVVGALVLGRLIDRFSAYTVLGAAYAASAGFIALIAFSglTGLLAGAALSGFGVVGAQIGCNALAAAIYPThaTGVGWALGVGRIGAIVGPLAGGSLLAAAWTPSS-------------------------
     797 UniRef50_B8IVL0        Major facilitator superfami...   171     4e-41  1  12.0%  9:433  13:429     --------PETHERQLASAIRKNTWRLVPILGLAYLFNYLDRTSVGFAALQMNQAIGLTAAQFGWGAGILFFSYCLLEVPSNIAMYRFGARLWLARIMITWGLAAAATAFAVGPMSF---YVIRFLLGVFEAGFFPGVIWYISIWFPARYRTQVLALFMASTPLSSLLGSPISAAllGLGGWQWMFLIEGLPACLLGLACLWLLADTPKDATWLTEGERAALI-------------AELAADKHEKPKKDLWAAMKDIRVLMLTGITFAFTIGSYGIGIWLPLILKN--HGLSTMQIGWVTAIPYLFATIGMLAWARLVDAAGRKilMTALICGALGLALSVVFSSLIPAVACLTLALIGTISARTVFYTIPqlTGAAAAGGLAFINSVGAFGGFVGPYLVGFLKDATGSFDAGMLGMAAILFASTLLAWSLK-----
     798 UniRef50_D0LNK3        Drug resistance transporter...   171     5e-41  1  14.5%  6:405   2:426     -----SPNGDSVPASGAKVLGRYPYKVMGVALLGTYLIAINTTVLGVALPAMARDFGIHGSGADWIINAYLVALAVSMPATGWLMERLGRRRAFILALSVFTVGALMSTLATEVST---LLAGRALQGLGGGPLMPLAVSSIYELFPVEQRGTVLGIWGVAVAAAPAVGPPLGGWLVTEASWRWIFAFLCAGGVIGIVAAQRALRDLIAPRRVPLDVKGWLAVtlALGALFVGASALFVRWSLRSSAPVLDVRVFGERTFSITMLLLAFFALGQYTRLNFLPIEL-QVVRGMSALEVGMLLTPAAVAVAVAMPLGGRLSDRYGPRLPVVAGMALLALTMSGLAftPTWIIVALLVGQGFGAGCTFSPVQVTAMTAVHSRLNAQAAALtnRQISAAVGTAIMGALL---------------------------------
     799 UniRef50_C7Q6V9        Drug resistance transporter...   171     5e-41  1  13.7% 12:435   2:460     -----------AASPAARGGRPNRGVLLAVTCLGQFMVLLDNTIVGAALPDMQRRLHTQLTGLQWIVDAYVLVVAMLLLSGGVFADRFGRKRVYLAGVAVFTAASLMCSFA---PTVGWLISGRVLQGVGAAALSPASLAILAAAYppQERIKAIGLWAGLSGIGLAAGPVAGGVLVDAFGWSAIFLVNVPIGVVLLLVGLRTLAETRNPNAPAIDVPGTALSVLGvfGAAAILLAAFVAVEARRSVPMLPLRLFRQRLFTVSNTAMVVVGFALMGSSFFFSQFFV-YVQGSSILRAGLQTLPSTLAMVIVSPVAGRLAVRYTFRAVVTAGLVLAGVGLLALGTVHAAtvWWRLALVGIGFGLTMSPLTGAAIQAVSPQEGGLASGitTRQIGAVLGVAILGAVVRtsGLNSAFLAAGAVTLATAVLTGLWLTKS---
     800 UniRef50_A8GHR1        Putative multidrug resistan...   171     5e-41  1  10.8% 26:414  11:423     -------------------------WQLWIVAFGFFMQTLDTTIVNTALPSMAVSLGENPLRMQSVIVSYVLTVAVMLPASGWLADRVGVQRVFFSAIVLFTLGSILC---ARSETLNELIASRVVQGIGGAMMVPVGRLTVMKIVPREQYMAAMTFVTLPGQIGPLMGPALGGFLVQYASWHWIFLINIPVGIAGAIATLLLMPNYRMQTRRFdgMGLSATAIAGLVVAGVAALAGYWWHAHGNSRALFSLRLFKTRTYKVGLTASLLGRIGS-GMLPFMTPLFMQVGMGFSPFHAGLMMIPMIIGSMGMKRIVVRVVNRFGYRNVLVAATLMLALISLSFPLVAMLGWIWLLPVVLFFQGMvfSAMNTLTLKDLPDRLASSglLSMVMQLSMSLGVSIAGILIGSFAHHQVV------------------------
     801 UniRef50_Q67R18        Multidrug efflux protein n=...   171     5e-41  1  13.1%  3:431   4:461     --TSREQKAAPTGEGRAAVNDSYRWLVLIVAGTSAFMGALDGSIINIIIPQIQAQYQATLGDISWVSTAYLVTISSLLLSAGRLGDMWGYRPVFGAGFIVFGLGSLLCGLA---PTLPTLIGGRLVQGVGAAVMMALSPALITTTFPGRERGRALGMQATLTFTGLTLGPSLGGFIAGRWGWHWVFLINLPVAAVGAVLAYTQLRPTERRSGQAFDFAGALLFAAGLASVLLALSQAEtwQERRAAQPMLPLWMFRVPAFTGGVAAALLQFSATFVLTFLLPFYLQQFR-GLSPSAAGAVMTAQPAAMVAVAGLAGWLSDRIGTRIPATAGMAAIACGLWLvaATPVTQVALCLALIGLGAGFFNPPNNSSIMSAAPWDRQGVAAanVGMVTGITIASTLFAHLSQRMDFLAAFRTTLAVPVGLAVTGALL-------
     802 UniRef50_C5C2T0        Major facilitator superfami...   171     6e-41  1  11.9% 14:433   1:457     -------------MTTTPAERDTRWPAFAVCLGAGFMTLLDVSIVNVALPSIETSLDAGPSALQWIVAGYALSFGLALVPAGRLGDVYGRRTLFLVGLAAFIVTSAACGFA---TTDTMLAVTRIAQGFSAGILNPQVIGFIQDLFRGPERGRAFGLFGATIGVSTAIGPLVGGLLIAAfgWRSVFLVNVPIGLVLLPIAWRLLPRPrrASGVRLDGVGAALLGVAVLAIMYpfAWWERRLERRGGSPVISAALLRIRSYTFGGAVTTLYFAGFSGI-FLTSTLYLQQGLLLEPWEAGLVLTPFAVTGAVSAALGGRWVNVWGRRLVVVGIVIVLVGLVAVDVAvaAWWVAGILAVAGFGNGVVISPNQTLTLAEVpsAGVAAGSLQTLQRVGAAIGLSITSGVFFTTLASSGDYSEAFALGIRIVLLFIVGS-----
     803 UniRef50_B8IVM1        Major facilitator superfami...   171     6e-41  1  13.4%  8:433   9:430     -------PEQAPQSLEKATMRRVILRLVPFLMVCYFFALLDRVNVGFAALQMNKDLGLTPAMFGFAASLFFVSYFLVEVPSNLALQRVGARRWIARIMITWGLVTMGM---ALVIGPYSLYAMRFILGAAEAGFFPGAILYLTYWLPNEYRARILATFTVSIPLATFLGSPLSVSLLELdgWQWLFVLEGLPTVLLGICCLFLLTDKPRDAVWLSDA----------QREWLVGRLADEAARKKPIGHISLWQLARNRYFVTMALVCAGASATGSVLSVWQPQIIKS--FGLTNLQTGFVNAIPYGLATILMILWGRRSDRSGERTWHTAIPLMLAAFGLSYLNLSgvTTIVAVSCALVGAYAFKGPFWALSAgsAGTLAAGLAGINAIAniGGGLMVNIVGLVKEATGSFALGMLPVAALDAAAAVCVLMIS-----
     804 UniRef50_A4FDD3        Organic anion transporter f...   171     6e-41  1  12.7%  6:437   2:431     -----TNTAVEDTTPRSVDRKRFLVRLTIVASGGMFIDGYVLGIVGPVIAAITADLNMSVYGEGLIGAAALIGIFAGGPLGGWLADKLGRKPMFTADLAIFVVGSVMQFF---VDSSWQLFLVRLLMGVAIGAEYSIGWPLMAEFAPARLRGRCMSFAEVAWYIGFVAAFVVGYVLMAVDADWRVVLGTSTLPAVLLFLGRLGVPESPRWLMNK-GRVEEARQIADTYIEDVADRDDITGEQERQGTFGMLFSPQHWRATAFISVFWFCTVTPYFAIATFSASVLSQYGLGEDGLAGA---IGVNGVALVGVVVSCLLIDRIGRRKLTiwVCAVVLVIIGLWASAPPLVVLACFLIFAFANAMCTALTGVYPGEVLPTEVRGIGTGFATarVGAGLGTFLFPWSMQELGAGTTMLIAAGVCVVGGAVSQVLAPETVG-
     805 UniRef50_Q1YU91        Major facilitator family tr...   171     6e-41  1  12.1%  6:435  11:430     -----AAKASGADNAAAPVSNGYRRYVLVLLTLVYALNFIDRQILVILQESIKVDMDLSDSQLGLLTgaFAIFYVSVGIPIARWADLGNRRNIVSLAVAVWSGMTALSGFT---QNFWQLLMARIGVGVGEAGGSPPSHSMISDYYPVEQRGSALSFYSTGVYLGILLGFLIGGWINSEFGWRTAFFVVGVPGFLVALLVRFTIREPVRG------------------------GLEGRALETPATFGETLRTLKGFGSFKLFAIAAGLNAFSSYGIGNFTPSFLIRSHGFSSLEVGTSLALITGIGGALGTYMGGVLADRFGarWYLWVSGIPAACSVPLMFTadPRLALGFLFFATMLGAFYLGPTIAISHTLVSPSMRAMASAILfnLIGLGLGPLVVGMLSDLLasLRYALGIVSFVNLISAAFFFLAARK---
     806 UniRef50_A6WAE7        Drug resistance transporter...   171     6e-41  1  11.9% 25:435  15:478     ------------------------RWLVAVAVLGSALAQVEATVVNVALPSIGTGLGADVSHLQWVLNAYLLTLASLVLLGGSLGDRLGRRRVFIVGTMLFCVASTVC---ALAPDLSVLIAARAVQGVGAALVVPGSLAMLESMLAPGDRARGIGLWSALGGIAGAVGPVLGGVLVE-VSWRWVFILPVPLGLLAAAAARQHLplGGLTFALVQASVGPLWMVWASGGLGLAAAVAFVLVEQHAHDPLLPLRIFASRQFSAANLLTFVVYAALGGVFFLLVVVL-QTGLGYSPLIAGAATLPITLVMLVLSARAGQLAQKIGPRLPLTGGPLVIAAGLLLLSRLAPGsvLPAVLVLAFGLSATVAPVTATVLAAVPAQQAGVAAgnAVARTAQLIAISALPLVVGLNGtfATAMRMCAVLALTGAAIAWAMIRT---
     807 UniRef50_D0B856        Tetracycline resistance pro...   171     6e-41  1  11.6%  6:436   9:462     -----TAIQQGVSLAPDGLPRPRIYWAWATLMVGLTLAVIDGTIANVALPTIAADFSAGPAASIWIVNGYQLAIVITMLPLAALGEIYGYRRVYVAGVALFTIASIGCVFS---RSLEALTLARIIQGLGAAGLMSVNTALLRYTVPQAKFGTAIGLNALFVAVSSTIGPSLAGVMLSSLSWPWLFVINIPLGIAAVLMGLRSLPDNDRSARKFDVVSAILCAVTFGLLITTIDSawLTRRSFHMSDPLLPLDLLRIPVFTLSICTSIMSFLAQMMAFISLP-FLFQTVFGFRPIEVGFLMMPWPIALALVAPLSGKLSDKYSPAILGLLGLITFSVGLALVGLLPGHPTiwRMAICGIGFGLFQAPNNRMMITSTPRARSGAASGmtARLLGQSVGAALVAFLLSQWGVEGTPYILFLASGFALFASVISISRLR--
     808 UniRef50_Q93HE9        Transmembrane efflux protei...   171     6e-41  1  13.7% 11:405  23:452     ----------AGAPAATVAEPPPRWSPLILVSLGTFITVLDFFIVNVAVPDIQQSLHASSVAVQFVLAGYGLPLATLMITSGRMGDLYGRRRLFVTGLALFTAASAC---AGLAQSPAQLVAARVFQGIAASLVTPQVLALLGAMYQGRARAVAFNVYGLAIGLAAVFGQLIGGSLIAllGWRAIFLVNVPVGLVAVALVPRLVPESRGGGRTRLDVIGMLLVMLGLVAVVLPLTEGRerGTVRGGAPLVNTTLFRSRAFSVGLFAMMFYYATMGACFLVLSLYLQQGR-GMSPLGSGLLYLPLGAGFFAATALAGRLVGRLGRQAPAVGALLVVVGYGTLAVLVSGiwLAGPLLVAGLGMGLTMAPLSSMVLAPITADHAAAASGvtAQEIGATVGTALIGSIF---------------------------------
     809 UniRef50_B2JL71        Major facilitator superfami...   170     6e-41  1  13.7%  6:429   3:429     -----PRIIDVQQFLDDHRFSAFQWTILVLCFFVVAVDGLDTAAMGFIAPSLVTEWGVTKAALAPVMSAALFGLAIGALTAGPLADKYGRKRVIVASALIFGVASLSSSASWSLWSLT---AFRFLTGLGLGAAMPNTVTLISEYAPRSRRALLSTLMFCGFSLGSASSGFVASHIIPAYGWRSLLVVGGVLPLVLVLLLIIVLPESARFLVCKGAPAARIAKILCRISSDTDFSNatVPEVVGAASESSIKALFRhtGTVLLWVTYFMGLVVVYMLTGWLPTLMKEA--GIPLAQAAVVTGMFMFGSTFGTILMGWLMDRMNNHVVMGVSYAAAAICVVAIGMHPGDVDLLRVLVFAAGFAMGAQVSMVILAAQfqYRATGVSWMLGIGRFGGILGASTGGVLMTLGWDFQTIFFGLAIPAVLAAMAV---------
     810 UniRef50_D1VEN7        Major facilitator superfami...   170     6e-41  1  11.3%  1:425   1:455     MSDLTSTRIDLPARHVTVptRAGRGLALTAMIFAVAMTFIDQTIVAVAAPKIQTDLGLSSTGLQWAVNAYLLALAALFAFGGRLADTVGHRRMVVIGVVVFAAASALCGLTPSGPAagWLVAFRAVQGAGGALMYPAALAIVVGSYDVRTRGRALALFFGIAGGLTAVGPGFGGYLT-AWTWRAIFWVNIPIALIALVLIAVARPENERRPAPMDYRGLVLIvtWLCVALGLVLIAAFTRVELHADAPLINVRAFRDRVFLTDNAILTIAMTVFVPVFFFASEY-AQISLDESPSQASLLLLYFFAGYVVAAQLGGRMLDRSGARRPVVIGCALACAGLAlvTTLDVGQQVWCIVLAGAGMGLMLGQANTDALNHSPADAYGESTGltVRNYGAALGLAVLGTILVTVLRSHLATSLTALGVPAG-------------
     811 UniRef50_B9L4L5        Drug resistance MFS transpo...   170     6e-41  1  13.3% 14:405  35:451     -------------AQRPELGRRRTVAIVSGVLAATFLAALDVSIVGTAMPTIVGELR-GFALYPWVVTAYLLTSTTTIPLYGRLADLYGRKRILLAAITLFLAGSALCGLA---QSMLQLVLFRALQGLGAGGIIPVTLTVLGDLFPLEQRARLQGLTSAVWGAAAVAGPSVGAAVTDLAGWRWIFYLNVPVGLVALGLLGAALQERVGRREHRLDYRGALLLTAGMTLLLSGLSAafWRTEQRAALPIVPPELVRRRLMAVVGLGSILIGAGMFGLISFLP-LAMQGLGAGTATTAGLTIMPFAVSWSVASTAAGRVILRFGFRSSVVLGMGAMLAGALVLQVVPRwwAVAAAALFGVGMGFSATAFLIAVQNAVaeRGIATALVGLSRTIGGAVGVAVLGAVL---------------------------------
     812 UniRef50_D0J1V3        Major facilitator superfami...   170     6e-41  1  15.4%  3:431  62:508     --ASAAQMQQLENALNQIGVTRSHKSIIFLVVCGVLFDVFEQNAVGLVGPLLRQQWGLDATDIAFLNTITFFAAAMGRLLSGYLADRMGRRFMLNVNLALFTLGAVGC---ALAPDYAFLAVARAIVGFGLGGEITTAVTMLAEFCSARFRGTAVGLIngGGGLGNMLAPAFALGVFTLfsWRWLFGCLVMPAI-FIVFYRRFVPETPRFllSMLAAGKLANAQYELREFITPGSAQEQTAAAQTVQRSSFTDIFraRRTIAVGVASWMTFGAQLSVLTLMPTILV--AQGYSITKSFSFTIVMQMGSLLGAIAASTMGYYFPRKRVLTVGAIAACLAGLAFGNFTDSVAMILVclFQFCVLTLNTSIWIFAPELYPTRIrgTSFLLALGTIGGAMSQVLAGKMFDLHGVSGMFGMIAAMYFIFAIAVQFA-------
     813 UniRef50_B5WAQ8        Major facilitator superfami...   170     6e-41  1  14.2%  3:433   7:439     --ASNARTLVLQDLINERRLSRFQVVTFLLCFAILVLDGYDTVVVGYIAPALKAHFGAAPAQLAPMFGAGLFGLTLGSFIFGPVADRFGRKPTLIASIAVFALFSLL---SAGADSIGMLIVLRFLTGLGLGGAMPNAYTLAAEYCPDRLRSTLVAPIGCGIAVGGALGGLFASRMIGAFGWGSMLVLGGVLPLLLVVVLALWLPESVRYLIARGGKEAQARAILKRIVPDADLENVTITLEERRVQGLPIRQLLggGGTLLLWTTAFMALLVIYFLGNWLPILIQQS--GVSFHNASLMTALYLTGNSLGAVLLGVLMDRMNPQYVLCGAFVCASISLASFGHLSGMPGLALLALfgTGGTMTGTNILSASYYATASRATGVAWTLGMGRVGSIVGSMVGGAMLAAHWEAKMIFGAVAVPVVIAAISVYVLA-----
     814 UniRef50_B5ZNV1        Major facilitator superfami...   170     6e-41  1  14.0% 15:421   1:428     --------------MSNAAHRSNRVLVVATIMFATFMVAIEATIVATAMPRIVGQLG-GFSYYSWVFSAFLLAQSTTTVIYGKLSDIFGRKPVLIGGILIFLLGSLLCGLA---WSMMSLVLFRLLQGLGAGAIQPVTMTIIGDLFKLEERGRVQGAMATVWATSAVVGPLAGGIIVDNISWAWIFWINLPIGILSIIAFMIFLKEEVAHKQAKIDYLGSVLflLTLFAVFIIAGLLFLAQEKRAPEPIISIPLWSRRLIATSNAATLLAGMALIGLSTILPIY-VQGVLGRSPIVAGFTLTMLVVGWPLAVMLSSRFYKAFGIRRTLRVGSLlaCFLLFLTPESSPALAGAGSFFMGFGMGLISLTSIVLVQDSvsMRGSATASIIFARSLGNTLGATVLGAILNAGINHYAGGEAAAGL-----------------
     815 UniRef50_Q5YMN1        Putative transporter n=1 Ta...   170     7e-41  1  12.5% 28:428   1:426     ---------------------------MAALVVALLTVGLDLMVLNVALPTLAQDLGASTTQLQWIVNAYTLVFAALMLPAGGFGDRYGRKRLLLVGLVAFVAASAWAAYSGSTGS---LIAARAVMGIGAAIIVPLSLGILPTLFGPDQRRRAIAVWVGALGVGLPLGPIVGGWLLQHFWWGSVFLINVPVGVAALVACVVLLPESADPHAPPLDWLGIITavLTTLAAGVVLIVGFLVWERHTRYPLVDLGLFANPAFTWPTLAATAGTFTLVGVLFVLPQYL-QILRHYDAFGTGLRLVPLVLAIIIAAAAVDKIVTRVGAKIPIVTGMLIAAAGFVLASRITADsvAVCLGVVGLGAGLALAPAVDAVMASLPEhaAGAGLLMAIRQVGAAFSVAVLGTLLTLVYTRDLDPHLSALPEAVVGAA----------
     816 UniRef50_UPI0001C3137D drug resistance transporter...   170     7e-41  1  13.5%  1:407   1:435     MSQPTTLTSQSGPASADRP-GRERWIALTVLSAAFLMIVLDTTIVSVAMPSIQADLGLSQSGLAWVVNAYLIAFGGLLLLAGRLGDLLGRPRVFMAGLTVFLAASLLGGFA---HNEQLLIAARFIQGIGGALSSAVILGMIVTLFppRERAKAIGVYAFVGSAGASIGLVLGGVLTDLLSWNWIFFVNLPIGLLTAVFALRVLRREEGVGLGRGADVPGALLIVAALMLglALLVGFVLRESRAATPLVPLRIFRVPNVSAANAVQALMIAGMFG-QQFIIALFLQRVLDFSPTEVGLAMLPMAVAIGVFSlfTARLMARFGAKAILLAGLALIVGGLVVLSRVQADalMPAMIVMGIGAGLALPAITTLAMSGATETDSGvgLANTTQQVGAALGLAVLATFSGT-------------------------------
     817 UniRef50_UPI000051015D multidrug resistance efflux...   170     7e-41  1  13.5% 12:419   3:434     -----------TTQAPQVRAGRREWAGLAVLMIPVLLISIDNTVLGFAIPAISTGLHPTGTQLLWIVDIYALMLAGLLVAMGSIGDRVGRRKLLVIGAIGFGLASLL---AAFSTSAEMLIASRALLGIFGATLMPSTLSLIRNIfnAKDRRVAIATWSAMFSGGAALGPIVGGILLEHFHWSAIFFINLPLIAIFIPAAIVLLPESRDPNPGRIDPLSIVLSMLMLTPLVYAIKHVMADGADlsSRPLLDVRLFTNKVFTSAVASNLLSVMGLAGFLYFGTQLL-QLVLGLSPVEAALVLIPGLLAAIISGYAAVPIMARLQPRVVVPCALVLNAFGLGIVAFTpvAGMLISFLILGIGIGTAEVITNDLILSAVPAHKAGAASAitAYEFGSVMGTAVLGGLSTMVFGSHLQSTLGA-------------------
     818 UniRef50_C4DPU9        Arabinose efflux permease f...   170     8e-41  1  12.4%  9:437   2:476     --------TGTTVHKPETTSGLRRRLVLAALLSGTFMLLLDTTIVNLALPPITADLGAGESALQWIVSGYALAYGLFLLPAGWLGDRIGHKSVLILGLSVFTVASLLCGVANGS---GELIAWRVVQGVAAGAVNPSILAFIRLLYSNSERGRAFAAYGTVAGAATSLGPILGGLLIDwlSWRPIFLANLppGLLLVTAAMFALTFPLTQGREIGWPVWTFVTLAAAPVLLLVFTRWQLFLIRRGRDPLVDVRLFARRSFAAGVGLIMAFFAGFIALMFAVSLYL-QLGIGFSTLEAGLTMMPFAIGTGLGSVLgtVIAPRLGRGVLHLGTAIVcaVLGFATVPPNAGWLLGPFLVAGIGCGMIIGPNANIVLSDVPNNVAGIASGttSQRLGTALGVAAIGVVldYTHATMIAVACSLGAMVLTGILAFLLPGRKS-
     819 UniRef50_C1AU30        Drug resistance efflux prot...   170     8e-41  1  13.5% 14:405  15:431     -------------APGHSSASRRDWLGLVVLAFAVLLIAVDGTVLDLALPFISADLEPSSTQLLWIIDVYSFVLAGLLITMGTLGDRIGRRRLLLIGAAGFGIASLI---AAWAPTPEMLIAARVLQGISGATLMPATLGLIRTIfdPRQRTLAIGVWGAMAGGGTAAGPLIGGWLLEHFWWGSVFLINIPVMLVLIAVGPLVIPESKDPAPGRFDLLSAALSMTTMLPLVYAVKETVvrRQKSMQDPMIDIGLFAKPAFSTAVLTNLLSIFALAGVLFFGSQYL-QLVLGNTAFESGVLMLPGMLMSAVTALAAAWMVRRWATSHVLGGGLAVAGVGAALMLTLgpTMFVVGFGLAGAGVGIALTLTSDLVVSAVEPERAGAASAvtAYELGIALGVAVLGSVV---------------------------------
     820 UniRef50_D1X0V6        Drug resistance transporter...   170     8e-41  1  14.2% 21:407   4:418     --------------------ARSRWIALTVLCIGTLMTILDETIVNVALPVMREELGFSQGGVSWVINAYLIAYGGLLIFAGRLGDLIGHKNVLLLGVSLFTVSSVV---AGFSQNAPTLVAARFGQGAGAALVTAVTLAIIVMMfdPGEQTRAIGFYSFTFAGGGALGLIAGGVLMQLTTWHWLFFINLPIGVVSVILGWKLLPSGKGLGLSAGLDVSGAamTLAYLAGSVILMIAFVIRQKKAKAPLFNLNILSDRDVAGANIVQFLVSGGLYG-SFFVATLYLQQVLGYSPMEMALAFLPLTVITALGSilSPYLTAKLGERIGLIIGLAIFVAGALFLARTPLEavLPSMLLLGLGIGLCLPPIMSLAMSTASEDEVGVISGLttGQVGGALWVAIVASAAGS-------------------------------
     821 UniRef50_D2PVZ0        Major facilitator superfami...   170     8e-41  1  10.2% 15:348   1:352     --------------MRQQKTTAEQRWVLGLTSIGSVMVALDVLVVAVALTTIRQDLGASIEQLEWTVNAYSLSFAVLLLTAAALGDRWGRRRTFAAGLVLFTVASVGC---ALATSVPLLIGARALQGVGAAVVMPLAMSLLGAAFPPERRGWAIGIFSGVTGLAVLGGPMVGGAVTEGLAWQWIFWINVPVGLLAVPLVLSRVRESKGAVRRLDPVGAGLATLAVLGPVWGVVRGEAaaWEARTEQPMIPLGFFRTAAFSAGNAAGFFLSAALLGAVFFLSQFM-QVQLSSGPLEAGLQLLPWTATLFLVAPVAGRLVDRFGERPFVVTGLLLQGAGLAWIALIAAP------------------------------------------------------------------------------------------
     822 UniRef50_A5W0Q9        Major facilitator superfami...   170     8e-41  1  14.8% 23:414   6:422     ----------------------QRWLVLAVLSFALLLVAIDMTVLYIALPTLTHALGASTSEKLWIINMYPLVVAGLLLGAGTFGDRIGHQRLFVIGLVLFGAASLL---AAFAPSSVLLILARGALGVGAAAMMPATLAIISLTfdERERGFAIGVWTAVASGGAAIGPLIGGALLEHFWWGSVFLINVPIVLVALVLSLLLIRNTQQANAGPWDLLgsLVAALGALAICAGFGWMFVRGQRKRGFPLIDLQIFRSPAFSSAVIASLAAAGCLMGINLVLSQRL-QLVVGLSPLETGLYFLPLSVGAIVAGPLSGWLLPKVRCDRFLVLALLIYAGAIGLFMYssVALQLLLLFVMGACVGASMTGASTTIMASAPPERAGMAASaiSYELGGGLGIAFMGSLMSVVYSRSLV------------------------
     823 UniRef50_D1VGI9        Drug resistance transporter...   170     8e-41  1  12.7% 20:414   2:422     -------------------SPRRRLAVLVTVCLAVFAINLDTTIVNVALPDLARQLGATTRDLQWIVDGYNLAFAALVLTAGSIGDRFGRRPVLLGGLVGFALMS---GIGALCDGAGALVAVRFVMGAFAALIFPTTLSIITNAYPDreRAKAIGVWGAVTGLGVAIGPVTGGLLLAHFWWGSVFVALVPVALVAAVLAFVLVPESSDPAAARLDLPGLVTSSAAIGLLVYTIIEAPDRgeRRHPAPMLDVSLFRTPAFSAASGAVTVAFFALFGFIFLITQYF-QFIRGFGTVSTGVRILPVALTIALGSVTGTLLAGRLGTRTIVVTGLVLFGGSFAWIAVspYLQIAAQMVLMGTGLGLTTAPATESILSVLPAAKAGVGSAvaTREAGGTLGVAVIGSVFTSIYTHHLA------------------------
     824 UniRef50_C3NIB2        Drug resistance transporter...   170     8e-41  1  11.1% 26:432   6:437     -------------------------LALLVLVFGTLMSAIDTTIVVLAIPSITEELHADLFIMIWVIILYLLVIAVFTTQLGRLGDIYGRAKFYNLGFAIFTLGSALCGAS---PNAISLVAFRGIQGIGAAMMQANAGAIIADIFPPNRRGRAYGYTAIGWNAGATLGIVLGGFITTFIGWRYIFYINVPIGIIALILGLRYIksSMVYGAVDIAGYGIRTLNIVLISLGLVILLTFFWLERKHEFPIIDLRAFKGNRVFTFSLLASFLQSTGYLATAFIIIMYLQGIRGLSPLNASLLLVPGYVLASLVAPFTGRVSDKIGARIPATIGVGLMLIAVLIYLTLSLNTPLYIVILtgLGSSLFFPANNSAIMANAPkyGGASGLARTLANLGSIISYTIAISISSIVVPRYVAfvFLGTSNLIGGVASAFL------
     825 UniRef50_UPI000185C2DA permease of the major facil...   170     8e-41  1  13.5%  1:414   1:447     MKGTTATAIANEDQIAEFAASPQRWWGLLVLAVGLGMIVLDGTIVGVSLPTIISELGLDIVGAQWITTIYSVVFAALLLTSGRAGDRFGRRTLFLVGLVIFTVGSVV---AALSTALAPLVIARVIQGIGGACILPSTLSSVNALFRNKDRATAFGIWGAVMSGAAAVGPLLGGVLTQFAGWEAIFWVNVPIAVVLFVLALRWVPNTAGDTNGDGGFDVlvVTLLIGAVVLVAFVLWENRRRKNADPALLDVSMFSYATFSWGNTTAMLVAVGEFALVFVLPLYLVSAI-GLSTIATGLVLAAMALGAFFAGAMARHLAARITPAGVVIVGLGLEVFGSLQLAalPLWLVVFALIVYGLGLGLASAQLTSLVLGDIPVRLSGQASAttIRQIGSALGAALGGMALTIGLDREIA------------------------
     826 UniRef50_B4RFB9        Major facilitator family tr...   170     8e-41  1  12.5%  3:419   2:414     --SATTTAAGADGHITGFGSKPYRSYVLNALLLIYILNFVDRGLLSVVAPQMKPELGISDTAFGLLTggFALLYTFVGIPLAQFAETRHRVWIMTVCVALWSLMTALCGLAAPItgFWILLACRVGVGIGEAGCTPPANSLIADYYPPQRRSTALGYYAMGVTLGGLLANLIGGPITDAFGWRMAFFVVGLPGLLVAVVFKMTVKEPPRGY----------------------TDPPGTVRKARPKFADGMRELASKPSFWWMTAGATIASFCGYGIASFQSLFINRSFDLSAGQAAVYINAPVALAAAIGTLATGWLAERLGKrwLPGVGLTLSVPFYFVAFTTQNLTLCLIALIIGGGiyGYLAAQYTIGQGVVTAQVRAValLFVINLLGYGLGPLFIGALSDMLFRMKVANLGAA-------------------
     827 UniRef50_Q39QP0        Major facilitator superfami...   170     9e-41  1  14.8% 39:430  31:403     --------------------------------------YIDRQVLYAVFPLIQHDFSLSDTALGLLGSGFMVTYMVSAPLFGWLGDRWSRTRLAAAGLGIWSVATAA---AGLAPTYPALLTARTTVGVGEASFGTVSPGLLAEFFDRERRGRILSYFYLAIPVGSALGYLLGGVIGQQWGWHAAF--------------------------MMVGLPGLLLVLPVWLMREPPRSADAALEQNDNPDNGGYRALFRNRSFIANTLAMAAMTFALGGLAQWIPTFLYREHGLSVSTGNTLFGGLTVVTGICGTLTGGWLGDRLQRRTpgWGFLLGTPAAAYAILTPSLNHCLGGMFLAEFFLFLNTGPLNTVIVNVTRPAVRAMAfiFFIHALGDAISPTILGRLSDIWGLRTALLSTPVAILVAALFAFV--------
     828 UniRef50_B6SEG9        AlnT1 transporter n=1 Tax=S...   170     9e-41  1  13.3%  6:433   1:469     -----MTVEEQADTAPPAQYSPKRWATLAVTLFAVFMDMVDNTVLNVALPAVQQDLDASSAQLEWSVAGYTLAFAAAMITGARLGDQLGRRRIYLIGLGAFVVTSAL---AGAAVNPEMLIASRILQGGAAALMVPQVLAMLQVDFPKSERPKAMSMYGMSLAVGGIGGPLLGGVLLEalGWRPVFYVNVPVGLAALVAAAILTRESRVETRESFDIRGTLIATVGLISLLFPLVQGRerVIARGESPIIDPALLHHRSSLGGLLVAILFFCGM--AYQLVLTVHLQTGEGYSPIRTAVALVTFTVGVGIGSAVAPQLMP-LGRRVVLLGCAVMAVGMGVITWTVDHWslAPGMIVSGIGLAMVAGTLLTIVLAQMPKSASGAAsiNTAIQIGVATGVAIVGTVytPTDSAVVGLLTVVGLYTLAGLLALVLP-----
     829 UniRef50_B1KAU3        Major facilitator superfami...   170     9e-41  1  14.2%  4:434   6:438     ---PDARTVDVSRLIDEQRIGRFAILLIASTWLVMLTDGYELSALAFAAPSLIRAWHIERSVLGPVFGVNVFGIMIGSILFGYIGDRIGRKRAILFGACWYGLVTLAT---AWASSVDHLLWLRFAAGIGIGGAVPNAFVLVSEFAPKRLRATWVTLMFTGYTLGAGFGGGVAVWLVPHFGWPAVFVVGGLAPLVVAAALSFVMPESLRYQVLKGWPRDAIAATAARVRPELALpaRFVVTDERRVAKFSPRMLFAGrvTTALWLAYIANSMALFFLQNWLPVLIEAT--GVAAHRAALMTTLFSVGGTLGGLVLMRFIDRHGVRLVTCLPLVGFPLVAALGMNLETAWLTAAVFGVGFCVAGTQAGLNAVASIVYPtrSKGTGTAIGVAKIGSISGPMIGGMLLAAHVPVRELFQVAALPVVAVAALMFVLGR----
     830 UniRef50_A0B1K1        Major facilitator superfami...   170     9e-41  1  15.1%  1:416  29:476     MTNNTLAPCAPACAAAAATPRSHHSWALVVLLVGAILPPLDYFIVNLALPAIRDGIGAHQAELQLVVSAYACANAVVQITGGRLGDLYGRKRMFMIGMAGFVLASTLCGLA---DNGTVLVGGRVLQGLFAAILAPQVLATIRSVFSPQEQVRVMGFYGFAFGLAAVIGQLGGGALISllGWRAIFLVNLPIGILALIGSWRFIPENRAPRGQRIDVPGTVLMSLFLLMllGALLAVEARRLARGHDPLLDVRLLRNPVVALGLLLAFLFYTLSAFFLSYG--IYLQGCLNWSPLASGFAILPLGLGFLASPLLTTRLVARFGGYRVLTLGFAMLAAGVAIAAaaPGPGFYAGIAAIGIGQGLVLPSVVRIVLAEVDAARAGVASGmaMLQIGAAVGAATIGGVFFARLGVHPAAL----------------------
     831 UniRef50_UPI0001C3150A drug resistance transporter...   170     1e-40  1  13.1%  3:406   4:432     --ASAPGERITLVRAPRLTDDNRRWWILATMTGSLSMILIDQTVVSVALPTMQRDLDLSTVGLQWVVNAYLLAIAAFVALGGKLGDLLGNARIFRLGAAVFVLASAACGFA---QGEEWIIVARSIEGLGAAMMTPATGAIVMNAFRPSERGRAMGIYAGVSMVFLALGPLIGGVLTEWISWRAVFFVNLPVGIAMLVLARVTLKGREQPAGGRMDWGGVPLIVLGLGCLVLALMQSRSWgeLRQEEPLVQLRLFANRNFTADNVVLAAVQFALMGVSVF-GAIWVQDVLGFGPIEAGLSLLPLTLSLLVLAPRVGVLYDKIGPRMPVALGALAVAAaaIWLHELSYAWIVPGYLLMGVGLAFVMTPANTDGMNAAPPELRGQASGvtMRQVGGTIGIAVMGTVIA--------------------------------
     832 UniRef50_D1VF77        Drug resistance transporter...   170     1e-40  1  13.1% 31:405  26:428     ------------------------------VALCLLAVGLDTTVLNTALPTLSTTLGASTSELQWITDSYNLVLAALLLPAGLLGDRYGRKRLIMGALAVFGAGSVW---SAYSTSPGELAAARAVLGVGAAFLIPLVVAGVLVLFEPAERPRAIAVVTLGSMVGIPLGPIAGGLLLHGFWWGSVFLINAPVAVVGLIAVATLLPESRNPDASGLDPFGIALSAAGMVGVTYGVIEAgeRRVARTRDALIDLALFRARAYTAGTILVTIMAFALFGVLFNTPQYL-RGVLGADSLGTGLRLLPMLGAMMVGVQTATRVVQRIGPKAIVTVGLLVTSAGLFLGAFTTTAtaAVWFALFGLGVGLSIPTATLAAVGSLEKARAGAGSALVfrQLGSTVGVAILGTLA---------------------------------
     833 UniRef50_Q143U8        Major facilitator superfami...   170     1e-40  1  10.9% 13:433   9:425     ------------AEIERRIVSKVNWRVMLIFMLGYLISFVDRANLGVLAGPISKDLHLSAASFGLAAGVFYIGYLLFAIPSNMAIVRFGGRFWMGCIMAGWG---LVCFGLAAARSETWLLACRILLGVTEAGFYPGAMFLMTLWYPPRALAKAYATYTAFTPLALVFGALATSALLSLHgwRLVFVLEGIPAFLLGIYTWLSLPSRPKDAKWLSAEEKAYLA----------SQIPEVARGQRGDATRALVKTLKDPFSWLFALLYFLMLLGYWGLIYFMPRIL-QSRFHTDPVHAGFISTLPWLFACVLIYAMGKSSAMTgrRWHMAIGLILSGAGLYLAASTDSSVLTLLGLCLGAGGAPAAAAFFWTMPATvaTVAIAMAMVNSVGNLSGFAGPWVIGVLTDLSGDSRLALYVLACMCILAAALAFTMA-----
     834 UniRef50_C3K299        Putative antibiotic transpo...   170     1e-40  1  12.4%  7:417   1:437     ------MNIDRSASDNPVTRRFPRIAALCAAYLGTFLATLDISVVNVALPTLQDALQTDISGLQWVVNAYTICLSAFMLSSGPIADRYGHKRAWLAGVGVFTVGSAVC---AMASNLDLLLFGRAVQGVAGALLIPGALPILSHAFpaEERAHVIGGWSAFSALALILGPLLGGLLLHGIGWQSIFVINLPLGMIAIGLGIWGIREHKQQARTALDPAGQVLSVVCLASLTYGLISIGQPgeRCVDRPLLPLSLFRRRSFAVVNLASFTLGFSYYSCLFFFSIYL-QTIQGLSVVETGWRMMPQFLVTGCVSILYGRLSAVMTSRRLLVAGYGVTALAmtFTAHTPYWIVGTLFGLLGLGAGLAVPATSMAVMTAAPIDRMGVAsmNALRQMGMTIGVAFLGTLMSSEASRVLAAAL---------------------
     835 UniRef50_A1B192        Major facilitator superfami...   170     1e-40  1  15.4%  6:433   1:428     -----MRSIDVNEAIDQGRFGGFQWMVVALCGTLLIVDGYDVFVAGTVLPTLIAEWGLTKPQAGALQAWALFGMMFGALILGPLADRIGRKKGVAISFVLFTTATLLTGFA---NSPEQFKVFRFVAGLGCGGLMPNAVALMNEYAPRRLRGTMVALMFSGYSVGGMIAAGLGIGLIPGFGWKPMFFIAAVPLLLLPLVLWKLPESLGFLIRQGRQDEARRIFARISPSTVLAADDRLVFSETKGASASVAELFRHNrrTLMLWVSFFCCLLLVYLLSSWLPKVLQEA--GYAERASLLSLFSLNFGGMAGAIAGGWMGDRFGLPKVVVAFFAAAAASIALIGLNPagVLFLLVFVAGATTIGTQILLYASVAQLysVRSTGLGWASGVGRIGAIVGPTLGGVLLARELPLGQNFLIFAIPAAVSALAMLVFA-----
     836 UniRef50_Q0RTN3        Transmembrane efflux protei...   170     1e-40  1  14.5%  7:419   1:443     ------MTSSTPAPPRTDGARTAGWLPLVVVLAGTFVTFLDFFIVNVALPSIETDLAAGSATLSLVVAGYGLTFAVGMVTGGRLGDLHGRRRMFLVGLALFTLTSAACGLA---PNAEVLVVARFLQGASGALLTPQVLAILGILYVGRRRGPAFAAYGFAMGIAGVLGQLIGGALIEAdgWRAVFLINVPVGLLAMPAARRVLPESRGPRARLDLAGAALVTAAATLLILPLVEGRerRLAARGGAPLIDLGLFRHRAFAVGTCVALGFALIPSSFFFVLALDLQQGR-GYGALFSGIVFAAVGAGYMLAMFLAGPLGDRLGHrvGALGVAAGGALLVATASAASALALVPGLAVTGLGIGLVLVPLSSTVLAGVDPRHAGAAAGvmAQQIGGALGVAVIGVVFFGAGTAEGAFTASL-------------------
     837 UniRef50_C5BDY9        Transporter, major facilita...   170     1e-40  1  10.6% 12:409   2:424     -----------TPSLGDGLPLRQRYSAMLAIALGIAIAVLDGAIANVALPSIARDLHASSANAIWIVNAYQLSVTVSLLSLAALGERIGYRRIFLSGCLLFSLTSLTCALSDSLLTLTL---SRVLQGFAAAALMSVNAALIRLIYPQHQLGRGMGLNALVVAVSSAAGPTIAAAVLALGDWPWLFAINIPFGLAAWLIGRRTLPRNPPAAVRPPFDRQSALLNALTFGLLLSLISGLarRERRQPQPLLPIDLLRIPIFALSIATSICSFCAQMLALVSLPFFLQRT-LGYGEVATGLLLTPWPLATMVMAPIAGRLVERFNAGLLGCVGIALTGVGLIALALLpsAAIIWRMALCGAGFGLFQSPNNHTMIASAPRQRSGGASGmtARLFGQTLGAALVALMFNWLG-----------------------------
     838 UniRef50_A3VM32        Putative multidrug-efflux t...   170     1e-40  1  11.6% 38:408  22:418     -------------------------------------AALDQTIVSTALPTIVADLG-GLEHLSWVVTAYILASTIAAPLYGKLGDLYGRRNIVFVSVGLFLLGSAL---AGAAQSMVWLIGSRAVQGLGGGGLFVLALSVIGDVIPPKDRGKTQGVFAATFSIASVIGPLIGGWFVEQFSWHWIFYINLPIGLAAVVGFATAFKPTGVRTKHVIDWGGAAAliLGLAVLAVAAGILFVWVENRSAEPLLPLGLFRINVFWVTSFMSAITGAAMFGGITFLPIYL-QIAKGLTPTQSGLMLIPMTAGILLSSMMSGRFMGKTGRYRVLPMLGMGSLAFGFLLLttPIWGFAARLVFVGLGLGAIFPVLTTAAQNAVSRegTATASGLMFRQVGGSVAVAGFGALFATT------------------------------
     839 UniRef50_C1YGZ7        Drug resistance transporter...   170     1e-40  1  11.6%  2:431   3:458     -AQTVPKAAPETETERKQRWTESPWATLVAIAFGVMMVALDGTIVAVANPAIGTSLGASLAELQWVTHGYLLGLAVFLITAGKIGDRFGYRNTYLVGAVGFVLSSVAIALSAGV---IMLVAFRVLQGVFGALLLPSAMGLLRASFPPSKLGRAFGVFGSLIGAATAGGPILGGVLVGSFGWESVFYINVPVGAVALGLGLWLLAANKPTDAGSRMDVPGIVLLSIAIFALVWALVEAPSveRRPEQPLLPLALFANPSVSIGAVLTVAMALSLMGSLFFI-TFYLQGVRGMSPAQTGLQLISMTALMAVTSPIAGRVLDRVGARPPTTVGLLLASAGMFMLSLLRTDTGvaAFVLLGMGLSLIMTGATAAIIGNAPVRYAGVASAvaAMQLGGSLGTAVLGAVMSATIVATLPGHFAAAGLAEPAAEELA-------
     840 UniRef50_B4STQ6        Glucose/galactose transport...   170     1e-40  1  35.0%  5:435   2:429     ----PISATPRPSGSSGNAPAVTNGKALAVVTTIFFMWGFLTCLNDILIPHLKAVFELNYAKAMLVQFTFFGTYFLMSLPAGRLVAALGYKKGIVAGLVIAGIGALGFWPAAELRVYGAFLGALFVLATGITVLQVAANPYVALLGPEQTSSSRLTLAQALNSLGTAIAPIFGGMLILSNTVKSADELNALPAAEQL-AYRAAEAQAVQGPYVGLAVALVLLALFVFLFRLPALSDATEQAD--QGHHHSYLDALRKRHLLLGVLGIFFYVGAEVSIGSFLVNYLSmsIGGFSEQEATHYVSAYWTMAMIGRFAGSALLARFSPSRLLAIFALVNVGLLATTMLTSGNVALYSVVAIGLFNSIMFPTIFALSIERLGPLTNKGSSLLIMAIVGGAVVPYLQGVLADHIGV-QASFILPLLCYGYIIFYGLVGART---
     841 UniRef50_A6WYE3        Drug resistance transporter...   170     1e-40  1  11.8% 12:434  11:456     -----------TSVAPDGLPKPRIYWAWATLMVGLTLAVIDGTIANVALPTIAADFSAGPAASIWIVNGYQLAIVVTLLPLAALGEIYGYRRVYLGGVALFTVASVACVFS---RSLEALTFARIIQGLGAAGLMSVNTALLRYTVPQAKFGTAIGLNALFVAVSSTIGPTLAGVMLSSLSWPWLFVINIPLGVAAVVMGLKSLPENERSVRKFDVVSAILSALTFGLLVTTIDSAGNerRSLRMADPLLPLDLLRIPVFTLSICTSIMSFLAQMMAFISLP-FLFQVVFGFRPIEVGFLMMPWPIALAIVAPLSGKLSDKHSPAILGLLGLIIFAIGLALVGMLPEHPSiwRMAICGIGFGLFQAPNNRMMITSTPRSRSGAASGmtARLLGQSLGAAFVAFLLSQWGVEATPYILFFASGFALFASLISVTR----
     842 UniRef50_Q8CN98        Multidrug resistance protei...   233     1e-59  1  12.0% 24:407 151:559     -----------------------RGKILAAMLFGMFIAILNQTLLNVALPKINTEFNISASTGQWLMTGFMLVNGILIPISAFLFNKYSYRKLFIIGLALFTLGSLVC---AISFNFPIMMSGRVLQAIGAGILMPLGSNVIVTIFPPEKRGVAMGTMGIAMILAPAIGPTLSGYIVQNYDWNVMFYGMFFIGIIAIVIGLFWFKLYQSTTNPKADIPGIIYSTIGFGSLLYGFSEAGNkrELRMKAPMLSLEVLKYPTYTLTTVINMIVMMSLYGGMILLPLYL-QNLRGFSALDSGLLLLPGALVMGALGPVAGKLLDTIGIKPLAIFGIGIMTYATwlNMDTTYLHIMWIYIVRSFGMAFVMMPIMTAGMNALPPrsHGNAFVNTMRQLAGSIGTAILVTVMTT-------------------------------
     843 UniRef50_C8W084        Drug resistance transporter...   229     2e-58  1  12.2% 24:416  52:469     -----------------------PWGALLILVLGAFMAILDTSIVNVALPKMMVIFGASADEIQWILTGYMLTSGMVIPMTGFLGDRYGNKLMYIWSLIIFTIGSALCGLAWSNNSM---IAFRVIQAIGGGMVMPVTMAIIYRIVPMRKIGTALGVWGIGAIMGPAIGPTLGGYLVDKFSWHWIFTINIPVGILTIILAYVLLKETPLMPHLKIDIPGMILSSSGCFCLLLALSKGQDEGWTSeeHPLLEVRLLKNKVIVASLLSTSLVTVGLFSAVFLVPIY-AQNLMGYTPMQTGLMMMPAALVTGFMMPISGKLFDKYGALPLGLVGLTILAVLTYQMKYISTDTTfvLLSIRAIGLGLAMMPLTTAGMNTVPRfsRASALNNVVRQISGSMGIAYLTYVMLQRQTYHTVWL----------------------
     844 UniRef50_UPI0001B55153 drug resistance efflux prot...   224     7e-57  1  11.8% 32:405   1:406     -------------------------------MCGMFLAALDQTIVGTSIVRIANDLH-GFDLQAWATTAYLITSTIATPIYGKLSDIYGRKPFYLAAIAIFVVGSAA---ASFSTSMYELAAFRAVQGLGAGGLMSLAMTIIGDVVPPRERARYQGYFLAVFGTSTVLGPVLGGFFagLHGWRWVFLINVPIGVIALFVVAKVLNVPHNRHDHKIDWWGALTMVIAVVPFLIVAEQGQKWGWGDQkaALIPLRLFKNSTFSVAIIGGVIVGVAMFGAITMIPQYL-QVVQGYTPTESGLLMLPLMVGIMSASIISGRITSKTGRYKIfvIGTLLIAAGAFFFAqtPIWHPLVAALVIGLGLGQCMQTLIIAVQNAGPRKDMgtASATFFRQIGGTAGVAVFLTIL---------------------------------
     845 UniRef50_C6CV95        Drug resistance transporter...   217     7e-55  1  11.4% 27:420  14:432     --------------------------IMASLLIAAFVALLSQTVLNVALPKMMADLDVGESTIQWLSNGYMLVNGVLVPISAYLINRFTTRKLFLVASSLFAIGTVVCALSG---DFSSLLAGRLVQACGAGILMPLMTIVTLTIFPVEERGKAMGLMGVAMIFAPAVGPTLSGWVVEHYDWHVLFYIVLPLAILAVVFGAFSMKDVIKTSRPNLDILSVVLSTLGFGGLLYGFSEAGTEGWDStkAPLLEMRVFKYSMFSLTALINAIITMAMFSGMILLPIFL-QNIRGFTPLESGLLLLPGAILMGIMSPITGMVFDKIGARWLAVIGLIITTVTTYEFShsSYNHMMLFYTLRMFGMSMLMMPIQTAGLNQLPRraHGSAMSQTLRNVSGALGTAILVTIMTNKAASHAKELIIAG------------------
     846 UniRef50_B5YFM2        Multidrug resistance protei...   215     2e-54  1  13.9% 23:417   2:425     ----------------------KRFWIVLTVMLPTFIEILDTTINNVALRHIQGSLSAGVDESTWIITSYLVSNAIVIPMAGWLSKIFGRKNYLIFSITVFTISSFLCGMA---WSLTSLIFFRVLQGIGGGGLQPLSQSILLETFPKEKYGTAMAIYGMGIIMAPILGPIVGGWIADNFSWRWIYYINIPVGIISILMTYLIIEDplKREKLRIDYPGIIFLALgfVISILSLATLLWWELKRAEHPIVNFRLFKDRNFFFGNLVMFFTFVNLFGSIILLPIY-VQNLMGYTAFLAGLVLGPAGIVQFIAFPISGKIVDRINPKIPLAFGIIMCalMSLFNLQAGFWDFVYPRAVLALGMAFVITPLAAMTVAYIPKEKmaTPLNGVIRNIGGSVGTAIVTTIVSQRTQFHQARLV---------------------
     847 UniRef50_Q97TJ2        Permease MDR type n=1 Tax=C...   215     2e-54  1  11.6% 21:407   3:415     --------------------KKYQIISFIAIVLGFFMTLLDTTIVNITLPKMTEYFNTNMNHISWVVNAYNLAFAVIILTASRLADQFGRKKIFIGGVFLFTIASLL---AGISNSLEVLIFLRALQGLSAAFVVPVTMPLSAEIFPPEKRGTIMSLWGAFAGLAAASGPTLGGILTQFFNWRYIFFINVPIGCLCIFLTIKFIKESYDQAASKSIDFGGNITilSLFAASAITLIIFIIIELKVNEPMLSLSLFKSLQFTNGSISLFLLGLGMMCGSYFLSFFLTQ-IKGLNELSAGLIISTMSLSSMFFSIVAAILTKKVGKRFISAFGIFLLCFSCYLNSssSNIDVILRLIITGAGTGLSMATLLSSTIANVPINKIGIASgnMTRTLGTVLGVALFLTIFTS-------------------------------
     848 UniRef50_C6PUA3        Drug resistance transporter...   214     5e-54  1  11.6% 21:416   3:424     --------------------KKHQIISFLAIILGFFMALLDTTVVNITLPKMAEYFNTTMDHISWVVNSYNLATAVILVTVSRLADQFGRKKLFIAGVFLFTISSLLCGIS---NSLQALILFRTIQGLAAAFVVTISAPLSLEIFPPEKRRNIMALWGAFSGLAAASGPSIGGIVTQFFNWRYIFFINVPIGCICILLTMKFIKESYDPTASKSIDFGGIifILSLFAVSAIALILFIIIELKVKEPMVPLSLFKSSPFTNGSIALFLLGLGMMSGTYLLSFFLIQ-VKGLEQLSAGLIISTMSLTSMFFSLLATILTKKLGSRVTSALGILLLSTSCYLNSssSNIDIILRLIVAGSGTGLSMATIIGSIVANVPVDKIGIASgnMTRTLGTVLGVALFLTIFTSNMTTQMSYA----------------------
     849 UniRef50_C1F8F9        Drug resistance transporter...   213     1e-53  1  10.8%  1:407   1:445     MSQSSVAPRPAAAASDqwTPRFNPWVITFTVTLATFMEALDSSIANVALPHIAGSLGASQDEATWVLTSYLVSNAIVLPISGWISNRIGRKRFYMACVAAFTLFSFFCGLA---PTLTWLVIFRVIQGAAGGGLQPSERAILADTFAPEKRSLAFSLYGMAVVLAPAIGPTIGGWITDNYTWRWIFFLNIPVGILSLLLTSRIVEDPPYLKRQLARLKESVDGIGLGLLALCIGAAqfLYRESTVEHPIVDLKLYRTRNFAMTQIVMLLIGAALYSTTVMIPQFL-QVLMGYTATQAGLALSIGGVVLMILFPIMGFLGQKMDPRLMITLGFAVLTFGIwlNLNISFGTALSWRAVMVLGMPMLFVPISVMSYVGIPQEKNNEVSGLtaRNIGGSVGISFVTTLITR-------------------------------
     850 UniRef50_D2RH27        Drug resistance transporter...   212     2e-53  1  10.9% 23:407   6:415     ----------------------RSWLAFLPVSLGLFMVLLDVSVLNVALPRIAEDFHARMSDLQWVLNAYTLTMVVLLVLAGRIGDIVRRDRYFVLGMGIFVLGSFLC---AQSWSIEVLIFSRIIQAVGGAILSSNTLAIVTELFPPGQRGAVMGLNAILMASSFALGPIVGGWLTTNLSWHWVFYINVPIGIISIALAFMLLPPLEPKEKVPIDLAGTILLAIGLGSLTLGIIEGQNWGWDNQKtpILDLSLFKIRNFTVCVAATSIIFFGTSSSFFVIP-YFLQGLKGLTAEEAGYWMISIPIANTFVAPIAGRLSDKMNPKYMMCLGPILFAMGMYNMTDVDVDIKYWEFFfmGIGMGLLTSPAFNVLMSSVPPAKAGMANGtsVNTLAQAMGVAIGGVLITH-------------------------------
     851 UniRef50_B3WAZ7        Permease of the major facil...   212     2e-53  1  11.4% 23:407   7:416     ----------------------RNILSFIGLSIAMFMGTLDSTIVNIALPKIMRAFGSSLNDTSWVTTIYVLSLSVFMITSSKVADRIGRKKVMLCGLVLFGGFSTACMLA---PSLELLIVFRFVQGIGGAIITPLALPMGIEAFGKKHISILSAAVGAITALAAAGGPPIGGVILQVSTWRWVFGINVPLAIVASIFVFFFTNEspFGTVLLTASLGGISFGLLQGRQMGWHSMAITGseRKVTSPVIELTLFKNKAFASSTIVYFVTGFGLV-CPTLVFNYFLQDVMNYAPLHAAMLIIPVSLTVMFAMPLGTRIMDVVGAVPVNLTGMLLVSMSLFSFAAIDTNTavMLMILNGFGFGFSTISIVS-SLNHLPKEKSGIGSgnAARQIGTCLGIALLVTVLDT-------------------------------
     852 UniRef50_Q0STI2        Drug resistance transporter...   211     4e-53  1  11.5%  6:421   1:441     -----MNNANENSKNTEDLVYKNRWFILAVLVMQPFMACLDSSIVNVALPILQKELGATMAGTEWIVSSYLIIISASILIFGRLGDMHSKSSVFIKGILIFVLGSFLCGIS---PSLTILVLSRVVQAIGAAMLMSTNQGIITDVFSPKERGKALGISGSFVALGSILGPALGGFIVTYFTWHYIFLINVPIGIICYIFAKKYLPIRIPKESESMDKPGATMFFIATILIFTSILISQHLgeNKVKNPMLHLSLFKKPIFSVSLICAFISFTAINTINVIQPFYL-NDILGYSPGKISVIMTAYPIVLFVIAPLSGTLSDKIGSKILTLIGLFLTGVSMILLSSLNstSIFLMLSLLGFSNGLFQSPNTNLIMSSVPKDKLGIAGGTniRNLGLAFGVSASTSILYAKMSKLAGFRVLGSV-----------------
     853 UniRef50_Q5LBX2        Putative membrane protein n...   211     4e-53  1  13.1% 31:413   4:415     ------------------------------IMIGTFMAVLDSTVVNTGLPVIMGTLGADINVAEWVLTGYMLSMASILPAAGWLSERFGYKKIYFLSLLVFTAGSFMCGSSS---TIEELIFWRVIEGFGCGMLLPVGMAIVSDVFPPEQRGTALGFWSIASAASVSFGPAIGGYLVDYMDWNYIFYVNIPIGILALIVTAIVQKEHVKGTGVPFDIPGFITSAIFLPVFMYGLSEVNSSTNstVKTPLINLRLFVDRDFALSNLILFVFGIGMFGSTFLIPLYL-QDNLGYSALQAGMFFMPVGIIQGVASPLSGKLMQRINPKVFIVSGILLMALSfyLSFLTEKWYIILSLYLRGLGMGLLFTPLLTLSLVNIRNsaQASSITNIVRQMGGSFGVAIFSHLLTQRTAFHT-------------------------
     854 UniRef50_A5CYH9        Hypothetical transporter n=...   210     6e-53  1  11.0% 15:405  28:443     --------------MEDHPTGRIPLAALMTLIIGAFMAILDGSIVNVALPRMMSIFNSTPDQIQWVITAYLLASGVVVPVTGYLSDRFGAKRLYIVSLGAFTAGSALCSLAWSNHS---LVAFRVVQAIGGGMMMPVTMTMIYHIVPRDKIGTALGIWGISAMAAPTVGPTLGGYLVDNFSWHWIFTINIPIGAVAVFLAAMILEETPKKAGLKVDIPGILLSSAGCFALLLALSEGQDKgeLTADQPMLDIRLLKNKVFTASLVCVSITTIGLFSAIFLVPLF-VQNVQGLTPMQTGLLMMPAALASGIMMPISGRLFDKIGALPLCLVGLSVTVVTTYQLHTITYDTSywLLVERSLGLGLCMMPMATAGMNTVPriGRASALNNLVRQISASFGIAFITYVM---------------------------------
     855 UniRef50_B8HDG0        Drug resistance transporter...   210     8e-53  1  13.3%  2:408  18:454     -SAKQESRQSKRHEPGAPMNHRQIMEALTGLLAAFFTAILSSTIVANALPTIMSELKGTQTDFAWVITAALLANAATTPIWGKLADLFDKKVLVQLSIVIFVAGSVM---AGFSENIPFLLTARVIQGIAMGGLTALAQAIIGSIIPPRERGKYSGYMGAVMAVGTAGGPLLGGFIVdsLGWRWTFFVCVPLAVVALILLQITLKIPHVKRPAKIDWLGAILLTSGVSLLLIWVSFAGKAdeSKVSAPIIPLKIISDRTTALAIVASVAVGVAMFGSSTFLGQYY-QVARGATPTEAGLLTLPMIAGNLVGSVVSGQLISRYGKWKGFLIGGTVLLIGGLAMatTELWLTGIYTGIFGIGLGMLMQNLVLAVQNTVRAqgSASASVAFFRSVGGAIGVSVLGAVMANH------------------------------
     856 UniRef50_C2C2I1        MFS family major facilitato...   210     8e-53  1  12.0%  1:407  66:497     LPAAPSEEPKAQAPSKNNNYPDHLVTLLMVLILGAFVTILNQTLLNNALPKIMNSFNVTTNTAQWLSTAYMLVNGVVIPFSAFLIETISSRKLFIFAMSMFGIGTLI---AGVAPTFSILLIGRMVQAVGAGIIMPLMTTLFMVLFPPEKRGSVMGIMGVAMIFAPAIGPTLSGYIVEYSTWRLLFWVVLPIALLDIILALIYFKDVGERSYPKLDVWGLIFSTIGLSSLLYGFSEAGNDGWTSTthPLLNLRVFKFPIFTLASVINLIVTMSLFASMILLPVYL-QNIRGFTPVESGLLLLPGAIIMGIMSPIAGALFDKVGARPLAIVGLLVMIFTTWEFGNLTLDDSLLYIGTlsFGISLVMMPIMTEALNSVPReaHATATFNTLRQIAGSLGTAILVTVMST-------------------------------
     857 UniRef50_Q1YU96        Efflux pump protein FarB n=...   210     9e-53  1  12.1% 20:416   8:429     -------------------TPRAKSAVTLAVMLASIMQMLDTTIANVALPHMQGSLSATQDQLAWVLTSYIVASAIMTLPIGWLSGRYGRKNVFLISIAGFTLTSLLCGAA---TSLNEMIGFRILQGLFGAALVPLSQTIMLDINAKEDHVKAMAMWTVSIMIGPILGPTLGGFLTEYYSWRWVFYINLPFGVVVLFIILTLMPETEREERPFDGLGFFALALVIAgaVVLSALWVYVVHTKTAKNPFLTPAILRDRNFTGALIFMFFMGLILLATMALLPNYL-QRIMGYPVLDVGTILAPRGIGTMLSMFLLGKFADRFDPRALVVVGLLLTAYSLWLmtFVPAHRIVSTGFLQGLGLGFVFMPLSTLAYLTLEPQYRTEAAGLfvRNFGSSIGVSAAFVLFSRDLQTQHAYL----------------------
     858 UniRef50_A6LR83        Drug resistance transporter...   210     1e-52  1  10.3% 21:419  10:432     --------------------PNNKWIVLFVVVAMTFMATLDSSIVNVTLPVMSKNLEVPLSSIEWVIASYSIIICSTILFFGRLGDMIGKTKVFQCGSVVFTLGSLLCG---VSHSFISLIIFRFIQGIGGAAYMANNHGIITEIFPREERGKALGILTTAVALGTMIGPPVGGIIASALNWHYVFLINIPIGVIVFIIGIKYLPRIKRDSQKLDIAGAAlkWIMVALIVSIILIVLFIYIEIKSKHPLLALKIFKNKLFSVNLICAFISFTCIAASTILLPFYF-QYTLEVSPSKTGFLLMVSPIILAIFSPICGTLSDKIGSEILCLIGLTLMSIAFFLLSFLTEYSFiiFMALMSLGQSLFQPANNSLIMSNCPKEQLGIAGSVnvRNLGQIVGISLSTTILYLFMSQKLHYQVLG-------------------
     859 UniRef50_A8Z542        MFS family major facilitato...   209     2e-52  1  11.9% 23:401 137:540     ----------------------SRGKILAALLFGMFIAILNQTLLNVALPKINTEFNISASTGQWLMTGFMLVNGILIPITAYLFNKYSYRKLFLVALVLFTIGSLIC---AISMNFPIMMVGRVLQAIGAGVLMPLGSIVIITIYPPEKRGAAMGTMGIAMILAPAIGPTLSGYIVQNYHWNVMFYGMFIIGIIAILIGFVWFKLYQYTTNPKADIPGIIFSTIGFGALLYGFSEafVIRELRMKSPMLNLEVLKFPTFTLTTIINMVVMLSLYGGMILLPIYL-QNLRGFSALDSGLLLLPGSLIMGLLGPFAGKLLDTIGLKPLAIFGIAVMTYATwlNMDTPYMTIMGIYVLRSFGMAFIMMPMVTAAINALPGRLagNAFLNTMRQLAGSIGTAIL-------------------------------------
     860 UniRef50_C6PTT6        Drug resistance transporter...   207     7e-52  1  12.0% 18:408  12:427     -----------------QLSKSKRKLAVAAVALGTFMSALDSSVVNIALPNISAHFNTNLSTIEWVVMSYLLIISSLLITYGRMGDMYGHKKVYVRGFIIFTLGSFLCGIS---PNIIILIISRIIQAVGAGMLMSMSSAIITNITPPKERGKSLGIIAVSVSIALATGPVIGGILTSLLGWESIFYINIPIGIFGCFFAEKVIPKSTIIDKQPFDIKGSVLIFASLITILLPLSYTETYgeKKTQYPMMDLTMFKNKLFSMSNLSALLSFIAQFSVVLIMPFYLQQLR-GLPPSKAGFLMIPMPLTTMFIAPISGAVSDRIDSRYISALGMAIASFGIYLliGSSHSYIAMSLMITGLGTGLFQTPNNSAIMGSVANNRRGIAslATMRNIGMVLGIAISGAIFSTH------------------------------
     861 UniRef50_A6LXI4        Drug resistance transporter...   205     2e-51  1  10.4% 15:407   1:417     --------------MENKKESSSKWLIMSVVIMAIFMVNLDTSIINISITKMMQTFNASIDQIQWVVSSYTLTLGVVIPSTSYFGDKFGTKSVFVMALILFTLGSLLCGIS---WNENIMIIARVIQGIGGACIISLGMTILMTTFDKSEIGMAIGLMGMCVMAAPALGPSLGGYIIQNFNWRFLFFINLPVGIVAIIMAILIFKKSEHTSSKKFDIIGFLTSSIGMSCVLYVLGKsfVVNELLIEEPMLDLKLLKNYTFCMSNIIMNIAMLALYGGVFLMPIFLQQIR-GLDSMSTGLILFPEAIATAISMILYGKIGNKFDVRLFAVFALVLIGINSYSMSKITLDtiTILLMIRGFGVGFLMAPVQTVGFSGLPKAAmaSALTNTVKQVGTSIGVTIITSIMQH-------------------------------
     862 UniRef50_C9W392        Putative sisomicin exporter...   205     3e-51  1  13.5%  4:432  15:485     ---ASGETVVLRDTAHPLRSLRERQLALIVLCVGILISVIDGSAVYVALPSIQEGLGFSQANLAWVVNAYLIPFGGLLLLAGRLGDLIGTKRVFLSGLSVFTVASMVCGLA---TDQAVLVGARFVQGVGGALTTAVVLSMVVNMFppREQARALGLYAFVAASGSAIGQLAGAALTASLSWHWIFFVNAPIGLVTILMGARLLDNVRDaaGKGIDWIGAVALVGSLMLTVYTIVQADSGaqRRTSNPLVPASVLRARNVAWSNVVLALMIAGPTAM-FFLCALYLQNVLGFSVYELGFAFVPAALAIGIGSlvAPRLIRKNDAKVLLVPAMALMALGLLLLARIPADGSYwaILLIGIGSGLATPPviALADATLDDSGIRSGLLNTTQQIGSALGLAVlaAAVALTEGFQMAFLVGFGTMVAAIVLAIFA------
     863 UniRef50_B3DY96        Permease of the major facil...   204     4e-51  1  13.5% 17:401  10:423     ----------------AWKPRHNPWIIALSVMLATFMEVLDTTILNVALPYIAGGLAASNSQATWVLTSYLVSNAVVLPMTDWLGRTFGRKRLLIGCIASFTLSSALCGAA---PNLGILILGRIIQGAGGGGLQPISQAILLESFPPEKRGQAMGLFALGVVVAPILGPVFGGWLTDNLNWRWCFFINLPVGILAIIASKITVEDPPYLQRNATKKLDIllWLRWMGGLSLLGMICFIYRELTTDNPIVDLKIFKDKNFAVAIFEIFIVGIVLYATLSGLPLFL-QTLISYTAYQSGLAISPRGIGAVAGAIIAGRLLGVLSGRLIVALGFSMLALSSLQIGFFNLEIavIPNIINGIGAPFVFIPLTTAAVVTLRQegAATGLFNLFRNIGGSVGTSMV-------------------------------------
     864 UniRef50_C6SSV4        Permease n=1 Tax=Streptococ...   204     5e-51  1   9.3% 28:405  10:412     ---------------------------FIGLILAMFMGALDATIVNIAIPDIMDDLHTGLTDTSWVATIYVLAMSVFIITVSKLADIYGRKLVMLIGVVLFGGFSFACM---TANSLLPLIIYRFFQGLGGAILTPIVLPMGIELFGKEKTSRITAVMGAFGALAAAGGPVIGGVIINWTSYRWIFGINIPIAILAFLLILIGTKEswLGMIFLTITLGGLVFGLLEGREYGWSSQMIVSseRKVKSPIIELTLFKEKTFTASSIVYMIFGFAII-VPSFVVNYFLQNVRNYSALHSAYLIVPASLAIAVSMPLATKMYQKISAKLLIGIGIVVTAGGLFMLGltPKSIIICCNIIIGLGLGFMAMSLTSSvyLPVTKTGIGSGIVNASRYIGQALGIALLVTIL---------------------------------
     865 UniRef50_B8I645        Drug resistance transporter...   204     8e-51  1  12.2% 14:415   1:427     -------------MENTEKQYKNKGLILLNIVLLTFMSCLDSSIVNVALPVMANEFSVGMGSISTIVSTYLIAISATVLIFGRLGDIKGKVKIFKTGIVVFTFGSLLC---AVSRTLNILVISRIIQAIGAASFMATNQGIITRTFPANERGRALGITGSFVALGTLAGPPLGGFIVDVASWEYIFLINIPIGIFAFIMGIKVLPKDEEVTDTKFDIKGAILFLISIISLFSALLAGEqrIEGRVESPLLQLSIFRNKLFSLSIFCGFLLFVCMSCSNIILPFYFQDIIK-MTPWLTGIYLISYPLILLVVSPVSGYLSDKTGSETLTFVGLSIFSIGCFLMATINQTfiILFISLMAVGNGMFQSPNNALVMSTVPRSRLGIAGSInvRNLGLVIGVSVSTLVLYGMMSFKVGY-----------------------
     866 UniRef50_D0L8G5        Drug resistance transporter...   203     1e-50  1   9.5% 37:405   1:397     ------------------------------------MIMLDQTVVTVALPSMTHDLGLSSSGQQWVVNAYVLAMAACVALGGKLGDRLGPVTCFCLGVVTFFAASVFCGLAPGGGGETWILSARAAQGVGAALMMPVSAKIVMEAFPITERGRAMAVYAGVSQIFLAVGPLIGGALTEWISWRAVFWLNVPVGLLALVLVAIAKPDNSRDRAARVSLRGAAmaTLASLIVGVLILGVFVLTQWRSATPLVAVRLLARRAFTANLVTLGLVRFSLLATILFATLYL-QDLLHMSPMKAGAAVLPLILPITVAAQLGGRWYDRRGNRPPVITGLAIATIGMaaLPHLDYVLQVPGMIITGFGLGLVFSPTNTDALSRVSAAERSQASGltIRQLGGTLGVAVIGSIV---------------------------------
     867 UniRef50_A9KFF5        Multidrug resistance protei...   203     1e-50  1   9.8% 10:416   2:433     ---------NTTALTKNEILYSRRWLIIVTIMMVAILEVLDTTIVNVALPNMMSSLGANQNQITWVLTSYVVASAIMLPLTGFFSNRLGQKQLLLINITGFMITSFLCGIA---QSLPEIVFFRIFQGLFGASLIPLSQSILRETFPLEEQGKAMAIWGIGIMAAPVFGPTLGGFITEHMNWRWIFYINMPICLLGLMLTLFVIPSSERHYQRIDWGGLLLmlILALFITAIFCLVFFIIRSLIHRYPVIKLKIFKDRNFRISCLALALFAGSMFALITLEP-IMLERLFNYPAVTAGWTMAPLGIGGAVVMMFVPFLMKHLNIKIILTVGILCCFYGAILFAGVNLNSTMQEFlvLGFGMGFLMVPLTTYSLATLPAktEAAGLYSYSRMLGTSIGISLLSTLVSRTTQIHWHFL----------------------
     868 UniRef50_A5FA66        Drug resistance transporter...   203     1e-50  1  10.7%  7:409   1:434     ------MAGAVQADDDLVEYGFRRVIITITAVLCALLEIVDTTIVNVALTDMRGSLGATLTDVAWVITAYAIANVIVIPMTSWLSQQFGRRNYFVASIIIFTVCSFLCG---NATNIWELVAFRFVQGMGGGALLVTAQTIITESYPVAKRGMAQAIYGMGVIVGPTLGPPLGGYLVDNYSWPYIFYINIPLGIIATILALTFVRSpwWGIILLSTFIGSlsLIVTLSVVTVLGLVLFIWRELTYKHPIVNLSVLKDGNLRIGTVMCFILGFGLYGSTLIIPIY-TQSILGWTATDAGLLLIPGSITTAIMMPFVGNMIQKGVPQGYMVGVGFLIFFFFTFMMytGVEHMYWPLILRGIGLGLLFVPITTLSLSTLKGKQIGEGAAFtmRQLGGSFGIAIITTFITRFS-----------------------------
     869 UniRef50_A6M0S9        Drug resistance transporter...   202     2e-50  1  12.2% 22:414  10:428     ---------------------ASSWLALAVVIIGTFMSILDSSIVNIALPKMMAVFGVSLDDIKWVLTAYTLALGAIIPLTGYLQEILGAKRIYVFALAMFTVGSMLCGLSWSNTSM---IAFRVLQAIGGGMIMPVGMSIIYQIFPREKIGLALGFWGIAAMAAPAIGPTLGGYIIEKMDWRLIFNVNVPVGIVGVILALILLKGTERKPFKSFDIIGFLSSTVGLVSILYVLGEGSSIDWSkhPDPLLDLRVFKLFDFTISQIITSVLTLAMMGGVYVLPLFL-QNIRGYTPMEAGLIMLPGALVMGIMMPLSGNLLNKVGVKALVIPGLIILalATAINMNSSKDYIILVNCIRSIGIGLSMMPISTTGMNVVPAhsRASALSNTLRQVAGSVSVTLMSTLIQGRNDYNYA------------------------
     870 UniRef50_D2NPV8        Permease of the major facil...   202     2e-50  1  11.9%  5:408   2:442     ----SSRPKKAPLVGNPAKTPYKPWPALWSLVVGFFMILVDGNIVTIALPHMLQDLDASLSAGMWVTSAYLLAYAVPLLITGRMGDRFGQKNLYMIGMAIFTAASLWCGLA---PNVESLITARVMQGLGASLMTPQTMSLITLMFPPNARGVAMSIWGATAGVASLVGPILGGVLVDTLSWGWIFFINIPVGLVGLFLAWRNVPVFEQKKHSFDWLGVVLSAVGLFLLVFGIQEGAtgWQAINPREPLVPLSLFSDRNFSVSNVAISAMGVVAISMAFPLTLYLQQ-VEGLDPTQAALMTAPMALFSGALAPVVGARLNRNDPKWIAVIGFTLLVIGFALlaDGNLWLMVGPMIILGAANACIWGPLSVSATRNLPPQRAGAGSgnETRQMASVLGSAAITTIMASA------------------------------
     871 UniRef50_C1DVS6        Major facilitator family tr...   200     8e-50  1  11.1% 24:401  16:421     -----------------------RALITFIVMSGAFMAILDTTIVDVVVPKMMGPLQTDLYGIQWVITAYMIASAVMLILSEWLDKVIGLRKVYIAGIVLFTFSSFMCG---QAQNLDWMITARVFQGIGEALIMATAQTILFSVYPEEKKGMAMGIFGLGVSFAPALGPTLGGYITEYLNWRWVFFINIPFGILTTILAIFYLPEtvSYFFLSVFTISLLIFlvYLFIVSILSLLLYILSEILSKEPLIDFRIFLIkyFVGFSVFFLLLGFSMYQVFYLIPLYY-ENLKGLSTFDAGLHILAFAMFIAIFSPVAGILSDKWNERYVLYIATAIYLISSIFIlyTPKVRAALMTIPLGIAMGMFFAPVTTLALRKLGEKTsgTGLMHYGRFVGGSFGTAIA-------------------------------------
     872 UniRef50_C4KWB5        Drug:H+ antiporter-2 n=59 T...   200     9e-50  1   9.1%  1:405   1:441     MNGSTPTPPAAPRRDrtWRPAANPWLIAVVVTLAAFMEVLDTTIVNVALPHIAGTMSASYDEATWTLTSYLVANGIVLPISGFLGRLLGRKRYFVLCIVAFTICSFLCGIA---TDLGQLIVFRVLQGLFGGGLQPNQQSIILDTFPPEQRNRAFSISAVAIVVAPVLGPTLGGWITDNFSWRWVFLLNVPIGVLTSLAVIQLVEDPPWKRGRARGLSIDYIGITLIAIGLGCLQVMLDRGEDeaKKPVVDLSCLKDRNFALGCVTIATFAVVLYGSAVLVPQ-LAQQRLGYTAMLAGLVLSPGALLITLEIPIVSKLMPYVQTRFLVCFGFLLLAASLvlVPDIDYPNLLKIRSAQSLAIGFLFVPITTLAYLTVPRRLnaSALFTMFRNVAGSIGISLSTALI---------------------------------
     873 UniRef50_C3BVQ4        Permease MDR type n=6 Tax=B...   199     1e-49  1  12.1% 23:395   5:403     ----------------------RNIFVLIALVSGFFMAILDSNIVNIALPGMAKTFHTSIDAISWIANGYNVAFVTCLLMAARLADQFGRKKLYLIGLLGFSISSFMCGVAS---SFQMLVIFRVLQGISAAIIVPVAMPLGLELVPKEKQGMIGGVMGAFGGLAAAIGPSLGGVLIDKLSWNWVFFINVPVGIFSLIFIFLFIKESYDHTASsiDWAGMVTSSCALFLLVYALIQVNKAteKKSKNPMLPLYLFSYDKFSLSNLALFFVGMGLMNFLFIFAFYLVQ-VEGMSELKSGMIISTLAIVSIIITAIMTPIAAKRGSSVISSVGVIAFIVVSYLFGHmsAWDYIWRLVIVGFGAGCTLAPLTTTAVLSVPIEKSGIAssNISRTLGSI-------------------------------------------
     874 UniRef50_O28026        Multidrug resistance protei...   199     1e-49  1  11.6% 23:417  10:429     ----------------------KAWIAFLPVSAGLFMVLLDVSVLNVALPRIAEDFGAKMSDLQWIMNAYTLTMVVLLVLAGRIGDMVRRDRFFILGMVIFVLGSFLCAQSWNTQSM---IAFRTLQAIGGTILSGNVLAIAAELFPPGRRGEVMGLNAILTASSFTLGPIIGGWLTTHLSWHWVFYINIPIGIVAIAAAWFTLPPLGGREKVPIDWVGAVLLSIGLGALTLGIIEGQNWgeLRTPYPMLDLSLFKIRNFSVGVVATAILFFGVSASLFVFP-YFLQGLKFLSAEEAGYWLVAIPIMNTFVAPVAGRLSDRMNPKYLMSLGPLFFAIGLINITSIDVDIKYWDFFamGIGMGMLMSPSFNVILSSVPLEKVGMANGTvvNTLGQAMGIAVGGVLLTTRMSDWIPGYA---------------------
     875 UniRef50_D2L5Z9        Drug resistance transporter...   198     3e-49  1   9.8% 21:417   5:431     --------------------APNKWLITLAVMVPTLIEILDTSIANVALGHIQGSLSAGQDEVTWVLTSYLVSNAIVIPISGFLSKLFGRRNYLLLSVAVFTIASMLCGLA---TSLGMLIFFRIVQGIGGGGLQPMSQAILLEAYPPHERGLAMAIFAMGAVLGPILGPLLGGYITDNYSWRWIFNINVPVGIAAIGLIWLYIKDprRKAGDTVDYIGLAlaILALTVVAAVCLGAFLVWELRTKAPIVDLTVFRDRSFATGNVVMFFGYFAFFGAIVLLPLYL-QNLMGYTAFLSGVVLGPGGLIMLLVLPVVGKMTQKIDARYLLFVGLLISAYSLffTLGIDLGTAITARNIQAVGIAFFFVPLSYLTMAYIPKEGmaSAVFNLLRNLGGSFGVAFITTLLARRAQFHQARLI---------------------
     876 UniRef50_C6XXE7        Drug resistance transporter...   198     3e-49  1  11.5% 23:405   7:417     ----------------------KKWIITFTVITASLLELIDTTIVNVAIPQIQGNLGATLEDVAWLSTGYAVANVIVLPMSGWLGSRFGRKNYFLFSIVLFTVASFLCG---NATNLEELIAFRILQGLAGGGLISTAQAILIETWPREDVGIATALFGLGAVVGPTVGPTIGGYLLEISTWPLIFYVNIPVGILAAYCTYMFVRETPKdpVDWWGIVLLAVAVGSLQTVLEKGESEDwwRELSTDHPIVNFKIMRHRSFSVGMFTSFILGFGLYGSVFVFPVF-CQNLLGFSPLQTGELLFPGGLCTIVMMPFIGIMLKkiPAQFMATIGMFLFFVFCSMllQSGTNDFFLPLMIRGVGMALLFVPLTTLAIQDLKGAEIGQGSgnMMRQLGGSFGIAALTTLI---------------------------------
     877 UniRef50_B7J6B6        Multidrug resistance protei...   198     3e-49  1   9.5%  5:406  40:468     ----AGPSAPERSPSVAQESPASRLTITVAVMLAVVMQVLDLTIVNVALTYMRGSLHANSDQITWVLTSYMVANVIILPLTGLLVERYGQRTIMLWSVVGFVISSVLCG---QSHSLVEIVLWRFLQGIFGASLAPVGQTIMLGAYPSDKRGQAMAILGMGIMLGPILGPTLGGYLTDTLSWRWVFYVNIPFGILAFLLMRTIPDGGKSTTPRPVDWTGFTLMAVGLGSLQGMLSLgfVWRSLSTPYPVVDLRLLKDRNLSIGSMGIGIFGLALFGTMVILP-IMLEGLMRYEAFTAGLVMAPQGIGAMIAMMFAGRMLGrvNPRNIVLVGIVFGAFGTYLTTliSMAWVIWPSFIRGIGFGLVTIPLFTLAFTTLEKAQqgSGIFNLMRTLGGSIGIAIVSTVMT--------------------------------
     878 UniRef50_A5MZX5        Predicted transport protein...   197     6e-49  1  10.9% 22:405   5:412     ---------------------KEKRNIIIASMVAMFLAAVEGTVVITAVPTIVKNLN-GFHLISWVFSTYLLTSTITTPIYGKLADLYGRKNILTFGIIIFLIGSFLCGLS---QNMYFLIASRAVQGIGAGSIFTLTYTIIGDLFSVTGRAKVQGWLSTVWGVASLVGPFLGGFLIDTLSWHWIFFINIPFGIISVVLIQRNLRENFQKRDVHIDYFGTLILTISIILFLYGFLAGEKKeeKKAKEPVMPFEIFTKSSTIV-NILGFLQSAVLIAMDVYVVLY-IQNVLSFSATISGLCMAPMSLTWLMSSMFLAKYITKYSKKNIVLLSSIILLIGSMVLPlsPLILVILAVSILGFGFGGNLNTQTIVIQDSVEYSTRGAAVAVNtrNLGQTIGISVFGSIF---------------------------------
     879 UniRef50_D2M242        Drug resistance transporter...   197     9e-49  1  11.8% 22:401   5:410     ---------------------PHKWLVVITVLLGTFTIILNNSMLNPAVPHLMNVFGGDAVATGWVITIFMVTMGITMPVTGYLGDKFGKKQLYMAGLFIFILGSIL---GAFSWDLSSLILFRGLQGIGGGLMMPTSMALIFEVFPRKERGLATGIYGIAAMMAPTIGPTLGGFIIEMGSWQWLFLCNIPTGLLGLIFSYLYLKQTKKVNGLTFDLSGFVAVTLGVGAILLALGRvfIRIENRKEQPLLDLSIFKVRAYTYSVWIGSISSISLFAGIFLVP-LLVQNVYGYGAIMTGLSLLPGALLSGIFMSIGGRMLDKKGPALVVTTGLILTTIPTFLYGFLSLETALWVIFVlgIGMGLSTMPSTTAGMNAIPEqtRGSAMNNVLRQMSSSLGIVFI-------------------------------------
     880 UniRef50_C6J3M3        Drug resistance transporter...   195     2e-48  1  11.1%  8:438   4:475     -------PGELAASPSKMKIDPAVMKVAWILLVGMLAPLFDTTIMNVAIDTLGNVLHAPVTSIQWVMTSYLLAISLVIPISGWLVDRYGGKNMWNLALSLFLVGSVLCGLS---WNVGSLIAFRVIQGLGGGLMMPIMQTMIVRAAGGQNLGRVMAIVGLPVLIGPILGPVLGGVIIHNLDWRWIFYVNIPVCLIALFLSLKGLpdDVANHPQKLDLLGLTLVSPALVLMIYGLTKVSSEHgrKTDHPIVDLRIFKSTTFSASACLLFISGLSSYAGMLLLPLYYQQVRGH-SVLASGLLLIPQGLGMLMTRSLAGKLTDTIGSRWVVLGGTILTLLGTLPFAMSSVDtlAISLVVRGGGLGGLMLPIMATAYEGLSKELvaSSATRILQQIGGAFGASVFAVILqlNTAFNHTFMWSVVFTIVSLVFIIFLPHKKKN
     881 UniRef50_Q633M8        Multidrug resistance protei...   195     3e-48  1  12.5% 31:414 103:511     ------------------------------LILGMFVSILNQTIINVALPPLMNEFNVSTSTAQWLITGFMLVNGILVPISAFLVSRFTYRKLFVAAMLFFTVGSIIC---ATSGNFTMMMTGRVIQAVGAGILMPVGMNIFMTLFPPHKRGAAMGLLGVAMILAPAIGPTVTGWVIENYSWNLMFYAMFIIGLIITFLSLKFFTLAQPVSNTKLDIFGVVSSSIGLGSLLYGFSEafIWRELTTDNKMLDLQVFKYPVFTFTLVINAIVTMALFGGMLLLPVYL-QNIRGFTPIESGLLLLPGSLIMGIMGPVAGKLFDKYGIRPLAIIGLAITTYATylSMDTPYSVIMTDYIIRSIGMSFIMMPIMTAGMNALPMksHGTATQNTSRQVAGSIGTAILITLMTQQTTAHVA------------------------
     882 UniRef50_A3EUZ1        Drug resistance transporter...   194     5e-48  1  10.2%  7:407   1:430     ------METTVSEVEDNHPGYPLSLRVPLTLTaaTLIETIDSTVVNVGLPKMMGGLDASVDEIAWVITAYSIGNVLMIPMTRFVSDRIGRKKYFTVSILLFTLFSYLC---AVSTSLMWVVVFRLLQGVTGAAFFATSQTLLIEAFPKEQIGLANALFAVGISLGPALGPVIGGYLVYHETWPWMFYINVPIGIVLTVMSWRFVPDSPYAIEKEETDFWGILLLLTGVPALQTFLEDGQrrQFFARHPLIDLRVLKNRSLSAGSIGLFLLGTVYFGTLFTVP-LMGQSLLGWNPLLTGIVLLPGILGFAFTSMLVGGSMGKLPLFPILLLGVTMVEISLfiSPLVSPDAFFWPLMFRGMGLACLFPPIMTLAMATLPRqaSGAAIVSMMGQLGGAIGIAVLATLMQR-------------------------------
     883 UniRef50_A4J1P8        Drug resistance transporter...   194     6e-48  1  11.8% 30:428   2:425     -----------------------------ILVIGAFMAILDSSIVNVALPRFMTLFGSSADEIQWILTGYMLTSGVVVPITGYLGDRFGNKRMYIWSVAAFTIGSLLCGLAWSTNS---LTIFRVIQAIGGGMIIPISMAMIYRIIPRQKIGMALGIWGIAAIMAPAIGPTLGGYLVDHFSWQWIFTINIPIGIAAIMLSIAYLEETPIQKNLKPDIPGILLSSVGCFALLLALSEGQDKgeLQAPNPLIDIRLLNNPVLSASLLATCIATIGLFSAVFLIPIY-AQNLLGYTPMETGLMMMPMALVTGFMMPISGKLFDKFGAFWLGIVGMSIVVGVTYYLHTLGLDTSyiILSIRAVGLGLATMPLTTAGMNTVPRfgRASALNNTVRQISGSMGIAYLTYVMLQRQAYHTAILTEGVSISSMAAV----------
     884 UniRef50_C6DDE0        Drug resistance transporter...   194     6e-48  1  11.5% 14:404   1:419     -------------MQREPLKGASLAWMTVALSLATFMQVLDSTIANVAIPTIAGNLGASNSQGTWVITSFGVANAISIPITGWLAKRFGEVRLFLWSTALFALTSWLCG---VSTSLEMLIFARVLQGIVAGPLIPLSQSLLLSNYPPAKRSIALALWSMTVVVAPICGPILGGWISDNYHWGWIFFINVPLGIAVVFIAMQTlpIDTIGLALLIVGIGSLQMMLDRGKELDWFNSTEIITLTVVahPVVDLSLFKSRNFTIGCLCISLAYMFYFGAIVLLPQLL-QEVYGYTATWAGLASAPVGLMPVVLSPIIGRFAPRLDMRKLVTFSFIMYAVCFYWRAYtdFGASAWPQFVQGFAVACFFMPLTTITLSGLPPeaAASSLSNFTRTLAGSIGTSITTTL----------------------------------
     885 UniRef50_B1LVU0        Drug resistance transporter...   194     7e-48  1  12.8%  5:401  19:451     ----AGQARGSKAASGKAPGGHNPWLIAGVVALATFMEVLDTTIANVALRYISGGLAVGPDEAAWVVTSYLVANAITLTASSFLAKRYGRKAFFMWSVALFTASSILCGFA---WSLESLLLFRVMQGLGGGGMAPLAQSILADSFPPAKRGQAFALYGVAIVVAPVIGPTLGGWLSDNASWHWCFLINGPVGVIALGLMYWLIEDSDAAKkiRFDIVGFVLVALFLGSLEVILDEGQRKDwlTRENPVVDLRLIGNRQFGSCFLVMMFTGAILIATTQFIPQI-TQEYYGYTATLSGLVLGPGGIVTVVMMFLTGRISSYVQPKWLIATGMTIVALGMYDLTRIDGSTTFAFFAwiGIGLPMVFLSITSASYEGIRKDQtaSALINVARNVGGSMGVSLA-------------------------------------
     886 UniRef50_Q21EY4        Drug resistance transporter...   194     8e-48  1  12.3% 20:408  13:430     -------------------STHNKWAVALSVSMGGVMSSLDTFILYVATPNLRGVFSATVAEVSWVSTSYAIASMMCMFLSGWFVDRLGSKRVYQAGLVLFVIGSALC---AMATSLEQLILYRVIQGLGAGILLPVEGVILRRTFPPVQHGLVMGLYGTSIMCGPAFGPMLGGILIDQFSWHFIFIVNIPIGIISFVMVRHYLIDDpdTPKRTFDAPGILWLLFGVVGTVWLLERGDraHSLTIKQPLLDLKVLKHKTFTAANSLNFLAAFMITGTLFVLPIYM-QELLGFSPTQAGTTMAPRALVMMLAFPLVGWLFNRVPMRLLITTGLVLGIGSGVMMAGFTFEtmILPQIIQGLGAAFILGPVTTAALISIPKAtaAAALESTTRLLGSTLGIAVFASLITHY------------------------------
     887 UniRef50_B1YHW2        Drug resistance transporter...   194     8e-48  1  12.7% 16:408   4:421     ---------------EKSATARPPYGILAVLMIGAFIAFLNNTLLNIALPSIMKDLEIETSTVQWLSTGFMLVNGILIPTSAFLIQKFSVRRLFLLAMTLFSAGTIL---AGFADAFPVLLAGRMIQASGSAIMMPLLMNVMLVSFPIEKRGTAMGFFGLIMMGAPAIGPTLSGWIIEHYDWRMLFHFITPIALIVLVAGFVLLRDVKERSGAKLDFMSVVLSSFGFGGLLYGFSSAGSkrQLRMERPMLNFKIYRYPMFALSSAISIVVTIAMFSGMLLLPIY-VQTIRGISPLDAGLMLLPGAILMAVMSPINGKLFDKIGGRPLAITGLFITVVTTYLFSqtTYTHLIVLYSLRMFGMSMVMMPVSTNGLNQLPTRyhGTAMNNTLQQVSGAIGTALLVTIMSTH------------------------------
     888 UniRef50_C6I0Q5        Drug resistance transporter...   193     1e-47  1  11.9% 20:407  12:427     -------------------SPHYRWWALGVVMLSLFLPVLDTTIVNVALPYMIGSLDTNQDEVRWVITAYSMAFAVSTLASAWLRTVFGIKNLYLGSIVLFVASSF---FAGISPNLNLMIVFRVLQAVGGGIMMPLGFTIITEAFPAPERPKAFGFFGIVVVLAPTIGPILGGWLVDNMNWRDVFFINVPFGFLSFFFTMFILKKDRSHTLVPFDYAGFISLGTALSFLLVGLTEGERWGWTavKHPLIDLSIFRDLDFVLIMVANFFRAIGLFGRMFLLPLF-VQTFNAFTATDAGLVLLPSSLMAGIAMPVLGAVSAKGskRGLLVAGFLMLAFsaFLMGVPSMSQIIVAQLVFGLSMGMLNALLSSIPQTLVAPRHIGLASSlnMLQIGGALGVAVLGNILDH-------------------------------
     889 UniRef50_Q81BF3        Multidrug resistance protei...   193     1e-47  1  12.9% 14:408  22:443     -------------MSETLHKRKPPYLMLVILFIGAFVSFLNNSLLNVALPSIMKDLNidYSTIQWLSTGYMLVSGILIPASAFLITRFSNRSLFITSMVIFILGTAL---AAVAPNFGLLLTGRMVQAAGSSVMGPLLMNIMLVSFPREKRGTAMGIFGLVMITAPAIGPTLSGYIVEYYDWRLLFEMILPLAIISLLLGIwaKLDYLSLLLSSVGFGGLlkVVLTALIIGAIALIAFIIRQLKMDEPLLDLRVYKYPMFALASVIAIVNAVAMFSGMILTPAY-VQNVRGISPLSSGLMMLPGAVIMGIMSPITGKLFDKYGPRILGIVGLSITAVSTYMLAssSHTHIILIYTLRMFGMAMVMMPLMTNGLNQLPTRlhGTAVNNTAQQVSGSIGTAILVTIMNSV------------------------------
     890 UniRef50_A3EUY6        Drug resistance transporter...   193     1e-47  1  10.3% 20:407  11:426     -------------------SPHYRWWALTVVMVGLFLPVLDTTIVNVGLPNMVGSLDTNTDEVRWVITAYAMAFAIVTLASAWTRTIFGVKRLYLISTFVFTFSSFLCGLS---PNLNAMIFFRVLQAVGGGLMMPLGFTIITEAFRPEERAKAFGFFGVVIVLAPTIGPILGGYLIDNFNWRDIFFVNIPVGILSFALTFFFLRKDTAQTVVPFDFAGFISLGTSLAFLLVGLTEGQRWGWtrVKHPIIDLTVFRDWDFSAIMVLNILRAISLFGRMFLLPLF-VQTFNRFPATDAGMLQLPASLIAGIFMPVMGHVSGIigKRLIMLSGFILLASAQFMFAftSFYQILIPQLVFGLSLGMVNALLSSLPQNLVERKHIGLASTlnMLQIGGSIGVAILGNILDH-------------------------------
     891 UniRef50_C7PTA5        Drug resistance transporter...   192     2e-47  1  11.0% 22:404   3:412     ---------------------RYKKYVLATLMIGTSMAAIDSSIVNVSLPVIQRQFDVGLDDVSLVITAYMITFLLFIPLTNWLKNRVGYYHLYMASIIVFVLGSALCSIAG---SIDMLVWSRVIQAVGGGSIAPVSLAILSESFPQDERGSAIGWWGIGNVMGPALGPTLGGVLTEYLGWQAIFYVNIPIGIIAILMNMRYlpFDFKGYFLFidKFGFTSWQFISGVLLTVLSLWLFIRSSRKPSALLDLSVFRVAAFNRAFIIVALRSLALFGGMFFLP-FLLQGYLKYTEIQSALLILPNALVMLLTRPLAGKMADAGEIRNISVFGIVLVSASFFLFAqtPVWFIVLSMIVRGLGISFLIAPVSTAMLNAVSPSQTATATSLnmLQLGGSVGIAISGSM----------------------------------
     892 UniRef50_C2EQN9        Drug resistance transporter...   191     4e-47  1  11.6% 20:399   2:406     -------------------SKTRKIIGFVGLILAMFMGALDATIVNIALPDIMKDLKTGLTDTSWVATIYVLAMAAFIITASKLADIWGRKKVMLIGVILFGGFSFACM---TANSLNLLIIYRFFQGIGGAILTPIVLPMGIELFGKENTSKITALMGAFSALAAAGGPAIGGFIINYESYHWIFGINVPIAIVAFLMILIGTNEswLGVIFLTTFMGSLCFGLLEGREYGWSSnlFILVEAKVKSPVVNLSLFKEKTFSSSCIIYMVFGFAIIGPSLIL-NYFLQNVKSYSALHSAYLIIPASLAIAVGMPLATKMYKTVSSKMLIGIGLVITAGGLAMLGmtTQEIIVCCNIIIGLGLGFTAIALTSSV-KFLPVEKTGIGSgnAARYVGQAIGMA---------------------------------------
     893 UniRef50_C8WB01        Drug resistance transporter...   191     5e-47  1  10.7%  5:398  22:442     ----PPDDQRKPASAEGLLSGSKQAIACIILALTNFMVVLDTTIANVSVPHIAGDLAVSNSQGTWVITSYAVAEAICVPLTGWLSRRFGTVLLFFISIIGFTSFSCLCGFS---HSLMVLLIFRCLQGFFGGPLMPITQTLLLRVFRKEQHAQAMGIWAMTTITAPIIGPIMGGWLSDNWSWPWIFYINIPIGIICAMGVFALLRseTRTLKEYIDKGGLTIMVIWIACLQIALDLGHDHdeLTEKQPIVDLKIFRHRGFTISVLSLSFSFGVFFASAVIIPQWL-QRVMGYTATDSGLVTAMSGILAVCFSPIVAKLSGKVDARILVSFGILWLGGCTALRTfsSYWIFAVPQFLQGIGMPFFFVPLTTLALSSVLPetSAAGLMNFLRTLAGAIGT----------------------------------------
     894 UniRef50_A5FEE9        Major facilitator superfami...   190     6e-47  1  12.4% 41:435  22:460     ----------------------------------------DIFIVNVAIPSIQRGLGSSNGKIQLVVAMYMVGFASFLIIGGKTGDYFGRKKIFVLGMLLFMISSAGCGFA---DSTDHLIILRFFQGISAGLMSPQVLSYIQVLFTdkERTYAMSWYGIAIGIGTMLGQFLGGFLVElqSWRYIFLINIPICASGIFLAIRYLNPSRDYSSLQMDYWSAFILCIGLALLVFSMAVGLEqrKSNKKEPLLNLELFKNRNFNMAVSASALFMLMLDAYFFVLAVFLQEGIQ-LSPMQAGYFIVFQGSGFILASFLSARLVPRFGKTVLIFGVLLLISAIILQLVLFYYPIvyVIMFLHGVGVALVLPSFANIALKNLPQNMIGNASGvtVQQLFGALGIALTGSVfdFKHFYNAFFYGTFicLISVLLILFLLPKS---
     895 UniRef50_Q024G5        Drug resistance transporter...   190     7e-47  1  11.4% 13:417   4:441     ------------DESQGWHPGHSPWTVALTVTIATFMEVMDTSIANVSLPHIAGGLSAGVDESTWILTSYLVSNAIVLPISAWLSNRFGRKRFYMTSVAIFTVSSLLCGLA---PSLSLLIFFRILQGVGGGGLGPSEQAILTDTFPAAKRGMAFAVYGMAVVLAPAIGPTLGGWITDQYSWRWIFFINVPFGILSLFLTNHMVQDPPDMERAKQDAKKAPVDFLGLVLIATGLGaaFVIWEWNHRHPIVELGLLKNRSFAVACMLMLVTFAVMLGSTLLIPQF-AQLELGYTARQAGELLSPGGFTILILMPMIGYLVSRVDARYLIGIGYLIFAASLflYLGVDFRTAVMWRVYQAAGMAFLFVPTNTIAYTDMTPGAsvSALTNLMRNMGGSVGISAVTTLLARRQQTHQVFLV---------------------
     896 UniRef50_D1AMZ2        Drug resistance transporter...   190     7e-47  1  11.7% 22:405  10:418     ---------------------KNKNVILITVLLLAFMTSLDGSIVNVALPMMSESLSVNTQSISWVFSSYLIGICTLILAFGKLGDLKGKMKVFKTGILIFTLGSMMSGLSAA---FPFLITARIIQAVGAAASMATSQGIITEAVPRNEIGKAFGLFGTCIALGTMMGAPIGGFIISIFKWNYIFFFNVPIGIIIFILCFKFLPKEHVNNGKFPDIRGFLLFVITIVSFFIAVMQGGAVgeKRADDPMLDLDIFKSKSFSISIFCSFLSFVAIFCLLI-INLFYLHYAREYDPSFIGLLMMFYSIILTLSSLFSGILSDKIRPELLTFTGLAIMGAGFFFMTltPIFLLLIFMALIGLGAGLFQSPNNSLVMSAASKDKLGIAGSVnvRNIGMSIGIAVATILL---------------------------------
     897 UniRef50_C7QJJ8        Major facilitator superfami...   190     7e-47  1  11.1% 15:436  33:510     --------------PSQSAIPKGAWAVMFTVLGASMMDLLDATVMNVAAPSIRNGLGASNTEYQWISTGYVLSFSVLLIAGGRLGDIAGRRRMFLIGLTGFTIMSAVC---AIAQNPGELIAARLLQGGASAMMIPQGIGMIREKFGRENSQKAFAIFGPFMGLSAALGPVLGGALITYSSWRWVFVINLPVGVIALYFAAKVLPkpVIQGREHHWDAGIWLMLAGSAVVMALFAVYARARHKRNLDPFLETSLFRKRAFTTGTMTIFLFFGACAAAFTVSP-LLLQVSLGWSPLRAGLTGAWWSLGTIISMGAGQAFVKKTPRRVLHAGLLTLAAGMALSasGVTSWNLAPALLVSGIGMGLVFAPFFGLVLAAVDDhgSANGVISSFNQLGNAVAAALFSTLfeSGGSpeLVYWLAAGILVLTWLLAFTVPKTA--
     898 UniRef50_A5VLP0        Drug resistance transporter...   190     8e-47  1  11.5% 23:406  16:424     ----------------------NRSLMIFVLLIGAFCTILNQTILSTAFPALMDAFNISTATVQWLTTGFLMVNGIMIPVSAYLTSRFNTKSLFIIAMSTFEVGTIL---AWIAPSFAVLLAGRLIQAVGVGINMPLMQNIMLTVYPPEKRGAAMGVNGLVIGLAPAIGPALSGWVIDSYSWRWLFGMIAPITALVIIVSFFAVKNVIPNKKPHLDWLSVVISTLGFGSMLYGFSSVGDKGWTDpdDPFLEFKVFESKEFSLATILSSIVMMAMVGVEFVIPLYL-QIIHGMSAFHSGLTLLFGALFMGIMSPITGNLFDRHGAKRLAFTGMFILTVGTIPFAftPTIYIVFLYAVRMFGISMVMMPVTTAGMNSLPYnsHGTAVNNTIRQVATSVGTAIMISVLT--------------------------------
     899 UniRef50_B1YME5        Drug resistance transporter...   190     1e-46  1  12.0% 15:407   1:418     --------------MQSTKQSSRLYLILAVLMAGAFVAVLNSTLLNIALPSIMKSFNIEASTAQWLTTGYMLVNGIMIPTSAFLVQKFSTRQLFLTAMGLFSIGTIV---AGQADLFPVLLGSRMLQASGSAIMMPLLMNVLLNGFPIEKRGQAMGIFGLVITFAPAIGPTLSGWVLEHYEWRMLFHIVTPISLLVLVIGFFLLKKEVVTSTLRLEKLSLVLSSFGFGGLLYGFSSAGSAGWdrLDEPMLEFRIFKYPMFALSQAISMVLNMSMFSAMILMPIY-VQTIRGISPFHSGLLMLPGALVMAFMSPITGRLFDRFGARVLAMIGLSLTVLTTFFFSRLTADTAYSFLVImfLGISMVMMPVMTNGLNHIPQHLtgTALNNTLSQVSGAIGSGLLVTVMTS-------------------------------
     900 UniRef50_C9RAJ9        Drug resistance transporter...   189     2e-46  1  12.2% 21:413   5:422     --------------------RALPWGSLGVLVLGTFMGVLDSSIVNVALPHLMALFSATEDQIQWVMTIYLLVGGMVIPAAGFLGDRFGYKKAYLGSVLAFVLASALCGLSWNTTSI---IVARAIQALGGGMVIPLSMAYLFRIWPREKIGVATGLWGMTITVAPAIGPTLGGYLVDYVSWHWIFYINLPIGIFTVLWGWLALKETPIQEDLKLDWLGLFLIAGSAFSLLLALSKGQDWGWTSppNPVLDVRLILNPTFMASLVASNLTSVALF-VGIFLVPLFCQNIQGYSAMQTGLILMPAALTTAFFMPIAGKLFDTVGAVFPGLLGMGIVAAVTHALIHLTADMPiiLLCIRNAGLALAMMPLMTAGINTIPTARTgtAIASVTRQVAASFGIALVSYVLTNRTVFHA-------------------------
     901 UniRef50_A3ZY25        Drug resistance transporter...   188     3e-46  1  10.9%  7:401  14:446     ------TDVPRAAASATMFRSVNPWVIAAIVVIPTFMEVLDTTIANVALRYIAGGLSAAVIDSEWVITSYLAANATILPISGWLSSRLGRRNYFIGSIVVFTFASALCGFA---TSLEQLICFRILQGLAGGGLQPSSQGVLLDAFPQEKQGSAMTVFGVAALIAPVIGPTLGGYLTVNFDWRWIFYINIPIGAFAALAAWTVLEDPprKAGWRLDGIGLGVLAITVSAWEVLMSKGQEWdeMRIADPVVNFRPLAERNFLISTLVIFSSFGVLYAASTTLPNLL-QTLFGYDAFASGLVLSPSGIFAVATILIVGPLITrwDARIFVACGLVLIALGCYWMSLMtpWQAVWPRVVMIIGLSMIFAPLNVAAFLYIPRNLRGAAVGLFarNEGGSVGTSVA-------------------------------------
     902 UniRef50_A1A3I9        Possible efflux transporter...   188     4e-46  1  14.9% 36:438  45:486     -----------------------------------FIALLNQTVMSPALPALMRDFNITTGTVQWVTSVYMLVSGIMVPISGYLIDKFSTRKLFAGALATFMVGTLLC---AVAPNFVLLLVGRILQSAGSGVLLPLVAVVPMLVYPPDKRGTAMGMAGIVMAAGPAIGPVVGGLVIDGFGWRPMFIGIAIVALVILVGGTMMLKNVGELKNPKLNILSVILSTIAFGGLLYGFSSASTMGWASpdEPLLRVDTLATRNFRNSAILVTLINAAVAATNVTLP-IFIQNVLGQSATVTGMVMLPAAAVGIILSPVAGAAFDKFGPRGVGIGGLALMTISLGLLGTINTRTSVLFVAVfaSGQAIANMPINTWGVNALPNdaHGNAIANTGRQIAAAIATSLlgVKSATASGIAFSYLLCAAISLVALIICIFTVTSRAK
     903 UniRef50_C6D3D1        Drug resistance transporter...   188     4e-46  1   9.0% 14:413   1:425     -------------MNTSSSQNVRFWPIMIAIFFGAFLSILGISTINVALTIFMQDFHSDLSTVQWTLTGFMLSLGTIAPLSGYLGEKFGYKNVYLYAMIGFVIFSLLCGFS---WNAGSLIAFRIIQGIFTGLVMPATMTIIFQIIPKEKQPFAVSIWGLSGMLAPAFGPTLSGWLIQQFDWRWIFFMNVPIGIVAILFIIAMIPDVRIGTAKVLDKLGLTTvvLGLFGLGAVMLVLFIWHELRTQNPLLNLRVFGNYRFSITLVANTIITISLYSGTLLVPLFL-QNVQQITPMDTGLILLPSSLVMALAMPIAGKLYPRVGAKWMTIGGLVLIIFGSYEMTHLHTDsvIFWMAVRNLGVSFAAAATSTAGMEEIPPQMVGHASSVtvRNVGGSFAIALFTSLLASHTITHV-------------------------
     904 UniRef50_O34691        Putative metabolite transpo...   188     5e-46  1  14.0% 23:436   8:394     ----------------------SQRKLLGVAGLGWLFDAMDVGILSFIIAALHVEWNLSPEEMKWIGSVNSIGMAAGAFLFGLLADRIGRKKVFIITLLCFSIGS---GISAFVTSLSAFLILRFVIGMGLGGELPVASTLVSEAVVPEKRGRVIVLLESFWAVGWLAAALISYFVIPSFGWQ----------------------------AALLLTALTAFYALYLRTSLPDSPKYESLSAKKRSMWENVKSVWArrPTVMLSIVWFCVVFSYYGMFLWLPSVML--LKGFSMIQSFEYVLLMTLAQLPGYFSAAWLIEKAGRKWILVVYLIGTAGSAYFFGTasLSLLLTAGVLLSFFNLGAWGVLYAYTPEQYPTAIRATGSGTtfGRIGGIFGPLLVGTLAARHISFSVIFSIFCIAILLAVACILIMGKET--
     905 UniRef50_A6SC37        Putative uncharacterized pr...   187     5e-46  1  13.4%  3:406  62:498     --APTTTITAGDEPVAAFAPGKRYIAACTSILIVNLACALDATTIAVALPTISEALNGNATEAFWAGTSFLLTSTIWQPVFIALSHVFGRRPLLLLSLILFTIGSCLGGAA---RSMALLLVGRCLQGSGVGGILALTEALITDTVPLRQRGNAMALLGVVWALGSVTGPLIGGILAEKNDWRWIFYLNLPIIAVGFVGCVWFLKLERKErlSEIDFIGSIIFVGSLTSFLIPLTWGGVseALLAKKPIIPTRLFRNPSTTIAYFCTFLHGMILWSIVYYAPFYFM-SVQGYTSMMAGVAALPETLTIVPMAMIVGIIAAKTGKYrwLGWALTVFGCGTLYLLDVGTPVVAWIFLMlgIGMGLLYPAMSLAIQASAPQKDAATAAGlfFRALGQTVGVAIGGGILQ--------------------------------
     906 UniRef50_Q0W4M4        Multidrug resistance transp...   187     6e-46  1  11.5% 22:413  15:432     ---------------------RNRYKIMLVVLPSIFMSVIDGTVTNIALPTITSYFNVDVALSQWVITGYLLTITSLLLVFGKISERTGKIPIFIAGFAIFTVSSLACGLA---PNLPVLIGCRVLQAVGGAMVFSISGAILFQAFPVKERGRAMGYIGSTVAIGGIMGPVVGGFLVSTLGWQYIFLINVPIGVVVLLAALAYLRMpvLCLGQLADTAAITPPIVALAAIFAVSLTAFVWIESRARSPILDLEVFRIKNFTLPCLSMLLFFVGSFTVTIVGPFYF-EGVMGFTPAQVGMFFLINPIIMMIGAPIGGWLYDKHHSKYYSTAGMLIITAAMFLYAyaSIPAIIAGMVLLGIGGALFQSPNNTELMSALPRQKLGIASSvtVRNLGFTLGTSFAVLLLTVQFSLAG-------------------------
     907 UniRef50_C0Z7Y5        Putative multidrug resistan...   187     7e-46  1  12.6% 25:414  14:428     ------------------------WLSLVAILSGTFVAILNNSLINVALPAMVNIFGSSTETMQWVLTGYMLANAVMIPMSGSLSAKFGAKKIFVLSLSAFTCSSILC---ALAWSDSSLIAFRVVQGVSGGMIMPIGMSMIYMIVPREKIGMALGIFGIASMTAPALGPTLGGYLIEFLSWQFLFLVGVPFGIFAVIMSIVLLKETPKKPELKFDFLGAFLAIVGFGTLLLALSKgfVWVELGKESPLLDLRLLKIPTFTISILTSGFVMMGMMGGIFLMPIFL-QNIQGLTAMESGILLMPQSIAMAIMMPISGKLMDKYGVGPIGLVGLTIMSITTylSADSMHSWIDMILTIRGIGIGLCMMTLSTVGMNAVPRTSVGDAssNVLRQVMSSFAIAILTVIMQARQNFHMA------------------------
     908 UniRef50_Q8CUZ7        Multidrug resistance protei...   187     8e-46  1  10.8% 23:430   9:451     ----------------------SRKVVCFIYILAMFMASLDGTIVYVALPTIGEDLNVSSADLSGVTVWYLVGVAAILPIAGWLGDRFGSKKVFLSALSIFTIASIICGL---VQTVGLLNIARFIQGLGGGMLAPIGMAMIFRTFSVEERPKVSRSLVLPIAIAPALGPIVGGLILEILSWQWIFFINIPIGVIAIVIGMFYLTEHQEENVGRMDWKGFVLIVVGYPLLMFSLTQGSSRGWTskEKPIMDVKLLSEPTFRKVSILSFFAVSGLQSLLFIFPIMYQQAV-GATALESGIVVFIEAIGLMLASRLMPFSLKKLGVYRVILFGFLGACISFILMsfANPWVLRILLFTIGLTLgsVIAMQYTTFTNITSQNMsaTTLFNVQNRLGAAIGISMIASLLITlnPYQISIFIAAIFLAISFILTF--------
     909 UniRef50_Q2NFU0        Predicted arabinose efflux ...   187     1e-45  1  13.1% 26:438   4:451     -------------------------YVILIAMLASFGVAFTSNAVSVALPTIAVDFNITNIMQNWLVNIYLLVIAAASVPFGKICGKYGLNKTMGIGLIGYVVGSILSGIA---FNIEFMLVARIIQGIASAVLFVNSMAIITEQVPPQKRGQAIGITVTGVYLGLTLAPTVSGFLVEYVGWRSIFYITVPLILISYYLLTRIDKEWIIGGGDPIDVKGSLLYVVGILILMYGFtaIFAKYELKEQYPIYDMHLFRNVKYTSSNIASLISYFATF-VVTYILNYHLQYLNGFSPETTGLILIVTPLIMAIGAPIAGRLSDKINPQILAAIGMIIVSIALVILCftPLYMIFISMILQGVGFSLFSTPNNNVILGSVDKkaTASASLSTVRTIGQSFSLGLLTLVfqLILSSQVTMILSTILCIIAILLSLMGIKSGNK
     910 UniRef50_A8H4M3        Drug resistance transporter...   186     1e-45  1  11.1%  4:401   2:424     ---TELSQASSSPGDAQVLSEGSRKLVTLAVMLSAIMVLLDMTIANVALPHMMGALGVTSDQVTWVLTSYSMAEAIFIPLASFLALKFGIRNLLLISVSGFIVSSALCG---QADTITEMVTFRVMQGAFGASVIPLSQSIMVQIYPANQRGKAMALFSVGVLLGPILGPTLGGIITENMDWRWIFYVNLPVGAICLTLIYTFVKLSGKGKPKIDWPIVIAmtILFSTIISAIAIIFFVARSFTTKSEIAPVWLLRDRNLAMSCLVMAGFSMGMFGITQLQPMMLEQ-LLNYPVETTGFAMAPRGLASAFVLLMMARYMDRIDARLLIVIGLSLNALGTYLMTQYSlyWILLPSIIQGAGMGLVFAPLSQLAYATLAPkiGGAVVFNLCRTIGGSFGISIV-------------------------------------
     911 UniRef50_B0MYW2        Putative uncharacterized pr...   186     1e-45  1  11.6% 18:438   9:475     -----------------RNSRGYKWWILSLVMLGTFMAVMDVTVVNVGLPTIMSVFHIPISTAEWVITAYMITMTLMLPSAGWIADRIGNKRMYILGLVLFTFGSWLCGRAG---SDMFLISARALQGFGSGIIQSLGLAIVTREFPPQQRGLALGLWSVAAAASISFGPLIGGYLVDDYSWHLIFDVNVPVGLAAILFAIFIQKEWRGARAGSFDWPGFLCvvIGCFAVAAAALIVFIVRELRCENPLLNLKLLGERNFGVSMAVLAIFGIGMLGGTYLLPLYM-QKGLGYTAIMAGSVFLPVGLIQGVLSTCSGFLTRYVKPLFIAVTGILVMTLSFYFalHTTHAQIMLVLYLRGFGMGLTFAPLNDFSLMNLSqmASAAGISNSIKQLSGSVSIALLTVILTGRTAFHSafLFVTFVSLASALPFLWLLRPRRK
     912 UniRef50_B0TDY6        Drug resistance transporter...   186     1e-45  1  11.8% 33:413  20:425     --------------------------------IGTFMAVLDTSILNVALPKLMVLFSVDTKEIQWILTAYMLVSGAVIPIMSYLGDTYGYRSLYAYCLAAFTAGSLLCGLA---WNNESLIVFRVIQALGGGLIQPASMALMFRFVPKEKMGMAMGLFGLSIAVAPSIGPSLGGFIVEDFSWRWLFMINVPLGVLGFVLCQTLLPETEKIPSAHFDFWGLLLsvVMLLLTATAMAALLVVVELNHTHPMLDLRLFKIPQFTYSVVISSCLYIILISGVLLWPIYL-QNIRGYSAVQTGLILMPQAIAMGLMMPVAGKLYDKIGARPIVMVGLPLIGVSTYLMHttPQSVFNLWLILRGLGLGLTFMPVNTAGVSAVPLMKAGAAsnNLVRAVAGSFGIAITTSMLENRQAFHA-------------------------
     913 UniRef50_A3IG12        Drug resistance transporter...   186     2e-45  1  13.3% 40:414  17:417     ---------------------------------------IEGTIVSTAIPSITADL-LGVDLISWIYSAYLLASAIAAIIFGKLADLFGRKRMIITGIIIFLLGSMLCGLA---QSMEQLIVFRAIQGIGAGSILPITLTMVGELFTTEkrAKGQSYLSMVWGVSGVVGPLFGGFIVDQVSWHFIFFINVPFGLASIYLIVKHYKEQLEAVKRKIDYLGAGLFTVGMVSLLYVIIevFIWVELRAEEPIIPLTLFKNGRLMVINSLTLSTMSIVIGVTVYIPIY-AQSVLGKNATQAGLLLTPMSIFWTMNSIAAGYLIGRLTNKRIIQMGTILLVTGTIMLARLSslSVYLGSSLIGLGMGFIMPMLMISIQKVANPKQLGISIGlfTNTFSQAVGAALFGMVFNLATSEKMA------------------------
     914 UniRef50_Q2YVZ7        Multidrug resistanc-related...   186     2e-45  1  11.8% 20:409   2:416     -------------------SKKQKLTMIITMLMGGFFGLLNETLLVTALPSIMKDFEISYIQVQWLTTAFLLTNGIVIPLSALVIQRYTTRQVFLVGISIFFLGTLLGGLS---PHFATLLVARIIQALGAGIMMPLMMTTILDVFQPHERGKYMGIFGLVIGLAPAIGPTLSGYLVEYFNWRSLFHVVAPIAAVTFLIGFKTIKNVGTTIKVPIDFISVIFSVLGFGGLLYGTsaLFVLRQYRLSTPLLNFAVFKNKQFTVGIIIMGVTMVSMIGSETILP-IFVQNLLHRSALDSGLTLLPGAIVMAFMSMTSGALYEKFGPRKLALVGMAIVVITTAYFVVMDEQTSTIMLATvmVGIALGLIPVMTHTMNQLKPeaHGSSMTNTVQQIAGSIGTAALITILSHAS-----------------------------
     915 UniRef50_Q2H3G7        Putative uncharacterized pr...   185     2e-45  1  12.4%  6:407  36:469     -----STPGAPGASEPPANTPVQLALILVALCLAVFLAAIDSVIITPAMPTITKELNASDAGFAWIGSAYLLALSATSPFWSKVSDIFGRKPILIVANVIYLIGSLV---AALSNSLVMLIAARAVQGTGGGGLITLVEISVGDMFSQRERGLFYGIYGAVWAVSTAIGPVIGGVFTERATWRWCFWFNLPFDALSLIITIIFlkTPLVKGLIAIDWVGSVLIIGATLMFLIGLDSGGVSheRYARYPVIPRRIFVGLSRSCIFGVVFCHGAGFIAPIFFLPLYF-QVALGATPIQSGVWMLAIAISFTLSGIIMGIVIQRTGHYLWIIRGSMALFTLAVGLMVTFGPtiIIFQILLAAGIGANMQTLVIAIQALVAPegVATGTLNFVRNIATAISVVLGQVIFQS-------------------------------
     916 UniRef50_Q04GG7        Permease of the major facil...   185     2e-45  1  12.2% 20:420   1:426     -------------------MKQKQMAILMTMTISIFLCMLDTTVMNIALPAIQTGLHTDLDTLQWALNVYTITFAAFTIPLGRIADQFGRNKVYFAGLILFLLGSL---TSASSSTVAILIIGRALQSIGAAIVFPASMTIGINSVQLNKRNTAVLILGITQGLAAAFGPTIGGLLTQFCGWRGIFYINVPLVLLAAIMCVALLpsLTLALVKASAWGWTSGKILSLFAGFVIALILFIWRESMASDPMIRLHLFKYRHFTGAVVMTVLSGILFVGVMVLMPSFFTK-IQGHTELEAALMITPASIMVFLLSPVSGLLLKKMGARQLIALGIVLLGLGYVGLSVMNpwQFAISCILIGTGYGIIIGPITVLSAGDFTGELLTASQSVtfRQIGTVLAVAIFVSALSTNLATAKAQVWSAA------------------
     917 UniRef50_D2SH23        Drug resistance transporter...   185     3e-45  1  11.2%  6:405   9:441     -----TETVEGAVPGDGAFSHRQVLTVLAGLMAAMFLAALDQTIVATAVRTIADDLD-GFSLQAWATTAFLITSTISTPLYGKLSDLYGRRPLYLFAISVFIGGSVCCGVA---DSMYQLAAARAVQGVGAGGLMSLALAIIGDMVPPRERSRYQGYTMAVWGSSSVLGPVLGGLLAGqdGWRWIFLVNVPLGAVAFTIVFRVLHLPHERRDHRIDWPGALALTTCAVPLLVVAEQGRGWGWTSPAAllLPLRLFGNRTFVVTALGSIVLGAGMLGGLLLIPQYL-QIVHGSSPTVAGLQMLPLVAGIMAGAGSSGVAISKTGRYrlLGVGLMATALFGfaGADTPYGLLVPFLAMFGVGVGFTFQPVVVAVQSAVRpiGVATSSVAFFRQTGATVGTAAFLSLL---------------------------------
     918 UniRef50_Q3B6T7        Drug resistance transporter...   185     4e-45  1  10.1%  4:401   9:435     ---SSMPSVANGSEAHAYETGVRRTIITLTVIVAAMLELIDTTIVNVAINHISGNLGASIEDVSWVVTSYAIANVIVIPLSGFLGNLLGRRAYFIGSILLFTLASLLCGLA---DNIWTLVFFRFLQGIGGGALLPTSQAILYETFRPEERGAATGIFSMGLVLGPTIGPLLGGYLVDYFSWEWCFFVNIPVGLLAAWSAFTFIREpwTGIGLLAAGIGSLQFIlwFTLIALTSLVAFVWWELHTEHPAVDLSVlrSKNLAIAAVLTFIVGYGLYGSLFVFPVFVQRLLGFTAVLTGLVLFPSAMLTGAISLPLGIALQKGASAKLMMAFGMAAFMVFSWELGQQTLQsfFAVLLLRGLALGFIFIPVTMLAVTGLHGrgQATGLNNMVRQLGGSFGIAIT-------------------------------------
     919 UniRef50_P0AEJ1        Multidrug resistance protei...   184     4e-45  1  10.6% 26:404  14:420     -------------------------IMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSS---SLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTltLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELdeLTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLL-QEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYtdFGASAWPQFIQGFAVACFFMPLTTITLSGLPPeaAASSLSNFTRTLAGSIGTSITTTM----------------------------------
     920 UniRef50_Q6US32        LinCd n=6 Tax=Clostridium d...   184     4e-45  1  14.5% 15:435   1:460     --------------METQSNNKKGNLIIAIVMTGAFISSLSQTLLSTALPNIMSDFKITADIGQWLTTIYLLIAGIIVPTTAYLINRFSTRKLFITSMSIFSIG---CIIALFSNNFSTMLIARVLQAMGSGSLMPLLQVIILYLCPEEKRGAAMSLVGITVGFAPAIGPTLSGWLVDSFGWHSLFLFLSPIAILDVILSFILLRNVGETQKLKLDIPSIVLSSLGFGGLLIGFTNqfTLRQLKSKEPFLELRVFKNKPFLISTILIMIVYASMMSATLMIPLY-VQSVRGFSALSSGSLMLPGAILMVVLNPIAGRHLDKYGPHALSILGTGCLLLGTLSFAFLGRDTSLIHVSLmmIGISMVLMPLTTWGIKTLDResHATAINNTLRQISGAIGSAILITIMTSahGIDVAFSIAATLAFTGLIVSICFIKR---
     921 UniRef50_D2BLJ3        Multidrug resistance protei...   184     4e-45  1  11.3% 19:433   2:436     ------------------KNKKTFGLILFIILFSYFLILMDNSIIFTSSLKISQDLKMNESTLSWVSNAYTITFGGFLLLAGRLGDLLGRKIIFLLGLFIFGLSSLVVGLS---TSSEMMIIARAVQGIGSAILAPTSLALLMDTYKGDLRVRAISYYGATAGIGSSFGLILGGWLTSALSWRVGFLLNVPFSLLLIILTLvfLGSFLSVLISVLFVFGITVSNLFIIILSFILIILFILWEKKLTYALIPLELFKNKVRTGSYVARFAFMMAMLTYWFILPQIM-QKMYHFSPLQSGLAFLPLTIVNFIAALFLPRLTRALGNSKVMILGQVILLTGMILSLVSQPEWGYFymMIIGLGQGWLLAPLTAAGVEEVSPELSGAASgnMMHQLGGPVGLSIVVliVDLSAYYHLVMGFITAFLSVGLLVLIFTR-----
     922 UniRef50_B2AAQ8        Predicted CDS Pa_1_4860 n=2...   184     7e-45  1  10.9%  6:408  54:488     -----PPVAASGPAPEESRTKLETTLVITALASALFLGALDITIVSVAIPTIAEEFG-STAGYTWIGSVYMLASAAGAPMWGKISDIWGRKPIMLIAVGIFWIGSLL---SALSKNIGMLIAARAIQGIGGGGIIILVNVCISDLFSMRKRGIYFGVMGIVWAVASAVGPVLGGVFTSQVTWRWCFWINLPVSGVGFAVLAWVlrTPMRQGLAAVDWLGSLAVIGGTLMVLFGLEFGGVteWKVAKFPLMPLRLFRRRSSIASLGVAAFQGIVFISGSYYLPLYF-QAVLGASPLMSGIYVLPFVLSLSVVSAITGVVIKKTGKYLpiIFGMSIMTLGFGLFIALEPQaiVVFQLIAGIGVGPNFQAPLIALQTTVGPraSATATFGFIRQLFTAISVVIGGVVFQNG------------------------------
     923 UniRef50_C5AMF9        Drug resistance transporter...   184     7e-45  1   9.9%  1:413  31:471     MNAALPPPAGPEPADAAPPMRGARLALlfALSLATFIEVLDSTVTNVAVPSISGSLGVSNSQGTWVISSYSVAAAIAVPLTGWLARRVGERRLFVTSIVLFTLTSLLCGLAGDLR---VLVACRALQGLFSGPMVPLSQTILMRAFPPERRTLALALWAMTVLLAPILGPVAGGWIVDNYSWPWIFLVNLPIGLFSFTVCVTLlpAREGGHAGPIDVVGIVLLVIGVGALQAMLDLGHDRgeRGEAHPVVDLSLFRDRTFSFCVLIISLGMMAFSVVGVVFPLWL-QTVMGYNAFHSGLAAAPLGILAFVFSILVGLYSSRFDARVLATFGFLVFAGVQwfTLTMTFTQIITPGLIQGMGLPCFFIPLTAATLSRIPDdaAASSLSNFLRTLSAAFGTAMSVTLWQNRATYHY-------------------------
     924 UniRef50_C6D6S0        Drug resistance transporter...   184     9e-45  1  11.7% 23:406   9:417     ----------------------RFWFVILAIFFGNFSSILNSGTVTVALPFMMKDLHSDLNDTQWVTTGFMLAMGSIAPIVGYLGDKISYKRLYMFSLVGFLICSVLCGCS---WNIGSLVLFRILQGLFCGAILPATLTIVYQAVPAEKQALGVSLWSVASMFAPAIGPTLGGLLTEYYGWKAIFFMNIPLALLAIVLASRYLPMQQVNKGSSLDLAGLLTAviLWITLGVVSIALFIRRELTAKAPLLNLRVFRHTTFTFGIVVNCILTIGLYAGAFLLPIYM-ENALGSSSLTVGLMMLPGALLMIGASLLSGRLHGKIRPEYPLLGGAFLLIIATWAFSRLSLTTSYAFIIGWMigLGFSSPNIMTLSMSAIPKESTGHASAItlRQVIASFAIGIFSSVYS--------------------------------
     925 UniRef50_C3X2F7        Drug resistance transporter...   184     9e-45  1   9.0%  3:401   5:430     --TSTPSISALNTEFNQPLKGNMLWFAAILLSGANFIAVLDMTIANVSVSSIAGNLGVTTSQGTWVITSYAVAEAITVPLTGWLAARFGAVRVFCCAMACFGVCSAMCGFA---NSLGFLVAARVLQGLSGGPMLPLTQTLLLRIFPREKAMAANGLWAMTTLTAPVIGPILGGWICDNYSWSWIFFINVPIAIICSWLTWQLlrELVRSPIDVIGLVLLVVWVGAFQIMIDEGkaTFLIWELGEKHPIVNLSVFRHRGYSICVFTISLAFGGYFAANVITPLWL-QNFMGYTPTWSGETTAWSGVTAFFVAPLAAIWARKTDPRRLIFGGLMWLGLicFLNTDASYWWIALPIMLMGLGSPFFFVPLIGLALMNVEEsaSAAGLMTFLRTLSGAFATSLV-------------------------------------
     926 UniRef50_UPI0001B9EDEF drug resistance transporter...   183     9e-45  1  14.9% 26:414  33:446     -------------------------ILLTILILGCFLSTLNQTLLNVALSNLMDVFDVTAATVQWISTGFMLVNGILIPITAYLMKRFTTRQLFISAMSFLLIGSVIC---AAAPSFVVLLLGRMVQAAGAGIVMPLMMSVVLAIFPVEKRGSAMGLLGLAMIFAPAIGPTLAGFIVEYHSWRWLFIGLIPLVIMVIALAFKYLVNVSETAKSKLDVGSVLLSTIGFGFILYGFSSAGSkrQVKSDDPLLNLSVFKNKIFTLTSLINVLVTMLMYADMILLPIYL-QDGRGFTAFDAGLLLLPGAVVNALMSPVTGRLYDRFGARPLFIIGLLFIIPSMWAVTDLSESTTYMYLMilRIGLSFITMPLNTAGLNALPKHLggTAVNNTVRQIAGAIGTAVVITIYTVQATSHAA------------------------
     927 UniRef50_B2JME3        Drug resistance transporter...   183     1e-44  1   8.9%  1:403  55:484     LTATQVNIVQTQATQPSPLQGGQLALATFAVALATFMNVLDTSIANVAIPTISGNLGVSVDEGTWVITVFAASNAVSIPLTGWFTQRFGQIKLFVGAILGFVIASWLCGVA---PSLPVLLFARVLQGVVAGPLIPLSQAILLSSWPKEKSSSALALWAMTATVGPIAGPALGGWITDSYSWSWIFYINIPVGIFAAGVTWMIYrpTRKLPIDVVGLGLLITwiVALAITAVISFAFFLVWELTEPNPVVDLRLFKQRNFLGGTVAISVAYGVFFGNLVLLPQWM-QEYLNYRSVDAGLATAPLGIFAVILAPVMGRVLPRSDARIIATLAFAGFAIVFFmvIEIDTWHLVLPTLLQGIPMAMFFVPLTAIILAggPKVPAAAGLSNFVRVFCGAVGTSIAGT-----------------------------------
     928 UniRef50_A7MEZ7        Putative uncharacterized pr...   183     1e-44  1   8.5% 11:400   2:421     ----------SEQAHSGWRPASNPWSVAIVVTIAVFMEILDTTIVNVALPHIAGSLSSSYSESTWVLTSYLVANGIVLPLSAFFSRLFGRKQFFLICIVMFTVCSFLCGIA---TELWQIILFRILQGFFGGGLQPTQQSVLLDYFKPEDRGKAFGLSSIAIIVAPVLGPTLGGWITDNYSWRWVFFINIPVGIVCVLAVYQLLEDPPWedWTGIGLIALGLGCLQVMLDRGEDEDWFASDFIrtRRPVVDLHCVRDKNFAVSSVLMAGMALILYGSSVVIPQLAQQD-LGYTATWSGLILSPGAVLIVFTIPIVLKLMPLVQTRWIIAFGFLCLGVSFFwvPNVDFETLVLMRSAQSIGLGFLFVPLTTIAFITIPqnADAAALFTMFRNVAGSIGISL--------------------------------------
     929 UniRef50_D2QLV2        Drug resistance transporter...   183     1e-44  1  11.6%  6:401   2:430     -----ATQPLALPTQAAMPTGFKKWIIVVTAISAAIIELIDTSIVNVGLTDIAGNLGVTVEDVSWVVTAYAIANVIVIPMTGFLQRYFGRKNYYIGSIILFTVASYGCGFA---DNLWTLVAFRFLQGIGGGALLSTSQGLMFDAFPPSQRPLASALFGMGIVLGPTLGPTLGGFIIDNYHWSWMFYINVPIGIAAVMLSLAFieLNIDRKSIQIDQMGILLLAVGIGSLQYVLERGEawELKGTKEPVVDLRTFKNRNLAIGSILMVVIGYGLFTSVLLYPLFAQRIV-GLTATQTGKLLIPGGIVTLPMFAIVGRLLAKgsPRTLVAVGYVAFASFCFMMAtaSNGDFITALIIRGIGLAFVNVPLINQSVATLEPRqtGIAIVNMMRQVGGAFGVAIT-------------------------------------
     930 UniRef50_C8VXL2        Major facilitator superfami...   183     1e-44  1  10.9% 33:436   1:441     --------------------------------MAIVLAAIEVTIVSTAMPTIVRDLG-NIHLMSWVFAIYLLATAITTPIYGKLADLFGRKKVFTIGIVIFLIGSSLC---SLAHSMAHLIFFRAIQGIGAGALFPVSLTIIGDIFNIEERAKIQGLISAIWFISGILGPLVGGFIVDLLSWHWIFLINIPFGLLSISLIKLFFHEQFTKKKRYIDYPGAITFTIGMTSLLYAIILGGQNkeLKSPEPILPLNLFKLPMVMVPNLATFFLCTVLIGLNVYLPIW-VQGVLSYKATGSGIALIPMSVGWTLGAFYCGKLLMKFSVRNtlGAGAILAGCSLLVAMGFSIFELIFGMFIIGLGFGLALTSSGIVIQSSVelRGSATALFTFTQALGQTVGVAMLGVLFYHTVSTGSafIALSVISVLGLFINLWIPKQK--
     931 UniRef50_B5L5U7        Drug resistance transporter...   182     2e-44  1   9.4%  7:400   1:425     ------MAEARTAPLPPGEYPPLRGIALVLLSIAifMEILDMTIVNVSIPAIAGSMGVSPSEGTWAISSYLLAAAVVQPLAGWIGRRFGEVRTFVISNLLFIVFSALCGLA---TSMPMLIACRLLQGLVSGPMMSVAQALLLRNYPVHLRGLAMGLWAMVVIVAPIMGPILGGWITDNYSWPWLFYINVPVGLGSAAITWFLLRRRETLRVKVPIDAIGLSLLViaAVIGVVALVFFIPWELTDKHPIVDLALFRRRNFRVGTITLAIAYFAFTGVNIIFPLWL-QTAMGYTATWAGLAMAPIGLVAIVMAPIVGRNLHRINLRAAPTIGFMVLAFALLWFsqASFSQMATPRFVMGIGLALFFLPLNQIIMSGLPSsaSAAGLSNFLRTFAGSASTAI--------------------------------------
     932 UniRef50_C7PM27        Major facilitator superfami...   182     2e-44  1  14.3% 26:431  17:450     -------------------------LILVIASMGIFVEALDIAIINLALPKIEKDLGLTNDSSYKLQSVYVLIYGCFLILGGKLSDFMGRKTVFIWGAIIFLLTSLG---AGLSQTYHALLLFRTLQGLGAALIMPSAFSIVNYYFTarERSRAIGIFGSFAATGSAAGLSVGGIIASYLGWSWVFLINVPILLIVIVIAYLYLENDEKSHSKLPDIPAAIALVAAMLSLTWATELLSKPAENrqPIPLLDLKVLALPSLRKGN-TLFILLGALFTGYLFLMSFLIQQNFHFSAAESGFIMMPFNVLSiiGRFGLPVLSRRIPAKTIALLGASSMLAGTLSLVAAVYYQSLFFllIAGIGMTLCFTGYSVIAMEKVPTEQLGVSGSLTTtfVGGGIGLPVVSMFMSNTAGEWNGRPILVLCAIALGSITLL-------
     933 UniRef50_D0WLW6        Drug resistance transporter...   182     2e-44  1  11.4%  6:409   1:435     -----MSAITQESTATSGGKTKNKAAILTSIITTQLMIVLDMTIIAVALPSMQSSLDMTNAQRPWIVTAYTLAFGGLVLFGGRLVGIIGIRRAYPIGLMGFSIASLVGGLA---PSFAVLAGARAAQGVFGALLAPTILAFINNSfnPKERAGAFALIGATGGIGAAVGLLLGGALTDLLNWRWAMFVNIFIAAFALVTSRKTLPPTHkgASITDDFFGLVLGCMGLFSVVFGLDRAERtrETTARKPVLPLWIVANPARSASYGTQFTFGAAQMGTAVFM-TYYLQEHLGYSPMKTGVAMLPMVAGIVVAAAISGKLipRLGAQAAFPLGLGLSAAGAGILSLMdaQAALPGLIVFGLGMGVAVPIAFNTGTRGIGPSHIGLAslNASQQVGSSFGVAILSTYATHLG-----------------------------
     934 UniRef50_B9L6P1        Major facilitator family tr...   182     2e-44  1  13.8% 26:401  13:415     -------------------------LLILLVVVGAFMAVLDTTVVDIIVPRLKGPLSTDMYGVQWVITAYMIAAAVGLLIVEWLIKKFGNKWIYIISVAVFTIASFLCGIA---NSLSFIIVARVIQGFAEAMIMVTAQAMLFGFFPPEKRGIAMGIFALGVAFAPAIGPTLGGYLTEWFSWRAVFFVNVPIGIVLVIFGSLLLPDRDERKEEKLNFISVAFLTVATVALLILLSKGQQYGWFNSpeSLFDYTLFKNPYYSLGILIYFVLLGFSMYQYFYLIPMFYEHIKGLSSIQTGLGVLGFGIWIGVFSMIAGALSDKFSPVPVLIVGAIIYLISSFLLfyTPFWEAVLKTMPFGIAMGLFFAPITVLVMNNsgKIEQGIMTMDYVRFIGGSFGTAIA-------------------------------------
     935 UniRef50_UPI0001AF7060 multidrug resistance integr...   181     4e-44  1  10.9%  3:407  30:463     --ARTGGSPAVPDPGPDCRLDSRLLLITVTCMMLPLMVTLDTTVVNVAQRTFIEEFASDQAVVAWASTGYTLALAAVIPLTGWLANRLGTKRLLMASVLMFTAGSLLCALAS---NIALLVAFRAVQGFGGGMLLPLQLIILARAAGPARLGRVMTISMITVLLAPIAGPILGGWLIDSFGWQWIFLINLPIGVLTLVLAVVTLPRDDSLPAESLDLVGMVLLsvPATMGVLLIGAFVAHALRRTDCVLIDLRLLKYRSVAAANATRFLFAVTFFGSCLLFPAYFQQ-VLGKTPMQSGLLLIPQTVAAAAVIPIVGRLMESRGPRSVVLVGIAVTVVGMAMFAHalTVLLSGLGLFGLGTACLMVPVTWSAVQTLDSSEVagSTLFNVNHNVAASVGTALMSVILTS-------------------------------
     936 UniRef50_B5EKD4        Drug resistance transporter...   181     5e-44  1   9.2%  6:406   1:426     -----MAASAIHATTPPESSQEHRWLITIAFMLAMVMVLLDMTVVSVALPYMMGTLAATPNRITWVLTAYLAANAVTIPLTSHLAALFGRRRLFLISVSGFVVASGLCGAS---QTLAEIVFLRTLQGGFGALMVVLAQSTMVNLFPGKERGRAMAIWGMVLMVAPAMGPVFGGYITQHMGWRWLFYINLPVGIFSLLLGAATMRKSERKNLATDWPGLLLMaiVALSILAVFGILTFLLRGWMIADNIIDLHLFRDRSFATATLITGVFGLGLFG-TTAMQPLMLEGLLNYMPETIGWVMFPRGVASAVTMMIVGRFINRYQPRLFIVAGVLLTGISTWImlYISPVWVIYPGIIRGIGMGMIFVPLTVIAFDTLPLAVsaSGIFNLARTLGNSIGIAIDGTVLT--------------------------------
     937 UniRef50_Q6FDN5        Multidrug resistance transm...   180     7e-44  1  10.4%  4:406   2:431     ---TAQSQASSTKTPFAELSGGRLLLAAFVIALSNFMVVLDTTIANVSVPHITGNLAVSASQGTWVVTSYAVAEAICVPLTGWLASRFGTVRVFVMGLIGFTVFSFLCGLS---TSLEMLVLCRIGQGLSGGPLMPLSQTLLMRIFPQEKHSQAMGLWAMTTVLGPILGPILGGLISDNLSWHWIFFINIPVGIICVLGTIRLltETIRVRIDAIGLFLLVLWIGALQLMLDLGHERDwiWEMTDRLPVVNLWVFRHRGFTVSVLALSFGFGAFFGSIVLIPQWL-QMNLNYTATWAGYLTATMGFGSLMMSPVVAKLAAKYDPRALASFGLLLLGGVTLMRAFWTsmTLAWPQILQGFAVPFFFIPLSNLALSSVQPqaSAAGLMNFLRTMAGAIGASIAVTIWD--------------------------------
     938 UniRef50_Q2T151        Drug resistance transporter...   180     9e-44  1  13.8% 22:405  36:447     ---------------------RESLLAMLGISFVTMLVALDQTVVGTALPTIVAELR-GFDLYAWVATSYLLASVITVPIFGRLGDYYGRKPFVIASLIVFTGASVLCGMA---HDMLSLVLARGLQGIGGGMLVGTAFACIPDLFPDSvrLRWQVLMSSAFGIANAVGPSLGGVLTQNYGWRSVFYVNLPVGLLSLVFVWRYLPHMrhTAKMRLDWPGALLIAalLLVVALASGVALWRWEQRCAQPILPFDMFSNRALSTLFILAILAGFAMFSLLFYAPLLF-QGGFGMSPQQAGVVITPLVVFITIGSIMNGRVITRIrpNAMLYAGFLLFALACAGVvaTPGWALMALMVAGGVGLGFVLPNLTVFAQQTAGREHLGIATAlsLRMVGGMAGAALTGTLI---------------------------------
     939 UniRef50_B7B8J0        Putative uncharacterized pr...   179     1e-43  1  11.6% 26:431   7:431     -------------------------FILTIVLLSYLATAINGAIVITGLENMAKDLDLNQSVLSWVQNSYVLAWGCFMLLGGRLSDAFGRRGILNLSLLLFGIGSL---FAGIATSATILIFSRFIQGVGASILAPTSLALIMDYFTGEERIKAIAWYSSISGLGMCIGLVIGGTLASFFSWRYGFFIYLPLIVFMLIVSMKVliASVIGIFSFVYAVNGASNIWLWLIVSCISLFLFMWIESKATAPIMPLRLF-NKSRTRANIARILFAGAMMGFYFFVSEYL-QEVFMFSPLWVGIAFFPLTLFTFWGAIEVPRAVRHWGNKKTLFGGFVLMLTGFIGMLYLNTTSSYWlmMLIGFGQGLVMSPLTNLGIQEVRPEDSGAASgnAAHQIGCSVGLSVMVACTTHTADMVAICHTAMLIGFIFTLLSFI-------
     940 UniRef50_C8PUC0        Inner membrane transport pr...   179     1e-43  1  13.0% 17:438  20:485     ----------------AALTPAQTKYLPIVVAIALFMQILDSTVLNTALPAMAHDLNQPALSMQWTVISYALTLAIFTPISGFIADKYGTKTTFMVAIGVFTAGSMMC---AVSPTLNSLIFSRVVQGLGGAMLMPVGKLTLIKSYPRERMLSVMNYAVMPAMIAPVIGPLVGGYLVELASWHWIFLINIPMGALGMWAGWKLMpnNIHADNLASAVFPVMVALLAIMLLIGYYYHAKYSESRNGQQPLFGLDLFQVRTFRVGIVGNLLTRLGMSAIP-FLLPLLLQVVQGYSPSQAGWMLAPIAVGALLTKPLVTRIVKQFGYRRTLAGNTLLIGVNIMLLstTPIWLSVPFLTFMGACNSLQFSTMNTISIARLRPGQtaISFGIGFGAMLLHLLTPARASLAQTQTAFSYSFIILGIMTILSGLYFLRLHQSDGK
     941 UniRef50_B4SQ46        Drug resistance transporter...   179     2e-43  1  12.2% 29:404  34:436     ----------------------------IGLAMASFMQVLDTTIANVSLPTIAGNLGASSQQATWVITSFAVSTAIALPLTGWLSRRFGERKLFVWATLAFVITSLLCGLA---QSMGMLVLSRALQGFVAGPMYPITQSLLVSIYPREKRGQALALLAMITVVAPICGPILGGWITDNYSWEWIFLINVPLGIFAALVvlKGRPEHIEKPKMDYVGLVTLVIGVGALQLVLDLGNDEDwwELTDKDPIVDLKLFRHRNFRAGTLAMVVAYAAFFSVALLIPQWLQRD-MGYTAIWAGLATAPIGILPVIMTPFVGKYASRFDMRMLATIAFVFLSMTSFlnLQVDFQHVAGVQLIMGIGVALFFMPVLQILLSDLDGREIAAGSGLAtrTLGGSFAASLTTWL----------------------------------
     942 UniRef50_A0YF58        Permease of the major facil...   179     3e-43  1  12.2% 23:407  34:444     ----------------------YAWLAMFAVMIAMLATMLTATIVNIAIPQIMGSFGIGQDQAQWLSTANLAASTVGMLTTFWVVQFWGMRKMITVTMTIFMVS---CVIGGLSTNFELMVFTRVIQGLATGMVTPLTISIIFQLFPFHKQGLVMGLSSVAAIMGPALGPSVGGVLIDYFNWRYVFFIGVPLSMICLPLAILFLPErpQQAFDWMGTVSLSMAITAMLVAMSNGEKEGWsgQIHTEHPLLNLKILLNKRFATFSLTAFTFGAGLYGSAYLIPLFL-QIVQGMKPTDAGLSMMPAGLLMGIASPLFGRLADRLAPRLMIIAGSLLFFLSFYLmaDTSFWTFVWWMCIGRVGISCAFPSMSMGAIRSVPAELTGQASgnFIRNLGGAYGVNVLSVVLAR-------------------------------
     943 UniRef50_C3VLW4        MFS-type efflux pump n=2 Ta...   179     3e-43  1  11.5% 15:414   1:425     --------------MSPQRATLRDWVGLAVLVVPVLMMSMDMTVLYFALPFLSATLEPSATEQLWIVDIYAFMLAGLLIAMGTLGDHIGRRRLLIIGAVVFGASSLA---SAYATSAELLILARAVLGMSGAVLAPSTLSLIRNMfdPGQRRTAIAVWTAGLSGGAALGPIVSGVLLEHYWWGSVFLINIPVTILIVVLGPILLPEHRDPEPGRFDFLGAVLSLAAMLPVIYGIKELADdrQRAAPNPLIDLSLFRDRGFTASIGVNLVALFAMIGFLLFATQW-IQLVHGLNPLEAGLWTLPAPLAVAVTTSVAVGLAKKIRPGYIMAIGMVIASAGFAIMTqsSLAMAVIGASVLSAGVGMAIPLTADLIVSAAPEDRVGAAAAltANQLGGALGVAILGSIGAAVYTRDVA------------------------
     944 UniRef50_B8GGH7        Drug resistance transporter...   178     3e-43  1  12.6% 14:432  10:456     -------------SPQREKLDPKILRVSVIMVIGALAPLLDSTMVNVAINIIAGDLNSTISIIQWVITGYILAMALAVPVSGWAVNRFGGKRVYMFSLFVFFAGSVL---SSLSWNIDSLIGFRLLQGVGAGLMIPTLQTVLVHIAGSRNLGRVMSIVSIPALLGPILGPVLGGVIVNSLNWRWIFYVNIPITIIALLLTWRGVpdEPSTSKQSLDIIGILLVSPGFALLIYGISQISShaLRTKNAPVIDVRLFKSRNFSASTALLFLSGIITNGAMLLLPLYYQQVR-GESVLFAGLLLIPQGVGMLLTRNWVGRLADRIGSRSIVAISLVVTMIGTVPFACAGpiLLAVALLIRGAGLGGLLIPIMASAYQGLSRDQvaSSATRIFLTIGGAFGSAVLAILIEHQPSGLSVLDIHTVVSAYNGAFWWLI------
     945 UniRef50_B1L4N7        Major facilitator superfami...   178     4e-43  1  14.2% 21:385   4:391     --------------------RREILHVLSVTTLASFLTGINARILVVGIPELAHSLGADVEQVIWLTQAYMLGSTAVQLIVGSLSDIYGRVNLFSMGFAFFSLSSLLCGFSS---NVFQLISLRLIQGIGAAFLMSLSLTIITDSVPKGQLGTWIGVNQIAFRLGSLIGLTLGGLIIDNLGWRWVFWVHVPLGLISVFWSKMRLKEVYRPVKAKIDYPGflRASLILASLGSLILLLFIYLELKSSSPALDLRIFRNWQFAGGIVAQFLYSLAFGSVTVLLVIYL-SVVKGLSASLTGMLLLPFEFSFLIFGTLGGKLSDKYGYAPITMLGLALSSTSLYMMSLFSTQTsvATMLLLGCGAGLFVTPNASSIMAGAPQERRGVAS-----------------------------------------------------
     946 UniRef50_Q15TE2        Major facilitator superfami...   178     4e-43  1  11.6% 22:408  12:420     ---------------------PLTTVALIVVCAGSFIGPLGMASVNIAIPDLAAELQANAKMVSWLPTIFLLANVALMLPFGKLADNYGRKRIYSYGLVLNVISSTMC---ALAFNIEWLLFWRFMQGAAAAMIFGTGVAILTSVTPAERRGFALGIAAACVYIGLTVAPAVGGWLTELWGWRSVFLFQVPLVVMLLVLIkrKAKFDWRGSGIFIIAATCLVFGllLLGIALIFMVWFVVHQSKRDQPLIRVQMFksRVFSMSLATSLLMYASNYPLTFLLSLYL-QYVKGFSPSESGQIILLQAMAMAFLAPLSGKLSDKVQPRLLATTGCAIVACGFFILSRMDIDTQAwsLLLVGIGFGLFSTPNNNAIMGAvtELGVASASLNLARTIGNLVGMSMVNLLVHHY------------------------------
     947 UniRef50_C7MPF9        Drug resistance transporter...   178     4e-43  1  11.3% 21:436   4:458     --------------------TRQQKMMVAVILSGALLVVLNMTMLSPALPHIMRDTGVDATTVQWLTSGYALVEAVVIPLNAFFIGRFSSRRLFMAGIAWF---SVAAVVAAVAPNFWVILLARVMMAMATGIIMPMSFTLVLLVFPRENRGAAMGVIGLIISFAPAIGPSLSGLLVDSVGWRMLFVIVAVLGAIVVLFASFSLHIPTNFERVPFDKPSVvmIPAALIAVGIVLLAVFARRQTKLEVPLLRIQVLKERRFRTVVILIAILEAALVGSEVVLPLYVQQ-VMGETATVSGLLMLPGALLGAVCGLAAGRLFDKRGVRGLAVFGALFLTAAAIGLTMFSMSMPILIVTvmSIGIQFLITPLNTWGINSLDNSVvgNALSSTMNQVGASFGTAFIVSLTALSSVFaiAFIGMCVLLLIVSVGILLFVRDR--
     948 UniRef50_C7PY57        Major facilitator superfami...   178     4e-43  1  10.1% 14:417   6:446     -------------PATAGPPYRWRWAAFAVVLLASVMDLLDSLVTNIAGPTIRADIGGGPALIQWLGAGYTLAMAAGLITGGRLGDIYGRKPVFIVGVIGFTVASVLC---ASSFSPGMLIGCRVAQGLFGAVMLPQGLGVIKAVFPPQELAKAFGAYGPAMGFSTVLGPVIAGTLIDAnsWRMIFLINLPLGLVALVGAIKYLPSDreRAPIKLDLLGTVLASSAALLVVYPVVQGRSLGWprGGDPLVVPTLFRKRAFTGGLFTGLAFFTAIVGFSLVF-TVFVQIGLGYSPLKAGLTTLPQAVGSVVGFIAAGAGLAAKLGRRMLHLGLVSMTAGVIGTFLttPYDLIPSLLFTGIGLGMFLAPFFDIVLAGvgEYGSASGTLNAVQQFAGALGIAVVGTVFFGVLGGHVASAV---------------------
     949 UniRef50_C1P9E5        Drug resistance transporter...   178     5e-43  1  13.2% 14:408   1:422     -------------MNPAIQHKKPPYLMIGVLFIGAFVSFLNNSLLNVALPSIMADLHidYSTIQWLATGYMLVSGVLVPASAFLLTRFTNRQLFITAMLIFTLGTAL---AAFAPNFGLLLTGRMIQAAGSSVMGPLLMNIMLVSFPIEKRGTAMGVFGLVMITAPAIGPTLSGYIVEYFDWRFLFEMILPLAVISLVLGIWKAENveQNKKATLDYLSVVLSSIGFGGLLYGFSSASSDGWTDpdEPLLDLRVYKYPMFALASVIAIVNAAAMFSGMILTPAY-VQNVRGISPLDSGLMMLPGAIVMGIMSPITGKLFDQFGPRVLAVTGLSITAVSTYMLANLQIDSSYTYIILvmFGMSMVMMPIMTNGLNQLPSRlhGTAVNNTAQQVSGSIGTAVFVTIMNAV------------------------------
     950 UniRef50_C1F3Z8        Multidrug resistance protei...   177     6e-43  1  11.7%  2:420   3:459     -ATATLLPETLAPKKLAARAAINPWVIALTVTLATFMELLDTSIANVSLPYIAGGLGRSYDEVTWILTTYLVANAVVLPMSAWLSRVFGRKTYYMACVALFTVTSFFCGIA---PSLNVILIARILQGIGGGGLAPVEQAILVDTFPANKRASAFALYTVAIVTAPAIGPVLGGWITDNFSWRWVFFINIPIGLLSLFLTNRFVHDPPQfgKLRIDGVGIALIGIGSAALEVTLDraAIVWELRQKDPIIDLHLLRSRNFAIASFLYFLFGFGLFGSTTMIPQLL-QSLYGYRATDAGLVLGPGAFVITMLAPVGAQLVQriVAARTLLFFALITVGLSFLylATDYDHYAWARALQGLGYAFFFVPLSVITYSQLRPDqrASSITNFFRNWGGSFGVAFITTMTERRQNFHQAVLGASL------------------
     951 UniRef50_Q0BWA3        Multidrug resistance protei...   177     6e-43  1  12.8% 14:403  49:468     -------------TQPRSSRPVSSRILALIVSAALFMELMDGTILATALPQMAQSFDVAPLQMSVALTAYLLSLAVFIPASGWMADRFGSRRIFMGAIALFVTGSMVCGMA---NALPEMVIARLVQGAGGAMMVPVGRLLLLRNVPRHELVSAIAWMTIPATLGPVLGPPVGGFLTTWLSWRWIFYINLPIGLIGMGLAARFVPNVTEAELRPLDVKGLLLSGTALASLLWAMETLGrrHSRTIPHPILNPMLMRIRTFRLSVLGGACSRVVAGAMPFLLPMTM-QLGMGMSAAESGSLTFVGAAGSLLIRPWAAGILRRFGFRRVMIwgALSSTAVLLCATFQPSwwFFLVLAPAGLFQALQFIAYNTIAYADVPRERmaTSFYTTFQQMTLSAGICIAGI-----------------------------------
     952 UniRef50_A8VWC4        Arabinose efflux permease-l...   177     6e-43  1  11.4% 23:435   8:460     ----------------------NKILIAGLLLAGSFIAVLNQTLMITAIPPIMQEMGITANTAQWLTTVFMLISGIMIPISAFFIEKFTTRHIFLTAMGIFTLGTLV---SAVATDFPVLITGRVIQSVGAGVMLPLMQTVFLMIFPVERRGTAMGYIGLVISFAPAIGPTLSGYVTSNFEWRFLFYGILPLSLIMIVIAYFKMVNVTELKNPKVDPKSIILSTLGFGGLLYGFTSAGNNGWTHpaHPMLEFRVFRAKVFTISTVITAIGFTGLIGLETLIPLYM-QNMRGFSAVEAGIVLFPGALIAGLMAPITGRVFDRIGARMLAIPGLIIMIISTFAFIFIDTETSMLYLSImmFGFSMVMMPTNTAGLNQMPKKlhGAAVTNTIRQLSASIGTAMLVTVMTTtlGAAVSFGLIGLITLLAFVLSFQIHKT---
     953 UniRef50_C0ZE91        Putative multidrug resistan...   177     6e-43  1  11.3% 18:405   2:414     -----------------SRSEKRNRFIIFAMALGLLMSSLDNTITSAAISHIIKDIG-GFESMSWVFTSYVLAATSTMLIFGKMSDLFGRKLFYLLGITIFLIGSALCGVA---QSIEQLIAFRALQGIGSGALFPITFTIltLSSDPKYTARISGVFAGIFGLSSIAGPQVGTLLSDYLGWRWCFYVNVPIGLLSLLTLLFSLKESRSQSKPKIDYLGTVTLIvsLFALAIIVGIAFILVERHAQEPILPLQIFKNRMVVATCIACLSQGAIMFAAITYLPIFAV-AVLGYPNSNS--VLTPLMLSLTGGAVVFGMLQTKFSFRSLMAFSMLASVVSSILLMYVSTGISFFFLTLLMILFGfaIGPLMSVAQNAipYIGISSSIVGFCRNMGGVLGASITAAVV---------------------------------
     954 UniRef50_C6IX53        Drug resistance transporter...   177     7e-43  1  12.8% 17:414   3:425     ----------------TATPNVNKKILMPVLLLGSFLSILNQTILNVALPDLMKEFAISATTVQWLITGFMLVNGILVPITAFLMQRFTTRQLFISSMLLLLAGTFI---SAVAPSFPFLLTGRLIQAAGAGIIMPLLMMVVMVIFPKEGRGAAMGLIGLAMIFAPAIGPTLAGLVIEHFSWRWIFIGMLPLVAIVIPLALKYMVNVSETSKPKLDLVSIvaEVLVCLIVGGIFLLMFCWRQLTSSVPLMDLRVFTEKMFSVTTIISIMIMMVMYADMILLPIYLQTSRS-FSVLDTGLLLLPGALINALLSPVSGRLLDKFGVKPIAIIGLLFTIPAIWGVTHLTETTSYTYLvvLRIGLSFLTMPLNTAGLNALPKqaHGSAVTNTVRQVAGAIGTALVVTIYTTRTKSHAA------------------------
     955 UniRef50_D2U8U7        Probable transmembrane mult...   177     7e-43  1  10.9% 29:404  31:433     ----------------------------FGLALASFMQVLDTTIANVSLPTIAGNLGASSQQATWVITSFAVSNAIALPLTGFLSRRFGETKLFVWATLAFTMASLLCGLA---QSMGMLVVSRALQGFVCGPMYPITQSLLVSVYPREKRGHALALLAMITVVAPIAGPILGGWITDNYSWEWIFFINVPLGILAATVVGGQLRDRPEPvrPRMDYVGLITliVVLSAISVVALAIFAIWEFTDKDPIVNLRLFRHRNFRSGTMALIVAYAGFFAVSLLIPQWLQRD-MGYTAIWAGLATAPIGILPVIMTPFVGKYASRFDLRLLASISFVVMAITSFmnLRISFESVAGVQLLMGIGVALFFMPVLQILLSDLDGREIAAGSGLAtrTLGGSFAASLTTYL----------------------------------
     956 UniRef50_C8WFK1        Major facilitator superfami...   177     8e-43  1   9.4% 20:434  20:458     -------------------TRQNRNQAMGAISVSVAMAILDTAIVNTALPSIAKDLGVGHSDSVWIITAYQMSMVAAMLPFAAYGDLKGHRKVFLTGLGVFILASLACGIS---PSFLGLVAARFVQGIGAAAIMSANTALVRQIYPARILGRGLGLNALVMAFSFAAGPPMASIILSFTSWHWLFLINVPICILAFFLSWQKLPKEDKGKSQKFDVVPAVICASLFALWVHGLGQLavRWQSSHERPLLAVDLFRISFFSLSAITAFLAFIVQ-GMIFVAMPFLLQGKLGFDVIMTGFLIAPWPLMGAFLAPIAGRLSDRYPAGILGGIGLAILGLGIGVISVLPPHtaVIMMALCGGGFGFFLSPNQRALMSSAPTTRSGAASGviSRILGQTTGATLVAFCLYLSSDHGAEIALRIGIFIAFAACMVSLSR----
     957 UniRef50_B6HQZ7        Pc22g07500 protein n=6 Tax=...   177     9e-43  1  15.0% 26:437  79:528     -------------------------LILLVTSGSQFLDNVFMTSANIALSSIQQDFDVSSTDLQWMISAYTLSFGGFLLLAGALSDRYGRKKILCLGLAWLSLWTLAIGFG---QSFIQLTVFRGIQGIGAAMTVPSAIGIISSYFSGVDRTRALSIYGASGTLGFCTGLIFGGFLTSSLGWRYIFYLIVIITGSLGILGFIVLPSDVpyIGAVMSTAGLIlfIIVLLILAVGLLVGFTILEKYVSNPIMPLSLWKIRNFAGLWVIGFTGYGTYQNVIYYIV-LMAQEVDKLSAGDTALRFLPMGAIGFIVSLGTGKLLEFMNGKHLLIMGLVLAVVAPISSALTSNPESGFWllISISSVSFIFVTTSTVVLTSVPVEVkaGGMLNTAFQIGSGVALAISAAVTDAVDiyATGLWCSVGLAGLGLIIGIVSVRHKG-
     958 UniRef50_UPI000169462D hypothetical protein Plarl_...   177     9e-43  1  11.0% 27:400  11:409     --------------------------VTLSIMLITFLSSLEGTIVSTAIPKIVSDLG-GMHLMNWVVSIYLLTTAVATPIVGKLSDLYGRKLMFICGTILFLIGSML---SGMSQSMEQLIVFRAIQGLGAGAILPVTMIIIGDIYSFEERAKIQGWISGIWGISGILGPLTGGLMVDYVSWHWIFYFNVPFGLLSILFIVMYLHEHLDKKKQKVDYLGIALFTvgILILAVVTLALFLVVEYYVKEPMLPLRLFAMRLISVSNLSGFLLSAILVGITIYLPLW-IQGVAGKGATDSGFTLIPLSVCWPVGAALAGRWFVRMGVRSTTLIglAAAAGLYFVGIHTPYLLLVALMGLFGLGFGFAFTSYTITVQSAVGWQMRGTAMatFLRTLGQTLGISV--------------------------------------
     959 UniRef50_B3QX01        Major facilitator superfami...   177     1e-42  1  12.2% 20:404   3:411     -------------------STTKQRLLTAGILLVMFLAAMDNMITSTIMPSVISSVG-GLSLYPWIGTVFMLTTTITTPLYGKLSDLYGHKRFVLIAIGIFMLGSMLCGMA---QTMEQLILFRGIQGIGGGGLVTMSFIVFGILFSPEKRAKMQSALSSVWAVASVVGPAVGAFFVETLTWRWAFYVNLPIGLLSAWTIIMFLKVPKEQHTDHRIDYGGAALFASGGILLLFGLLETSqhERNEPEPIIPIALFSNKNFLAPVLLGFIAGSTLFSISNLTPLF-IQGALGESAGISGRVVTGISFGWVTGSLICGRLLNKTGFRTISIFGALFMLVGLFLmlASAWWHLFIYNIILGFGMGLIATTTLVAVQSAVSKRTIGAATSTnfRSVGGTIGLSVLGGL----------------------------------
     960 UniRef50_B9JAF8        Multidrug efflux transporte...   177     1e-42  1  11.5% 17:406  23:440     ----------------DERIDPKKLIAFLAMVLGMFMSILDIQIVSASLSEIQAGLSAGSDEIGWVQTAYLIAEVIMIPLSGTLARIISTRSLFAISAAGFTMASAL---AATATNIDQMIIYRALQGFIGGGMIPSVFAAAFTIFPPSKRNIVSPIIGLIATLAPTIGPTVGGYLSNAFSWHWLFLVNIPPGIIVAIVTWNYikFDWWGLFSMGVFLGALEYVliAAIASGIGAIIFFYRAFSVDFPVVDLKAFANKNFSFGSVFSFVMGIGLYGLTYIYPLYLARIR-GYDSLQIGETMFVSGLTMFFTAPLAGFLSSKLDLRIMMVIGFTSFSAGTYIMMHLTTDwlLIPQILRGFGLMLCMVPINNIALGTMPParGASGLFNLTRNLGGAVGLAIINTLLT--------------------------------
     961 UniRef50_P31474        Probable transport protein ...   177     1e-42  1  12.0% 29:438  14:456     ----------------------------WIAAMAFFMQALDATILNTALPAIAHSLNRSPLAMQSAIISYTLTVAMLIPVSGWLADRFGTRRIFTLAVSLFTLGSLAC---ALSNSLPQLVVFRVIQGIGGAMMMPVARLALLRAYPRNELLPVLNFVAMPGLVGPILGPVLGGVLVTWATWHWIFLINIPIGIAGLLYARKHMPntARRRFDITGFLLFGLSLVLFSSGIELFGEKIVahARRTPNPLISLDLFKTRTFSIGIVGNIATRLGTGCVPFLMP-LMLQVGFGYQAFIAGCMMAPTALGSIIAKSMVTQVLRRLGYRHTLVGITVIIGLMIAQFSLQSpwMLILPLFILGMAMSTQFTAMNTITLADldNASSGNSVLAVTQQLSISLGVAVSAAVltTVEQFHYTFITMGIITVASAAMFMLLKTTDGN
     962 UniRef50_C6D7M0        Drug resistance transporter...   176     1e-42  1  13.0%  8:430   4:453     -------SQAKAVKAPKEKIDPGILKIALILVLGAIVPLLDSTMINVAINTLTVDLHSTVSTTQWVITGYVLTMGLAVPVSGWAIQRFGGKNLYLFSLVVFLVSSLLC---SLAWNTESLIGFRLLQGAGAGLLVPTITNVLVQSAGGRGLGRLIALISIPTLIGPILGPVIGGLIMDNMSWRWIFYVNIPVMLVALWLSWRHIPKSEAAAGRPKFDFLGLLLLSPAFAAlvLTAAYIVYALRTKQAPLLDLHLFRSRHFLASNIILFFSGMVMNGALLLLPLYYEQVR-GESVLTTGLLLIPQGIGMLLTRSWIGKLADRAGSRNIVLVSLAVTLASSIPFAFAGTDTSHIVLSVagAAMNGIFIPIMVSAYEGLQREQIPHASIStfQTIGGAFGSAVLATVIGHQLKSGAGGSLAALADAYQVAFWW--------
     963 UniRef50_C6D6H2        Drug resistance transporter...   176     1e-42  1  11.8% 27:407  16:421     --------------------------ILFVMILGAFIATLNQTIMSVAGPELMKDFSISATTVQWLTTGYMLVNGILIPITAFLMQRFTTRELFQTSMILFLAGTIV---SALASDFNVLLIGRLIQAAGAGIIMPLLMTVILTLFPPEKRGGAMGMVGFAIIFAPAIGPTLAGWVLENFKWEMMFYGMIPLALIVILCGFIFLTNVSERTYPKIDVISVILSTVGFGAMLYGFSRAGSAGWESAEvpLLDLRAFKYNMYSLTTFINIAITMIMYADMMLLPLYL-QNARGYTAMESGLLLLPGALIMGFLMPVTGRLFDKFGAKWLSVAGMIIVIVTTLGFINLTDTTSYTYLVLMsiGMALLMMPVQTAGLNQLPNraHGTAISNTIRQVAGAVGTSLLVTILTT-------------------------------
     964 UniRef50_A6LRC7        Drug resistance transporter...   176     1e-42  1  13.8% 18:401   2:410     -----------------TNSKSHKWSILLVVTLVSFITNLDSTIVIIGLPNMMEGLNISVTTGLWIITGYIIASTVLILPAGKWADTVGTKRIFMLGLIIFAVGTILCGIA---DSGLTLNLYRLIQGGGAALAMATATPTIIKTFHSNELGLALSINATSWVIGAIIGPVAGGALISSFGWRSIFFITVPFVLLCIIGAFLVMEETKPNINQKNDWIGILTFSLGLILTMIVLSeaFIITELRVENPLFNFKLFLYRNYSIGLVITLFYCIAYFSLPLLLSIYL-QSALHLSPTMSGLLMISLSVPQLILGPFAGKLVDNIGSLKTLTFGIVFLIIGIFFLGNLGGELsvTPLILLSIANGLAWPSLAKTVLSAVPKEQSGSASGmtIMNVGKALSQTLA-------------------------------------
     965 UniRef50_D0KF91        Major facilitator superfami...   176     2e-42  1  15.9% 21:415   3:422     --------------------SPKKWLILAIVSSALFLIVIDMTVLYTALPTLTHDLHATASDKLWIVNIYALVASGLLLGMGTLGDKLGHKPLFISGLVVFGTASLL---AAYSPSPGILIAARALLAVGAAMMMPATLSIIRLTfdERERALAIGIWAAVASGGAAFGPVMGGILLEYFWWGSVFLINVPVVLLALIMGITMIPHRPGNASHRWDFIGSLLiaLIALLIGVVFITLFVRRQRNSTHPLVDFSLFRLRPFSAAVAAAIVAAAALIGMELAFTQRL-QLVVGLSPLQAGLFILPLSLASFISGPLTGKILPHVNSGKILAAGLLISGLGMGSYLLLHNATiiISLTVIGAGVGSTMTAASSTIMQVAPAEKAGMAASivSYELGGATGVTLMGSLLSFAYSATFML-----------------------
     966 UniRef50_D1VJX0        Drug resistance transporter...   176     2e-42  1  10.8%  9:414  10:443     --------TTRSARSTKVQSTKAQWWILVIIACAQLMVVLDSTIMIIALPSAQKALGFSDTERQWVITGYTLAFGGFLLLGGRISDMLGPRRTLMVGVIGFA---LASALGGAAPDTVVLIAARGLQGLCGALLAPSVLSLLSATFtpRERARAFGIYASIAIGGSAFGLILGGLLTQYADWRWCLYVNLPIAALVIFGIVTMIPKSVGRSGVRLDVAGVILGCGGLVALVYGLGEAGADgqSKGPNPLLPLRVLRDRNRSGAYLTILLAMTAMFGTFVSL-TYLFQAVDGYSPLRSGIAFLPLMVlgLASTQLASRLMPYVPTRLLIVPGLLAAAVGVALLTRLTptHVLPTEILLGVGLGIAMVPVISTATSNADPGDVGvaMSTTSQQIGASIGTALLNTIAASAVTSYLA------------------------
     967 UniRef50_C0WMK0        Transporter protein n=3 Tax...   175     2e-42  1  14.3% 23:407   4:413     ----------------------KQKLIIFSMMIGIFLCMLDTTVMNIALPAIQSGLNVNLGTLSWALNIYTITFAVFTIPFGRIADIIGRNKTYLVGLVLFALGSLL---SGSANSAEFLIIGRGIQSLGAAIIFPASMTIGISTTDVKHRTGVLAALGVTQGFASAFGPTIGGIVTQYLGWHYVFLINLPLILIVLILCCGLLPLKNEHRFKArdWGWSSRLIIGLFTTAIVSLACFIVAEHVTKDPMVPLGLFKSRQFTGASLVTILTEIFLVAVLVIMPSFFT-NILNKSELTAAFMITPTSFMIFIFSPIGGILNDKIGPRLLVSVGFLQIIAGYMILSIVNPatIISLLLIGGGFGIIAGPLVVLGASNFTGKLLSAssVLGVFRQIGTLLAVAIFVSALTA-------------------------------
     968 UniRef50_B3QFP3        Drug resistance transporter...   175     2e-42  1  10.6%  1:406   1:435     MSATTTADTPIAAPAEPshVPATRLIAFLIMVFGMFMSILDIQIVSASLSEIQAGLSASSSEVSWVQTAYLIAEVIAIPLSGFLSRALGTRNLFAISAAGFTFASLMCGFTS---SIAEMIVWRAIQGFLGAGMIPTVFASAYTVFPRSKFNMVGPIIGLVATLAPTIGPTVGGYITDLMSWHWLFFINIVPGIGITIGVLALvhFDWWGLGFMAGFLGSLEYVliFAIVCVVSAVAFFWRVLTAREPIVDIRAFTDRNFAIGCMFQFCVGIGLYGLTYIYPRYLAEVR-GYSALMIGETMFVSGIAMFLSAPLVGRLMALVDMRILIAVGLLLFAGGTWQMTWItfYELLWPQIFRGVGMMMAMVPVNNIALGTLPPHRvaSGLFNLTRNLGGALGLALINTILD--------------------------------
     969 UniRef50_C1ZHC1        Arabinose efflux permease f...   175     3e-42  1  11.6%  2:388   4:413     -SRAENSSQQPDDLPVEGKSSRSSRAIALLVAACFFMEHLDSTVIATALPQMAISFGENPVDLNMGLSAYLFALAIFIPLSGWLADRLGARRVFATAIVVFTLASVLCGFS---QSLSQFTCARVLQGLGGAMMVPVGRAVVLQATSKQDLLRSIAYLTWPALFGPLIGPPLGGLITTYASWPWIFYLNVPLGVVAFALTLRMIPPIPSEHQNPFDLMGFCLCGLASSCLLYGMELIGQPGEnrTPHPLFDLRVFWYPTFQVTMLGGGLFRMVVGSTSFLFPQLF-QVGFGYSAAKSGFLMLAIFAGNLGMKPATTFMLRRYGIRRVLIVNGLICAATLWAcaQTPIMLIMAILFAGGLSRSMQFTCLNTLAFSDIPPTLTGQANVIF--------------------------------------------------
     970 UniRef50_C7PJ42        Major facilitator superfami...   175     3e-42  1  14.0% 23:416  20:455     ----------------------YRWVALLIVSTAAFLSVVDLFIVNVALPSIREGIHGTNGDSQMVIALYLLGHAIFLITGGRFGDYYGHKKVFIWSMLLFTVASVCC---AAAQNATQLNIARLLQGTFAAFMVPQSIAYIQFLFPehERAKALGIYGAIAGIASVLGQYLGGLlsAISGWRWLFLVNLPAGLLSAAAAAYWLKAPATKINGRPDYSGVLKLSLGLIALIYPLIRGRELgqKKGKQSLIDLQLFHNRSFNTGLMTATAYFIAQDSY-FLINTVLLQTGIGLSPSSTGNYFVIQGVGYVVAAIFSIRLTVRYGKAVLQAGVLLMLTMlaLLSATAYRQVFLAVLFLYGMGCGSVLPSLLTITLKKIPTHLASTAAgvTFQQISIALGVCITGGLFFQFLGAHPSLA----------------------
     971 UniRef50_B2KD41        Major facilitator superfami...   174     5e-42  1  11.0% 15:432   1:445     --------------MSAAKFLSKNKLLILAISVASFMVNLDTYIINVSLPSIAGGFNASTADISWVAMAYNLTVVSLLLIFGKLGDKVGLKFLFITGFIIFTLSSILCGFA---PSLPFLVAGRLLQGIGASILYALPQAMIPKYLPKEERGMAFGILASAAALGITLGAPLSGIITGLYSWRWIFFINLPVGILAVIVLNYSIPstITKREPHFDIPGAVLSFLMALAFTFWINRgfIKREKKAKYPLLDLSLFNNITFNFANIAMFLVSAFLAGTNFLMPFYLAE-IKGLSPARTGAAFMVYSVSYMLTGLVSGKLSAKIPAGKLCAWSMLLASVTLAGLvtSGIYYIILYFTLTGVSFAFFITSNNNFVMSMAPENKEGMVSGamVGRMGMLCGVALFEAVFSFYGSENLINGFRGAYALGAAMCFAAM------
     972 UniRef50_B4AVF7        Drug resistance transporter...   174     7e-42  1   9.3% 21:418  29:455     --------------------GPRKWAIAVTASLGAILEVIDTSIINVALTDIQTTLGATITEIAWVATGYAIANVILIPLSAWLGDFFGKKTYFVFSMVGFTFASVLCGLS---PNLAILVIARILQGLFGGGLLAKAQAILFESFPPAEQGVAQSVFGVGVIAGPAIGPTLGGYLTDNLGWRWIFFINLPIGLVAIAMSMIFLRPDPPKvwWGIALLAVSVGSCQAFLEEGERNDWFewRELNIKAPAVDLRVLKHKSLAAGSLYSGILGMGLYGALFAVPLF-AQGVLGFSATQTGDLLAPGALASAIVMIILGKMSGKVDARILIGLGAVGTSAVMFNLATITPQtlFWPLVWRGATTVLMFLPLSLACLGPIPKQDISAASgnLSRQLGGSIGIAILTTLLQQREAFHQTILLA--------------------
     973 UniRef50_A5EVP1        Drug resistance transporter...   174     9e-42  1  14.8% 14:413   1:423     -------------MTEPATQQPSRYLPC-LLTLAIFMQMLDTTILNTALPSIARSLHESPLSMQSAIVAYALTVALLMPLSGYLCDRYGTRKVFANAMLLFVVGSVLC---AAAPSLTFLVLGRMIQGMGGAMLSPVPRVVVMRAYPRNQIVSMLNLIVMPALIGPIIGPLLGGYLVEYAHWSWIFLINLPIGILAILATHRVMPDFTGAANPRLDIVGFLLFAGGALGISLAMETVLHPAGKLFSSLTALLglFKVRTYRVGLSGNLVSRLGMSSVPFLLP-LLLQVVFGYSASAAGWMLMPIAFAAMFGKMVTLPLISYFGYRRLLIINTRLIGILIMSLAltSPWLLMPLLAGIGLSNSVQFTSMNTISLADLRIYQTGSGNSLLaqQLSISMGITLGAAVLTGFRSSQW-------------------------
     974 UniRef50_C2FLG2        MFS family major facilitato...   174     9e-42  1  11.9% 20:414   3:420     -------------------TKRRMAIATIALLIANFMGGLDATIVNTALPAITSDLN-GIRLIGWISSIFLLGTAVTTVLWGRVGELIGNKLTFQISVVLFIISSVVGGLS---TNMVMLIIARAFMGIGAGGMVSIPFIIYADLYepAERARALGWVTAFYTLSTVVGPLIGGWLVDTLSWHWVFFINLPIGIISLLLLQFSYRESEHEafASDAIAPNLTQALVLLVIGLILMVIFYQVEKRQKNALVPTELLKNWRIQSQNVIMFLINGFFIGYSVYAPMW-SQGLLGTSATLGGLTQIAGSILLLVGTRYTAHLMVKMPYKRIVMFGILSVLLSALSMvfAPYWWLLVSGGFNGLGMGLSFTPMQVSLQDGVRRDLISVsfGLLFRTLGQTFMSSIFGAILSISTASQIG------------------------
     975 UniRef50_C9R1R2        Inner membrane transport pr...   173     1e-41  1  11.8% 10:408  15:437     ---------ASAERENQMSERQHYRNLALIAAMALFMQSLDATILNTALPAISADLHESPLEMQMTIISYSLTVALFIPLTGWIADKYGTLNVFRVAMTTFVLGSVAC---AVSNSLNALIWSRVLQGLGGALMMPVARLAIIRNVPKTQLVAAWNAMAMAGLIGPVLGPIVGGWLVTHATWHWIFLINIPIGLLGVWFAGRHMPNSTGNIGKLDWRGFVLFAGGLAGLTLGLDLLSEDRvaRRAQYPLLSLNIFAVRTFRVGIVANLFIRLSGSGIPFLMP-LMLQVVFNYGADAAGWLLAPIAVSSVLTKSFAGKVLSRFGYKTTLILTALSMTFAIATMSLLDQQSPIWLLVLigCSMSIIFTAVNTLTISDLNDHNASTGslSVIQQVGIGISIAVSSVILDLY------------------------------
     976 UniRef50_C6AZT7        Major facilitator superfami...   173     1e-41  1  11.0%  1:437  36:506     MALSPPKAYGLRQSIAASRLPVPRLTPM-ILAVALFMEQMDSTVIATSLPAIAADIGTSPIALKLAVTSYLVALAIFIPISGWMSDRFGARNIFRMAIFVFMIGSIAC---AFSNSITAFVISRLIQGAGGSMMTPVSRLLLVRGTPRHELVDAMAWLTIPALIGPIMGPPIGGFLTTYLTWHWIFWINVPIGVLGIILVTRFLPAVEPRSPRPMDFPGFFLCGIGFSGFVFGVSVISLPaaRRAPYPLLDPKMFRYPMFRAAILGASNFRMGLGALPFLMP-LMLQLGFGLTPLQSGSVTFVSALGSMGSKFAASRTFNAFGFRTVISLTTLLAAIFllFTAETPLFLIMACLLIGGLFRSMAFSGVNAMAFGDVDDasQATAINAVAQRISMAMGVAIAGGILEISSsfHIAFFSVSAISALACITFLRLPHDAG-
     977 UniRef50_C0QKD8        Multidrug resistance protei...   173     1e-41  1  11.8% 22:410   6:421     ---------------------KNKWLIFACVALGVFMSTLDSSIVNIALPYIMQDMGTGVETIQWVVVGYLLTISSLLLTFGRLSDIRGKRMVYTGGFLIFTAGSGLC---AMAQTPLFLIISRVVQACGAAMLMACSPALIVDTFPVRERGKALGMVGAVVAAGLTAGPVAGGILLDLFSWRFIFYINIPIGIGAALAGSLILkePMDKTGSLLQAVSLVCLIVVLTHLNQwaSLGFVWNETQTLYPLFDPALLKIRLFVLPVITSAILFGTLFVIVFMMPFFLV-HPCGLSASATGLIMITPFILLFFISPVSGALYNRTGSRGPCSLGMTILALALFAFARIEPSSGMTalALAGTGTALFVSPNNTAAMGAVPANRRGIASAttARNLGMVIGVATAGLIFTGTFT----------------------------
     978 UniRef50_D2EJP8        Major facilitator superfami...   173     1e-41  1  10.4% 17:400   6:415     ----------------TSAFKNKKTLILIALGIFTFMSTLDGSIVNIAMPIMSKEMNISLSRIEWVVSIYLIVISALLMFFGRLGDVIGKSKVFRIGTAIFILGSLL---AGINLGLAFLLFARAVQAIGAAMTMSNSFGITTSTFPIEQRGRAMGVIGTFVALGAVAGPAIGGLILNYLTWNYIFWINVPIGIIAVLIGVKSLPHDQPLAANAPIDWTGAilILGALLIAIISFILFIHTENHRRHPLLDLSIFQYADFTLGLIAALLVFINGFFYNVLMPYYLVNAR-GLSSGVAGTLLSIIPLTMVIFGPVGGFLSDKFGGAKITVIGVTLLLISQFLImqTPYWFFIFASIVTGMGTGLFQSPNNASVMSAVPHNRLGIAGSVnaRNLGMILGVTI--------------------------------------
     979 UniRef50_A7I4C0        Major facilitator superfami...   173     2e-41  1  12.6% 23:412   4:415     ----------------------KQKIIIAILMLGTLMGSLDSTIVILAFPTISDSLHAEFVTTLWIILIYLLVVAICTTQLGRIGDIYGRSRMFNAGFGIFTVGSLFCGLS---PGISWLIASRGVQAVGGALMQANSGAIVADTFPPNVRGTAFGYISLGWTSGAMLGIVLGGIITTFVGWEYIFFVNIPIGIIATILGFRYLTDNSRVHAELDLVGMLLLGAALTFISYAGVDFATEGteRRTSHPIIDFSALRNRILRYSIMATFFLSLGYLSVVFLITMYL-QGIRALSPLDAALLLTPGYVVGSLLSPRMGRLSDKYGARVLATAGTAVLIVATLIYLvtPLWEVLVASGVSGLGTAMFFPSNNSAVMANAPQGsgGISGILRTMQNIGILGSFVIAITVSAASIPR--------------------------
     980 UniRef50_Q08VR8        Drug resistance transporter...   173     2e-41  1   9.2% 27:408  13:421     --------------------------ITIAAMAAALMSVLDISIVNVALNDIRASFGTPLDQIAWVSTGYMMANVVVIPMTGWLQRRFGFRRYFTFSILMFTAASVLCGLA---WNLPSLVAFRVLQGIGGGAIIPTSQAILFARYPREEHGMAGALFGLGAVTGPLLGPTVGGLLIDASSWHWIFLINVPIGLFAAFMAWrfEPSTERVDRYGIALLAVGMAAlaLAVIAGVALITFIVHELETPSPVVDLRVFANRSYAAATGINLMVGTSLFS-GTFLFSLFLGSVAHYSALDIGLLFLKGSVVQILLMPLVGRFGSKIDGRVLVALGIVGVSMSLwlATSADEAALITPIFIRSCSLGLVFVPLSVIALSDLKPEQRGNAAGllTRELGGSIGTAWMSSSLSRT------------------------------
     981 UniRef50_B2HHW0        Multidrug resistance integr...   172     2e-41  1  12.7% 25:418  44:466     ------------------------LMTTATCLMLPVMVTLDTTVVNVAQRTFIEEFSSTQAVVAWTSTGYTLSLASVIPLTGWAANRLGTKRLVMGSVLLFTLGSLLC---AMASSITLLVAFRAAQGLGGGILIPLQLIILARAAGPARLGRVLTISMISVLMAPIAGPILGGWLIDAFGWQWIFLINLPIGALTLILAGLVLPGDDSLPAESLDLVGMALLSPALVLLLYGLSALPAraLHRGDHALIDLRLLKNRAVAAANATRFMFAVTFFGSCLLFPAYFQQ-VLGKTPLQSGLLLIPQTLAAAAVMPIVGRLMEKRGPRDVVLMGTALTVVGMGIFIyvHLPALLIGLGTFGVGTAAMMVPvsAVHMLNSSEVAHGSTLFNVNHNVAASVGAALMSVVLTSRFNGSADIAAA--------------------
     982 UniRef50_B9JTC6        MFS permease n=14 Tax=Rhizo...   172     2e-41  1  11.6%  2:415   8:447     -PAAAPKTVAPPPFQSLVPDPRLRMMLFLFLMTALFMATLDNQIVSTALPTIVGEFG-QLERFGWVGSAYLLATSAVMPLYGKLGDLFGRKYVMMTAIAIFTVGSLICG---SAVSMNTLIAARVLQGLGGGGIMVSIFSVNADLFEPRVRARYQSYSSLVLMASGAVGPTLGGTMSDLFGWRSIFLVNLPIGILVLVGLGLYLPYRKPHRRPKIDYAGALLLACAVTSVVFWADSgfVQVEKRAAEPMVPISLMRNSTARLLWIISLASGAVGIGSVNYVALYL-QTTTGLSPTLAGLLFIAVTGGIAIGSLSSGRLISSTGRYKIfiIGGAGSCIAFILFSQLPVGTPIAVIGVLMLMHGISVGIGQQIPVIGVQNagAATGTVTLTRMGGASIAISIYGAVLSAFMTGGAAI-----------------------
     983 UniRef50_A4YF61        Major facilitator superfami...   172     2e-41  1  13.8% 23:420   2:423     ----------------------NRTVILLVLVLGTLMAAVDGTIVLLALPQIAQDLHADLFTAIWVLLAYLLVTAILTTQTGRIGDIYGRAKIFNLGFVIFTVASALCGLS---NSIYLLIAFRLIQGVGGAMMTANSGAIVADHFPPNMMGRAYGYTSLGWNIGALLGIVLGGTLTTFFGWPYIFYINVPIGVVATILGVKYIKdlVSYSSIVMASVGVDSLNLGILVVGIILVGAFIFNESRAKSPVIDLKMFRYRLLGYSLTATFLQAIGGLAITFLLIMYL-QGVRGLSPLDASLLLLPGYVVASFLAPYMGKLTDRYGSRWFATGGIAIIMLSVIMFYftPYTWILLISGINGVGSGMFWPSNTSAIMSSAPKGYFGSVSGltLGNVGIILSYVITLSVAAAAIPKEVAFKIFLG------------------
     984 UniRef50_D1A772        Major facilitator superfami...   172     3e-41  1  11.0% 20:436   2:458     -------------------TRGRYRWALAVVAVSAFMITIDNSVVTIAQETIRRDLGLTYSALRWVTVGYILMFSCLMIAGGRLTDLYGCRVTFVVGMSIFTAASAVSGLA---DTGAVLIGARVVQGAGAALALPATLVMITVGRSDRQRALGQVVWLGSLSLAMAGGPSIGGFIVEHWHWGWIFLINVPVGLAVIALGLLVLVGRDNEQGTLLDLPGVILSATTLFALVYAFHAgfVLVESWAPDPMIDLEFFRNRAFTGGIATSMLWGIGFNGVM-YFSALFMQTVLGFTPTTAALAYVPSAVLVLAMTPVSFILAAKVGSRLTISVGMVLMAVGMAAFTAlgFPELMPGIALVSVGSALTLPLAM-YVLKTVPDERAGVAGgnVVRELSAGVGIAVLGLVVDTlqGAAVGLLVGAALVVLGALISAFTLPTK--
     985 UniRef50_Q03HT6        Permease of the major facil...   172     3e-41  1  10.6% 23:400  12:415     ----------------------NKTLILIALGMFTFMSTLDGSIVNIAMPIMSKELSVTASQIEWVVSIYLIIISSLLMFFGRLGDVVGKTRIFKIGTAIFIIGSLI---AGINLGLPFLLFARGVQAVGAAMTMSNSFGITTSSFPINQRGRAMGFIGTFVALGSVAGPAVGGLILNYLPWNYIFWINVPIGIIAILLGLKSLPKDVpaILRGQAIGYTHPIILGALLIAVVSIILFIRTEKQLKHPLLDFSIFKYSDFTFGLIAALLVFINGFFYNVLMPYYLVNAR-GLSSGLSGILLSIIPLTMVIFGPIGGVLADKFNSTKITIIGVTLVLLAQFLIMgtPFWYFIFTSIVTGIGIGMFQSPNNASVMSAVPSNRLGIAGSVnaRNLGMILGVSI--------------------------------------
     986 UniRef50_UPI0001788B1A drug resistance transporter...   172     3e-41  1   9.5% 21:418   6:428     --------------------KSSFWLIMSAVFFGNFLAVLSITTINVAFPVVMEQFHATLSTTQWLMAGYLLATGIVAPIVGYMGDQLSYKRLFVLALTGFTLSSLLCVVA---WNIETLIAFRITQGVFGGMIIPITMTIIYQVFPRERQAYAMGLWSLASMLAPVIGPTLGGWLVQYFGWKSIFILNVPIGLISIVIVSKFIPFYRLTGKKTFDLLGFLTVVAGSSCLLLSFSHGNDWgeLRISSPLLQLKVFKFPRFRYSLILNCIVTISLYTGTLLVPLYL-QTVLKLSPMDTGLIMLPGAIVMAAASPIIGKFYDRIGPFRLVITGVLIIVAATLAFSGIGTNTSVLYISMLqlGIALCNMPLTNAAMSAVSSEYSGHASSItaRQGLASLSIGIFSALVVTRTSYYMGAGTV--------------------
     987 UniRef50_B6YZ23        Transmembrane efflux protei...   171     4e-41  1  12.2% 22:407   2:412     ---------------------ARKHLVLLNMIGALALVMIDQTVLGVILPSLQRTFMFGPVHLQWSVNAYLIALASMLMCGGWLGDKFGYFTSLRMGVALFTAASLAC---AYAPTGEFFITARVFQGAGAALMQPAATALVFSAYPADERGKALAHYVGAGLFFLACGPLVGGLLVEFFSWRVVFLLNVPIGLAVLIMAFAIGKSKTNKETGSFDFQGAILFVMALLVFTVAVQLFGdvRRHRVAHPFIQFSLFENKVYLGCCLLLFCIPFALLAQVVFGAVFL-QNVLSLTPLEAGLSMLPVVLTIIICAQFGGRLVGNIKFRNLAVCGSLAMGIGflVIHFNNLWLLFPGMILMGAGLGFLISTVSTEALSHVsaRARATALLQTCRQVGGVFGIACVGALINW-------------------------------
     988 UniRef50_A4YF77        Major facilitator superfami...   171     4e-41  1  13.6% 20:408   1:415     -------------------MDRKARETLIILISVSLLINYVETMVVPAVPKIQQDFATTETLVAWVTSAFTIVGAVVSPVFGKLGDLYGKRRVYLLSMVFY---TFAVVMAGFSPNIYFLIAARAIQGLGFA-MFPLSLAIITDILPPEMIATAQGIISGTMGIGTALGLVVGAFIDQDLGWQYAFHIAFVISLILLFAAVKLVPETGVRKKAMIDYVGFGTLTAGVTLILIYLTQESSWgeQRVKNPVIELRLLKIRNVMVANIAG-LISGIMILALFYGIIYYTQlgLGLDIISAGLTLAPSTLVMFVVGPILGRMINRVGPKPIIAVGSLVMMLGFYLLIVNRATPLDVTmvVGMLGLLCLMIPIVNMISVSLPPEDRGVGIGMniRNIGSAVGPVITTSIMSSY------------------------------
     989 UniRef50_A5VC62        Drug resistance transporter...   171     6e-41  1  11.5% 26:407   2:408     -------------------------IVTTAIMAATILVVLDQTIATVALPHMQAALGATPDTVTWVLTSYIMATAVGTPLTAWLTGRFGRRQVFLVCVLGFTISSMLCGAA---TSLPMMVACRLAQGFFGAFLMPMSQAFLYDMNPPSLQVRAITMWGIGAMVGPIVGPVLGGYLTDAFDWRWVFFVNVPVGIVALAGVFFGLPEFPSARRSFDHVGFIMIAVALCSLQLALDRGTQQdhLRRSRHPIISPGLFANPSFSGAMVLAFVLMPTIIASNALLPQLFVQ-LLGYPVATAGEMMLPRGIAMTIGIFLGGQFTRWMDGRLQVALGVCIVIASLYVQTgmDQHLIIWAGVLQGFGTGLSMTVLNFTAMSSAphRTEAAALYSLSRNTGSSIMLAIFSGLLAH-------------------------------
     990 UniRef50_A8HR21        Drug resistance translocase...   171     6e-41  1  12.4%  4:429  15:469     ---SPEAPPASHARKGGPRRQPGYRAVALIVASAMFMEQLDATVLATALPAMARDFGVTAPHMSIALTSYLLSLAVFIPASGWAADRFGSRTVFRLAIAVFTIGSLLC---AQSQSLAFLVFARLLQGMGGAMMIPVGRLVLLRSTTKADLVSAMSWLLVPAMIGPMVGPPLGGFLVTFLDWRWIFYINLPIGVLGLVLVSIFIADSRAEKPDRFDGLGLVLSGASLGGLLFAFELSSRGesAAGGHPILDLSLMNIETFRLSVIAGNITRITQ-GAQPFLIPLMLQLGFGMTAAEAGMISLSTAVGSLLMKGVAPKVLRRYGFRNTLLVNGIICTGTYAVCALmpHWSIYVLLTAAGFFMSLQFTAYNTVAYDEVPAAraAASFYSTFQQLMLSMGICVAGFALATSMAANGRSVAGLADFSVAFVTV---------
     991 UniRef50_B9J8W5        Efflux-type transporter n=5...   170     6e-41  1  10.8% 13:438   7:467     ------------QAAPTRRAAPNFRVVALIVASAMFMEQLDATVLATALPTMARDFGVSAPAMSIALTSYLLSLAIFIPASGAIADRFGSRTVFRTAIAIFVVGSILC---AQAPNLFLLVIARLIQGLGGAMMLPVGRLVLMRSVARKDMVNAMSWLLIPALVGPILGPPVGGLFVTYLDWRWIFYINVPIGIIGFILVSMFIEEVKGPRNGRFDLSGFIlmAIFLIAIGLLFGIAYLRHARKHPSPIMDFSLMKVPTFRTSVIAGSLTRISQGAHPFLIP-LMLQLGFGMSAAAAGQIAIATALGSMAMKPLQVTILRTLGFRTALLIFGVIGTLGYGLCSIfpLPVIFAILFFCGFFMSFQFTAYNTIAYDEIERDqsATSFYSTFQQLMLSLGICIAALALHGssDFSVAFIVVTAIALLAGIWNAQFSRTAGS
     992 UniRef50_P76269        Uncharacterized transporter...   170     7e-41  1  11.4% 22:434  12:449     ---------------------PQRYGAILTIVIGISMAVLDGAIANVALPTIATDLHATPASSIWVVNAYQIAIVISLLSFSFLGDMFGYRRIYKCGLVVFLLSSL---FCALSDSLQMLTLARVIQGFGGAALMSVNTALIRLIYPQRFLGRGMGINSFIVAVSSAAGPTIAAAILSIASWKWLFLINVPLGIIALLLAMRFLPPnlITALSGFAQGQSLTLIAAELVVMVVVGIFFIRRQLSLPVPLLPVDLLRIPLFSLSICTSVCSFCAQMLAMVSLPFYL-QTVLGRSEVETGLLLTPWPLATMVMAPLAGYLIERVHAGLLGALGLFIMAAGLFSLVLLPASPaiWPMILCGAGFGLFQSPNNHTIITSAPRERSGGASGmtARLLGQSSGAALVALMLNQFGDNGTHVSLMAAAILAVIAACVSGLR----
     993 UniRef50_B2JRB9        Major facilitator superfami...   170     8e-41  1  12.0% 29:435  39:477     ----------------------------VIVACAMFMESVDANVIVTALPEMARAFGRDPVTLKIAVTSYVLGLGVFIPVCGWLADRFGARSVFRTAIGIFVVGSLLC---AASTSLATFTVARFIQGVGGAMMVPVGRIIIFRVVERSDYVRAMNYLSVPAMLGPAAGPLLGGFITTYLHWRLIFFINIPVGILGIWLTNKYIKNTREPHPGPLDWAGFILSAGGASLFLLGLSLTDGElaRRVERPLLDLRFFRVPTFQASVLGGSLFRIGLGAVPFLLP-LVLQEGLGMSAFKSGLITCASAFGGMFMRTLAATVLRRWGFRTVlaFSGIAIAACGAFFPGTPTWLIWVIVLLGGFFPALQFTSLNSMTYAEIESrgRATSLGSVVQQISLGLGVTVAGIVLshGALQWSDFWPAFVVVGLCSVASISVTRR---
     994 UniRef50_C6BU56        Major facilitator superfami...   170     8e-41  1  12.6% 27:408   9:412     --------------------------VIFTVAVTQFTMPFMFSAVGITLPVMGREFGASGLDLSLVESVYIGSVAALLLPFGRLADMHGRQPMFRLGVLLFAIFTLLIGFA---QNIETVICLRMIQGMVGGMGIATNMALLTNSVPKDERGKAMGLAVAAVYVGLSAGPYVGGLVTSHMGWRWIYYLSMIPLGISYYVAHrvVALSVAAIVFGGTSLGAGWFGPAALISGLLGVALFVYMQNRSESPLVELTLFKERrfSDAALVQFINYAGTFGIVFLFSLYM-QSVKGFSPHDAGLVLVIQPIVQAVLSPLCGRLADKFSPRVLALLGMLACTAGTIMGAMVTADTSLpmFVVLGIGFALFSSPNMIILMSSVPPSRYGFASAigLRTIGMVFSMVIIAIFLSTV------------------------------
     995 UniRef50_A1C187        Transmembrane efflux protei...   170     8e-41  1  11.2%  2:413   3:440     -SNSASAQTGAPSSVPTARLAGRTGIALTIIVVCQLMIVLDMMIVQIALPDMKSSLGLSTASMSWVINAYTLAFGGLLLLGGRAGDILGRRRVFLIGVAVFTLASFAGGLATED---WQLLAARAVQGAGGAMAAPNTLALIMSIFEEgkRARAIAMYSVVGGSGAAIGLILGGVLTDVASWRWVMFVNVPIGVAVFLLTPLFISETEKHSGRFDLAGALttSTLVAFALAVVLLPSFVAIERTARQPVVSLKLFLDRTRASSYIAMLLIQGSMIGMLFFLSQFVQQ-IFDYSPLTAGLCFLPVAAVLVPVAGMVTKLVAQVGSKVLVIAGAVLLTGANWWLSRLDEGSSYWamLIFGVGMALATIPPTMLALSGVAPEESGSAslNALQQVGGSLGLAVLVTVFTEGGHRAA-------------------------
     996 UniRef50_B2KBE9        Major facilitator superfami...   170     9e-41  1  12.8% 17:413   8:429     ----------------AGRLRGSKKVIAWLVAVAFFMQMLDGTILNTALPEIAKSFGENPLRMQSVVISYMLTVAFILPISGWLADFLGTKRVFISAIFIFSLGSLCC---ALSNTLTQLVLSRVLQGVGGALMVPVGRLAVMRIFPKKELVSALSFITIPALVGPIVGPFAGGVIVQYVSWHWIFLINLPIGVVCAVFTYIAMPKVTPVKFKFDWIGYLLFSAAVILISLSLGSVDEATLGRRAAVLMFlpRLFYERSFTVGIIANLFIRFAGGSLPFLAPLFL-QTALNYSPLKAGVAMLPLGVMSIAAKTFVEPVLNKLGYRRLMTYNAIIIGIMLCFLAFIGPNTslVYLGVLGIFNSMQFTSLNTLTLIAVPPrsQANSLLSAVMQISMGLGVSLVSAALAYFGAHTA-------------------------
     997 UniRef50_B1VE81        Putative permease of the ma...   170     9e-41  1  14.4% 22:410   8:422     ---------------------PRRWFLLATVGMGVFLVCLDNTVLYTALPTIVAELDATAPQMLWIINAYPIVICGLLLGTGTLGDKVGHRRLFIIGLIIFGLASLL---GGYSTNVATLITARGLLAIGAATMMPATLALIRHTfePAEMNLAIGIWSALATLAAAFGPVVGGLLLEYFRWGSVFLMNVPIVLAALIALPFVSKRDEPNPHQAWDFRSVLQAMLLLVsvSVTFGFRFAKRQGRLQEPLLDFAIFRSPPFLSGVFGAGLAMFAVAGF-DFLTTQRLQLIDGFSPLHAGVYVTIVAVGSLISSLIASRLFTVHGARPFIAGGMAVGAFGALIVAFgsNAVILTGLAILGIGLGAAMAVSSIAMIGGAPPNRAGMASSivSYELGALMSVAILGSAITLVYS----------------------------
     998 UniRef50_B8GHK7        Drug resistance transporter...   170     1e-40  1  12.0%  8:407   4:429     -------TRDSNQPDLPPLGYNTRHIILAIVLVGLFMCVLDVQIVAIALPTLMQSLGAGIGEVQWIATGYVIVVLATVLLFGSLSHSLGNGRLFKAGLLLFTLSSLGCGLS---QSIPELILFRILQAVGASMLMGVSVAIIIQVFPPGEQGRAMGYYTAVIALGLIVGPSAGGFIVDLLSWPFIFLVNVPIGLVLLVCTLRYLTVDRDPPAvlSNPPIRLDFFGIWSGIFLLLLIAFVARERSVDNPILPITIFCKRSFLLPTISLILYIMAVFLLLTIQPFYF-EYVMGLRPSHIGLIALILPLSMLFASPVFGWLYDRYRSSRYPFIGIVIVggCGAAFSCMDFGLIIALFIIGGISRSIYQGPNSIEIMTALPPAQQGIGslTALQYLGILLGISFATFLMTA-------------------------------
     999 UniRef50_Q5ZVI6        Multidrug efflux protein n=...   170     1e-40  1  10.4% 26:438   5:454     -------------------------IIMFIVSCAMFMEAIDTTIINTAIPVMAHSLEVNPIDLKLALISYLLSLAIFIPISGWIADKYGVKKVFIAAIGVFTLSSLWCGFT---QSLWELVLARIIQGVGGSLTVPVGRLIILRTCERHELITKMSIVVMIASLGMLLGPLLGGIITDYFSWRWIFWVNIPVGIIAMLLSHKLLPTILPRSVPPLDKSGFIMFGAGLAFLTLGLSLFSETKarSKRNPIIKVTLLNIRTFRIAVFGNLLTRLSFGGIPFLLPLLF-QIILEYSPQLSGMLLTPVALGVFLVKPLSFSILRRLGYKKLLLLNTVLVCFSLWSFATINQSTSVIYifLYGFFIALQYTGMNSLAYANIDDNDmaTSIMSTVQQLSQSFGVAISALLVSLFTffHLTFFALGILTILSGLIFTSLKKEDGK
    1000 UniRef50_B2TEE0        Major facilitator superfami...   170     1e-40  1  10.3%  8:405  37:462     -------ASDKTPQSATFLSLRKNTLALGAVCLASLMFGLEISSVPVILPTLERVLHGDFKGMQWIMNAYTLAVTTVLMATGTLADRFGRRRIFVVGIALFGITSLICGLA---QSVPTLIVARLLQGASGGAMLICQVAVLSHQfeGPERARAFSAWGIIFGIGLGFGPIIGGAIVALSSWQWVFWVHALLAVVTLMLVFSGVQESRDPHAHTLDVAGIVTLSLAVFGLVYFITqaFLFAERLNTRPMFDFSVFRIPQFSGALMGSAGMNFSFWPFMIYLPIYF-QIGLGYDSVSAGLALLAYTLPTLLFPPLGERLALRYGSGIAIPAGLFTIGLGFMLmaHADLWTLLPGCMIAGAGLGLTNTPVTNTTTAAVPAERAGMASgmSARMITLAINIALMGAIL---------------------------------
         consensus/100%                                                                                     ...................................................h...h.......................................................................u...s..................................................................................................................................................................................................................................................................................................................
         consensus/90%                                                                                       .........................hh.hhhhh.hh..hs...hshsh..h.ttht.s...hthh.s.h.hs.hhh....shh.phhG.+.hhhh.hhha.h.shh........s...hhhhRhh.Ghs.u.h.s....hh..hhs.tthshh.shh..h..hu.hhu..hsshhh..hsWp.hahh.h..shhhhhhhhhhh............................................h..hthht...h.h..hh.hh..hh.h.h..hhs.h..p.....s....shh.h...hh.hhh..h.s.h.thht.h.hhhh.hhh.hh.hhhh........h..hhh.hhh..h.......h..t.h..t..u.u....ht.hu..hs..hhs.h.................................
         consensus/80%                                                                                         .....................hhhh.hhhhshhhshhDtshlshuhsth.tphths.sththhhshahlshshh....uhhh-hhGt+hhhhhshhhashhohh........s...hhhhRhl.Ghutuhhhs.s.hhl.thhs.ppRuhhhuhh.hsh.hushhus.luuhlht.hsWphhFhlth.hulhhhhhhhhhh.p.........t....hh...................t.t..t.h..hthht...hhhh.hh.hhh.hshhsh.hhhs.hh.p.h.shs.htsuhhhh...hhhhhs..hsuhh.s+hs.phhhhhshhhhshhhhhhhhhs..hhhhhhhhhshshthh.ssh.shs.t.hs.t.huhu.h.hhtphushhu.hhhshhht.............................
         consensus/70%                                                                                           ..................hhhhhhhlhhshhhshlDtshlshAhPtltpphshs.sththlhssahlshshhhh.sGhluDhhGt+phhhhuhhhaslsohhh..s....sh..LhhhRhl.GlutuhhhPsshshlsphas.pcRupshuhhssshslushlGshluGhlhphhuWchlFhlshshullhhhhhhhhl.p..tttthh.s..thhh.hh.hh.h.hhh..h..htttpttpshh.hplhpptthhhhhhhhhhhhhshhuhhhhhP.hh.p.hhshsshpsGhhhh..hlshhlss.hsGhhhs+hs.+hhhhhuhhhhshshhhhhhhs.hhhhhhhhlhuhuhshhhsshhshs.shhstpttusu.h.hhtplGuhlusslhuhlhs...........................

MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown